*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 4 1d1q_c00 TYROSINE PHOSPHATASE (E.C.3.1.3.48) user 1 4 # 1 A 13 ALA A 36 ALA.? 14.13 O1 EDO A 124 A 19 ARG A 33 ARG.? 17.39 O2 EDO A 124 A 20 SER A 34 SER.? 10.92 O1 EDO A 124 A 132 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 4.53 4.32 26.47 3.96 3.36 27.51 -18.11 -33.66 -20.67 -17.40 -34.10 -19.41 coo 2.60 -1.55 27.54 1.76 0.32 25.25 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 6.18 2.66 31.27 5.30 4.91 30.67 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo -1.40 -1.52 24.89 -2.64 -0.24 26.07 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 4 1d1q_c00 TYROSINE PHOSPHATASE (E.C.3.1.3.48) user 2 4 # 2 A 13 ALA B 36 ALA.? 11.83 C1 EDO A 124 A 19 ARG B 33 ARG.? 19.94 O1 EDO A 124 A 20 SER B 34 SER.? 9.94 O1 EDO A 124 A 132 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 4.53 4.32 26.47 3.96 3.36 27.51 -37.66 -22.00 -23.01 -38.34 -21.47 -24.23 coo 2.60 -1.55 27.54 1.76 0.32 25.25 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 6.18 2.66 31.27 5.30 4.91 30.67 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 coo -1.40 -1.52 24.89 -2.64 -0.24 26.07 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1d1q_c00 source 1d1q TYROSINE PHOSPHATASE (E.C.3.1.3.48) : 2 hits 1d1q_c00 naa= 4 ULMN 4 1d1q_c01 TYROSINE PHOSPHATASE (E.C.3.1.3.48) user 1 4 # 1 B 13 ALA A 36 ALA.? 14.13 O1 EDO A 124 B 19 ARG A 33 ARG.? 17.39 O2 EDO A 124 B 20 SER A 34 SER.? 10.92 O1 EDO A 124 B 132 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 38.65 2.95 14.51 39.11 4.15 13.64 -18.11 -33.66 -20.67 -17.40 -34.10 -19.41 coo 42.92 5.91 10.91 43.29 4.74 13.73 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 36.38 5.51 10.33 35.80 5.67 12.73 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo 45.55 7.51 14.40 44.23 8.91 15.26 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 4 1d1q_c01 TYROSINE PHOSPHATASE (E.C.3.1.3.48) user 2 4 # 2 B 13 ALA B 36 ALA.? 11.83 C1 EDO A 124 B 19 ARG B 33 ARG.? 19.94 O1 EDO A 124 B 20 SER B 34 SER.? 9.94 O1 EDO A 124 B 132 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 38.65 2.95 14.51 39.11 4.15 13.64 -37.66 -22.00 -23.01 -38.34 -21.47 -24.23 coo 42.92 5.91 10.91 43.29 4.74 13.73 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 36.38 5.51 10.33 35.80 5.67 12.73 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 coo 45.55 7.51 14.40 44.23 8.91 15.26 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1d1q_c01 source 1d1q TYROSINE PHOSPHATASE (E.C.3.1.3.48) : 2 hits 1d1q_c01 naa= 4 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 4 # 1 166 LYS A 28 LYS^? 7.39 O2 EDO A 124 270 ASP A 86 ASP^? 9.05 O1 EDO A 125 297 HIS A 79 HIS^? 12.23 O1 EDO A 125 317 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 27.27 1.43 25.09 29.18 5.25 22.89 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 29.40 9.25 9.79 31.51 9.14 10.05 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 29.05 8.65 14.00 30.25 7.04 14.30 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 29.25 11.66 19.43 29.42 9.79 18.51 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 4 # 2 166 LYS B 28 LYS^? -17.65 O1 EDO A 124s 270 ASP B 86 ASP^? 26.97 C1 EDO A 124 297 HIS B 79 HIS^? 26.86 C1 EDO A 124 317 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 27.27 1.43 25.09 29.18 5.25 22.89 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 29.40 9.25 9.79 31.51 9.14 10.05 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 29.05 8.65 14.00 30.25 7.04 14.30 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 29.25 11.66 19.43 29.42 9.79 18.51 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1mdr_c00 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 2 hits 1mdr_c00 naa= 4 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 102 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 193 GLY B 75 GLY.? 21.06 O2 EDO A 125 coo 25.57 41.22 61.68 24.18 39.98 62.50 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 22.33 45.48 59.73 23.35 43.67 60.06 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 22.57 32.23 64.13 21.98 32.82 64.22 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 1a0j_c12 source 1a0j TRYPSIN : 1 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS B 79 HIS^? 26.86 C1 EDO A 124 C 102 ASP B 86 ASP^? 26.97 C1 EDO A 124 C 193 GLY B 75 GLY.? 21.06 O2 EDO A 125 coo 34.37 41.18 73.21 34.04 43.09 73.87 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 34.89 38.34 78.12 35.11 39.59 76.42 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 35.43 51.03 72.12 35.20 50.72 72.87 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 1a0j_c14 source 1a0j TRYPSIN : 1 hits 1a0j_c14 naa= 3 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 1 3 # 1 252 THR A 47 THR^? 4.31 C1 EDO A 124 350 PHE A 50 PHE^? 8.88 O1 EDO A 125 357 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo 17.85 20.47 14.62 16.85 19.84 12.80 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 7.92 21.96 13.27 8.57 20.30 15.42 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 8.82 20.77 7.90 10.59 19.75 9.80 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 2 3 # 2 252 THR B 47 THR^? 9.39 O1 EDO A 124 350 PHE B 50 PHE^? 13.90 C1 EDO A 124 357 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo 17.85 20.47 14.62 16.85 19.84 12.80 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 7.92 21.96 13.27 8.57 20.30 15.42 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 8.82 20.77 7.90 10.59 19.75 9.80 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 1akd_c01 source 1akd CYTOCHROME P450CAM : 2 hits 1akd_c01 naa= 3 ULMN 3 1am5_c04 PEPSIN user 1 3 # 1 32 ASP A 32 ASP^? 7.79 O1 EDO A 124 35 SER A 34 SER.? 10.92 O1 EDO A 124 215 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1am5_c04 PEPSIN user 2 3 # 2 32 ASP A 32 ASP^? 7.79 O1 EDO A 124 35 SER A 35 SER.? 8.67 O1 EDO A 124 215 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 1am5_c04 source 1am5 PEPSIN : 2 hits 1am5_c04 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 32 ASP^? 7.79 O1 EDO A 124 214 ASP B 86 ASP^? 26.97 C1 EDO A 124 289 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo -0.62 65.95 29.97 0.31 67.47 31.05 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 26.86 59.76 46.36 25.42 58.23 45.92 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 9.42 68.07 30.27 7.35 68.27 30.10 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP B 32 ASP^? 9.42 O1 EDO A 124 214 ASP A 86 ASP^? 9.05 O1 EDO A 125 289 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 26.86 59.76 46.36 25.42 58.23 45.92 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 9.42 68.07 30.27 7.35 68.27 30.10 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 2 hits 1amy_c01 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 32 ASP^? 7.79 O1 EDO A 124 227 GLU A 70 GLU^? 16.40 O1 EDO A 125 289 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -0.62 65.95 29.97 0.31 67.47 31.05 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 3.96 55.76 41.24 4.83 57.69 41.17 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 9.42 68.07 30.27 7.35 68.27 30.10 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 41 ASP^? -2.91 O2 EDO A 124s 227 GLU A 70 GLU^? 16.40 O1 EDO A 125 289 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo -0.62 65.95 29.97 0.31 67.47 31.05 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 3.96 55.76 41.24 4.83 57.69 41.17 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 9.42 68.07 30.27 7.35 68.27 30.10 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 63 ASP~? 17.25 O1 EDO A 124 227 GLU A 59 GLU.? 11.26 O1 EDO A 125 289 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo -0.62 65.95 29.97 0.31 67.47 31.05 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 3.96 55.76 41.24 4.83 57.69 41.17 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 9.42 68.07 30.27 7.35 68.27 30.10 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 63 ASP~? 17.25 O1 EDO A 124 227 GLU A 70 GLU^? 16.40 O1 EDO A 125 289 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo -0.62 65.95 29.97 0.31 67.47 31.05 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 3.96 55.76 41.24 4.83 57.69 41.17 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 9.42 68.07 30.27 7.35 68.27 30.10 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 32 ASP^? 9.42 O1 EDO A 124 227 GLU B 70 GLU^? 26.28 O1 EDO A 124 289 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 3.96 55.76 41.24 4.83 57.69 41.17 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 41 ASP^? 12.31 O1 EDO A 124 227 GLU B 70 GLU^? 26.28 O1 EDO A 124 289 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo -0.62 65.95 29.97 0.31 67.47 31.05 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 3.96 55.76 41.24 4.83 57.69 41.17 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP B 63 ASP~? 17.37 O1 EDO A 124 227 GLU B 59 GLU.? 24.69 C1 EDO A 124 289 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo -0.62 65.95 29.97 0.31 67.47 31.05 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 3.96 55.76 41.24 4.83 57.69 41.17 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP B 63 ASP~? 17.37 O1 EDO A 124 227 GLU B 70 GLU^? 26.28 O1 EDO A 124 289 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo -0.62 65.95 29.97 0.31 67.47 31.05 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 3.96 55.76 41.24 4.83 57.69 41.17 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 8 hits 1amy_c06 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 37 ARG^? 13.77 O1 EDO A 124 B 342 ASP A 63 ASP~? 17.25 O1 EDO A 124 B 531 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG B 30 ARG^? 10.56 O1 EDO A 124 B 342 ASP B 63 ASP~? 17.37 O1 EDO A 124 B 531 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 2 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 342 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 531 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG B 30 ARG^? 10.56 O1 EDO A 124 A 342 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 531 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 2 hits 1asy_c01 naa= 3 ULMN 3 1avf_c04 GASTRICSIN user 1 3 # 1 A 32 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 35 SER A 34 SER.? 10.92 O1 EDO A 124 A 217 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1avf_c04 GASTRICSIN user 2 3 # 2 A 32 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 35 SER A 35 SER.? 8.67 O1 EDO A 124 A 217 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1avf_c04 GASTRICSIN user 3 3 # 3 A 32 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 35 SER B 34 SER.? 9.94 O1 EDO A 124 A 217 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1avf_c04 source 1avf GASTRICSIN : 3 hits 1avf_c04 naa= 3 ULMN 3 1avf_c05 GASTRICSIN user 1 3 # 1 J 32 ASP A 32 ASP^? 7.79 O1 EDO A 124 J 35 SER A 34 SER.? 10.92 O1 EDO A 124 J 217 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1avf_c05 GASTRICSIN user 2 3 # 2 J 32 ASP A 32 ASP^? 7.79 O1 EDO A 124 J 35 SER A 35 SER.? 8.67 O1 EDO A 124 J 217 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 1avf_c05 source 1avf GASTRICSIN : 2 hits 1avf_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 50 PHE^? 8.88 O1 EDO A 125 A 159 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 188 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 13.91 34.58 14.67 12.95 36.00 12.47 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 20.97 28.40 16.26 20.19 30.15 15.34 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 22.55 41.65 15.60 18.92 37.20 14.63 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE B 50 PHE^? 13.90 C1 EDO A 124 A 159 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 188 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 13.91 34.58 14.67 12.95 36.00 12.47 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 20.97 28.40 16.26 20.19 30.15 15.34 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 22.55 41.65 15.60 18.92 37.20 14.63 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 2 hits 1b9h_c02 naa= 3 ULMN 3 1bbs_c06 RENIN user 1 3 # 1 32 ASP A 32 ASP^? 7.79 O1 EDO A 124 35 SER A 34 SER.? 10.92 O1 EDO A 124 215 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 61.19 45.85 78.73 62.86 45.48 77.48 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 66.00 46.17 80.29 64.31 47.92 79.91 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo 63.61 40.10 74.06 64.05 42.07 74.70 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1bbs_c06 RENIN user 2 3 # 2 32 ASP A 32 ASP^? 7.79 O1 EDO A 124 35 SER A 35 SER.? 8.67 O1 EDO A 124 215 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 61.19 45.85 78.73 62.86 45.48 77.48 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 66.00 46.17 80.29 64.31 47.92 79.91 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo 63.61 40.10 74.06 64.05 42.07 74.70 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 1bbs_c06 source 1bbs RENIN : 2 hits 1bbs_c06 naa= 3 ULMN 3 1bbs_c07 RENIN user 1 3 # 1 32 ASP A 32 ASP^? 7.79 O1 EDO A 124 35 SER A 34 SER.? 10.92 O1 EDO A 124 215 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 61.19 45.85 78.73 62.86 45.48 77.48 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 66.00 46.17 80.29 64.31 47.92 79.91 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo 63.61 40.10 74.06 64.05 42.07 74.70 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1bbs_c07 RENIN user 2 3 # 2 32 ASP A 32 ASP^? 7.79 O1 EDO A 124 35 SER A 35 SER.? 8.67 O1 EDO A 124 215 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 61.19 45.85 78.73 62.86 45.48 77.48 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 66.00 46.17 80.29 64.31 47.92 79.91 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo 63.61 40.10 74.06 64.05 42.07 74.70 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 1bbs_c07 source 1bbs RENIN : 2 hits 1bbs_c07 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 141 THR B 47 THR^? 9.39 O1 EDO A 124 A 235 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 6.21 93.81 36.58 4.58 96.33 37.17 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 6.80 92.87 28.33 4.91 92.74 27.40 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 12.98 90.36 47.57 11.26 89.62 46.62 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG B 37 ARG^? 8.36 C1 EDO A 124 A 141 THR A 47 THR^? 4.31 C1 EDO A 124 A 235 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 6.21 93.81 36.58 4.58 96.33 37.17 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 6.80 92.87 28.33 4.91 92.74 27.40 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 12.98 90.36 47.57 11.26 89.62 46.62 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 37 ARG^? 13.77 O1 EDO A 124 D 141 THR B 47 THR^? 9.39 O1 EDO A 124 D 235 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG B 37 ARG^? 8.36 C1 EDO A 124 D 141 THR A 47 THR^? 4.31 C1 EDO A 124 D 235 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 37 ARG^? 13.77 O1 EDO A 124 C 141 THR B 47 THR^? 9.39 O1 EDO A 124 C 235 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG B 37 ARG^? 8.36 C1 EDO A 124 C 141 THR A 47 THR^? 4.31 C1 EDO A 124 C 235 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 37 ARG^? 13.77 O1 EDO A 124 B 141 THR B 47 THR^? 9.39 O1 EDO A 124 B 235 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 8.13 67.41 100.27 7.18 68.35 97.45 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 8.28 67.78 108.81 6.22 67.65 109.43 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 14.55 73.52 89.47 12.81 73.95 90.56 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG B 37 ARG^? 8.36 C1 EDO A 124 B 141 THR A 47 THR^? 4.31 C1 EDO A 124 B 235 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 8.13 67.41 100.27 7.18 68.35 97.45 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 8.28 67.78 108.81 6.22 67.65 109.43 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 14.55 73.52 89.47 12.81 73.95 90.56 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_c03 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 84 ASP.? 13.20 O1 EDO A 125 16 HIS A 79 HIS^? 12.23 O1 EDO A 125 67 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP B 84 ASP.? 30.86 C1 EDO A 124 16 HIS B 79 HIS^? 26.86 C1 EDO A 124 67 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 1be1_c02 source 1be1 GLUTAMATE MUTASE : 2 hits 1be1_c02 naa= 3 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 A 757 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 759 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 810 SER A 88 SER^? -5.03 C1 EDO A 125s coo 30.11 61.02 29.12 29.36 59.77 27.63 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 30.94 56.62 25.28 29.94 54.94 26.14 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 25.05 62.74 29.97 26.88 61.45 29.19 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 3 # 2 A 757 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 759 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 810 SER B 88 SER^? 19.82 O2 EDO A 125 coo 30.11 61.02 29.12 29.36 59.77 27.63 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 30.94 56.62 25.28 29.94 54.94 26.14 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 25.05 62.74 29.97 26.88 61.45 29.19 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 1bmt_c04 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 2 hits 1bmt_c04 naa= 3 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 B 757 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 759 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 810 SER A 88 SER^? -5.03 C1 EDO A 125s coo -2.30 64.08 6.41 -0.36 64.72 6.26 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 1.96 66.39 3.07 2.10 68.48 3.58 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 3 # 2 B 757 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 759 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 810 SER B 88 SER^? 19.82 O2 EDO A 125 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 1.96 66.39 3.07 2.10 68.48 3.58 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 1bmt_c05 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 2 hits 1bmt_c05 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY A 77 GLY^? 7.89 O1 EDO A 125 48 HIS A 79 HIS^? 12.23 O1 EDO A 125 99 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 12.38 5.55 24.25 13.27 5.59 24.39 -28.29 -45.93 -31.97 -28.42 -45.22 -32.28 coo 18.80 12.68 24.53 17.69 13.54 26.08 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 17.07 18.51 26.62 16.67 17.07 28.09 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 2 3 # 2 30 GLY B 73 GLY.? 24.47 O2 EDO A 125 48 HIS B 79 HIS^? 26.86 C1 EDO A 124 99 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 12.38 5.55 24.25 13.27 5.59 24.39 -43.26 -39.74 -6.71 -42.70 -39.15 -6.19 coo 18.80 12.68 24.53 17.69 13.54 26.08 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 17.07 18.51 26.62 16.67 17.07 28.09 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 3 3 # 3 30 GLY B 75 GLY.? 21.06 O2 EDO A 125 48 HIS B 79 HIS^? 26.86 C1 EDO A 124 99 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 12.38 5.55 24.25 13.27 5.59 24.39 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 coo 18.80 12.68 24.53 17.69 13.54 26.08 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 17.07 18.51 26.62 16.67 17.07 28.09 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 3 hits 1bp2_c00 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 48 PHE^? 10.34 O2 EDO A 125 A 205 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 236 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 4.14 2.10 36.34 6.69 3.08 36.92 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE B 48 PHE^? 12.04 C1 EDO A 124 A 205 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 236 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 4.14 2.10 36.34 6.69 3.08 36.92 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 2 hits 1bs0_c01 naa= 3 ULMN 3 1bu7_c02 CYTOCHROME P450 user 1 3 # 1 A 268 THR A 47 THR^? 4.31 C1 EDO A 124 A 393 PHE A 50 PHE^? 8.88 O1 EDO A 125 A 400 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo 45.81 71.19 43.26 47.70 70.19 43.25 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 48.54 63.17 48.16 46.74 64.99 49.22 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 53.76 64.39 46.87 52.06 66.55 47.33 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 3 1bu7_c02 CYTOCHROME P450 user 2 3 # 2 A 268 THR B 47 THR^? 9.39 O1 EDO A 124 A 393 PHE B 50 PHE^? 13.90 C1 EDO A 124 A 400 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo 45.81 71.19 43.26 47.70 70.19 43.25 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 48.54 63.17 48.16 46.74 64.99 49.22 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 53.76 64.39 46.87 52.06 66.55 47.33 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 1bu7_c02 source 1bu7 CYTOCHROME P450 : 2 hits 1bu7_c02 naa= 3 ULMN 3 1bu7_c03 CYTOCHROME P450 user 1 3 # 1 B 268 THR A 47 THR^? 4.31 C1 EDO A 124 B 393 PHE A 50 PHE^? 8.88 O1 EDO A 125 B 400 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo 37.20 116.32 52.00 35.18 117.07 52.13 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 33.81 121.65 59.26 35.49 119.55 59.81 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 28.79 121.15 57.00 30.51 118.99 56.70 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 3 1bu7_c03 CYTOCHROME P450 user 2 3 # 2 B 268 THR B 47 THR^? 9.39 O1 EDO A 124 B 393 PHE B 50 PHE^? 13.90 C1 EDO A 124 B 400 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo 37.20 116.32 52.00 35.18 117.07 52.13 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 33.81 121.65 59.26 35.49 119.55 59.81 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 28.79 121.15 57.00 30.51 118.99 56.70 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 1bu7_c03 source 1bu7 CYTOCHROME P450 : 2 hits 1bu7_c03 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 16 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 67 GLY A 57 GLY.? 9.42 O1 EDO A 125 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -16.91 -49.31 -24.24 -17.01 -48.68 -23.74 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 2 3 # 2 A 14 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 16 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 67 GLY B 57 GLY.? 23.79 C1 EDO A 124 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -51.53 -29.44 -19.30 -51.09 -29.07 -19.90 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 2 hits 1cb7_c06 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP A 86 ASP^? 9.05 O1 EDO A 125 C 16 HIS A 79 HIS^? 12.23 O1 EDO A 125 C 67 GLY A 57 GLY.? 9.42 O1 EDO A 125 coo 10.04 44.27 88.44 9.47 42.32 89.03 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 6.38 39.80 88.71 6.88 38.89 86.87 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 17.63 42.50 89.25 18.11 42.29 88.64 -16.91 -49.31 -24.24 -17.01 -48.68 -23.74 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 2 3 # 2 C 14 ASP B 86 ASP^? 26.97 C1 EDO A 124 C 16 HIS B 79 HIS^? 26.86 C1 EDO A 124 C 67 GLY B 57 GLY.? 23.79 C1 EDO A 124 coo 10.04 44.27 88.44 9.47 42.32 89.03 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 6.38 39.80 88.71 6.88 38.89 86.87 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 17.63 42.50 89.25 18.11 42.29 88.64 -51.53 -29.44 -19.30 -51.09 -29.07 -19.90 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 2 hits 1cb7_c07 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 32 ASP^? 7.79 O1 EDO A 124 264 GLU A 59 GLU.? 11.26 O1 EDO A 125 328 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 45.62 80.42 43.69 45.65 82.01 45.07 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 59.69 92.71 39.85 58.53 92.03 41.47 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 45.39 90.72 40.63 45.07 89.14 41.90 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP B 32 ASP^? 9.42 O1 EDO A 124 264 GLU B 59 GLU.? 24.69 C1 EDO A 124 328 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 45.62 80.42 43.69 45.65 82.01 45.07 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 59.69 92.71 39.85 58.53 92.03 41.47 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 45.39 90.72 40.63 45.07 89.14 41.90 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 2 hits 1cdg_c00 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 60 GLY.? 16.17 O1 EDO A 125 A 228 SER A 62 SER~? 19.90 O1 EDO A 125 A 549 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -11.24 -44.68 -21.35 -11.80 -44.53 -21.88 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY A 60 GLY.? 16.17 O1 EDO A 125 A 228 SER A 62 SER~? 19.90 O1 EDO A 125 A 549 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -11.24 -44.68 -21.35 -11.80 -44.53 -21.88 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY A 91 GLY~? 3.77 O2 EDO A 125 A 228 SER A 88 SER^? -5.03 C1 EDO A 125s A 549 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -31.34 -48.06 -23.33 -31.38 -47.22 -23.45 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY B 60 GLY.? 23.13 C1 EDO A 124 A 228 SER B 62 SER~? 23.65 O1 EDO A 124 A 549 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -50.57 -21.34 -22.29 -50.23 -21.86 -21.81 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -46.80 -18.27 -18.25 -47.35 -17.46 -16.02 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 A 198 GLY B 60 GLY.? 23.13 C1 EDO A 124 A 228 SER B 62 SER~? 23.65 O1 EDO A 124 A 549 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -50.57 -21.34 -22.29 -50.23 -21.86 -21.81 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -46.80 -18.27 -18.25 -47.35 -17.46 -16.02 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 A 198 GLY B 91 GLY~? 18.21 O2 EDO A 125 A 228 SER B 88 SER^? 19.82 O2 EDO A 125 A 549 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -43.74 -41.04 -20.11 -43.00 -40.62 -20.02 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 6 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 60 GLY.? 16.17 O1 EDO A 125 B1228 SER A 62 SER~? 19.90 O1 EDO A 125 B1549 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 126.34 72.75 125.66 125.95 73.27 126.11 -11.24 -44.68 -21.35 -11.80 -44.53 -21.88 coo 131.65 74.68 129.41 130.31 72.73 128.82 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo 134.72 69.43 130.42 133.03 70.65 130.08 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 60 GLY.? 16.17 O1 EDO A 125 B1228 SER A 62 SER~? 19.90 O1 EDO A 125 B1549 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 126.34 72.75 125.66 125.95 73.27 126.11 -11.24 -44.68 -21.35 -11.80 -44.53 -21.88 coo 131.65 74.68 129.41 130.31 72.73 128.82 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo 134.72 69.43 130.42 133.03 70.65 130.08 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY A 91 GLY~? 3.77 O2 EDO A 125 B1228 SER A 88 SER^? -5.03 C1 EDO A 125s B1549 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 126.34 72.75 125.66 125.95 73.27 126.11 -31.34 -48.06 -23.33 -31.38 -47.22 -23.45 coo 131.65 74.68 129.41 130.31 72.73 128.82 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 coo 134.72 69.43 130.42 133.03 70.65 130.08 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 B1198 GLY B 60 GLY.? 23.13 C1 EDO A 124 B1228 SER B 62 SER~? 23.65 O1 EDO A 124 B1549 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 126.34 72.75 125.66 125.95 73.27 126.11 -50.57 -21.34 -22.29 -50.23 -21.86 -21.81 coo 131.65 74.68 129.41 130.31 72.73 128.82 -46.80 -18.27 -18.25 -47.35 -17.46 -16.02 coo 134.72 69.43 130.42 133.03 70.65 130.08 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 B1198 GLY B 60 GLY.? 23.13 C1 EDO A 124 B1228 SER B 62 SER~? 23.65 O1 EDO A 124 B1549 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 126.34 72.75 125.66 125.95 73.27 126.11 -50.57 -21.34 -22.29 -50.23 -21.86 -21.81 coo 131.65 74.68 129.41 130.31 72.73 128.82 -46.80 -18.27 -18.25 -47.35 -17.46 -16.02 coo 134.72 69.43 130.42 133.03 70.65 130.08 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 B1198 GLY B 91 GLY~? 18.21 O2 EDO A 125 B1228 SER B 88 SER^? 19.82 O2 EDO A 125 B1549 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 126.34 72.75 125.66 125.95 73.27 126.11 -43.74 -41.04 -20.11 -43.00 -40.62 -20.02 coo 131.65 74.68 129.41 130.31 72.73 128.82 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 coo 134.72 69.43 130.42 133.03 70.65 130.08 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 6 hits 1cjy_c01 naa= 3 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 3 # 1 34 ASP A 32 ASP^? 7.79 O1 EDO A 124 37 SER A 34 SER.? 10.92 O1 EDO A 124 216 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 16.90 26.20 29.49 16.22 24.50 28.41 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 12.23 24.31 30.40 14.55 23.96 31.03 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo 13.93 25.52 22.10 14.75 24.44 23.75 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 2 3 # 2 34 ASP A 32 ASP^? 7.79 O1 EDO A 124 37 SER A 35 SER.? 8.67 O1 EDO A 124 216 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 16.90 26.20 29.49 16.22 24.50 28.41 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 12.23 24.31 30.40 14.55 23.96 31.03 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo 13.93 25.52 22.10 14.75 24.44 23.75 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 3 3 # 3 34 ASP B 32 ASP^? 9.42 O1 EDO A 124 37 SER B 34 SER.? 9.94 O1 EDO A 124 216 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 16.90 26.20 29.49 16.22 24.50 28.41 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 12.23 24.31 30.40 14.55 23.96 31.03 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 coo 13.93 25.52 22.10 14.75 24.44 23.75 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1cms_c04 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 3 hits 1cms_c04 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 31 TYR^? 13.43 O2 EDO A 124 A 173 ASP A 32 ASP^? 7.79 O1 EDO A 124 C 48 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 24.35 4.55 25.11 25.94 3.23 25.53 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR A 31 TYR^? 13.43 O2 EDO A 124 A 173 ASP A 63 ASP~? 17.25 O1 EDO A 124 C 48 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 24.35 4.55 25.11 25.94 3.23 25.53 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR A 31 TYR^? 13.43 O2 EDO A 124 A 173 ASP A 63 ASP~? 17.25 O1 EDO A 124 C 48 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 24.35 4.55 25.11 25.94 3.23 25.53 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 101 TYR A 31 TYR^? 13.43 O2 EDO A 124 A 173 ASP A 64 ASP~? 20.53 O2 EDO A 124 C 48 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 24.35 4.55 25.11 25.94 3.23 25.53 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 A 173 ASP B 32 ASP^? 9.42 O1 EDO A 124 C 48 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 24.35 4.55 25.11 25.94 3.23 25.53 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 A 173 ASP B 63 ASP~? 17.37 O1 EDO A 124 C 48 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 24.35 4.55 25.11 25.94 3.23 25.53 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 A 173 ASP B 63 ASP~? 17.37 O1 EDO A 124 C 48 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 24.35 4.55 25.11 25.94 3.23 25.53 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 A 173 ASP B 64 ASP~? 23.62 O1 EDO A 124 C 48 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 24.35 4.55 25.11 25.94 3.23 25.53 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 A 173 ASP B 64 ASP~? 23.62 O1 EDO A 124 C 48 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 24.35 4.55 25.11 25.94 3.23 25.53 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 30 ARG^? -2.97 O2 EDO A 124s C 101 TYR A 31 TYR^? 13.43 O2 EDO A 124 C 173 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 32.27 5.62 48.15 31.93 6.48 51.06 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 29.64 3.64 57.39 31.22 5.14 55.65 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG A 30 ARG^? -2.97 O2 EDO A 124s C 101 TYR A 31 TYR^? 13.43 O2 EDO A 124 C 173 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 32.27 5.62 48.15 31.93 6.48 51.06 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 29.64 3.64 57.39 31.22 5.14 55.65 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG A 37 ARG^? 13.77 O1 EDO A 124 C 101 TYR A 31 TYR^? 13.43 O2 EDO A 124 C 173 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 32.27 5.62 48.15 31.93 6.48 51.06 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 29.64 3.64 57.39 31.22 5.14 55.65 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 48 ARG A 53 ARG~? 17.45 O1 EDO A 125 C 101 TYR A 31 TYR^? 13.43 O2 EDO A 124 C 173 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 32.27 5.62 48.15 31.93 6.48 51.06 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 29.64 3.64 57.39 31.22 5.14 55.65 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 48 ARG B 30 ARG^? 10.56 O1 EDO A 124 C 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 C 173 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 32.27 5.62 48.15 31.93 6.48 51.06 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 29.64 3.64 57.39 31.22 5.14 55.65 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 48 ARG B 30 ARG^? 10.56 O1 EDO A 124 C 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 C 173 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 32.27 5.62 48.15 31.93 6.48 51.06 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 29.64 3.64 57.39 31.22 5.14 55.65 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 48 ARG B 37 ARG^? 8.36 C1 EDO A 124 C 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 C 173 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 32.27 5.62 48.15 31.93 6.48 51.06 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 29.64 3.64 57.39 31.22 5.14 55.65 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 48 ARG B 53 ARG~? 17.71 C1 EDO A 124 C 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 C 173 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 32.27 5.62 48.15 31.93 6.48 51.06 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 29.64 3.64 57.39 31.22 5.14 55.65 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 48 ARG B 53 ARG~? 17.71 C1 EDO A 124 C 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 C 173 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 32.27 5.62 48.15 31.93 6.48 51.06 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 29.64 3.64 57.39 31.22 5.14 55.65 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 30 ARG^? -2.97 O2 EDO A 124s D 101 TYR A 31 TYR^? 13.43 O2 EDO A 124 D 173 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 69.08 8.58 32.60 69.70 10.81 30.58 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 71.77 11.86 24.26 70.23 12.22 26.56 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 71.60 6.14 19.25 70.26 6.87 20.69 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG A 30 ARG^? -2.97 O2 EDO A 124s D 101 TYR A 31 TYR^? 13.43 O2 EDO A 124 D 173 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 69.08 8.58 32.60 69.70 10.81 30.58 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 71.77 11.86 24.26 70.23 12.22 26.56 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 71.60 6.14 19.25 70.26 6.87 20.69 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 48 ARG A 37 ARG^? 13.77 O1 EDO A 124 D 101 TYR A 31 TYR^? 13.43 O2 EDO A 124 D 173 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 69.08 8.58 32.60 69.70 10.81 30.58 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 71.77 11.86 24.26 70.23 12.22 26.56 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 71.60 6.14 19.25 70.26 6.87 20.69 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 48 ARG A 53 ARG~? 17.45 O1 EDO A 125 D 101 TYR A 31 TYR^? 13.43 O2 EDO A 124 D 173 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 69.08 8.58 32.60 69.70 10.81 30.58 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 71.77 11.86 24.26 70.23 12.22 26.56 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 71.60 6.14 19.25 70.26 6.87 20.69 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 48 ARG B 30 ARG^? 10.56 O1 EDO A 124 D 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 D 173 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 69.08 8.58 32.60 69.70 10.81 30.58 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 71.77 11.86 24.26 70.23 12.22 26.56 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 71.60 6.14 19.25 70.26 6.87 20.69 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 48 ARG B 30 ARG^? 10.56 O1 EDO A 124 D 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 D 173 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 69.08 8.58 32.60 69.70 10.81 30.58 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 71.77 11.86 24.26 70.23 12.22 26.56 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 71.60 6.14 19.25 70.26 6.87 20.69 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 48 ARG B 37 ARG^? 8.36 C1 EDO A 124 D 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 D 173 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 69.08 8.58 32.60 69.70 10.81 30.58 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 71.77 11.86 24.26 70.23 12.22 26.56 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 71.60 6.14 19.25 70.26 6.87 20.69 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 48 ARG B 53 ARG~? 17.71 C1 EDO A 124 D 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 D 173 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 69.08 8.58 32.60 69.70 10.81 30.58 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 71.77 11.86 24.26 70.23 12.22 26.56 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 71.60 6.14 19.25 70.26 6.87 20.69 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 48 ARG B 53 ARG~? 17.71 C1 EDO A 124 D 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 D 173 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 69.08 8.58 32.60 69.70 10.81 30.58 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 71.77 11.86 24.26 70.23 12.22 26.56 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 71.60 6.14 19.25 70.26 6.87 20.69 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 31 TYR^? 13.43 O2 EDO A 124 B 173 ASP A 32 ASP^? 7.79 O1 EDO A 124 D 48 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR A 31 TYR^? 13.43 O2 EDO A 124 B 173 ASP A 63 ASP~? 17.25 O1 EDO A 124 D 48 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR A 31 TYR^? 13.43 O2 EDO A 124 B 173 ASP A 63 ASP~? 17.25 O1 EDO A 124 D 48 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 101 TYR A 31 TYR^? 13.43 O2 EDO A 124 B 173 ASP A 64 ASP~? 20.53 O2 EDO A 124 D 48 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 B 173 ASP B 32 ASP^? 9.42 O1 EDO A 124 D 48 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 B 173 ASP B 63 ASP~? 17.37 O1 EDO A 124 D 48 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 B 173 ASP B 63 ASP~? 17.37 O1 EDO A 124 D 48 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 B 173 ASP B 64 ASP~? 23.62 O1 EDO A 124 D 48 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 101 TYR B 31 TYR^? 14.49 O1 EDO A 124 B 173 ASP B 64 ASP~? 23.62 O1 EDO A 124 D 48 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1cs1_c03 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 646 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 739 GLY A 75 GLY.? 13.18 O1 EDO A 125 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 11.37 50.89 2.29 11.05 51.63 2.25 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 1ddj_c12 source 1ddj PLASMINOGEN : 1 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 79 HIS^? 12.23 O1 EDO A 125 D 646 ASP A 84 ASP.? 13.20 O1 EDO A 125 D 739 GLY A 98 GLY.? 4.74 C2 EDO A 125 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -24.21 -51.77 -20.47 -24.90 -51.86 -20.04 1ddj_c15 source 1ddj PLASMINOGEN : 1 hits 1ddj_c15 naa= 3 ULMN 3 1ecf_c00 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 1 3 # 1 A 1 CYH A 46 CYH.? 11.48 C1 EDO A 124 A 101 ASN A 44 ASN.? 12.85 O2 EDO A 124 A 102 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 71.16 56.96 42.22 68.62 58.09 42.46 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 72.93 61.40 42.14 73.34 60.57 44.12 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 coo 70.24 64.11 45.02 69.59 63.75 44.65 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 3 1ecf_c00 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 2 3 # 2 A 1 CYH B 46 CYH.? 10.55 O2 EDO A 125 A 101 ASN B 44 ASN.? 11.30 O2 EDO A 125 A 102 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 71.16 56.96 42.22 68.62 58.09 42.46 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo 72.93 61.40 42.14 73.34 60.57 44.12 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 coo 70.24 64.11 45.02 69.59 63.75 44.65 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 1ecf_c00 source 1ecf GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRA: 2 hits 1ecf_c00 naa= 3 ULMN 3 1ecf_c01 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 1 3 # 1 B 1 CYH A 46 CYH.? 11.48 C1 EDO A 124 B 101 ASN A 44 ASN.? 12.85 O2 EDO A 124 B 102 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 75.18 21.70 37.98 75.10 20.53 35.34 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 75.17 17.26 39.63 77.17 18.02 39.88 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 coo 77.89 14.61 36.82 77.45 14.93 36.19 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 3 1ecf_c01 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 2 3 # 2 B 1 CYH B 46 CYH.? 10.55 O2 EDO A 125 B 101 ASN B 44 ASN.? 11.30 O2 EDO A 125 B 102 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 75.18 21.70 37.98 75.10 20.53 35.34 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo 75.17 17.26 39.63 77.17 18.02 39.88 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 coo 77.89 14.61 36.82 77.45 14.93 36.19 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 1ecf_c01 source 1ecf GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRA: 2 hits 1ecf_c01 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 260 ARG A 25 ARG.? 17.39 O2 EDO A 124 A 270 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 50.99 29.43 12.86 52.11 29.45 14.65 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 39.80 27.50 22.98 42.20 26.56 21.34 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 48.83 21.70 19.50 47.44 24.99 15.25 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 260 ARG B 25 ARG.? 18.77 O2 EDO A 125 A 270 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 50.99 29.43 12.86 52.11 29.45 14.65 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 39.80 27.50 22.98 42.20 26.56 21.34 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 48.83 21.70 19.50 47.44 24.99 15.25 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 2 hits 1euy_c00 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 50 PHE^? 8.88 O1 EDO A 125 A 210 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 244 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 9.23 46.77 25.11 11.48 48.39 24.76 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 10.51 37.86 19.71 9.07 39.38 20.04 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -1.20 42.34 17.67 3.19 45.13 19.06 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE B 50 PHE^? 13.90 C1 EDO A 124 A 210 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 244 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 9.23 46.77 25.11 11.48 48.39 24.76 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 10.51 37.86 19.71 9.07 39.38 20.04 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -1.20 42.34 17.67 3.19 45.13 19.06 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 50 PHE^? 8.88 O1 EDO A 125 B 210 ASP A 32 ASP^? 7.79 O1 EDO A 124 B 244 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 8.76 47.85 34.91 11.08 46.36 35.41 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 9.06 56.85 40.30 7.71 55.27 39.90 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -2.38 51.82 41.62 2.07 49.19 40.42 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE B 50 PHE^? 13.90 C1 EDO A 124 B 210 ASP B 32 ASP^? 9.42 O1 EDO A 124 B 244 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 8.76 47.85 34.91 11.08 46.36 35.41 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 9.06 56.85 40.30 7.71 55.27 39.90 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -2.38 51.82 41.62 2.07 49.19 40.42 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c03 naa= 3 ULMN 3 1ff3_c00 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 1 3 # 1 A 94 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 198 CYH A 67 CYH~? 14.35 O2 EDO A 124 A 206 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo 49.92 26.66 0.19 51.26 25.02 0.19 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 51.25 11.31 6.04 51.91 8.58 5.83 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo 38.98 17.42 20.63 38.42 14.68 20.70 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 ULMN 3 1ff3_c00 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 2 3 # 2 A 94 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 198 CYH A 46 CYH.? 11.48 C1 EDO A 124 A 206 CYH B 67 CYH~? 18.88 O1 EDO A 124 coo 49.92 26.66 0.19 51.26 25.02 0.19 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 51.25 11.31 6.04 51.91 8.58 5.83 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 38.98 17.42 20.63 38.42 14.68 20.70 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 ULMN 3 1ff3_c00 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 3 3 # 3 A 94 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 198 CYH B 67 CYH~? 18.88 O1 EDO A 124 A 206 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo 49.92 26.66 0.19 51.26 25.02 0.19 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 51.25 11.31 6.04 51.91 8.58 5.83 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo 38.98 17.42 20.63 38.42 14.68 20.70 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 1ff3_c00 source 1ff3 PEPTIDE METHIONINE SULFOXIDE REDUCTASE : 3 hits 1ff3_c00 naa= 3 ULMN 3 1ff3_c01 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 1 3 # 1 A 94 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 198 CYH A 67 CYH~? 14.35 O2 EDO A 124 A 206 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo 49.92 26.66 0.19 51.26 25.02 0.19 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 51.25 11.31 6.04 51.91 8.58 5.83 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo 38.98 17.42 20.63 38.42 14.68 20.70 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 ULMN 3 1ff3_c01 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 2 3 # 2 A 94 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 198 CYH A 46 CYH.? 11.48 C1 EDO A 124 A 206 CYH B 67 CYH~? 18.88 O1 EDO A 124 coo 49.92 26.66 0.19 51.26 25.02 0.19 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 51.25 11.31 6.04 51.91 8.58 5.83 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 38.98 17.42 20.63 38.42 14.68 20.70 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 ULMN 3 1ff3_c01 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 3 3 # 3 A 94 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 198 CYH B 67 CYH~? 18.88 O1 EDO A 124 A 206 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo 49.92 26.66 0.19 51.26 25.02 0.19 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 51.25 11.31 6.04 51.91 8.58 5.83 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo 38.98 17.42 20.63 38.42 14.68 20.70 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 1ff3_c01 source 1ff3 PEPTIDE METHIONINE SULFOXIDE REDUCTASE : 3 hits 1ff3_c01 naa= 3 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 1 3 # 1 A 314 TRP A 80 TRP^? 10.72 O1 EDO A 125 A 317 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 365 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 79.91 26.87 38.77 78.95 23.18 37.81 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 85.55 26.30 41.25 85.59 24.97 39.65 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 83.47 25.30 27.10 83.44 27.82 25.29 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 2 3 # 2 A 314 TRP B 80 TRP^? 20.31 C1 EDO A 124 A 317 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 365 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 79.91 26.87 38.77 78.95 23.18 37.81 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 85.55 26.30 41.25 85.59 24.97 39.65 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 83.47 25.30 27.10 83.44 27.82 25.29 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 1g8o_c01 source 1g8o N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALACTOSYLTRA: 2 hits 1g8o_c01 naa= 3 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 B 1 CYH A 46 CYH.? 11.48 C1 EDO A 124 B 98 ASN A 44 ASN.? 12.85 O2 EDO A 124 B 99 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 60.40 53.51 86.58 58.33 55.30 85.83 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 61.33 49.28 88.22 61.64 50.04 86.28 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 coo 60.75 49.64 92.68 61.49 50.04 92.62 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 B 1 CYH B 46 CYH.? 10.55 O2 EDO A 125 B 98 ASN B 44 ASN.? 11.30 O2 EDO A 125 B 99 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 60.40 53.51 86.58 58.33 55.30 85.83 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo 61.33 49.28 88.22 61.64 50.04 86.28 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 coo 60.75 49.64 92.68 61.49 50.04 92.62 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 1gdo_c00 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1gdo_c00 naa= 3 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 D 1 CYH A 46 CYH.? 11.48 C1 EDO A 124 D 98 ASN A 44 ASN.? 12.85 O2 EDO A 124 D 99 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 45.17 35.76 43.57 47.17 33.90 42.78 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 44.24 40.01 45.19 43.94 39.25 43.24 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 coo 44.81 39.60 49.65 44.07 39.23 49.57 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 D 1 CYH B 46 CYH.? 10.55 O2 EDO A 125 D 98 ASN B 44 ASN.? 11.30 O2 EDO A 125 D 99 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 45.17 35.76 43.57 47.17 33.90 42.78 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo 44.24 40.01 45.19 43.94 39.25 43.24 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 coo 44.81 39.60 49.65 44.07 39.23 49.57 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 1gdo_c01 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1gdo_c01 naa= 3 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 A 1 CYH A 46 CYH.? 11.48 C1 EDO A 124 A 98 ASN A 44 ASN.? 12.85 O2 EDO A 124 A 99 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 9.96 -7.64 43.39 12.01 -9.40 42.74 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 A 1 CYH B 46 CYH.? 10.55 O2 EDO A 125 A 98 ASN B 44 ASN.? 11.30 O2 EDO A 125 A 99 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 9.96 -7.64 43.39 12.01 -9.40 42.74 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 1gdo_c02 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1gdo_c02 naa= 3 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 C 1 CYH A 46 CYH.? 11.48 C1 EDO A 124 C 98 ASN A 44 ASN.? 12.85 O2 EDO A 124 C 99 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 25.27 14.39 86.45 23.28 16.25 85.80 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 25.97 10.04 88.17 26.35 10.81 86.26 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 coo 25.32 10.47 92.61 26.06 10.86 92.54 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 C 1 CYH B 46 CYH.? 10.55 O2 EDO A 125 C 98 ASN B 44 ASN.? 11.30 O2 EDO A 125 C 99 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 25.27 14.39 86.45 23.28 16.25 85.80 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo 25.97 10.04 88.17 26.35 10.81 86.26 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 coo 25.32 10.47 92.61 26.06 10.86 92.54 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 1gdo_c03 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1gdo_c03 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 50 PHE^? 8.88 O1 EDO A 125 A 298 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 329 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 2.59 0.29 25.55 4.65 0.18 25.07 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 12.42 6.10 23.27 9.95 1.57 20.16 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE B 50 PHE^? 13.90 C1 EDO A 124 A 298 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 329 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 2.59 0.29 25.55 4.65 0.18 25.07 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 12.42 6.10 23.27 9.95 1.57 20.16 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 50 PHE^? 8.88 O1 EDO A 125 B 298 ASP A 32 ASP^? 7.79 O1 EDO A 124 B 329 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE B 50 PHE^? 13.90 C1 EDO A 124 B 298 ASP B 32 ASP^? 9.42 O1 EDO A 124 B 329 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 50 PHE^? 8.88 O1 EDO A 125 C 298 ASP A 32 ASP^? 7.79 O1 EDO A 124 C 329 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 17.41 60.57 64.39 18.40 58.12 65.34 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 24.10 66.43 63.33 24.18 64.30 63.40 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 27.64 56.61 58.17 22.18 57.92 60.36 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE B 50 PHE^? 13.90 C1 EDO A 124 C 298 ASP B 32 ASP^? 9.42 O1 EDO A 124 C 329 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 17.41 60.57 64.39 18.40 58.12 65.34 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 24.10 66.43 63.33 24.18 64.30 63.40 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 27.64 56.61 58.17 22.18 57.92 60.36 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 50 PHE^? 8.88 O1 EDO A 125 D 298 ASP A 32 ASP^? 7.79 O1 EDO A 124 D 329 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 35.44 53.35 83.81 35.65 54.53 81.28 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 29.72 46.46 83.60 30.79 47.36 81.99 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 36.89 44.91 74.55 37.33 48.94 79.01 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE B 50 PHE^? 13.90 C1 EDO A 124 D 298 ASP B 32 ASP^? 9.42 O1 EDO A 124 D 329 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 35.44 53.35 83.81 35.65 54.53 81.28 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 29.72 46.46 83.60 30.79 47.36 81.99 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 36.89 44.91 74.55 37.33 48.94 79.01 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c03 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 58 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 424 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 58.42 47.76 20.67 58.01 49.10 19.12 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 58.59 41.80 18.81 58.94 43.89 18.94 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 52.85 46.34 13.34 54.09 44.97 14.42 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 2 3 # 2 A 55 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 58 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 424 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 58.42 47.76 20.67 58.01 49.10 19.12 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 58.59 41.80 18.81 58.94 43.89 18.94 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 52.85 46.34 13.34 54.09 44.97 14.42 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 3 3 # 3 A 55 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 58 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 424 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 58.42 47.76 20.67 58.01 49.10 19.12 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 58.59 41.80 18.81 58.94 43.89 18.94 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 52.85 46.34 13.34 54.09 44.97 14.42 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 4 3 # 4 A 55 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 58 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 424 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 58.42 47.76 20.67 58.01 49.10 19.12 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 58.59 41.80 18.81 58.94 43.89 18.94 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 52.85 46.34 13.34 54.09 44.97 14.42 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 4 hits 1js4_c00 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 58 ASP A 84 ASP.? 13.20 O1 EDO A 125 B 424 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 112.10 61.46 19.99 111.82 60.65 18.07 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 117.85 63.62 21.08 115.96 63.25 20.18 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 118.47 57.23 15.57 119.32 58.77 16.73 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 2 3 # 2 B 55 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 58 ASP B 84 ASP.? 30.86 C1 EDO A 124 B 424 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 112.10 61.46 19.99 111.82 60.65 18.07 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 117.85 63.62 21.08 115.96 63.25 20.18 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 118.47 57.23 15.57 119.32 58.77 16.73 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 2 hits 1js4_c01 naa= 3 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 A 1 CYH A 46 CYH.? 11.48 C1 EDO A 124 A 98 ASN A 44 ASN.? 12.85 O2 EDO A 124 A 99 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 A 1 CYH B 46 CYH.? 10.55 O2 EDO A 125 A 98 ASN B 44 ASN.? 11.30 O2 EDO A 125 A 99 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 1jxa_c02 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1jxa_c02 naa= 3 ULMN 3 1jxa_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 B 1 CYH A 46 CYH.? 11.48 C1 EDO A 124 B 98 ASN A 44 ASN.? 12.85 O2 EDO A 124 B 99 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 5.70 59.29 33.36 6.39 60.24 35.89 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 7.58 64.91 33.71 8.60 63.38 34.75 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 coo 6.08 65.78 38.20 5.37 65.61 37.90 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 3 1jxa_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 B 1 CYH B 46 CYH.? 10.55 O2 EDO A 125 B 98 ASN B 44 ASN.? 11.30 O2 EDO A 125 B 99 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 5.70 59.29 33.36 6.39 60.24 35.89 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo 7.58 64.91 33.71 8.60 63.38 34.75 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 coo 6.08 65.78 38.20 5.37 65.61 37.90 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 1jxa_c03 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1jxa_c03 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 265 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 369 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 11.74 38.14 80.19 10.63 36.40 80.65 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 17.36 23.57 72.04 18.68 21.92 71.98 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 12.19 31.08 87.29 11.13 32.66 86.38 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 265 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 369 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 11.74 38.14 80.19 10.63 36.40 80.65 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 17.36 23.57 72.04 18.68 21.92 71.98 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 12.19 31.08 87.29 11.13 32.66 86.38 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 265 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 369 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 11.74 38.14 80.19 10.63 36.40 80.65 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 17.36 23.57 72.04 18.68 21.92 71.98 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 265 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 369 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 11.74 38.14 80.19 10.63 36.40 80.65 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 17.36 23.57 72.04 18.68 21.92 71.98 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 4 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 279 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 369 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 11.74 38.14 80.19 10.63 36.40 80.65 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 16.54 46.37 63.94 14.77 45.79 62.95 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 12.19 31.08 87.29 11.13 32.66 86.38 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 279 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 369 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 11.74 38.14 80.19 10.63 36.40 80.65 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 16.54 46.37 63.94 14.77 45.79 62.95 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 12.19 31.08 87.29 11.13 32.66 86.38 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 2 hits 1m53_c06 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 75 GLY.? 13.18 O1 EDO A 125 A 501 ASP A 64 ASP~? 20.53 O2 EDO A 124 B 367 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 75 GLY.? 13.18 O1 EDO A 125 A 501 ASP A 64 ASP~? 20.53 O2 EDO A 124 B 367 TYR B 76 TYR.? 17.92 O2 EDO A 125 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY B 75 GLY.? 21.06 O2 EDO A 125 A 501 ASP B 64 ASP~? 23.62 O1 EDO A 124 B 367 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY B 75 GLY.? 21.06 O2 EDO A 125 A 501 ASP B 64 ASP~? 23.62 O1 EDO A 124 B 367 TYR A 76 TYR.? 12.73 O1 EDO A 125 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 4 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 75 GLY.? 13.18 O1 EDO A 125 D 501 ASP A 64 ASP~? 20.53 O2 EDO A 124 E 367 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 75 GLY.? 13.18 O1 EDO A 125 D 501 ASP A 64 ASP~? 20.53 O2 EDO A 124 E 367 TYR B 76 TYR.? 17.92 O2 EDO A 125 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY B 75 GLY.? 21.06 O2 EDO A 125 D 501 ASP B 64 ASP~? 23.62 O1 EDO A 124 E 367 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY B 75 GLY.? 21.06 O2 EDO A 125 D 501 ASP B 64 ASP~? 23.62 O1 EDO A 124 E 367 TYR A 76 TYR.? 12.73 O1 EDO A 125 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 4 hits 1mro_c01 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 197 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 223 ALA A 55 ALA~? 6.66 O1 EDO A 125 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -21.18 -46.19 -20.96 -21.62 -45.51 -22.25 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 197 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 223 ALA A 61 ALA.? 14.64 O1 EDO A 125 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -11.93 -42.70 -24.53 -13.20 -42.73 -25.33 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 197 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 223 ALA A 26 ALA^? 11.43 O2 EDO A 124 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -31.83 -39.03 -32.30 -30.50 -39.69 -32.00 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 197 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 223 ALA A 29 ALA^? 9.43 O2 EDO A 124 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -25.58 -35.99 -31.45 -25.46 -37.49 -31.45 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 197 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 223 ALA A 61 ALA.? 14.64 O1 EDO A 125 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -11.93 -42.70 -24.53 -13.20 -42.73 -25.33 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 A 114 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 197 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 223 ALA B 55 ALA~? 18.17 C1 EDO A 124 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -46.89 -31.34 -22.78 -46.09 -31.26 -21.50 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 A 114 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 197 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 223 ALA B 61 ALA.? 21.66 C1 EDO A 124 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -48.78 -21.46 -18.93 -48.15 -22.68 -18.28 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 7 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 197 ASP A 84 ASP.? 13.20 O1 EDO A 125 B 223 ALA A 55 ALA~? 6.66 O1 EDO A 125 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -21.18 -46.19 -20.96 -21.62 -45.51 -22.25 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 197 ASP A 84 ASP.? 13.20 O1 EDO A 125 B 223 ALA A 61 ALA.? 14.64 O1 EDO A 125 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -11.93 -42.70 -24.53 -13.20 -42.73 -25.33 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 197 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 223 ALA A 26 ALA^? 11.43 O2 EDO A 124 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -31.83 -39.03 -32.30 -30.50 -39.69 -32.00 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 197 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 223 ALA A 29 ALA^? 9.43 O2 EDO A 124 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -25.58 -35.99 -31.45 -25.46 -37.49 -31.45 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 197 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 223 ALA A 61 ALA.? 14.64 O1 EDO A 125 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -11.93 -42.70 -24.53 -13.20 -42.73 -25.33 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 B 114 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 197 ASP B 84 ASP.? 30.86 C1 EDO A 124 B 223 ALA B 55 ALA~? 18.17 C1 EDO A 124 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -46.89 -31.34 -22.78 -46.09 -31.26 -21.50 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 B 114 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 197 ASP B 84 ASP.? 30.86 C1 EDO A 124 B 223 ALA B 61 ALA.? 21.66 C1 EDO A 124 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -48.78 -21.46 -18.93 -48.15 -22.68 -18.28 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 7 hits 1n2t_c03 naa= 3 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 33 ARG.? 17.39 O2 EDO A 124 A 101 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 132 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 11.61 22.83 17.30 14.06 21.71 15.78 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 11.37 24.94 11.48 12.48 24.45 13.28 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 16.14 18.17 13.37 15.92 19.81 14.71 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 1nu3_c00 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 1 hits 1nu3_c00 naa= 3 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 33 ARG.? 17.39 O2 EDO A 124 B 101 ASP A 63 ASP~? 17.25 O1 EDO A 124 B 132 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 11.61 3.43 18.38 9.11 4.29 16.86 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 11.74 0.51 12.98 10.75 1.32 14.67 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 6.93 7.52 14.08 7.18 6.08 15.65 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG B 33 ARG.? 19.94 O1 EDO A 124 B 101 ASP B 63 ASP~? 17.37 O1 EDO A 124 B 132 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 11.61 3.43 18.38 9.11 4.29 16.86 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 11.74 0.51 12.98 10.75 1.32 14.67 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 6.93 7.52 14.08 7.18 6.08 15.65 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 1nu3_c01 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 2 hits 1nu3_c01 naa= 3 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 33 ARG.? 17.39 O2 EDO A 124 A 101 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 132 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 11.50 22.77 17.24 14.00 21.62 15.86 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 11.19 25.00 11.76 12.16 24.45 13.59 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 16.04 18.11 13.43 15.88 19.70 14.83 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG B 33 ARG.? 19.94 O1 EDO A 124 A 101 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 132 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 11.50 22.77 17.24 14.00 21.62 15.86 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 11.19 25.00 11.76 12.16 24.45 13.59 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 16.04 18.11 13.43 15.88 19.70 14.83 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 1nww_c02 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 2 hits 1nww_c02 naa= 3 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 33 ARG.? 17.39 O2 EDO A 124 B 101 ASP A 63 ASP~? 17.25 O1 EDO A 124 B 132 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 11.48 3.09 18.25 9.01 4.07 16.77 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 11.83 0.33 13.01 10.88 1.04 14.81 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 6.85 7.33 14.07 7.10 5.88 15.60 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG B 33 ARG.? 19.94 O1 EDO A 124 B 101 ASP B 63 ASP~? 17.37 O1 EDO A 124 B 132 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 11.48 3.09 18.25 9.01 4.07 16.77 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 11.83 0.33 13.01 10.88 1.04 14.81 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 6.85 7.33 14.07 7.10 5.88 15.60 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 1nww_c03 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 2 hits 1nww_c03 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 35 SER.? 8.67 O1 EDO A 124 A 154 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 261 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 16.10 74.10 3.11 17.18 73.52 5.20 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo 16.07 84.71 8.14 15.20 82.81 8.14 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 10.59 77.85 4.81 13.09 76.36 5.76 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER B 35 SER.? 7.36 O1 EDO A 124 A 154 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 261 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 16.10 74.10 3.11 17.18 73.52 5.20 -33.90 -21.70 -23.70 -33.48 -23.60 -22.25 coo 16.07 84.71 8.14 15.20 82.81 8.14 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 10.59 77.85 4.81 13.09 76.36 5.76 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 2 hits 1o98_c00 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 247 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 342 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 44.36 35.68 9.71 43.29 36.20 11.51 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 41.40 28.81 12.91 40.82 30.90 12.97 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 40.37 33.11 18.06 39.99 34.93 17.06 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 3 1oyg_c00 LEVANSUCRASE user 2 3 # 2 A 86 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 247 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 342 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 44.36 35.68 9.71 43.29 36.20 11.51 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 41.40 28.81 12.91 40.82 30.90 12.97 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 40.37 33.11 18.06 39.99 34.93 17.06 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1oyg_c00 source 1oyg LEVANSUCRASE : 2 hits 1oyg_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 61 ALA.? 14.64 O1 EDO A 125 A 126 LEU A 58 LEU.? 9.87 O1 EDO A 125 A 158 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -11.93 -42.70 -24.53 -13.20 -42.73 -25.33 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -17.29 -44.63 -24.09 -18.05 -44.29 -26.14 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA B 61 ALA.? 21.66 C1 EDO A 124 A 126 LEU B 58 LEU.? 19.52 C1 EDO A 124 A 158 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -48.78 -21.46 -18.93 -48.15 -22.68 -18.28 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -47.35 -27.17 -19.69 -46.30 -27.92 -17.93 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 61 ALA.? 14.64 O1 EDO A 125 B 126 LEU A 58 LEU.? 9.87 O1 EDO A 125 B 158 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -11.93 -42.70 -24.53 -13.20 -42.73 -25.33 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -17.29 -44.63 -24.09 -18.05 -44.29 -26.14 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA B 61 ALA.? 21.66 C1 EDO A 124 B 126 LEU B 58 LEU.? 19.52 C1 EDO A 124 B 158 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -48.78 -21.46 -18.93 -48.15 -22.68 -18.28 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -47.35 -27.17 -19.69 -46.30 -27.92 -17.93 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 61 ALA.? 14.64 O1 EDO A 125 C 126 LEU A 58 LEU.? 9.87 O1 EDO A 125 C 158 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -11.93 -42.70 -24.53 -13.20 -42.73 -25.33 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -17.29 -44.63 -24.09 -18.05 -44.29 -26.14 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA B 61 ALA.? 21.66 C1 EDO A 124 C 126 LEU B 58 LEU.? 19.52 C1 EDO A 124 C 158 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -48.78 -21.46 -18.93 -48.15 -22.68 -18.28 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -47.35 -27.17 -19.69 -46.30 -27.92 -17.93 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c02 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 30 ARG^? -2.97 O2 EDO A 124s C 163 TYR A 31 TYR^? 13.43 O2 EDO A 124 C 236 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 39.01 29.77 22.02 37.48 31.30 19.84 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 39.51 34.34 13.63 37.63 32.61 14.79 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 45.78 31.11 9.51 44.25 30.06 10.53 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG B 30 ARG^? 10.56 O1 EDO A 124 C 163 TYR B 31 TYR^? 14.49 O1 EDO A 124 C 236 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 39.01 29.77 22.02 37.48 31.30 19.84 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 39.51 34.34 13.63 37.63 32.61 14.79 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG B 53 ARG~? 17.71 C1 EDO A 124 C 163 TYR B 31 TYR^? 14.49 O1 EDO A 124 C 236 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 39.01 29.77 22.02 37.48 31.30 19.84 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 39.51 34.34 13.63 37.63 32.61 14.79 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 30 ARG^? -2.97 O2 EDO A 124s D 163 TYR A 31 TYR^? 13.43 O2 EDO A 124 D 236 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG B 30 ARG^? 10.56 O1 EDO A 124 D 163 TYR B 31 TYR^? 14.49 O1 EDO A 124 D 236 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG B 53 ARG~? 17.71 C1 EDO A 124 D 163 TYR B 31 TYR^? 14.49 O1 EDO A 124 D 236 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 31 TYR^? 13.43 O2 EDO A 124 A 236 ASP A 64 ASP~? 20.53 O2 EDO A 124 C 110 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 55.48 26.51 40.65 55.39 23.99 39.43 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 48.87 29.19 44.63 49.10 27.34 43.63 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 52.39 23.42 32.10 54.51 23.27 34.29 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 31 TYR^? 14.49 O1 EDO A 124 A 236 ASP B 64 ASP~? 23.62 O1 EDO A 124 C 110 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 55.48 26.51 40.65 55.39 23.99 39.43 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 52.39 23.42 32.10 54.51 23.27 34.29 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR B 31 TYR^? 14.49 O1 EDO A 124 A 236 ASP B 64 ASP~? 23.62 O1 EDO A 124 C 110 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 55.48 26.51 40.65 55.39 23.99 39.43 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 52.39 23.42 32.10 54.51 23.27 34.29 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 31 TYR^? 13.43 O2 EDO A 124 B 236 ASP A 64 ASP~? 20.53 O2 EDO A 124 D 110 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 31 TYR^? 14.49 O1 EDO A 124 B 236 ASP B 64 ASP~? 23.62 O1 EDO A 124 D 110 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 31 TYR^? 14.49 O1 EDO A 124 B 236 ASP B 64 ASP~? 23.62 O1 EDO A 124 D 110 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 30 ARG^? -2.97 O2 EDO A 124s G 163 TYR A 31 TYR^? 13.43 O2 EDO A 124 G 236 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG B 30 ARG^? 10.56 O1 EDO A 124 G 163 TYR B 31 TYR^? 14.49 O1 EDO A 124 G 236 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG B 53 ARG~? 17.71 C1 EDO A 124 G 163 TYR B 31 TYR^? 14.49 O1 EDO A 124 G 236 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 30 ARG^? -2.97 O2 EDO A 124s H 163 TYR A 31 TYR^? 13.43 O2 EDO A 124 H 236 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG B 30 ARG^? 10.56 O1 EDO A 124 H 163 TYR B 31 TYR^? 14.49 O1 EDO A 124 H 236 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG B 53 ARG~? 17.71 C1 EDO A 124 H 163 TYR B 31 TYR^? 14.49 O1 EDO A 124 H 236 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 31 TYR^? 13.43 O2 EDO A 124 E 236 ASP A 64 ASP~? 20.53 O2 EDO A 124 G 110 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 31 TYR^? 14.49 O1 EDO A 124 E 236 ASP B 64 ASP~? 23.62 O1 EDO A 124 G 110 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR B 31 TYR^? 14.49 O1 EDO A 124 E 236 ASP B 64 ASP~? 23.62 O1 EDO A 124 G 110 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 31 TYR^? 13.43 O2 EDO A 124 F 236 ASP A 64 ASP~? 20.53 O2 EDO A 124 H 110 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 31 TYR^? 14.49 O1 EDO A 124 F 236 ASP B 64 ASP~? 23.62 O1 EDO A 124 H 110 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR B 31 TYR^? 14.49 O1 EDO A 124 F 236 ASP B 64 ASP~? 23.62 O1 EDO A 124 H 110 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 147 THR A 47 THR^? 4.31 C1 EDO A 124 A 294 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 147 THR A 47 THR^? 4.31 C1 EDO A 124 A 294 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 3 3 # 3 A 49 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 147 THR B 47 THR^? 9.39 O1 EDO A 124 A 294 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 3 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 261 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 329 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 34.02 79.89 42.60 34.73 78.01 41.86 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 37.87 70.12 31.80 36.61 69.74 30.15 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 261 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 329 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 34.02 79.89 42.60 34.73 78.01 41.86 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 261 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 329 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 34.02 79.89 42.60 34.73 78.01 41.86 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 1qho_c05 source 1qho ALPHA-AMYLASE : 3 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 260 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 329 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 28.46 69.88 26.74 30.40 70.70 26.53 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 30.73 81.29 37.61 31.23 82.07 35.69 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 37.87 70.12 31.80 36.61 69.74 30.15 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 260 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 329 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 30.73 81.29 37.61 31.23 82.07 35.69 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 37.87 70.12 31.80 36.61 69.74 30.15 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 260 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 329 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 30.73 81.29 37.61 31.23 82.07 35.69 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 37.87 70.12 31.80 36.61 69.74 30.15 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 260 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 329 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 30.73 81.29 37.61 31.23 82.07 35.69 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 1qho_c07 source 1qho ALPHA-AMYLASE : 4 hits 1qho_c07 naa= 3 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 102 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 193 GLY A 75 GLY.? 13.18 O1 EDO A 125 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 102 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 193 GLY B 75 GLY.? 21.06 O2 EDO A 125 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 1rtf_c06 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 2 hits 1rtf_c06 naa= 3 ULMN 3 1sme_c05 PLASMEPSIN II user 1 3 # 1 B 34 ASP A 32 ASP^? 7.79 O1 EDO A 124 B 37 SER A 34 SER.? 10.92 O1 EDO A 124 B 214 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 17.69 97.58 52.73 17.33 97.19 54.77 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 20.67 100.44 55.84 20.21 98.51 54.45 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo 12.41 98.71 58.47 14.37 98.17 58.05 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 3 1sme_c05 PLASMEPSIN II user 2 3 # 2 B 34 ASP A 32 ASP^? 7.79 O1 EDO A 124 B 37 SER A 35 SER.? 8.67 O1 EDO A 124 B 214 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 17.69 97.58 52.73 17.33 97.19 54.77 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 20.67 100.44 55.84 20.21 98.51 54.45 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo 12.41 98.71 58.47 14.37 98.17 58.05 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 1sme_c05 source 1sme PLASMEPSIN II : 2 hits 1sme_c05 naa= 3 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 102 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 193 GLY A 75 GLY.? 13.18 O1 EDO A 125 coo 15.02 29.17 19.44 15.63 29.96 17.60 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 19.67 30.58 22.61 18.30 29.87 21.17 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 14.52 29.10 10.01 15.08 29.66 10.19 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 102 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 193 GLY B 75 GLY.? 21.06 O2 EDO A 125 coo 15.02 29.17 19.44 15.63 29.96 17.60 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 19.67 30.58 22.61 18.30 29.87 21.17 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 14.52 29.10 10.01 15.08 29.66 10.19 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 1ssx_c02 source 1ssx ALPHA-LYTIC PROTEASE : 2 hits 1ssx_c02 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 80 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 223 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 80 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 223 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 3 3 # 3 B 8 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 80 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 223 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 3 hits 1t0u_c01 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 41 ASP^? -2.91 O2 EDO A 124s 242 GLU B 59 GLU.? 24.69 C1 EDO A 124 329 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 49.16 35.16 15.19 51.08 34.43 15.65 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 30.42 34.74 5.00 29.09 35.09 3.38 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 59.16 37.82 13.95 57.63 37.03 15.12 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP B 41 ASP^? 12.31 O1 EDO A 124 242 GLU A 59 GLU.? 11.26 O1 EDO A 125 329 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 49.16 35.16 15.19 51.08 34.43 15.65 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 30.42 34.74 5.00 29.09 35.09 3.38 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 2 hits 1uok_c05 naa= 3 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 A 100 PHE A 97 PHE.? 7.14 O2 EDO A 125 A 197 ASN B 44 ASN.? 11.30 O2 EDO A 125 A 198 PRO B 24 PRO.? 11.94 O2 EDO A 125 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -34.76 -42.94 -16.24 -33.94 -43.43 -14.22 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 A 100 PHE B 97 PHE.? 16.35 C1 EDO A 124 A 197 ASN A 44 ASN.? 12.85 O2 EDO A 124 A 198 PRO A 24 PRO.? 13.79 O2 EDO A 125 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -37.37 -41.75 -27.30 -38.43 -41.33 -29.23 1vq1_c00 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 2 hits 1vq1_c00 naa= 3 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 B 100 PHE A 97 PHE.? 7.14 O2 EDO A 125 B 197 ASN B 44 ASN.? 11.30 O2 EDO A 125 B 198 PRO B 24 PRO.? 11.94 O2 EDO A 125 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -34.76 -42.94 -16.24 -33.94 -43.43 -14.22 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 B 100 PHE B 97 PHE.? 16.35 C1 EDO A 124 B 197 ASN A 44 ASN.? 12.85 O2 EDO A 124 B 198 PRO A 24 PRO.? 13.79 O2 EDO A 125 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -37.37 -41.75 -27.30 -38.43 -41.33 -29.23 1vq1_c01 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 2 hits 1vq1_c01 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY A 77 GLY^? 7.89 O1 EDO A 125 B 419 GLY A 75 GLY.? 13.18 O1 EDO A 125 B 420 ALA A 26 ALA^? 11.43 O2 EDO A 124 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -28.29 -45.93 -31.97 -28.42 -45.22 -32.28 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -31.83 -39.03 -32.30 -30.50 -39.69 -32.00 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 183 GLY B 77 GLY^? 22.66 C1 EDO A 124 B 419 GLY B 75 GLY.? 21.06 O2 EDO A 125 B 420 ALA B 26 ALA^? 18.43 C1 EDO A 124 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -43.26 -37.30 -11.50 -42.54 -37.05 -11.23 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -35.37 -36.70 -11.28 -36.61 -35.88 -11.60 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 2 hits 1xny_c00 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 26 ALA^? 11.43 O2 EDO A 124 B 182 GLY A 73 GLY.? 12.76 O1 EDO A 125 B 183 GLY A 77 GLY^? 7.89 O1 EDO A 125 coo 38.36-101.47-135.52 39.62-101.29-136.35 -31.83 -39.03 -32.30 -30.50 -39.69 -32.00 coo 41.93-102.35-126.87 41.52-101.89-126.30 -30.36 -47.03 -37.01 -30.17 -46.21 -37.42 coo 38.37-101.99-128.11 38.63-102.24-127.37 -28.29 -45.93 -31.97 -28.42 -45.22 -32.28 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA A 26 ALA^? 11.43 O2 EDO A 124 B 182 GLY A 77 GLY^? 7.89 O1 EDO A 125 B 183 GLY A 73 GLY.? 12.76 O1 EDO A 125 coo 38.36-101.47-135.52 39.62-101.29-136.35 -31.83 -39.03 -32.30 -30.50 -39.69 -32.00 coo 41.93-102.35-126.87 41.52-101.89-126.30 -28.29 -45.93 -31.97 -28.42 -45.22 -32.28 coo 38.37-101.99-128.11 38.63-102.24-127.37 -30.36 -47.03 -37.01 -30.17 -46.21 -37.42 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 420 ALA A 27 ALA^? 9.68 O2 EDO A 124 B 182 GLY A 73 GLY.? 12.76 O1 EDO A 125 B 183 GLY A 75 GLY.? 13.18 O1 EDO A 125 coo 38.36-101.47-135.52 39.62-101.29-136.35 -31.77 -36.20 -34.87 -32.75 -35.04 -34.84 coo 41.93-102.35-126.87 41.52-101.89-126.30 -30.36 -47.03 -37.01 -30.17 -46.21 -37.42 coo 38.37-101.99-128.11 38.63-102.24-127.37 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 420 ALA A 27 ALA^? 9.68 O2 EDO A 124 B 182 GLY A 77 GLY^? 7.89 O1 EDO A 125 B 183 GLY A 75 GLY.? 13.18 O1 EDO A 125 coo 38.36-101.47-135.52 39.62-101.29-136.35 -31.77 -36.20 -34.87 -32.75 -35.04 -34.84 coo 41.93-102.35-126.87 41.52-101.89-126.30 -28.29 -45.93 -31.97 -28.42 -45.22 -32.28 coo 38.37-101.99-128.11 38.63-102.24-127.37 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 420 ALA B 26 ALA^? 18.43 C1 EDO A 124 B 182 GLY B 73 GLY.? 24.47 O2 EDO A 125 B 183 GLY B 77 GLY^? 22.66 C1 EDO A 124 coo 38.36-101.47-135.52 39.62-101.29-136.35 -35.37 -36.70 -11.28 -36.61 -35.88 -11.60 coo 41.93-102.35-126.87 41.52-101.89-126.30 -43.26 -39.74 -6.71 -42.70 -39.15 -6.19 coo 38.37-101.99-128.11 38.63-102.24-127.37 -43.26 -37.30 -11.50 -42.54 -37.05 -11.23 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 5 hits 1xny_c01 naa= 3 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 1 3 # 1 A 243 THR A 47 THR^? 4.31 C1 EDO A 124 A 345 PHE A 50 PHE^? 8.88 O1 EDO A 125 A 352 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo 9.58 21.79 21.50 11.25 23.03 20.90 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 19.40 19.75 18.58 17.39 17.81 18.80 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 21.57 22.52 22.79 19.20 21.13 23.26 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 2 3 # 2 A 243 THR B 47 THR^? 9.39 O1 EDO A 124 A 345 PHE B 50 PHE^? 13.90 C1 EDO A 124 A 352 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo 9.58 21.79 21.50 11.25 23.03 20.90 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 19.40 19.75 18.58 17.39 17.81 18.80 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 21.57 22.52 22.79 19.20 21.13 23.26 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 1xqd_c02 source 1xqd CYTOCHROME P450 55A1 : 2 hits 1xqd_c02 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA B 29 ALA^? 16.76 O1 EDO A 124 B 126 ARG B 30 ARG^? 10.56 O1 EDO A 124 B 138 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 2.11 4.00 19.31 3.14 4.86 19.99 -36.15 -29.79 -12.19 -37.52 -30.44 -12.12 coo 2.45 5.53 11.28 3.59 7.56 13.29 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 6.10 2.00 25.24 6.12 1.84 23.13 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA B 29 ALA^? 16.76 O1 EDO A 124 C 126 ARG B 30 ARG^? 10.56 O1 EDO A 124 C 138 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -36.15 -29.79 -12.19 -37.52 -30.44 -12.12 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 29 ALA^? 9.43 O2 EDO A 124 D 126 ARG A 30 ARG^? -2.97 O2 EDO A 124s D 138 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -25.58 -35.99 -31.45 -25.46 -37.49 -31.45 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 6.23 0.50 57.10 5.93 0.72 59.19 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA B 29 ALA^? 16.76 O1 EDO A 124 D 126 ARG B 30 ARG^? 10.56 O1 EDO A 124 D 138 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -36.15 -29.79 -12.19 -37.52 -30.44 -12.12 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 6.23 0.50 57.10 5.93 0.72 59.19 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 29 ALA^? 9.43 O2 EDO A 124 E 126 ARG A 30 ARG^? -2.97 O2 EDO A 124s E 138 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -25.58 -35.99 -31.45 -25.46 -37.49 -31.45 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA B 29 ALA^? 16.76 O1 EDO A 124 E 126 ARG B 30 ARG^? 10.56 O1 EDO A 124 E 138 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -36.15 -29.79 -12.19 -37.52 -30.44 -12.12 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA B 29 ALA^? 16.76 O1 EDO A 124 F 126 ARG B 30 ARG^? 10.56 O1 EDO A 124 F 138 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -36.15 -29.79 -12.19 -37.52 -30.44 -12.12 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c11 naa= 3 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 1 3 # 1 142 TRP A 80 TRP^? 10.72 O1 EDO A 125 223 ASP A 63 ASP~? 17.25 O1 EDO A 124 258 ALA A 49 ALA^? 7.86 C1 EDO A 124 coo 128.40 33.01 26.67 128.12 36.28 28.81 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 127.91 41.73 23.55 129.18 40.35 24.44 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 141.00 37.49 25.74 139.80 37.53 24.78 -27.58 -35.61 -22.27 -27.19 -34.24 -21.71 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 2 3 # 2 142 TRP A 80 TRP^? 10.72 O1 EDO A 125 223 ASP A 64 ASP~? 20.53 O2 EDO A 124 258 ALA A 36 ALA.? 14.13 O1 EDO A 124 coo 128.40 33.01 26.67 128.12 36.28 28.81 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 127.91 41.73 23.55 129.18 40.35 24.44 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 141.00 37.49 25.74 139.80 37.53 24.78 -18.11 -33.66 -20.67 -17.40 -34.10 -19.41 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 3 3 # 3 142 TRP A 80 TRP^? 10.72 O1 EDO A 125 223 ASP A 86 ASP^? 9.05 O1 EDO A 125 258 ALA A 26 ALA^? 11.43 O2 EDO A 124 coo 128.40 33.01 26.67 128.12 36.28 28.81 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 127.91 41.73 23.55 129.18 40.35 24.44 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 141.00 37.49 25.74 139.80 37.53 24.78 -31.83 -39.03 -32.30 -30.50 -39.69 -32.00 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 4 3 # 4 142 TRP B 80 TRP^? 20.31 C1 EDO A 124 223 ASP B 64 ASP~? 23.62 O1 EDO A 124 258 ALA B 36 ALA.? 11.83 C1 EDO A 124 coo 128.40 33.01 26.67 128.12 36.28 28.81 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 127.91 41.73 23.55 129.18 40.35 24.44 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 141.00 37.49 25.74 139.80 37.53 24.78 -37.66 -22.00 -23.01 -38.34 -21.47 -24.23 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 5 3 # 5 142 TRP B 80 TRP^? 20.31 C1 EDO A 124 223 ASP B 86 ASP^? 26.97 C1 EDO A 124 258 ALA B 26 ALA^? 18.43 C1 EDO A 124 coo 128.40 33.01 26.67 128.12 36.28 28.81 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 127.91 41.73 23.55 129.18 40.35 24.44 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 141.00 37.49 25.74 139.80 37.53 24.78 -35.37 -36.70 -11.28 -36.61 -35.88 -11.60 2aat_c01 source 2aat ASPARTATE AMINOTRANSFERASE (E.C.2.6.1.1) MUTAN: 5 hits 2aat_c01 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP B 32 ASP^? 9.42 O1 EDO A 124 231 ASP B 84 ASP.? 30.86 C1 EDO A 124 294 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 27.89 102.52 14.98 29.35 101.92 13.57 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 33.16 106.80 7.72 33.34 104.87 6.92 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP B 41 ASP^? 12.31 O1 EDO A 124 231 ASP A 63 ASP~? 17.25 O1 EDO A 124 294 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 27.89 102.52 14.98 29.35 101.92 13.57 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 33.16 106.80 7.72 33.34 104.87 6.92 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP B 41 ASP^? 12.31 O1 EDO A 124 231 ASP B 84 ASP.? 30.86 C1 EDO A 124 294 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 27.89 102.52 14.98 29.35 101.92 13.57 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 33.16 106.80 7.72 33.34 104.87 6.92 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 3 hits 2amg_c06 naa= 3 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 1 3 # 1 65 THR A 47 THR^? 4.31 C1 EDO A 124 242 CYH B 46 CYH.? 10.55 O2 EDO A 125 270 PHE A 50 PHE^? 8.88 O1 EDO A 125 coo 12.97 28.35 3.84 11.81 28.07 2.09 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 2 3 # 2 65 THR B 47 THR^? 9.39 O1 EDO A 124 242 CYH A 46 CYH.? 11.48 C1 EDO A 124 270 PHE B 50 PHE^? 13.90 C1 EDO A 124 coo 12.97 28.35 3.84 11.81 28.07 2.09 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 2cnd_c01 source 2cnd NADH-DEPENDENT NITRATE REDUCTASE (CYTOCHROME B: 2 hits 2cnd_c01 naa= 3 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 1 3 # 1 A 197 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 233 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 300 ASN A 44 ASN.? 12.85 O2 EDO A 124 coo 12.51 17.07 49.46 12.44 16.89 47.35 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 6.52 19.14 48.16 7.77 18.42 46.61 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 9.30 22.40 41.76 10.10 20.96 40.36 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 2cpu_c01 source 2cpu ALPHA-AMYLASE : 1 hits 2cpu_c01 naa= 3 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 102 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 193 GLY A 75 GLY.? 13.18 O1 EDO A 125 coo 14.96 29.22 19.55 15.62 29.93 17.67 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 19.64 30.69 22.61 18.18 29.94 21.25 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 14.54 28.99 9.76 15.06 29.59 10.02 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 102 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 193 GLY B 75 GLY.? 21.06 O2 EDO A 125 coo 14.96 29.22 19.55 15.62 29.93 17.67 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 19.64 30.69 22.61 18.18 29.94 21.25 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 14.54 28.99 9.76 15.06 29.59 10.02 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 2lpr_c02 source 2lpr ALPHA-LYTIC PROTEASE : 2 hits 2lpr_c02 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 50 PHE^? 8.88 O1 EDO A 125 A 263 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 292 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 51.51 50.32 16.39 52.13 49.68 13.75 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 54.43 44.82 23.74 55.21 45.06 21.80 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 63.95 45.30 16.71 59.11 49.15 16.05 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE B 50 PHE^? 13.90 C1 EDO A 124 A 263 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 292 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 51.51 50.32 16.39 52.13 49.68 13.75 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 54.43 44.82 23.74 55.21 45.06 21.80 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 63.95 45.30 16.71 59.11 49.15 16.05 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 50 PHE^? 8.88 O1 EDO A 125 B 263 ASP A 32 ASP^? 7.79 O1 EDO A 124 B 292 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 49.99 26.05 6.28 51.46 26.87 8.49 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 60.53 31.67 0.97 57.79 27.51 3.63 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE B 50 PHE^? 13.90 C1 EDO A 124 B 263 ASP B 32 ASP^? 9.42 O1 EDO A 124 B 292 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 49.99 26.05 6.28 51.46 26.87 8.49 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 60.53 31.67 0.97 57.79 27.51 3.63 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 50 PHE^? 8.88 O1 EDO A 125 C 263 ASP A 32 ASP^? 7.79 O1 EDO A 124 C 292 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 19.84 12.02 9.33 18.68 11.23 7.75 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 12.82 3.49 4.98 17.80 5.59 1.90 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE B 50 PHE^? 13.90 C1 EDO A 124 C 263 ASP B 32 ASP^? 9.42 O1 EDO A 124 C 292 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 19.84 12.02 9.33 18.68 11.23 7.75 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 12.82 3.49 4.98 17.80 5.59 1.90 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c05 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 32 ASP^? 7.79 O1 EDO A 124 166 GLY A 75 GLY.? 13.18 O1 EDO A 125 169 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 8.28 6.87 1.62 10.08 5.77 1.34 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 32 ASP^? 7.79 O1 EDO A 124 166 GLY A 77 GLY^? 7.89 O1 EDO A 125 169 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 8.28 6.87 1.62 10.08 5.77 1.34 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -28.29 -45.93 -31.97 -28.42 -45.22 -32.28 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 41 ASP^? -2.91 O2 EDO A 124s 166 GLY A 95 GLY.? 7.33 O2 EDO A 125 169 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 8.28 6.87 1.62 10.08 5.77 1.34 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 41 ASP^? -2.91 O2 EDO A 124s 166 GLY B 45 GLY.? 14.70 O2 EDO A 125 169 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 8.28 6.87 1.62 10.08 5.77 1.34 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP A 63 ASP~? 17.25 O1 EDO A 124 166 GLY B 45 GLY.? 14.70 O2 EDO A 125 169 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 8.28 6.87 1.62 10.08 5.77 1.34 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP A 84 ASP.? 13.20 O1 EDO A 125 166 GLY A 73 GLY.? 12.76 O1 EDO A 125 169 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 8.28 6.87 1.62 10.08 5.77 1.34 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -30.36 -47.03 -37.01 -30.17 -46.21 -37.42 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP A 84 ASP.? 13.20 O1 EDO A 125 166 GLY A 75 GLY.? 13.18 O1 EDO A 125 169 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 8.28 6.87 1.62 10.08 5.77 1.34 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP A 84 ASP.? 13.20 O1 EDO A 125 166 GLY A 75 GLY.? 13.18 O1 EDO A 125 169 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 8.28 6.87 1.62 10.08 5.77 1.34 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP A 84 ASP.? 13.20 O1 EDO A 125 166 GLY A 91 GLY~? 3.77 O2 EDO A 125 169 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 8.28 6.87 1.62 10.08 5.77 1.34 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -31.34 -48.06 -23.33 -31.38 -47.22 -23.45 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP A 86 ASP^? 9.05 O1 EDO A 125 166 GLY A 95 GLY.? 7.33 O2 EDO A 125 169 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 8.28 6.87 1.62 10.08 5.77 1.34 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP B 32 ASP^? 9.42 O1 EDO A 124 166 GLY B 75 GLY.? 21.06 O2 EDO A 125 169 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 8.28 6.87 1.62 10.08 5.77 1.34 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP B 32 ASP^? 9.42 O1 EDO A 124 166 GLY B 77 GLY^? 22.66 C1 EDO A 124 169 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 8.28 6.87 1.62 10.08 5.77 1.34 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -43.26 -37.30 -11.50 -42.54 -37.05 -11.23 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP B 84 ASP.? 30.86 C1 EDO A 124 166 GLY B 75 GLY.? 21.06 O2 EDO A 125 169 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 8.28 6.87 1.62 10.08 5.77 1.34 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP B 84 ASP.? 30.86 C1 EDO A 124 166 GLY B 75 GLY.? 21.06 O2 EDO A 125 169 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 8.28 6.87 1.62 10.08 5.77 1.34 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP B 84 ASP.? 30.86 C1 EDO A 124 166 GLY B 91 GLY~? 18.21 O2 EDO A 125 169 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 8.28 6.87 1.62 10.08 5.77 1.34 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -43.74 -41.04 -20.11 -43.00 -40.62 -20.02 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 15 hits 2tdt_c00 naa= 3 ULMN 2 132l_c00 LYSOZYME user 1 2 # 1 A 35 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 52 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 0.57 10.10 59.04 0.13 9.60 61.00 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -3.95 14.26 64.11 -2.90 13.35 65.69 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 132l_c00 LYSOZYME user 2 2 # 2 A 35 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 52 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 0.57 10.10 59.04 0.13 9.60 61.00 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo -3.95 14.26 64.11 -2.90 13.35 65.69 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 132l_c00 LYSOZYME user 3 2 # 3 A 35 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 52 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 0.57 10.10 59.04 0.13 9.60 61.00 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -3.95 14.26 64.11 -2.90 13.35 65.69 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 132l_c00 LYSOZYME user 4 2 # 4 A 35 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 52 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 0.57 10.10 59.04 0.13 9.60 61.00 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo -3.95 14.26 64.11 -2.90 13.35 65.69 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 132l_c00 source 132l LYSOZYME : 4 hits 132l_c00 naa= 2 ULMN 2 135l_c00 LYSOZYME user 1 2 # 1 35 GLU A 43 GLU.? 14.35 O2 EDO A 124 52 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 11.73 12.37 28.72 9.72 13.02 28.94 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 9.54 19.42 32.23 7.70 18.49 32.58 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 135l_c00 LYSOZYME user 2 2 # 2 35 GLU A 81 GLU.? 16.59 O1 EDO A 125 52 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 11.73 12.37 28.72 9.72 13.02 28.94 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 9.54 19.42 32.23 7.70 18.49 32.58 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 135l_c00 LYSOZYME user 3 2 # 3 35 GLU B 43 GLU.? 19.28 O2 EDO A 125 52 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 11.73 12.37 28.72 9.72 13.02 28.94 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 9.54 19.42 32.23 7.70 18.49 32.58 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 135l_c00 LYSOZYME user 4 2 # 4 35 GLU B 81 GLU.? 30.69 O1 EDO A 124 52 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 11.73 12.37 28.72 9.72 13.02 28.94 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 9.54 19.42 32.23 7.70 18.49 32.58 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 135l_c00 source 135l LYSOZYME : 4 hits 135l_c00 naa= 2 ULMN 2 1a26_c00 POLY (ADP-RIBOSE) POLYMERASE user 1 2 # 1 907 TYR A 76 TYR.? 12.73 O1 EDO A 125 988 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 42.62 20.46 18.03 40.71 19.08 19.58 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 coo 38.29 21.82 26.74 37.66 20.24 25.49 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1a26_c00 POLY (ADP-RIBOSE) POLYMERASE user 2 2 # 2 907 TYR B 76 TYR.? 17.92 O2 EDO A 125 988 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 42.62 20.46 18.03 40.71 19.08 19.58 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 coo 38.29 21.82 26.74 37.66 20.24 25.49 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 1a26_c00 source 1a26 POLY (ADP-RIBOSE) POLYMERASE : 2 hits 1a26_c00 naa= 2 ULMN 2 1a30_c01 HIV-1 PROTEASE user 1 2 # 1 A 25 ASP A 84 ASP.? 13.20 O1 EDO A 125 B 25 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 16.19 28.53 6.78 15.21 26.90 5.90 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 15.69 25.44 0.11 15.17 25.11 2.13 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1a30_c01 HIV-1 PROTEASE user 2 2 # 2 A 25 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 25 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 16.19 28.53 6.78 15.21 26.90 5.90 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 15.69 25.44 0.11 15.17 25.11 2.13 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1a30_c01 HIV-1 PROTEASE user 3 2 # 3 A 25 ASP B 63 ASP~? 17.37 O1 EDO A 124 B 25 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 16.19 28.53 6.78 15.21 26.90 5.90 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 15.69 25.44 0.11 15.17 25.11 2.13 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1a30_c01 HIV-1 PROTEASE user 4 2 # 4 A 25 ASP B 64 ASP~? 23.62 O1 EDO A 124 B 25 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 16.19 28.53 6.78 15.21 26.90 5.90 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 15.69 25.44 0.11 15.17 25.11 2.13 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1a30_c01 HIV-1 PROTEASE user 5 2 # 5 A 25 ASP B 84 ASP.? 30.86 C1 EDO A 124 B 25 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 16.19 28.53 6.78 15.21 26.90 5.90 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 15.69 25.44 0.11 15.17 25.11 2.13 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1a30_c01 HIV-1 PROTEASE user 6 2 # 6 A 25 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 25 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 16.19 28.53 6.78 15.21 26.90 5.90 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 15.69 25.44 0.11 15.17 25.11 2.13 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1a30_c01 source 1a30 HIV-1 PROTEASE : 6 hits 1a30_c01 naa= 2 ULMN 2 1a4g_c00 NEURAMINIDASE user 1 2 # 1 A 148 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 275 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 1.48 57.43 -11.18 0.69 58.45 -9.51 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo -7.02 52.62 -6.46 -5.66 54.00 -5.65 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1a4g_c00 NEURAMINIDASE user 2 2 # 2 A 148 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 275 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 1.48 57.43 -11.18 0.69 58.45 -9.51 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -7.02 52.62 -6.46 -5.66 54.00 -5.65 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1a4g_c00 NEURAMINIDASE user 3 2 # 3 A 148 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 275 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 1.48 57.43 -11.18 0.69 58.45 -9.51 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -7.02 52.62 -6.46 -5.66 54.00 -5.65 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1a4g_c00 NEURAMINIDASE user 4 2 # 4 A 148 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 275 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 1.48 57.43 -11.18 0.69 58.45 -9.51 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo -7.02 52.62 -6.46 -5.66 54.00 -5.65 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1a4g_c00 NEURAMINIDASE user 5 2 # 5 A 148 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 275 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 1.48 57.43 -11.18 0.69 58.45 -9.51 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo -7.02 52.62 -6.46 -5.66 54.00 -5.65 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1a4g_c00 NEURAMINIDASE user 6 2 # 6 A 148 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 275 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 1.48 57.43 -11.18 0.69 58.45 -9.51 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo -7.02 52.62 -6.46 -5.66 54.00 -5.65 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1a4g_c00 source 1a4g NEURAMINIDASE : 6 hits 1a4g_c00 naa= 2 ULMN 2 1a4g_c01 NEURAMINIDASE user 1 2 # 1 B 148 ASP A 84 ASP.? 13.20 O1 EDO A 125 B 275 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 34.98 38.01 -27.14 34.06 39.37 -28.44 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 26.72 33.17 -32.28 27.02 35.22 -31.99 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1a4g_c01 NEURAMINIDASE user 2 2 # 2 B 148 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 275 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 34.98 38.01 -27.14 34.06 39.37 -28.44 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 26.72 33.17 -32.28 27.02 35.22 -31.99 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1a4g_c01 NEURAMINIDASE user 3 2 # 3 B 148 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 275 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 34.98 38.01 -27.14 34.06 39.37 -28.44 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 26.72 33.17 -32.28 27.02 35.22 -31.99 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1a4g_c01 NEURAMINIDASE user 4 2 # 4 B 148 ASP B 84 ASP.? 30.86 C1 EDO A 124 B 275 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 34.98 38.01 -27.14 34.06 39.37 -28.44 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 26.72 33.17 -32.28 27.02 35.22 -31.99 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1a4g_c01 NEURAMINIDASE user 5 2 # 5 B 148 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 275 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 34.98 38.01 -27.14 34.06 39.37 -28.44 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 26.72 33.17 -32.28 27.02 35.22 -31.99 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1a4g_c01 NEURAMINIDASE user 6 2 # 6 B 148 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 275 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 34.98 38.01 -27.14 34.06 39.37 -28.44 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 26.72 33.17 -32.28 27.02 35.22 -31.99 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1a4g_c01 source 1a4g NEURAMINIDASE : 6 hits 1a4g_c01 naa= 2 ULMN 2 1a69_c00 PURINE NUCLEOSIDE PHOSPHORYLASE user 1 2 # 1 A 204 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 217 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo -24.32 68.31 63.50 -22.74 69.45 64.25 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -24.22 66.54 70.62 -24.40 68.56 68.30 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1a69_c00 PURINE NUCLEOSIDE PHOSPHORYLASE user 2 2 # 2 A 204 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 217 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo -24.32 68.31 63.50 -22.74 69.45 64.25 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -24.22 66.54 70.62 -24.40 68.56 68.30 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1a69_c00 PURINE NUCLEOSIDE PHOSPHORYLASE user 3 2 # 3 A 204 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 217 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo -24.32 68.31 63.50 -22.74 69.45 64.25 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -24.22 66.54 70.62 -24.40 68.56 68.30 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1a69_c00 PURINE NUCLEOSIDE PHOSPHORYLASE user 4 2 # 4 A 204 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 217 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo -24.32 68.31 63.50 -22.74 69.45 64.25 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo -24.22 66.54 70.62 -24.40 68.56 68.30 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1a69_c00 PURINE NUCLEOSIDE PHOSPHORYLASE user 5 2 # 5 A 204 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 217 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -24.32 68.31 63.50 -22.74 69.45 64.25 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo -24.22 66.54 70.62 -24.40 68.56 68.30 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1a69_c00 PURINE NUCLEOSIDE PHOSPHORYLASE user 6 2 # 6 A 204 ASP A 64 ASP~? 20.53 O2 EDO A 124 A 217 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo -24.32 68.31 63.50 -22.74 69.45 64.25 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo -24.22 66.54 70.62 -24.40 68.56 68.30 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1a69_c00 PURINE NUCLEOSIDE PHOSPHORYLASE user 7 2 # 7 A 204 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 217 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo -24.32 68.31 63.50 -22.74 69.45 64.25 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -24.22 66.54 70.62 -24.40 68.56 68.30 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1a69_c00 PURINE NUCLEOSIDE PHOSPHORYLASE user 8 2 # 8 A 204 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 217 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo -24.32 68.31 63.50 -22.74 69.45 64.25 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -24.22 66.54 70.62 -24.40 68.56 68.30 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1a69_c00 PURINE NUCLEOSIDE PHOSPHORYLASE user 9 2 # 9 A 204 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 217 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo -24.32 68.31 63.50 -22.74 69.45 64.25 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -24.22 66.54 70.62 -24.40 68.56 68.30 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1a69_c00 PURINE NUCLEOSIDE PHOSPHORYLASE user 10 2 # 10 A 204 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 217 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo -24.32 68.31 63.50 -22.74 69.45 64.25 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo -24.22 66.54 70.62 -24.40 68.56 68.30 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1a69_c00 PURINE NUCLEOSIDE PHOSPHORYLASE user 11 2 # 11 A 204 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 217 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo -24.32 68.31 63.50 -22.74 69.45 64.25 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo -24.22 66.54 70.62 -24.40 68.56 68.30 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 1a69_c00 source 1a69 PURINE NUCLEOSIDE PHOSPHORYLASE : 11 hits 1a69_c00 naa= 2 ULMN 2 1a69_c02 PURINE NUCLEOSIDE PHOSPHORYLASE user 1 2 # 1 C 204 ASP A 32 ASP^? 7.79 O1 EDO A 124 C 217 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo -3.24 84.82 92.39 -3.67 84.32 90.40 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -8.68 83.28 98.52 -7.90 81.07 100.50 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1a69_c02 PURINE NUCLEOSIDE PHOSPHORYLASE user 2 2 # 2 C 204 ASP A 32 ASP^? 7.79 O1 EDO A 124 C 217 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo -3.24 84.82 92.39 -3.67 84.32 90.40 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -8.68 83.28 98.52 -7.90 81.07 100.50 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1a69_c02 PURINE NUCLEOSIDE PHOSPHORYLASE user 3 2 # 3 C 204 ASP A 41 ASP^? -2.91 O2 EDO A 124s C 217 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo -3.24 84.82 92.39 -3.67 84.32 90.40 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo -8.68 83.28 98.52 -7.90 81.07 100.50 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1a69_c02 PURINE NUCLEOSIDE PHOSPHORYLASE user 4 2 # 4 C 204 ASP A 41 ASP^? -2.91 O2 EDO A 124s C 217 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo -3.24 84.82 92.39 -3.67 84.32 90.40 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo -8.68 83.28 98.52 -7.90 81.07 100.50 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1a69_c02 PURINE NUCLEOSIDE PHOSPHORYLASE user 5 2 # 5 C 204 ASP A 63 ASP~? 17.25 O1 EDO A 124 C 217 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -3.24 84.82 92.39 -3.67 84.32 90.40 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo -8.68 83.28 98.52 -7.90 81.07 100.50 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1a69_c02 PURINE NUCLEOSIDE PHOSPHORYLASE user 6 2 # 6 C 204 ASP A 64 ASP~? 20.53 O2 EDO A 124 C 217 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo -3.24 84.82 92.39 -3.67 84.32 90.40 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo -8.68 83.28 98.52 -7.90 81.07 100.50 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1a69_c02 PURINE NUCLEOSIDE PHOSPHORYLASE user 7 2 # 7 C 204 ASP B 32 ASP^? 9.42 O1 EDO A 124 C 217 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo -3.24 84.82 92.39 -3.67 84.32 90.40 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -8.68 83.28 98.52 -7.90 81.07 100.50 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1a69_c02 PURINE NUCLEOSIDE PHOSPHORYLASE user 8 2 # 8 C 204 ASP B 32 ASP^? 9.42 O1 EDO A 124 C 217 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo -3.24 84.82 92.39 -3.67 84.32 90.40 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -8.68 83.28 98.52 -7.90 81.07 100.50 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1a69_c02 PURINE NUCLEOSIDE PHOSPHORYLASE user 9 2 # 9 C 204 ASP B 41 ASP^? 12.31 O1 EDO A 124 C 217 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo -3.24 84.82 92.39 -3.67 84.32 90.40 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo -8.68 83.28 98.52 -7.90 81.07 100.50 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1a69_c02 PURINE NUCLEOSIDE PHOSPHORYLASE user 10 2 # 10 C 204 ASP B 41 ASP^? 12.31 O1 EDO A 124 C 217 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo -3.24 84.82 92.39 -3.67 84.32 90.40 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo -8.68 83.28 98.52 -7.90 81.07 100.50 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1a69_c02 PURINE NUCLEOSIDE PHOSPHORYLASE user 11 2 # 11 C 204 ASP B 63 ASP~? 17.37 O1 EDO A 124 C 217 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo -3.24 84.82 92.39 -3.67 84.32 90.40 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo -8.68 83.28 98.52 -7.90 81.07 100.50 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1a69_c02 PURINE NUCLEOSIDE PHOSPHORYLASE user 12 2 # 12 C 204 ASP B 64 ASP~? 23.62 O1 EDO A 124 C 217 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo -3.24 84.82 92.39 -3.67 84.32 90.40 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo -8.68 83.28 98.52 -7.90 81.07 100.50 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 1a69_c02 source 1a69 PURINE NUCLEOSIDE PHOSPHORYLASE : 12 hits 1a69_c02 naa= 2 ULMN 2 1aam_c00 ASPARTATE AMINOTRANSFERASE user 1 2 # 1 142 TRP A 80 TRP^? 10.72 O1 EDO A 125 223 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 127.19 33.46 26.14 126.78 36.79 28.15 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 126.95 41.66 23.38 128.48 40.72 24.51 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1aam_c00 ASPARTATE AMINOTRANSFERASE user 2 2 # 2 142 TRP A 80 TRP^? 10.72 O1 EDO A 125 223 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 127.19 33.46 26.14 126.78 36.79 28.15 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 126.95 41.66 23.38 128.48 40.72 24.51 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1aam_c00 ASPARTATE AMINOTRANSFERASE user 3 2 # 3 142 TRP A 80 TRP^? 10.72 O1 EDO A 125 223 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 127.19 33.46 26.14 126.78 36.79 28.15 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 126.95 41.66 23.38 128.48 40.72 24.51 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1aam_c00 ASPARTATE AMINOTRANSFERASE user 4 2 # 4 142 TRP A 80 TRP^? 10.72 O1 EDO A 125 223 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 127.19 33.46 26.14 126.78 36.79 28.15 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 126.95 41.66 23.38 128.48 40.72 24.51 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1aam_c00 ASPARTATE AMINOTRANSFERASE user 5 2 # 5 142 TRP B 80 TRP^? 20.31 C1 EDO A 124 223 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 127.19 33.46 26.14 126.78 36.79 28.15 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 126.95 41.66 23.38 128.48 40.72 24.51 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1aam_c00 ASPARTATE AMINOTRANSFERASE user 6 2 # 6 142 TRP B 80 TRP^? 20.31 C1 EDO A 124 223 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 127.19 33.46 26.14 126.78 36.79 28.15 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 126.95 41.66 23.38 128.48 40.72 24.51 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1aam_c00 ASPARTATE AMINOTRANSFERASE user 7 2 # 7 142 TRP B 80 TRP^? 20.31 C1 EDO A 124 223 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 127.19 33.46 26.14 126.78 36.79 28.15 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 126.95 41.66 23.38 128.48 40.72 24.51 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1aam_c00 source 1aam ASPARTATE AMINOTRANSFERASE : 7 hits 1aam_c00 naa= 2 ULMN 2 1abr_c00 ABRIN-A COMPLEXED WITH TWO SUGAR CHAuser 1 2 # 1 A 164 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 167 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 62.73 6.07 37.74 64.13 7.43 36.88 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 64.19 10.87 39.90 66.62 8.97 39.90 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1abr_c00 ABRIN-A COMPLEXED WITH TWO SUGAR CHAuser 2 2 # 2 A 164 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 167 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 62.73 6.07 37.74 64.13 7.43 36.88 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 64.19 10.87 39.90 66.62 8.97 39.90 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1abr_c00 ABRIN-A COMPLEXED WITH TWO SUGAR CHAuser 3 2 # 3 A 164 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 167 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 62.73 6.07 37.74 64.13 7.43 36.88 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 64.19 10.87 39.90 66.62 8.97 39.90 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1abr_c00 ABRIN-A COMPLEXED WITH TWO SUGAR CHAuser 4 2 # 4 A 164 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 167 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo 62.73 6.07 37.74 64.13 7.43 36.88 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 64.19 10.87 39.90 66.62 8.97 39.90 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1abr_c00 ABRIN-A COMPLEXED WITH TWO SUGAR CHAuser 5 2 # 5 A 164 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 167 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 62.73 6.07 37.74 64.13 7.43 36.88 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 64.19 10.87 39.90 66.62 8.97 39.90 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1abr_c00 ABRIN-A COMPLEXED WITH TWO SUGAR CHAuser 6 2 # 6 A 164 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 167 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 62.73 6.07 37.74 64.13 7.43 36.88 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 64.19 10.87 39.90 66.62 8.97 39.90 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1abr_c00 ABRIN-A COMPLEXED WITH TWO SUGAR CHAuser 7 2 # 7 A 164 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 167 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 62.73 6.07 37.74 64.13 7.43 36.88 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 64.19 10.87 39.90 66.62 8.97 39.90 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1abr_c00 source 1abr ABRIN-A COMPLEXED WITH TWO SUGAR CHAINS : 7 hits 1abr_c00 naa= 2 ULMN 2 1af7_c00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 1 2 # 1 98 ARG A 25 ARG.? 17.39 O2 EDO A 124 154 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 30.46 16.14 41.59 29.16 15.67 44.34 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 29.87 29.36 46.86 29.51 27.55 47.90 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1af7_c00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 2 2 # 2 98 ARG A 25 ARG.? 17.39 O2 EDO A 124 154 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 30.46 16.14 41.59 29.16 15.67 44.34 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 29.87 29.36 46.86 29.51 27.55 47.90 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1af7_c00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 3 2 # 3 98 ARG A 30 ARG^? -2.97 O2 EDO A 124s 154 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 30.46 16.14 41.59 29.16 15.67 44.34 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 29.87 29.36 46.86 29.51 27.55 47.90 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1af7_c00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 4 2 # 4 98 ARG A 30 ARG^? -2.97 O2 EDO A 124s 154 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 30.46 16.14 41.59 29.16 15.67 44.34 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 29.87 29.36 46.86 29.51 27.55 47.90 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1af7_c00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 5 2 # 5 98 ARG A 37 ARG^? 13.77 O1 EDO A 124 154 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 30.46 16.14 41.59 29.16 15.67 44.34 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 29.87 29.36 46.86 29.51 27.55 47.90 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1af7_c00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 6 2 # 6 98 ARG A 37 ARG^? 13.77 O1 EDO A 124 154 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 30.46 16.14 41.59 29.16 15.67 44.34 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 29.87 29.36 46.86 29.51 27.55 47.90 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1af7_c00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 7 2 # 7 98 ARG A 53 ARG~? 17.45 O1 EDO A 125 154 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 30.46 16.14 41.59 29.16 15.67 44.34 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 29.87 29.36 46.86 29.51 27.55 47.90 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1af7_c00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 8 2 # 8 98 ARG B 25 ARG.? 18.77 O2 EDO A 125 154 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 30.46 16.14 41.59 29.16 15.67 44.34 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 29.87 29.36 46.86 29.51 27.55 47.90 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1af7_c00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 9 2 # 9 98 ARG B 25 ARG.? 18.77 O2 EDO A 125 154 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 30.46 16.14 41.59 29.16 15.67 44.34 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 29.87 29.36 46.86 29.51 27.55 47.90 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1af7_c00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 10 2 # 10 98 ARG B 30 ARG^? 10.56 O1 EDO A 124 154 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 30.46 16.14 41.59 29.16 15.67 44.34 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 29.87 29.36 46.86 29.51 27.55 47.90 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1af7_c00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 11 2 # 11 98 ARG B 30 ARG^? 10.56 O1 EDO A 124 154 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 30.46 16.14 41.59 29.16 15.67 44.34 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 29.87 29.36 46.86 29.51 27.55 47.90 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1af7_c00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 12 2 # 12 98 ARG B 37 ARG^? 8.36 C1 EDO A 124 154 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 30.46 16.14 41.59 29.16 15.67 44.34 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 29.87 29.36 46.86 29.51 27.55 47.90 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1af7_c00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 13 2 # 13 98 ARG B 37 ARG^? 8.36 C1 EDO A 124 154 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 30.46 16.14 41.59 29.16 15.67 44.34 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 29.87 29.36 46.86 29.51 27.55 47.90 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1af7_c00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 14 2 # 14 98 ARG B 37 ARG^? 8.36 C1 EDO A 124 154 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 30.46 16.14 41.59 29.16 15.67 44.34 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 29.87 29.36 46.86 29.51 27.55 47.90 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1af7_c00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 15 2 # 15 98 ARG B 53 ARG~? 17.71 C1 EDO A 124 154 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 30.46 16.14 41.59 29.16 15.67 44.34 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 29.87 29.36 46.86 29.51 27.55 47.90 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1af7_c00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 16 2 # 16 98 ARG B 53 ARG~? 17.71 C1 EDO A 124 154 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 30.46 16.14 41.59 29.16 15.67 44.34 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 29.87 29.36 46.86 29.51 27.55 47.90 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 1af7_c00 source 1af7 CHEMOTAXIS RECEPTOR METHYLTRANSFERASE CHER : 16 hits 1af7_c00 naa= 2 ULMN 2 1agm_c00 GLUCOAMYLASE-471 (GLUCAN 1,4-ALPHA-Guser 1 2 # 1 179 GLU A 23 GLU.? 13.04 O2 EDO A 125 400 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 32.98 15.63 8.99 31.06 16.43 9.08 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 34.51 26.41 7.72 33.50 24.94 6.68 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1agm_c00 GLUCOAMYLASE-471 (GLUCAN 1,4-ALPHA-Guser 2 2 # 2 179 GLU A 43 GLU.? 14.35 O2 EDO A 124 400 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 32.98 15.63 8.99 31.06 16.43 9.08 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 34.51 26.41 7.72 33.50 24.94 6.68 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1agm_c00 GLUCOAMYLASE-471 (GLUCAN 1,4-ALPHA-Guser 3 2 # 3 179 GLU B 23 GLU.? 12.57 O2 EDO A 125 400 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 32.98 15.63 8.99 31.06 16.43 9.08 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 34.51 26.41 7.72 33.50 24.94 6.68 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1agm_c00 GLUCOAMYLASE-471 (GLUCAN 1,4-ALPHA-Guser 4 2 # 4 179 GLU B 43 GLU.? 19.28 O2 EDO A 125 400 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 32.98 15.63 8.99 31.06 16.43 9.08 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 34.51 26.41 7.72 33.50 24.94 6.68 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1agm_c00 source 1agm GLUCOAMYLASE-471 (GLUCAN 1,4-ALPHA-GLUCOSIDASE: 4 hits 1agm_c00 naa= 2 ULMN 2 1akd_c00 CYTOCHROME P450CAM user 1 2 # 1 251 ASP A 41 ASP^? -2.91 O2 EDO A 124s 252 THR A 47 THR^? 4.31 C1 EDO A 124 coo 22.35 20.89 12.77 23.04 22.54 13.90 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 17.85 20.47 14.62 16.85 19.84 12.80 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 ULMN 2 1akd_c00 CYTOCHROME P450CAM user 2 2 # 2 251 ASP A 84 ASP.? 13.20 O1 EDO A 125 252 THR A 82 THR.? 18.68 O1 EDO A 125 coo 22.35 20.89 12.77 23.04 22.54 13.90 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 17.85 20.47 14.62 16.85 19.84 12.80 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 ULMN 2 1akd_c00 CYTOCHROME P450CAM user 3 2 # 3 251 ASP B 41 ASP^? 12.31 O1 EDO A 124 252 THR B 47 THR^? 9.39 O1 EDO A 124 coo 22.35 20.89 12.77 23.04 22.54 13.90 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 17.85 20.47 14.62 16.85 19.84 12.80 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 ULMN 2 1akd_c00 CYTOCHROME P450CAM user 4 2 # 4 251 ASP B 84 ASP.? 30.86 C1 EDO A 124 252 THR B 82 THR.? 29.24 O1 EDO A 124 coo 22.35 20.89 12.77 23.04 22.54 13.90 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 17.85 20.47 14.62 16.85 19.84 12.80 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 1akd_c00 source 1akd CYTOCHROME P450CAM : 4 hits 1akd_c00 naa= 2 ULMN 2 1alk_c00 ALKALINE PHOSPHATASE (E.C.3.1.3.1) user 1 2 # 1 A 102 SER A 34 SER.? 10.92 O1 EDO A 124 A 166 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 77.14 38.59 40.00 75.03 39.65 40.47 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo 80.16 39.46 45.79 77.49 39.97 44.40 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1alk_c00 ALKALINE PHOSPHATASE (E.C.3.1.3.1) user 2 2 # 2 A 102 SER A 35 SER.? 8.67 O1 EDO A 124 A 166 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 77.14 38.59 40.00 75.03 39.65 40.47 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo 80.16 39.46 45.79 77.49 39.97 44.40 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1alk_c00 ALKALINE PHOSPHATASE (E.C.3.1.3.1) user 3 2 # 3 A 102 SER A 62 SER~? 19.90 O1 EDO A 125 A 166 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 77.14 38.59 40.00 75.03 39.65 40.47 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo 80.16 39.46 45.79 77.49 39.97 44.40 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1alk_c00 ALKALINE PHOSPHATASE (E.C.3.1.3.1) user 4 2 # 4 A 102 SER B 34 SER.? 9.94 O1 EDO A 124 A 166 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 77.14 38.59 40.00 75.03 39.65 40.47 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 coo 80.16 39.46 45.79 77.49 39.97 44.40 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1alk_c00 ALKALINE PHOSPHATASE (E.C.3.1.3.1) user 5 2 # 5 A 102 SER B 35 SER.? 7.36 O1 EDO A 124 A 166 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 77.14 38.59 40.00 75.03 39.65 40.47 -33.90 -21.70 -23.70 -33.48 -23.60 -22.25 coo 80.16 39.46 45.79 77.49 39.97 44.40 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1alk_c00 ALKALINE PHOSPHATASE (E.C.3.1.3.1) user 6 2 # 6 A 102 SER B 62 SER~? 23.65 O1 EDO A 124 A 166 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 77.14 38.59 40.00 75.03 39.65 40.47 -46.80 -18.27 -18.25 -47.35 -17.46 -16.02 coo 80.16 39.46 45.79 77.49 39.97 44.40 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1alk_c00 source 1alk ALKALINE PHOSPHATASE (E.C.3.1.3.1) : 6 hits 1alk_c00 naa= 2 ULMN 2 1alk_c01 ALKALINE PHOSPHATASE (E.C.3.1.3.1) user 1 2 # 1 B 102 SER A 34 SER.? 10.92 O1 EDO A 124 B 166 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 49.65 19.46 28.35 51.43 18.07 29.31 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo 44.56 16.48 30.76 47.68 16.19 30.95 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1alk_c01 ALKALINE PHOSPHATASE (E.C.3.1.3.1) user 2 2 # 2 B 102 SER A 35 SER.? 8.67 O1 EDO A 124 B 166 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 49.65 19.46 28.35 51.43 18.07 29.31 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo 44.56 16.48 30.76 47.68 16.19 30.95 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1alk_c01 ALKALINE PHOSPHATASE (E.C.3.1.3.1) user 3 2 # 3 B 102 SER A 62 SER~? 19.90 O1 EDO A 125 B 166 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 49.65 19.46 28.35 51.43 18.07 29.31 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo 44.56 16.48 30.76 47.68 16.19 30.95 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1alk_c01 ALKALINE PHOSPHATASE (E.C.3.1.3.1) user 4 2 # 4 B 102 SER B 34 SER.? 9.94 O1 EDO A 124 B 166 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 49.65 19.46 28.35 51.43 18.07 29.31 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 coo 44.56 16.48 30.76 47.68 16.19 30.95 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1alk_c01 ALKALINE PHOSPHATASE (E.C.3.1.3.1) user 5 2 # 5 B 102 SER B 35 SER.? 7.36 O1 EDO A 124 B 166 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 49.65 19.46 28.35 51.43 18.07 29.31 -33.90 -21.70 -23.70 -33.48 -23.60 -22.25 coo 44.56 16.48 30.76 47.68 16.19 30.95 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1alk_c01 ALKALINE PHOSPHATASE (E.C.3.1.3.1) user 6 2 # 6 B 102 SER B 62 SER~? 23.65 O1 EDO A 124 B 166 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 49.65 19.46 28.35 51.43 18.07 29.31 -46.80 -18.27 -18.25 -47.35 -17.46 -16.02 coo 44.56 16.48 30.76 47.68 16.19 30.95 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1alk_c01 source 1alk ALKALINE PHOSPHATASE (E.C.3.1.3.1) : 6 hits 1alk_c01 naa= 2 ULMN 2 1amy_c00 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 2 # 1 179 ASP A 41 ASP^? -2.91 O2 EDO A 124s 204 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -0.62 65.95 29.97 0.31 67.47 31.05 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 4.34 62.44 32.05 4.22 64.48 32.53 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1amy_c00 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 2 # 2 179 ASP A 84 ASP.? 13.20 O1 EDO A 125 204 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo -0.62 65.95 29.97 0.31 67.47 31.05 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 4.34 62.44 32.05 4.22 64.48 32.53 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1amy_c00 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 2 # 3 179 ASP B 84 ASP.? 30.86 C1 EDO A 124 204 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo -0.62 65.95 29.97 0.31 67.47 31.05 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 4.34 62.44 32.05 4.22 64.48 32.53 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1amy_c00 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 3 hits 1amy_c00 naa= 2 ULMN 2 1aq0_c02 1,3-1,4-BETA-GLUCANASE user 1 2 # 1 A 232 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 288 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 5.76 85.47 37.35 6.76 85.56 39.24 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 13.49 92.75 43.16 12.39 91.15 42.33 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1aq0_c02 1,3-1,4-BETA-GLUCANASE user 2 2 # 2 A 232 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 288 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 5.76 85.47 37.35 6.76 85.56 39.24 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 13.49 92.75 43.16 12.39 91.15 42.33 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1aq0_c02 1,3-1,4-BETA-GLUCANASE user 3 2 # 3 A 232 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 288 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 5.76 85.47 37.35 6.76 85.56 39.24 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 13.49 92.75 43.16 12.39 91.15 42.33 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1aq0_c02 1,3-1,4-BETA-GLUCANASE user 4 2 # 4 A 232 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 288 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 5.76 85.47 37.35 6.76 85.56 39.24 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 13.49 92.75 43.16 12.39 91.15 42.33 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1aq0_c02 source 1aq0 1,3-1,4-BETA-GLUCANASE : 4 hits 1aq0_c02 naa= 2 ULMN 2 1aq0_c03 1,3-1,4-BETA-GLUCANASE user 1 2 # 1 B 232 GLU A 23 GLU.? 13.04 O2 EDO A 125 B 288 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1aq0_c03 1,3-1,4-BETA-GLUCANASE user 2 2 # 2 B 232 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 288 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1aq0_c03 1,3-1,4-BETA-GLUCANASE user 3 2 # 3 B 232 GLU B 23 GLU.? 12.57 O2 EDO A 125 B 288 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1aq0_c03 1,3-1,4-BETA-GLUCANASE user 4 2 # 4 B 232 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 288 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1aq0_c03 source 1aq0 1,3-1,4-BETA-GLUCANASE : 4 hits 1aq0_c03 naa= 2 ULMN 2 1ar1_c01 CYTOCHROME C OXIDASE user 1 2 # 1 A 278 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 354 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 10.31 15.79 49.32 9.85 15.75 51.40 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 ULMN 2 1ar1_c01 CYTOCHROME C OXIDASE user 2 2 # 2 A 278 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 354 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 10.31 15.79 49.32 9.85 15.75 51.40 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 1ar1_c01 source 1ar1 CYTOCHROME C OXIDASE : 2 hits 1ar1_c01 naa= 2 ULMN 2 1ast_c00 ASTACIN (E.C.3.4.24.21) user 1 2 # 1 93 GLU A 43 GLU.? 14.35 O2 EDO A 124 149 TYR A 76 TYR.? 12.73 O1 EDO A 125 coo 15.94 26.98 26.92 17.27 26.11 25.50 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 21.50 28.85 18.49 20.74 27.28 20.66 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 ULMN 2 1ast_c00 ASTACIN (E.C.3.4.24.21) user 2 2 # 2 93 GLU B 43 GLU.? 19.28 O2 EDO A 125 149 TYR B 76 TYR.? 17.92 O2 EDO A 125 coo 15.94 26.98 26.92 17.27 26.11 25.50 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 21.50 28.85 18.49 20.74 27.28 20.66 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 1ast_c00 source 1ast ASTACIN (E.C.3.4.24.21) : 2 hits 1ast_c00 naa= 2 ULMN 2 1aui_c00 SERINE/THREONINE PHOSPHATASE 2B user 1 2 # 1 A 121 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 151 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 36.02 34.17 59.82 36.67 36.08 60.21 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 39.14 33.02 62.65 39.91 32.02 60.97 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1aui_c00 SERINE/THREONINE PHOSPHATASE 2B user 2 2 # 2 A 121 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 151 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 36.02 34.17 59.82 36.67 36.08 60.21 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 39.14 33.02 62.65 39.91 32.02 60.97 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1aui_c00 source 1aui SERINE/THREONINE PHOSPHATASE 2B : 2 hits 1aui_c00 naa= 2 ULMN 2 1avf_c09 GASTRICSIN user 1 2 # 1 A 32 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 217 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1avf_c09 GASTRICSIN user 2 2 # 2 A 32 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 217 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1avf_c09 GASTRICSIN user 3 2 # 3 A 32 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 217 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1avf_c09 GASTRICSIN user 4 2 # 4 A 32 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 217 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1avf_c09 GASTRICSIN user 5 2 # 5 A 32 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 217 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1avf_c09 GASTRICSIN user 6 2 # 6 A 32 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 217 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1avf_c09 GASTRICSIN user 7 2 # 7 A 32 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 217 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1avf_c09 GASTRICSIN user 8 2 # 8 A 32 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 217 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1avf_c09 source 1avf GASTRICSIN : 8 hits 1avf_c09 naa= 2 ULMN 2 1avf_c10 GASTRICSIN user 1 2 # 1 J 32 ASP A 32 ASP^? 7.79 O1 EDO A 124 J 217 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1avf_c10 GASTRICSIN user 2 2 # 2 J 32 ASP A 63 ASP~? 17.25 O1 EDO A 124 J 217 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1avf_c10 GASTRICSIN user 3 2 # 3 J 32 ASP A 84 ASP.? 13.20 O1 EDO A 125 J 217 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1avf_c10 GASTRICSIN user 4 2 # 4 J 32 ASP A 86 ASP^? 9.05 O1 EDO A 125 J 217 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1avf_c10 GASTRICSIN user 5 2 # 5 J 32 ASP B 84 ASP.? 30.86 C1 EDO A 124 J 217 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1avf_c10 GASTRICSIN user 6 2 # 6 J 32 ASP B 86 ASP^? 26.97 C1 EDO A 124 J 217 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1avf_c10 source 1avf GASTRICSIN : 6 hits 1avf_c10 naa= 2 ULMN 2 1ay4_c00 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 2 # 1 A 140 TRP A 80 TRP^? 10.72 O1 EDO A 125 A 222 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 89.83 15.40 0.01 90.61 18.86 1.71 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 82.92 20.43 2.47 84.82 20.45 1.55 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1ay4_c00 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 2 # 2 A 140 TRP A 80 TRP^? 10.72 O1 EDO A 125 A 222 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 89.83 15.40 0.01 90.61 18.86 1.71 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 82.92 20.43 2.47 84.82 20.45 1.55 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1ay4_c00 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 2 # 3 A 140 TRP A 80 TRP^? 10.72 O1 EDO A 125 A 222 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 89.83 15.40 0.01 90.61 18.86 1.71 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 82.92 20.43 2.47 84.82 20.45 1.55 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1ay4_c00 AROMATIC AMINO ACID AMINOTRANSFERASEuser 4 2 # 4 A 140 TRP A 80 TRP^? 10.72 O1 EDO A 125 A 222 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 89.83 15.40 0.01 90.61 18.86 1.71 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 82.92 20.43 2.47 84.82 20.45 1.55 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1ay4_c00 AROMATIC AMINO ACID AMINOTRANSFERASEuser 5 2 # 5 A 140 TRP B 80 TRP^? 20.31 C1 EDO A 124 A 222 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 89.83 15.40 0.01 90.61 18.86 1.71 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 82.92 20.43 2.47 84.82 20.45 1.55 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1ay4_c00 AROMATIC AMINO ACID AMINOTRANSFERASEuser 6 2 # 6 A 140 TRP B 80 TRP^? 20.31 C1 EDO A 124 A 222 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 89.83 15.40 0.01 90.61 18.86 1.71 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 82.92 20.43 2.47 84.82 20.45 1.55 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1ay4_c00 AROMATIC AMINO ACID AMINOTRANSFERASEuser 7 2 # 7 A 140 TRP B 80 TRP^? 20.31 C1 EDO A 124 A 222 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 89.83 15.40 0.01 90.61 18.86 1.71 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 82.92 20.43 2.47 84.82 20.45 1.55 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1ay4_c00 AROMATIC AMINO ACID AMINOTRANSFERASEuser 8 2 # 8 A 140 TRP B 80 TRP^? 20.31 C1 EDO A 124 A 222 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 89.83 15.40 0.01 90.61 18.86 1.71 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 82.92 20.43 2.47 84.82 20.45 1.55 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1ay4_c00 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 8 hits 1ay4_c00 naa= 2 ULMN 2 1ay4_c01 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 2 # 1 B 140 TRP A 80 TRP^? 10.72 O1 EDO A 125 B 222 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 103.45 44.39 16.20 102.66 41.02 14.32 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 110.10 38.66 15.58 108.40 39.41 14.53 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1ay4_c01 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 2 # 2 B 140 TRP A 80 TRP^? 10.72 O1 EDO A 125 B 222 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 103.45 44.39 16.20 102.66 41.02 14.32 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 110.10 38.66 15.58 108.40 39.41 14.53 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1ay4_c01 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 2 # 3 B 140 TRP A 80 TRP^? 10.72 O1 EDO A 125 B 222 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 103.45 44.39 16.20 102.66 41.02 14.32 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 110.10 38.66 15.58 108.40 39.41 14.53 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1ay4_c01 AROMATIC AMINO ACID AMINOTRANSFERASEuser 4 2 # 4 B 140 TRP A 80 TRP^? 10.72 O1 EDO A 125 B 222 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 103.45 44.39 16.20 102.66 41.02 14.32 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 110.10 38.66 15.58 108.40 39.41 14.53 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1ay4_c01 AROMATIC AMINO ACID AMINOTRANSFERASEuser 5 2 # 5 B 140 TRP B 80 TRP^? 20.31 C1 EDO A 124 B 222 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 103.45 44.39 16.20 102.66 41.02 14.32 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 110.10 38.66 15.58 108.40 39.41 14.53 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1ay4_c01 AROMATIC AMINO ACID AMINOTRANSFERASEuser 6 2 # 6 B 140 TRP B 80 TRP^? 20.31 C1 EDO A 124 B 222 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 103.45 44.39 16.20 102.66 41.02 14.32 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 110.10 38.66 15.58 108.40 39.41 14.53 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1ay4_c01 AROMATIC AMINO ACID AMINOTRANSFERASEuser 7 2 # 7 B 140 TRP B 80 TRP^? 20.31 C1 EDO A 124 B 222 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 103.45 44.39 16.20 102.66 41.02 14.32 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 110.10 38.66 15.58 108.40 39.41 14.53 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1ay4_c01 AROMATIC AMINO ACID AMINOTRANSFERASEuser 8 2 # 8 B 140 TRP B 80 TRP^? 20.31 C1 EDO A 124 B 222 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 103.45 44.39 16.20 102.66 41.02 14.32 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 110.10 38.66 15.58 108.40 39.41 14.53 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1ay4_c01 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 8 hits 1ay4_c01 naa= 2 ULMN 2 1b2r_c01 FERREDOXIN-NADP+ REDUCTASE user 1 2 # 1 A 80 SER A 35 SER.? 8.67 O1 EDO A 124 A 301 ALA A 49 ALA^? 7.86 C1 EDO A 124 coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo -22.54 45.09 5.28 -22.99 46.36 4.56 -27.58 -35.61 -22.27 -27.19 -34.24 -21.71 ULMN 2 1b2r_c01 FERREDOXIN-NADP+ REDUCTASE user 2 2 # 2 A 80 SER A 62 SER~? 19.90 O1 EDO A 125 A 301 ALA A 36 ALA.? 14.13 O1 EDO A 124 coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo -22.54 45.09 5.28 -22.99 46.36 4.56 -18.11 -33.66 -20.67 -17.40 -34.10 -19.41 ULMN 2 1b2r_c01 FERREDOXIN-NADP+ REDUCTASE user 3 2 # 3 A 80 SER A 62 SER~? 19.90 O1 EDO A 125 A 301 ALA A 68 ALA.? 16.39 O1 EDO A 125 coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo -22.54 45.09 5.28 -22.99 46.36 4.56 -16.63 -39.03 -33.40 -15.61 -40.17 -33.58 ULMN 2 1b2r_c01 FERREDOXIN-NADP+ REDUCTASE user 4 2 # 4 A 80 SER A 88 SER^? -5.03 C1 EDO A 125s A 301 ALA A 26 ALA^? 11.43 O2 EDO A 124 coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 coo -22.54 45.09 5.28 -22.99 46.36 4.56 -31.83 -39.03 -32.30 -30.50 -39.69 -32.00 ULMN 2 1b2r_c01 FERREDOXIN-NADP+ REDUCTASE user 5 2 # 5 A 80 SER A 88 SER^? -5.03 C1 EDO A 125s A 301 ALA A 55 ALA~? 6.66 O1 EDO A 125 coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 coo -22.54 45.09 5.28 -22.99 46.36 4.56 -21.18 -46.19 -20.96 -21.62 -45.51 -22.25 ULMN 2 1b2r_c01 FERREDOXIN-NADP+ REDUCTASE user 6 2 # 6 A 80 SER A 88 SER^? -5.03 C1 EDO A 125s A 301 ALA A 94 ALA~? 7.26 O2 EDO A 125 coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 coo -22.54 45.09 5.28 -22.99 46.36 4.56 -33.85 -46.06 -19.52 -34.14 -47.43 -20.08 ULMN 2 1b2r_c01 FERREDOXIN-NADP+ REDUCTASE user 7 2 # 7 A 80 SER B 35 SER.? 7.36 O1 EDO A 124 A 301 ALA B 49 ALA^? 7.26 C1 EDO A 124 coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 -33.90 -21.70 -23.70 -33.48 -23.60 -22.25 coo -22.54 45.09 5.28 -22.99 46.36 4.56 -35.14 -31.27 -21.36 -34.12 -30.27 -21.87 ULMN 2 1b2r_c01 FERREDOXIN-NADP+ REDUCTASE user 8 2 # 8 A 80 SER B 62 SER~? 23.65 O1 EDO A 124 A 301 ALA B 36 ALA.? 11.83 C1 EDO A 124 coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 -46.80 -18.27 -18.25 -47.35 -17.46 -16.02 coo -22.54 45.09 5.28 -22.99 46.36 4.56 -37.66 -22.00 -23.01 -38.34 -21.47 -24.23 ULMN 2 1b2r_c01 FERREDOXIN-NADP+ REDUCTASE user 9 2 # 9 A 80 SER B 62 SER~? 23.65 O1 EDO A 124 A 301 ALA B 68 ALA.? 23.26 O1 EDO A 124 coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 -46.80 -18.27 -18.25 -47.35 -17.46 -16.02 coo -22.54 45.09 5.28 -22.99 46.36 4.56 -43.26 -23.68 -10.03 -44.76 -23.42 -9.87 ULMN 2 1b2r_c01 FERREDOXIN-NADP+ REDUCTASE user 10 2 # 10 A 80 SER B 88 SER^? 19.82 O2 EDO A 125 A 301 ALA B 26 ALA^? 18.43 C1 EDO A 124 coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 coo -22.54 45.09 5.28 -22.99 46.36 4.56 -35.37 -36.70 -11.28 -36.61 -35.88 -11.60 ULMN 2 1b2r_c01 FERREDOXIN-NADP+ REDUCTASE user 11 2 # 11 A 80 SER B 88 SER^? 19.82 O2 EDO A 125 A 301 ALA B 55 ALA~? 18.17 C1 EDO A 124 coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 coo -22.54 45.09 5.28 -22.99 46.36 4.56 -46.89 -31.34 -22.78 -46.09 -31.26 -21.50 ULMN 2 1b2r_c01 FERREDOXIN-NADP+ REDUCTASE user 12 2 # 12 A 80 SER B 88 SER^? 19.82 O2 EDO A 125 A 301 ALA B 94 ALA~? 15.22 O2 EDO A 125 coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 coo -22.54 45.09 5.28 -22.99 46.36 4.56 -40.74 -42.37 -23.75 -41.76 -43.26 -23.09 1b2r_c01 source 1b2r FERREDOXIN-NADP+ REDUCTASE : 12 hits 1b2r_c01 naa= 2 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 1 2 # 1 A 28 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 120 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo -6.26 14.85 21.66 -7.83 16.24 21.69 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -19.49 15.64 24.83 -18.39 16.64 23.30 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 2 2 # 2 A 28 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 120 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -6.26 14.85 21.66 -7.83 16.24 21.69 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -19.49 15.64 24.83 -18.39 16.64 23.30 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 3 2 # 3 A 28 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 120 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo -6.26 14.85 21.66 -7.83 16.24 21.69 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -19.49 15.64 24.83 -18.39 16.64 23.30 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 4 2 # 4 A 28 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 120 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo -6.26 14.85 21.66 -7.83 16.24 21.69 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -19.49 15.64 24.83 -18.39 16.64 23.30 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 5 2 # 5 A 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 120 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo -6.26 14.85 21.66 -7.83 16.24 21.69 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -19.49 15.64 24.83 -18.39 16.64 23.30 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 6 2 # 6 A 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 120 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo -6.26 14.85 21.66 -7.83 16.24 21.69 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -19.49 15.64 24.83 -18.39 16.64 23.30 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 7 2 # 7 A 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 120 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo -6.26 14.85 21.66 -7.83 16.24 21.69 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -19.49 15.64 24.83 -18.39 16.64 23.30 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 8 2 # 8 A 28 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 120 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo -6.26 14.85 21.66 -7.83 16.24 21.69 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo -19.49 15.64 24.83 -18.39 16.64 23.30 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 9 2 # 9 A 28 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 120 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo -6.26 14.85 21.66 -7.83 16.24 21.69 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -19.49 15.64 24.83 -18.39 16.64 23.30 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 10 2 # 10 A 28 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 120 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -6.26 14.85 21.66 -7.83 16.24 21.69 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -19.49 15.64 24.83 -18.39 16.64 23.30 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 11 2 # 11 A 28 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 120 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo -6.26 14.85 21.66 -7.83 16.24 21.69 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -19.49 15.64 24.83 -18.39 16.64 23.30 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 12 2 # 12 A 28 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 120 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo -6.26 14.85 21.66 -7.83 16.24 21.69 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -19.49 15.64 24.83 -18.39 16.64 23.30 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 13 2 # 13 A 28 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 120 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo -6.26 14.85 21.66 -7.83 16.24 21.69 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -19.49 15.64 24.83 -18.39 16.64 23.30 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 14 2 # 14 A 28 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 120 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo -6.26 14.85 21.66 -7.83 16.24 21.69 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -19.49 15.64 24.83 -18.39 16.64 23.30 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 15 2 # 15 A 28 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 120 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo -6.26 14.85 21.66 -7.83 16.24 21.69 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -19.49 15.64 24.83 -18.39 16.64 23.30 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 16 2 # 16 A 28 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 120 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo -6.26 14.85 21.66 -7.83 16.24 21.69 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo -19.49 15.64 24.83 -18.39 16.64 23.30 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 1b5t_c00 source 1b5t METHYLENETETRAHYDROFOLATE REDUCTASE : 16 hits 1b5t_c00 naa= 2 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 1 2 # 1 B 28 GLU A 23 GLU.? 13.04 O2 EDO A 125 B 120 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 19.99 54.72 24.39 18.91 52.94 24.71 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 19.27 43.87 32.88 18.74 43.97 30.83 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 2 2 # 2 B 28 GLU A 59 GLU.? 11.26 O1 EDO A 125 B 120 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 19.99 54.72 24.39 18.91 52.94 24.71 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 19.27 43.87 32.88 18.74 43.97 30.83 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 3 2 # 3 B 28 GLU A 59 GLU.? 11.26 O1 EDO A 125 B 120 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 19.99 54.72 24.39 18.91 52.94 24.71 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 19.27 43.87 32.88 18.74 43.97 30.83 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 4 2 # 4 B 28 GLU A 59 GLU.? 11.26 O1 EDO A 125 B 120 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 19.99 54.72 24.39 18.91 52.94 24.71 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 19.27 43.87 32.88 18.74 43.97 30.83 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 5 2 # 5 B 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 120 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 19.99 54.72 24.39 18.91 52.94 24.71 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 19.27 43.87 32.88 18.74 43.97 30.83 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 6 2 # 6 B 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 120 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 19.99 54.72 24.39 18.91 52.94 24.71 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 19.27 43.87 32.88 18.74 43.97 30.83 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 7 2 # 7 B 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 120 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 19.99 54.72 24.39 18.91 52.94 24.71 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 19.27 43.87 32.88 18.74 43.97 30.83 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 8 2 # 8 B 28 GLU A 81 GLU.? 16.59 O1 EDO A 125 B 120 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 19.99 54.72 24.39 18.91 52.94 24.71 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 19.27 43.87 32.88 18.74 43.97 30.83 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 9 2 # 9 B 28 GLU B 23 GLU.? 12.57 O2 EDO A 125 B 120 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 19.99 54.72 24.39 18.91 52.94 24.71 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 19.27 43.87 32.88 18.74 43.97 30.83 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 10 2 # 10 B 28 GLU B 59 GLU.? 24.69 C1 EDO A 124 B 120 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 19.99 54.72 24.39 18.91 52.94 24.71 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 19.27 43.87 32.88 18.74 43.97 30.83 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 11 2 # 11 B 28 GLU B 59 GLU.? 24.69 C1 EDO A 124 B 120 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 19.99 54.72 24.39 18.91 52.94 24.71 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 19.27 43.87 32.88 18.74 43.97 30.83 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 12 2 # 12 B 28 GLU B 59 GLU.? 24.69 C1 EDO A 124 B 120 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 19.99 54.72 24.39 18.91 52.94 24.71 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 19.27 43.87 32.88 18.74 43.97 30.83 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 13 2 # 13 B 28 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 120 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 19.99 54.72 24.39 18.91 52.94 24.71 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 19.27 43.87 32.88 18.74 43.97 30.83 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 14 2 # 14 B 28 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 120 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 19.99 54.72 24.39 18.91 52.94 24.71 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 19.27 43.87 32.88 18.74 43.97 30.83 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 15 2 # 15 B 28 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 120 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 19.99 54.72 24.39 18.91 52.94 24.71 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 19.27 43.87 32.88 18.74 43.97 30.83 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 16 2 # 16 B 28 GLU B 81 GLU.? 30.69 O1 EDO A 124 B 120 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 19.99 54.72 24.39 18.91 52.94 24.71 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 19.27 43.87 32.88 18.74 43.97 30.83 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 1b5t_c01 source 1b5t METHYLENETETRAHYDROFOLATE REDUCTASE : 16 hits 1b5t_c01 naa= 2 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 1 2 # 1 C 28 GLU A 23 GLU.? 13.04 O2 EDO A 125 C 120 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo -14.39 50.83 66.85 -15.79 51.94 65.73 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -15.26 61.78 57.87 -16.19 60.59 59.37 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 2 2 # 2 C 28 GLU A 59 GLU.? 11.26 O1 EDO A 125 C 120 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -14.39 50.83 66.85 -15.79 51.94 65.73 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -15.26 61.78 57.87 -16.19 60.59 59.37 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 3 2 # 3 C 28 GLU A 59 GLU.? 11.26 O1 EDO A 125 C 120 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo -14.39 50.83 66.85 -15.79 51.94 65.73 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -15.26 61.78 57.87 -16.19 60.59 59.37 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 4 2 # 4 C 28 GLU A 59 GLU.? 11.26 O1 EDO A 125 C 120 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo -14.39 50.83 66.85 -15.79 51.94 65.73 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -15.26 61.78 57.87 -16.19 60.59 59.37 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 5 2 # 5 C 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 C 120 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo -14.39 50.83 66.85 -15.79 51.94 65.73 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -15.26 61.78 57.87 -16.19 60.59 59.37 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 6 2 # 6 C 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 C 120 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo -14.39 50.83 66.85 -15.79 51.94 65.73 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -15.26 61.78 57.87 -16.19 60.59 59.37 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 7 2 # 7 C 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 C 120 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -14.39 50.83 66.85 -15.79 51.94 65.73 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -15.26 61.78 57.87 -16.19 60.59 59.37 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 8 2 # 8 C 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 C 120 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo -14.39 50.83 66.85 -15.79 51.94 65.73 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -15.26 61.78 57.87 -16.19 60.59 59.37 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 9 2 # 9 C 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 C 120 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo -14.39 50.83 66.85 -15.79 51.94 65.73 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -15.26 61.78 57.87 -16.19 60.59 59.37 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 10 2 # 10 C 28 GLU A 81 GLU.? 16.59 O1 EDO A 125 C 120 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo -14.39 50.83 66.85 -15.79 51.94 65.73 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo -15.26 61.78 57.87 -16.19 60.59 59.37 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 11 2 # 11 C 28 GLU B 23 GLU.? 12.57 O2 EDO A 125 C 120 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo -14.39 50.83 66.85 -15.79 51.94 65.73 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -15.26 61.78 57.87 -16.19 60.59 59.37 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 12 2 # 12 C 28 GLU B 59 GLU.? 24.69 C1 EDO A 124 C 120 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -14.39 50.83 66.85 -15.79 51.94 65.73 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -15.26 61.78 57.87 -16.19 60.59 59.37 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 13 2 # 13 C 28 GLU B 59 GLU.? 24.69 C1 EDO A 124 C 120 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo -14.39 50.83 66.85 -15.79 51.94 65.73 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -15.26 61.78 57.87 -16.19 60.59 59.37 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 14 2 # 14 C 28 GLU B 59 GLU.? 24.69 C1 EDO A 124 C 120 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo -14.39 50.83 66.85 -15.79 51.94 65.73 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -15.26 61.78 57.87 -16.19 60.59 59.37 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 15 2 # 15 C 28 GLU B 70 GLU^? 26.28 O1 EDO A 124 C 120 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo -14.39 50.83 66.85 -15.79 51.94 65.73 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -15.26 61.78 57.87 -16.19 60.59 59.37 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 16 2 # 16 C 28 GLU B 70 GLU^? 26.28 O1 EDO A 124 C 120 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo -14.39 50.83 66.85 -15.79 51.94 65.73 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -15.26 61.78 57.87 -16.19 60.59 59.37 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 17 2 # 17 C 28 GLU B 70 GLU^? 26.28 O1 EDO A 124 C 120 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo -14.39 50.83 66.85 -15.79 51.94 65.73 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -15.26 61.78 57.87 -16.19 60.59 59.37 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 18 2 # 18 C 28 GLU B 81 GLU.? 30.69 O1 EDO A 124 C 120 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo -14.39 50.83 66.85 -15.79 51.94 65.73 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo -15.26 61.78 57.87 -16.19 60.59 59.37 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 1b5t_c02 source 1b5t METHYLENETETRAHYDROFOLATE REDUCTASE : 18 hits 1b5t_c02 naa= 2 ULMN 2 1b66_c03 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 2 # 1 A 88 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 89 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 41.02 25.18 1.74 41.80 25.44 -0.17 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 39.09 26.59 -2.92 40.82 26.90 -4.06 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1b66_c03 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 2 # 2 A 88 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 89 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 41.02 25.18 1.74 41.80 25.44 -0.17 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 39.09 26.59 -2.92 40.82 26.90 -4.06 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1b66_c03 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 2 hits 1b66_c03 naa= 2 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 1 2 # 1 A 204 ARG A 25 ARG.? 17.39 O2 EDO A 124 A 314 ALA A 49 ALA^? 7.86 C1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 27.03 64.92 14.26 27.11 64.46 15.71 -27.58 -35.61 -22.27 -27.19 -34.24 -21.71 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 2 2 # 2 A 204 ARG A 25 ARG.? 17.39 O2 EDO A 124 A 314 ALA A 94 ALA~? 7.26 O2 EDO A 125 coo 11.90 60.00 22.81 13.91 61.27 20.88 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 27.03 64.92 14.26 27.11 64.46 15.71 -33.85 -46.06 -19.52 -34.14 -47.43 -20.08 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 3 2 # 3 A 204 ARG A 25 ARG.? 17.39 O2 EDO A 124 A 314 ALA B 49 ALA^? 7.26 C1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 27.03 64.92 14.26 27.11 64.46 15.71 -35.14 -31.27 -21.36 -34.12 -30.27 -21.87 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 4 2 # 4 A 204 ARG A 25 ARG.? 17.39 O2 EDO A 124 A 314 ALA B 55 ALA~? 18.17 C1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 27.03 64.92 14.26 27.11 64.46 15.71 -46.89 -31.34 -22.78 -46.09 -31.26 -21.50 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 5 2 # 5 A 204 ARG A 25 ARG.? 17.39 O2 EDO A 124 A 314 ALA B 104 ALA.? 26.82 O2 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 27.03 64.92 14.26 27.11 64.46 15.71 -52.83 -34.72 -32.75 -54.04 -35.60 -32.82 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 6 2 # 6 A 204 ARG A 30 ARG^? -2.97 O2 EDO A 124s A 314 ALA A 55 ALA~? 6.66 O1 EDO A 125 coo 11.90 60.00 22.81 13.91 61.27 20.88 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 27.03 64.92 14.26 27.11 64.46 15.71 -21.18 -46.19 -20.96 -21.62 -45.51 -22.25 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 7 2 # 7 A 204 ARG A 30 ARG^? -2.97 O2 EDO A 124s A 314 ALA A 61 ALA.? 14.64 O1 EDO A 125 coo 11.90 60.00 22.81 13.91 61.27 20.88 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 27.03 64.92 14.26 27.11 64.46 15.71 -11.93 -42.70 -24.53 -13.20 -42.73 -25.33 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 8 2 # 8 A 204 ARG A 30 ARG^? -2.97 O2 EDO A 124s A 314 ALA B 36 ALA.? 11.83 C1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 27.03 64.92 14.26 27.11 64.46 15.71 -37.66 -22.00 -23.01 -38.34 -21.47 -24.23 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 9 2 # 9 A 204 ARG A 33 ARG.? 17.39 O2 EDO A 124 A 314 ALA A 55 ALA~? 6.66 O1 EDO A 125 coo 11.90 60.00 22.81 13.91 61.27 20.88 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 27.03 64.92 14.26 27.11 64.46 15.71 -21.18 -46.19 -20.96 -21.62 -45.51 -22.25 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 10 2 # 10 A 204 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 314 ALA A 26 ALA^? 11.43 O2 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 27.03 64.92 14.26 27.11 64.46 15.71 -31.83 -39.03 -32.30 -30.50 -39.69 -32.00 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 11 2 # 11 A 204 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 314 ALA A 27 ALA^? 9.68 O2 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 27.03 64.92 14.26 27.11 64.46 15.71 -31.77 -36.20 -34.87 -32.75 -35.04 -34.84 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 12 2 # 12 A 204 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 314 ALA B 94 ALA~? 15.22 O2 EDO A 125 coo 11.90 60.00 22.81 13.91 61.27 20.88 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 27.03 64.92 14.26 27.11 64.46 15.71 -40.74 -42.37 -23.75 -41.76 -43.26 -23.09 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 13 2 # 13 A 204 ARG A 53 ARG~? 17.45 O1 EDO A 125 A 314 ALA A 29 ALA^? 9.43 O2 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 27.03 64.92 14.26 27.11 64.46 15.71 -25.58 -35.99 -31.45 -25.46 -37.49 -31.45 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 14 2 # 14 A 204 ARG A 53 ARG~? 17.45 O1 EDO A 125 A 314 ALA A 104 ALA~? 14.55 C2 EDO A 125 coo 11.90 60.00 22.81 13.91 61.27 20.88 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 27.03 64.92 14.26 27.11 64.46 15.71 -21.28 -56.62 -12.26 -21.83 -58.03 -12.43 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 15 2 # 15 A 204 ARG A 53 ARG~? 17.45 O1 EDO A 125 A 314 ALA A 107 ALA.? 20.71 C2 EDO A 125 coo 11.90 60.00 22.81 13.91 61.27 20.88 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 27.03 64.92 14.26 27.11 64.46 15.71 -16.42 -54.53 -7.60 -16.03 -56.00 -7.26 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 16 2 # 16 A 204 ARG A 106 ARG.? 12.91 O2 EDO A 125 A 314 ALA A 36 ALA.? 14.13 O1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo 27.03 64.92 14.26 27.11 64.46 15.71 -18.11 -33.66 -20.67 -17.40 -34.10 -19.41 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 17 2 # 17 A 204 ARG A 106 ARG.? 12.91 O2 EDO A 125 A 314 ALA A 49 ALA^? 7.86 C1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo 27.03 64.92 14.26 27.11 64.46 15.71 -27.58 -35.61 -22.27 -27.19 -34.24 -21.71 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 18 2 # 18 A 204 ARG A 106 ARG.? 12.91 O2 EDO A 125 A 314 ALA A 94 ALA~? 7.26 O2 EDO A 125 coo 11.90 60.00 22.81 13.91 61.27 20.88 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo 27.03 64.92 14.26 27.11 64.46 15.71 -33.85 -46.06 -19.52 -34.14 -47.43 -20.08 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 19 2 # 19 A 204 ARG B 25 ARG.? 18.77 O2 EDO A 125 A 314 ALA A 49 ALA^? 7.86 C1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 27.03 64.92 14.26 27.11 64.46 15.71 -27.58 -35.61 -22.27 -27.19 -34.24 -21.71 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 20 2 # 20 A 204 ARG B 25 ARG.? 18.77 O2 EDO A 125 A 314 ALA B 49 ALA^? 7.26 C1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 27.03 64.92 14.26 27.11 64.46 15.71 -35.14 -31.27 -21.36 -34.12 -30.27 -21.87 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 21 2 # 21 A 204 ARG B 25 ARG.? 18.77 O2 EDO A 125 A 314 ALA B 68 ALA.? 23.26 O1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 27.03 64.92 14.26 27.11 64.46 15.71 -43.26 -23.68 -10.03 -44.76 -23.42 -9.87 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 22 2 # 22 A 204 ARG B 30 ARG^? 10.56 O1 EDO A 124 A 314 ALA A 36 ALA.? 14.13 O1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 27.03 64.92 14.26 27.11 64.46 15.71 -18.11 -33.66 -20.67 -17.40 -34.10 -19.41 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 23 2 # 23 A 204 ARG B 30 ARG^? 10.56 O1 EDO A 124 A 314 ALA B 55 ALA~? 18.17 C1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 27.03 64.92 14.26 27.11 64.46 15.71 -46.89 -31.34 -22.78 -46.09 -31.26 -21.50 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 24 2 # 24 A 204 ARG B 30 ARG^? 10.56 O1 EDO A 124 A 314 ALA B 61 ALA.? 21.66 C1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 27.03 64.92 14.26 27.11 64.46 15.71 -48.78 -21.46 -18.93 -48.15 -22.68 -18.28 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 25 2 # 25 A 204 ARG B 33 ARG.? 19.94 O1 EDO A 124 A 314 ALA B 55 ALA~? 18.17 C1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 27.03 64.92 14.26 27.11 64.46 15.71 -46.89 -31.34 -22.78 -46.09 -31.26 -21.50 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 26 2 # 26 A 204 ARG B 37 ARG^? 8.36 C1 EDO A 124 A 314 ALA A 36 ALA.? 14.13 O1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 27.03 64.92 14.26 27.11 64.46 15.71 -18.11 -33.66 -20.67 -17.40 -34.10 -19.41 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 27 2 # 27 A 204 ARG B 37 ARG^? 8.36 C1 EDO A 124 A 314 ALA A 94 ALA~? 7.26 O2 EDO A 125 coo 11.90 60.00 22.81 13.91 61.27 20.88 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 27.03 64.92 14.26 27.11 64.46 15.71 -33.85 -46.06 -19.52 -34.14 -47.43 -20.08 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 28 2 # 28 A 204 ARG B 37 ARG^? 8.36 C1 EDO A 124 A 314 ALA B 26 ALA^? 18.43 C1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 27.03 64.92 14.26 27.11 64.46 15.71 -35.37 -36.70 -11.28 -36.61 -35.88 -11.60 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 29 2 # 29 A 204 ARG B 37 ARG^? 8.36 C1 EDO A 124 A 314 ALA B 27 ALA^? 18.83 O1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 27.03 64.92 14.26 27.11 64.46 15.71 -32.94 -35.10 -8.82 -31.45 -35.26 -8.89 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 30 2 # 30 A 204 ARG B 37 ARG^? 8.36 C1 EDO A 124 A 314 ALA B 68 ALA.? 23.26 O1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 27.03 64.92 14.26 27.11 64.46 15.71 -43.26 -23.68 -10.03 -44.76 -23.42 -9.87 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 31 2 # 31 A 204 ARG B 37 ARG^? 8.36 C1 EDO A 124 A 314 ALA B 104 ALA.? 26.82 O2 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 27.03 64.92 14.26 27.11 64.46 15.71 -52.83 -34.72 -32.75 -54.04 -35.60 -32.82 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 32 2 # 32 A 204 ARG B 53 ARG~? 17.71 C1 EDO A 124 A 314 ALA B 29 ALA^? 16.76 O1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 27.03 64.92 14.26 27.11 64.46 15.71 -36.15 -29.79 -12.19 -37.52 -30.44 -12.12 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 33 2 # 33 A 204 ARG B 53 ARG~? 17.71 C1 EDO A 124 A 314 ALA B 101 ALA.? 30.45 C1 EDO A 124 coo 11.90 60.00 22.81 13.91 61.27 20.88 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 27.03 64.92 14.26 27.11 64.46 15.71 -56.51 -37.88 -28.60 -57.76 -37.79 -27.70 1b7y_c00 source 1b7y PHENYLALANYL-TRNA SYNTHETASE : 33 hits 1b7y_c00 naa= 2 ULMN 2 1b8g_c00 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 2 # 1 A 145 TYR A 31 TYR^? 13.43 O2 EDO A 124 A 230 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 9.23 21.44 106.88 10.18 19.34 105.31 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 1.45 22.80 104.16 2.58 21.02 104.01 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1b8g_c00 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 2 # 2 A 145 TYR B 31 TYR^? 14.49 O1 EDO A 124 A 230 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 9.23 21.44 106.88 10.18 19.34 105.31 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 1.45 22.80 104.16 2.58 21.02 104.01 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 1b8g_c00 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c00 naa= 2 ULMN 2 1b8g_c02 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 2 # 1 B 145 TYR A 31 TYR^? 13.43 O2 EDO A 124 B 230 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 11.81 13.41 73.03 10.00 13.03 75.12 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 19.17 11.01 76.14 17.26 10.42 76.77 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1b8g_c02 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 2 # 2 B 145 TYR B 31 TYR^? 14.49 O1 EDO A 124 B 230 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 11.81 13.41 73.03 10.00 13.03 75.12 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 19.17 11.01 76.14 17.26 10.42 76.77 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 1b8g_c02 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c02 naa= 2 ULMN 2 1b8g_c06 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 2 # 1 A 273 LYS A 28 LYS^? 7.39 O2 EDO A 124 A 398 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo 2.97 11.64 107.87 6.59 15.13 107.03 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 13.10 26.17 112.42 12.37 23.74 113.49 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 2 1b8g_c06 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 2 # 2 A 273 LYS A 100 LYS~? 11.56 C2 EDO A 125 A 398 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo 2.97 11.64 107.87 6.59 15.13 107.03 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo 13.10 26.17 112.42 12.37 23.74 113.49 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 2 1b8g_c06 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 2 # 3 A 273 LYS B 28 LYS^? -17.65 O1 EDO A 124s A 398 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo 2.97 11.64 107.87 6.59 15.13 107.03 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 13.10 26.17 112.42 12.37 23.74 113.49 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 1b8g_c06 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 3 hits 1b8g_c06 naa= 2 ULMN 2 1b8g_c07 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 2 # 1 B 273 LYS A 28 LYS^? 7.39 O2 EDO A 124 B 398 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo 11.10 2.31 76.60 10.24 7.24 75.62 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 10.80 16.99 65.65 9.83 14.36 65.68 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 2 1b8g_c07 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 2 # 2 B 273 LYS A 100 LYS~? 11.56 C2 EDO A 125 B 398 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo 11.10 2.31 76.60 10.24 7.24 75.62 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo 10.80 16.99 65.65 9.83 14.36 65.68 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 2 1b8g_c07 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 2 # 3 B 273 LYS B 28 LYS^? -17.65 O1 EDO A 124s B 398 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo 11.10 2.31 76.60 10.24 7.24 75.62 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 10.80 16.99 65.65 9.83 14.36 65.68 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 1b8g_c07 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 3 hits 1b8g_c07 naa= 2 ULMN 2 1b9h_c00 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 2 # 1 A 88 PHE A 48 PHE^? 10.34 O2 EDO A 125 A 159 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 13.91 34.58 14.67 12.95 36.00 12.47 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 20.97 28.40 16.26 20.19 30.15 15.34 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1b9h_c00 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 2 # 2 A 88 PHE A 50 PHE^? 8.88 O1 EDO A 125 A 159 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 13.91 34.58 14.67 12.95 36.00 12.47 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 20.97 28.40 16.26 20.19 30.15 15.34 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1b9h_c00 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 2 # 3 A 88 PHE B 48 PHE^? 12.04 C1 EDO A 124 A 159 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 13.91 34.58 14.67 12.95 36.00 12.47 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 20.97 28.40 16.26 20.19 30.15 15.34 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1b9h_c00 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 2 # 4 A 88 PHE B 50 PHE^? 13.90 C1 EDO A 124 A 159 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 13.91 34.58 14.67 12.95 36.00 12.47 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 20.97 28.40 16.26 20.19 30.15 15.34 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 1b9h_c00 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 4 hits 1b9h_c00 naa= 2 ULMN 2 1be1_c01 GLUTAMATE MUTASE user 1 2 # 1 14 ASP A 84 ASP.? 13.20 O1 EDO A 125 16 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1be1_c01 GLUTAMATE MUTASE user 2 2 # 2 14 ASP A 86 ASP^? 9.05 O1 EDO A 125 16 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1be1_c01 GLUTAMATE MUTASE user 3 2 # 3 14 ASP B 84 ASP.? 30.86 C1 EDO A 124 16 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 ULMN 2 1be1_c01 GLUTAMATE MUTASE user 4 2 # 4 14 ASP B 86 ASP^? 26.97 C1 EDO A 124 16 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1be1_c01 source 1be1 GLUTAMATE MUTASE : 4 hits 1be1_c01 naa= 2 ULMN 2 1bf2_c02 ISOAMYLASE user 1 2 # 1 375 ASP A 41 ASP^? -2.91 O2 EDO A 124s 435 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 88.62 69.90 41.16 89.05 70.67 43.04 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 89.52 76.11 40.17 89.01 75.16 41.97 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1bf2_c02 ISOAMYLASE user 2 2 # 2 375 ASP A 84 ASP.? 13.20 O1 EDO A 125 435 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 88.62 69.90 41.16 89.05 70.67 43.04 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 89.52 76.11 40.17 89.01 75.16 41.97 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1bf2_c02 ISOAMYLASE user 3 2 # 3 375 ASP B 84 ASP.? 30.86 C1 EDO A 124 435 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 88.62 69.90 41.16 89.05 70.67 43.04 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 89.52 76.11 40.17 89.01 75.16 41.97 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1bf2_c02 source 1bf2 ISOAMYLASE : 3 hits 1bf2_c02 naa= 2 ULMN 2 1bg6_c00 N-(1-D-CARBOXYLETHYL)-L-NORVALINE DEuser 1 2 # 1 202 HIS A 79 HIS^? 12.23 O1 EDO A 125 297 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 8.51 27.65 41.61 9.10 25.98 42.75 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 10.75 28.94 37.47 11.47 27.45 38.80 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1bg6_c00 N-(1-D-CARBOXYLETHYL)-L-NORVALINE DEuser 2 2 # 2 202 HIS B 79 HIS^? 26.86 C1 EDO A 124 297 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 8.51 27.65 41.61 9.10 25.98 42.75 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 10.75 28.94 37.47 11.47 27.45 38.80 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1bg6_c00 source 1bg6 N-(1-D-CARBOXYLETHYL)-L-NORVALINE DEHYDROGENAS: 2 hits 1bg6_c00 naa= 2 ULMN 2 1bgl_c00 BETA-GALACTOSIDASE user 1 2 # 1 A 461 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 537 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 24.06 146.21 11.09 22.89 146.18 9.36 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 16.65 144.44 13.24 18.34 145.22 12.33 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1bgl_c00 BETA-GALACTOSIDASE user 2 2 # 2 A 461 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 537 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 24.06 146.21 11.09 22.89 146.18 9.36 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 16.65 144.44 13.24 18.34 145.22 12.33 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1bgl_c00 BETA-GALACTOSIDASE user 3 2 # 3 A 461 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 537 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 24.06 146.21 11.09 22.89 146.18 9.36 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 16.65 144.44 13.24 18.34 145.22 12.33 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1bgl_c00 BETA-GALACTOSIDASE user 4 2 # 4 A 461 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 537 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 24.06 146.21 11.09 22.89 146.18 9.36 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 16.65 144.44 13.24 18.34 145.22 12.33 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1bgl_c00 source 1bgl BETA-GALACTOSIDASE : 4 hits 1bgl_c00 naa= 2 ULMN 2 1bhg_c00 BETA-GLUCURONIDASE user 1 2 # 1 A 451 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 540 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 81.34 87.29 87.22 82.36 86.09 88.61 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 79.94 80.46 88.84 81.11 81.36 87.27 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1bhg_c00 BETA-GLUCURONIDASE user 2 2 # 2 A 451 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 540 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 81.34 87.29 87.22 82.36 86.09 88.61 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 79.94 80.46 88.84 81.11 81.36 87.27 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1bhg_c00 BETA-GLUCURONIDASE user 3 2 # 3 A 451 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 540 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 81.34 87.29 87.22 82.36 86.09 88.61 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 79.94 80.46 88.84 81.11 81.36 87.27 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1bhg_c00 BETA-GLUCURONIDASE user 4 2 # 4 A 451 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 540 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 81.34 87.29 87.22 82.36 86.09 88.61 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 79.94 80.46 88.84 81.11 81.36 87.27 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1bhg_c00 source 1bhg BETA-GLUCURONIDASE : 4 hits 1bhg_c00 naa= 2 ULMN 2 1bhg_c01 BETA-GLUCURONIDASE user 1 2 # 1 B 451 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 540 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 86.52 35.28 112.74 87.08 36.38 110.99 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 83.38 41.19 112.55 85.47 40.59 112.72 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1bhg_c01 BETA-GLUCURONIDASE user 2 2 # 2 B 451 GLU A 81 GLU.? 16.59 O1 EDO A 125 B 540 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 86.52 35.28 112.74 87.08 36.38 110.99 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 83.38 41.19 112.55 85.47 40.59 112.72 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1bhg_c01 BETA-GLUCURONIDASE user 3 2 # 3 B 451 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 540 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 86.52 35.28 112.74 87.08 36.38 110.99 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 83.38 41.19 112.55 85.47 40.59 112.72 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1bhg_c01 BETA-GLUCURONIDASE user 4 2 # 4 B 451 GLU B 81 GLU.? 30.69 O1 EDO A 124 B 540 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 86.52 35.28 112.74 87.08 36.38 110.99 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 83.38 41.19 112.55 85.47 40.59 112.72 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1bhg_c01 source 1bhg BETA-GLUCURONIDASE : 4 hits 1bhg_c01 naa= 2 ULMN 2 1bjo_c01 PHOSPHOSERINE AMINOTRANSFERASE user 1 2 # 1 B 102 TRP B 80 TRP^? 20.31 C1 EDO A 124 B 174 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 4.77 55.75 65.93 6.30 59.02 64.41 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 2.21 52.73 59.53 3.97 53.77 60.07 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1bjo_c01 source 1bjo PHOSPHOSERINE AMINOTRANSFERASE : 1 hits 1bjo_c01 naa= 2 ULMN 2 1bjp_c00 4-OXALOCROTONATE TAUTOMERASE user 1 2 # 1 A 50 PHE A 48 PHE^? 10.34 O2 EDO A 125 B 39 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo -8.84 8.66 90.43 -10.27 8.22 88.05 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1bjp_c00 4-OXALOCROTONATE TAUTOMERASE user 2 2 # 2 A 50 PHE A 50 PHE^? 8.88 O1 EDO A 125 B 39 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -8.84 8.66 90.43 -10.27 8.22 88.05 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1bjp_c00 4-OXALOCROTONATE TAUTOMERASE user 3 2 # 3 A 50 PHE A 97 PHE.? 7.14 O2 EDO A 125 B 39 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo -8.84 8.66 90.43 -10.27 8.22 88.05 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1bjp_c00 4-OXALOCROTONATE TAUTOMERASE user 4 2 # 4 A 50 PHE A 97 PHE.? 7.14 O2 EDO A 125 B 39 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo -8.84 8.66 90.43 -10.27 8.22 88.05 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1bjp_c00 4-OXALOCROTONATE TAUTOMERASE user 5 2 # 5 A 50 PHE B 48 PHE^? 12.04 C1 EDO A 124 B 39 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo -8.84 8.66 90.43 -10.27 8.22 88.05 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1bjp_c00 4-OXALOCROTONATE TAUTOMERASE user 6 2 # 6 A 50 PHE B 50 PHE^? 13.90 C1 EDO A 124 B 39 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo -8.84 8.66 90.43 -10.27 8.22 88.05 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1bjp_c00 4-OXALOCROTONATE TAUTOMERASE user 7 2 # 7 A 50 PHE B 97 PHE.? 16.35 C1 EDO A 124 B 39 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo -8.84 8.66 90.43 -10.27 8.22 88.05 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 1bjp_c00 source 1bjp 4-OXALOCROTONATE TAUTOMERASE : 7 hits 1bjp_c00 naa= 2 ULMN 2 1bjp_c05 4-OXALOCROTONATE TAUTOMERASE user 1 2 # 1 A 50 PHE A 48 PHE^? 10.34 O2 EDO A 125 B 39 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo -8.84 8.66 90.43 -10.27 8.22 88.05 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1bjp_c05 4-OXALOCROTONATE TAUTOMERASE user 2 2 # 2 A 50 PHE A 50 PHE^? 8.88 O1 EDO A 125 B 39 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -8.84 8.66 90.43 -10.27 8.22 88.05 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1bjp_c05 4-OXALOCROTONATE TAUTOMERASE user 3 2 # 3 A 50 PHE A 97 PHE.? 7.14 O2 EDO A 125 B 39 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo -8.84 8.66 90.43 -10.27 8.22 88.05 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1bjp_c05 4-OXALOCROTONATE TAUTOMERASE user 4 2 # 4 A 50 PHE A 97 PHE.? 7.14 O2 EDO A 125 B 39 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo -8.84 8.66 90.43 -10.27 8.22 88.05 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1bjp_c05 4-OXALOCROTONATE TAUTOMERASE user 5 2 # 5 A 50 PHE B 48 PHE^? 12.04 C1 EDO A 124 B 39 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo -8.84 8.66 90.43 -10.27 8.22 88.05 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1bjp_c05 4-OXALOCROTONATE TAUTOMERASE user 6 2 # 6 A 50 PHE B 50 PHE^? 13.90 C1 EDO A 124 B 39 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo -8.84 8.66 90.43 -10.27 8.22 88.05 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1bjp_c05 4-OXALOCROTONATE TAUTOMERASE user 7 2 # 7 A 50 PHE B 97 PHE.? 16.35 C1 EDO A 124 B 39 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo -8.84 8.66 90.43 -10.27 8.22 88.05 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 1bjp_c05 source 1bjp 4-OXALOCROTONATE TAUTOMERASE : 7 hits 1bjp_c05 naa= 2 ULMN 2 1bjp_c06 4-OXALOCROTONATE TAUTOMERASE user 1 2 # 1 B 1 PRO A 51 PRO~? 12.56 O2 EDO A 125 B 50 PHE B 97 PHE.? 16.35 C1 EDO A 124 coo -15.48 1.51 87.57 -13.84 2.98 87.27 -22.81 -39.07 -17.47 -22.64 -38.62 -19.64 coo 1.73 -12.31 75.00 0.52 -13.19 77.35 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 ULMN 2 1bjp_c06 4-OXALOCROTONATE TAUTOMERASE user 2 2 # 2 B 1 PRO A 52 PRO~? 11.69 O1 EDO A 125 B 50 PHE B 97 PHE.? 16.35 C1 EDO A 124 coo -15.48 1.51 87.57 -13.84 2.98 87.27 -19.24 -39.24 -23.00 -20.61 -40.50 -21.76 coo 1.73 -12.31 75.00 0.52 -13.19 77.35 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 ULMN 2 1bjp_c06 4-OXALOCROTONATE TAUTOMERASE user 3 2 # 3 B 1 PRO B 51 PRO~? 11.19 C1 EDO A 124 B 50 PHE A 97 PHE.? 7.14 O2 EDO A 125 coo -15.48 1.51 87.57 -13.84 2.98 87.27 -40.15 -28.68 -26.59 -39.89 -28.23 -24.42 coo 1.73 -12.31 75.00 0.52 -13.19 77.35 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 1bjp_c06 source 1bjp 4-OXALOCROTONATE TAUTOMERASE : 3 hits 1bjp_c06 naa= 2 ULMN 2 1bjp_c07 4-OXALOCROTONATE TAUTOMERASE user 1 2 # 1 C 1 PRO A 51 PRO~? 12.56 O2 EDO A 125 C 50 PHE B 97 PHE.? 16.35 C1 EDO A 124 coo -1.04 -15.72 39.11 0.69 -14.29 39.31 -22.81 -39.07 -17.47 -22.64 -38.62 -19.64 coo -11.95 3.44 51.82 -13.09 2.37 49.45 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 ULMN 2 1bjp_c07 4-OXALOCROTONATE TAUTOMERASE user 2 2 # 2 C 1 PRO A 52 PRO~? 11.69 O1 EDO A 125 C 50 PHE B 97 PHE.? 16.35 C1 EDO A 124 coo -1.04 -15.72 39.11 0.69 -14.29 39.31 -19.24 -39.24 -23.00 -20.61 -40.50 -21.76 coo -11.95 3.44 51.82 -13.09 2.37 49.45 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 ULMN 2 1bjp_c07 4-OXALOCROTONATE TAUTOMERASE user 3 2 # 3 C 1 PRO B 51 PRO~? 11.19 C1 EDO A 124 C 50 PHE A 97 PHE.? 7.14 O2 EDO A 125 coo -1.04 -15.72 39.11 0.69 -14.29 39.31 -40.15 -28.68 -26.59 -39.89 -28.23 -24.42 coo -11.95 3.44 51.82 -13.09 2.37 49.45 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 1bjp_c07 source 1bjp 4-OXALOCROTONATE TAUTOMERASE : 3 hits 1bjp_c07 naa= 2 ULMN 2 1bjp_c08 4-OXALOCROTONATE TAUTOMERASE user 1 2 # 1 D 1 PRO A 51 PRO~? 12.56 O2 EDO A 125 D 50 PHE B 97 PHE.? 16.35 C1 EDO A 124 coo -14.38 -5.86 49.10 -13.60 -3.76 48.78 -22.81 -39.07 -17.47 -22.64 -38.62 -19.64 coo 7.23 -10.13 36.48 6.65 -11.47 38.96 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 ULMN 2 1bjp_c08 4-OXALOCROTONATE TAUTOMERASE user 2 2 # 2 D 1 PRO A 52 PRO~? 11.69 O1 EDO A 125 D 50 PHE B 97 PHE.? 16.35 C1 EDO A 124 coo -14.38 -5.86 49.10 -13.60 -3.76 48.78 -19.24 -39.24 -23.00 -20.61 -40.50 -21.76 coo 7.23 -10.13 36.48 6.65 -11.47 38.96 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 ULMN 2 1bjp_c08 4-OXALOCROTONATE TAUTOMERASE user 3 2 # 3 D 1 PRO B 51 PRO~? 11.19 C1 EDO A 124 D 50 PHE A 97 PHE.? 7.14 O2 EDO A 125 coo -14.38 -5.86 49.10 -13.60 -3.76 48.78 -40.15 -28.68 -26.59 -39.89 -28.23 -24.42 coo 7.23 -10.13 36.48 6.65 -11.47 38.96 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 1bjp_c08 source 1bjp 4-OXALOCROTONATE TAUTOMERASE : 3 hits 1bjp_c08 naa= 2 ULMN 2 1bjp_c09 4-OXALOCROTONATE TAUTOMERASE user 1 2 # 1 E 1 PRO A 51 PRO~? 12.56 O2 EDO A 125 E 50 PHE B 97 PHE.? 16.35 C1 EDO A 124 coo 13.77 -7.39 -4.94 13.14 -5.26 -4.80 -22.81 -39.07 -17.47 -22.64 -38.62 -19.64 coo -8.19 -9.44 7.68 -7.65 -10.85 5.31 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 ULMN 2 1bjp_c09 4-OXALOCROTONATE TAUTOMERASE user 2 2 # 2 E 1 PRO A 52 PRO~? 11.69 O1 EDO A 125 E 50 PHE B 97 PHE.? 16.35 C1 EDO A 124 coo 13.77 -7.39 -4.94 13.14 -5.26 -4.80 -19.24 -39.24 -23.00 -20.61 -40.50 -21.76 coo -8.19 -9.44 7.68 -7.65 -10.85 5.31 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 ULMN 2 1bjp_c09 4-OXALOCROTONATE TAUTOMERASE user 3 2 # 3 E 1 PRO B 51 PRO~? 11.19 C1 EDO A 124 E 50 PHE A 97 PHE.? 7.14 O2 EDO A 125 coo 13.77 -7.39 -4.94 13.14 -5.26 -4.80 -40.15 -28.68 -26.59 -39.89 -28.23 -24.42 coo -8.19 -9.44 7.68 -7.65 -10.85 5.31 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 1bjp_c09 source 1bjp 4-OXALOCROTONATE TAUTOMERASE : 3 hits 1bjp_c09 naa= 2 ULMN 2 1bmt_c02 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 2 # 1 A 757 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 759 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 30.11 61.02 29.12 29.36 59.77 27.63 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 30.94 56.62 25.28 29.94 54.94 26.14 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1bmt_c02 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 2 # 2 A 757 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 759 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 30.11 61.02 29.12 29.36 59.77 27.63 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 30.94 56.62 25.28 29.94 54.94 26.14 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1bmt_c02 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 2 hits 1bmt_c02 naa= 2 ULMN 2 1bmt_c03 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 2 # 1 B 757 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 759 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 1.96 66.39 3.07 2.10 68.48 3.58 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1bmt_c03 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 2 # 2 B 757 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 759 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 1.96 66.39 3.07 2.10 68.48 3.58 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1bmt_c03 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 2 hits 1bmt_c03 naa= 2 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 1 2 # 1 A 150 LYS A 28 LYS^? 7.39 O2 EDO A 124 A 278 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 43.46 54.32 43.90 48.56 57.30 46.35 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 55.33 66.46 41.57 56.47 67.38 40.06 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 2 2 # 2 A 150 LYS A 28 LYS^? 7.39 O2 EDO A 124 A 278 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 43.46 54.32 43.90 48.56 57.30 46.35 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 55.33 66.46 41.57 56.47 67.38 40.06 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 3 2 # 3 A 150 LYS A 100 LYS~? 11.56 C2 EDO A 125 A 278 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 43.46 54.32 43.90 48.56 57.30 46.35 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo 55.33 66.46 41.57 56.47 67.38 40.06 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 4 2 # 4 A 150 LYS B 28 LYS^? -17.65 O1 EDO A 124s A 278 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 43.46 54.32 43.90 48.56 57.30 46.35 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 55.33 66.46 41.57 56.47 67.38 40.06 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 5 2 # 5 A 150 LYS B 28 LYS^? -17.65 O1 EDO A 124s A 278 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 43.46 54.32 43.90 48.56 57.30 46.35 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 55.33 66.46 41.57 56.47 67.38 40.06 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 6 2 # 6 A 150 LYS B 28 LYS^? -17.65 O1 EDO A 124s A 278 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 43.46 54.32 43.90 48.56 57.30 46.35 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 55.33 66.46 41.57 56.47 67.38 40.06 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1bo1_c00 source 1bo1 PHOSPHATIDYLINOSITOL PHOSPHATE KINASE IIBETA : 6 hits 1bo1_c00 naa= 2 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 1 2 # 1 B 150 LYS A 28 LYS^? 7.39 O2 EDO A 124 B 278 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 35.25 10.18 29.50 33.26 8.54 24.76 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 23.28 1.35 20.09 22.28 1.00 18.22 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 2 2 # 2 B 150 LYS A 28 LYS^? 7.39 O2 EDO A 124 B 278 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 35.25 10.18 29.50 33.26 8.54 24.76 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 23.28 1.35 20.09 22.28 1.00 18.22 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 3 2 # 3 B 150 LYS A 28 LYS^? 7.39 O2 EDO A 124 B 278 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 35.25 10.18 29.50 33.26 8.54 24.76 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 23.28 1.35 20.09 22.28 1.00 18.22 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 4 2 # 4 B 150 LYS A 100 LYS~? 11.56 C2 EDO A 125 B 278 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 35.25 10.18 29.50 33.26 8.54 24.76 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo 23.28 1.35 20.09 22.28 1.00 18.22 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 5 2 # 5 B 150 LYS B 28 LYS^? -17.65 O1 EDO A 124s B 278 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 35.25 10.18 29.50 33.26 8.54 24.76 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 23.28 1.35 20.09 22.28 1.00 18.22 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 6 2 # 6 B 150 LYS B 28 LYS^? -17.65 O1 EDO A 124s B 278 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 35.25 10.18 29.50 33.26 8.54 24.76 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 23.28 1.35 20.09 22.28 1.00 18.22 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 7 2 # 7 B 150 LYS B 28 LYS^? -17.65 O1 EDO A 124s B 278 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 35.25 10.18 29.50 33.26 8.54 24.76 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 23.28 1.35 20.09 22.28 1.00 18.22 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1bo1_c01 source 1bo1 PHOSPHATIDYLINOSITOL PHOSPHATE KINASE IIBETA : 7 hits 1bo1_c01 naa= 2 ULMN 2 1bqc_c02 BETA-MANNANASE user 1 2 # 1 A 128 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 225 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 36.48 24.43 22.02 36.86 26.34 21.13 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 40.16 23.71 17.01 38.52 24.96 17.40 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1bqc_c02 BETA-MANNANASE user 2 2 # 2 A 128 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 225 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 36.48 24.43 22.02 36.86 26.34 21.13 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 40.16 23.71 17.01 38.52 24.96 17.40 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1bqc_c02 BETA-MANNANASE user 3 2 # 3 A 128 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 225 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 36.48 24.43 22.02 36.86 26.34 21.13 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 40.16 23.71 17.01 38.52 24.96 17.40 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1bqc_c02 BETA-MANNANASE user 4 2 # 4 A 128 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 225 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 36.48 24.43 22.02 36.86 26.34 21.13 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 40.16 23.71 17.01 38.52 24.96 17.40 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1bqc_c02 source 1bqc BETA-MANNANASE : 4 hits 1bqc_c02 naa= 2 ULMN 2 1bu7_c00 CYTOCHROME P450 user 1 2 # 1 A 267 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 268 THR A 82 THR.? 18.68 O1 EDO A 125 coo 45.43 74.80 39.41 46.09 75.11 37.45 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 45.81 71.19 43.26 47.70 70.19 43.25 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 ULMN 2 1bu7_c00 CYTOCHROME P450 user 2 2 # 2 A 267 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 268 THR B 82 THR.? 29.24 O1 EDO A 124 coo 45.43 74.80 39.41 46.09 75.11 37.45 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 45.81 71.19 43.26 47.70 70.19 43.25 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 1bu7_c00 source 1bu7 CYTOCHROME P450 : 2 hits 1bu7_c00 naa= 2 ULMN 2 1bu7_c01 CYTOCHROME P450 user 1 2 # 1 B 267 GLU A 81 GLU.? 16.59 O1 EDO A 125 B 268 THR A 82 THR.? 18.68 O1 EDO A 125 coo 37.51 113.26 46.73 39.45 112.75 46.09 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 37.20 116.32 52.00 35.18 117.07 52.13 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 ULMN 2 1bu7_c01 CYTOCHROME P450 user 2 2 # 2 B 267 GLU B 81 GLU.? 30.69 O1 EDO A 124 B 268 THR B 82 THR.? 29.24 O1 EDO A 124 coo 37.51 113.26 46.73 39.45 112.75 46.09 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 37.20 116.32 52.00 35.18 117.07 52.13 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 1bu7_c01 source 1bu7 CYTOCHROME P450 : 2 hits 1bu7_c01 naa= 2 ULMN 2 1bvv_c00 ENDO-1,4-BETA-XYLANASE user 1 2 # 1 78 GLU A 23 GLU.? 13.04 O2 EDO A 125 172 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 29.78 23.72 34.61 31.02 22.02 34.93 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 36.89 20.40 30.23 35.07 20.37 31.31 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1bvv_c00 ENDO-1,4-BETA-XYLANASE user 2 2 # 2 78 GLU A 43 GLU.? 14.35 O2 EDO A 124 172 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 29.78 23.72 34.61 31.02 22.02 34.93 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 36.89 20.40 30.23 35.07 20.37 31.31 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1bvv_c00 ENDO-1,4-BETA-XYLANASE user 3 2 # 3 78 GLU A 70 GLU^? 16.40 O1 EDO A 125 172 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 29.78 23.72 34.61 31.02 22.02 34.93 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 36.89 20.40 30.23 35.07 20.37 31.31 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1bvv_c00 ENDO-1,4-BETA-XYLANASE user 4 2 # 4 78 GLU A 81 GLU.? 16.59 O1 EDO A 125 172 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 29.78 23.72 34.61 31.02 22.02 34.93 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 36.89 20.40 30.23 35.07 20.37 31.31 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1bvv_c00 ENDO-1,4-BETA-XYLANASE user 5 2 # 5 78 GLU B 70 GLU^? 26.28 O1 EDO A 124 172 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 29.78 23.72 34.61 31.02 22.02 34.93 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 36.89 20.40 30.23 35.07 20.37 31.31 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1bvv_c00 ENDO-1,4-BETA-XYLANASE user 6 2 # 6 78 GLU B 81 GLU.? 30.69 O1 EDO A 124 172 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 29.78 23.72 34.61 31.02 22.02 34.93 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 36.89 20.40 30.23 35.07 20.37 31.31 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1bvv_c00 source 1bvv ENDO-1,4-BETA-XYLANASE : 6 hits 1bvv_c00 naa= 2 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 1 2 # 1 A 325 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 350 LEU A 42 LEU^? 10.34 O2 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 17.08 44.76 64.40 16.58 45.38 62.42 -35.18 -36.23 -29.00 -34.50 -37.80 -27.68 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 2 2 # 2 A 325 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 350 LEU A 54 LEU~? 11.35 O2 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 17.08 44.76 64.40 16.58 45.38 62.42 -21.53 -43.50 -17.11 -21.49 -42.48 -15.18 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 3 2 # 3 A 325 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 350 LEU A 58 LEU.? 9.87 O1 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 17.08 44.76 64.40 16.58 45.38 62.42 -17.29 -44.63 -24.09 -18.05 -44.29 -26.14 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 4 2 # 4 A 325 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 350 LEU A 78 LEU^? 8.41 O1 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 17.08 44.76 64.40 16.58 45.38 62.42 -25.02 -43.13 -29.94 -26.24 -41.39 -29.47 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 5 2 # 5 A 325 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 350 LEU A 87 LEU^? -4.03 O1 EDO A 125s coo 31.05 49.37 64.51 31.97 51.11 63.85 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 17.08 44.76 64.40 16.58 45.38 62.42 -24.54 -46.53 -26.85 -22.75 -46.35 -25.59 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 6 2 # 6 A 325 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 350 LEU A 92 LEU~? 5.17 O2 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 17.08 44.76 64.40 16.58 45.38 62.42 -28.52 -44.11 -23.20 -26.40 -44.39 -23.68 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 7 2 # 7 A 325 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 350 LEU B 42 LEU^? 14.47 O2 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 17.08 44.76 64.40 16.58 45.38 62.42 -31.56 -38.10 -14.56 -33.31 -38.25 -15.79 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 8 2 # 8 A 325 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 350 LEU A 66 LEU~? 14.48 O1 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 17.08 44.76 64.40 16.58 45.38 62.42 -15.97 -38.44 -26.63 -16.10 -39.71 -24.86 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 9 2 # 9 A 325 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 350 LEU A 72 LEU^? 13.09 O1 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 17.08 44.76 64.40 16.58 45.38 62.42 -25.96 -45.98 -36.98 -24.33 -45.96 -38.50 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 10 2 # 10 A 325 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 350 LEU A 87 LEU^? -4.03 O1 EDO A 125s coo 31.05 49.37 64.51 31.97 51.11 63.85 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 17.08 44.76 64.40 16.58 45.38 62.42 -24.54 -46.53 -26.85 -22.75 -46.35 -25.59 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 11 2 # 11 A 325 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 350 LEU A 92 LEU~? 5.17 O2 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 17.08 44.76 64.40 16.58 45.38 62.42 -28.52 -44.11 -23.20 -26.40 -44.39 -23.68 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 12 2 # 12 A 325 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 350 LEU B 54 LEU~? 14.98 C1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 17.08 44.76 64.40 16.58 45.38 62.42 -44.12 -30.81 -26.43 -43.06 -31.04 -28.33 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 13 2 # 13 A 325 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 350 LEU B 92 LEU~? 16.78 C1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 17.08 44.76 64.40 16.58 45.38 62.42 -41.76 -36.62 -20.33 -43.11 -34.97 -19.88 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 14 2 # 14 A 325 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 350 LEU A 54 LEU~? 11.35 O2 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 17.08 44.76 64.40 16.58 45.38 62.42 -21.53 -43.50 -17.11 -21.49 -42.48 -15.18 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 15 2 # 15 A 325 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 350 LEU A 78 LEU^? 8.41 O1 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 17.08 44.76 64.40 16.58 45.38 62.42 -25.02 -43.13 -29.94 -26.24 -41.39 -29.47 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 16 2 # 16 A 325 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 350 LEU A 83 LEU.? 13.93 O1 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 17.08 44.76 64.40 16.58 45.38 62.42 -14.15 -46.42 -30.21 -12.97 -45.12 -28.95 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 17 2 # 17 A 325 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 350 LEU A 66 LEU~? 14.48 O1 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 17.08 44.76 64.40 16.58 45.38 62.42 -15.97 -38.44 -26.63 -16.10 -39.71 -24.86 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 18 2 # 18 A 325 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 350 LEU A 78 LEU^? 8.41 O1 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 17.08 44.76 64.40 16.58 45.38 62.42 -25.02 -43.13 -29.94 -26.24 -41.39 -29.47 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 19 2 # 19 A 325 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 350 LEU A 54 LEU~? 11.35 O2 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 17.08 44.76 64.40 16.58 45.38 62.42 -21.53 -43.50 -17.11 -21.49 -42.48 -15.18 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 20 2 # 20 A 325 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 350 LEU A 66 LEU~? 14.48 O1 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 17.08 44.76 64.40 16.58 45.38 62.42 -15.97 -38.44 -26.63 -16.10 -39.71 -24.86 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 21 2 # 21 A 325 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 350 LEU B 42 LEU^? 14.47 O2 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 17.08 44.76 64.40 16.58 45.38 62.42 -31.56 -38.10 -14.56 -33.31 -38.25 -15.79 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 22 2 # 22 A 325 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 350 LEU B 54 LEU~? 14.98 C1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 17.08 44.76 64.40 16.58 45.38 62.42 -44.12 -30.81 -26.43 -43.06 -31.04 -28.33 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 23 2 # 23 A 325 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 350 LEU B 58 LEU.? 19.52 C1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 17.08 44.76 64.40 16.58 45.38 62.42 -47.35 -27.17 -19.69 -46.30 -27.92 -17.93 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 24 2 # 24 A 325 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 350 LEU B 78 LEU^? 18.42 C1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 17.08 44.76 64.40 16.58 45.38 62.42 -42.62 -33.09 -13.72 -40.58 -33.23 -14.47 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 25 2 # 25 A 325 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 350 LEU B 87 LEU^? 20.22 C1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 17.08 44.76 64.40 16.58 45.38 62.42 -45.62 -34.34 -16.64 -46.54 -32.89 -17.98 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 26 2 # 26 A 325 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 350 LEU B 92 LEU~? 16.78 C1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 17.08 44.76 64.40 16.58 45.38 62.42 -41.76 -36.62 -20.33 -43.11 -34.97 -19.88 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 27 2 # 27 A 325 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 350 LEU A 54 LEU~? 11.35 O2 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 17.08 44.76 64.40 16.58 45.38 62.42 -21.53 -43.50 -17.11 -21.49 -42.48 -15.18 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 28 2 # 28 A 325 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 350 LEU A 92 LEU~? 5.17 O2 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 17.08 44.76 64.40 16.58 45.38 62.42 -28.52 -44.11 -23.20 -26.40 -44.39 -23.68 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 29 2 # 29 A 325 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 350 LEU B 66 LEU~? 17.96 C1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 17.08 44.76 64.40 16.58 45.38 62.42 -43.15 -22.70 -16.79 -44.19 -23.46 -18.56 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 30 2 # 30 A 325 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 350 LEU B 72 LEU^? 26.85 C1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 17.08 44.76 64.40 16.58 45.38 62.42 -44.25 -35.46 -6.58 -45.01 -34.22 -4.94 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 31 2 # 31 A 325 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 350 LEU B 87 LEU^? 20.22 C1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 17.08 44.76 64.40 16.58 45.38 62.42 -45.62 -34.34 -16.64 -46.54 -32.89 -17.98 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 32 2 # 32 A 325 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 350 LEU B 92 LEU~? 16.78 C1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 17.08 44.76 64.40 16.58 45.38 62.42 -41.76 -36.62 -20.33 -43.11 -34.97 -19.88 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 33 2 # 33 A 325 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 350 LEU B 54 LEU~? 14.98 C1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 17.08 44.76 64.40 16.58 45.38 62.42 -44.12 -30.81 -26.43 -43.06 -31.04 -28.33 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 34 2 # 34 A 325 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 350 LEU B 78 LEU^? 18.42 C1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 17.08 44.76 64.40 16.58 45.38 62.42 -42.62 -33.09 -13.72 -40.58 -33.23 -14.47 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 35 2 # 35 A 325 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 350 LEU B 83 LEU.? 25.07 C1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 17.08 44.76 64.40 16.58 45.38 62.42 -50.68 -25.61 -13.23 -49.92 -24.11 -14.54 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 36 2 # 36 A 325 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 350 LEU B 58 LEU.? 19.52 C1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 17.08 44.76 64.40 16.58 45.38 62.42 -47.35 -27.17 -19.69 -46.30 -27.92 -17.93 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 37 2 # 37 A 325 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 350 LEU B 66 LEU~? 17.96 C1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 17.08 44.76 64.40 16.58 45.38 62.42 -43.15 -22.70 -16.79 -44.19 -23.46 -18.56 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 38 2 # 38 A 325 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 350 LEU B 54 LEU~? 14.98 C1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 17.08 44.76 64.40 16.58 45.38 62.42 -44.12 -30.81 -26.43 -43.06 -31.04 -28.33 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 39 2 # 39 A 325 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 350 LEU B 66 LEU~? 17.96 C1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 17.08 44.76 64.40 16.58 45.38 62.42 -43.15 -22.70 -16.79 -44.19 -23.46 -18.56 1bvz_c00 source 1bvz ALPHA-AMYLASE II : 39 hits 1bvz_c00 naa= 2 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 1 2 # 1 B 325 ASP A 32 ASP^? 7.79 O1 EDO A 124 B 350 LEU A 42 LEU^? 10.34 O2 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 39.81 12.72 56.17 40.30 13.16 54.11 -35.18 -36.23 -29.00 -34.50 -37.80 -27.68 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 2 2 # 2 B 325 ASP A 32 ASP^? 7.79 O1 EDO A 124 B 350 LEU A 54 LEU~? 11.35 O2 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 39.81 12.72 56.17 40.30 13.16 54.11 -21.53 -43.50 -17.11 -21.49 -42.48 -15.18 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 3 2 # 3 B 325 ASP A 32 ASP^? 7.79 O1 EDO A 124 B 350 LEU A 58 LEU.? 9.87 O1 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 39.81 12.72 56.17 40.30 13.16 54.11 -17.29 -44.63 -24.09 -18.05 -44.29 -26.14 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 4 2 # 4 B 325 ASP A 32 ASP^? 7.79 O1 EDO A 124 B 350 LEU A 78 LEU^? 8.41 O1 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 39.81 12.72 56.17 40.30 13.16 54.11 -25.02 -43.13 -29.94 -26.24 -41.39 -29.47 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 5 2 # 5 B 325 ASP A 32 ASP^? 7.79 O1 EDO A 124 B 350 LEU A 87 LEU^? -4.03 O1 EDO A 125s coo 25.90 8.19 53.87 25.36 6.97 52.29 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 39.81 12.72 56.17 40.30 13.16 54.11 -24.54 -46.53 -26.85 -22.75 -46.35 -25.59 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 6 2 # 6 B 325 ASP A 32 ASP^? 7.79 O1 EDO A 124 B 350 LEU A 89 LEU~? 8.99 O1 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 39.81 12.72 56.17 40.30 13.16 54.11 -31.04 -43.51 -28.26 -31.53 -41.41 -28.05 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 7 2 # 7 B 325 ASP A 32 ASP^? 7.79 O1 EDO A 124 B 350 LEU A 92 LEU~? 5.17 O2 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 39.81 12.72 56.17 40.30 13.16 54.11 -28.52 -44.11 -23.20 -26.40 -44.39 -23.68 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 8 2 # 8 B 325 ASP A 32 ASP^? 7.79 O1 EDO A 124 B 350 LEU B 42 LEU^? 14.47 O2 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 39.81 12.72 56.17 40.30 13.16 54.11 -31.56 -38.10 -14.56 -33.31 -38.25 -15.79 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 9 2 # 9 B 325 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 350 LEU A 66 LEU~? 14.48 O1 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 39.81 12.72 56.17 40.30 13.16 54.11 -15.97 -38.44 -26.63 -16.10 -39.71 -24.86 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 10 2 # 10 B 325 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 350 LEU A 72 LEU^? 13.09 O1 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 39.81 12.72 56.17 40.30 13.16 54.11 -25.96 -45.98 -36.98 -24.33 -45.96 -38.50 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 11 2 # 11 B 325 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 350 LEU A 87 LEU^? -4.03 O1 EDO A 125s coo 25.90 8.19 53.87 25.36 6.97 52.29 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 39.81 12.72 56.17 40.30 13.16 54.11 -24.54 -46.53 -26.85 -22.75 -46.35 -25.59 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 12 2 # 12 B 325 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 350 LEU A 92 LEU~? 5.17 O2 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 39.81 12.72 56.17 40.30 13.16 54.11 -28.52 -44.11 -23.20 -26.40 -44.39 -23.68 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 13 2 # 13 B 325 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 350 LEU B 54 LEU~? 14.98 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 39.81 12.72 56.17 40.30 13.16 54.11 -44.12 -30.81 -26.43 -43.06 -31.04 -28.33 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 14 2 # 14 B 325 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 350 LEU B 92 LEU~? 16.78 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 39.81 12.72 56.17 40.30 13.16 54.11 -41.76 -36.62 -20.33 -43.11 -34.97 -19.88 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 15 2 # 15 B 325 ASP A 63 ASP~? 17.25 O1 EDO A 124 B 350 LEU A 54 LEU~? 11.35 O2 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 39.81 12.72 56.17 40.30 13.16 54.11 -21.53 -43.50 -17.11 -21.49 -42.48 -15.18 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 16 2 # 16 B 325 ASP A 63 ASP~? 17.25 O1 EDO A 124 B 350 LEU A 78 LEU^? 8.41 O1 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 39.81 12.72 56.17 40.30 13.16 54.11 -25.02 -43.13 -29.94 -26.24 -41.39 -29.47 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 17 2 # 17 B 325 ASP A 63 ASP~? 17.25 O1 EDO A 124 B 350 LEU A 83 LEU.? 13.93 O1 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 39.81 12.72 56.17 40.30 13.16 54.11 -14.15 -46.42 -30.21 -12.97 -45.12 -28.95 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 18 2 # 18 B 325 ASP A 84 ASP.? 13.20 O1 EDO A 125 B 350 LEU A 66 LEU~? 14.48 O1 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 39.81 12.72 56.17 40.30 13.16 54.11 -15.97 -38.44 -26.63 -16.10 -39.71 -24.86 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 19 2 # 19 B 325 ASP A 84 ASP.? 13.20 O1 EDO A 125 B 350 LEU A 78 LEU^? 8.41 O1 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 39.81 12.72 56.17 40.30 13.16 54.11 -25.02 -43.13 -29.94 -26.24 -41.39 -29.47 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 20 2 # 20 B 325 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 350 LEU A 54 LEU~? 11.35 O2 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 39.81 12.72 56.17 40.30 13.16 54.11 -21.53 -43.50 -17.11 -21.49 -42.48 -15.18 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 21 2 # 21 B 325 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 350 LEU A 66 LEU~? 14.48 O1 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 39.81 12.72 56.17 40.30 13.16 54.11 -15.97 -38.44 -26.63 -16.10 -39.71 -24.86 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 22 2 # 22 B 325 ASP B 32 ASP^? 9.42 O1 EDO A 124 B 350 LEU A 42 LEU^? 10.34 O2 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 39.81 12.72 56.17 40.30 13.16 54.11 -35.18 -36.23 -29.00 -34.50 -37.80 -27.68 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 23 2 # 23 B 325 ASP B 32 ASP^? 9.42 O1 EDO A 124 B 350 LEU B 42 LEU^? 14.47 O2 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 39.81 12.72 56.17 40.30 13.16 54.11 -31.56 -38.10 -14.56 -33.31 -38.25 -15.79 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 24 2 # 24 B 325 ASP B 32 ASP^? 9.42 O1 EDO A 124 B 350 LEU B 54 LEU~? 14.98 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 39.81 12.72 56.17 40.30 13.16 54.11 -44.12 -30.81 -26.43 -43.06 -31.04 -28.33 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 25 2 # 25 B 325 ASP B 32 ASP^? 9.42 O1 EDO A 124 B 350 LEU B 58 LEU.? 19.52 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 39.81 12.72 56.17 40.30 13.16 54.11 -47.35 -27.17 -19.69 -46.30 -27.92 -17.93 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 26 2 # 26 B 325 ASP B 32 ASP^? 9.42 O1 EDO A 124 B 350 LEU B 78 LEU^? 18.42 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 39.81 12.72 56.17 40.30 13.16 54.11 -42.62 -33.09 -13.72 -40.58 -33.23 -14.47 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 27 2 # 27 B 325 ASP B 32 ASP^? 9.42 O1 EDO A 124 B 350 LEU B 87 LEU^? 20.22 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 39.81 12.72 56.17 40.30 13.16 54.11 -45.62 -34.34 -16.64 -46.54 -32.89 -17.98 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 28 2 # 28 B 325 ASP B 32 ASP^? 9.42 O1 EDO A 124 B 350 LEU B 89 LEU~? 17.71 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 39.81 12.72 56.17 40.30 13.16 54.11 -39.89 -38.23 -15.28 -37.88 -37.43 -15.63 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 29 2 # 29 B 325 ASP B 32 ASP^? 9.42 O1 EDO A 124 B 350 LEU B 92 LEU~? 16.78 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 39.81 12.72 56.17 40.30 13.16 54.11 -41.76 -36.62 -20.33 -43.11 -34.97 -19.88 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 30 2 # 30 B 325 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 350 LEU A 54 LEU~? 11.35 O2 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 39.81 12.72 56.17 40.30 13.16 54.11 -21.53 -43.50 -17.11 -21.49 -42.48 -15.18 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 31 2 # 31 B 325 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 350 LEU A 92 LEU~? 5.17 O2 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 39.81 12.72 56.17 40.30 13.16 54.11 -28.52 -44.11 -23.20 -26.40 -44.39 -23.68 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 32 2 # 32 B 325 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 350 LEU B 66 LEU~? 17.96 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 39.81 12.72 56.17 40.30 13.16 54.11 -43.15 -22.70 -16.79 -44.19 -23.46 -18.56 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 33 2 # 33 B 325 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 350 LEU B 72 LEU^? 26.85 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 39.81 12.72 56.17 40.30 13.16 54.11 -44.25 -35.46 -6.58 -45.01 -34.22 -4.94 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 34 2 # 34 B 325 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 350 LEU B 87 LEU^? 20.22 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 39.81 12.72 56.17 40.30 13.16 54.11 -45.62 -34.34 -16.64 -46.54 -32.89 -17.98 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 35 2 # 35 B 325 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 350 LEU B 92 LEU~? 16.78 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 39.81 12.72 56.17 40.30 13.16 54.11 -41.76 -36.62 -20.33 -43.11 -34.97 -19.88 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 36 2 # 36 B 325 ASP B 63 ASP~? 17.37 O1 EDO A 124 B 350 LEU B 54 LEU~? 14.98 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 39.81 12.72 56.17 40.30 13.16 54.11 -44.12 -30.81 -26.43 -43.06 -31.04 -28.33 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 37 2 # 37 B 325 ASP B 63 ASP~? 17.37 O1 EDO A 124 B 350 LEU B 78 LEU^? 18.42 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 39.81 12.72 56.17 40.30 13.16 54.11 -42.62 -33.09 -13.72 -40.58 -33.23 -14.47 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 38 2 # 38 B 325 ASP B 63 ASP~? 17.37 O1 EDO A 124 B 350 LEU B 83 LEU.? 25.07 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 39.81 12.72 56.17 40.30 13.16 54.11 -50.68 -25.61 -13.23 -49.92 -24.11 -14.54 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 39 2 # 39 B 325 ASP B 64 ASP~? 23.62 O1 EDO A 124 B 350 LEU B 58 LEU.? 19.52 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 39.81 12.72 56.17 40.30 13.16 54.11 -47.35 -27.17 -19.69 -46.30 -27.92 -17.93 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 40 2 # 40 B 325 ASP B 84 ASP.? 30.86 C1 EDO A 124 B 350 LEU B 66 LEU~? 17.96 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 39.81 12.72 56.17 40.30 13.16 54.11 -43.15 -22.70 -16.79 -44.19 -23.46 -18.56 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 41 2 # 41 B 325 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 350 LEU B 54 LEU~? 14.98 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 39.81 12.72 56.17 40.30 13.16 54.11 -44.12 -30.81 -26.43 -43.06 -31.04 -28.33 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 42 2 # 42 B 325 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 350 LEU B 66 LEU~? 17.96 C1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 39.81 12.72 56.17 40.30 13.16 54.11 -43.15 -22.70 -16.79 -44.19 -23.46 -18.56 1bvz_c01 source 1bvz ALPHA-AMYLASE II : 42 hits 1bvz_c01 naa= 2 ULMN 2 1bvz_c04 ALPHA-AMYLASE II user 1 2 # 1 A 325 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 354 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 29.07 50.42 58.36 29.02 52.18 59.49 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1bvz_c04 ALPHA-AMYLASE II user 2 2 # 2 A 325 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 354 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 31.05 49.37 64.51 31.97 51.11 63.85 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 29.07 50.42 58.36 29.02 52.18 59.49 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1bvz_c04 ALPHA-AMYLASE II user 3 2 # 3 A 325 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 354 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 31.05 49.37 64.51 31.97 51.11 63.85 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 29.07 50.42 58.36 29.02 52.18 59.49 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1bvz_c04 source 1bvz ALPHA-AMYLASE II : 3 hits 1bvz_c04 naa= 2 ULMN 2 1bvz_c05 ALPHA-AMYLASE II user 1 2 # 1 B 325 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 354 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 27.87 10.66 47.95 27.82 8.60 48.27 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1bvz_c05 ALPHA-AMYLASE II user 2 2 # 2 B 325 ASP A 84 ASP.? 13.20 O1 EDO A 125 B 354 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 27.87 10.66 47.95 27.82 8.60 48.27 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1bvz_c05 ALPHA-AMYLASE II user 3 2 # 3 B 325 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 354 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 25.90 8.19 53.87 25.36 6.97 52.29 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 27.87 10.66 47.95 27.82 8.60 48.27 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1bvz_c05 ALPHA-AMYLASE II user 4 2 # 4 B 325 ASP B 84 ASP.? 30.86 C1 EDO A 124 B 354 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 25.90 8.19 53.87 25.36 6.97 52.29 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 27.87 10.66 47.95 27.82 8.60 48.27 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1bvz_c05 source 1bvz ALPHA-AMYLASE II : 4 hits 1bvz_c05 naa= 2 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 1 2 # 1 101 ASP A 32 ASP^? 7.79 O1 EDO A 124 186 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -0.56 17.74 21.75 0.00 19.22 23.13 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 6.70 33.61 26.27 5.12 32.50 27.11 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 2 2 # 2 101 ASP A 32 ASP^? 7.79 O1 EDO A 124 186 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -0.56 17.74 21.75 0.00 19.22 23.13 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 6.70 33.61 26.27 5.12 32.50 27.11 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 3 2 # 3 101 ASP A 63 ASP~? 17.25 O1 EDO A 124 186 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -0.56 17.74 21.75 0.00 19.22 23.13 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 6.70 33.61 26.27 5.12 32.50 27.11 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 4 2 # 4 101 ASP A 63 ASP~? 17.25 O1 EDO A 124 186 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo -0.56 17.74 21.75 0.00 19.22 23.13 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 6.70 33.61 26.27 5.12 32.50 27.11 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 5 2 # 5 101 ASP A 64 ASP~? 20.53 O2 EDO A 124 186 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -0.56 17.74 21.75 0.00 19.22 23.13 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 6.70 33.61 26.27 5.12 32.50 27.11 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 6 2 # 6 101 ASP A 86 ASP^? 9.05 O1 EDO A 125 186 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -0.56 17.74 21.75 0.00 19.22 23.13 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 6.70 33.61 26.27 5.12 32.50 27.11 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 7 2 # 7 101 ASP A 86 ASP^? 9.05 O1 EDO A 125 186 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -0.56 17.74 21.75 0.00 19.22 23.13 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 6.70 33.61 26.27 5.12 32.50 27.11 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 8 2 # 8 101 ASP B 32 ASP^? 9.42 O1 EDO A 124 186 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -0.56 17.74 21.75 0.00 19.22 23.13 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 6.70 33.61 26.27 5.12 32.50 27.11 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 9 2 # 9 101 ASP B 32 ASP^? 9.42 O1 EDO A 124 186 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -0.56 17.74 21.75 0.00 19.22 23.13 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 6.70 33.61 26.27 5.12 32.50 27.11 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 10 2 # 10 101 ASP B 32 ASP^? 9.42 O1 EDO A 124 186 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo -0.56 17.74 21.75 0.00 19.22 23.13 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 6.70 33.61 26.27 5.12 32.50 27.11 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 11 2 # 11 101 ASP B 63 ASP~? 17.37 O1 EDO A 124 186 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo -0.56 17.74 21.75 0.00 19.22 23.13 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 6.70 33.61 26.27 5.12 32.50 27.11 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 12 2 # 12 101 ASP B 63 ASP~? 17.37 O1 EDO A 124 186 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo -0.56 17.74 21.75 0.00 19.22 23.13 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 6.70 33.61 26.27 5.12 32.50 27.11 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 13 2 # 13 101 ASP B 64 ASP~? 23.62 O1 EDO A 124 186 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -0.56 17.74 21.75 0.00 19.22 23.13 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 6.70 33.61 26.27 5.12 32.50 27.11 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 14 2 # 14 101 ASP B 86 ASP^? 26.97 C1 EDO A 124 186 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -0.56 17.74 21.75 0.00 19.22 23.13 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 6.70 33.61 26.27 5.12 32.50 27.11 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 15 2 # 15 101 ASP B 86 ASP^? 26.97 C1 EDO A 124 186 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -0.56 17.74 21.75 0.00 19.22 23.13 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 6.70 33.61 26.27 5.12 32.50 27.11 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 1bya_c00 source 1bya BETA-AMYLASE (E.C.3.2.1.2) : 15 hits 1bya_c00 naa= 2 ULMN 2 1bzy_c12 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 A 105 CYH A 46 CYH.? 11.48 C1 EDO A 124 A 137 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 1.51 81.58 37.40 -0.24 80.35 35.63 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 11.51 80.72 44.41 10.38 78.98 44.80 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1bzy_c12 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 A 105 CYH B 46 CYH.? 10.55 O2 EDO A 125 A 137 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 1.51 81.58 37.40 -0.24 80.35 35.63 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo 11.51 80.72 44.41 10.38 78.98 44.80 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 1bzy_c12 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 2 hits 1bzy_c12 naa= 2 ULMN 2 1bzy_c13 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 B 105 CYH A 46 CYH.? 11.48 C1 EDO A 124 B 137 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 12.29 118.86 36.37 14.58 119.51 34.93 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 1.33 120.54 41.38 2.37 122.32 41.83 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1bzy_c13 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 B 105 CYH B 46 CYH.? 10.55 O2 EDO A 125 B 137 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 12.29 118.86 36.37 14.58 119.51 34.93 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo 1.33 120.54 41.38 2.37 122.32 41.83 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 1bzy_c13 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 2 hits 1bzy_c13 naa= 2 ULMN 2 1bzy_c14 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 C 105 CYH A 46 CYH.? 11.48 C1 EDO A 124 C 137 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 13.83 89.09 94.43 15.92 89.35 96.30 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 5.10 82.97 88.07 6.79 81.71 87.85 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1bzy_c14 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 C 105 CYH B 46 CYH.? 10.55 O2 EDO A 125 C 137 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 13.83 89.09 94.43 15.92 89.35 96.30 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo 5.10 82.97 88.07 6.79 81.71 87.85 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 1bzy_c14 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 2 hits 1bzy_c14 naa= 2 ULMN 2 1bzy_c15 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 D 105 CYH A 46 CYH.? 11.48 C1 EDO A 124 D 137 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo -10.58 118.36 90.34 -12.93 118.38 91.82 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo -0.72 123.60 84.94 -2.32 124.82 84.32 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1bzy_c15 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 D 105 CYH B 46 CYH.? 10.55 O2 EDO A 125 D 137 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo -10.58 118.36 90.34 -12.93 118.38 91.82 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo -0.72 123.60 84.94 -2.32 124.82 84.32 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 1bzy_c15 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 2 hits 1bzy_c15 naa= 2 ULMN 2 1bzy_c16 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 A 104 TYR A 31 TYR^? 13.43 O2 EDO A 124 A 137 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 6.06 82.60 40.26 8.21 81.19 41.35 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 11.51 80.72 44.41 10.38 78.98 44.80 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1bzy_c16 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 A 104 TYR A 31 TYR^? 13.43 O2 EDO A 124 A 137 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 6.06 82.60 40.26 8.21 81.19 41.35 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 11.51 80.72 44.41 10.38 78.98 44.80 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1bzy_c16 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 3 2 # 3 A 104 TYR A 31 TYR^? 13.43 O2 EDO A 124 A 137 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 6.06 82.60 40.26 8.21 81.19 41.35 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 11.51 80.72 44.41 10.38 78.98 44.80 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1bzy_c16 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 4 2 # 4 A 104 TYR B 31 TYR^? 14.49 O1 EDO A 124 A 137 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 6.06 82.60 40.26 8.21 81.19 41.35 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 11.51 80.72 44.41 10.38 78.98 44.80 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1bzy_c16 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 5 2 # 5 A 104 TYR B 31 TYR^? 14.49 O1 EDO A 124 A 137 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 6.06 82.60 40.26 8.21 81.19 41.35 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 11.51 80.72 44.41 10.38 78.98 44.80 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1bzy_c16 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 5 hits 1bzy_c16 naa= 2 ULMN 2 1bzy_c17 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 B 104 TYR A 31 TYR^? 13.43 O2 EDO A 124 B 137 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 7.21 118.18 38.45 4.99 119.76 39.04 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 1.33 120.54 41.38 2.37 122.32 41.83 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1bzy_c17 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 B 104 TYR A 31 TYR^? 13.43 O2 EDO A 124 B 137 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 7.21 118.18 38.45 4.99 119.76 39.04 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 1.33 120.54 41.38 2.37 122.32 41.83 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1bzy_c17 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 3 2 # 3 B 104 TYR A 31 TYR^? 13.43 O2 EDO A 124 B 137 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 7.21 118.18 38.45 4.99 119.76 39.04 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 1.33 120.54 41.38 2.37 122.32 41.83 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1bzy_c17 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 4 2 # 4 B 104 TYR B 31 TYR^? 14.49 O1 EDO A 124 B 137 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 7.21 118.18 38.45 4.99 119.76 39.04 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 1.33 120.54 41.38 2.37 122.32 41.83 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1bzy_c17 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 5 2 # 5 B 104 TYR B 31 TYR^? 14.49 O1 EDO A 124 B 137 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 7.21 118.18 38.45 4.99 119.76 39.04 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 1.33 120.54 41.38 2.37 122.32 41.83 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1bzy_c17 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 5 hits 1bzy_c17 naa= 2 ULMN 2 1bzy_c18 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 C 104 TYR A 31 TYR^? 13.43 O2 EDO A 124 C 137 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 9.22 87.61 91.72 7.84 85.28 91.02 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 5.10 82.97 88.07 6.79 81.71 87.85 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1bzy_c18 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 C 104 TYR A 31 TYR^? 13.43 O2 EDO A 124 C 137 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 9.22 87.61 91.72 7.84 85.28 91.02 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 5.10 82.97 88.07 6.79 81.71 87.85 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1bzy_c18 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 3 2 # 3 C 104 TYR A 31 TYR^? 13.43 O2 EDO A 124 C 137 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 9.22 87.61 91.72 7.84 85.28 91.02 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 5.10 82.97 88.07 6.79 81.71 87.85 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1bzy_c18 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 4 2 # 4 C 104 TYR B 31 TYR^? 14.49 O1 EDO A 124 C 137 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 9.22 87.61 91.72 7.84 85.28 91.02 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 5.10 82.97 88.07 6.79 81.71 87.85 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1bzy_c18 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 5 2 # 5 C 104 TYR B 31 TYR^? 14.49 O1 EDO A 124 C 137 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 9.22 87.61 91.72 7.84 85.28 91.02 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 5.10 82.97 88.07 6.79 81.71 87.85 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1bzy_c18 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 5 hits 1bzy_c18 naa= 2 ULMN 2 1bzy_c19 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 D 104 TYR A 31 TYR^? 13.43 O2 EDO A 124 D 137 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo -5.64 119.47 88.35 -4.20 121.69 87.46 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo -0.72 123.60 84.94 -2.32 124.82 84.32 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1bzy_c19 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 D 104 TYR A 31 TYR^? 13.43 O2 EDO A 124 D 137 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -5.64 119.47 88.35 -4.20 121.69 87.46 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo -0.72 123.60 84.94 -2.32 124.82 84.32 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1bzy_c19 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 3 2 # 3 D 104 TYR A 31 TYR^? 13.43 O2 EDO A 124 D 137 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo -5.64 119.47 88.35 -4.20 121.69 87.46 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo -0.72 123.60 84.94 -2.32 124.82 84.32 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1bzy_c19 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 4 2 # 4 D 104 TYR B 31 TYR^? 14.49 O1 EDO A 124 D 137 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo -5.64 119.47 88.35 -4.20 121.69 87.46 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo -0.72 123.60 84.94 -2.32 124.82 84.32 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1bzy_c19 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 5 2 # 5 D 104 TYR B 31 TYR^? 14.49 O1 EDO A 124 D 137 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -5.64 119.47 88.35 -4.20 121.69 87.46 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo -0.72 123.60 84.94 -2.32 124.82 84.32 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1bzy_c19 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 6 2 # 6 D 104 TYR B 31 TYR^? 14.49 O1 EDO A 124 D 137 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo -5.64 119.47 88.35 -4.20 121.69 87.46 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo -0.72 123.60 84.94 -2.32 124.82 84.32 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 1bzy_c19 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 6 hits 1bzy_c19 naa= 2 ULMN 2 1c2t_c04 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 2 # 1 A 108 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 144 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 16.00 9.54 19.61 16.53 10.80 21.20 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 20.15 8.89 19.42 18.82 8.12 20.82 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1c2t_c04 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 2 # 2 A 108 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 144 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 16.00 9.54 19.61 16.53 10.80 21.20 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 20.15 8.89 19.42 18.82 8.12 20.82 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1c2t_c04 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 2 hits 1c2t_c04 naa= 2 ULMN 2 1c2t_c05 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 2 # 1 B 108 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 144 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 35.12 16.22 2.69 37.05 17.04 2.40 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1c2t_c05 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 2 # 2 B 108 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 144 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 35.12 16.22 2.69 37.05 17.04 2.40 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1c2t_c05 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 2 hits 1c2t_c05 naa= 2 ULMN 2 1c3j_c00 BETA-GLUCOSYLTRANSFERASE user 1 2 # 1 A 22 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 100 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 12.93 -8.26 7.64 14.85 -9.21 7.82 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 20.71 -13.59 6.11 21.09 -14.85 7.76 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1c3j_c00 BETA-GLUCOSYLTRANSFERASE user 2 2 # 2 A 22 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 100 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 12.93 -8.26 7.64 14.85 -9.21 7.82 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 20.71 -13.59 6.11 21.09 -14.85 7.76 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1c3j_c00 BETA-GLUCOSYLTRANSFERASE user 3 2 # 3 A 22 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 100 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 12.93 -8.26 7.64 14.85 -9.21 7.82 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 20.71 -13.59 6.11 21.09 -14.85 7.76 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1c3j_c00 BETA-GLUCOSYLTRANSFERASE user 4 2 # 4 A 22 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 100 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 12.93 -8.26 7.64 14.85 -9.21 7.82 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 20.71 -13.59 6.11 21.09 -14.85 7.76 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1c3j_c00 BETA-GLUCOSYLTRANSFERASE user 5 2 # 5 A 22 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 100 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 12.93 -8.26 7.64 14.85 -9.21 7.82 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 20.71 -13.59 6.11 21.09 -14.85 7.76 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1c3j_c00 BETA-GLUCOSYLTRANSFERASE user 6 2 # 6 A 22 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 100 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 12.93 -8.26 7.64 14.85 -9.21 7.82 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 20.71 -13.59 6.11 21.09 -14.85 7.76 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1c3j_c00 source 1c3j BETA-GLUCOSYLTRANSFERASE : 6 hits 1c3j_c00 naa= 2 ULMN 2 1c9u_c00 SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROuser 1 2 # 1 A 144 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 163 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo -1.62 24.04 7.39 -0.21 25.28 6.44 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -7.14 26.54 6.91 -5.10 26.92 6.49 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1c9u_c00 SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROuser 2 2 # 2 A 144 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 163 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo -1.62 24.04 7.39 -0.21 25.28 6.44 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -7.14 26.54 6.91 -5.10 26.92 6.49 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1c9u_c00 SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROuser 3 2 # 3 A 144 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 163 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo -1.62 24.04 7.39 -0.21 25.28 6.44 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -7.14 26.54 6.91 -5.10 26.92 6.49 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1c9u_c00 source 1c9u SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE : 3 hits 1c9u_c00 naa= 2 ULMN 2 1c9u_c01 SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROuser 1 2 # 1 B 144 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 163 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 33.06 -15.51 28.71 33.71 -15.47 26.71 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 36.29 -19.04 31.61 36.05 -18.17 29.69 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1c9u_c01 SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROuser 2 2 # 2 B 144 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 163 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 33.06 -15.51 28.71 33.71 -15.47 26.71 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 36.29 -19.04 31.61 36.05 -18.17 29.69 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1c9u_c01 source 1c9u SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE : 2 hits 1c9u_c01 naa= 2 ULMN 2 1ca0_c00 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 1 2 # 1 B 144 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 163 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 33.06 -15.51 28.71 33.71 -15.47 26.71 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 36.29 -19.04 31.61 36.05 -18.17 29.69 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1ca0_c00 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 2 2 # 2 B 144 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 163 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 33.06 -15.51 28.71 33.71 -15.47 26.71 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 36.29 -19.04 31.61 36.05 -18.17 29.69 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1ca0_c00 source 1c9u PROTEASE INHIBITOR DOMAIN OF ALZHEIMER'S AMYLO: 2 hits 1ca0_c00 naa= 2 ULMN 2 1ca0_c01 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 1 2 # 1 B 144 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 163 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 33.06 -15.51 28.71 33.71 -15.47 26.71 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 36.29 -19.04 31.61 36.05 -18.17 29.69 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1ca0_c01 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 2 2 # 2 B 144 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 163 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 33.06 -15.51 28.71 33.71 -15.47 26.71 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 36.29 -19.04 31.61 36.05 -18.17 29.69 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1ca0_c01 source 1c9u PROTEASE INHIBITOR DOMAIN OF ALZHEIMER'S AMYLO: 2 hits 1ca0_c01 naa= 2 ULMN 2 1ca2_c00 CARBONIC ANHYDRASE II (CARBONATE DEHuser 1 2 # 1 106 GLU B 81 GLU.? 30.69 O1 EDO A 124 199 THR B 82 THR.? 29.24 O1 EDO A 124 coo -5.18 -6.65 17.84 -4.18 -4.84 17.57 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo -2.11 -0.86 19.01 -3.95 -2.03 19.08 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 1ca2_c00 source 1ca2 CARBONIC ANHYDRASE II (CARBONATE DEHYDRATASE) : 1 hits 1ca2_c00 naa= 2 ULMN 2 1ca2_c01 CARBONIC ANHYDRASE II (CARBONATE DEHuser 1 2 # 1 64 HIS A 79 HIS^? 12.23 O1 EDO A 125 199 THR A 82 THR.? 18.68 O1 EDO A 125 coo -0.75 -0.87 9.12 -1.30 1.12 9.42 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -2.11 -0.86 19.01 -3.95 -2.03 19.08 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 ULMN 2 1ca2_c01 CARBONIC ANHYDRASE II (CARBONATE DEHuser 2 2 # 2 64 HIS B 79 HIS^? 26.86 C1 EDO A 124 199 THR B 82 THR.? 29.24 O1 EDO A 124 coo -0.75 -0.87 9.12 -1.30 1.12 9.42 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -2.11 -0.86 19.01 -3.95 -2.03 19.08 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 1ca2_c01 source 1ca2 CARBONIC ANHYDRASE II (CARBONATE DEHYDRATASE) : 2 hits 1ca2_c01 naa= 2 ULMN 2 1ca3_c00 CARBONIC ANHYDRASE II (CARBONATE DEHuser 1 2 # 1 A 106 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 199 THR A 82 THR.? 18.68 O1 EDO A 125 coo -5.31 -6.51 17.94 -4.14 -4.86 17.52 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo -2.15 -1.17 19.07 -3.99 -2.15 19.07 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 ULMN 2 1ca3_c00 CARBONIC ANHYDRASE II (CARBONATE DEHuser 2 2 # 2 A 106 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 199 THR B 82 THR.? 29.24 O1 EDO A 124 coo -5.31 -6.51 17.94 -4.14 -4.86 17.52 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo -2.15 -1.17 19.07 -3.99 -2.15 19.07 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 1ca3_c00 source 1ca3 CARBONIC ANHYDRASE II (CARBONATE DEHYDRATASE) : 2 hits 1ca3_c00 naa= 2 ULMN 2 1cb7_c04 GLUTAMATE MUTASE user 1 2 # 1 A 14 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 16 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1cb7_c04 GLUTAMATE MUTASE user 2 2 # 2 A 14 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 16 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1cb7_c04 source 1cb7 GLUTAMATE MUTASE : 2 hits 1cb7_c04 naa= 2 ULMN 2 1cb7_c05 GLUTAMATE MUTASE user 1 2 # 1 C 14 ASP A 86 ASP^? 9.05 O1 EDO A 125 C 16 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 10.04 44.27 88.44 9.47 42.32 89.03 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 6.38 39.80 88.71 6.88 38.89 86.87 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1cb7_c05 GLUTAMATE MUTASE user 2 2 # 2 C 14 ASP B 86 ASP^? 26.97 C1 EDO A 124 C 16 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 10.04 44.27 88.44 9.47 42.32 89.03 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 6.38 39.80 88.71 6.88 38.89 86.87 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1cb7_c05 source 1cb7 GLUTAMATE MUTASE : 2 hits 1cb7_c05 naa= 2 ULMN 2 1cbg_c01 CYANOGENIC BETA-GLUCOSIDASE user 1 2 # 1 183 GLU A 70 GLU^? 16.40 O1 EDO A 125 397 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 39.31 34.78 85.95 38.51 34.50 84.04 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 42.23 29.47 82.87 40.46 30.21 83.67 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1cbg_c01 CYANOGENIC BETA-GLUCOSIDASE user 2 2 # 2 183 GLU A 81 GLU.? 16.59 O1 EDO A 125 397 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 39.31 34.78 85.95 38.51 34.50 84.04 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 42.23 29.47 82.87 40.46 30.21 83.67 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1cbg_c01 CYANOGENIC BETA-GLUCOSIDASE user 3 2 # 3 183 GLU B 70 GLU^? 26.28 O1 EDO A 124 397 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 39.31 34.78 85.95 38.51 34.50 84.04 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 42.23 29.47 82.87 40.46 30.21 83.67 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1cbg_c01 CYANOGENIC BETA-GLUCOSIDASE user 4 2 # 4 183 GLU B 81 GLU.? 30.69 O1 EDO A 124 397 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 39.31 34.78 85.95 38.51 34.50 84.04 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 42.23 29.47 82.87 40.46 30.21 83.67 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1cbg_c01 source 1cbg CYANOGENIC BETA-GLUCOSIDASE : 4 hits 1cbg_c01 naa= 2 ULMN 2 1cbx_c00 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 2 # 1 127 ARG A 30 ARG^? -2.97 O2 EDO A 124s 270 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1cbx_c00 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 2 # 2 127 ARG A 37 ARG^? 13.77 O1 EDO A 124 270 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1cbx_c00 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 3 2 # 3 127 ARG A 37 ARG^? 13.77 O1 EDO A 124 270 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1cbx_c00 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 4 2 # 4 127 ARG B 30 ARG^? 10.56 O1 EDO A 124 270 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1cbx_c00 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 4 hits 1cbx_c00 naa= 2 ULMN 2 1cc1_c00 HYDROGENASE (LARGE SUBUNIT) user 1 2 # 1 S 19 THR A 82 THR.? 18.68 O1 EDO A 125 L 23 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 39.82 19.80 46.49 40.70 18.87 48.29 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 coo 39.80 15.56 49.54 37.67 16.01 49.64 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1cc1_c00 HYDROGENASE (LARGE SUBUNIT) user 2 2 # 2 S 19 THR B 82 THR.? 29.24 O1 EDO A 124 L 23 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 39.82 19.80 46.49 40.70 18.87 48.29 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 coo 39.80 15.56 49.54 37.67 16.01 49.64 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1cc1_c00 source 1cc1 HYDROGENASE (LARGE SUBUNIT) : 2 hits 1cc1_c00 naa= 2 ULMN 2 1cde_c08 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 2 # 1 108 HIS A 79 HIS^? 12.23 O1 EDO A 125 144 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1cde_c08 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 2 # 2 108 HIS B 79 HIS^? 26.86 C1 EDO A 124 144 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1cde_c08 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 2 hits 1cde_c08 naa= 2 ULMN 2 1cde_c09 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 2 # 1 108 HIS A 79 HIS^? 12.23 O1 EDO A 125 144 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1cde_c09 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 2 # 2 108 HIS B 79 HIS^? 26.86 C1 EDO A 124 144 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1cde_c09 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 2 hits 1cde_c09 naa= 2 ULMN 2 1cde_c10 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 2 # 1 108 HIS A 79 HIS^? 12.23 O1 EDO A 125 144 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1cde_c10 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 2 # 2 108 HIS B 79 HIS^? 26.86 C1 EDO A 124 144 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1cde_c10 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 2 hits 1cde_c10 naa= 2 ULMN 2 1cde_c11 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 2 # 1 108 HIS A 79 HIS^? 12.23 O1 EDO A 125 144 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1cde_c11 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 2 # 2 108 HIS B 79 HIS^? 26.86 C1 EDO A 124 144 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1cde_c11 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 2 hits 1cde_c11 naa= 2 ULMN 2 1cdg_c02 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 2 # 1 229 ASP A 41 ASP^? -2.91 O2 EDO A 124s 257 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 45.62 80.42 43.69 45.65 82.01 45.07 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 48.97 85.16 40.39 47.18 86.25 40.47 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1cdg_c02 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 2 # 2 229 ASP A 84 ASP.? 13.20 O1 EDO A 125 257 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 45.62 80.42 43.69 45.65 82.01 45.07 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 48.97 85.16 40.39 47.18 86.25 40.47 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1cdg_c02 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 2 # 3 229 ASP B 41 ASP^? 12.31 O1 EDO A 124 257 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 45.62 80.42 43.69 45.65 82.01 45.07 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 48.97 85.16 40.39 47.18 86.25 40.47 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1cdg_c02 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 2 # 4 229 ASP B 84 ASP.? 30.86 C1 EDO A 124 257 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 45.62 80.42 43.69 45.65 82.01 45.07 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 48.97 85.16 40.39 47.18 86.25 40.47 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1cdg_c02 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 4 hits 1cdg_c02 naa= 2 ULMN 2 1cev_c00 ARGINASE user 1 2 # 1 A 126 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 271 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 56.42 -26.69 44.89 57.03 -25.42 43.36 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 61.43 -23.42 38.04 59.66 -23.99 37.00 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1cev_c00 ARGINASE user 2 2 # 2 A 126 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 271 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 56.42 -26.69 44.89 57.03 -25.42 43.36 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 61.43 -23.42 38.04 59.66 -23.99 37.00 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1cev_c00 ARGINASE user 3 2 # 3 A 126 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 271 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 56.42 -26.69 44.89 57.03 -25.42 43.36 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 61.43 -23.42 38.04 59.66 -23.99 37.00 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1cev_c00 ARGINASE user 4 2 # 4 A 126 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 271 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 56.42 -26.69 44.89 57.03 -25.42 43.36 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 61.43 -23.42 38.04 59.66 -23.99 37.00 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1cev_c00 ARGINASE user 5 2 # 5 A 126 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 271 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 56.42 -26.69 44.89 57.03 -25.42 43.36 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 61.43 -23.42 38.04 59.66 -23.99 37.00 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1cev_c00 ARGINASE user 6 2 # 6 A 126 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 271 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 56.42 -26.69 44.89 57.03 -25.42 43.36 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 61.43 -23.42 38.04 59.66 -23.99 37.00 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1cev_c00 ARGINASE user 7 2 # 7 A 126 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 271 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 56.42 -26.69 44.89 57.03 -25.42 43.36 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 61.43 -23.42 38.04 59.66 -23.99 37.00 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1cev_c00 ARGINASE user 8 2 # 8 A 126 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 271 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 56.42 -26.69 44.89 57.03 -25.42 43.36 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 61.43 -23.42 38.04 59.66 -23.99 37.00 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1cev_c00 source 1cev ARGINASE : 8 hits 1cev_c00 naa= 2 ULMN 2 1cev_c01 ARGINASE user 1 2 # 1 B 126 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 271 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 88.66 4.10 42.84 87.11 4.00 41.44 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 82.56 6.85 36.70 83.82 5.71 35.47 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1cev_c01 ARGINASE user 2 2 # 2 B 126 ASP A 84 ASP.? 13.20 O1 EDO A 125 B 271 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 88.66 4.10 42.84 87.11 4.00 41.44 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 82.56 6.85 36.70 83.82 5.71 35.47 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1cev_c01 ARGINASE user 3 2 # 3 B 126 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 271 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 88.66 4.10 42.84 87.11 4.00 41.44 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 82.56 6.85 36.70 83.82 5.71 35.47 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1cev_c01 ARGINASE user 4 2 # 4 B 126 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 271 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 88.66 4.10 42.84 87.11 4.00 41.44 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 82.56 6.85 36.70 83.82 5.71 35.47 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1cev_c01 ARGINASE user 5 2 # 5 B 126 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 271 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 88.66 4.10 42.84 87.11 4.00 41.44 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 82.56 6.85 36.70 83.82 5.71 35.47 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1cev_c01 ARGINASE user 6 2 # 6 B 126 ASP B 84 ASP.? 30.86 C1 EDO A 124 B 271 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 88.66 4.10 42.84 87.11 4.00 41.44 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 82.56 6.85 36.70 83.82 5.71 35.47 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1cev_c01 ARGINASE user 7 2 # 7 B 126 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 271 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 88.66 4.10 42.84 87.11 4.00 41.44 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 82.56 6.85 36.70 83.82 5.71 35.47 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1cev_c01 ARGINASE user 8 2 # 8 B 126 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 271 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 88.66 4.10 42.84 87.11 4.00 41.44 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 82.56 6.85 36.70 83.82 5.71 35.47 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1cev_c01 source 1cev ARGINASE : 8 hits 1cev_c01 naa= 2 ULMN 2 1cev_c02 ARGINASE user 1 2 # 1 C 126 ASP A 41 ASP^? -2.91 O2 EDO A 124s C 271 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 45.89 16.49 45.35 46.56 15.26 43.82 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 45.78 10.17 38.80 46.02 11.92 37.61 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1cev_c02 ARGINASE user 2 2 # 2 C 126 ASP A 84 ASP.? 13.20 O1 EDO A 125 C 271 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 45.89 16.49 45.35 46.56 15.26 43.82 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 45.78 10.17 38.80 46.02 11.92 37.61 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1cev_c02 ARGINASE user 3 2 # 3 C 126 ASP A 86 ASP^? 9.05 O1 EDO A 125 C 271 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 45.89 16.49 45.35 46.56 15.26 43.82 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 45.78 10.17 38.80 46.02 11.92 37.61 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1cev_c02 ARGINASE user 4 2 # 4 C 126 ASP A 86 ASP^? 9.05 O1 EDO A 125 C 271 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 45.89 16.49 45.35 46.56 15.26 43.82 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 45.78 10.17 38.80 46.02 11.92 37.61 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1cev_c02 ARGINASE user 5 2 # 5 C 126 ASP B 41 ASP^? 12.31 O1 EDO A 124 C 271 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 45.89 16.49 45.35 46.56 15.26 43.82 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 45.78 10.17 38.80 46.02 11.92 37.61 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1cev_c02 ARGINASE user 6 2 # 6 C 126 ASP B 84 ASP.? 30.86 C1 EDO A 124 C 271 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 45.89 16.49 45.35 46.56 15.26 43.82 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 45.78 10.17 38.80 46.02 11.92 37.61 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1cev_c02 ARGINASE user 7 2 # 7 C 126 ASP B 86 ASP^? 26.97 C1 EDO A 124 C 271 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 45.89 16.49 45.35 46.56 15.26 43.82 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 45.78 10.17 38.80 46.02 11.92 37.61 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1cev_c02 ARGINASE user 8 2 # 8 C 126 ASP B 86 ASP^? 26.97 C1 EDO A 124 C 271 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 45.89 16.49 45.35 46.56 15.26 43.82 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 45.78 10.17 38.80 46.02 11.92 37.61 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1cev_c02 source 1cev ARGINASE : 8 hits 1cev_c02 naa= 2 ULMN 2 1cev_c03 ARGINASE user 1 2 # 1 D 126 ASP A 41 ASP^? -2.91 O2 EDO A 124s D 271 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 56.62 -22.51 83.64 56.67 -21.03 85.13 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 53.70 -16.83 90.05 54.85 -18.21 91.20 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1cev_c03 ARGINASE user 2 2 # 2 D 126 ASP A 84 ASP.? 13.20 O1 EDO A 125 D 271 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 56.62 -22.51 83.64 56.67 -21.03 85.13 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 53.70 -16.83 90.05 54.85 -18.21 91.20 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1cev_c03 ARGINASE user 3 2 # 3 D 126 ASP A 86 ASP^? 9.05 O1 EDO A 125 D 271 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 56.62 -22.51 83.64 56.67 -21.03 85.13 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 53.70 -16.83 90.05 54.85 -18.21 91.20 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1cev_c03 ARGINASE user 4 2 # 4 D 126 ASP A 86 ASP^? 9.05 O1 EDO A 125 D 271 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 56.62 -22.51 83.64 56.67 -21.03 85.13 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 53.70 -16.83 90.05 54.85 -18.21 91.20 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1cev_c03 ARGINASE user 5 2 # 5 D 126 ASP B 41 ASP^? 12.31 O1 EDO A 124 D 271 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 56.62 -22.51 83.64 56.67 -21.03 85.13 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 53.70 -16.83 90.05 54.85 -18.21 91.20 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1cev_c03 ARGINASE user 6 2 # 6 D 126 ASP B 84 ASP.? 30.86 C1 EDO A 124 D 271 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 56.62 -22.51 83.64 56.67 -21.03 85.13 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 53.70 -16.83 90.05 54.85 -18.21 91.20 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1cev_c03 ARGINASE user 7 2 # 7 D 126 ASP B 86 ASP^? 26.97 C1 EDO A 124 D 271 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 56.62 -22.51 83.64 56.67 -21.03 85.13 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 53.70 -16.83 90.05 54.85 -18.21 91.20 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1cev_c03 ARGINASE user 8 2 # 8 D 126 ASP B 86 ASP^? 26.97 C1 EDO A 124 D 271 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 56.62 -22.51 83.64 56.67 -21.03 85.13 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 53.70 -16.83 90.05 54.85 -18.21 91.20 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1cev_c03 source 1cev ARGINASE : 8 hits 1cev_c03 naa= 2 ULMN 2 1cev_c04 ARGINASE user 1 2 # 1 E 126 ASP A 41 ASP^? -2.91 O2 EDO A 124s E 271 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 45.56 20.87 83.32 46.70 20.05 84.89 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 51.57 20.36 90.15 49.76 20.10 91.22 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1cev_c04 ARGINASE user 2 2 # 2 E 126 ASP A 84 ASP.? 13.20 O1 EDO A 125 E 271 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 45.56 20.87 83.32 46.70 20.05 84.89 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 51.57 20.36 90.15 49.76 20.10 91.22 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1cev_c04 ARGINASE user 3 2 # 3 E 126 ASP A 86 ASP^? 9.05 O1 EDO A 125 E 271 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 45.56 20.87 83.32 46.70 20.05 84.89 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 51.57 20.36 90.15 49.76 20.10 91.22 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1cev_c04 ARGINASE user 4 2 # 4 E 126 ASP A 86 ASP^? 9.05 O1 EDO A 125 E 271 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 45.56 20.87 83.32 46.70 20.05 84.89 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 51.57 20.36 90.15 49.76 20.10 91.22 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1cev_c04 ARGINASE user 5 2 # 5 E 126 ASP B 41 ASP^? 12.31 O1 EDO A 124 E 271 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 45.56 20.87 83.32 46.70 20.05 84.89 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 51.57 20.36 90.15 49.76 20.10 91.22 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1cev_c04 ARGINASE user 6 2 # 6 E 126 ASP B 84 ASP.? 30.86 C1 EDO A 124 E 271 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 45.56 20.87 83.32 46.70 20.05 84.89 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 51.57 20.36 90.15 49.76 20.10 91.22 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1cev_c04 ARGINASE user 7 2 # 7 E 126 ASP B 86 ASP^? 26.97 C1 EDO A 124 E 271 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 45.56 20.87 83.32 46.70 20.05 84.89 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 51.57 20.36 90.15 49.76 20.10 91.22 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1cev_c04 ARGINASE user 8 2 # 8 E 126 ASP B 86 ASP^? 26.97 C1 EDO A 124 E 271 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 45.56 20.87 83.32 46.70 20.05 84.89 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 51.57 20.36 90.15 49.76 20.10 91.22 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1cev_c04 source 1cev ARGINASE : 8 hits 1cev_c04 naa= 2 ULMN 2 1cev_c05 ARGINASE user 1 2 # 1 F 126 ASP A 41 ASP^? -2.91 O2 EDO A 124s F 271 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 88.43 8.76 85.43 87.07 8.09 86.86 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 84.65 3.46 91.79 85.25 5.11 93.00 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1cev_c05 ARGINASE user 2 2 # 2 F 126 ASP A 84 ASP.? 13.20 O1 EDO A 125 F 271 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 88.43 8.76 85.43 87.07 8.09 86.86 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 84.65 3.46 91.79 85.25 5.11 93.00 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1cev_c05 ARGINASE user 3 2 # 3 F 126 ASP A 86 ASP^? 9.05 O1 EDO A 125 F 271 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 88.43 8.76 85.43 87.07 8.09 86.86 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 84.65 3.46 91.79 85.25 5.11 93.00 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1cev_c05 ARGINASE user 4 2 # 4 F 126 ASP A 86 ASP^? 9.05 O1 EDO A 125 F 271 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 88.43 8.76 85.43 87.07 8.09 86.86 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 84.65 3.46 91.79 85.25 5.11 93.00 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1cev_c05 ARGINASE user 5 2 # 5 F 126 ASP B 41 ASP^? 12.31 O1 EDO A 124 F 271 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 88.43 8.76 85.43 87.07 8.09 86.86 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 84.65 3.46 91.79 85.25 5.11 93.00 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1cev_c05 ARGINASE user 6 2 # 6 F 126 ASP B 84 ASP.? 30.86 C1 EDO A 124 F 271 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 88.43 8.76 85.43 87.07 8.09 86.86 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 84.65 3.46 91.79 85.25 5.11 93.00 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1cev_c05 ARGINASE user 7 2 # 7 F 126 ASP B 86 ASP^? 26.97 C1 EDO A 124 F 271 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 88.43 8.76 85.43 87.07 8.09 86.86 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 84.65 3.46 91.79 85.25 5.11 93.00 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1cev_c05 ARGINASE user 8 2 # 8 F 126 ASP B 86 ASP^? 26.97 C1 EDO A 124 F 271 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 88.43 8.76 85.43 87.07 8.09 86.86 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 84.65 3.46 91.79 85.25 5.11 93.00 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1cev_c05 source 1cev ARGINASE : 8 hits 1cev_c05 naa= 2 ULMN 2 1cf2_c04 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGEuser 1 2 # 1 P 140 CYH A 67 CYH~? 14.35 O2 EDO A 124 P 167 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 37.00 55.45 21.55 35.73 54.16 19.38 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo 37.39 54.72 11.98 34.62 53.51 12.78 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1cf2_c04 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGEuser 2 2 # 2 P 140 CYH A 67 CYH~? 14.35 O2 EDO A 124 P 167 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 37.00 55.45 21.55 35.73 54.16 19.38 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo 37.39 54.72 11.98 34.62 53.51 12.78 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1cf2_c04 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGEuser 3 2 # 3 P 140 CYH B 67 CYH~? 18.88 O1 EDO A 124 P 167 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 37.00 55.45 21.55 35.73 54.16 19.38 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo 37.39 54.72 11.98 34.62 53.51 12.78 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1cf2_c04 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGEuser 4 2 # 4 P 140 CYH B 67 CYH~? 18.88 O1 EDO A 124 P 167 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 37.00 55.45 21.55 35.73 54.16 19.38 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo 37.39 54.72 11.98 34.62 53.51 12.78 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 1cf2_c04 source 1cf2 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE : 4 hits 1cf2_c04 naa= 2 ULMN 2 1cf2_c05 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGEuser 1 2 # 1 R 140 CYH A 67 CYH~? 14.35 O2 EDO A 124 R 167 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 36.65 20.05 20.49 37.97 21.41 18.43 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo 36.68 21.37 10.97 39.29 22.52 12.09 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1cf2_c05 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGEuser 2 2 # 2 R 140 CYH A 67 CYH~? 14.35 O2 EDO A 124 R 167 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 36.65 20.05 20.49 37.97 21.41 18.43 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo 36.68 21.37 10.97 39.29 22.52 12.09 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1cf2_c05 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGEuser 3 2 # 3 R 140 CYH B 67 CYH~? 18.88 O1 EDO A 124 R 167 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 36.65 20.05 20.49 37.97 21.41 18.43 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo 36.68 21.37 10.97 39.29 22.52 12.09 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1cf2_c05 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGEuser 4 2 # 4 R 140 CYH B 67 CYH~? 18.88 O1 EDO A 124 R 167 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 36.65 20.05 20.49 37.97 21.41 18.43 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo 36.68 21.37 10.97 39.29 22.52 12.09 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 1cf2_c05 source 1cf2 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE : 4 hits 1cf2_c05 naa= 2 ULMN 2 1cf2_c06 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGEuser 1 2 # 1 O 140 CYH A 67 CYH~? 14.35 O2 EDO A 124 O 167 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 53.22 46.39 -5.99 52.38 44.62 -3.93 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo 51.98 45.74 3.36 52.10 42.70 2.65 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1cf2_c06 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGEuser 2 2 # 2 O 140 CYH A 67 CYH~? 14.35 O2 EDO A 124 O 167 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 53.22 46.39 -5.99 52.38 44.62 -3.93 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo 51.98 45.74 3.36 52.10 42.70 2.65 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1cf2_c06 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGEuser 3 2 # 3 O 140 CYH B 67 CYH~? 18.88 O1 EDO A 124 O 167 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 53.22 46.39 -5.99 52.38 44.62 -3.93 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo 51.98 45.74 3.36 52.10 42.70 2.65 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1cf2_c06 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGEuser 4 2 # 4 O 140 CYH B 67 CYH~? 18.88 O1 EDO A 124 O 167 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 53.22 46.39 -5.99 52.38 44.62 -3.93 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo 51.98 45.74 3.36 52.10 42.70 2.65 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 1cf2_c06 source 1cf2 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE : 4 hits 1cf2_c06 naa= 2 ULMN 2 1cf2_c07 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGEuser 1 2 # 1 Q 140 CYH A 67 CYH~? 14.35 O2 EDO A 124 Q 167 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 21.38 30.68 -7.01 21.99 32.31 -4.79 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo 22.22 30.73 2.56 22.17 33.68 1.65 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1cf2_c07 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGEuser 2 2 # 2 Q 140 CYH A 67 CYH~? 14.35 O2 EDO A 124 Q 167 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 21.38 30.68 -7.01 21.99 32.31 -4.79 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo 22.22 30.73 2.56 22.17 33.68 1.65 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1cf2_c07 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGEuser 3 2 # 3 Q 140 CYH B 67 CYH~? 18.88 O1 EDO A 124 Q 167 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 21.38 30.68 -7.01 21.99 32.31 -4.79 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo 22.22 30.73 2.56 22.17 33.68 1.65 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1cf2_c07 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGEuser 4 2 # 4 Q 140 CYH B 67 CYH~? 18.88 O1 EDO A 124 Q 167 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 21.38 30.68 -7.01 21.99 32.31 -4.79 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo 22.22 30.73 2.56 22.17 33.68 1.65 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 1cf2_c07 source 1cf2 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE : 4 hits 1cf2_c07 naa= 2 ULMN 2 1cg6_c00 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSuser 1 2 # 1 A 220 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 222 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 58.27 13.03 22.20 58.95 14.66 23.40 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 57.70 19.17 20.72 57.19 20.68 22.14 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1cg6_c00 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSuser 2 2 # 2 A 220 ASP A 64 ASP~? 20.53 O2 EDO A 124 A 222 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 58.27 13.03 22.20 58.95 14.66 23.40 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 57.70 19.17 20.72 57.19 20.68 22.14 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1cg6_c00 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSuser 3 2 # 3 A 220 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 222 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 58.27 13.03 22.20 58.95 14.66 23.40 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 57.70 19.17 20.72 57.19 20.68 22.14 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1cg6_c00 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSuser 4 2 # 4 A 220 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 222 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 58.27 13.03 22.20 58.95 14.66 23.40 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 57.70 19.17 20.72 57.19 20.68 22.14 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1cg6_c00 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSuser 5 2 # 5 A 220 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 222 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 58.27 13.03 22.20 58.95 14.66 23.40 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 57.70 19.17 20.72 57.19 20.68 22.14 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1cg6_c00 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSuser 6 2 # 6 A 220 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 222 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 58.27 13.03 22.20 58.95 14.66 23.40 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 57.70 19.17 20.72 57.19 20.68 22.14 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1cg6_c00 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSuser 7 2 # 7 A 220 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 222 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 58.27 13.03 22.20 58.95 14.66 23.40 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 57.70 19.17 20.72 57.19 20.68 22.14 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1cg6_c00 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSuser 8 2 # 8 A 220 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 222 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 58.27 13.03 22.20 58.95 14.66 23.40 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 57.70 19.17 20.72 57.19 20.68 22.14 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1cg6_c00 source 1cg6 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE : 8 hits 1cg6_c00 naa= 2 ULMN 2 1chk_c00 CHITOSANASE user 1 2 # 1 B 22 GLU A 23 GLU.? 13.04 O2 EDO A 125 B 40 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 8.24 11.09 5.99 6.67 9.69 5.66 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1chk_c00 CHITOSANASE user 2 2 # 2 B 22 GLU A 59 GLU.? 11.26 O1 EDO A 125 B 40 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 8.24 11.09 5.99 6.67 9.69 5.66 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1chk_c00 CHITOSANASE user 3 2 # 3 B 22 GLU A 59 GLU.? 11.26 O1 EDO A 125 B 40 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 8.24 11.09 5.99 6.67 9.69 5.66 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1chk_c00 CHITOSANASE user 4 2 # 4 B 22 GLU A 59 GLU.? 11.26 O1 EDO A 125 B 40 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 8.24 11.09 5.99 6.67 9.69 5.66 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1chk_c00 CHITOSANASE user 5 2 # 5 B 22 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 40 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 8.24 11.09 5.99 6.67 9.69 5.66 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1chk_c00 CHITOSANASE user 6 2 # 6 B 22 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 40 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 8.24 11.09 5.99 6.67 9.69 5.66 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1chk_c00 CHITOSANASE user 7 2 # 7 B 22 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 40 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 8.24 11.09 5.99 6.67 9.69 5.66 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1chk_c00 CHITOSANASE user 8 2 # 8 B 22 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 40 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 8.24 11.09 5.99 6.67 9.69 5.66 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1chk_c00 CHITOSANASE user 9 2 # 9 B 22 GLU A 81 GLU.? 16.59 O1 EDO A 125 B 40 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 8.24 11.09 5.99 6.67 9.69 5.66 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1chk_c00 CHITOSANASE user 10 2 # 10 B 22 GLU B 23 GLU.? 12.57 O2 EDO A 125 B 40 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 8.24 11.09 5.99 6.67 9.69 5.66 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1chk_c00 CHITOSANASE user 11 2 # 11 B 22 GLU B 59 GLU.? 24.69 C1 EDO A 124 B 40 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 8.24 11.09 5.99 6.67 9.69 5.66 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1chk_c00 CHITOSANASE user 12 2 # 12 B 22 GLU B 59 GLU.? 24.69 C1 EDO A 124 B 40 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 8.24 11.09 5.99 6.67 9.69 5.66 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1chk_c00 CHITOSANASE user 13 2 # 13 B 22 GLU B 59 GLU.? 24.69 C1 EDO A 124 B 40 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 8.24 11.09 5.99 6.67 9.69 5.66 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1chk_c00 CHITOSANASE user 14 2 # 14 B 22 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 40 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 8.24 11.09 5.99 6.67 9.69 5.66 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1chk_c00 CHITOSANASE user 15 2 # 15 B 22 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 40 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 8.24 11.09 5.99 6.67 9.69 5.66 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1chk_c00 CHITOSANASE user 16 2 # 16 B 22 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 40 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 8.24 11.09 5.99 6.67 9.69 5.66 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1chk_c00 CHITOSANASE user 17 2 # 17 B 22 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 40 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 8.24 11.09 5.99 6.67 9.69 5.66 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1chk_c00 CHITOSANASE user 18 2 # 18 B 22 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 40 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 8.24 11.09 5.99 6.67 9.69 5.66 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1chk_c00 CHITOSANASE user 19 2 # 19 B 22 GLU B 81 GLU.? 30.69 O1 EDO A 124 B 40 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 8.24 11.09 5.99 6.67 9.69 5.66 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 1chk_c00 source 1chk CHITOSANASE : 19 hits 1chk_c00 naa= 2 ULMN 2 1chk_c01 CHITOSANASE user 1 2 # 1 A 22 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 40 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 44.97 21.98 32.76 46.32 21.69 34.45 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 57.72 22.56 24.95 56.25 21.01 24.85 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1chk_c01 CHITOSANASE user 2 2 # 2 A 22 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 40 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 44.97 21.98 32.76 46.32 21.69 34.45 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 57.72 22.56 24.95 56.25 21.01 24.85 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1chk_c01 CHITOSANASE user 3 2 # 3 A 22 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 40 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 44.97 21.98 32.76 46.32 21.69 34.45 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 57.72 22.56 24.95 56.25 21.01 24.85 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1chk_c01 CHITOSANASE user 4 2 # 4 A 22 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 40 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 44.97 21.98 32.76 46.32 21.69 34.45 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 57.72 22.56 24.95 56.25 21.01 24.85 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1chk_c01 CHITOSANASE user 5 2 # 5 A 22 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 40 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 44.97 21.98 32.76 46.32 21.69 34.45 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 57.72 22.56 24.95 56.25 21.01 24.85 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1chk_c01 CHITOSANASE user 6 2 # 6 A 22 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 40 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 44.97 21.98 32.76 46.32 21.69 34.45 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 57.72 22.56 24.95 56.25 21.01 24.85 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1chk_c01 CHITOSANASE user 7 2 # 7 A 22 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 40 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 44.97 21.98 32.76 46.32 21.69 34.45 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 57.72 22.56 24.95 56.25 21.01 24.85 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1chk_c01 CHITOSANASE user 8 2 # 8 A 22 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 40 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 44.97 21.98 32.76 46.32 21.69 34.45 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 57.72 22.56 24.95 56.25 21.01 24.85 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1chk_c01 CHITOSANASE user 9 2 # 9 A 22 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 40 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 44.97 21.98 32.76 46.32 21.69 34.45 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 57.72 22.56 24.95 56.25 21.01 24.85 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1chk_c01 CHITOSANASE user 10 2 # 10 A 22 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 40 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 44.97 21.98 32.76 46.32 21.69 34.45 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 57.72 22.56 24.95 56.25 21.01 24.85 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1chk_c01 CHITOSANASE user 11 2 # 11 A 22 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 40 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 44.97 21.98 32.76 46.32 21.69 34.45 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 57.72 22.56 24.95 56.25 21.01 24.85 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1chk_c01 CHITOSANASE user 12 2 # 12 A 22 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 40 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 44.97 21.98 32.76 46.32 21.69 34.45 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 57.72 22.56 24.95 56.25 21.01 24.85 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1chk_c01 CHITOSANASE user 13 2 # 13 A 22 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 40 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 44.97 21.98 32.76 46.32 21.69 34.45 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 57.72 22.56 24.95 56.25 21.01 24.85 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1chk_c01 CHITOSANASE user 14 2 # 14 A 22 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 40 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 44.97 21.98 32.76 46.32 21.69 34.45 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 57.72 22.56 24.95 56.25 21.01 24.85 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1chk_c01 CHITOSANASE user 15 2 # 15 A 22 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 40 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 44.97 21.98 32.76 46.32 21.69 34.45 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 57.72 22.56 24.95 56.25 21.01 24.85 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1chk_c01 CHITOSANASE user 16 2 # 16 A 22 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 40 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 44.97 21.98 32.76 46.32 21.69 34.45 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 57.72 22.56 24.95 56.25 21.01 24.85 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1chk_c01 CHITOSANASE user 17 2 # 17 A 22 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 40 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 44.97 21.98 32.76 46.32 21.69 34.45 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 57.72 22.56 24.95 56.25 21.01 24.85 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1chk_c01 CHITOSANASE user 18 2 # 18 A 22 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 40 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 44.97 21.98 32.76 46.32 21.69 34.45 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 57.72 22.56 24.95 56.25 21.01 24.85 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1chk_c01 CHITOSANASE user 19 2 # 19 A 22 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 40 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 44.97 21.98 32.76 46.32 21.69 34.45 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 57.72 22.56 24.95 56.25 21.01 24.85 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1chk_c01 CHITOSANASE user 20 2 # 20 A 22 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 40 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 44.97 21.98 32.76 46.32 21.69 34.45 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 57.72 22.56 24.95 56.25 21.01 24.85 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1chk_c01 CHITOSANASE user 21 2 # 21 A 22 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 40 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 44.97 21.98 32.76 46.32 21.69 34.45 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 57.72 22.56 24.95 56.25 21.01 24.85 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1chk_c01 CHITOSANASE user 22 2 # 22 A 22 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 40 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 44.97 21.98 32.76 46.32 21.69 34.45 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 57.72 22.56 24.95 56.25 21.01 24.85 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 1chk_c01 source 1chk CHITOSANASE : 22 hits 1chk_c01 naa= 2 ULMN 2 1chm_c04 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 2 # 1 A 331 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 358 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 32.65 64.88 45.53 33.25 66.88 46.21 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 27.06 50.43 44.36 27.99 52.27 44.74 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1chm_c04 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 2 # 2 A 331 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 358 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 32.65 64.88 45.53 33.25 66.88 46.21 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 27.06 50.43 44.36 27.99 52.27 44.74 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 1chm_c04 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 2 hits 1chm_c04 naa= 2 ULMN 2 1chm_c05 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 2 # 1 B 331 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 358 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 38.59 73.13 46.90 37.84 71.22 47.24 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 44.05 87.61 48.73 43.15 85.67 48.52 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1chm_c05 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 2 # 2 B 331 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 358 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 38.59 73.13 46.90 37.84 71.22 47.24 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 44.05 87.61 48.73 43.15 85.67 48.52 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 1chm_c05 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 2 hits 1chm_c05 naa= 2 ULMN 2 1ck7_c00 GELATINASE A user 1 2 # 1 A 404 ALA A 49 ALA^? 7.86 C1 EDO A 124 A 421 MET A 93 MET?? 10.81 O2 EDO A 125 coo 51.38 82.26 144.01 50.56 83.14 143.08 -27.58 -35.61 -22.27 -27.19 -34.24 -21.71 coo 56.67 81.44 150.10 55.06 79.66 147.53 -32.62 -43.10 -21.62 -33.95 -40.68 -24.94 ULMN 2 1ck7_c00 GELATINASE A user 2 2 # 2 A 404 ALA A 55 ALA~? 6.66 O1 EDO A 125 A 421 MET A 103 MET?? 8.30 O2 EDO A 125 coo 51.38 82.26 144.01 50.56 83.14 143.08 -21.18 -46.19 -20.96 -21.62 -45.51 -22.25 coo 56.67 81.44 150.10 55.06 79.66 147.53 -21.98 -53.69 -14.57 -25.85 -52.15 -15.50 ULMN 2 1ck7_c00 GELATINASE A user 3 2 # 3 A 404 ALA A 94 ALA~? 7.26 O2 EDO A 125 A 421 MET B 93 MET?? 13.65 O2 EDO A 125 coo 51.38 82.26 144.01 50.56 83.14 143.08 -33.85 -46.06 -19.52 -34.14 -47.43 -20.08 coo 56.67 81.44 150.10 55.06 79.66 147.53 -38.81 -39.61 -21.96 -36.01 -39.35 -18.74 ULMN 2 1ck7_c00 GELATINASE A user 4 2 # 4 A 404 ALA A 107 ALA.? 20.71 C2 EDO A 125 A 421 MET A 103 MET?? 8.30 O2 EDO A 125 coo 51.38 82.26 144.01 50.56 83.14 143.08 -16.42 -54.53 -7.60 -16.03 -56.00 -7.26 coo 56.67 81.44 150.10 55.06 79.66 147.53 -21.98 -53.69 -14.57 -25.85 -52.15 -15.50 ULMN 2 1ck7_c00 GELATINASE A user 5 2 # 5 A 404 ALA B 49 ALA^? 7.26 C1 EDO A 124 A 421 MET B 93 MET?? 13.65 O2 EDO A 125 coo 51.38 82.26 144.01 50.56 83.14 143.08 -35.14 -31.27 -21.36 -34.12 -30.27 -21.87 coo 56.67 81.44 150.10 55.06 79.66 147.53 -38.81 -39.61 -21.96 -36.01 -39.35 -18.74 ULMN 2 1ck7_c00 GELATINASE A user 6 2 # 6 A 404 ALA B 55 ALA~? 18.17 C1 EDO A 124 A 421 MET B 103 MET?? 21.79 C1 EDO A 124 coo 51.38 82.26 144.01 50.56 83.14 143.08 -46.89 -31.34 -22.78 -46.09 -31.26 -21.50 coo 56.67 81.44 150.10 55.06 79.66 147.53 -51.26 -35.87 -29.54 -48.31 -38.03 -27.58 ULMN 2 1ck7_c00 GELATINASE A user 7 2 # 7 A 404 ALA B 94 ALA~? 15.22 O2 EDO A 125 A 421 MET A 93 MET?? 10.81 O2 EDO A 125 coo 51.38 82.26 144.01 50.56 83.14 143.08 -40.74 -42.37 -23.75 -41.76 -43.26 -23.09 coo 56.67 81.44 150.10 55.06 79.66 147.53 -32.62 -43.10 -21.62 -33.95 -40.68 -24.94 1ck7_c00 source 1ck7 GELATINASE A : 7 hits 1ck7_c00 naa= 2 ULMN 2 1cl1_c00 CYSTATHIONINE BETA-LYASE user 1 2 # 1 A 111 TYR A 31 TYR^? 13.43 O2 EDO A 124 A 185 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo -6.99 5.69 52.91 -8.09 7.69 51.31 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo -0.22 4.86 55.08 -1.23 6.48 54.18 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1cl1_c00 CYSTATHIONINE BETA-LYASE user 2 2 # 2 A 111 TYR A 31 TYR^? 13.43 O2 EDO A 124 A 185 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -6.99 5.69 52.91 -8.09 7.69 51.31 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo -0.22 4.86 55.08 -1.23 6.48 54.18 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1cl1_c00 CYSTATHIONINE BETA-LYASE user 3 2 # 3 A 111 TYR A 31 TYR^? 13.43 O2 EDO A 124 A 185 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo -6.99 5.69 52.91 -8.09 7.69 51.31 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo -0.22 4.86 55.08 -1.23 6.48 54.18 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1cl1_c00 CYSTATHIONINE BETA-LYASE user 4 2 # 4 A 111 TYR B 31 TYR^? 14.49 O1 EDO A 124 A 185 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo -6.99 5.69 52.91 -8.09 7.69 51.31 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo -0.22 4.86 55.08 -1.23 6.48 54.18 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1cl1_c00 CYSTATHIONINE BETA-LYASE user 5 2 # 5 A 111 TYR B 31 TYR^? 14.49 O1 EDO A 124 A 185 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -6.99 5.69 52.91 -8.09 7.69 51.31 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo -0.22 4.86 55.08 -1.23 6.48 54.18 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1cl1_c00 source 1cl1 CYSTATHIONINE BETA-LYASE : 5 hits 1cl1_c00 naa= 2 ULMN 2 1cl1_c02 CYSTATHIONINE BETA-LYASE user 1 2 # 1 B 111 TYR A 31 TYR^? 13.43 O2 EDO A 124 B 185 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo -8.78 52.08 24.38 -9.63 50.05 26.11 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo -2.31 52.89 21.38 -3.20 51.27 22.38 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1cl1_c02 CYSTATHIONINE BETA-LYASE user 2 2 # 2 B 111 TYR A 31 TYR^? 13.43 O2 EDO A 124 B 185 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -8.78 52.08 24.38 -9.63 50.05 26.11 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo -2.31 52.89 21.38 -3.20 51.27 22.38 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1cl1_c02 CYSTATHIONINE BETA-LYASE user 3 2 # 3 B 111 TYR A 31 TYR^? 13.43 O2 EDO A 124 B 185 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo -8.78 52.08 24.38 -9.63 50.05 26.11 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo -2.31 52.89 21.38 -3.20 51.27 22.38 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1cl1_c02 CYSTATHIONINE BETA-LYASE user 4 2 # 4 B 111 TYR B 31 TYR^? 14.49 O1 EDO A 124 B 185 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo -8.78 52.08 24.38 -9.63 50.05 26.11 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo -2.31 52.89 21.38 -3.20 51.27 22.38 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1cl1_c02 CYSTATHIONINE BETA-LYASE user 5 2 # 5 B 111 TYR B 31 TYR^? 14.49 O1 EDO A 124 B 185 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -8.78 52.08 24.38 -9.63 50.05 26.11 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo -2.31 52.89 21.38 -3.20 51.27 22.38 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1cl1_c02 source 1cl1 CYSTATHIONINE BETA-LYASE : 5 hits 1cl1_c02 naa= 2 ULMN 2 1cqg_c00 REF-1 PEPTIDE user 1 2 # 1 A 32 CYH A 46 CYH.? 11.48 C1 EDO A 124 A 35 ALA B 49 ALA^? 7.26 C1 EDO A 124 coo 10.88 10.50 2.65 10.80 11.19 -0.01 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 5.86 10.20 0.80 6.89 9.09 0.56 -35.14 -31.27 -21.36 -34.12 -30.27 -21.87 ULMN 2 1cqg_c00 REF-1 PEPTIDE user 2 2 # 2 A 32 CYH A 67 CYH~? 14.35 O2 EDO A 124 A 35 ALA A 68 ALA.? 16.39 O1 EDO A 125 coo 10.88 10.50 2.65 10.80 11.19 -0.01 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo 5.86 10.20 0.80 6.89 9.09 0.56 -16.63 -39.03 -33.40 -15.61 -40.17 -33.58 ULMN 2 1cqg_c00 REF-1 PEPTIDE user 3 2 # 3 A 32 CYH B 46 CYH.? 10.55 O2 EDO A 125 A 35 ALA A 49 ALA^? 7.86 C1 EDO A 124 coo 10.88 10.50 2.65 10.80 11.19 -0.01 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo 5.86 10.20 0.80 6.89 9.09 0.56 -27.58 -35.61 -22.27 -27.19 -34.24 -21.71 ULMN 2 1cqg_c00 REF-1 PEPTIDE user 4 2 # 4 A 32 CYH B 67 CYH~? 18.88 O1 EDO A 124 A 35 ALA B 68 ALA.? 23.26 O1 EDO A 124 coo 10.88 10.50 2.65 10.80 11.19 -0.01 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo 5.86 10.20 0.80 6.89 9.09 0.56 -43.26 -23.68 -10.03 -44.76 -23.42 -9.87 1cqg_c00 source 1cqg REF-1 PEPTIDE : 4 hits 1cqg_c00 naa= 2 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 2 # 1 A 87 PHE A 48 PHE^? 10.34 O2 EDO A 125 A 173 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 17.25 11.19 35.89 19.13 13.25 35.57 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 24.35 4.55 25.11 25.94 3.23 25.53 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 2 2 # 2 A 87 PHE A 48 PHE^? 10.34 O2 EDO A 125 A 173 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 17.25 11.19 35.89 19.13 13.25 35.57 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 24.35 4.55 25.11 25.94 3.23 25.53 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 3 2 # 3 A 87 PHE A 48 PHE^? 10.34 O2 EDO A 125 A 173 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 17.25 11.19 35.89 19.13 13.25 35.57 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 24.35 4.55 25.11 25.94 3.23 25.53 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 4 2 # 4 A 87 PHE A 50 PHE^? 8.88 O1 EDO A 125 A 173 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 17.25 11.19 35.89 19.13 13.25 35.57 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 24.35 4.55 25.11 25.94 3.23 25.53 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 5 2 # 5 A 87 PHE A 50 PHE^? 8.88 O1 EDO A 125 A 173 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 17.25 11.19 35.89 19.13 13.25 35.57 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 24.35 4.55 25.11 25.94 3.23 25.53 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 6 2 # 6 A 87 PHE A 50 PHE^? 8.88 O1 EDO A 125 A 173 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 17.25 11.19 35.89 19.13 13.25 35.57 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 24.35 4.55 25.11 25.94 3.23 25.53 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 7 2 # 7 A 87 PHE A 50 PHE^? 8.88 O1 EDO A 125 A 173 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 17.25 11.19 35.89 19.13 13.25 35.57 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 24.35 4.55 25.11 25.94 3.23 25.53 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 8 2 # 8 A 87 PHE A 97 PHE.? 7.14 O2 EDO A 125 A 173 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 17.25 11.19 35.89 19.13 13.25 35.57 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 24.35 4.55 25.11 25.94 3.23 25.53 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 9 2 # 9 A 87 PHE A 97 PHE.? 7.14 O2 EDO A 125 A 173 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 17.25 11.19 35.89 19.13 13.25 35.57 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 24.35 4.55 25.11 25.94 3.23 25.53 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 10 2 # 10 A 87 PHE B 48 PHE^? 12.04 C1 EDO A 124 A 173 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 17.25 11.19 35.89 19.13 13.25 35.57 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 24.35 4.55 25.11 25.94 3.23 25.53 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 11 2 # 11 A 87 PHE B 48 PHE^? 12.04 C1 EDO A 124 A 173 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 17.25 11.19 35.89 19.13 13.25 35.57 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 24.35 4.55 25.11 25.94 3.23 25.53 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 12 2 # 12 A 87 PHE B 48 PHE^? 12.04 C1 EDO A 124 A 173 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 17.25 11.19 35.89 19.13 13.25 35.57 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 24.35 4.55 25.11 25.94 3.23 25.53 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 13 2 # 13 A 87 PHE B 50 PHE^? 13.90 C1 EDO A 124 A 173 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 17.25 11.19 35.89 19.13 13.25 35.57 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 24.35 4.55 25.11 25.94 3.23 25.53 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 14 2 # 14 A 87 PHE B 50 PHE^? 13.90 C1 EDO A 124 A 173 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 17.25 11.19 35.89 19.13 13.25 35.57 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 24.35 4.55 25.11 25.94 3.23 25.53 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 15 2 # 15 A 87 PHE B 50 PHE^? 13.90 C1 EDO A 124 A 173 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 17.25 11.19 35.89 19.13 13.25 35.57 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 24.35 4.55 25.11 25.94 3.23 25.53 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 16 2 # 16 A 87 PHE B 50 PHE^? 13.90 C1 EDO A 124 A 173 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 17.25 11.19 35.89 19.13 13.25 35.57 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 24.35 4.55 25.11 25.94 3.23 25.53 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 17 2 # 17 A 87 PHE B 97 PHE.? 16.35 C1 EDO A 124 A 173 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 17.25 11.19 35.89 19.13 13.25 35.57 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 24.35 4.55 25.11 25.94 3.23 25.53 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 18 2 # 18 A 87 PHE B 97 PHE.? 16.35 C1 EDO A 124 A 173 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 17.25 11.19 35.89 19.13 13.25 35.57 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 24.35 4.55 25.11 25.94 3.23 25.53 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1cs1_c04 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 18 hits 1cs1_c04 naa= 2 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 2 # 1 B 87 PHE A 48 PHE^? 10.34 O2 EDO A 125 B 173 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 84.13 3.94 45.72 82.40 5.78 46.90 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 2 2 # 2 B 87 PHE A 48 PHE^? 10.34 O2 EDO A 125 B 173 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 84.13 3.94 45.72 82.40 5.78 46.90 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 3 2 # 3 B 87 PHE A 48 PHE^? 10.34 O2 EDO A 125 B 173 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 84.13 3.94 45.72 82.40 5.78 46.90 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 4 2 # 4 B 87 PHE A 50 PHE^? 8.88 O1 EDO A 125 B 173 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 84.13 3.94 45.72 82.40 5.78 46.90 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 5 2 # 5 B 87 PHE A 50 PHE^? 8.88 O1 EDO A 125 B 173 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 84.13 3.94 45.72 82.40 5.78 46.90 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 6 2 # 6 B 87 PHE A 50 PHE^? 8.88 O1 EDO A 125 B 173 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 84.13 3.94 45.72 82.40 5.78 46.90 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 7 2 # 7 B 87 PHE A 50 PHE^? 8.88 O1 EDO A 125 B 173 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 84.13 3.94 45.72 82.40 5.78 46.90 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 8 2 # 8 B 87 PHE A 97 PHE.? 7.14 O2 EDO A 125 B 173 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 84.13 3.94 45.72 82.40 5.78 46.90 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 9 2 # 9 B 87 PHE A 97 PHE.? 7.14 O2 EDO A 125 B 173 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 84.13 3.94 45.72 82.40 5.78 46.90 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 10 2 # 10 B 87 PHE B 48 PHE^? 12.04 C1 EDO A 124 B 173 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 84.13 3.94 45.72 82.40 5.78 46.90 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 11 2 # 11 B 87 PHE B 48 PHE^? 12.04 C1 EDO A 124 B 173 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 84.13 3.94 45.72 82.40 5.78 46.90 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 12 2 # 12 B 87 PHE B 48 PHE^? 12.04 C1 EDO A 124 B 173 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 84.13 3.94 45.72 82.40 5.78 46.90 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 13 2 # 13 B 87 PHE B 50 PHE^? 13.90 C1 EDO A 124 B 173 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 84.13 3.94 45.72 82.40 5.78 46.90 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 14 2 # 14 B 87 PHE B 50 PHE^? 13.90 C1 EDO A 124 B 173 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 84.13 3.94 45.72 82.40 5.78 46.90 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 15 2 # 15 B 87 PHE B 50 PHE^? 13.90 C1 EDO A 124 B 173 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 84.13 3.94 45.72 82.40 5.78 46.90 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 16 2 # 16 B 87 PHE B 50 PHE^? 13.90 C1 EDO A 124 B 173 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 84.13 3.94 45.72 82.40 5.78 46.90 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 17 2 # 17 B 87 PHE B 97 PHE.? 16.35 C1 EDO A 124 B 173 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 84.13 3.94 45.72 82.40 5.78 46.90 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 18 2 # 18 B 87 PHE B 97 PHE.? 16.35 C1 EDO A 124 B 173 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 84.13 3.94 45.72 82.40 5.78 46.90 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1cs1_c05 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 18 hits 1cs1_c05 naa= 2 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 2 # 1 C 87 PHE A 48 PHE^? 10.34 O2 EDO A 125 C 173 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 2 2 # 2 C 87 PHE A 48 PHE^? 10.34 O2 EDO A 125 C 173 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 3 2 # 3 C 87 PHE A 50 PHE^? 8.88 O1 EDO A 125 C 173 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 4 2 # 4 C 87 PHE A 50 PHE^? 8.88 O1 EDO A 125 C 173 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 5 2 # 5 C 87 PHE A 50 PHE^? 8.88 O1 EDO A 125 C 173 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 6 2 # 6 C 87 PHE A 50 PHE^? 8.88 O1 EDO A 125 C 173 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 7 2 # 7 C 87 PHE A 97 PHE.? 7.14 O2 EDO A 125 C 173 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 8 2 # 8 C 87 PHE A 97 PHE.? 7.14 O2 EDO A 125 C 173 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 9 2 # 9 C 87 PHE B 48 PHE^? 12.04 C1 EDO A 124 C 173 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 10 2 # 10 C 87 PHE B 48 PHE^? 12.04 C1 EDO A 124 C 173 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 11 2 # 11 C 87 PHE B 48 PHE^? 12.04 C1 EDO A 124 C 173 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 12 2 # 12 C 87 PHE B 50 PHE^? 13.90 C1 EDO A 124 C 173 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 13 2 # 13 C 87 PHE B 50 PHE^? 13.90 C1 EDO A 124 C 173 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 14 2 # 14 C 87 PHE B 50 PHE^? 13.90 C1 EDO A 124 C 173 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 15 2 # 15 C 87 PHE B 50 PHE^? 13.90 C1 EDO A 124 C 173 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 16 2 # 16 C 87 PHE B 97 PHE.? 16.35 C1 EDO A 124 C 173 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 17 2 # 17 C 87 PHE B 97 PHE.? 16.35 C1 EDO A 124 C 173 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1cs1_c06 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 17 hits 1cs1_c06 naa= 2 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 2 # 1 D 87 PHE A 48 PHE^? 10.34 O2 EDO A 125 D 173 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 71.60 6.14 19.25 70.26 6.87 20.69 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 2 2 # 2 D 87 PHE A 48 PHE^? 10.34 O2 EDO A 125 D 173 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 71.60 6.14 19.25 70.26 6.87 20.69 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 3 2 # 3 D 87 PHE A 48 PHE^? 10.34 O2 EDO A 125 D 173 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 71.60 6.14 19.25 70.26 6.87 20.69 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 4 2 # 4 D 87 PHE A 50 PHE^? 8.88 O1 EDO A 125 D 173 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 71.60 6.14 19.25 70.26 6.87 20.69 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 5 2 # 5 D 87 PHE A 50 PHE^? 8.88 O1 EDO A 125 D 173 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 71.60 6.14 19.25 70.26 6.87 20.69 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 6 2 # 6 D 87 PHE A 50 PHE^? 8.88 O1 EDO A 125 D 173 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 71.60 6.14 19.25 70.26 6.87 20.69 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 7 2 # 7 D 87 PHE A 50 PHE^? 8.88 O1 EDO A 125 D 173 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 71.60 6.14 19.25 70.26 6.87 20.69 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 8 2 # 8 D 87 PHE A 97 PHE.? 7.14 O2 EDO A 125 D 173 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 71.60 6.14 19.25 70.26 6.87 20.69 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 9 2 # 9 D 87 PHE A 97 PHE.? 7.14 O2 EDO A 125 D 173 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 71.60 6.14 19.25 70.26 6.87 20.69 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 10 2 # 10 D 87 PHE B 48 PHE^? 12.04 C1 EDO A 124 D 173 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 71.60 6.14 19.25 70.26 6.87 20.69 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 11 2 # 11 D 87 PHE B 48 PHE^? 12.04 C1 EDO A 124 D 173 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 71.60 6.14 19.25 70.26 6.87 20.69 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 12 2 # 12 D 87 PHE B 48 PHE^? 12.04 C1 EDO A 124 D 173 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 71.60 6.14 19.25 70.26 6.87 20.69 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 13 2 # 13 D 87 PHE B 50 PHE^? 13.90 C1 EDO A 124 D 173 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 71.60 6.14 19.25 70.26 6.87 20.69 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 14 2 # 14 D 87 PHE B 50 PHE^? 13.90 C1 EDO A 124 D 173 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 71.60 6.14 19.25 70.26 6.87 20.69 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 15 2 # 15 D 87 PHE B 50 PHE^? 13.90 C1 EDO A 124 D 173 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 71.60 6.14 19.25 70.26 6.87 20.69 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 16 2 # 16 D 87 PHE B 50 PHE^? 13.90 C1 EDO A 124 D 173 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 71.60 6.14 19.25 70.26 6.87 20.69 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 17 2 # 17 D 87 PHE B 97 PHE.? 16.35 C1 EDO A 124 D 173 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 71.60 6.14 19.25 70.26 6.87 20.69 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 18 2 # 18 D 87 PHE B 97 PHE.? 16.35 C1 EDO A 124 D 173 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 71.60 6.14 19.25 70.26 6.87 20.69 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1cs1_c07 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 18 hits 1cs1_c07 naa= 2 ULMN 2 1ctn_c02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 2 # 1 311 ASP A 84 ASP.? 13.20 O1 EDO A 125 315 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 31.76 104.69 22.47 30.78 102.79 22.26 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 32.04 94.22 18.23 30.57 94.75 16.88 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1ctn_c02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 2 # 2 311 ASP A 86 ASP^? 9.05 O1 EDO A 125 315 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 31.76 104.69 22.47 30.78 102.79 22.26 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 32.04 94.22 18.23 30.57 94.75 16.88 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1ctn_c02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 3 2 # 3 311 ASP A 86 ASP^? 9.05 O1 EDO A 125 315 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 31.76 104.69 22.47 30.78 102.79 22.26 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 32.04 94.22 18.23 30.57 94.75 16.88 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1ctn_c02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 4 2 # 4 311 ASP B 84 ASP.? 30.86 C1 EDO A 124 315 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 31.76 104.69 22.47 30.78 102.79 22.26 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 32.04 94.22 18.23 30.57 94.75 16.88 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1ctn_c02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 5 2 # 5 311 ASP B 86 ASP^? 26.97 C1 EDO A 124 315 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 31.76 104.69 22.47 30.78 102.79 22.26 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 32.04 94.22 18.23 30.57 94.75 16.88 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1ctn_c02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 6 2 # 6 311 ASP B 86 ASP^? 26.97 C1 EDO A 124 315 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 31.76 104.69 22.47 30.78 102.79 22.26 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 32.04 94.22 18.23 30.57 94.75 16.88 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1ctn_c02 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 6 hits 1ctn_c02 naa= 2 ULMN 2 1cw0_c00 DNA (5'-D(P*TP*AP*GP*GP*TP*AP*CP*GP*user 1 2 # 1 A 69 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 97 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 39.79 13.91 6.63 38.81 12.07 6.79 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 44.85 11.31 7.44 42.79 11.63 7.79 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1cw0_c00 DNA (5'-D(P*TP*AP*GP*GP*TP*AP*CP*GP*user 2 2 # 2 A 69 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 97 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 39.79 13.91 6.63 38.81 12.07 6.79 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 44.85 11.31 7.44 42.79 11.63 7.79 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1cw0_c00 source 1cw0 DNA (5'-D(P*TP*AP*GP*GP*TP*AP*CP*GP*T)-3') : 2 hits 1cw0_c00 naa= 2 ULMN 2 1cz1_c01 EXO-B-(1,3)-GLUCANASE user 1 2 # 1 A 192 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 292 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 29.26 36.42 59.28 31.05 37.29 58.52 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 34.58 32.58 59.98 33.75 33.73 58.43 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1cz1_c01 EXO-B-(1,3)-GLUCANASE user 2 2 # 2 A 192 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 292 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 29.26 36.42 59.28 31.05 37.29 58.52 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 34.58 32.58 59.98 33.75 33.73 58.43 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1cz1_c01 EXO-B-(1,3)-GLUCANASE user 3 2 # 3 A 192 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 292 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 29.26 36.42 59.28 31.05 37.29 58.52 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 34.58 32.58 59.98 33.75 33.73 58.43 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1cz1_c01 EXO-B-(1,3)-GLUCANASE user 4 2 # 4 A 192 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 292 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 29.26 36.42 59.28 31.05 37.29 58.52 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 34.58 32.58 59.98 33.75 33.73 58.43 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1cz1_c01 source 1cz1 EXO-B-(1,3)-GLUCANASE : 4 hits 1cz1_c01 naa= 2 ULMN 2 1czf_c02 POLYGALACTURONASE II user 1 2 # 1 B 180 ASP A 63 ASP~? 17.25 O1 EDO A 124 B 201 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 56.34 26.92 42.01 57.88 28.32 41.72 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 55.85 31.42 43.00 57.45 32.12 41.78 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1czf_c02 POLYGALACTURONASE II user 2 2 # 2 B 180 ASP A 64 ASP~? 20.53 O2 EDO A 124 B 201 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 56.34 26.92 42.01 57.88 28.32 41.72 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 55.85 31.42 43.00 57.45 32.12 41.78 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1czf_c02 POLYGALACTURONASE II user 3 2 # 3 B 180 ASP B 63 ASP~? 17.37 O1 EDO A 124 B 201 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 56.34 26.92 42.01 57.88 28.32 41.72 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 55.85 31.42 43.00 57.45 32.12 41.78 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1czf_c02 POLYGALACTURONASE II user 4 2 # 4 B 180 ASP B 64 ASP~? 23.62 O1 EDO A 124 B 201 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 56.34 26.92 42.01 57.88 28.32 41.72 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 55.85 31.42 43.00 57.45 32.12 41.78 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1czf_c02 source 1czf POLYGALACTURONASE II : 4 hits 1czf_c02 naa= 2 ULMN 2 1d7r_c00 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 2 # 1 A 138 TRP A 80 TRP^? 10.72 O1 EDO A 125 A 243 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 18.21 54.75 18.05 19.91 55.17 21.59 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 16.93 55.67 9.65 17.16 54.23 11.19 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1d7r_c00 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 2 # 2 A 138 TRP A 80 TRP^? 10.72 O1 EDO A 125 A 243 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 18.21 54.75 18.05 19.91 55.17 21.59 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 16.93 55.67 9.65 17.16 54.23 11.19 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1d7r_c00 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 2 # 3 A 138 TRP A 80 TRP^? 10.72 O1 EDO A 125 A 243 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 18.21 54.75 18.05 19.91 55.17 21.59 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 16.93 55.67 9.65 17.16 54.23 11.19 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1d7r_c00 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 2 # 4 A 138 TRP B 80 TRP^? 20.31 C1 EDO A 124 A 243 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 18.21 54.75 18.05 19.91 55.17 21.59 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 16.93 55.67 9.65 17.16 54.23 11.19 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1d7r_c00 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 2 # 5 A 138 TRP B 80 TRP^? 20.31 C1 EDO A 124 A 243 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 18.21 54.75 18.05 19.91 55.17 21.59 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 16.93 55.67 9.65 17.16 54.23 11.19 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1d7r_c00 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 2 # 6 A 138 TRP B 80 TRP^? 20.31 C1 EDO A 124 A 243 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 18.21 54.75 18.05 19.91 55.17 21.59 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 16.93 55.67 9.65 17.16 54.23 11.19 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1d7r_c00 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 6 hits 1d7r_c00 naa= 2 ULMN 2 1db3_c02 GDP-MANNOSE 4,6-DEHYDRATASE user 1 2 # 1 A 153 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 160 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 11.64 53.62 31.80 11.17 52.00 34.34 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 5.78 61.30 21.65 8.04 62.89 17.54 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1db3_c02 GDP-MANNOSE 4,6-DEHYDRATASE user 2 2 # 2 A 153 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 160 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 11.64 53.62 31.80 11.17 52.00 34.34 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 5.78 61.30 21.65 8.04 62.89 17.54 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 ULMN 2 1db3_c02 GDP-MANNOSE 4,6-DEHYDRATASE user 3 2 # 3 A 153 ARG B 37 ARG^? 8.36 C1 EDO A 124 A 160 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 11.64 53.62 31.80 11.17 52.00 34.34 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 5.78 61.30 21.65 8.04 62.89 17.54 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1db3_c02 GDP-MANNOSE 4,6-DEHYDRATASE user 4 2 # 4 A 153 ARG B 37 ARG^? 8.36 C1 EDO A 124 A 160 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 11.64 53.62 31.80 11.17 52.00 34.34 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 5.78 61.30 21.65 8.04 62.89 17.54 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1db3_c02 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 4 hits 1db3_c02 naa= 2 ULMN 2 1dbt_c00 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 1 2 # 1 B 60 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 62 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 58.78 69.55 10.14 57.19 68.14 10.07 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 57.51 66.37 15.65 56.43 65.69 10.35 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1dbt_c00 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 2 2 # 2 B 60 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 62 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 58.78 69.55 10.14 57.19 68.14 10.07 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 57.51 66.37 15.65 56.43 65.69 10.35 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1dbt_c00 source 1dbt OROTIDINE 5'-PHOSPHATE DECARBOXYLASE : 2 hits 1dbt_c00 naa= 2 ULMN 2 1dbt_c01 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 1 2 # 1 C 60 ASP A 41 ASP^? -2.91 O2 EDO A 124s C 62 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 46.15 51.25 57.34 45.59 51.66 59.34 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 43.68 46.22 60.72 43.55 51.70 60.99 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1dbt_c01 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 2 2 # 2 C 60 ASP B 41 ASP^? 12.31 O1 EDO A 124 C 62 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 46.15 51.25 57.34 45.59 51.66 59.34 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 43.68 46.22 60.72 43.55 51.70 60.99 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1dbt_c01 source 1dbt OROTIDINE 5'-PHOSPHATE DECARBOXYLASE : 2 hits 1dbt_c01 naa= 2 ULMN 2 1dbt_c05 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 1 2 # 1 A 60 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 62 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 66.44 58.31 23.16 64.45 58.00 23.81 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 61.71 58.67 18.68 62.06 59.06 24.07 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1dbt_c05 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 2 2 # 2 A 60 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 62 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 66.44 58.31 23.16 64.45 58.00 23.81 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 61.71 58.67 18.68 62.06 59.06 24.07 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1dbt_c05 source 1dbt OROTIDINE 5'-PHOSPHATE DECARBOXYLASE : 2 hits 1dbt_c05 naa= 2 ULMN 2 1dci_c00 DIENOYL-COA ISOMERASE user 1 2 # 1 A 196 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 204 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 90.70 34.85 -4.41 92.58 34.16 -5.05 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 91.55 34.15 2.80 89.93 32.93 2.11 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1dci_c00 DIENOYL-COA ISOMERASE user 2 2 # 2 A 196 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 204 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 91.55 34.15 2.80 89.93 32.93 2.11 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1dci_c00 DIENOYL-COA ISOMERASE user 3 2 # 3 A 196 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 204 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 91.55 34.15 2.80 89.93 32.93 2.11 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1dci_c00 DIENOYL-COA ISOMERASE user 4 2 # 4 A 196 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 204 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 91.55 34.15 2.80 89.93 32.93 2.11 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1dci_c00 source 1dci DIENOYL-COA ISOMERASE : 4 hits 1dci_c00 naa= 2 ULMN 2 1dci_c01 DIENOYL-COA ISOMERASE user 1 2 # 1 B 196 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 204 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 117.17 62.16 2.87 115.86 61.14 1.55 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 114.89 59.78 9.34 114.72 61.90 9.19 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1dci_c01 DIENOYL-COA ISOMERASE user 2 2 # 2 B 196 GLU A 81 GLU.? 16.59 O1 EDO A 125 B 204 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 117.17 62.16 2.87 115.86 61.14 1.55 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 114.89 59.78 9.34 114.72 61.90 9.19 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1dci_c01 DIENOYL-COA ISOMERASE user 3 2 # 3 B 196 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 204 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 117.17 62.16 2.87 115.86 61.14 1.55 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 114.89 59.78 9.34 114.72 61.90 9.19 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1dci_c01 DIENOYL-COA ISOMERASE user 4 2 # 4 B 196 GLU B 81 GLU.? 30.69 O1 EDO A 124 B 204 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 117.17 62.16 2.87 115.86 61.14 1.55 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 114.89 59.78 9.34 114.72 61.90 9.19 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1dci_c01 source 1dci DIENOYL-COA ISOMERASE : 4 hits 1dci_c01 naa= 2 ULMN 2 1dci_c02 DIENOYL-COA ISOMERASE user 1 2 # 1 C 196 GLU A 43 GLU.? 14.35 O2 EDO A 124 C 204 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 127.57 24.91 0.86 127.56 26.90 0.05 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 125.57 26.17 7.79 127.49 25.34 7.72 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1dci_c02 DIENOYL-COA ISOMERASE user 2 2 # 2 C 196 GLU A 81 GLU.? 16.59 O1 EDO A 125 C 204 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 127.57 24.91 0.86 127.56 26.90 0.05 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 125.57 26.17 7.79 127.49 25.34 7.72 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1dci_c02 DIENOYL-COA ISOMERASE user 3 2 # 3 C 196 GLU B 43 GLU.? 19.28 O2 EDO A 125 C 204 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 127.57 24.91 0.86 127.56 26.90 0.05 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 125.57 26.17 7.79 127.49 25.34 7.72 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1dci_c02 DIENOYL-COA ISOMERASE user 4 2 # 4 C 196 GLU B 81 GLU.? 30.69 O1 EDO A 124 C 204 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 127.57 24.91 0.86 127.56 26.90 0.05 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 125.57 26.17 7.79 127.49 25.34 7.72 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1dci_c02 source 1dci DIENOYL-COA ISOMERASE : 4 hits 1dci_c02 naa= 2 ULMN 2 1dci_c03 DIENOYL-COA ISOMERASE user 1 2 # 1 A 176 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 196 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 96.44 30.26 -3.26 95.11 31.92 -3.28 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1dci_c03 DIENOYL-COA ISOMERASE user 2 2 # 2 A 176 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 196 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 96.44 30.26 -3.26 95.11 31.92 -3.28 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1dci_c03 DIENOYL-COA ISOMERASE user 3 2 # 3 A 176 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 196 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 96.44 30.26 -3.26 95.11 31.92 -3.28 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1dci_c03 DIENOYL-COA ISOMERASE user 4 2 # 4 A 176 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 196 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 96.44 30.26 -3.26 95.11 31.92 -3.28 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1dci_c03 source 1dci DIENOYL-COA ISOMERASE : 4 hits 1dci_c03 naa= 2 ULMN 2 1dci_c04 DIENOYL-COA ISOMERASE user 1 2 # 1 B 176 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 196 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 110.25 59.26 2.17 112.32 59.63 2.53 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 117.17 62.16 2.87 115.86 61.14 1.55 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1dci_c04 DIENOYL-COA ISOMERASE user 2 2 # 2 B 176 ASP A 84 ASP.? 13.20 O1 EDO A 125 B 196 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 110.25 59.26 2.17 112.32 59.63 2.53 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 117.17 62.16 2.87 115.86 61.14 1.55 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1dci_c04 DIENOYL-COA ISOMERASE user 3 2 # 3 B 176 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 196 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 110.25 59.26 2.17 112.32 59.63 2.53 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 117.17 62.16 2.87 115.86 61.14 1.55 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1dci_c04 DIENOYL-COA ISOMERASE user 4 2 # 4 B 176 ASP B 84 ASP.? 30.86 C1 EDO A 124 B 196 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 110.25 59.26 2.17 112.32 59.63 2.53 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 117.17 62.16 2.87 115.86 61.14 1.55 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1dci_c04 source 1dci DIENOYL-COA ISOMERASE : 4 hits 1dci_c04 naa= 2 ULMN 2 1dci_c05 DIENOYL-COA ISOMERASE user 1 2 # 1 C 176 ASP A 41 ASP^? -2.91 O2 EDO A 124s C 196 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 128.37 32.38 2.45 127.70 30.37 2.17 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 127.57 24.91 0.86 127.56 26.90 0.05 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1dci_c05 DIENOYL-COA ISOMERASE user 2 2 # 2 C 176 ASP A 84 ASP.? 13.20 O1 EDO A 125 C 196 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 128.37 32.38 2.45 127.70 30.37 2.17 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 127.57 24.91 0.86 127.56 26.90 0.05 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1dci_c05 DIENOYL-COA ISOMERASE user 3 2 # 3 C 176 ASP B 41 ASP^? 12.31 O1 EDO A 124 C 196 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 128.37 32.38 2.45 127.70 30.37 2.17 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 127.57 24.91 0.86 127.56 26.90 0.05 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1dci_c05 DIENOYL-COA ISOMERASE user 4 2 # 4 C 176 ASP B 84 ASP.? 30.86 C1 EDO A 124 C 196 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 128.37 32.38 2.45 127.70 30.37 2.17 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 127.57 24.91 0.86 127.56 26.90 0.05 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1dci_c05 source 1dci DIENOYL-COA ISOMERASE : 4 hits 1dci_c05 naa= 2 ULMN 2 1dek_c00 DEOXYNUCLEOSIDE MONOPHOSPHATE KINASEuser 1 2 # 1 A 68 ARG A 25 ARG.? 17.39 O2 EDO A 124 A 206 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 43.62 6.34 2.39 44.53 4.47 4.58 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 54.10 -0.86 -3.09 55.51 0.68 -2.87 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1dek_c00 DEOXYNUCLEOSIDE MONOPHOSPHATE KINASEuser 2 2 # 2 A 68 ARG B 25 ARG.? 18.77 O2 EDO A 125 A 206 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 43.62 6.34 2.39 44.53 4.47 4.58 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 54.10 -0.86 -3.09 55.51 0.68 -2.87 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1dek_c00 source 1dek DEOXYNUCLEOSIDE MONOPHOSPHATE KINASE : 2 hits 1dek_c00 naa= 2 ULMN 2 1dfo_c08 SERINE HYDROXYMETHYLTRANSFERASE user 1 2 # 1 A 203 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 234 PRO A 52 PRO~? 11.69 O1 EDO A 125 coo 6.89 92.05 42.22 8.64 90.94 42.56 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 12.67 104.20 50.99 13.64 103.14 49.30 -19.24 -39.24 -23.00 -20.61 -40.50 -21.76 ULMN 2 1dfo_c08 SERINE HYDROXYMETHYLTRANSFERASE user 2 2 # 2 A 203 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 234 PRO A 90 PRO~? 7.68 O2 EDO A 125 coo 6.89 92.05 42.22 8.64 90.94 42.56 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 12.67 104.20 50.99 13.64 103.14 49.30 -34.27 -46.71 -27.76 -33.11 -45.80 -26.06 ULMN 2 1dfo_c08 SERINE HYDROXYMETHYLTRANSFERASE user 3 2 # 3 A 203 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 234 PRO B 52 PRO~? 14.52 C1 EDO A 124 coo 6.89 92.05 42.22 8.64 90.94 42.56 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 12.67 104.20 50.99 13.64 103.14 49.30 -42.56 -25.03 -21.82 -42.59 -27.16 -22.47 ULMN 2 1dfo_c08 SERINE HYDROXYMETHYLTRANSFERASE user 4 2 # 4 A 203 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 234 PRO B 90 PRO~? 16.38 O2 EDO A 125 coo 6.89 92.05 42.22 8.64 90.94 42.56 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 12.67 104.20 50.99 13.64 103.14 49.30 -40.98 -42.73 -15.66 -40.85 -41.32 -17.39 1dfo_c08 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 4 hits 1dfo_c08 naa= 2 ULMN 2 1dfo_c09 SERINE HYDROXYMETHYLTRANSFERASE user 1 2 # 1 B 203 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 234 PRO A 52 PRO~? 11.69 O1 EDO A 125 coo 19.31 99.02 77.11 17.71 100.31 76.67 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 24.28 99.99 61.88 23.82 101.66 63.27 -19.24 -39.24 -23.00 -20.61 -40.50 -21.76 ULMN 2 1dfo_c09 SERINE HYDROXYMETHYLTRANSFERASE user 2 2 # 2 B 203 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 234 PRO A 90 PRO~? 7.68 O2 EDO A 125 coo 19.31 99.02 77.11 17.71 100.31 76.67 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 24.28 99.99 61.88 23.82 101.66 63.27 -34.27 -46.71 -27.76 -33.11 -45.80 -26.06 ULMN 2 1dfo_c09 SERINE HYDROXYMETHYLTRANSFERASE user 3 2 # 3 B 203 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 234 PRO B 52 PRO~? 14.52 C1 EDO A 124 coo 19.31 99.02 77.11 17.71 100.31 76.67 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 24.28 99.99 61.88 23.82 101.66 63.27 -42.56 -25.03 -21.82 -42.59 -27.16 -22.47 ULMN 2 1dfo_c09 SERINE HYDROXYMETHYLTRANSFERASE user 4 2 # 4 B 203 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 234 PRO B 90 PRO~? 16.38 O2 EDO A 125 coo 19.31 99.02 77.11 17.71 100.31 76.67 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 24.28 99.99 61.88 23.82 101.66 63.27 -40.98 -42.73 -15.66 -40.85 -41.32 -17.39 1dfo_c09 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 4 hits 1dfo_c09 naa= 2 ULMN 2 1dfo_c10 SERINE HYDROXYMETHYLTRANSFERASE user 1 2 # 1 C 203 HIS A 79 HIS^? 12.23 O1 EDO A 125 C 234 PRO A 52 PRO~? 11.69 O1 EDO A 125 coo 28.39 51.38 77.52 28.92 52.50 75.82 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 23.65 39.23 68.10 25.58 40.32 68.07 -19.24 -39.24 -23.00 -20.61 -40.50 -21.76 ULMN 2 1dfo_c10 SERINE HYDROXYMETHYLTRANSFERASE user 2 2 # 2 C 203 HIS A 79 HIS^? 12.23 O1 EDO A 125 C 234 PRO A 90 PRO~? 7.68 O2 EDO A 125 coo 28.39 51.38 77.52 28.92 52.50 75.82 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 23.65 39.23 68.10 25.58 40.32 68.07 -34.27 -46.71 -27.76 -33.11 -45.80 -26.06 ULMN 2 1dfo_c10 SERINE HYDROXYMETHYLTRANSFERASE user 3 2 # 3 C 203 HIS B 79 HIS^? 26.86 C1 EDO A 124 C 234 PRO B 52 PRO~? 14.52 C1 EDO A 124 coo 28.39 51.38 77.52 28.92 52.50 75.82 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 23.65 39.23 68.10 25.58 40.32 68.07 -42.56 -25.03 -21.82 -42.59 -27.16 -22.47 ULMN 2 1dfo_c10 SERINE HYDROXYMETHYLTRANSFERASE user 4 2 # 4 C 203 HIS B 79 HIS^? 26.86 C1 EDO A 124 C 234 PRO B 90 PRO~? 16.38 O2 EDO A 125 coo 28.39 51.38 77.52 28.92 52.50 75.82 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 23.65 39.23 68.10 25.58 40.32 68.07 -40.98 -42.73 -15.66 -40.85 -41.32 -17.39 1dfo_c10 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 4 hits 1dfo_c10 naa= 2 ULMN 2 1dfo_c11 SERINE HYDROXYMETHYLTRANSFERASE user 1 2 # 1 D 203 HIS A 79 HIS^? 12.23 O1 EDO A 125 D 234 PRO A 52 PRO~? 11.69 O1 EDO A 125 coo 3.73 44.27 49.83 3.38 42.95 51.43 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 19.52 43.51 52.76 18.11 41.83 52.49 -19.24 -39.24 -23.00 -20.61 -40.50 -21.76 ULMN 2 1dfo_c11 SERINE HYDROXYMETHYLTRANSFERASE user 2 2 # 2 D 203 HIS A 79 HIS^? 12.23 O1 EDO A 125 D 234 PRO A 90 PRO~? 7.68 O2 EDO A 125 coo 3.73 44.27 49.83 3.38 42.95 51.43 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 19.52 43.51 52.76 18.11 41.83 52.49 -34.27 -46.71 -27.76 -33.11 -45.80 -26.06 ULMN 2 1dfo_c11 SERINE HYDROXYMETHYLTRANSFERASE user 3 2 # 3 D 203 HIS B 79 HIS^? 26.86 C1 EDO A 124 D 234 PRO B 52 PRO~? 14.52 C1 EDO A 124 coo 3.73 44.27 49.83 3.38 42.95 51.43 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 19.52 43.51 52.76 18.11 41.83 52.49 -42.56 -25.03 -21.82 -42.59 -27.16 -22.47 ULMN 2 1dfo_c11 SERINE HYDROXYMETHYLTRANSFERASE user 4 2 # 4 D 203 HIS B 79 HIS^? 26.86 C1 EDO A 124 D 234 PRO B 90 PRO~? 16.38 O2 EDO A 125 coo 3.73 44.27 49.83 3.38 42.95 51.43 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 19.52 43.51 52.76 18.11 41.83 52.49 -40.98 -42.73 -15.66 -40.85 -41.32 -17.39 1dfo_c11 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 4 hits 1dfo_c11 naa= 2 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 1 2 # 1 A 22 LEU A 42 LEU^? 10.34 O2 EDO A 124 A 30 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 30.17 24.15 15.83 30.23 26.01 16.90 -35.18 -36.23 -29.00 -34.50 -37.80 -27.68 coo 32.29 33.65 17.58 30.85 33.19 19.08 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 2 2 # 2 A 22 LEU A 66 LEU~? 14.48 O1 EDO A 125 A 30 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 30.17 24.15 15.83 30.23 26.01 16.90 -15.97 -38.44 -26.63 -16.10 -39.71 -24.86 coo 32.29 33.65 17.58 30.85 33.19 19.08 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 3 2 # 3 A 22 LEU A 72 LEU^? 13.09 O1 EDO A 125 A 30 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 30.17 24.15 15.83 30.23 26.01 16.90 -25.96 -45.98 -36.98 -24.33 -45.96 -38.50 coo 32.29 33.65 17.58 30.85 33.19 19.08 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 4 2 # 4 A 22 LEU A 78 LEU^? 8.41 O1 EDO A 125 A 30 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 30.17 24.15 15.83 30.23 26.01 16.90 -25.02 -43.13 -29.94 -26.24 -41.39 -29.47 coo 32.29 33.65 17.58 30.85 33.19 19.08 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 5 2 # 5 A 22 LEU A 83 LEU.? 13.93 O1 EDO A 125 A 30 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 30.17 24.15 15.83 30.23 26.01 16.90 -14.15 -46.42 -30.21 -12.97 -45.12 -28.95 coo 32.29 33.65 17.58 30.85 33.19 19.08 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 6 2 # 6 A 22 LEU A 83 LEU.? 13.93 O1 EDO A 125 A 30 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 30.17 24.15 15.83 30.23 26.01 16.90 -14.15 -46.42 -30.21 -12.97 -45.12 -28.95 coo 32.29 33.65 17.58 30.85 33.19 19.08 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 7 2 # 7 A 22 LEU A 83 LEU.? 13.93 O1 EDO A 125 A 30 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 30.17 24.15 15.83 30.23 26.01 16.90 -14.15 -46.42 -30.21 -12.97 -45.12 -28.95 coo 32.29 33.65 17.58 30.85 33.19 19.08 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 8 2 # 8 A 22 LEU A 89 LEU~? 8.99 O1 EDO A 125 A 30 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 30.17 24.15 15.83 30.23 26.01 16.90 -31.04 -43.51 -28.26 -31.53 -41.41 -28.05 coo 32.29 33.65 17.58 30.85 33.19 19.08 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 9 2 # 9 A 22 LEU A 89 LEU~? 8.99 O1 EDO A 125 A 30 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 30.17 24.15 15.83 30.23 26.01 16.90 -31.04 -43.51 -28.26 -31.53 -41.41 -28.05 coo 32.29 33.65 17.58 30.85 33.19 19.08 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 10 2 # 10 A 22 LEU B 42 LEU^? 14.47 O2 EDO A 125 A 30 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 30.17 24.15 15.83 30.23 26.01 16.90 -31.56 -38.10 -14.56 -33.31 -38.25 -15.79 coo 32.29 33.65 17.58 30.85 33.19 19.08 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 11 2 # 11 A 22 LEU B 54 LEU~? 14.98 C1 EDO A 124 A 30 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 30.17 24.15 15.83 30.23 26.01 16.90 -44.12 -30.81 -26.43 -43.06 -31.04 -28.33 coo 32.29 33.65 17.58 30.85 33.19 19.08 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 12 2 # 12 A 22 LEU B 66 LEU~? 17.96 C1 EDO A 124 A 30 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 30.17 24.15 15.83 30.23 26.01 16.90 -43.15 -22.70 -16.79 -44.19 -23.46 -18.56 coo 32.29 33.65 17.58 30.85 33.19 19.08 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 13 2 # 13 A 22 LEU B 72 LEU^? 26.85 C1 EDO A 124 A 30 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 30.17 24.15 15.83 30.23 26.01 16.90 -44.25 -35.46 -6.58 -45.01 -34.22 -4.94 coo 32.29 33.65 17.58 30.85 33.19 19.08 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 14 2 # 14 A 22 LEU B 78 LEU^? 18.42 C1 EDO A 124 A 30 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 30.17 24.15 15.83 30.23 26.01 16.90 -42.62 -33.09 -13.72 -40.58 -33.23 -14.47 coo 32.29 33.65 17.58 30.85 33.19 19.08 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 15 2 # 15 A 22 LEU B 83 LEU.? 25.07 C1 EDO A 124 A 30 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 30.17 24.15 15.83 30.23 26.01 16.90 -50.68 -25.61 -13.23 -49.92 -24.11 -14.54 coo 32.29 33.65 17.58 30.85 33.19 19.08 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 16 2 # 16 A 22 LEU B 83 LEU.? 25.07 C1 EDO A 124 A 30 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 30.17 24.15 15.83 30.23 26.01 16.90 -50.68 -25.61 -13.23 -49.92 -24.11 -14.54 coo 32.29 33.65 17.58 30.85 33.19 19.08 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 17 2 # 17 A 22 LEU B 83 LEU.? 25.07 C1 EDO A 124 A 30 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 30.17 24.15 15.83 30.23 26.01 16.90 -50.68 -25.61 -13.23 -49.92 -24.11 -14.54 coo 32.29 33.65 17.58 30.85 33.19 19.08 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 18 2 # 18 A 22 LEU B 87 LEU^? 20.22 C1 EDO A 124 A 30 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 30.17 24.15 15.83 30.23 26.01 16.90 -45.62 -34.34 -16.64 -46.54 -32.89 -17.98 coo 32.29 33.65 17.58 30.85 33.19 19.08 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 19 2 # 19 A 22 LEU B 89 LEU~? 17.71 C1 EDO A 124 A 30 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 30.17 24.15 15.83 30.23 26.01 16.90 -39.89 -38.23 -15.28 -37.88 -37.43 -15.63 coo 32.29 33.65 17.58 30.85 33.19 19.08 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1dhf_c00 source 1dhf DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) ( DHFR ): 19 hits 1dhf_c00 naa= 2 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 1 2 # 1 B 22 LEU A 42 LEU^? 10.34 O2 EDO A 124 B 30 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 3.16 26.59 72.60 5.24 26.56 72.94 -35.18 -36.23 -29.00 -34.50 -37.80 -27.68 coo 10.81 21.08 75.40 10.64 21.05 73.28 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 2 2 # 2 B 22 LEU A 66 LEU~? 14.48 O1 EDO A 125 B 30 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 3.16 26.59 72.60 5.24 26.56 72.94 -15.97 -38.44 -26.63 -16.10 -39.71 -24.86 coo 10.81 21.08 75.40 10.64 21.05 73.28 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 3 2 # 3 B 22 LEU A 72 LEU^? 13.09 O1 EDO A 125 B 30 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 3.16 26.59 72.60 5.24 26.56 72.94 -25.96 -45.98 -36.98 -24.33 -45.96 -38.50 coo 10.81 21.08 75.40 10.64 21.05 73.28 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 4 2 # 4 B 22 LEU A 78 LEU^? 8.41 O1 EDO A 125 B 30 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 3.16 26.59 72.60 5.24 26.56 72.94 -25.02 -43.13 -29.94 -26.24 -41.39 -29.47 coo 10.81 21.08 75.40 10.64 21.05 73.28 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 5 2 # 5 B 22 LEU A 83 LEU.? 13.93 O1 EDO A 125 B 30 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 3.16 26.59 72.60 5.24 26.56 72.94 -14.15 -46.42 -30.21 -12.97 -45.12 -28.95 coo 10.81 21.08 75.40 10.64 21.05 73.28 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 6 2 # 6 B 22 LEU A 83 LEU.? 13.93 O1 EDO A 125 B 30 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 3.16 26.59 72.60 5.24 26.56 72.94 -14.15 -46.42 -30.21 -12.97 -45.12 -28.95 coo 10.81 21.08 75.40 10.64 21.05 73.28 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 7 2 # 7 B 22 LEU A 83 LEU.? 13.93 O1 EDO A 125 B 30 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 3.16 26.59 72.60 5.24 26.56 72.94 -14.15 -46.42 -30.21 -12.97 -45.12 -28.95 coo 10.81 21.08 75.40 10.64 21.05 73.28 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 8 2 # 8 B 22 LEU A 89 LEU~? 8.99 O1 EDO A 125 B 30 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 3.16 26.59 72.60 5.24 26.56 72.94 -31.04 -43.51 -28.26 -31.53 -41.41 -28.05 coo 10.81 21.08 75.40 10.64 21.05 73.28 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 9 2 # 9 B 22 LEU A 89 LEU~? 8.99 O1 EDO A 125 B 30 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 3.16 26.59 72.60 5.24 26.56 72.94 -31.04 -43.51 -28.26 -31.53 -41.41 -28.05 coo 10.81 21.08 75.40 10.64 21.05 73.28 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 10 2 # 10 B 22 LEU B 42 LEU^? 14.47 O2 EDO A 125 B 30 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 3.16 26.59 72.60 5.24 26.56 72.94 -31.56 -38.10 -14.56 -33.31 -38.25 -15.79 coo 10.81 21.08 75.40 10.64 21.05 73.28 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 11 2 # 11 B 22 LEU B 54 LEU~? 14.98 C1 EDO A 124 B 30 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 3.16 26.59 72.60 5.24 26.56 72.94 -44.12 -30.81 -26.43 -43.06 -31.04 -28.33 coo 10.81 21.08 75.40 10.64 21.05 73.28 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 12 2 # 12 B 22 LEU B 72 LEU^? 26.85 C1 EDO A 124 B 30 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 3.16 26.59 72.60 5.24 26.56 72.94 -44.25 -35.46 -6.58 -45.01 -34.22 -4.94 coo 10.81 21.08 75.40 10.64 21.05 73.28 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 13 2 # 13 B 22 LEU B 78 LEU^? 18.42 C1 EDO A 124 B 30 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 3.16 26.59 72.60 5.24 26.56 72.94 -42.62 -33.09 -13.72 -40.58 -33.23 -14.47 coo 10.81 21.08 75.40 10.64 21.05 73.28 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 14 2 # 14 B 22 LEU B 83 LEU.? 25.07 C1 EDO A 124 B 30 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 3.16 26.59 72.60 5.24 26.56 72.94 -50.68 -25.61 -13.23 -49.92 -24.11 -14.54 coo 10.81 21.08 75.40 10.64 21.05 73.28 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 15 2 # 15 B 22 LEU B 83 LEU.? 25.07 C1 EDO A 124 B 30 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 3.16 26.59 72.60 5.24 26.56 72.94 -50.68 -25.61 -13.23 -49.92 -24.11 -14.54 coo 10.81 21.08 75.40 10.64 21.05 73.28 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 16 2 # 16 B 22 LEU B 83 LEU.? 25.07 C1 EDO A 124 B 30 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 3.16 26.59 72.60 5.24 26.56 72.94 -50.68 -25.61 -13.23 -49.92 -24.11 -14.54 coo 10.81 21.08 75.40 10.64 21.05 73.28 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 17 2 # 17 B 22 LEU B 89 LEU~? 17.71 C1 EDO A 124 B 30 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 3.16 26.59 72.60 5.24 26.56 72.94 -39.89 -38.23 -15.28 -37.88 -37.43 -15.63 coo 10.81 21.08 75.40 10.64 21.05 73.28 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1dhf_c01 source 1dhf DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) ( DHFR ): 17 hits 1dhf_c01 naa= 2 ULMN 2 1dpg_c00 GLUCOSE 6-PHOSPHATE DEHYDROGENASE user 1 2 # 1 A 177 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 240 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 2.26 56.20 112.47 1.44 54.50 111.51 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 0.37 50.68 111.57 0.88 50.88 113.60 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1dpg_c00 GLUCOSE 6-PHOSPHATE DEHYDROGENASE user 2 2 # 2 A 177 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 240 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 2.26 56.20 112.47 1.44 54.50 111.51 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 0.37 50.68 111.57 0.88 50.88 113.60 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1dpg_c00 source 1dpg GLUCOSE 6-PHOSPHATE DEHYDROGENASE : 2 hits 1dpg_c00 naa= 2 ULMN 2 1dpg_c01 GLUCOSE 6-PHOSPHATE DEHYDROGENASE user 1 2 # 1 B 177 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 240 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 21.87 38.39 60.26 23.35 39.51 61.35 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 26.68 40.16 63.39 27.30 38.51 62.24 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1dpg_c01 GLUCOSE 6-PHOSPHATE DEHYDROGENASE user 2 2 # 2 B 177 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 240 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 21.87 38.39 60.26 23.35 39.51 61.35 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 26.68 40.16 63.39 27.30 38.51 62.24 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1dpg_c01 source 1dpg GLUCOSE 6-PHOSPHATE DEHYDROGENASE : 2 hits 1dpg_c01 naa= 2 ULMN 2 1dtw_c00 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 1 2 # 1 A 291 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 76 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 72.33 2.23 1.35 73.00 2.99 3.18 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 77.60 2.15 30.40 76.57 1.77 32.21 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1dtw_c00 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 2 2 # 2 A 291 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 76 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 72.33 2.23 1.35 73.00 2.99 3.18 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 77.60 2.15 30.40 76.57 1.77 32.21 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 1dtw_c00 source 1dtw BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE B: 2 hits 1dtw_c00 naa= 2 ULMN 2 1dtw_c01 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 1 2 # 1 A 291 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 76 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 72.33 2.23 1.35 73.00 2.99 3.18 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 77.60 2.15 30.40 76.57 1.77 32.21 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1dtw_c01 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 2 2 # 2 A 291 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 76 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 72.33 2.23 1.35 73.00 2.99 3.18 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 77.60 2.15 30.40 76.57 1.77 32.21 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 1dtw_c01 source 1dtw BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE B: 2 hits 1dtw_c01 naa= 2 ULMN 2 1dub_c06 2-ENOYL-COA HYDRATASE user 1 2 # 1 A 164 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 172 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 65.46 104.88 175.81 64.47 105.72 174.12 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 65.25 99.24 172.80 64.76 99.68 172.43 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1dub_c06 2-ENOYL-COA HYDRATASE user 2 2 # 2 A 164 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 172 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 65.46 104.88 175.81 64.47 105.72 174.12 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 65.25 99.24 172.80 64.76 99.68 172.43 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1dub_c06 2-ENOYL-COA HYDRATASE user 3 2 # 3 A 164 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 172 GLY A 75 GLY.? 13.18 O1 EDO A 125 coo 65.46 104.88 175.81 64.47 105.72 174.12 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 65.25 99.24 172.80 64.76 99.68 172.43 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 ULMN 2 1dub_c06 2-ENOYL-COA HYDRATASE user 4 2 # 4 A 164 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 172 GLY A 57 GLY.? 9.42 O1 EDO A 125 coo 65.46 104.88 175.81 64.47 105.72 174.12 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 65.25 99.24 172.80 64.76 99.68 172.43 -16.91 -49.31 -24.24 -17.01 -48.68 -23.74 ULMN 2 1dub_c06 2-ENOYL-COA HYDRATASE user 5 2 # 5 A 164 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 172 GLY A 60 GLY.? 16.17 O1 EDO A 125 coo 65.46 104.88 175.81 64.47 105.72 174.12 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 65.25 99.24 172.80 64.76 99.68 172.43 -11.24 -44.68 -21.35 -11.80 -44.53 -21.88 ULMN 2 1dub_c06 2-ENOYL-COA HYDRATASE user 6 2 # 6 A 164 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 172 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 65.46 104.88 175.81 64.47 105.72 174.12 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 65.25 99.24 172.80 64.76 99.68 172.43 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1dub_c06 2-ENOYL-COA HYDRATASE user 7 2 # 7 A 164 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 172 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 65.46 104.88 175.81 64.47 105.72 174.12 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 65.25 99.24 172.80 64.76 99.68 172.43 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1dub_c06 2-ENOYL-COA HYDRATASE user 8 2 # 8 A 164 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 172 GLY B 75 GLY.? 21.06 O2 EDO A 125 coo 65.46 104.88 175.81 64.47 105.72 174.12 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 65.25 99.24 172.80 64.76 99.68 172.43 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 ULMN 2 1dub_c06 2-ENOYL-COA HYDRATASE user 9 2 # 9 A 164 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 172 GLY B 57 GLY.? 23.79 C1 EDO A 124 coo 65.46 104.88 175.81 64.47 105.72 174.12 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 65.25 99.24 172.80 64.76 99.68 172.43 -51.53 -29.44 -19.30 -51.09 -29.07 -19.90 ULMN 2 1dub_c06 2-ENOYL-COA HYDRATASE user 10 2 # 10 A 164 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 172 GLY B 60 GLY.? 23.13 C1 EDO A 124 coo 65.46 104.88 175.81 64.47 105.72 174.12 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 65.25 99.24 172.80 64.76 99.68 172.43 -50.57 -21.34 -22.29 -50.23 -21.86 -21.81 1dub_c06 source 1dub 2-ENOYL-COA HYDRATASE : 10 hits 1dub_c06 naa= 2 ULMN 2 1dub_c07 2-ENOYL-COA HYDRATASE user 1 2 # 1 B 164 GLU A 23 GLU.? 13.04 O2 EDO A 125 B 172 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 88.14 113.46 145.73 86.79 113.92 147.30 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 88.37 107.75 148.54 88.01 108.21 149.05 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1dub_c07 2-ENOYL-COA HYDRATASE user 2 2 # 2 B 164 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 172 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 88.14 113.46 145.73 86.79 113.92 147.30 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 88.37 107.75 148.54 88.01 108.21 149.05 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1dub_c07 2-ENOYL-COA HYDRATASE user 3 2 # 3 B 164 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 172 GLY A 75 GLY.? 13.18 O1 EDO A 125 coo 88.14 113.46 145.73 86.79 113.92 147.30 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 88.37 107.75 148.54 88.01 108.21 149.05 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 ULMN 2 1dub_c07 2-ENOYL-COA HYDRATASE user 4 2 # 4 B 164 GLU A 59 GLU.? 11.26 O1 EDO A 125 B 172 GLY A 57 GLY.? 9.42 O1 EDO A 125 coo 88.14 113.46 145.73 86.79 113.92 147.30 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 88.37 107.75 148.54 88.01 108.21 149.05 -16.91 -49.31 -24.24 -17.01 -48.68 -23.74 ULMN 2 1dub_c07 2-ENOYL-COA HYDRATASE user 5 2 # 5 B 164 GLU A 59 GLU.? 11.26 O1 EDO A 125 B 172 GLY A 60 GLY.? 16.17 O1 EDO A 125 coo 88.14 113.46 145.73 86.79 113.92 147.30 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 88.37 107.75 148.54 88.01 108.21 149.05 -11.24 -44.68 -21.35 -11.80 -44.53 -21.88 ULMN 2 1dub_c07 2-ENOYL-COA HYDRATASE user 6 2 # 6 B 164 GLU B 23 GLU.? 12.57 O2 EDO A 125 B 172 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 88.14 113.46 145.73 86.79 113.92 147.30 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 88.37 107.75 148.54 88.01 108.21 149.05 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1dub_c07 2-ENOYL-COA HYDRATASE user 7 2 # 7 B 164 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 172 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 88.14 113.46 145.73 86.79 113.92 147.30 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 88.37 107.75 148.54 88.01 108.21 149.05 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1dub_c07 2-ENOYL-COA HYDRATASE user 8 2 # 8 B 164 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 172 GLY B 75 GLY.? 21.06 O2 EDO A 125 coo 88.14 113.46 145.73 86.79 113.92 147.30 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 88.37 107.75 148.54 88.01 108.21 149.05 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 ULMN 2 1dub_c07 2-ENOYL-COA HYDRATASE user 9 2 # 9 B 164 GLU B 59 GLU.? 24.69 C1 EDO A 124 B 172 GLY B 57 GLY.? 23.79 C1 EDO A 124 coo 88.14 113.46 145.73 86.79 113.92 147.30 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 88.37 107.75 148.54 88.01 108.21 149.05 -51.53 -29.44 -19.30 -51.09 -29.07 -19.90 ULMN 2 1dub_c07 2-ENOYL-COA HYDRATASE user 10 2 # 10 B 164 GLU B 59 GLU.? 24.69 C1 EDO A 124 B 172 GLY B 60 GLY.? 23.13 C1 EDO A 124 coo 88.14 113.46 145.73 86.79 113.92 147.30 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 88.37 107.75 148.54 88.01 108.21 149.05 -50.57 -21.34 -22.29 -50.23 -21.86 -21.81 1dub_c07 source 1dub 2-ENOYL-COA HYDRATASE : 10 hits 1dub_c07 naa= 2 ULMN 2 1dub_c08 2-ENOYL-COA HYDRATASE user 1 2 # 1 C 164 GLU A 23 GLU.? 13.04 O2 EDO A 125 C 172 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 51.71 102.03 140.09 53.02 103.62 140.54 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 56.53 97.84 139.65 56.86 98.55 139.57 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1dub_c08 2-ENOYL-COA HYDRATASE user 2 2 # 2 C 164 GLU A 43 GLU.? 14.35 O2 EDO A 124 C 172 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 51.71 102.03 140.09 53.02 103.62 140.54 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 56.53 97.84 139.65 56.86 98.55 139.57 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1dub_c08 2-ENOYL-COA HYDRATASE user 3 2 # 3 C 164 GLU A 43 GLU.? 14.35 O2 EDO A 124 C 172 GLY A 75 GLY.? 13.18 O1 EDO A 125 coo 51.71 102.03 140.09 53.02 103.62 140.54 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 56.53 97.84 139.65 56.86 98.55 139.57 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 ULMN 2 1dub_c08 2-ENOYL-COA HYDRATASE user 4 2 # 4 C 164 GLU A 59 GLU.? 11.26 O1 EDO A 125 C 172 GLY A 57 GLY.? 9.42 O1 EDO A 125 coo 51.71 102.03 140.09 53.02 103.62 140.54 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 56.53 97.84 139.65 56.86 98.55 139.57 -16.91 -49.31 -24.24 -17.01 -48.68 -23.74 ULMN 2 1dub_c08 2-ENOYL-COA HYDRATASE user 5 2 # 5 C 164 GLU A 59 GLU.? 11.26 O1 EDO A 125 C 172 GLY A 60 GLY.? 16.17 O1 EDO A 125 coo 51.71 102.03 140.09 53.02 103.62 140.54 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 56.53 97.84 139.65 56.86 98.55 139.57 -11.24 -44.68 -21.35 -11.80 -44.53 -21.88 ULMN 2 1dub_c08 2-ENOYL-COA HYDRATASE user 6 2 # 6 C 164 GLU B 23 GLU.? 12.57 O2 EDO A 125 C 172 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 51.71 102.03 140.09 53.02 103.62 140.54 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 56.53 97.84 139.65 56.86 98.55 139.57 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1dub_c08 2-ENOYL-COA HYDRATASE user 7 2 # 7 C 164 GLU B 43 GLU.? 19.28 O2 EDO A 125 C 172 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 51.71 102.03 140.09 53.02 103.62 140.54 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 56.53 97.84 139.65 56.86 98.55 139.57 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1dub_c08 2-ENOYL-COA HYDRATASE user 8 2 # 8 C 164 GLU B 43 GLU.? 19.28 O2 EDO A 125 C 172 GLY B 75 GLY.? 21.06 O2 EDO A 125 coo 51.71 102.03 140.09 53.02 103.62 140.54 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 56.53 97.84 139.65 56.86 98.55 139.57 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 ULMN 2 1dub_c08 2-ENOYL-COA HYDRATASE user 9 2 # 9 C 164 GLU B 59 GLU.? 24.69 C1 EDO A 124 C 172 GLY B 57 GLY.? 23.79 C1 EDO A 124 coo 51.71 102.03 140.09 53.02 103.62 140.54 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 56.53 97.84 139.65 56.86 98.55 139.57 -51.53 -29.44 -19.30 -51.09 -29.07 -19.90 ULMN 2 1dub_c08 2-ENOYL-COA HYDRATASE user 10 2 # 10 C 164 GLU B 59 GLU.? 24.69 C1 EDO A 124 C 172 GLY B 60 GLY.? 23.13 C1 EDO A 124 coo 51.71 102.03 140.09 53.02 103.62 140.54 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 56.53 97.84 139.65 56.86 98.55 139.57 -50.57 -21.34 -22.29 -50.23 -21.86 -21.81 1dub_c08 source 1dub 2-ENOYL-COA HYDRATASE : 10 hits 1dub_c08 naa= 2 ULMN 2 1dub_c09 2-ENOYL-COA HYDRATASE user 1 2 # 1 D 164 GLU A 23 GLU.? 13.04 O2 EDO A 125 D 172 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 91.47 83.05 136.24 90.35 81.38 136.84 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 86.64 87.31 136.66 86.30 86.60 136.64 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1dub_c09 2-ENOYL-COA HYDRATASE user 2 2 # 2 D 164 GLU A 43 GLU.? 14.35 O2 EDO A 124 D 172 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 91.47 83.05 136.24 90.35 81.38 136.84 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 86.64 87.31 136.66 86.30 86.60 136.64 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1dub_c09 2-ENOYL-COA HYDRATASE user 3 2 # 3 D 164 GLU A 43 GLU.? 14.35 O2 EDO A 124 D 172 GLY A 75 GLY.? 13.18 O1 EDO A 125 coo 91.47 83.05 136.24 90.35 81.38 136.84 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 86.64 87.31 136.66 86.30 86.60 136.64 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 ULMN 2 1dub_c09 2-ENOYL-COA HYDRATASE user 4 2 # 4 D 164 GLU A 59 GLU.? 11.26 O1 EDO A 125 D 172 GLY A 57 GLY.? 9.42 O1 EDO A 125 coo 91.47 83.05 136.24 90.35 81.38 136.84 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 86.64 87.31 136.66 86.30 86.60 136.64 -16.91 -49.31 -24.24 -17.01 -48.68 -23.74 ULMN 2 1dub_c09 2-ENOYL-COA HYDRATASE user 5 2 # 5 D 164 GLU A 59 GLU.? 11.26 O1 EDO A 125 D 172 GLY A 60 GLY.? 16.17 O1 EDO A 125 coo 91.47 83.05 136.24 90.35 81.38 136.84 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 86.64 87.31 136.66 86.30 86.60 136.64 -11.24 -44.68 -21.35 -11.80 -44.53 -21.88 ULMN 2 1dub_c09 2-ENOYL-COA HYDRATASE user 6 2 # 6 D 164 GLU B 23 GLU.? 12.57 O2 EDO A 125 D 172 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 91.47 83.05 136.24 90.35 81.38 136.84 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 86.64 87.31 136.66 86.30 86.60 136.64 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1dub_c09 2-ENOYL-COA HYDRATASE user 7 2 # 7 D 164 GLU B 43 GLU.? 19.28 O2 EDO A 125 D 172 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 91.47 83.05 136.24 90.35 81.38 136.84 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 86.64 87.31 136.66 86.30 86.60 136.64 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1dub_c09 2-ENOYL-COA HYDRATASE user 8 2 # 8 D 164 GLU B 43 GLU.? 19.28 O2 EDO A 125 D 172 GLY B 75 GLY.? 21.06 O2 EDO A 125 coo 91.47 83.05 136.24 90.35 81.38 136.84 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 86.64 87.31 136.66 86.30 86.60 136.64 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 ULMN 2 1dub_c09 2-ENOYL-COA HYDRATASE user 9 2 # 9 D 164 GLU B 59 GLU.? 24.69 C1 EDO A 124 D 172 GLY B 57 GLY.? 23.79 C1 EDO A 124 coo 91.47 83.05 136.24 90.35 81.38 136.84 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 86.64 87.31 136.66 86.30 86.60 136.64 -51.53 -29.44 -19.30 -51.09 -29.07 -19.90 ULMN 2 1dub_c09 2-ENOYL-COA HYDRATASE user 10 2 # 10 D 164 GLU B 59 GLU.? 24.69 C1 EDO A 124 D 172 GLY B 60 GLY.? 23.13 C1 EDO A 124 coo 91.47 83.05 136.24 90.35 81.38 136.84 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 86.64 87.31 136.66 86.30 86.60 136.64 -50.57 -21.34 -22.29 -50.23 -21.86 -21.81 1dub_c09 source 1dub 2-ENOYL-COA HYDRATASE : 10 hits 1dub_c09 naa= 2 ULMN 2 1dub_c10 2-ENOYL-COA HYDRATASE user 1 2 # 1 E 164 GLU A 23 GLU.? 13.04 O2 EDO A 125 E 172 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 84.40 80.02 173.80 85.08 79.06 172.03 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 84.01 85.71 170.92 84.43 85.28 170.44 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1dub_c10 2-ENOYL-COA HYDRATASE user 2 2 # 2 E 164 GLU A 43 GLU.? 14.35 O2 EDO A 124 E 172 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 84.40 80.02 173.80 85.08 79.06 172.03 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 84.01 85.71 170.92 84.43 85.28 170.44 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1dub_c10 2-ENOYL-COA HYDRATASE user 3 2 # 3 E 164 GLU A 43 GLU.? 14.35 O2 EDO A 124 E 172 GLY A 75 GLY.? 13.18 O1 EDO A 125 coo 84.40 80.02 173.80 85.08 79.06 172.03 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 84.01 85.71 170.92 84.43 85.28 170.44 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 ULMN 2 1dub_c10 2-ENOYL-COA HYDRATASE user 4 2 # 4 E 164 GLU A 59 GLU.? 11.26 O1 EDO A 125 E 172 GLY A 57 GLY.? 9.42 O1 EDO A 125 coo 84.40 80.02 173.80 85.08 79.06 172.03 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 84.01 85.71 170.92 84.43 85.28 170.44 -16.91 -49.31 -24.24 -17.01 -48.68 -23.74 ULMN 2 1dub_c10 2-ENOYL-COA HYDRATASE user 5 2 # 5 E 164 GLU A 59 GLU.? 11.26 O1 EDO A 125 E 172 GLY A 60 GLY.? 16.17 O1 EDO A 125 coo 84.40 80.02 173.80 85.08 79.06 172.03 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 84.01 85.71 170.92 84.43 85.28 170.44 -11.24 -44.68 -21.35 -11.80 -44.53 -21.88 ULMN 2 1dub_c10 2-ENOYL-COA HYDRATASE user 6 2 # 6 E 164 GLU B 23 GLU.? 12.57 O2 EDO A 125 E 172 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 84.40 80.02 173.80 85.08 79.06 172.03 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 84.01 85.71 170.92 84.43 85.28 170.44 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1dub_c10 2-ENOYL-COA HYDRATASE user 7 2 # 7 E 164 GLU B 43 GLU.? 19.28 O2 EDO A 125 E 172 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 84.40 80.02 173.80 85.08 79.06 172.03 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 84.01 85.71 170.92 84.43 85.28 170.44 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1dub_c10 2-ENOYL-COA HYDRATASE user 8 2 # 8 E 164 GLU B 43 GLU.? 19.28 O2 EDO A 125 E 172 GLY B 75 GLY.? 21.06 O2 EDO A 125 coo 84.40 80.02 173.80 85.08 79.06 172.03 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 84.01 85.71 170.92 84.43 85.28 170.44 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 ULMN 2 1dub_c10 2-ENOYL-COA HYDRATASE user 9 2 # 9 E 164 GLU B 59 GLU.? 24.69 C1 EDO A 124 E 172 GLY B 57 GLY.? 23.79 C1 EDO A 124 coo 84.40 80.02 173.80 85.08 79.06 172.03 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 84.01 85.71 170.92 84.43 85.28 170.44 -51.53 -29.44 -19.30 -51.09 -29.07 -19.90 ULMN 2 1dub_c10 2-ENOYL-COA HYDRATASE user 10 2 # 10 E 164 GLU B 59 GLU.? 24.69 C1 EDO A 124 E 172 GLY B 60 GLY.? 23.13 C1 EDO A 124 coo 84.40 80.02 173.80 85.08 79.06 172.03 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 84.01 85.71 170.92 84.43 85.28 170.44 -50.57 -21.34 -22.29 -50.23 -21.86 -21.81 1dub_c10 source 1dub 2-ENOYL-COA HYDRATASE : 10 hits 1dub_c10 naa= 2 ULMN 2 1dub_c11 2-ENOYL-COA HYDRATASE user 1 2 # 1 F 164 GLU A 23 GLU.? 13.04 O2 EDO A 125 F 172 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 56.75 71.71 148.46 58.44 71.01 149.54 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 57.02 77.49 151.32 57.42 77.01 151.76 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1dub_c11 2-ENOYL-COA HYDRATASE user 2 2 # 2 F 164 GLU A 43 GLU.? 14.35 O2 EDO A 124 F 172 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 56.75 71.71 148.46 58.44 71.01 149.54 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 57.02 77.49 151.32 57.42 77.01 151.76 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1dub_c11 2-ENOYL-COA HYDRATASE user 3 2 # 3 F 164 GLU A 43 GLU.? 14.35 O2 EDO A 124 F 172 GLY A 75 GLY.? 13.18 O1 EDO A 125 coo 56.75 71.71 148.46 58.44 71.01 149.54 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 57.02 77.49 151.32 57.42 77.01 151.76 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 ULMN 2 1dub_c11 2-ENOYL-COA HYDRATASE user 4 2 # 4 F 164 GLU A 59 GLU.? 11.26 O1 EDO A 125 F 172 GLY A 57 GLY.? 9.42 O1 EDO A 125 coo 56.75 71.71 148.46 58.44 71.01 149.54 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 57.02 77.49 151.32 57.42 77.01 151.76 -16.91 -49.31 -24.24 -17.01 -48.68 -23.74 ULMN 2 1dub_c11 2-ENOYL-COA HYDRATASE user 5 2 # 5 F 164 GLU A 59 GLU.? 11.26 O1 EDO A 125 F 172 GLY A 60 GLY.? 16.17 O1 EDO A 125 coo 56.75 71.71 148.46 58.44 71.01 149.54 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 57.02 77.49 151.32 57.42 77.01 151.76 -11.24 -44.68 -21.35 -11.80 -44.53 -21.88 ULMN 2 1dub_c11 2-ENOYL-COA HYDRATASE user 6 2 # 6 F 164 GLU B 23 GLU.? 12.57 O2 EDO A 125 F 172 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 56.75 71.71 148.46 58.44 71.01 149.54 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 57.02 77.49 151.32 57.42 77.01 151.76 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1dub_c11 2-ENOYL-COA HYDRATASE user 7 2 # 7 F 164 GLU B 43 GLU.? 19.28 O2 EDO A 125 F 172 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 56.75 71.71 148.46 58.44 71.01 149.54 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 57.02 77.49 151.32 57.42 77.01 151.76 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1dub_c11 2-ENOYL-COA HYDRATASE user 8 2 # 8 F 164 GLU B 43 GLU.? 19.28 O2 EDO A 125 F 172 GLY B 75 GLY.? 21.06 O2 EDO A 125 coo 56.75 71.71 148.46 58.44 71.01 149.54 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 57.02 77.49 151.32 57.42 77.01 151.76 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 ULMN 2 1dub_c11 2-ENOYL-COA HYDRATASE user 9 2 # 9 F 164 GLU B 59 GLU.? 24.69 C1 EDO A 124 F 172 GLY B 57 GLY.? 23.79 C1 EDO A 124 coo 56.75 71.71 148.46 58.44 71.01 149.54 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 57.02 77.49 151.32 57.42 77.01 151.76 -51.53 -29.44 -19.30 -51.09 -29.07 -19.90 ULMN 2 1dub_c11 2-ENOYL-COA HYDRATASE user 10 2 # 10 F 164 GLU B 59 GLU.? 24.69 C1 EDO A 124 F 172 GLY B 60 GLY.? 23.13 C1 EDO A 124 coo 56.75 71.71 148.46 58.44 71.01 149.54 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 57.02 77.49 151.32 57.42 77.01 151.76 -50.57 -21.34 -22.29 -50.23 -21.86 -21.81 1dub_c11 source 1dub 2-ENOYL-COA HYDRATASE : 10 hits 1dub_c11 naa= 2 ULMN 2 1dub_c12 2-ENOYL-COA HYDRATASE user 1 2 # 1 A 144 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 164 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 61.78 103.61 169.93 62.63 102.26 171.29 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 65.46 104.88 175.81 64.47 105.72 174.12 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1dub_c12 2-ENOYL-COA HYDRATASE user 2 2 # 2 A 144 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 164 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 61.78 103.61 169.93 62.63 102.26 171.29 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 65.46 104.88 175.81 64.47 105.72 174.12 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1dub_c12 2-ENOYL-COA HYDRATASE user 3 2 # 3 A 144 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 164 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 61.78 103.61 169.93 62.63 102.26 171.29 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 65.46 104.88 175.81 64.47 105.72 174.12 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1dub_c12 2-ENOYL-COA HYDRATASE user 4 2 # 4 A 144 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 164 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 61.78 103.61 169.93 62.63 102.26 171.29 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 65.46 104.88 175.81 64.47 105.72 174.12 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1dub_c12 source 1dub 2-ENOYL-COA HYDRATASE : 4 hits 1dub_c12 naa= 2 ULMN 2 1dup_c00 DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTuser 1 2 # 1 A 90 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 92 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo -8.87 38.72 40.39 -9.52 40.07 38.79 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo -10.84 34.98 43.59 -11.99 36.29 42.41 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1dup_c00 DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTuser 2 2 # 2 A 90 ASP A 64 ASP~? 20.53 O2 EDO A 124 A 92 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -8.87 38.72 40.39 -9.52 40.07 38.79 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo -10.84 34.98 43.59 -11.99 36.29 42.41 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1dup_c00 DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTuser 3 2 # 3 A 90 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 92 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo -8.87 38.72 40.39 -9.52 40.07 38.79 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo -10.84 34.98 43.59 -11.99 36.29 42.41 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1dup_c00 DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTuser 4 2 # 4 A 90 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 92 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -8.87 38.72 40.39 -9.52 40.07 38.79 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo -10.84 34.98 43.59 -11.99 36.29 42.41 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1dup_c00 source 1dup DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLA: 4 hits 1dup_c00 naa= 2 ULMN 2 1dve_c01 HEME OXYGENASE-1 user 1 2 # 1 A 140 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 144 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 50.80 17.38-128.07 52.55 18.37-127.41 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 48.41 20.84-131.50 47.60 20.71-131.72 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1dve_c01 HEME OXYGENASE-1 user 2 2 # 2 A 140 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 144 GLY A 77 GLY^? 7.89 O1 EDO A 125 coo 50.80 17.38-128.07 52.55 18.37-127.41 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 48.41 20.84-131.50 47.60 20.71-131.72 -28.29 -45.93 -31.97 -28.42 -45.22 -32.28 ULMN 2 1dve_c01 HEME OXYGENASE-1 user 3 2 # 3 A 140 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 144 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 50.80 17.38-128.07 52.55 18.37-127.41 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 48.41 20.84-131.50 47.60 20.71-131.72 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1dve_c01 HEME OXYGENASE-1 user 4 2 # 4 A 140 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 144 GLY B 77 GLY^? 22.66 C1 EDO A 124 coo 50.80 17.38-128.07 52.55 18.37-127.41 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 48.41 20.84-131.50 47.60 20.71-131.72 -43.26 -37.30 -11.50 -42.54 -37.05 -11.23 1dve_c01 source 1dve HEME OXYGENASE-1 : 4 hits 1dve_c01 naa= 2 ULMN 2 1dw9_c00 CYANATE LYASE user 1 2 # 1 A 99 GLU A 23 GLU.? 13.04 O2 EDO A 125 F 96 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -18.15 16.27 32.38 -18.04 15.42 34.32 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -16.38 12.12 38.65 -17.03 14.40 36.67 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1dw9_c00 CYANATE LYASE user 2 2 # 2 A 99 GLU A 43 GLU.? 14.35 O2 EDO A 124 F 96 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -18.15 16.27 32.38 -18.04 15.42 34.32 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -16.38 12.12 38.65 -17.03 14.40 36.67 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1dw9_c00 CYANATE LYASE user 3 2 # 3 A 99 GLU A 59 GLU.? 11.26 O1 EDO A 125 F 96 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -18.15 16.27 32.38 -18.04 15.42 34.32 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -16.38 12.12 38.65 -17.03 14.40 36.67 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1dw9_c00 CYANATE LYASE user 4 2 # 4 A 99 GLU A 59 GLU.? 11.26 O1 EDO A 125 F 96 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo -18.15 16.27 32.38 -18.04 15.42 34.32 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -16.38 12.12 38.65 -17.03 14.40 36.67 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1dw9_c00 CYANATE LYASE user 5 2 # 5 A 99 GLU B 23 GLU.? 12.57 O2 EDO A 125 F 96 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -18.15 16.27 32.38 -18.04 15.42 34.32 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -16.38 12.12 38.65 -17.03 14.40 36.67 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1dw9_c00 CYANATE LYASE user 6 2 # 6 A 99 GLU B 43 GLU.? 19.28 O2 EDO A 125 F 96 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -18.15 16.27 32.38 -18.04 15.42 34.32 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -16.38 12.12 38.65 -17.03 14.40 36.67 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1dw9_c00 CYANATE LYASE user 7 2 # 7 A 99 GLU B 59 GLU.? 24.69 C1 EDO A 124 F 96 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo -18.15 16.27 32.38 -18.04 15.42 34.32 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -16.38 12.12 38.65 -17.03 14.40 36.67 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1dw9_c00 source 1dw9 CYANATE LYASE : 7 hits 1dw9_c00 naa= 2 ULMN 2 1dw9_c01 CYANATE LYASE user 1 2 # 1 B 96 ARG A 25 ARG.? 17.39 O2 EDO A 124 G 99 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -21.00 -10.04 38.88 -20.40 -12.38 36.91 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo -19.35 -14.32 32.66 -19.46 -13.42 34.59 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1dw9_c01 CYANATE LYASE user 2 2 # 2 B 96 ARG A 25 ARG.? 17.39 O2 EDO A 124 G 99 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -21.00 -10.04 38.88 -20.40 -12.38 36.91 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo -19.35 -14.32 32.66 -19.46 -13.42 34.59 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1dw9_c01 CYANATE LYASE user 3 2 # 3 B 96 ARG A 53 ARG~? 17.45 O1 EDO A 125 G 99 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -21.00 -10.04 38.88 -20.40 -12.38 36.91 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo -19.35 -14.32 32.66 -19.46 -13.42 34.59 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1dw9_c01 CYANATE LYASE user 4 2 # 4 B 96 ARG A 106 ARG.? 12.91 O2 EDO A 125 G 99 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -21.00 -10.04 38.88 -20.40 -12.38 36.91 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo -19.35 -14.32 32.66 -19.46 -13.42 34.59 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1dw9_c01 CYANATE LYASE user 5 2 # 5 B 96 ARG B 25 ARG.? 18.77 O2 EDO A 125 G 99 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -21.00 -10.04 38.88 -20.40 -12.38 36.91 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo -19.35 -14.32 32.66 -19.46 -13.42 34.59 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1dw9_c01 CYANATE LYASE user 6 2 # 6 B 96 ARG B 25 ARG.? 18.77 O2 EDO A 125 G 99 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -21.00 -10.04 38.88 -20.40 -12.38 36.91 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo -19.35 -14.32 32.66 -19.46 -13.42 34.59 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1dw9_c01 CYANATE LYASE user 7 2 # 7 B 96 ARG B 53 ARG~? 17.71 C1 EDO A 124 G 99 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -21.00 -10.04 38.88 -20.40 -12.38 36.91 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo -19.35 -14.32 32.66 -19.46 -13.42 34.59 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 1dw9_c01 source 1dw9 CYANATE LYASE : 7 hits 1dw9_c01 naa= 2 ULMN 2 1dw9_c02 CYANATE LYASE user 1 2 # 1 B 99 GLU A 23 GLU.? 13.04 O2 EDO A 125 G 96 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -24.88 -6.19 37.18 -25.14 -8.31 37.00 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -24.24 -13.76 35.70 -24.73 -11.01 36.97 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1dw9_c02 CYANATE LYASE user 2 2 # 2 B 99 GLU A 43 GLU.? 14.35 O2 EDO A 124 G 96 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -24.88 -6.19 37.18 -25.14 -8.31 37.00 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -24.24 -13.76 35.70 -24.73 -11.01 36.97 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1dw9_c02 CYANATE LYASE user 3 2 # 3 B 99 GLU A 59 GLU.? 11.26 O1 EDO A 125 G 96 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -24.88 -6.19 37.18 -25.14 -8.31 37.00 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -24.24 -13.76 35.70 -24.73 -11.01 36.97 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1dw9_c02 CYANATE LYASE user 4 2 # 4 B 99 GLU A 59 GLU.? 11.26 O1 EDO A 125 G 96 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo -24.88 -6.19 37.18 -25.14 -8.31 37.00 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -24.24 -13.76 35.70 -24.73 -11.01 36.97 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1dw9_c02 CYANATE LYASE user 5 2 # 5 B 99 GLU B 23 GLU.? 12.57 O2 EDO A 125 G 96 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -24.88 -6.19 37.18 -25.14 -8.31 37.00 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -24.24 -13.76 35.70 -24.73 -11.01 36.97 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1dw9_c02 CYANATE LYASE user 6 2 # 6 B 99 GLU B 43 GLU.? 19.28 O2 EDO A 125 G 96 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -24.88 -6.19 37.18 -25.14 -8.31 37.00 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -24.24 -13.76 35.70 -24.73 -11.01 36.97 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1dw9_c02 CYANATE LYASE user 7 2 # 7 B 99 GLU B 59 GLU.? 24.69 C1 EDO A 124 G 96 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo -24.88 -6.19 37.18 -25.14 -8.31 37.00 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -24.24 -13.76 35.70 -24.73 -11.01 36.97 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1dw9_c02 source 1dw9 CYANATE LYASE : 7 hits 1dw9_c02 naa= 2 ULMN 2 1dw9_c03 CYANATE LYASE user 1 2 # 1 C 99 GLU A 23 GLU.? 13.04 O2 EDO A 125 E 96 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -20.36 -17.29 8.77 -21.11 -18.70 10.17 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -24.30 -21.14 14.16 -22.82 -20.30 11.65 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1dw9_c03 CYANATE LYASE user 2 2 # 2 C 99 GLU A 43 GLU.? 14.35 O2 EDO A 124 E 96 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -20.36 -17.29 8.77 -21.11 -18.70 10.17 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -24.30 -21.14 14.16 -22.82 -20.30 11.65 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1dw9_c03 CYANATE LYASE user 3 2 # 3 C 99 GLU A 59 GLU.? 11.26 O1 EDO A 125 E 96 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -20.36 -17.29 8.77 -21.11 -18.70 10.17 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -24.30 -21.14 14.16 -22.82 -20.30 11.65 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1dw9_c03 CYANATE LYASE user 4 2 # 4 C 99 GLU A 59 GLU.? 11.26 O1 EDO A 125 E 96 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo -20.36 -17.29 8.77 -21.11 -18.70 10.17 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -24.30 -21.14 14.16 -22.82 -20.30 11.65 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1dw9_c03 CYANATE LYASE user 5 2 # 5 C 99 GLU B 23 GLU.? 12.57 O2 EDO A 125 E 96 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -20.36 -17.29 8.77 -21.11 -18.70 10.17 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -24.30 -21.14 14.16 -22.82 -20.30 11.65 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1dw9_c03 CYANATE LYASE user 6 2 # 6 C 99 GLU B 43 GLU.? 19.28 O2 EDO A 125 E 96 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -20.36 -17.29 8.77 -21.11 -18.70 10.17 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -24.30 -21.14 14.16 -22.82 -20.30 11.65 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1dw9_c03 CYANATE LYASE user 7 2 # 7 C 99 GLU B 59 GLU.? 24.69 C1 EDO A 124 E 96 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo -20.36 -17.29 8.77 -21.11 -18.70 10.17 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -24.30 -21.14 14.16 -22.82 -20.30 11.65 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1dw9_c03 source 1dw9 CYANATE LYASE : 7 hits 1dw9_c03 naa= 2 ULMN 2 1dw9_c04 CYANATE LYASE user 1 2 # 1 D 96 ARG A 25 ARG.? 17.39 O2 EDO A 124 I 99 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -13.55 23.07 13.84 -15.10 22.15 11.37 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo -17.67 19.16 8.58 -16.84 20.55 9.92 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1dw9_c04 CYANATE LYASE user 2 2 # 2 D 96 ARG A 25 ARG.? 17.39 O2 EDO A 124 I 99 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -13.55 23.07 13.84 -15.10 22.15 11.37 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo -17.67 19.16 8.58 -16.84 20.55 9.92 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1dw9_c04 CYANATE LYASE user 3 2 # 3 D 96 ARG A 53 ARG~? 17.45 O1 EDO A 125 I 99 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -13.55 23.07 13.84 -15.10 22.15 11.37 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo -17.67 19.16 8.58 -16.84 20.55 9.92 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1dw9_c04 CYANATE LYASE user 4 2 # 4 D 96 ARG A 106 ARG.? 12.91 O2 EDO A 125 I 99 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -13.55 23.07 13.84 -15.10 22.15 11.37 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo -17.67 19.16 8.58 -16.84 20.55 9.92 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1dw9_c04 CYANATE LYASE user 5 2 # 5 D 96 ARG B 25 ARG.? 18.77 O2 EDO A 125 I 99 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -13.55 23.07 13.84 -15.10 22.15 11.37 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo -17.67 19.16 8.58 -16.84 20.55 9.92 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1dw9_c04 CYANATE LYASE user 6 2 # 6 D 96 ARG B 25 ARG.? 18.77 O2 EDO A 125 I 99 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -13.55 23.07 13.84 -15.10 22.15 11.37 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo -17.67 19.16 8.58 -16.84 20.55 9.92 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1dw9_c04 CYANATE LYASE user 7 2 # 7 D 96 ARG B 53 ARG~? 17.71 C1 EDO A 124 I 99 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -13.55 23.07 13.84 -15.10 22.15 11.37 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo -17.67 19.16 8.58 -16.84 20.55 9.92 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 1dw9_c04 source 1dw9 CYANATE LYASE : 7 hits 1dw9_c04 naa= 2 ULMN 2 1dw9_c05 CYANATE LYASE user 1 2 # 1 D 99 GLU A 23 GLU.? 13.04 O2 EDO A 125 I 96 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -9.50 19.20 15.72 -9.80 19.81 13.72 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -12.12 20.77 8.60 -10.73 20.87 11.34 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1dw9_c05 CYANATE LYASE user 2 2 # 2 D 99 GLU A 43 GLU.? 14.35 O2 EDO A 124 I 96 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -9.50 19.20 15.72 -9.80 19.81 13.72 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -12.12 20.77 8.60 -10.73 20.87 11.34 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1dw9_c05 CYANATE LYASE user 3 2 # 3 D 99 GLU A 59 GLU.? 11.26 O1 EDO A 125 I 96 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -9.50 19.20 15.72 -9.80 19.81 13.72 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -12.12 20.77 8.60 -10.73 20.87 11.34 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1dw9_c05 CYANATE LYASE user 4 2 # 4 D 99 GLU A 59 GLU.? 11.26 O1 EDO A 125 I 96 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo -9.50 19.20 15.72 -9.80 19.81 13.72 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -12.12 20.77 8.60 -10.73 20.87 11.34 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1dw9_c05 CYANATE LYASE user 5 2 # 5 D 99 GLU B 23 GLU.? 12.57 O2 EDO A 125 I 96 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -9.50 19.20 15.72 -9.80 19.81 13.72 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -12.12 20.77 8.60 -10.73 20.87 11.34 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1dw9_c05 CYANATE LYASE user 6 2 # 6 D 99 GLU B 43 GLU.? 19.28 O2 EDO A 125 I 96 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -9.50 19.20 15.72 -9.80 19.81 13.72 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -12.12 20.77 8.60 -10.73 20.87 11.34 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1dw9_c05 CYANATE LYASE user 7 2 # 7 D 99 GLU B 59 GLU.? 24.69 C1 EDO A 124 I 96 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo -9.50 19.20 15.72 -9.80 19.81 13.72 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -12.12 20.77 8.60 -10.73 20.87 11.34 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1dw9_c05 source 1dw9 CYANATE LYASE : 7 hits 1dw9_c05 naa= 2 ULMN 2 1dw9_c06 CYANATE LYASE user 1 2 # 1 H 99 GLU A 23 GLU.? 13.04 O2 EDO A 125 J 96 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -23.85 -1.67 -1.43 -23.09 -0.05 -2.54 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -19.46 3.79 -4.44 -21.42 1.50 -4.05 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1dw9_c06 CYANATE LYASE user 2 2 # 2 H 99 GLU A 43 GLU.? 14.35 O2 EDO A 124 J 96 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -23.85 -1.67 -1.43 -23.09 -0.05 -2.54 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -19.46 3.79 -4.44 -21.42 1.50 -4.05 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1dw9_c06 CYANATE LYASE user 3 2 # 3 H 99 GLU A 59 GLU.? 11.26 O1 EDO A 125 J 96 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -23.85 -1.67 -1.43 -23.09 -0.05 -2.54 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -19.46 3.79 -4.44 -21.42 1.50 -4.05 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1dw9_c06 CYANATE LYASE user 4 2 # 4 H 99 GLU A 59 GLU.? 11.26 O1 EDO A 125 J 96 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo -23.85 -1.67 -1.43 -23.09 -0.05 -2.54 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -19.46 3.79 -4.44 -21.42 1.50 -4.05 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1dw9_c06 CYANATE LYASE user 5 2 # 5 H 99 GLU B 23 GLU.? 12.57 O2 EDO A 125 J 96 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -23.85 -1.67 -1.43 -23.09 -0.05 -2.54 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -19.46 3.79 -4.44 -21.42 1.50 -4.05 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1dw9_c06 CYANATE LYASE user 6 2 # 6 H 99 GLU B 43 GLU.? 19.28 O2 EDO A 125 J 96 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -23.85 -1.67 -1.43 -23.09 -0.05 -2.54 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -19.46 3.79 -4.44 -21.42 1.50 -4.05 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1dw9_c06 CYANATE LYASE user 7 2 # 7 H 99 GLU B 59 GLU.? 24.69 C1 EDO A 124 J 96 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo -23.85 -1.67 -1.43 -23.09 -0.05 -2.54 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -19.46 3.79 -4.44 -21.42 1.50 -4.05 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1dw9_c06 source 1dw9 CYANATE LYASE : 7 hits 1dw9_c06 naa= 2 ULMN 2 1dw9_c07 CYANATE LYASE user 1 2 # 1 H 96 ARG A 25 ARG.? 17.39 O2 EDO A 124 J 99 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -18.96 -2.03 -4.48 -16.97 0.27 -4.13 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo -14.45 3.47 -1.63 -15.24 1.91 -2.68 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1dw9_c07 CYANATE LYASE user 2 2 # 2 H 96 ARG A 25 ARG.? 17.39 O2 EDO A 124 J 99 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -18.96 -2.03 -4.48 -16.97 0.27 -4.13 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo -14.45 3.47 -1.63 -15.24 1.91 -2.68 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1dw9_c07 CYANATE LYASE user 3 2 # 3 H 96 ARG A 53 ARG~? 17.45 O1 EDO A 125 J 99 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -18.96 -2.03 -4.48 -16.97 0.27 -4.13 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo -14.45 3.47 -1.63 -15.24 1.91 -2.68 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1dw9_c07 CYANATE LYASE user 4 2 # 4 H 96 ARG A 106 ARG.? 12.91 O2 EDO A 125 J 99 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -18.96 -2.03 -4.48 -16.97 0.27 -4.13 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo -14.45 3.47 -1.63 -15.24 1.91 -2.68 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1dw9_c07 CYANATE LYASE user 5 2 # 5 H 96 ARG B 25 ARG.? 18.77 O2 EDO A 125 J 99 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -18.96 -2.03 -4.48 -16.97 0.27 -4.13 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo -14.45 3.47 -1.63 -15.24 1.91 -2.68 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1dw9_c07 CYANATE LYASE user 6 2 # 6 H 96 ARG B 25 ARG.? 18.77 O2 EDO A 125 J 99 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -18.96 -2.03 -4.48 -16.97 0.27 -4.13 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo -14.45 3.47 -1.63 -15.24 1.91 -2.68 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1dw9_c07 CYANATE LYASE user 7 2 # 7 H 96 ARG B 53 ARG~? 17.71 C1 EDO A 124 J 99 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -18.96 -2.03 -4.48 -16.97 0.27 -4.13 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo -14.45 3.47 -1.63 -15.24 1.91 -2.68 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 1dw9_c07 source 1dw9 CYANATE LYASE : 7 hits 1dw9_c07 naa= 2 ULMN 2 1dw9_c08 CYANATE LYASE user 1 2 # 1 A 96 ARG A 25 ARG.? 17.39 O2 EDO A 124 F 99 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -13.18 15.76 35.37 -12.72 12.99 36.60 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo -12.53 8.23 36.79 -12.25 10.29 36.64 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1dw9_c08 CYANATE LYASE user 2 2 # 2 A 96 ARG A 25 ARG.? 17.39 O2 EDO A 124 F 99 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -13.18 15.76 35.37 -12.72 12.99 36.60 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo -12.53 8.23 36.79 -12.25 10.29 36.64 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1dw9_c08 CYANATE LYASE user 3 2 # 3 A 96 ARG A 53 ARG~? 17.45 O1 EDO A 125 F 99 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -13.18 15.76 35.37 -12.72 12.99 36.60 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo -12.53 8.23 36.79 -12.25 10.29 36.64 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1dw9_c08 CYANATE LYASE user 4 2 # 4 A 96 ARG A 106 ARG.? 12.91 O2 EDO A 125 F 99 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -13.18 15.76 35.37 -12.72 12.99 36.60 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo -12.53 8.23 36.79 -12.25 10.29 36.64 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1dw9_c08 CYANATE LYASE user 5 2 # 5 A 96 ARG B 25 ARG.? 18.77 O2 EDO A 125 F 99 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -13.18 15.76 35.37 -12.72 12.99 36.60 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo -12.53 8.23 36.79 -12.25 10.29 36.64 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1dw9_c08 CYANATE LYASE user 6 2 # 6 A 96 ARG B 25 ARG.? 18.77 O2 EDO A 125 F 99 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -13.18 15.76 35.37 -12.72 12.99 36.60 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo -12.53 8.23 36.79 -12.25 10.29 36.64 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1dw9_c08 CYANATE LYASE user 7 2 # 7 A 96 ARG B 53 ARG~? 17.71 C1 EDO A 124 F 99 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -13.18 15.76 35.37 -12.72 12.99 36.60 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo -12.53 8.23 36.79 -12.25 10.29 36.64 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 1dw9_c08 source 1dw9 CYANATE LYASE : 7 hits 1dw9_c08 naa= 2 ULMN 2 1dzr_c00 DTDP-4-DEHYDRORHAMNOSE 3,5-EPIMERASEuser 1 2 # 1 A 63 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 170 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 15.71 28.59 15.06 17.72 28.78 14.48 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 20.28 28.76 10.15 19.81 28.84 12.25 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1dzr_c00 DTDP-4-DEHYDRORHAMNOSE 3,5-EPIMERASEuser 2 2 # 2 A 63 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 170 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 15.71 28.59 15.06 17.72 28.78 14.48 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 20.28 28.76 10.15 19.81 28.84 12.25 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1dzr_c00 DTDP-4-DEHYDRORHAMNOSE 3,5-EPIMERASEuser 3 2 # 3 A 63 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 170 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 15.71 28.59 15.06 17.72 28.78 14.48 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 20.28 28.76 10.15 19.81 28.84 12.25 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1dzr_c00 DTDP-4-DEHYDRORHAMNOSE 3,5-EPIMERASEuser 4 2 # 4 A 63 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 170 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 15.71 28.59 15.06 17.72 28.78 14.48 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 20.28 28.76 10.15 19.81 28.84 12.25 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1dzr_c00 source 1dzr DTDP-4-DEHYDRORHAMNOSE 3,5-EPIMERASE : 4 hits 1dzr_c00 naa= 2 ULMN 2 1dzr_c01 DTDP-4-DEHYDRORHAMNOSE 3,5-EPIMERASEuser 1 2 # 1 B 63 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 170 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 18.73 49.99 47.33 19.36 51.78 46.42 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 22.03 55.92 47.90 20.85 54.48 46.92 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1dzr_c01 DTDP-4-DEHYDRORHAMNOSE 3,5-EPIMERASEuser 2 2 # 2 B 63 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 170 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 18.73 49.99 47.33 19.36 51.78 46.42 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 22.03 55.92 47.90 20.85 54.48 46.92 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1dzr_c01 DTDP-4-DEHYDRORHAMNOSE 3,5-EPIMERASEuser 3 2 # 3 B 63 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 170 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 18.73 49.99 47.33 19.36 51.78 46.42 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 22.03 55.92 47.90 20.85 54.48 46.92 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1dzr_c01 DTDP-4-DEHYDRORHAMNOSE 3,5-EPIMERASEuser 4 2 # 4 B 63 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 170 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 18.73 49.99 47.33 19.36 51.78 46.42 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 22.03 55.92 47.90 20.85 54.48 46.92 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1dzr_c01 source 1dzr DTDP-4-DEHYDRORHAMNOSE 3,5-EPIMERASE : 4 hits 1dzr_c01 naa= 2 ULMN 2 1e1a_c00 DIISOPROPYLFLUOROPHOSPHATASE user 1 2 # 1 A 37 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 287 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo -0.12 -1.99 23.42 -0.66 -3.31 21.87 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 2.10 -8.19 20.43 3.55 -6.67 20.40 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1e1a_c00 DIISOPROPYLFLUOROPHOSPHATASE user 2 2 # 2 A 37 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 287 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo -0.12 -1.99 23.42 -0.66 -3.31 21.87 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 2.10 -8.19 20.43 3.55 -6.67 20.40 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1e1a_c00 DIISOPROPYLFLUOROPHOSPHATASE user 3 2 # 3 A 37 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 287 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo -0.12 -1.99 23.42 -0.66 -3.31 21.87 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 2.10 -8.19 20.43 3.55 -6.67 20.40 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 ULMN 2 1e1a_c00 DIISOPROPYLFLUOROPHOSPHATASE user 4 2 # 4 A 37 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 287 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo -0.12 -1.99 23.42 -0.66 -3.31 21.87 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 2.10 -8.19 20.43 3.55 -6.67 20.40 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1e1a_c00 source 1e1a DIISOPROPYLFLUOROPHOSPHATASE : 4 hits 1e1a_c00 naa= 2 ULMN 2 1eb6_c01 NEUTRAL PROTEASE II user 1 2 # 1 A 129 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 146 TYR A 76 TYR.? 12.73 O1 EDO A 125 coo 10.94 7.38 49.06 9.46 8.67 48.23 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 5.52 7.95 39.13 5.05 9.43 41.44 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 ULMN 2 1eb6_c01 NEUTRAL PROTEASE II user 2 2 # 2 A 129 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 146 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 10.94 7.38 49.06 9.46 8.67 48.23 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 5.52 7.95 39.13 5.05 9.43 41.44 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1eb6_c01 NEUTRAL PROTEASE II user 3 2 # 3 A 129 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 146 TYR B 76 TYR.? 17.92 O2 EDO A 125 coo 10.94 7.38 49.06 9.46 8.67 48.23 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 5.52 7.95 39.13 5.05 9.43 41.44 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 ULMN 2 1eb6_c01 NEUTRAL PROTEASE II user 4 2 # 4 A 129 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 146 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo 10.94 7.38 49.06 9.46 8.67 48.23 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 5.52 7.95 39.13 5.05 9.43 41.44 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 1eb6_c01 source 1eb6 NEUTRAL PROTEASE II : 4 hits 1eb6_c01 naa= 2 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 1 2 # 1 A 28 ARG A 30 ARG^? -2.97 O2 EDO A 124s B 11 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 30.98 29.88 30.84 29.10 29.68 28.40 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 30.95 31.29 19.13 28.16 32.11 18.14 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 2 2 # 2 A 28 ARG A 30 ARG^? -2.97 O2 EDO A 124s B 11 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 30.98 29.88 30.84 29.10 29.68 28.40 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 30.95 31.29 19.13 28.16 32.11 18.14 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 3 2 # 3 A 28 ARG A 33 ARG.? 17.39 O2 EDO A 124 B 11 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 30.98 29.88 30.84 29.10 29.68 28.40 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 30.95 31.29 19.13 28.16 32.11 18.14 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 4 2 # 4 A 28 ARG A 33 ARG.? 17.39 O2 EDO A 124 B 11 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 30.98 29.88 30.84 29.10 29.68 28.40 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 30.95 31.29 19.13 28.16 32.11 18.14 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 5 2 # 5 A 28 ARG A 33 ARG.? 17.39 O2 EDO A 124 B 11 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 30.98 29.88 30.84 29.10 29.68 28.40 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 30.95 31.29 19.13 28.16 32.11 18.14 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 6 2 # 6 A 28 ARG A 37 ARG^? 13.77 O1 EDO A 124 B 11 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 30.98 29.88 30.84 29.10 29.68 28.40 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 30.95 31.29 19.13 28.16 32.11 18.14 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 7 2 # 7 A 28 ARG A 37 ARG^? 13.77 O1 EDO A 124 B 11 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 30.98 29.88 30.84 29.10 29.68 28.40 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 30.95 31.29 19.13 28.16 32.11 18.14 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 8 2 # 8 A 28 ARG A 37 ARG^? 13.77 O1 EDO A 124 B 11 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 30.98 29.88 30.84 29.10 29.68 28.40 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 30.95 31.29 19.13 28.16 32.11 18.14 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 9 2 # 9 A 28 ARG A 53 ARG~? 17.45 O1 EDO A 125 B 11 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 30.98 29.88 30.84 29.10 29.68 28.40 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 30.95 31.29 19.13 28.16 32.11 18.14 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 10 2 # 10 A 28 ARG A 53 ARG~? 17.45 O1 EDO A 125 B 11 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 30.98 29.88 30.84 29.10 29.68 28.40 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 30.95 31.29 19.13 28.16 32.11 18.14 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 11 2 # 11 A 28 ARG A 53 ARG~? 17.45 O1 EDO A 125 B 11 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo 30.98 29.88 30.84 29.10 29.68 28.40 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 30.95 31.29 19.13 28.16 32.11 18.14 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 12 2 # 12 A 28 ARG A 106 ARG.? 12.91 O2 EDO A 125 B 11 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 30.98 29.88 30.84 29.10 29.68 28.40 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo 30.95 31.29 19.13 28.16 32.11 18.14 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 13 2 # 13 A 28 ARG B 30 ARG^? 10.56 O1 EDO A 124 B 11 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 30.98 29.88 30.84 29.10 29.68 28.40 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 30.95 31.29 19.13 28.16 32.11 18.14 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 14 2 # 14 A 28 ARG B 30 ARG^? 10.56 O1 EDO A 124 B 11 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 30.98 29.88 30.84 29.10 29.68 28.40 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 30.95 31.29 19.13 28.16 32.11 18.14 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 15 2 # 15 A 28 ARG B 33 ARG.? 19.94 O1 EDO A 124 B 11 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 30.98 29.88 30.84 29.10 29.68 28.40 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 30.95 31.29 19.13 28.16 32.11 18.14 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 16 2 # 16 A 28 ARG B 33 ARG.? 19.94 O1 EDO A 124 B 11 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 30.98 29.88 30.84 29.10 29.68 28.40 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 30.95 31.29 19.13 28.16 32.11 18.14 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 17 2 # 17 A 28 ARG B 33 ARG.? 19.94 O1 EDO A 124 B 11 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 30.98 29.88 30.84 29.10 29.68 28.40 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 30.95 31.29 19.13 28.16 32.11 18.14 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 18 2 # 18 A 28 ARG B 37 ARG^? 8.36 C1 EDO A 124 B 11 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 30.98 29.88 30.84 29.10 29.68 28.40 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 30.95 31.29 19.13 28.16 32.11 18.14 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 19 2 # 19 A 28 ARG B 37 ARG^? 8.36 C1 EDO A 124 B 11 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 30.98 29.88 30.84 29.10 29.68 28.40 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 30.95 31.29 19.13 28.16 32.11 18.14 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 20 2 # 20 A 28 ARG B 37 ARG^? 8.36 C1 EDO A 124 B 11 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 30.98 29.88 30.84 29.10 29.68 28.40 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 30.95 31.29 19.13 28.16 32.11 18.14 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 21 2 # 21 A 28 ARG B 53 ARG~? 17.71 C1 EDO A 124 B 11 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 30.98 29.88 30.84 29.10 29.68 28.40 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 30.95 31.29 19.13 28.16 32.11 18.14 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1ecm_c00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 22 2 # 22 A 28 ARG B 53 ARG~? 17.71 C1 EDO A 124 B 11 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 30.98 29.88 30.84 29.10 29.68 28.40 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 30.95 31.29 19.13 28.16 32.11 18.14 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 1ecm_c00 source 1ecm ENDO-OXABICYCLIC TRANSITION STATE ANALOGUE : 22 hits 1ecm_c00 naa= 2 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 1 2 # 1 A 11 ARG A 30 ARG^? -2.97 O2 EDO A 124s B 28 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 32.63 17.54 55.00 30.02 17.07 56.50 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 31.11 19.53 43.50 29.63 19.98 46.20 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 2 2 # 2 A 11 ARG A 30 ARG^? -2.97 O2 EDO A 124s B 28 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 32.63 17.54 55.00 30.02 17.07 56.50 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 31.11 19.53 43.50 29.63 19.98 46.20 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 3 2 # 3 A 11 ARG A 33 ARG.? 17.39 O2 EDO A 124 B 28 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 32.63 17.54 55.00 30.02 17.07 56.50 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 31.11 19.53 43.50 29.63 19.98 46.20 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 4 2 # 4 A 11 ARG A 33 ARG.? 17.39 O2 EDO A 124 B 28 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 32.63 17.54 55.00 30.02 17.07 56.50 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 31.11 19.53 43.50 29.63 19.98 46.20 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 5 2 # 5 A 11 ARG A 33 ARG.? 17.39 O2 EDO A 124 B 28 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 32.63 17.54 55.00 30.02 17.07 56.50 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 31.11 19.53 43.50 29.63 19.98 46.20 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 6 2 # 6 A 11 ARG A 37 ARG^? 13.77 O1 EDO A 124 B 28 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 32.63 17.54 55.00 30.02 17.07 56.50 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 31.11 19.53 43.50 29.63 19.98 46.20 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 7 2 # 7 A 11 ARG A 37 ARG^? 13.77 O1 EDO A 124 B 28 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 32.63 17.54 55.00 30.02 17.07 56.50 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 31.11 19.53 43.50 29.63 19.98 46.20 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 8 2 # 8 A 11 ARG A 37 ARG^? 13.77 O1 EDO A 124 B 28 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 32.63 17.54 55.00 30.02 17.07 56.50 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 31.11 19.53 43.50 29.63 19.98 46.20 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 9 2 # 9 A 11 ARG A 53 ARG~? 17.45 O1 EDO A 125 B 28 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 32.63 17.54 55.00 30.02 17.07 56.50 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 31.11 19.53 43.50 29.63 19.98 46.20 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 10 2 # 10 A 11 ARG A 53 ARG~? 17.45 O1 EDO A 125 B 28 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 32.63 17.54 55.00 30.02 17.07 56.50 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 31.11 19.53 43.50 29.63 19.98 46.20 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 11 2 # 11 A 11 ARG A 53 ARG~? 17.45 O1 EDO A 125 B 28 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo 32.63 17.54 55.00 30.02 17.07 56.50 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 31.11 19.53 43.50 29.63 19.98 46.20 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 12 2 # 12 A 11 ARG A 106 ARG.? 12.91 O2 EDO A 125 B 28 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 32.63 17.54 55.00 30.02 17.07 56.50 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo 31.11 19.53 43.50 29.63 19.98 46.20 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 13 2 # 13 A 11 ARG B 30 ARG^? 10.56 O1 EDO A 124 B 28 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 32.63 17.54 55.00 30.02 17.07 56.50 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 31.11 19.53 43.50 29.63 19.98 46.20 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 14 2 # 14 A 11 ARG B 30 ARG^? 10.56 O1 EDO A 124 B 28 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 32.63 17.54 55.00 30.02 17.07 56.50 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 31.11 19.53 43.50 29.63 19.98 46.20 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 15 2 # 15 A 11 ARG B 33 ARG.? 19.94 O1 EDO A 124 B 28 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 32.63 17.54 55.00 30.02 17.07 56.50 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 31.11 19.53 43.50 29.63 19.98 46.20 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 16 2 # 16 A 11 ARG B 33 ARG.? 19.94 O1 EDO A 124 B 28 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 32.63 17.54 55.00 30.02 17.07 56.50 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 31.11 19.53 43.50 29.63 19.98 46.20 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 17 2 # 17 A 11 ARG B 33 ARG.? 19.94 O1 EDO A 124 B 28 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 32.63 17.54 55.00 30.02 17.07 56.50 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 31.11 19.53 43.50 29.63 19.98 46.20 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 18 2 # 18 A 11 ARG B 37 ARG^? 8.36 C1 EDO A 124 B 28 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 32.63 17.54 55.00 30.02 17.07 56.50 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 31.11 19.53 43.50 29.63 19.98 46.20 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 19 2 # 19 A 11 ARG B 37 ARG^? 8.36 C1 EDO A 124 B 28 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 32.63 17.54 55.00 30.02 17.07 56.50 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 31.11 19.53 43.50 29.63 19.98 46.20 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 20 2 # 20 A 11 ARG B 37 ARG^? 8.36 C1 EDO A 124 B 28 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 32.63 17.54 55.00 30.02 17.07 56.50 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 31.11 19.53 43.50 29.63 19.98 46.20 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 21 2 # 21 A 11 ARG B 53 ARG~? 17.71 C1 EDO A 124 B 28 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 32.63 17.54 55.00 30.02 17.07 56.50 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 31.11 19.53 43.50 29.63 19.98 46.20 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1ecm_c01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 22 2 # 22 A 11 ARG B 53 ARG~? 17.71 C1 EDO A 124 B 28 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 32.63 17.54 55.00 30.02 17.07 56.50 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 31.11 19.53 43.50 29.63 19.98 46.20 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 1ecm_c01 source 1ecm ENDO-OXABICYCLIC TRANSITION STATE ANALOGUE : 22 hits 1ecm_c01 naa= 2 ULMN 2 1ef8_c03 METHYLMALONYL COA DECARBOXYLASE user 1 2 # 1 A 113 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 133 PRO A 24 PRO.? 13.79 O2 EDO A 125 coo 17.89 4.28 6.66 17.21 3.76 4.71 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 25.19 8.51 2.90 27.26 7.49 2.69 -37.37 -41.75 -27.30 -38.43 -41.33 -29.23 ULMN 2 1ef8_c03 METHYLMALONYL COA DECARBOXYLASE user 2 2 # 2 A 113 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 133 PRO A 51 PRO~? 12.56 O2 EDO A 125 coo 17.89 4.28 6.66 17.21 3.76 4.71 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 25.19 8.51 2.90 27.26 7.49 2.69 -22.81 -39.07 -17.47 -22.64 -38.62 -19.64 ULMN 2 1ef8_c03 METHYLMALONYL COA DECARBOXYLASE user 3 2 # 3 A 113 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 133 PRO A 52 PRO~? 11.69 O1 EDO A 125 coo 17.89 4.28 6.66 17.21 3.76 4.71 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 25.19 8.51 2.90 27.26 7.49 2.69 -19.24 -39.24 -23.00 -20.61 -40.50 -21.76 ULMN 2 1ef8_c03 METHYLMALONYL COA DECARBOXYLASE user 4 2 # 4 A 113 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 133 PRO B 24 PRO.? 11.94 O2 EDO A 125 coo 17.89 4.28 6.66 17.21 3.76 4.71 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 25.19 8.51 2.90 27.26 7.49 2.69 -34.76 -42.94 -16.24 -33.94 -43.43 -14.22 ULMN 2 1ef8_c03 METHYLMALONYL COA DECARBOXYLASE user 5 2 # 5 A 113 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 133 PRO B 52 PRO~? 14.52 C1 EDO A 124 coo 17.89 4.28 6.66 17.21 3.76 4.71 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 25.19 8.51 2.90 27.26 7.49 2.69 -42.56 -25.03 -21.82 -42.59 -27.16 -22.47 1ef8_c03 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 5 hits 1ef8_c03 naa= 2 ULMN 2 1ef8_c04 METHYLMALONYL COA DECARBOXYLASE user 1 2 # 1 B 113 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 133 PRO A 24 PRO.? 13.79 O2 EDO A 125 coo 14.64 32.39 9.30 13.61 33.26 7.68 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 9.44 37.34 14.98 10.09 39.37 15.91 -37.37 -41.75 -27.30 -38.43 -41.33 -29.23 ULMN 2 1ef8_c04 METHYLMALONYL COA DECARBOXYLASE user 2 2 # 2 B 113 GLU A 59 GLU.? 11.26 O1 EDO A 125 B 133 PRO A 52 PRO~? 11.69 O1 EDO A 125 coo 14.64 32.39 9.30 13.61 33.26 7.68 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 9.44 37.34 14.98 10.09 39.37 15.91 -19.24 -39.24 -23.00 -20.61 -40.50 -21.76 ULMN 2 1ef8_c04 METHYLMALONYL COA DECARBOXYLASE user 3 2 # 3 B 113 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 133 PRO B 24 PRO.? 11.94 O2 EDO A 125 coo 14.64 32.39 9.30 13.61 33.26 7.68 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 9.44 37.34 14.98 10.09 39.37 15.91 -34.76 -42.94 -16.24 -33.94 -43.43 -14.22 ULMN 2 1ef8_c04 METHYLMALONYL COA DECARBOXYLASE user 4 2 # 4 B 113 GLU B 59 GLU.? 24.69 C1 EDO A 124 B 133 PRO B 52 PRO~? 14.52 C1 EDO A 124 coo 14.64 32.39 9.30 13.61 33.26 7.68 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 9.44 37.34 14.98 10.09 39.37 15.91 -42.56 -25.03 -21.82 -42.59 -27.16 -22.47 1ef8_c04 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 4 hits 1ef8_c04 naa= 2 ULMN 2 1ef8_c05 METHYLMALONYL COA DECARBOXYLASE user 1 2 # 1 C 113 GLU A 43 GLU.? 14.35 O2 EDO A 124 C 133 PRO A 24 PRO.? 13.79 O2 EDO A 125 coo -3.18 14.73 22.76 -5.01 14.47 21.69 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -2.61 5.73 24.31 -3.35 4.61 26.16 -37.37 -41.75 -27.30 -38.43 -41.33 -29.23 ULMN 2 1ef8_c05 METHYLMALONYL COA DECARBOXYLASE user 2 2 # 2 C 113 GLU A 59 GLU.? 11.26 O1 EDO A 125 C 133 PRO A 52 PRO~? 11.69 O1 EDO A 125 coo -3.18 14.73 22.76 -5.01 14.47 21.69 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -2.61 5.73 24.31 -3.35 4.61 26.16 -19.24 -39.24 -23.00 -20.61 -40.50 -21.76 ULMN 2 1ef8_c05 METHYLMALONYL COA DECARBOXYLASE user 3 2 # 3 C 113 GLU B 43 GLU.? 19.28 O2 EDO A 125 C 133 PRO B 24 PRO.? 11.94 O2 EDO A 125 coo -3.18 14.73 22.76 -5.01 14.47 21.69 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -2.61 5.73 24.31 -3.35 4.61 26.16 -34.76 -42.94 -16.24 -33.94 -43.43 -14.22 ULMN 2 1ef8_c05 METHYLMALONYL COA DECARBOXYLASE user 4 2 # 4 C 113 GLU B 59 GLU.? 24.69 C1 EDO A 124 C 133 PRO B 52 PRO~? 14.52 C1 EDO A 124 coo -3.18 14.73 22.76 -5.01 14.47 21.69 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -2.61 5.73 24.31 -3.35 4.61 26.16 -42.56 -25.03 -21.82 -42.59 -27.16 -22.47 1ef8_c05 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 4 hits 1ef8_c05 naa= 2 ULMN 2 1eix_c00 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 2 # 1 A 71 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 73 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 23.19 26.70 106.03 22.83 25.75 107.86 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 27.86 26.05 110.45 22.68 24.67 109.97 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1eix_c00 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 2 2 # 2 A 71 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 73 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 23.19 26.70 106.03 22.83 25.75 107.86 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 27.86 26.05 110.45 22.68 24.67 109.97 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1eix_c00 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 2 hits 1eix_c00 naa= 2 ULMN 2 1eix_c01 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 2 # 1 B 71 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 73 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 38.06 17.61 107.95 37.94 18.87 109.63 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 32.65 18.53 110.98 37.67 20.13 111.67 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1eix_c01 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 2 2 # 2 B 71 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 73 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 38.06 17.61 107.95 37.94 18.87 109.63 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 32.65 18.53 110.98 37.67 20.13 111.67 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1eix_c01 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 2 hits 1eix_c01 naa= 2 ULMN 2 1eix_c02 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 2 # 1 C 71 ASP A 41 ASP^? -2.91 O2 EDO A 124s C 73 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 41.24 46.44 65.36 41.30 47.43 67.22 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 46.67 48.87 67.69 41.63 48.86 69.39 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1eix_c02 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 2 2 # 2 C 71 ASP B 41 ASP^? 12.31 O1 EDO A 124 C 73 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 41.24 46.44 65.36 41.30 47.43 67.22 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 46.67 48.87 67.69 41.63 48.86 69.39 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1eix_c02 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 2 hits 1eix_c02 naa= 2 ULMN 2 1eix_c03 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 2 # 1 D 71 ASP A 41 ASP^? -2.91 O2 EDO A 124s D 73 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 56.16 40.71 72.48 56.48 42.77 72.42 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 51.52 44.76 73.92 56.76 45.26 72.14 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1eix_c03 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 2 2 # 2 D 71 ASP B 41 ASP^? 12.31 O1 EDO A 124 D 73 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 56.16 40.71 72.48 56.48 42.77 72.42 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 51.52 44.76 73.92 56.76 45.26 72.14 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1eix_c03 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 2 hits 1eix_c03 naa= 2 ULMN 2 1els_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 1 2 # 1 242 LYS A 28 LYS^? 7.39 O2 EDO A 124 345 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 99.58 55.20 43.27 102.49 58.24 46.31 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 103.59 43.46 23.85 98.61 47.18 23.58 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 ULMN 2 1els_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 2 2 # 2 242 LYS B 28 LYS^? -17.65 O1 EDO A 124s 345 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 99.58 55.20 43.27 102.49 58.24 46.31 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 103.59 43.46 23.85 98.61 47.18 23.58 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 1els_c03 source 1els ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-GLYCERATE : 2 hits 1els_c03 naa= 2 ULMN 2 1emd_c00 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 1 2 # 1 150 ASP A 86 ASP^? 9.05 O1 EDO A 125 177 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 6.83 2.75 19.17 7.40 0.75 19.11 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1emd_c00 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 2 2 # 2 150 ASP B 86 ASP^? 26.97 C1 EDO A 124 177 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 6.83 2.75 19.17 7.40 0.75 19.11 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1emd_c00 source 1emd MALATE DEHYDROGENASE (E.C.1.1.1.37) : 2 hits 1emd_c00 naa= 2 ULMN 2 1emd_c02 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 1 2 # 1 150 ASP A 63 ASP~? 17.25 O1 EDO A 124 178 SER A 34 SER.? 10.92 O1 EDO A 124 coo 6.83 2.75 19.17 7.40 0.75 19.11 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 9.80 -4.98 22.55 11.39 -5.35 24.35 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 ULMN 2 1emd_c02 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 2 2 # 2 150 ASP A 63 ASP~? 17.25 O1 EDO A 124 178 SER A 35 SER.? 8.67 O1 EDO A 124 coo 6.83 2.75 19.17 7.40 0.75 19.11 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 9.80 -4.98 22.55 11.39 -5.35 24.35 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 ULMN 2 1emd_c02 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 3 2 # 3 150 ASP A 86 ASP^? 9.05 O1 EDO A 125 178 SER A 88 SER^? -5.03 C1 EDO A 125s coo 6.83 2.75 19.17 7.40 0.75 19.11 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 9.80 -4.98 22.55 11.39 -5.35 24.35 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1emd_c02 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 4 2 # 4 150 ASP B 63 ASP~? 17.37 O1 EDO A 124 178 SER B 34 SER.? 9.94 O1 EDO A 124 coo 6.83 2.75 19.17 7.40 0.75 19.11 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 9.80 -4.98 22.55 11.39 -5.35 24.35 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 ULMN 2 1emd_c02 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 5 2 # 5 150 ASP B 63 ASP~? 17.37 O1 EDO A 124 178 SER B 35 SER.? 7.36 O1 EDO A 124 coo 6.83 2.75 19.17 7.40 0.75 19.11 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 9.80 -4.98 22.55 11.39 -5.35 24.35 -33.90 -21.70 -23.70 -33.48 -23.60 -22.25 ULMN 2 1emd_c02 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 6 2 # 6 150 ASP B 86 ASP^? 26.97 C1 EDO A 124 178 SER B 88 SER^? 19.82 O2 EDO A 125 coo 6.83 2.75 19.17 7.40 0.75 19.11 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 9.80 -4.98 22.55 11.39 -5.35 24.35 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 1emd_c02 source 1emd MALATE DEHYDROGENASE (E.C.1.1.1.37) : 6 hits 1emd_c02 naa= 2 ULMN 2 1ex1_c00 BETA-D-GLUCAN EXOHYDROLASE ISOENZYMEuser 1 2 # 1 A 285 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 491 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 28.57 22.90 36.39 26.87 24.09 36.82 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 23.17 29.31 41.02 24.36 29.21 39.27 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1ex1_c00 BETA-D-GLUCAN EXOHYDROLASE ISOENZYMEuser 2 2 # 2 A 285 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 491 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 28.57 22.90 36.39 26.87 24.09 36.82 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 23.17 29.31 41.02 24.36 29.21 39.27 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1ex1_c00 BETA-D-GLUCAN EXOHYDROLASE ISOENZYMEuser 3 2 # 3 A 285 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 491 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 28.57 22.90 36.39 26.87 24.09 36.82 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 23.17 29.31 41.02 24.36 29.21 39.27 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1ex1_c00 BETA-D-GLUCAN EXOHYDROLASE ISOENZYMEuser 4 2 # 4 A 285 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 491 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 28.57 22.90 36.39 26.87 24.09 36.82 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 23.17 29.31 41.02 24.36 29.21 39.27 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1ex1_c00 BETA-D-GLUCAN EXOHYDROLASE ISOENZYMEuser 5 2 # 5 A 285 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 491 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 28.57 22.90 36.39 26.87 24.09 36.82 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 23.17 29.31 41.02 24.36 29.21 39.27 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1ex1_c00 BETA-D-GLUCAN EXOHYDROLASE ISOENZYMEuser 6 2 # 6 A 285 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 491 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 28.57 22.90 36.39 26.87 24.09 36.82 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 23.17 29.31 41.02 24.36 29.21 39.27 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1ex1_c00 source 1ex1 BETA-D-GLUCAN EXOHYDROLASE ISOENZYME EXO1 : 6 hits 1ex1_c00 naa= 2 ULMN 2 1f7l_c02 HOLO-(ACYL CARRIER PROTEIN) SYNTHASEuser 1 2 # 1 A 62 LYS A 100 LYS~? 11.56 C2 EDO A 125 A 105 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 9.16 8.08 45.36 8.29 5.91 51.34 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo -7.37 8.81 56.82 -6.87 10.59 55.84 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 1f7l_c02 source 1f7l HOLO-(ACYL CARRIER PROTEIN) SYNTHASE : 1 hits 1f7l_c02 naa= 2 ULMN 2 1fc4_c08 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 2 # 1 A 136 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 210 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 11.28 44.53 18.60 9.91 46.00 19.20 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 10.51 37.86 19.71 9.07 39.38 20.04 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1fc4_c08 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 2 # 2 A 136 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 210 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 11.28 44.53 18.60 9.91 46.00 19.20 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 10.51 37.86 19.71 9.07 39.38 20.04 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1fc4_c08 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 2 # 3 A 136 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 210 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 11.28 44.53 18.60 9.91 46.00 19.20 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 10.51 37.86 19.71 9.07 39.38 20.04 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1fc4_c08 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 2 # 4 A 136 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 210 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 11.28 44.53 18.60 9.91 46.00 19.20 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 10.51 37.86 19.71 9.07 39.38 20.04 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1fc4_c08 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 4 hits 1fc4_c08 naa= 2 ULMN 2 1fc4_c09 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 2 # 1 B 136 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 210 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 10.08 50.18 41.78 8.91 48.61 41.04 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 9.06 56.85 40.30 7.71 55.27 39.90 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1fc4_c09 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 2 # 2 B 136 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 210 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 10.08 50.18 41.78 8.91 48.61 41.04 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 9.06 56.85 40.30 7.71 55.27 39.90 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1fc4_c09 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 2 # 3 B 136 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 210 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 10.08 50.18 41.78 8.91 48.61 41.04 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 9.06 56.85 40.30 7.71 55.27 39.90 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1fc4_c09 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 2 # 4 B 136 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 210 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 10.08 50.18 41.78 8.91 48.61 41.04 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 9.06 56.85 40.30 7.71 55.27 39.90 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1fc4_c09 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 4 hits 1fc4_c09 naa= 2 ULMN 2 1fft_c02 UBIQUINOL OXIDASE user 1 2 # 1 A 286 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 362 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 44.33 299.22 203.95 43.60 300.74 202.69 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 34.33 303.48 222.19 37.83 307.04 219.88 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 ULMN 2 1fft_c02 UBIQUINOL OXIDASE user 2 2 # 2 A 286 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 362 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 44.33 299.22 203.95 43.60 300.74 202.69 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 34.33 303.48 222.19 37.83 307.04 219.88 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 ULMN 2 1fft_c02 UBIQUINOL OXIDASE user 3 2 # 3 A 286 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 362 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 44.33 299.22 203.95 43.60 300.74 202.69 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 34.33 303.48 222.19 37.83 307.04 219.88 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1fft_c02 source 1fft UBIQUINOL OXIDASE : 3 hits 1fft_c02 naa= 2 ULMN 2 1fft_c03 UBIQUINOL OXIDASE user 1 2 # 1 F 286 GLU A 23 GLU.? 13.04 O2 EDO A 125 F 362 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo -1.93 167.64 87.36 -2.65 169.16 86.08 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -12.12 171.74 105.52 -8.57 175.32 103.28 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 ULMN 2 1fft_c03 UBIQUINOL OXIDASE user 2 2 # 2 F 286 GLU B 43 GLU.? 19.28 O2 EDO A 125 F 362 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo -1.93 167.64 87.36 -2.65 169.16 86.08 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -12.12 171.74 105.52 -8.57 175.32 103.28 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 ULMN 2 1fft_c03 UBIQUINOL OXIDASE user 3 2 # 3 F 286 GLU B 59 GLU.? 24.69 C1 EDO A 124 F 362 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo -1.93 167.64 87.36 -2.65 169.16 86.08 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -12.12 171.74 105.52 -8.57 175.32 103.28 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1fft_c03 source 1fft UBIQUINOL OXIDASE : 3 hits 1fft_c03 naa= 2 ULMN 2 1fiq_c01 XANTHINE OXIDASE user 1 2 # 1 C 880 ARG A 25 ARG.? 17.39 O2 EDO A 124 C1261 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 31.02 9.69 109.34 29.24 7.24 108.82 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 26.56 13.30 104.79 26.46 12.34 106.65 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1fiq_c01 XANTHINE OXIDASE user 2 2 # 2 C 880 ARG A 25 ARG.? 17.39 O2 EDO A 124 C1261 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 31.02 9.69 109.34 29.24 7.24 108.82 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 26.56 13.30 104.79 26.46 12.34 106.65 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1fiq_c01 XANTHINE OXIDASE user 3 2 # 3 C 880 ARG A 53 ARG~? 17.45 O1 EDO A 125 C1261 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 31.02 9.69 109.34 29.24 7.24 108.82 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 26.56 13.30 104.79 26.46 12.34 106.65 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1fiq_c01 XANTHINE OXIDASE user 4 2 # 4 C 880 ARG A 106 ARG.? 12.91 O2 EDO A 125 C1261 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 31.02 9.69 109.34 29.24 7.24 108.82 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo 26.56 13.30 104.79 26.46 12.34 106.65 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1fiq_c01 XANTHINE OXIDASE user 5 2 # 5 C 880 ARG B 25 ARG.? 18.77 O2 EDO A 125 C1261 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 31.02 9.69 109.34 29.24 7.24 108.82 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 26.56 13.30 104.79 26.46 12.34 106.65 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1fiq_c01 XANTHINE OXIDASE user 6 2 # 6 C 880 ARG B 25 ARG.? 18.77 O2 EDO A 125 C1261 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 31.02 9.69 109.34 29.24 7.24 108.82 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 26.56 13.30 104.79 26.46 12.34 106.65 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1fiq_c01 XANTHINE OXIDASE user 7 2 # 7 C 880 ARG B 53 ARG~? 17.71 C1 EDO A 124 C1261 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 31.02 9.69 109.34 29.24 7.24 108.82 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 26.56 13.30 104.79 26.46 12.34 106.65 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 1fiq_c01 source 1fiq XANTHINE OXIDASE : 7 hits 1fiq_c01 naa= 2 ULMN 2 1fiq_c02 XANTHINE OXIDASE user 1 2 # 1 C 767 GLN A 56 GLN.? 7.55 C1 EDO A 125 C 912 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 19.15 19.42 110.70 21.10 18.89 110.04 -19.66 -52.09 -22.06 -20.64 -53.94 -21.94 coo 26.51 17.67 102.36 24.83 17.76 99.83 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1fiq_c02 XANTHINE OXIDASE user 2 2 # 2 C 767 GLN A 65 GLN~? 18.24 O1 EDO A 125 C 912 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 19.15 19.42 110.70 21.10 18.89 110.04 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 coo 26.51 17.67 102.36 24.83 17.76 99.83 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1fiq_c02 XANTHINE OXIDASE user 3 2 # 3 C 767 GLN A 65 GLN~? 18.24 O1 EDO A 125 C 912 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 19.15 19.42 110.70 21.10 18.89 110.04 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 coo 26.51 17.67 102.36 24.83 17.76 99.83 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1fiq_c02 XANTHINE OXIDASE user 4 2 # 4 C 767 GLN B 56 GLN.? 26.20 C1 EDO A 124 C 912 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 19.15 19.42 110.70 21.10 18.89 110.04 -52.89 -32.90 -22.16 -54.01 -34.64 -22.72 coo 26.51 17.67 102.36 24.83 17.76 99.83 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1fiq_c02 XANTHINE OXIDASE user 5 2 # 5 C 767 GLN B 65 GLN~? 25.71 C1 EDO A 124 C 912 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 19.15 19.42 110.70 21.10 18.89 110.04 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 coo 26.51 17.67 102.36 24.83 17.76 99.83 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1fiq_c02 XANTHINE OXIDASE user 6 2 # 6 C 767 GLN B 65 GLN~? 25.71 C1 EDO A 124 C 912 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 19.15 19.42 110.70 21.10 18.89 110.04 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 coo 26.51 17.67 102.36 24.83 17.76 99.83 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1fiq_c02 source 1fiq XANTHINE OXIDASE : 6 hits 1fiq_c02 naa= 2 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 1 2 # 1 126 ARG A 25 ARG.? 17.39 O2 EDO A 124 253 PHE A 50 PHE^? 8.88 O1 EDO A 125 coo 11.87 35.64 105.40 9.89 33.34 105.30 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 10.33 21.73 96.74 11.72 23.84 97.98 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 2 2 # 2 126 ARG A 25 ARG.? 17.39 O2 EDO A 124 253 PHE B 48 PHE^? 12.04 C1 EDO A 124 coo 11.87 35.64 105.40 9.89 33.34 105.30 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 10.33 21.73 96.74 11.72 23.84 97.98 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 3 2 # 3 126 ARG A 25 ARG.? 17.39 O2 EDO A 124 253 PHE B 50 PHE^? 13.90 C1 EDO A 124 coo 11.87 35.64 105.40 9.89 33.34 105.30 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 10.33 21.73 96.74 11.72 23.84 97.98 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 4 2 # 4 126 ARG A 25 ARG.? 17.39 O2 EDO A 124 253 PHE B 97 PHE.? 16.35 C1 EDO A 124 coo 11.87 35.64 105.40 9.89 33.34 105.30 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 10.33 21.73 96.74 11.72 23.84 97.98 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 5 2 # 5 126 ARG A 30 ARG^? -2.97 O2 EDO A 124s 253 PHE B 48 PHE^? 12.04 C1 EDO A 124 coo 11.87 35.64 105.40 9.89 33.34 105.30 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 10.33 21.73 96.74 11.72 23.84 97.98 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 6 2 # 6 126 ARG A 33 ARG.? 17.39 O2 EDO A 124 253 PHE A 50 PHE^? 8.88 O1 EDO A 125 coo 11.87 35.64 105.40 9.89 33.34 105.30 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 10.33 21.73 96.74 11.72 23.84 97.98 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 7 2 # 7 126 ARG A 37 ARG^? 13.77 O1 EDO A 124 253 PHE B 50 PHE^? 13.90 C1 EDO A 124 coo 11.87 35.64 105.40 9.89 33.34 105.30 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 10.33 21.73 96.74 11.72 23.84 97.98 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 8 2 # 8 126 ARG A 53 ARG~? 17.45 O1 EDO A 125 253 PHE A 48 PHE^? 10.34 O2 EDO A 125 coo 11.87 35.64 105.40 9.89 33.34 105.30 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 10.33 21.73 96.74 11.72 23.84 97.98 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 9 2 # 9 126 ARG A 106 ARG.? 12.91 O2 EDO A 125 253 PHE A 50 PHE^? 8.88 O1 EDO A 125 coo 11.87 35.64 105.40 9.89 33.34 105.30 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo 10.33 21.73 96.74 11.72 23.84 97.98 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 10 2 # 10 126 ARG B 25 ARG.? 18.77 O2 EDO A 125 253 PHE A 48 PHE^? 10.34 O2 EDO A 125 coo 11.87 35.64 105.40 9.89 33.34 105.30 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 10.33 21.73 96.74 11.72 23.84 97.98 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 11 2 # 11 126 ARG B 25 ARG.? 18.77 O2 EDO A 125 253 PHE A 50 PHE^? 8.88 O1 EDO A 125 coo 11.87 35.64 105.40 9.89 33.34 105.30 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 10.33 21.73 96.74 11.72 23.84 97.98 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 12 2 # 12 126 ARG B 25 ARG.? 18.77 O2 EDO A 125 253 PHE A 97 PHE.? 7.14 O2 EDO A 125 coo 11.87 35.64 105.40 9.89 33.34 105.30 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 10.33 21.73 96.74 11.72 23.84 97.98 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 13 2 # 13 126 ARG B 25 ARG.? 18.77 O2 EDO A 125 253 PHE B 50 PHE^? 13.90 C1 EDO A 124 coo 11.87 35.64 105.40 9.89 33.34 105.30 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 10.33 21.73 96.74 11.72 23.84 97.98 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 14 2 # 14 126 ARG B 30 ARG^? 10.56 O1 EDO A 124 253 PHE A 48 PHE^? 10.34 O2 EDO A 125 coo 11.87 35.64 105.40 9.89 33.34 105.30 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 10.33 21.73 96.74 11.72 23.84 97.98 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 15 2 # 15 126 ARG B 33 ARG.? 19.94 O1 EDO A 124 253 PHE B 50 PHE^? 13.90 C1 EDO A 124 coo 11.87 35.64 105.40 9.89 33.34 105.30 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 10.33 21.73 96.74 11.72 23.84 97.98 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 16 2 # 16 126 ARG B 37 ARG^? 8.36 C1 EDO A 124 253 PHE A 50 PHE^? 8.88 O1 EDO A 125 coo 11.87 35.64 105.40 9.89 33.34 105.30 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 10.33 21.73 96.74 11.72 23.84 97.98 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 17 2 # 17 126 ARG B 53 ARG~? 17.71 C1 EDO A 124 253 PHE B 48 PHE^? 12.04 C1 EDO A 124 coo 11.87 35.64 105.40 9.89 33.34 105.30 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 10.33 21.73 96.74 11.72 23.84 97.98 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 1fps_c00 source 1fps AVIAN FARNESYL DIPHOSPHATE SYNTHASE (FPS) (E.C: 17 hits 1fps_c00 naa= 2 ULMN 2 1fq0_c00 KDPG ALDOLASE user 1 2 # 1 A 45 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 133 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 24.81 25.32 38.82 23.00 25.16 37.74 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 18.26 19.92 32.68 20.05 22.35 36.35 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1fq0_c00 KDPG ALDOLASE user 2 2 # 2 A 45 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 133 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 24.81 25.32 38.82 23.00 25.16 37.74 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 18.26 19.92 32.68 20.05 22.35 36.35 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1fq0_c00 KDPG ALDOLASE user 3 2 # 3 A 45 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 133 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 24.81 25.32 38.82 23.00 25.16 37.74 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 18.26 19.92 32.68 20.05 22.35 36.35 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 ULMN 2 1fq0_c00 KDPG ALDOLASE user 4 2 # 4 A 45 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 133 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 24.81 25.32 38.82 23.00 25.16 37.74 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 18.26 19.92 32.68 20.05 22.35 36.35 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1fq0_c00 source 1fq0 KDPG ALDOLASE : 4 hits 1fq0_c00 naa= 2 ULMN 2 1fq0_c01 KDPG ALDOLASE user 1 2 # 1 B 45 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 133 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 3.94 6.65 13.38 3.87 8.55 14.36 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 4.24 17.15 12.78 2.73 12.27 13.50 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1fq0_c01 KDPG ALDOLASE user 2 2 # 2 B 45 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 133 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 3.94 6.65 13.38 3.87 8.55 14.36 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 4.24 17.15 12.78 2.73 12.27 13.50 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1fq0_c01 KDPG ALDOLASE user 3 2 # 3 B 45 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 133 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 3.94 6.65 13.38 3.87 8.55 14.36 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 4.24 17.15 12.78 2.73 12.27 13.50 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 ULMN 2 1fq0_c01 KDPG ALDOLASE user 4 2 # 4 B 45 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 133 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 3.94 6.65 13.38 3.87 8.55 14.36 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 4.24 17.15 12.78 2.73 12.27 13.50 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1fq0_c01 source 1fq0 KDPG ALDOLASE : 4 hits 1fq0_c01 naa= 2 ULMN 2 1fq0_c02 KDPG ALDOLASE user 1 2 # 1 C 45 GLU A 43 GLU.? 14.35 O2 EDO A 124 C 133 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 8.38 43.77 10.65 8.15 42.35 12.20 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 12.43 39.26 19.13 9.45 41.97 16.24 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1fq0_c02 KDPG ALDOLASE user 2 2 # 2 C 45 GLU A 70 GLU^? 16.40 O1 EDO A 125 C 133 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 8.38 43.77 10.65 8.15 42.35 12.20 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 12.43 39.26 19.13 9.45 41.97 16.24 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1fq0_c02 KDPG ALDOLASE user 3 2 # 3 C 45 GLU B 43 GLU.? 19.28 O2 EDO A 125 C 133 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 8.38 43.77 10.65 8.15 42.35 12.20 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 12.43 39.26 19.13 9.45 41.97 16.24 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 ULMN 2 1fq0_c02 KDPG ALDOLASE user 4 2 # 4 C 45 GLU B 70 GLU^? 26.28 O1 EDO A 124 C 133 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 8.38 43.77 10.65 8.15 42.35 12.20 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 12.43 39.26 19.13 9.45 41.97 16.24 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1fq0_c02 source 1fq0 KDPG ALDOLASE : 4 hits 1fq0_c02 naa= 2 ULMN 2 1fsg_c04 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 A 118 TYR A 31 TYR^? 13.43 O2 EDO A 124 A 150 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 17.05 41.72 -19.12 16.18 39.08 -18.77 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 16.21 35.12 -15.07 14.15 35.53 -14.99 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1fsg_c04 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 A 118 TYR A 31 TYR^? 13.43 O2 EDO A 124 A 150 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 17.05 41.72 -19.12 16.18 39.08 -18.77 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 16.21 35.12 -15.07 14.15 35.53 -14.99 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1fsg_c04 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 3 2 # 3 A 118 TYR B 31 TYR^? 14.49 O1 EDO A 124 A 150 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 17.05 41.72 -19.12 16.18 39.08 -18.77 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 16.21 35.12 -15.07 14.15 35.53 -14.99 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1fsg_c04 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 4 2 # 4 A 118 TYR B 31 TYR^? 14.49 O1 EDO A 124 A 150 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 17.05 41.72 -19.12 16.18 39.08 -18.77 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 16.21 35.12 -15.07 14.15 35.53 -14.99 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 1fsg_c04 source 1fsg HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 4 hits 1fsg_c04 naa= 2 ULMN 2 1fsg_c05 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 C 118 TYR A 31 TYR^? 13.43 O2 EDO A 124 C 150 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 21.17 33.18 32.58 18.59 34.12 32.22 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 15.48 36.57 28.52 14.54 34.69 28.40 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1fsg_c05 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 C 118 TYR A 31 TYR^? 13.43 O2 EDO A 124 C 150 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 21.17 33.18 32.58 18.59 34.12 32.22 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 15.48 36.57 28.52 14.54 34.69 28.40 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1fsg_c05 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 3 2 # 3 C 118 TYR B 31 TYR^? 14.49 O1 EDO A 124 C 150 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 21.17 33.18 32.58 18.59 34.12 32.22 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 15.48 36.57 28.52 14.54 34.69 28.40 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1fsg_c05 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 4 2 # 4 C 118 TYR B 31 TYR^? 14.49 O1 EDO A 124 C 150 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 21.17 33.18 32.58 18.59 34.12 32.22 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 15.48 36.57 28.52 14.54 34.69 28.40 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 1fsg_c05 source 1fsg HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 4 hits 1fsg_c05 naa= 2 ULMN 2 1fua_c00 L-FUCULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 73 GLU A 70 GLU^? 16.40 O1 EDO A 125 113 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo -24.82 41.20 27.84 -23.33 41.85 29.24 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -9.67 68.24 34.92 -8.38 68.44 32.44 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 ULMN 2 1fua_c00 L-FUCULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 73 GLU A 70 GLU^? 16.40 O1 EDO A 125 113 TYR B 76 TYR.? 17.92 O2 EDO A 125 coo -24.82 41.20 27.84 -23.33 41.85 29.24 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -9.67 68.24 34.92 -8.38 68.44 32.44 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 ULMN 2 1fua_c00 L-FUCULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 73 GLU B 70 GLU^? 26.28 O1 EDO A 124 113 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo -24.82 41.20 27.84 -23.33 41.85 29.24 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -9.67 68.24 34.92 -8.38 68.44 32.44 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1fua_c00 L-FUCULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 73 GLU B 70 GLU^? 26.28 O1 EDO A 124 113 TYR A 76 TYR.? 12.73 O1 EDO A 125 coo -24.82 41.20 27.84 -23.33 41.85 29.24 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -9.67 68.24 34.92 -8.38 68.44 32.44 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 1fua_c00 source 1fua L-FUCULOSE-1-PHOSPHATE ALDOLASE : 4 hits 1fua_c00 naa= 2 ULMN 2 1fui_c00 L-FUCOSE ISOMERASE user 1 2 # 1 A 337 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 361 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 121.24 38.44 100.14 121.43 39.72 101.85 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 123.79 45.29 105.61 123.06 43.58 104.60 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1fui_c00 L-FUCOSE ISOMERASE user 2 2 # 2 A 337 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 361 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 121.24 38.44 100.14 121.43 39.72 101.85 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 123.79 45.29 105.61 123.06 43.58 104.60 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1fui_c00 L-FUCOSE ISOMERASE user 3 2 # 3 A 337 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 361 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 121.24 38.44 100.14 121.43 39.72 101.85 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 123.79 45.29 105.61 123.06 43.58 104.60 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1fui_c00 L-FUCOSE ISOMERASE user 4 2 # 4 A 337 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 361 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 121.24 38.44 100.14 121.43 39.72 101.85 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 123.79 45.29 105.61 123.06 43.58 104.60 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1fui_c00 L-FUCOSE ISOMERASE user 5 2 # 5 A 337 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 361 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 121.24 38.44 100.14 121.43 39.72 101.85 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 123.79 45.29 105.61 123.06 43.58 104.60 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1fui_c00 L-FUCOSE ISOMERASE user 6 2 # 6 A 337 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 361 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 121.24 38.44 100.14 121.43 39.72 101.85 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 123.79 45.29 105.61 123.06 43.58 104.60 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1fui_c00 L-FUCOSE ISOMERASE user 7 2 # 7 A 337 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 361 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 121.24 38.44 100.14 121.43 39.72 101.85 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 123.79 45.29 105.61 123.06 43.58 104.60 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1fui_c00 L-FUCOSE ISOMERASE user 8 2 # 8 A 337 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 361 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 121.24 38.44 100.14 121.43 39.72 101.85 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 123.79 45.29 105.61 123.06 43.58 104.60 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1fui_c00 source 1fui L-FUCOSE ISOMERASE : 8 hits 1fui_c00 naa= 2 ULMN 2 1fui_c01 L-FUCOSE ISOMERASE user 1 2 # 1 B 337 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 361 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 107.33 88.10 66.30 109.04 88.21 67.57 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 112.60 90.49 73.35 111.61 89.74 71.61 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1fui_c01 L-FUCOSE ISOMERASE user 2 2 # 2 B 337 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 361 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 107.33 88.10 66.30 109.04 88.21 67.57 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 112.60 90.49 73.35 111.61 89.74 71.61 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1fui_c01 L-FUCOSE ISOMERASE user 3 2 # 3 B 337 GLU A 81 GLU.? 16.59 O1 EDO A 125 B 361 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 107.33 88.10 66.30 109.04 88.21 67.57 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 112.60 90.49 73.35 111.61 89.74 71.61 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1fui_c01 L-FUCOSE ISOMERASE user 4 2 # 4 B 337 GLU A 81 GLU.? 16.59 O1 EDO A 125 B 361 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 107.33 88.10 66.30 109.04 88.21 67.57 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 112.60 90.49 73.35 111.61 89.74 71.61 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1fui_c01 L-FUCOSE ISOMERASE user 5 2 # 5 B 337 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 361 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 107.33 88.10 66.30 109.04 88.21 67.57 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 112.60 90.49 73.35 111.61 89.74 71.61 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1fui_c01 L-FUCOSE ISOMERASE user 6 2 # 6 B 337 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 361 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 107.33 88.10 66.30 109.04 88.21 67.57 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 112.60 90.49 73.35 111.61 89.74 71.61 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1fui_c01 L-FUCOSE ISOMERASE user 7 2 # 7 B 337 GLU B 81 GLU.? 30.69 O1 EDO A 124 B 361 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 107.33 88.10 66.30 109.04 88.21 67.57 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 112.60 90.49 73.35 111.61 89.74 71.61 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1fui_c01 L-FUCOSE ISOMERASE user 8 2 # 8 B 337 GLU B 81 GLU.? 30.69 O1 EDO A 124 B 361 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 107.33 88.10 66.30 109.04 88.21 67.57 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 112.60 90.49 73.35 111.61 89.74 71.61 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1fui_c01 source 1fui L-FUCOSE ISOMERASE : 8 hits 1fui_c01 naa= 2 ULMN 2 1fui_c02 L-FUCOSE ISOMERASE user 1 2 # 1 C 337 GLU A 43 GLU.? 14.35 O2 EDO A 124 C 361 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 72.24 72.88 114.67 73.47 74.62 114.75 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 79.16 78.14 117.33 77.48 77.13 116.54 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1fui_c02 L-FUCOSE ISOMERASE user 2 2 # 2 C 337 GLU A 70 GLU^? 16.40 O1 EDO A 125 C 361 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 72.24 72.88 114.67 73.47 74.62 114.75 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 79.16 78.14 117.33 77.48 77.13 116.54 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1fui_c02 L-FUCOSE ISOMERASE user 3 2 # 3 C 337 GLU A 81 GLU.? 16.59 O1 EDO A 125 C 361 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 72.24 72.88 114.67 73.47 74.62 114.75 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 79.16 78.14 117.33 77.48 77.13 116.54 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1fui_c02 L-FUCOSE ISOMERASE user 4 2 # 4 C 337 GLU A 81 GLU.? 16.59 O1 EDO A 125 C 361 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 72.24 72.88 114.67 73.47 74.62 114.75 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 79.16 78.14 117.33 77.48 77.13 116.54 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1fui_c02 L-FUCOSE ISOMERASE user 5 2 # 5 C 337 GLU B 43 GLU.? 19.28 O2 EDO A 125 C 361 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 72.24 72.88 114.67 73.47 74.62 114.75 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 79.16 78.14 117.33 77.48 77.13 116.54 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1fui_c02 L-FUCOSE ISOMERASE user 6 2 # 6 C 337 GLU B 70 GLU^? 26.28 O1 EDO A 124 C 361 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 72.24 72.88 114.67 73.47 74.62 114.75 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 79.16 78.14 117.33 77.48 77.13 116.54 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1fui_c02 L-FUCOSE ISOMERASE user 7 2 # 7 C 337 GLU B 81 GLU.? 30.69 O1 EDO A 124 C 361 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 72.24 72.88 114.67 73.47 74.62 114.75 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 79.16 78.14 117.33 77.48 77.13 116.54 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1fui_c02 L-FUCOSE ISOMERASE user 8 2 # 8 C 337 GLU B 81 GLU.? 30.69 O1 EDO A 124 C 361 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 72.24 72.88 114.67 73.47 74.62 114.75 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 79.16 78.14 117.33 77.48 77.13 116.54 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1fui_c02 source 1fui L-FUCOSE ISOMERASE : 8 hits 1fui_c02 naa= 2 ULMN 2 1fui_c03 L-FUCOSE ISOMERASE user 1 2 # 1 D 337 GLU A 43 GLU.? 14.35 O2 EDO A 124 D 361 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 88.24 74.80 51.29 86.40 73.84 50.89 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 82.09 68.51 48.80 83.27 70.10 49.47 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1fui_c03 L-FUCOSE ISOMERASE user 2 2 # 2 D 337 GLU A 70 GLU^? 16.40 O1 EDO A 125 D 361 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 88.24 74.80 51.29 86.40 73.84 50.89 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 82.09 68.51 48.80 83.27 70.10 49.47 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1fui_c03 L-FUCOSE ISOMERASE user 3 2 # 3 D 337 GLU A 81 GLU.? 16.59 O1 EDO A 125 D 361 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 88.24 74.80 51.29 86.40 73.84 50.89 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 82.09 68.51 48.80 83.27 70.10 49.47 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1fui_c03 L-FUCOSE ISOMERASE user 4 2 # 4 D 337 GLU A 81 GLU.? 16.59 O1 EDO A 125 D 361 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 88.24 74.80 51.29 86.40 73.84 50.89 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 82.09 68.51 48.80 83.27 70.10 49.47 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1fui_c03 L-FUCOSE ISOMERASE user 5 2 # 5 D 337 GLU B 43 GLU.? 19.28 O2 EDO A 125 D 361 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 88.24 74.80 51.29 86.40 73.84 50.89 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 82.09 68.51 48.80 83.27 70.10 49.47 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1fui_c03 L-FUCOSE ISOMERASE user 6 2 # 6 D 337 GLU B 70 GLU^? 26.28 O1 EDO A 124 D 361 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 88.24 74.80 51.29 86.40 73.84 50.89 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 82.09 68.51 48.80 83.27 70.10 49.47 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1fui_c03 L-FUCOSE ISOMERASE user 7 2 # 7 D 337 GLU B 81 GLU.? 30.69 O1 EDO A 124 D 361 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 88.24 74.80 51.29 86.40 73.84 50.89 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 82.09 68.51 48.80 83.27 70.10 49.47 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1fui_c03 L-FUCOSE ISOMERASE user 8 2 # 8 D 337 GLU B 81 GLU.? 30.69 O1 EDO A 124 D 361 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 88.24 74.80 51.29 86.40 73.84 50.89 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 82.09 68.51 48.80 83.27 70.10 49.47 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1fui_c03 source 1fui L-FUCOSE ISOMERASE : 8 hits 1fui_c03 naa= 2 ULMN 2 1fui_c04 L-FUCOSE ISOMERASE user 1 2 # 1 E 337 GLU A 43 GLU.? 14.35 O2 EDO A 124 E 361 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 107.93 24.28 80.50 106.97 23.96 78.62 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 101.66 22.07 74.20 103.27 22.69 75.42 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1fui_c04 L-FUCOSE ISOMERASE user 2 2 # 2 E 337 GLU A 70 GLU^? 16.40 O1 EDO A 125 E 361 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 107.93 24.28 80.50 106.97 23.96 78.62 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 101.66 22.07 74.20 103.27 22.69 75.42 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1fui_c04 L-FUCOSE ISOMERASE user 3 2 # 3 E 337 GLU A 81 GLU.? 16.59 O1 EDO A 125 E 361 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 107.93 24.28 80.50 106.97 23.96 78.62 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 101.66 22.07 74.20 103.27 22.69 75.42 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1fui_c04 L-FUCOSE ISOMERASE user 4 2 # 4 E 337 GLU A 81 GLU.? 16.59 O1 EDO A 125 E 361 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 107.93 24.28 80.50 106.97 23.96 78.62 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 101.66 22.07 74.20 103.27 22.69 75.42 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1fui_c04 L-FUCOSE ISOMERASE user 5 2 # 5 E 337 GLU B 43 GLU.? 19.28 O2 EDO A 125 E 361 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 107.93 24.28 80.50 106.97 23.96 78.62 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 101.66 22.07 74.20 103.27 22.69 75.42 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1fui_c04 L-FUCOSE ISOMERASE user 6 2 # 6 E 337 GLU B 70 GLU^? 26.28 O1 EDO A 124 E 361 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 107.93 24.28 80.50 106.97 23.96 78.62 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 101.66 22.07 74.20 103.27 22.69 75.42 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1fui_c04 L-FUCOSE ISOMERASE user 7 2 # 7 E 337 GLU B 81 GLU.? 30.69 O1 EDO A 124 E 361 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 107.93 24.28 80.50 106.97 23.96 78.62 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 101.66 22.07 74.20 103.27 22.69 75.42 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1fui_c04 L-FUCOSE ISOMERASE user 8 2 # 8 E 337 GLU B 81 GLU.? 30.69 O1 EDO A 124 E 361 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 107.93 24.28 80.50 106.97 23.96 78.62 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 101.66 22.07 74.20 103.27 22.69 75.42 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1fui_c04 source 1fui L-FUCOSE ISOMERASE : 8 hits 1fui_c04 naa= 2 ULMN 2 1fui_c05 L-FUCOSE ISOMERASE user 1 2 # 1 F 337 GLU A 43 GLU.? 14.35 O2 EDO A 124 F 361 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 57.76 53.97 100.56 57.50 52.10 99.61 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 55.55 47.88 94.16 56.19 49.11 95.81 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1fui_c05 L-FUCOSE ISOMERASE user 2 2 # 2 F 337 GLU A 70 GLU^? 16.40 O1 EDO A 125 F 361 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 57.76 53.97 100.56 57.50 52.10 99.61 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 55.55 47.88 94.16 56.19 49.11 95.81 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1fui_c05 L-FUCOSE ISOMERASE user 3 2 # 3 F 337 GLU A 81 GLU.? 16.59 O1 EDO A 125 F 361 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 57.76 53.97 100.56 57.50 52.10 99.61 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 55.55 47.88 94.16 56.19 49.11 95.81 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1fui_c05 L-FUCOSE ISOMERASE user 4 2 # 4 F 337 GLU A 81 GLU.? 16.59 O1 EDO A 125 F 361 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 57.76 53.97 100.56 57.50 52.10 99.61 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 55.55 47.88 94.16 56.19 49.11 95.81 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1fui_c05 L-FUCOSE ISOMERASE user 5 2 # 5 F 337 GLU B 43 GLU.? 19.28 O2 EDO A 125 F 361 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 57.76 53.97 100.56 57.50 52.10 99.61 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 55.55 47.88 94.16 56.19 49.11 95.81 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1fui_c05 L-FUCOSE ISOMERASE user 6 2 # 6 F 337 GLU B 70 GLU^? 26.28 O1 EDO A 124 F 361 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 57.76 53.97 100.56 57.50 52.10 99.61 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 55.55 47.88 94.16 56.19 49.11 95.81 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1fui_c05 L-FUCOSE ISOMERASE user 7 2 # 7 F 337 GLU B 81 GLU.? 30.69 O1 EDO A 124 F 361 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 57.76 53.97 100.56 57.50 52.10 99.61 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 55.55 47.88 94.16 56.19 49.11 95.81 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1fui_c05 L-FUCOSE ISOMERASE user 8 2 # 8 F 337 GLU B 81 GLU.? 30.69 O1 EDO A 124 F 361 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 57.76 53.97 100.56 57.50 52.10 99.61 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 55.55 47.88 94.16 56.19 49.11 95.81 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1fui_c05 source 1fui L-FUCOSE ISOMERASE : 8 hits 1fui_c05 naa= 2 ULMN 2 1g64_c00 COB(I)ALAMIN ADENOSYLTRANSFERASE user 1 2 # 1 A 41 LYS A 100 LYS~? 11.56 C2 EDO A 125 A 43 THR A 99 THR~? 7.67 C2 EDO A 125 coo 3.40 35.69 42.25 -0.97 35.48 38.92 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo 3.69 33.32 46.92 2.58 31.52 46.50 -24.60 -55.51 -20.10 -23.07 -56.46 -21.32 1g64_c00 source 1g64 COB(I)ALAMIN ADENOSYLTRANSFERASE : 1 hits 1g64_c00 naa= 2 ULMN 2 1g64_c01 COB(I)ALAMIN ADENOSYLTRANSFERASE user 1 2 # 1 B 241 LYS A 100 LYS~? 11.56 C2 EDO A 125 B 243 THR A 99 THR~? 7.67 C2 EDO A 125 coo 11.27 29.31 41.91 14.46 29.97 38.30 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo 11.07 31.88 46.68 12.01 33.74 46.14 -24.60 -55.51 -20.10 -23.07 -56.46 -21.32 1g64_c01 source 1g64 COB(I)ALAMIN ADENOSYLTRANSFERASE : 1 hits 1g64_c01 naa= 2 ULMN 2 1gdh_c02 D-GLYCERATE DEHYDROGENASE (APO FORM)user 1 2 # 1 A 269 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 287 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 23.48 10.69 22.39 22.24 12.31 21.83 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 20.16 15.49 22.94 18.67 14.36 21.99 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1gdh_c02 D-GLYCERATE DEHYDROGENASE (APO FORM)user 2 2 # 2 A 269 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 287 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 23.48 10.69 22.39 22.24 12.31 21.83 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 20.16 15.49 22.94 18.67 14.36 21.99 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1gdh_c02 D-GLYCERATE DEHYDROGENASE (APO FORM)user 3 2 # 3 A 269 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 287 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 23.48 10.69 22.39 22.24 12.31 21.83 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 20.16 15.49 22.94 18.67 14.36 21.99 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 ULMN 2 1gdh_c02 D-GLYCERATE DEHYDROGENASE (APO FORM)user 4 2 # 4 A 269 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 287 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 23.48 10.69 22.39 22.24 12.31 21.83 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 20.16 15.49 22.94 18.67 14.36 21.99 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1gdh_c02 source 1gdh D-GLYCERATE DEHYDROGENASE (APO FORM) (E.C.1.1.: 4 hits 1gdh_c02 naa= 2 ULMN 2 1gdh_c03 D-GLYCERATE DEHYDROGENASE (APO FORM)user 1 2 # 1 B 269 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 287 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 37.72 45.90 19.85 36.33 45.31 18.40 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 34.65 43.41 15.42 33.80 45.28 15.03 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1gdh_c03 D-GLYCERATE DEHYDROGENASE (APO FORM)user 2 2 # 2 B 269 GLU A 81 GLU.? 16.59 O1 EDO A 125 B 287 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 37.72 45.90 19.85 36.33 45.31 18.40 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 34.65 43.41 15.42 33.80 45.28 15.03 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1gdh_c03 D-GLYCERATE DEHYDROGENASE (APO FORM)user 3 2 # 3 B 269 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 287 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 37.72 45.90 19.85 36.33 45.31 18.40 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 34.65 43.41 15.42 33.80 45.28 15.03 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 ULMN 2 1gdh_c03 D-GLYCERATE DEHYDROGENASE (APO FORM)user 4 2 # 4 B 269 GLU B 81 GLU.? 30.69 O1 EDO A 124 B 287 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 37.72 45.90 19.85 36.33 45.31 18.40 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 34.65 43.41 15.42 33.80 45.28 15.03 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1gdh_c03 source 1gdh D-GLYCERATE DEHYDROGENASE (APO FORM) (E.C.1.1.: 4 hits 1gdh_c03 naa= 2 ULMN 2 1ge7_c00 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 1 2 # 1 A 100 PHE A 97 PHE.? 7.14 O2 EDO A 125 A 118 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 25.28 13.65 -10.03 22.92 15.15 -10.20 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 1ge7_c00 source 1ge7 PEPTIDYL-LYS METALLOENDOPEPTIDASE : 1 hits 1ge7_c00 naa= 2 ULMN 2 1ge7_c01 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 1 2 # 1 B 100 PHE A 97 PHE.? 7.14 O2 EDO A 125 B 118 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 3.67 17.54 51.97 6.00 19.03 52.32 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 4.10 21.86 44.74 2.66 21.47 43.23 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 1ge7_c01 source 1ge7 PEPTIDYL-LYS METALLOENDOPEPTIDASE : 1 hits 1ge7_c01 naa= 2 ULMN 2 1ge7_c02 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 1 2 # 1 A 118 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 133 TYR A 76 TYR.? 12.73 O1 EDO A 125 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 26.98 8.80 3.58 27.20 8.50 0.81 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 ULMN 2 1ge7_c02 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 2 2 # 2 A 118 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 133 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 26.98 8.80 3.58 27.20 8.50 0.81 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1ge7_c02 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 3 2 # 3 A 118 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 133 TYR B 76 TYR.? 17.92 O2 EDO A 125 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 26.98 8.80 3.58 27.20 8.50 0.81 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 ULMN 2 1ge7_c02 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 4 2 # 4 A 118 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 133 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 26.98 8.80 3.58 27.20 8.50 0.81 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 1ge7_c02 source 1ge7 PEPTIDYL-LYS METALLOENDOPEPTIDASE : 4 hits 1ge7_c02 naa= 2 ULMN 2 1ge7_c03 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 1 2 # 1 B 118 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 133 TYR A 76 TYR.? 12.73 O1 EDO A 125 coo 4.10 21.86 44.74 2.66 21.47 43.23 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 1.98 12.55 38.35 1.73 12.30 41.13 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 ULMN 2 1ge7_c03 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 2 2 # 2 B 118 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 133 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 4.10 21.86 44.74 2.66 21.47 43.23 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 1.98 12.55 38.35 1.73 12.30 41.13 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1ge7_c03 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 3 2 # 3 B 118 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 133 TYR B 76 TYR.? 17.92 O2 EDO A 125 coo 4.10 21.86 44.74 2.66 21.47 43.23 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 1.98 12.55 38.35 1.73 12.30 41.13 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 ULMN 2 1ge7_c03 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 4 2 # 4 B 118 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 133 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo 4.10 21.86 44.74 2.66 21.47 43.23 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 1.98 12.55 38.35 1.73 12.30 41.13 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 1ge7_c03 source 1ge7 PEPTIDYL-LYS METALLOENDOPEPTIDASE : 4 hits 1ge7_c03 naa= 2 ULMN 2 1ghs_c02 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 2 # 1 B 231 GLU A 23 GLU.? 13.04 O2 EDO A 125 B 288 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1ghs_c02 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 2 2 # 2 B 231 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 288 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1ghs_c02 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 3 2 # 3 B 231 GLU B 23 GLU.? 12.57 O2 EDO A 125 B 288 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1ghs_c02 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 4 2 # 4 B 231 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 288 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1ghs_c02 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 4 hits 1ghs_c02 naa= 2 ULMN 2 1ghs_c03 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 2 # 1 A 231 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 288 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1ghs_c03 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 2 2 # 2 A 231 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 288 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1ghs_c03 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 3 2 # 3 A 231 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 288 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1ghs_c03 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 4 2 # 4 A 231 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 288 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1ghs_c03 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 4 hits 1ghs_c03 naa= 2 ULMN 2 1gp1_c00 GLUTATHIONE PEROXIDASE (E.C.1.11.1.9user 1 2 # 1 A 80 GLN A 65 GLN~? 18.24 O1 EDO A 125 A 158 TRP A 80 TRP^? 10.72 O1 EDO A 125 coo 29.46 42.07 44.25 28.90 43.22 45.93 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 coo 30.53 47.84 47.89 32.80 44.75 48.27 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 ULMN 2 1gp1_c00 GLUTATHIONE PEROXIDASE (E.C.1.11.1.9user 2 2 # 2 A 80 GLN B 65 GLN~? 25.71 C1 EDO A 124 A 158 TRP B 80 TRP^? 20.31 C1 EDO A 124 coo 29.46 42.07 44.25 28.90 43.22 45.93 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 coo 30.53 47.84 47.89 32.80 44.75 48.27 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 1gp1_c00 source 1gp1 GLUTATHIONE PEROXIDASE (E.C.1.11.1.9) : 2 hits 1gp1_c00 naa= 2 ULMN 2 1gp1_c01 GLUTATHIONE PEROXIDASE (E.C.1.11.1.9user 1 2 # 1 B 80 GLN A 65 GLN~? 18.24 O1 EDO A 125 B 158 TRP A 80 TRP^? 10.72 O1 EDO A 125 coo 31.92 33.06 40.18 33.22 31.84 39.12 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 coo 35.57 27.11 39.76 36.97 30.23 41.57 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 ULMN 2 1gp1_c01 GLUTATHIONE PEROXIDASE (E.C.1.11.1.9user 2 2 # 2 B 80 GLN B 65 GLN~? 25.71 C1 EDO A 124 B 158 TRP B 80 TRP^? 20.31 C1 EDO A 124 coo 31.92 33.06 40.18 33.22 31.84 39.12 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 coo 35.57 27.11 39.76 36.97 30.23 41.57 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 1gp1_c01 source 1gp1 GLUTATHIONE PEROXIDASE (E.C.1.11.1.9) : 2 hits 1gp1_c01 naa= 2 ULMN 2 1gpj_c01 GLUTAMYL-TRNA REDUCTASE user 1 2 # 1 A 48 SER A 62 SER~? 19.90 O1 EDO A 125 A 84 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 73.61 56.25 53.64 74.51 58.42 54.29 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo 60.00 60.51 47.62 61.47 59.95 49.01 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1gpj_c01 GLUTAMYL-TRNA REDUCTASE user 2 2 # 2 A 48 SER B 62 SER~? 23.65 O1 EDO A 124 A 84 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 73.61 56.25 53.64 74.51 58.42 54.29 -46.80 -18.27 -18.25 -47.35 -17.46 -16.02 coo 60.00 60.51 47.62 61.47 59.95 49.01 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1gpj_c01 source 1gpj GLUTAMYL-TRNA REDUCTASE : 2 hits 1gpj_c01 naa= 2 ULMN 2 1grc_c04 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 2 # 1 A 108 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 144 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 52.62 57.63 23.12 50.77 57.51 22.26 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 46.65 56.95 20.09 48.42 58.17 20.01 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1grc_c04 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 2 # 2 A 108 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 144 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 52.62 57.63 23.12 50.77 57.51 22.26 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 46.65 56.95 20.09 48.42 58.17 20.01 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1grc_c04 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 2 # 3 A 108 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 144 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 52.62 57.63 23.12 50.77 57.51 22.26 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 46.65 56.95 20.09 48.42 58.17 20.01 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1grc_c04 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 2 # 4 A 108 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 144 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 52.62 57.63 23.12 50.77 57.51 22.26 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 46.65 56.95 20.09 48.42 58.17 20.01 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1grc_c04 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 4 hits 1grc_c04 naa= 2 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 A 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 A 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 A 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 A 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 A 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 A 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 A 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 A 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c00 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c00 naa= 2 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 B 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 B 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 B 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 B 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 B 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 B 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 B 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 B 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 B 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 B 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 B 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 B 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 B 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c01 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c01 naa= 2 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 C 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 C 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 C 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 C 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 C 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 C 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 C 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 C 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 C 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 C 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 C 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 C 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 C 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 C 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 C 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 C 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c02 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c02 naa= 2 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 D 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 D 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 D 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 D 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 D 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 D 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 D 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 D 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 D 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 D 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 D 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 D 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 D 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 D 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 D 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 D 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c03 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c03 naa= 2 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 E 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 E 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 E 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 E 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 E 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 E 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 E 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 E 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 E 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 E 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 E 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 E 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 E 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 E 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 E 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 E 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c04 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c04 naa= 2 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 F 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 F 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 F 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 F 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 F 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 F 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 F 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 F 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 F 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 F 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 F 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 F 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 F 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 F 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 F 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 F 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c05 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c05 naa= 2 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 G 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 G 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 G 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 G 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 G 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 G 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 G 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 G 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 G 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 G 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 G 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 G 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 G 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 G 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 G 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 G 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c06 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c06 naa= 2 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 H 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 H 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 2.65 118.13 54.75 2.20 117.91 52.65 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 H 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 H 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 2.65 118.13 54.75 2.20 117.91 52.65 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 H 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 H 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 2.65 118.13 54.75 2.20 117.91 52.65 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 H 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 H 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 2.65 118.13 54.75 2.20 117.91 52.65 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 H 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 H 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 2.65 118.13 54.75 2.20 117.91 52.65 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 H 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 H 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 2.65 118.13 54.75 2.20 117.91 52.65 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 H 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 H 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 2.65 118.13 54.75 2.20 117.91 52.65 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 H 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 H 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 2.65 118.13 54.75 2.20 117.91 52.65 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c07 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c07 naa= 2 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 I 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 I 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 21.75 35.77 66.58 21.06 37.00 64.94 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 39.40 18.83 55.43 40.64 19.47 57.06 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 I 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 I 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 21.75 35.77 66.58 21.06 37.00 64.94 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 39.40 18.83 55.43 40.64 19.47 57.06 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 I 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 I 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 21.75 35.77 66.58 21.06 37.00 64.94 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 39.40 18.83 55.43 40.64 19.47 57.06 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 I 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 I 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 21.75 35.77 66.58 21.06 37.00 64.94 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 39.40 18.83 55.43 40.64 19.47 57.06 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 I 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 I 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 21.75 35.77 66.58 21.06 37.00 64.94 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 39.40 18.83 55.43 40.64 19.47 57.06 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 I 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 I 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 21.75 35.77 66.58 21.06 37.00 64.94 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 39.40 18.83 55.43 40.64 19.47 57.06 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 I 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 I 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 21.75 35.77 66.58 21.06 37.00 64.94 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 39.40 18.83 55.43 40.64 19.47 57.06 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 I 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 I 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 21.75 35.77 66.58 21.06 37.00 64.94 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 39.40 18.83 55.43 40.64 19.47 57.06 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c08 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c08 naa= 2 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 J 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 J 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 49.72 57.74 77.19 50.16 59.17 75.67 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 29.89 43.66 65.68 31.09 41.98 66.25 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 J 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 J 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 49.72 57.74 77.19 50.16 59.17 75.67 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 29.89 43.66 65.68 31.09 41.98 66.25 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 J 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 J 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 49.72 57.74 77.19 50.16 59.17 75.67 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 29.89 43.66 65.68 31.09 41.98 66.25 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 J 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 J 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 49.72 57.74 77.19 50.16 59.17 75.67 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 29.89 43.66 65.68 31.09 41.98 66.25 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 J 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 J 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 49.72 57.74 77.19 50.16 59.17 75.67 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 29.89 43.66 65.68 31.09 41.98 66.25 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 J 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 J 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 49.72 57.74 77.19 50.16 59.17 75.67 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 29.89 43.66 65.68 31.09 41.98 66.25 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 J 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 J 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 49.72 57.74 77.19 50.16 59.17 75.67 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 29.89 43.66 65.68 31.09 41.98 66.25 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 J 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 J 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 49.72 57.74 77.19 50.16 59.17 75.67 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 29.89 43.66 65.68 31.09 41.98 66.25 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c09 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c09 naa= 2 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 K 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 K 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 73.94 31.71 67.00 74.74 32.13 65.03 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 56.59 52.03 70.37 55.28 50.47 70.94 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 K 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 K 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 73.94 31.71 67.00 74.74 32.13 65.03 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 56.59 52.03 70.37 55.28 50.47 70.94 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 K 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 K 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 73.94 31.71 67.00 74.74 32.13 65.03 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 56.59 52.03 70.37 55.28 50.47 70.94 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 K 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 K 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 73.94 31.71 67.00 74.74 32.13 65.03 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 56.59 52.03 70.37 55.28 50.47 70.94 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 K 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 K 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 73.94 31.71 67.00 74.74 32.13 65.03 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 56.59 52.03 70.37 55.28 50.47 70.94 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 K 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 K 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 73.94 31.71 67.00 74.74 32.13 65.03 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 56.59 52.03 70.37 55.28 50.47 70.94 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 K 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 K 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 73.94 31.71 67.00 74.74 32.13 65.03 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 56.59 52.03 70.37 55.28 50.47 70.94 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 K 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 K 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 73.94 31.71 67.00 74.74 32.13 65.03 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 56.59 52.03 70.37 55.28 50.47 70.94 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c10 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c10 naa= 2 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 L 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 L 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 45.97 9.66 56.63 45.65 9.77 54.50 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 66.14 27.14 60.19 64.84 27.91 61.76 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 L 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 L 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 45.97 9.66 56.63 45.65 9.77 54.50 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 66.14 27.14 60.19 64.84 27.91 61.76 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 L 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 L 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 45.97 9.66 56.63 45.65 9.77 54.50 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 66.14 27.14 60.19 64.84 27.91 61.76 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 L 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 L 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 45.97 9.66 56.63 45.65 9.77 54.50 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 66.14 27.14 60.19 64.84 27.91 61.76 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 L 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 L 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 45.97 9.66 56.63 45.65 9.77 54.50 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 66.14 27.14 60.19 64.84 27.91 61.76 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 L 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 L 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 45.97 9.66 56.63 45.65 9.77 54.50 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 66.14 27.14 60.19 64.84 27.91 61.76 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 L 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 L 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 45.97 9.66 56.63 45.65 9.77 54.50 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 66.14 27.14 60.19 64.84 27.91 61.76 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 L 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 L 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 45.97 9.66 56.63 45.65 9.77 54.50 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 66.14 27.14 60.19 64.84 27.91 61.76 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c11 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c11 naa= 2 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 M 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 M 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 M 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 M 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 M 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 M 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 M 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 M 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 M 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 M 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 M 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 M 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 M 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 M 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 M 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 M 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c12 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c12 naa= 2 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 N 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 N 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 N 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 N 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 N 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 N 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 N 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 N 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 N 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 N 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 N 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 N 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 N 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 N 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 N 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 N 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c13 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c13 naa= 2 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 O 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 O 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 O 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 O 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 O 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 O 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 O 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 O 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 O 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 O 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 O 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 O 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 O 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 O 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 O 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 O 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c14 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c14 naa= 2 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 P 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 P 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 P 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 P 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 P 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 P 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 P 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 P 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 P 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 P 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 P 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 P 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 P 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 P 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 P 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 P 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c15 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c15 naa= 2 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 Q 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 Q 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 Q 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 Q 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 Q 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 Q 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 Q 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 Q 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 Q 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 Q 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 Q 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 Q 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 Q 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 Q 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 Q 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 Q 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c16 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c16 naa= 2 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 R 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 R 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -102.35 28.87 93.43 -103.07 27.30 92.22 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -85.39 41.55 76.77 -86.50 43.25 77.42 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 R 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 R 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -102.35 28.87 93.43 -103.07 27.30 92.22 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -85.39 41.55 76.77 -86.50 43.25 77.42 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 R 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 R 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -102.35 28.87 93.43 -103.07 27.30 92.22 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -85.39 41.55 76.77 -86.50 43.25 77.42 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 R 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 R 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -102.35 28.87 93.43 -103.07 27.30 92.22 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -85.39 41.55 76.77 -86.50 43.25 77.42 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 R 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 R 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -102.35 28.87 93.43 -103.07 27.30 92.22 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -85.39 41.55 76.77 -86.50 43.25 77.42 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 R 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 R 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -102.35 28.87 93.43 -103.07 27.30 92.22 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -85.39 41.55 76.77 -86.50 43.25 77.42 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 R 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 R 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -102.35 28.87 93.43 -103.07 27.30 92.22 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -85.39 41.55 76.77 -86.50 43.25 77.42 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 R 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 R 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -102.35 28.87 93.43 -103.07 27.30 92.22 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -85.39 41.55 76.77 -86.50 43.25 77.42 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c17 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c17 naa= 2 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 S 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 S 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 S 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 S 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 S 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 S 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 S 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 S 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 S 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 S 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 S 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 S 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 S 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 S 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 S 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 S 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c18 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c18 naa= 2 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 T 117 GLU A 23 GLU.? 13.04 O2 EDO A 125 T 171 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 T 117 GLU A 43 GLU.? 14.35 O2 EDO A 124 T 171 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 T 117 GLU A 59 GLU.? 11.26 O1 EDO A 125 T 171 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 T 117 GLU A 70 GLU^? 16.40 O1 EDO A 125 T 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 T 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 T 171 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 T 117 GLU B 23 GLU.? 12.57 O2 EDO A 125 T 171 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 T 117 GLU B 43 GLU.? 19.28 O2 EDO A 125 T 171 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 T 117 GLU B 59 GLU.? 24.69 C1 EDO A 124 T 171 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1gt7_c19 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 8 hits 1gt7_c19 naa= 2 ULMN 2 1gxs_c00 HYDROXYNITRILE LYASE user 1 2 # 1 B 359 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 414 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 19.87 27.33 34.69 20.64 25.50 33.93 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 19.56 24.32 30.75 21.02 23.43 29.63 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1gxs_c00 HYDROXYNITRILE LYASE user 2 2 # 2 B 359 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 414 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 19.87 27.33 34.69 20.64 25.50 33.93 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 19.56 24.32 30.75 21.02 23.43 29.63 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1gxs_c00 source 1gxs HYDROXYNITRILE LYASE : 2 hits 1gxs_c00 naa= 2 ULMN 2 1gxs_c01 HYDROXYNITRILE LYASE user 1 2 # 1 D 359 ASP A 86 ASP^? 9.05 O1 EDO A 125 D 414 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 15.86 38.72 50.59 16.43 40.44 51.72 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 13.86 41.90 53.88 14.61 42.67 55.63 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1gxs_c01 HYDROXYNITRILE LYASE user 2 2 # 2 D 359 ASP B 86 ASP^? 26.97 C1 EDO A 124 D 414 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 15.86 38.72 50.59 16.43 40.44 51.72 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 13.86 41.90 53.88 14.61 42.67 55.63 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1gxs_c01 source 1gxs HYDROXYNITRILE LYASE : 2 hits 1gxs_c01 naa= 2 ULMN 2 1gxs_c02 HYDROXYNITRILE LYASE user 1 2 # 1 A 158 SER A 62 SER~? 19.90 O1 EDO A 125 A 270 TRP A 80 TRP^? 10.72 O1 EDO A 125 coo 25.48 22.83 23.91 26.62 20.91 22.80 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo 26.21 16.34 30.64 26.07 17.11 34.49 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 ULMN 2 1gxs_c02 HYDROXYNITRILE LYASE user 2 2 # 2 A 158 SER B 62 SER~? 23.65 O1 EDO A 124 A 270 TRP B 80 TRP^? 20.31 C1 EDO A 124 coo 25.48 22.83 23.91 26.62 20.91 22.80 -46.80 -18.27 -18.25 -47.35 -17.46 -16.02 coo 26.21 16.34 30.64 26.07 17.11 34.49 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 1gxs_c02 source 1gxs HYDROXYNITRILE LYASE : 2 hits 1gxs_c02 naa= 2 ULMN 2 1gxs_c03 HYDROXYNITRILE LYASE user 1 2 # 1 C 158 SER A 62 SER~? 19.90 O1 EDO A 125 C 270 TRP A 80 TRP^? 10.72 O1 EDO A 125 coo 14.97 42.83 62.88 15.69 44.52 64.50 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo 20.39 49.02 58.05 22.47 47.58 55.04 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 ULMN 2 1gxs_c03 HYDROXYNITRILE LYASE user 2 2 # 2 C 158 SER B 62 SER~? 23.65 O1 EDO A 124 C 270 TRP B 80 TRP^? 20.31 C1 EDO A 124 coo 14.97 42.83 62.88 15.69 44.52 64.50 -46.80 -18.27 -18.25 -47.35 -17.46 -16.02 coo 20.39 49.02 58.05 22.47 47.58 55.04 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 1gxs_c03 source 1gxs HYDROXYNITRILE LYASE : 2 hits 1gxs_c03 naa= 2 ULMN 2 1gz6_c04 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 A 161 GLN A 56 GLN.? 7.55 C1 EDO A 125 A 168 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 30.61 60.18 43.12 32.20 58.75 43.39 -19.66 -52.09 -22.06 -20.64 -53.94 -21.94 coo 26.96 50.99 47.03 31.03 48.83 44.33 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 1gz6_c04 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_c04 naa= 2 ULMN 2 1gz6_c05 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 B 161 GLN A 56 GLN.? 7.55 C1 EDO A 125 B 168 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 11.63 41.41 53.68 10.57 43.11 54.39 -19.66 -52.09 -22.06 -20.64 -53.94 -21.94 coo 15.72 50.86 51.22 10.77 52.35 51.39 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 1gz6_c05 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_c05 naa= 2 ULMN 2 1gz6_c06 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 C 161 GLN A 56 GLN.? 7.55 C1 EDO A 125 C 168 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 9.35 43.88 85.05 8.40 42.18 84.19 -19.66 -52.09 -22.06 -20.64 -53.94 -21.94 coo 12.98 34.46 88.14 8.11 32.96 87.14 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 1gz6_c06 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_c06 naa= 2 ULMN 2 1gz6_c07 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 D 161 GLN A 56 GLN.? 7.55 C1 EDO A 125 D 168 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 26.49 25.12 98.45 28.11 26.53 98.40 -19.66 -52.09 -22.06 -20.64 -53.94 -21.94 coo 23.46 34.31 94.02 27.08 36.46 97.29 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 1gz6_c07 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_c07 naa= 2 ULMN 2 1h3i_c00 HISTONE H3 LYSINE 4 SPECIFIC METHYLTuser 1 2 # 1 A 293 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 335 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo -2.26 -1.00 -46.64 -4.18 -1.85 -46.58 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 8.78 9.27 -52.41 7.07 9.24 -54.63 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1h3i_c00 HISTONE H3 LYSINE 4 SPECIFIC METHYLTuser 2 2 # 2 A 293 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 335 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo -2.26 -1.00 -46.64 -4.18 -1.85 -46.58 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 8.78 9.27 -52.41 7.07 9.24 -54.63 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 1h3i_c00 source 1h3i HISTONE H3 LYSINE 4 SPECIFIC METHYLTRANSFERASE: 2 hits 1h3i_c00 naa= 2 ULMN 2 1h3i_c01 HISTONE H3 LYSINE 4 SPECIFIC METHYLTuser 1 2 # 1 B 293 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 335 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 29.22 13.17 -7.68 31.08 14.14 -7.64 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 14.33 10.29 -1.79 15.33 11.66 0.43 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1h3i_c01 HISTONE H3 LYSINE 4 SPECIFIC METHYLTuser 2 2 # 2 B 293 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 335 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo 29.22 13.17 -7.68 31.08 14.14 -7.64 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 14.33 10.29 -1.79 15.33 11.66 0.43 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 1h3i_c01 source 1h3i HISTONE H3 LYSINE 4 SPECIFIC METHYLTRANSFERASE: 2 hits 1h3i_c01 naa= 2 ULMN 2 1h4g_c00 XYLANASE user 1 2 # 1 A 94 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 184 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -0.61 25.90 13.61 -2.32 25.64 14.83 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -4.48 18.79 18.25 -4.56 20.59 17.17 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1h4g_c00 XYLANASE user 2 2 # 2 A 94 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 184 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -0.61 25.90 13.61 -2.32 25.64 14.83 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -4.48 18.79 18.25 -4.56 20.59 17.17 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1h4g_c00 XYLANASE user 3 2 # 3 A 94 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 184 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -0.61 25.90 13.61 -2.32 25.64 14.83 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -4.48 18.79 18.25 -4.56 20.59 17.17 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1h4g_c00 XYLANASE user 4 2 # 4 A 94 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 184 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -0.61 25.90 13.61 -2.32 25.64 14.83 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -4.48 18.79 18.25 -4.56 20.59 17.17 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1h4g_c00 XYLANASE user 5 2 # 5 A 94 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 184 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo -0.61 25.90 13.61 -2.32 25.64 14.83 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -4.48 18.79 18.25 -4.56 20.59 17.17 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1h4g_c00 XYLANASE user 6 2 # 6 A 94 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 184 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo -0.61 25.90 13.61 -2.32 25.64 14.83 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo -4.48 18.79 18.25 -4.56 20.59 17.17 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1h4g_c00 source 1h4g XYLANASE : 6 hits 1h4g_c00 naa= 2 ULMN 2 1h4g_c01 XYLANASE user 1 2 # 1 B 94 GLU A 23 GLU.? 13.04 O2 EDO A 125 B 184 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -25.64 30.33 24.82 -24.05 29.57 23.64 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -24.12 22.11 20.80 -23.56 23.90 21.78 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1h4g_c01 XYLANASE user 2 2 # 2 B 94 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 184 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -25.64 30.33 24.82 -24.05 29.57 23.64 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -24.12 22.11 20.80 -23.56 23.90 21.78 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1h4g_c01 XYLANASE user 3 2 # 3 B 94 GLU B 23 GLU.? 12.57 O2 EDO A 125 B 184 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -25.64 30.33 24.82 -24.05 29.57 23.64 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -24.12 22.11 20.80 -23.56 23.90 21.78 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1h4g_c01 XYLANASE user 4 2 # 4 B 94 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 184 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -25.64 30.33 24.82 -24.05 29.57 23.64 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -24.12 22.11 20.80 -23.56 23.90 21.78 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1h4g_c01 XYLANASE user 5 2 # 5 B 94 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 184 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo -25.64 30.33 24.82 -24.05 29.57 23.64 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -24.12 22.11 20.80 -23.56 23.90 21.78 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1h4g_c01 XYLANASE user 6 2 # 6 B 94 GLU B 81 GLU.? 30.69 O1 EDO A 124 B 184 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo -25.64 30.33 24.82 -24.05 29.57 23.64 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo -24.12 22.11 20.80 -23.56 23.90 21.78 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1h4g_c01 source 1h4g XYLANASE : 6 hits 1h4g_c01 naa= 2 ULMN 2 1hfe_c02 FE-ONLY HYDROGENASE (SMALLER SUBUNITuser 1 2 # 1 L 178 CYH A 46 CYH.? 11.48 C1 EDO A 124 L 237 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo -4.05 26.62 30.38 -4.37 29.15 31.48 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 3.43 24.66 24.28 -1.03 26.98 26.24 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1hfe_c02 FE-ONLY HYDROGENASE (SMALLER SUBUNITuser 2 2 # 2 L 178 CYH B 46 CYH.? 10.55 O2 EDO A 125 L 237 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo -4.05 26.62 30.38 -4.37 29.15 31.48 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo 3.43 24.66 24.28 -1.03 26.98 26.24 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1hfe_c02 source 1hfe FE-ONLY HYDROGENASE (SMALLER SUBUNIT) : 2 hits 1hfe_c02 naa= 2 ULMN 2 1hfe_c03 FE-ONLY HYDROGENASE (SMALLER SUBUNITuser 1 2 # 1 M 178 CYH A 46 CYH.? 11.48 C1 EDO A 124 M 237 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo -30.58 3.73 3.41 -31.70 1.18 3.67 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo -24.56 6.02 -4.03 -26.50 3.59 0.41 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1hfe_c03 FE-ONLY HYDROGENASE (SMALLER SUBUNITuser 2 2 # 2 M 178 CYH B 46 CYH.? 10.55 O2 EDO A 125 M 237 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo -30.58 3.73 3.41 -31.70 1.18 3.67 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo -24.56 6.02 -4.03 -26.50 3.59 0.41 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1hfe_c03 source 1hfe FE-ONLY HYDROGENASE (SMALLER SUBUNIT) : 2 hits 1hfe_c03 naa= 2 ULMN 2 1hfs_c00 STROMELYSIN-1 user 1 2 # 1 202 GLU A 23 GLU.? 13.04 O2 EDO A 125 219 MET A 93 MET?? 10.81 O2 EDO A 125 coo 30.26 31.02 25.22 30.56 33.10 25.01 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 34.01 35.68 33.47 31.29 34.11 32.92 -32.62 -43.10 -21.62 -33.95 -40.68 -24.94 ULMN 2 1hfs_c00 STROMELYSIN-1 user 2 2 # 2 202 GLU A 23 GLU.? 13.04 O2 EDO A 125 219 MET B 93 MET?? 13.65 O2 EDO A 125 coo 30.26 31.02 25.22 30.56 33.10 25.01 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 34.01 35.68 33.47 31.29 34.11 32.92 -38.81 -39.61 -21.96 -36.01 -39.35 -18.74 ULMN 2 1hfs_c00 STROMELYSIN-1 user 3 2 # 3 202 GLU A 59 GLU.? 11.26 O1 EDO A 125 219 MET A 103 MET?? 8.30 O2 EDO A 125 coo 30.26 31.02 25.22 30.56 33.10 25.01 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 34.01 35.68 33.47 31.29 34.11 32.92 -21.98 -53.69 -14.57 -25.85 -52.15 -15.50 ULMN 2 1hfs_c00 STROMELYSIN-1 user 4 2 # 4 202 GLU B 23 GLU.? 12.57 O2 EDO A 125 219 MET A 93 MET?? 10.81 O2 EDO A 125 coo 30.26 31.02 25.22 30.56 33.10 25.01 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 34.01 35.68 33.47 31.29 34.11 32.92 -32.62 -43.10 -21.62 -33.95 -40.68 -24.94 ULMN 2 1hfs_c00 STROMELYSIN-1 user 5 2 # 5 202 GLU B 23 GLU.? 12.57 O2 EDO A 125 219 MET B 93 MET?? 13.65 O2 EDO A 125 coo 30.26 31.02 25.22 30.56 33.10 25.01 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 34.01 35.68 33.47 31.29 34.11 32.92 -38.81 -39.61 -21.96 -36.01 -39.35 -18.74 ULMN 2 1hfs_c00 STROMELYSIN-1 user 6 2 # 6 202 GLU B 59 GLU.? 24.69 C1 EDO A 124 219 MET B 103 MET?? 21.79 C1 EDO A 124 coo 30.26 31.02 25.22 30.56 33.10 25.01 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 34.01 35.68 33.47 31.29 34.11 32.92 -51.26 -35.87 -29.54 -48.31 -38.03 -27.58 1hfs_c00 source 1hfs STROMELYSIN-1 : 6 hits 1hfs_c00 naa= 2 ULMN 2 1hiv_c01 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 1 2 # 1 A 25 ASP A 63 ASP~? 17.25 O1 EDO A 124 B 25 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 1.46 1.38 19.19 2.92 0.53 17.93 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 8.70 2.26 18.89 7.00 1.20 18.15 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1hiv_c01 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 2 2 # 2 A 25 ASP A 64 ASP~? 20.53 O2 EDO A 124 B 25 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 1.46 1.38 19.19 2.92 0.53 17.93 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 8.70 2.26 18.89 7.00 1.20 18.15 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1hiv_c01 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 3 2 # 3 A 25 ASP A 84 ASP.? 13.20 O1 EDO A 125 B 25 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 1.46 1.38 19.19 2.92 0.53 17.93 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 8.70 2.26 18.89 7.00 1.20 18.15 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1hiv_c01 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 4 2 # 4 A 25 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 25 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 1.46 1.38 19.19 2.92 0.53 17.93 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 8.70 2.26 18.89 7.00 1.20 18.15 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1hiv_c01 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 5 2 # 5 A 25 ASP B 63 ASP~? 17.37 O1 EDO A 124 B 25 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 1.46 1.38 19.19 2.92 0.53 17.93 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 8.70 2.26 18.89 7.00 1.20 18.15 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1hiv_c01 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 6 2 # 6 A 25 ASP B 64 ASP~? 23.62 O1 EDO A 124 B 25 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 1.46 1.38 19.19 2.92 0.53 17.93 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 8.70 2.26 18.89 7.00 1.20 18.15 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1hiv_c01 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 7 2 # 7 A 25 ASP B 84 ASP.? 30.86 C1 EDO A 124 B 25 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 1.46 1.38 19.19 2.92 0.53 17.93 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 8.70 2.26 18.89 7.00 1.20 18.15 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1hiv_c01 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 8 2 # 8 A 25 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 25 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 1.46 1.38 19.19 2.92 0.53 17.93 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 8.70 2.26 18.89 7.00 1.20 18.15 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1hiv_c01 source 1hiv HIV-1 PROTEASE (HIV-1 PR) COMPLEX WITH U75875 : 8 hits 1hiv_c01 naa= 2 ULMN 2 1hka_c00 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYuser 1 2 # 1 82 ARG A 30 ARG^? -2.97 O2 EDO A 124s 92 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo -23.57 14.27 45.50 -26.54 13.45 45.12 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo -19.84 19.95 38.99 -22.62 18.73 39.19 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1hka_c00 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYuser 2 2 # 2 82 ARG A 33 ARG.? 17.39 O2 EDO A 124 92 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo -23.57 14.27 45.50 -26.54 13.45 45.12 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo -19.84 19.95 38.99 -22.62 18.73 39.19 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1hka_c00 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYuser 3 2 # 3 82 ARG A 37 ARG^? 13.77 O1 EDO A 124 92 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -23.57 14.27 45.50 -26.54 13.45 45.12 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo -19.84 19.95 38.99 -22.62 18.73 39.19 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1hka_c00 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYuser 4 2 # 4 82 ARG A 53 ARG~? 17.45 O1 EDO A 125 92 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo -23.57 14.27 45.50 -26.54 13.45 45.12 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo -19.84 19.95 38.99 -22.62 18.73 39.19 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1hka_c00 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYuser 5 2 # 5 82 ARG B 30 ARG^? 10.56 O1 EDO A 124 92 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo -23.57 14.27 45.50 -26.54 13.45 45.12 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo -19.84 19.95 38.99 -22.62 18.73 39.19 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1hka_c00 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYuser 6 2 # 6 82 ARG B 33 ARG.? 19.94 O1 EDO A 124 92 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo -23.57 14.27 45.50 -26.54 13.45 45.12 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo -19.84 19.95 38.99 -22.62 18.73 39.19 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1hka_c00 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYuser 7 2 # 7 82 ARG B 37 ARG^? 8.36 C1 EDO A 124 92 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo -23.57 14.27 45.50 -26.54 13.45 45.12 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo -19.84 19.95 38.99 -22.62 18.73 39.19 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1hka_c00 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYuser 8 2 # 8 82 ARG B 53 ARG~? 17.71 C1 EDO A 124 92 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo -23.57 14.27 45.50 -26.54 13.45 45.12 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo -19.84 19.95 38.99 -22.62 18.73 39.19 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 1hka_c00 source 1hka 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOK: 8 hits 1hka_c00 naa= 2 ULMN 2 1hqc_c02 RUVB user 1 2 # 1 A 146 THR A 47 THR^? 4.31 C1 EDO A 124 A 205 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 69.27 81.27 188.40 69.36 79.49 187.14 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 60.88 74.26 187.44 62.57 76.37 185.94 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1hqc_c02 RUVB user 2 2 # 2 A 146 THR A 47 THR^? 4.31 C1 EDO A 124 A 205 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 69.27 81.27 188.40 69.36 79.49 187.14 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 60.88 74.26 187.44 62.57 76.37 185.94 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1hqc_c02 RUVB user 3 2 # 3 A 146 THR A 99 THR~? 7.67 C2 EDO A 125 A 205 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo 69.27 81.27 188.40 69.36 79.49 187.14 -24.60 -55.51 -20.10 -23.07 -56.46 -21.32 coo 60.88 74.26 187.44 62.57 76.37 185.94 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1hqc_c02 RUVB user 4 2 # 4 A 146 THR B 47 THR^? 9.39 O1 EDO A 124 A 205 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 69.27 81.27 188.40 69.36 79.49 187.14 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 60.88 74.26 187.44 62.57 76.37 185.94 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1hqc_c02 RUVB user 5 2 # 5 A 146 THR B 47 THR^? 9.39 O1 EDO A 124 A 205 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 69.27 81.27 188.40 69.36 79.49 187.14 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 60.88 74.26 187.44 62.57 76.37 185.94 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 1hqc_c02 source 1hqc RUVB : 5 hits 1hqc_c02 naa= 2 ULMN 2 1hqc_c03 RUVB user 1 2 # 1 B 146 THR A 47 THR^? 4.31 C1 EDO A 124 B 205 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 88.07 98.17 129.05 89.88 98.18 130.23 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 95.53 106.44 130.09 93.33 104.73 131.40 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1hqc_c03 RUVB user 2 2 # 2 B 146 THR A 47 THR^? 4.31 C1 EDO A 124 B 205 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 88.07 98.17 129.05 89.88 98.18 130.23 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 95.53 106.44 130.09 93.33 104.73 131.40 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1hqc_c03 RUVB user 3 2 # 3 B 146 THR A 99 THR~? 7.67 C2 EDO A 125 B 205 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo 88.07 98.17 129.05 89.88 98.18 130.23 -24.60 -55.51 -20.10 -23.07 -56.46 -21.32 coo 95.53 106.44 130.09 93.33 104.73 131.40 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1hqc_c03 RUVB user 4 2 # 4 B 146 THR B 47 THR^? 9.39 O1 EDO A 124 B 205 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 88.07 98.17 129.05 89.88 98.18 130.23 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 95.53 106.44 130.09 93.33 104.73 131.40 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1hqc_c03 RUVB user 5 2 # 5 B 146 THR B 47 THR^? 9.39 O1 EDO A 124 B 205 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 88.07 98.17 129.05 89.88 98.18 130.23 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 95.53 106.44 130.09 93.33 104.73 131.40 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 1hqc_c03 source 1hqc RUVB : 5 hits 1hqc_c03 naa= 2 ULMN 2 1hzd_c06 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 A 209 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 217 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 28.99 1.64 37.28 29.39 1.00 37.06 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1hzd_c06 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 A 209 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 217 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 28.99 1.64 37.28 29.39 1.00 37.06 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1hzd_c06 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 A 209 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 217 GLY A 57 GLY.? 9.42 O1 EDO A 125 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 28.99 1.64 37.28 29.39 1.00 37.06 -16.91 -49.31 -24.24 -17.01 -48.68 -23.74 ULMN 2 1hzd_c06 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 A 209 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 217 GLY A 60 GLY.? 16.17 O1 EDO A 125 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 28.99 1.64 37.28 29.39 1.00 37.06 -11.24 -44.68 -21.35 -11.80 -44.53 -21.88 ULMN 2 1hzd_c06 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 5 2 # 5 A 209 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 217 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 28.99 1.64 37.28 29.39 1.00 37.06 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1hzd_c06 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 6 2 # 6 A 209 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 217 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 28.99 1.64 37.28 29.39 1.00 37.06 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1hzd_c06 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 7 2 # 7 A 209 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 217 GLY B 57 GLY.? 23.79 C1 EDO A 124 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 28.99 1.64 37.28 29.39 1.00 37.06 -51.53 -29.44 -19.30 -51.09 -29.07 -19.90 ULMN 2 1hzd_c06 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 8 2 # 8 A 209 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 217 GLY B 60 GLY.? 23.13 C1 EDO A 124 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 28.99 1.64 37.28 29.39 1.00 37.06 -50.57 -21.34 -22.29 -50.23 -21.86 -21.81 1hzd_c06 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 8 hits 1hzd_c06 naa= 2 ULMN 2 1hzd_c07 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 B 209 GLU A 23 GLU.? 13.04 O2 EDO A 125 B 217 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -2.99 -12.62 29.03 -2.59 -12.91 29.65 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1hzd_c07 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 B 209 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 217 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -2.99 -12.62 29.03 -2.59 -12.91 29.65 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1hzd_c07 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 B 209 GLU A 59 GLU.? 11.26 O1 EDO A 125 B 217 GLY A 57 GLY.? 9.42 O1 EDO A 125 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -2.99 -12.62 29.03 -2.59 -12.91 29.65 -16.91 -49.31 -24.24 -17.01 -48.68 -23.74 ULMN 2 1hzd_c07 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 B 209 GLU A 59 GLU.? 11.26 O1 EDO A 125 B 217 GLY A 60 GLY.? 16.17 O1 EDO A 125 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -2.99 -12.62 29.03 -2.59 -12.91 29.65 -11.24 -44.68 -21.35 -11.80 -44.53 -21.88 ULMN 2 1hzd_c07 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 5 2 # 5 B 209 GLU B 23 GLU.? 12.57 O2 EDO A 125 B 217 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -2.99 -12.62 29.03 -2.59 -12.91 29.65 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1hzd_c07 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 6 2 # 6 B 209 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 217 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -2.99 -12.62 29.03 -2.59 -12.91 29.65 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1hzd_c07 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 7 2 # 7 B 209 GLU B 59 GLU.? 24.69 C1 EDO A 124 B 217 GLY B 57 GLY.? 23.79 C1 EDO A 124 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -2.99 -12.62 29.03 -2.59 -12.91 29.65 -51.53 -29.44 -19.30 -51.09 -29.07 -19.90 ULMN 2 1hzd_c07 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 8 2 # 8 B 209 GLU B 59 GLU.? 24.69 C1 EDO A 124 B 217 GLY B 60 GLY.? 23.13 C1 EDO A 124 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -2.99 -12.62 29.03 -2.59 -12.91 29.65 -50.57 -21.34 -22.29 -50.23 -21.86 -21.81 1hzd_c07 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 8 hits 1hzd_c07 naa= 2 ULMN 2 1hzd_c08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 C 209 GLU A 23 GLU.? 13.04 O2 EDO A 125 C 217 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1hzd_c08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 C 209 GLU A 43 GLU.? 14.35 O2 EDO A 124 C 217 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1hzd_c08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 C 209 GLU A 43 GLU.? 14.35 O2 EDO A 124 C 217 GLY A 75 GLY.? 13.18 O1 EDO A 125 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 ULMN 2 1hzd_c08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 C 209 GLU A 59 GLU.? 11.26 O1 EDO A 125 C 217 GLY A 57 GLY.? 9.42 O1 EDO A 125 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 -16.91 -49.31 -24.24 -17.01 -48.68 -23.74 ULMN 2 1hzd_c08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 5 2 # 5 C 209 GLU A 59 GLU.? 11.26 O1 EDO A 125 C 217 GLY A 60 GLY.? 16.17 O1 EDO A 125 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 -11.24 -44.68 -21.35 -11.80 -44.53 -21.88 ULMN 2 1hzd_c08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 6 2 # 6 C 209 GLU B 23 GLU.? 12.57 O2 EDO A 125 C 217 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1hzd_c08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 7 2 # 7 C 209 GLU B 43 GLU.? 19.28 O2 EDO A 125 C 217 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1hzd_c08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 8 2 # 8 C 209 GLU B 43 GLU.? 19.28 O2 EDO A 125 C 217 GLY B 75 GLY.? 21.06 O2 EDO A 125 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 ULMN 2 1hzd_c08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 9 2 # 9 C 209 GLU B 59 GLU.? 24.69 C1 EDO A 124 C 217 GLY B 57 GLY.? 23.79 C1 EDO A 124 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 -51.53 -29.44 -19.30 -51.09 -29.07 -19.90 ULMN 2 1hzd_c08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 10 2 # 10 C 209 GLU B 59 GLU.? 24.69 C1 EDO A 124 C 217 GLY B 60 GLY.? 23.13 C1 EDO A 124 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 -50.57 -21.34 -22.29 -50.23 -21.86 -21.81 1hzd_c08 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 10 hits 1hzd_c08 naa= 2 ULMN 2 1hzd_c09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 D 209 GLU A 23 GLU.? 13.04 O2 EDO A 125 D 217 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1hzd_c09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 D 209 GLU A 43 GLU.? 14.35 O2 EDO A 124 D 217 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1hzd_c09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 D 209 GLU A 43 GLU.? 14.35 O2 EDO A 124 D 217 GLY A 75 GLY.? 13.18 O1 EDO A 125 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 ULMN 2 1hzd_c09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 D 209 GLU A 59 GLU.? 11.26 O1 EDO A 125 D 217 GLY A 57 GLY.? 9.42 O1 EDO A 125 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 -16.91 -49.31 -24.24 -17.01 -48.68 -23.74 ULMN 2 1hzd_c09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 5 2 # 5 D 209 GLU A 59 GLU.? 11.26 O1 EDO A 125 D 217 GLY A 60 GLY.? 16.17 O1 EDO A 125 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 -11.24 -44.68 -21.35 -11.80 -44.53 -21.88 ULMN 2 1hzd_c09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 6 2 # 6 D 209 GLU B 23 GLU.? 12.57 O2 EDO A 125 D 217 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1hzd_c09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 7 2 # 7 D 209 GLU B 43 GLU.? 19.28 O2 EDO A 125 D 217 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1hzd_c09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 8 2 # 8 D 209 GLU B 43 GLU.? 19.28 O2 EDO A 125 D 217 GLY B 75 GLY.? 21.06 O2 EDO A 125 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 ULMN 2 1hzd_c09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 9 2 # 9 D 209 GLU B 59 GLU.? 24.69 C1 EDO A 124 D 217 GLY B 57 GLY.? 23.79 C1 EDO A 124 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 -51.53 -29.44 -19.30 -51.09 -29.07 -19.90 ULMN 2 1hzd_c09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 10 2 # 10 D 209 GLU B 59 GLU.? 24.69 C1 EDO A 124 D 217 GLY B 60 GLY.? 23.13 C1 EDO A 124 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 -50.57 -21.34 -22.29 -50.23 -21.86 -21.81 1hzd_c09 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 10 hits 1hzd_c09 naa= 2 ULMN 2 1hzd_c10 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 E 209 GLU A 23 GLU.? 13.04 O2 EDO A 125 E 217 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 10.22 22.22 35.51 8.60 22.81 34.29 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 8.99 16.32 35.57 8.40 16.60 35.14 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1hzd_c10 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 E 209 GLU A 43 GLU.? 14.35 O2 EDO A 124 E 217 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 10.22 22.22 35.51 8.60 22.81 34.29 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 8.99 16.32 35.57 8.40 16.60 35.14 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1hzd_c10 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 E 209 GLU A 59 GLU.? 11.26 O1 EDO A 125 E 217 GLY A 57 GLY.? 9.42 O1 EDO A 125 coo 10.22 22.22 35.51 8.60 22.81 34.29 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 8.99 16.32 35.57 8.40 16.60 35.14 -16.91 -49.31 -24.24 -17.01 -48.68 -23.74 ULMN 2 1hzd_c10 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 E 209 GLU A 59 GLU.? 11.26 O1 EDO A 125 E 217 GLY A 60 GLY.? 16.17 O1 EDO A 125 coo 10.22 22.22 35.51 8.60 22.81 34.29 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 8.99 16.32 35.57 8.40 16.60 35.14 -11.24 -44.68 -21.35 -11.80 -44.53 -21.88 ULMN 2 1hzd_c10 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 5 2 # 5 E 209 GLU B 23 GLU.? 12.57 O2 EDO A 125 E 217 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 10.22 22.22 35.51 8.60 22.81 34.29 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 8.99 16.32 35.57 8.40 16.60 35.14 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1hzd_c10 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 6 2 # 6 E 209 GLU B 43 GLU.? 19.28 O2 EDO A 125 E 217 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 10.22 22.22 35.51 8.60 22.81 34.29 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 8.99 16.32 35.57 8.40 16.60 35.14 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1hzd_c10 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 7 2 # 7 E 209 GLU B 59 GLU.? 24.69 C1 EDO A 124 E 217 GLY B 57 GLY.? 23.79 C1 EDO A 124 coo 10.22 22.22 35.51 8.60 22.81 34.29 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 8.99 16.32 35.57 8.40 16.60 35.14 -51.53 -29.44 -19.30 -51.09 -29.07 -19.90 ULMN 2 1hzd_c10 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 8 2 # 8 E 209 GLU B 59 GLU.? 24.69 C1 EDO A 124 E 217 GLY B 60 GLY.? 23.13 C1 EDO A 124 coo 10.22 22.22 35.51 8.60 22.81 34.29 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 8.99 16.32 35.57 8.40 16.60 35.14 -50.57 -21.34 -22.29 -50.23 -21.86 -21.81 1hzd_c10 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 8 hits 1hzd_c10 naa= 2 ULMN 2 1hzd_c11 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 F 209 GLU A 23 GLU.? 13.04 O2 EDO A 125 F 217 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 28.20 13.18 0.91 27.61 14.93 1.92 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 28.90 10.06 6.12 28.78 10.83 6.32 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1hzd_c11 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 F 209 GLU A 43 GLU.? 14.35 O2 EDO A 124 F 217 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 28.20 13.18 0.91 27.61 14.93 1.92 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 28.90 10.06 6.12 28.78 10.83 6.32 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1hzd_c11 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 F 209 GLU A 59 GLU.? 11.26 O1 EDO A 125 F 217 GLY A 57 GLY.? 9.42 O1 EDO A 125 coo 28.20 13.18 0.91 27.61 14.93 1.92 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 28.90 10.06 6.12 28.78 10.83 6.32 -16.91 -49.31 -24.24 -17.01 -48.68 -23.74 ULMN 2 1hzd_c11 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 F 209 GLU A 59 GLU.? 11.26 O1 EDO A 125 F 217 GLY A 60 GLY.? 16.17 O1 EDO A 125 coo 28.20 13.18 0.91 27.61 14.93 1.92 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 28.90 10.06 6.12 28.78 10.83 6.32 -11.24 -44.68 -21.35 -11.80 -44.53 -21.88 ULMN 2 1hzd_c11 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 5 2 # 5 F 209 GLU B 23 GLU.? 12.57 O2 EDO A 125 F 217 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 28.20 13.18 0.91 27.61 14.93 1.92 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 28.90 10.06 6.12 28.78 10.83 6.32 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1hzd_c11 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 6 2 # 6 F 209 GLU B 43 GLU.? 19.28 O2 EDO A 125 F 217 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 28.20 13.18 0.91 27.61 14.93 1.92 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 28.90 10.06 6.12 28.78 10.83 6.32 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1hzd_c11 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 7 2 # 7 F 209 GLU B 59 GLU.? 24.69 C1 EDO A 124 F 217 GLY B 57 GLY.? 23.79 C1 EDO A 124 coo 28.20 13.18 0.91 27.61 14.93 1.92 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 28.90 10.06 6.12 28.78 10.83 6.32 -51.53 -29.44 -19.30 -51.09 -29.07 -19.90 ULMN 2 1hzd_c11 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 8 2 # 8 F 209 GLU B 59 GLU.? 24.69 C1 EDO A 124 F 217 GLY B 60 GLY.? 23.13 C1 EDO A 124 coo 28.20 13.18 0.91 27.61 14.93 1.92 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 28.90 10.06 6.12 28.78 10.83 6.32 -50.57 -21.34 -22.29 -50.23 -21.86 -21.81 1hzd_c11 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 8 hits 1hzd_c11 naa= 2 ULMN 2 1hzd_c12 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 A 189 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 209 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 31.14 -3.99 35.34 30.92 -2.18 36.39 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1hzd_c12 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 A 189 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 209 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 31.14 -3.99 35.34 30.92 -2.18 36.39 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1hzd_c12 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 A 189 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 209 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 31.14 -3.99 35.34 30.92 -2.18 36.39 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1hzd_c12 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 A 189 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 209 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 31.14 -3.99 35.34 30.92 -2.18 36.39 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1hzd_c12 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 4 hits 1hzd_c12 naa= 2 ULMN 2 1hzd_c13 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 B 189 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 209 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 1.43 -14.98 33.07 -0.42 -14.67 32.13 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1hzd_c13 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 B 189 GLU A 81 GLU.? 16.59 O1 EDO A 125 B 209 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 1.43 -14.98 33.07 -0.42 -14.67 32.13 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1hzd_c13 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 B 189 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 209 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 1.43 -14.98 33.07 -0.42 -14.67 32.13 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1hzd_c13 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 B 189 GLU B 81 GLU.? 30.69 O1 EDO A 124 B 209 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 1.43 -14.98 33.07 -0.42 -14.67 32.13 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1hzd_c13 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 4 hits 1hzd_c13 naa= 2 ULMN 2 1hzd_c14 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 C 189 GLU A 70 GLU^? 16.40 O1 EDO A 125 C 209 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 21.57 -18.82 8.95 22.63 -17.75 7.49 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1hzd_c14 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 C 189 GLU A 81 GLU.? 16.59 O1 EDO A 125 C 209 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 21.57 -18.82 8.95 22.63 -17.75 7.49 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1hzd_c14 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 C 189 GLU B 70 GLU^? 26.28 O1 EDO A 124 C 209 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 21.57 -18.82 8.95 22.63 -17.75 7.49 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1hzd_c14 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 C 189 GLU B 81 GLU.? 30.69 O1 EDO A 124 C 209 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 21.57 -18.82 8.95 22.63 -17.75 7.49 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1hzd_c14 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 4 hits 1hzd_c14 naa= 2 ULMN 2 1hzd_c15 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 D 189 GLU A 70 GLU^? 16.40 O1 EDO A 125 D 209 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo -2.98 4.12 3.98 -4.11 2.53 4.76 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1hzd_c15 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 D 189 GLU A 81 GLU.? 16.59 O1 EDO A 125 D 209 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -2.98 4.12 3.98 -4.11 2.53 4.76 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1hzd_c15 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 D 189 GLU B 70 GLU^? 26.28 O1 EDO A 124 D 209 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo -2.98 4.12 3.98 -4.11 2.53 4.76 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1hzd_c15 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 D 189 GLU B 81 GLU.? 30.69 O1 EDO A 124 D 209 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo -2.98 4.12 3.98 -4.11 2.53 4.76 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1hzd_c15 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 4 hits 1hzd_c15 naa= 2 ULMN 2 1hzd_c16 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 E 189 GLU A 70 GLU^? 16.40 O1 EDO A 125 E 209 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 4.93 18.46 31.25 6.09 18.34 33.00 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 10.22 22.22 35.51 8.60 22.81 34.29 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1hzd_c16 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 E 189 GLU A 81 GLU.? 16.59 O1 EDO A 125 E 209 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 4.93 18.46 31.25 6.09 18.34 33.00 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 10.22 22.22 35.51 8.60 22.81 34.29 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1hzd_c16 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 E 189 GLU B 70 GLU^? 26.28 O1 EDO A 124 E 209 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 4.93 18.46 31.25 6.09 18.34 33.00 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 10.22 22.22 35.51 8.60 22.81 34.29 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1hzd_c16 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 E 189 GLU B 81 GLU.? 30.69 O1 EDO A 124 E 209 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 4.93 18.46 31.25 6.09 18.34 33.00 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 10.22 22.22 35.51 8.60 22.81 34.29 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1hzd_c16 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 4 hits 1hzd_c16 naa= 2 ULMN 2 1hzd_c17 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 F 189 GLU A 70 GLU^? 16.40 O1 EDO A 125 F 209 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 26.45 15.67 7.87 27.70 14.18 7.03 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 28.20 13.18 0.91 27.61 14.93 1.92 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1hzd_c17 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 F 189 GLU A 81 GLU.? 16.59 O1 EDO A 125 F 209 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 26.45 15.67 7.87 27.70 14.18 7.03 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 28.20 13.18 0.91 27.61 14.93 1.92 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1hzd_c17 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 F 189 GLU B 70 GLU^? 26.28 O1 EDO A 124 F 209 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 26.45 15.67 7.87 27.70 14.18 7.03 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 28.20 13.18 0.91 27.61 14.93 1.92 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1hzd_c17 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 F 189 GLU B 81 GLU.? 30.69 O1 EDO A 124 F 209 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 26.45 15.67 7.87 27.70 14.18 7.03 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 28.20 13.18 0.91 27.61 14.93 1.92 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1hzd_c17 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 4 hits 1hzd_c17 naa= 2 ULMN 2 1i1i_c00 NEUROLYSIN user 1 2 # 1 P 503 GLU A 23 GLU.? 13.04 O2 EDO A 125 P 613 TYR A 76 TYR.? 12.73 O1 EDO A 125 coo 24.56 14.95 15.74 26.34 15.44 14.68 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 22.44 18.36 18.57 25.20 18.77 18.75 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 ULMN 2 1i1i_c00 NEUROLYSIN user 2 2 # 2 P 503 GLU B 23 GLU.? 12.57 O2 EDO A 125 P 613 TYR B 76 TYR.? 17.92 O2 EDO A 125 coo 24.56 14.95 15.74 26.34 15.44 14.68 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 22.44 18.36 18.57 25.20 18.77 18.75 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 1i1i_c00 source 1i1i NEUROLYSIN : 2 hits 1i1i_c00 naa= 2 ULMN 2 1i29_c02 CSDB user 1 2 # 1 A 226 LYS A 28 LYS^? 7.39 O2 EDO A 124 A 364 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo 34.47 51.09 7.19 28.58 51.18 7.53 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 21.18 48.73 0.09 23.82 48.36 -0.97 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 2 1i29_c02 CSDB user 2 2 # 2 A 226 LYS B 28 LYS^? -17.65 O1 EDO A 124s A 364 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo 34.47 51.09 7.19 28.58 51.18 7.53 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 21.18 48.73 0.09 23.82 48.36 -0.97 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 1i29_c02 source 1i29 CSDB : 2 hits 1i29_c02 naa= 2 ULMN 2 1i6p_c00 CARBONIC ANHYDRASE user 1 2 # 1 A 44 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 46 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 8.35 49.41 35.76 6.30 49.41 35.15 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 9.94 45.87 34.71 8.97 43.01 35.28 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1i6p_c00 CARBONIC ANHYDRASE user 2 2 # 2 A 44 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 46 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 8.35 49.41 35.76 6.30 49.41 35.15 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 9.94 45.87 34.71 8.97 43.01 35.28 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1i6p_c00 CARBONIC ANHYDRASE user 3 2 # 3 A 44 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 46 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 8.35 49.41 35.76 6.30 49.41 35.15 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 9.94 45.87 34.71 8.97 43.01 35.28 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1i6p_c00 CARBONIC ANHYDRASE user 4 2 # 4 A 44 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 46 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 8.35 49.41 35.76 6.30 49.41 35.15 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 9.94 45.87 34.71 8.97 43.01 35.28 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 1i6p_c00 source 1i6p CARBONIC ANHYDRASE : 4 hits 1i6p_c00 naa= 2 ULMN 2 1i8t_c00 UDP-GALACTOPYRANOSE MUTASE user 1 2 # 1 A 40 ALA A 26 ALA^? 11.43 O2 EDO A 124 A 45 CYH A 67 CYH~? 14.35 O2 EDO A 124 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -31.83 -39.03 -32.30 -30.50 -39.69 -32.00 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 ULMN 2 1i8t_c00 UDP-GALACTOPYRANOSE MUTASE user 2 2 # 2 A 40 ALA A 26 ALA^? 11.43 O2 EDO A 124 A 45 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -31.83 -39.03 -32.30 -30.50 -39.69 -32.00 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 2 1i8t_c00 UDP-GALACTOPYRANOSE MUTASE user 3 2 # 3 A 40 ALA A 27 ALA^? 9.68 O2 EDO A 124 A 45 CYH A 67 CYH~? 14.35 O2 EDO A 124 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -31.77 -36.20 -34.87 -32.75 -35.04 -34.84 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 ULMN 2 1i8t_c00 UDP-GALACTOPYRANOSE MUTASE user 4 2 # 4 A 40 ALA A 27 ALA^? 9.68 O2 EDO A 124 A 45 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -31.77 -36.20 -34.87 -32.75 -35.04 -34.84 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 2 1i8t_c00 UDP-GALACTOPYRANOSE MUTASE user 5 2 # 5 A 40 ALA A 29 ALA^? 9.43 O2 EDO A 124 A 45 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -25.58 -35.99 -31.45 -25.46 -37.49 -31.45 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 2 1i8t_c00 UDP-GALACTOPYRANOSE MUTASE user 6 2 # 6 A 40 ALA A 55 ALA~? 6.66 O1 EDO A 125 A 45 CYH A 67 CYH~? 14.35 O2 EDO A 124 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -21.18 -46.19 -20.96 -21.62 -45.51 -22.25 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 ULMN 2 1i8t_c00 UDP-GALACTOPYRANOSE MUTASE user 7 2 # 7 A 40 ALA A 94 ALA~? 7.26 O2 EDO A 125 A 45 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -33.85 -46.06 -19.52 -34.14 -47.43 -20.08 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 ULMN 2 1i8t_c00 UDP-GALACTOPYRANOSE MUTASE user 8 2 # 8 A 40 ALA B 26 ALA^? 18.43 C1 EDO A 124 A 45 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -35.37 -36.70 -11.28 -36.61 -35.88 -11.60 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 ULMN 2 1i8t_c00 UDP-GALACTOPYRANOSE MUTASE user 9 2 # 9 A 40 ALA B 26 ALA^? 18.43 C1 EDO A 124 A 45 CYH B 67 CYH~? 18.88 O1 EDO A 124 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -35.37 -36.70 -11.28 -36.61 -35.88 -11.60 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 ULMN 2 1i8t_c00 UDP-GALACTOPYRANOSE MUTASE user 10 2 # 10 A 40 ALA B 27 ALA^? 18.83 O1 EDO A 124 A 45 CYH B 67 CYH~? 18.88 O1 EDO A 124 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -32.94 -35.10 -8.82 -31.45 -35.26 -8.89 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 ULMN 2 1i8t_c00 UDP-GALACTOPYRANOSE MUTASE user 11 2 # 11 A 40 ALA B 29 ALA^? 16.76 O1 EDO A 124 A 45 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -36.15 -29.79 -12.19 -37.52 -30.44 -12.12 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 ULMN 2 1i8t_c00 UDP-GALACTOPYRANOSE MUTASE user 12 2 # 12 A 40 ALA B 55 ALA~? 18.17 C1 EDO A 124 A 45 CYH B 67 CYH~? 18.88 O1 EDO A 124 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -46.89 -31.34 -22.78 -46.09 -31.26 -21.50 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 ULMN 2 1i8t_c00 UDP-GALACTOPYRANOSE MUTASE user 13 2 # 13 A 40 ALA B 94 ALA~? 15.22 O2 EDO A 125 A 45 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -40.74 -42.37 -23.75 -41.76 -43.26 -23.09 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 2 1i8t_c00 UDP-GALACTOPYRANOSE MUTASE user 14 2 # 14 A 40 ALA B 104 ALA.? 26.82 O2 EDO A 124 A 45 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -52.83 -34.72 -32.75 -54.04 -35.60 -32.82 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 1i8t_c00 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 14 hits 1i8t_c00 naa= 2 ULMN 2 1i8t_c01 UDP-GALACTOPYRANOSE MUTASE user 1 2 # 1 B 40 ALA A 26 ALA^? 11.43 O2 EDO A 124 B 45 CYH A 67 CYH~? 14.35 O2 EDO A 124 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -31.83 -39.03 -32.30 -30.50 -39.69 -32.00 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 ULMN 2 1i8t_c01 UDP-GALACTOPYRANOSE MUTASE user 2 2 # 2 B 40 ALA A 26 ALA^? 11.43 O2 EDO A 124 B 45 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -31.83 -39.03 -32.30 -30.50 -39.69 -32.00 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 2 1i8t_c01 UDP-GALACTOPYRANOSE MUTASE user 3 2 # 3 B 40 ALA A 27 ALA^? 9.68 O2 EDO A 124 B 45 CYH A 67 CYH~? 14.35 O2 EDO A 124 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -31.77 -36.20 -34.87 -32.75 -35.04 -34.84 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 ULMN 2 1i8t_c01 UDP-GALACTOPYRANOSE MUTASE user 4 2 # 4 B 40 ALA A 27 ALA^? 9.68 O2 EDO A 124 B 45 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -31.77 -36.20 -34.87 -32.75 -35.04 -34.84 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 2 1i8t_c01 UDP-GALACTOPYRANOSE MUTASE user 5 2 # 5 B 40 ALA A 29 ALA^? 9.43 O2 EDO A 124 B 45 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -25.58 -35.99 -31.45 -25.46 -37.49 -31.45 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 2 1i8t_c01 UDP-GALACTOPYRANOSE MUTASE user 6 2 # 6 B 40 ALA A 55 ALA~? 6.66 O1 EDO A 125 B 45 CYH A 67 CYH~? 14.35 O2 EDO A 124 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -21.18 -46.19 -20.96 -21.62 -45.51 -22.25 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 ULMN 2 1i8t_c01 UDP-GALACTOPYRANOSE MUTASE user 7 2 # 7 B 40 ALA A 94 ALA~? 7.26 O2 EDO A 125 B 45 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -33.85 -46.06 -19.52 -34.14 -47.43 -20.08 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 ULMN 2 1i8t_c01 UDP-GALACTOPYRANOSE MUTASE user 8 2 # 8 B 40 ALA B 26 ALA^? 18.43 C1 EDO A 124 B 45 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -35.37 -36.70 -11.28 -36.61 -35.88 -11.60 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 ULMN 2 1i8t_c01 UDP-GALACTOPYRANOSE MUTASE user 9 2 # 9 B 40 ALA B 26 ALA^? 18.43 C1 EDO A 124 B 45 CYH B 67 CYH~? 18.88 O1 EDO A 124 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -35.37 -36.70 -11.28 -36.61 -35.88 -11.60 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 ULMN 2 1i8t_c01 UDP-GALACTOPYRANOSE MUTASE user 10 2 # 10 B 40 ALA B 27 ALA^? 18.83 O1 EDO A 124 B 45 CYH B 67 CYH~? 18.88 O1 EDO A 124 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -32.94 -35.10 -8.82 -31.45 -35.26 -8.89 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 ULMN 2 1i8t_c01 UDP-GALACTOPYRANOSE MUTASE user 11 2 # 11 B 40 ALA B 29 ALA^? 16.76 O1 EDO A 124 B 45 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -36.15 -29.79 -12.19 -37.52 -30.44 -12.12 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 ULMN 2 1i8t_c01 UDP-GALACTOPYRANOSE MUTASE user 12 2 # 12 B 40 ALA B 55 ALA~? 18.17 C1 EDO A 124 B 45 CYH B 67 CYH~? 18.88 O1 EDO A 124 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -46.89 -31.34 -22.78 -46.09 -31.26 -21.50 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 ULMN 2 1i8t_c01 UDP-GALACTOPYRANOSE MUTASE user 13 2 # 13 B 40 ALA B 94 ALA~? 15.22 O2 EDO A 125 B 45 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -40.74 -42.37 -23.75 -41.76 -43.26 -23.09 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 2 1i8t_c01 UDP-GALACTOPYRANOSE MUTASE user 14 2 # 14 B 40 ALA B 104 ALA.? 26.82 O2 EDO A 124 B 45 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -52.83 -34.72 -32.75 -54.04 -35.60 -32.82 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 1i8t_c01 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 14 hits 1i8t_c01 naa= 2 ULMN 2 1idj_c02 PECTIN LYASE A user 1 2 # 1 A 154 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 236 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 23.38 30.01 45.27 22.92 28.01 45.81 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 24.08 20.68 39.34 22.77 19.80 41.96 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1idj_c02 PECTIN LYASE A user 2 2 # 2 A 154 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 236 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 23.38 30.01 45.27 22.92 28.01 45.81 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 24.08 20.68 39.34 22.77 19.80 41.96 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1idj_c02 PECTIN LYASE A user 3 2 # 3 A 154 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 236 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 23.38 30.01 45.27 22.92 28.01 45.81 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 24.08 20.68 39.34 22.77 19.80 41.96 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1idj_c02 PECTIN LYASE A user 4 2 # 4 A 154 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 236 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 23.38 30.01 45.27 22.92 28.01 45.81 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 24.08 20.68 39.34 22.77 19.80 41.96 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1idj_c02 PECTIN LYASE A user 5 2 # 5 A 154 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 236 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 23.38 30.01 45.27 22.92 28.01 45.81 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 24.08 20.68 39.34 22.77 19.80 41.96 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1idj_c02 PECTIN LYASE A user 6 2 # 6 A 154 ASP A 64 ASP~? 20.53 O2 EDO A 124 A 236 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 23.38 30.01 45.27 22.92 28.01 45.81 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 24.08 20.68 39.34 22.77 19.80 41.96 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1idj_c02 PECTIN LYASE A user 7 2 # 7 A 154 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 236 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 23.38 30.01 45.27 22.92 28.01 45.81 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 24.08 20.68 39.34 22.77 19.80 41.96 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1idj_c02 PECTIN LYASE A user 8 2 # 8 A 154 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 236 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 23.38 30.01 45.27 22.92 28.01 45.81 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 24.08 20.68 39.34 22.77 19.80 41.96 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1idj_c02 PECTIN LYASE A user 9 2 # 9 A 154 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 236 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 23.38 30.01 45.27 22.92 28.01 45.81 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 24.08 20.68 39.34 22.77 19.80 41.96 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1idj_c02 PECTIN LYASE A user 10 2 # 10 A 154 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 236 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 23.38 30.01 45.27 22.92 28.01 45.81 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 24.08 20.68 39.34 22.77 19.80 41.96 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1idj_c02 PECTIN LYASE A user 11 2 # 11 A 154 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 236 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 23.38 30.01 45.27 22.92 28.01 45.81 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 24.08 20.68 39.34 22.77 19.80 41.96 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1idj_c02 PECTIN LYASE A user 12 2 # 12 A 154 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 236 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 23.38 30.01 45.27 22.92 28.01 45.81 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 24.08 20.68 39.34 22.77 19.80 41.96 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1idj_c02 source 1idj PECTIN LYASE A : 12 hits 1idj_c02 naa= 2 ULMN 2 1idj_c03 PECTIN LYASE A user 1 2 # 1 B 154 ASP A 32 ASP^? 7.79 O1 EDO A 124 B 236 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 34.14 70.03 63.55 33.67 72.04 63.02 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 34.83 79.32 69.54 33.52 80.22 66.94 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1idj_c03 PECTIN LYASE A user 2 2 # 2 B 154 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 236 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 34.14 70.03 63.55 33.67 72.04 63.02 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 34.83 79.32 69.54 33.52 80.22 66.94 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1idj_c03 PECTIN LYASE A user 3 2 # 3 B 154 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 236 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 34.14 70.03 63.55 33.67 72.04 63.02 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 34.83 79.32 69.54 33.52 80.22 66.94 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1idj_c03 PECTIN LYASE A user 4 2 # 4 B 154 ASP A 63 ASP~? 17.25 O1 EDO A 124 B 236 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 34.14 70.03 63.55 33.67 72.04 63.02 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 34.83 79.32 69.54 33.52 80.22 66.94 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1idj_c03 PECTIN LYASE A user 5 2 # 5 B 154 ASP A 63 ASP~? 17.25 O1 EDO A 124 B 236 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 34.14 70.03 63.55 33.67 72.04 63.02 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 34.83 79.32 69.54 33.52 80.22 66.94 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1idj_c03 PECTIN LYASE A user 6 2 # 6 B 154 ASP A 64 ASP~? 20.53 O2 EDO A 124 B 236 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 34.14 70.03 63.55 33.67 72.04 63.02 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 34.83 79.32 69.54 33.52 80.22 66.94 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1idj_c03 PECTIN LYASE A user 7 2 # 7 B 154 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 236 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 34.14 70.03 63.55 33.67 72.04 63.02 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 34.83 79.32 69.54 33.52 80.22 66.94 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1idj_c03 PECTIN LYASE A user 8 2 # 8 B 154 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 236 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 34.14 70.03 63.55 33.67 72.04 63.02 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 34.83 79.32 69.54 33.52 80.22 66.94 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1idj_c03 PECTIN LYASE A user 9 2 # 9 B 154 ASP B 63 ASP~? 17.37 O1 EDO A 124 B 236 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 34.14 70.03 63.55 33.67 72.04 63.02 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 34.83 79.32 69.54 33.52 80.22 66.94 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1idj_c03 PECTIN LYASE A user 10 2 # 10 B 154 ASP B 63 ASP~? 17.37 O1 EDO A 124 B 236 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 34.14 70.03 63.55 33.67 72.04 63.02 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 34.83 79.32 69.54 33.52 80.22 66.94 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1idj_c03 PECTIN LYASE A user 11 2 # 11 B 154 ASP B 63 ASP~? 17.37 O1 EDO A 124 B 236 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 34.14 70.03 63.55 33.67 72.04 63.02 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 34.83 79.32 69.54 33.52 80.22 66.94 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1idj_c03 PECTIN LYASE A user 12 2 # 12 B 154 ASP B 64 ASP~? 23.62 O1 EDO A 124 B 236 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 34.14 70.03 63.55 33.67 72.04 63.02 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 34.83 79.32 69.54 33.52 80.22 66.94 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1idj_c03 source 1idj PECTIN LYASE A : 12 hits 1idj_c03 naa= 2 ULMN 2 1ima_c00 INOSITOL MONOPHOSPHATASE (E.C.3.1.3.user 1 2 # 1 A 70 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 95 THR A 47 THR^? 4.31 C1 EDO A 124 coo 9.44 55.07 5.90 7.73 55.00 7.18 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 0.81 57.04 9.53 1.79 56.94 7.62 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 ULMN 2 1ima_c00 INOSITOL MONOPHOSPHATASE (E.C.3.1.3.user 2 2 # 2 A 70 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 95 THR A 82 THR.? 18.68 O1 EDO A 125 coo 9.44 55.07 5.90 7.73 55.00 7.18 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 0.81 57.04 9.53 1.79 56.94 7.62 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 ULMN 2 1ima_c00 INOSITOL MONOPHOSPHATASE (E.C.3.1.3.user 3 2 # 3 A 70 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 95 THR B 47 THR^? 9.39 O1 EDO A 124 coo 9.44 55.07 5.90 7.73 55.00 7.18 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 0.81 57.04 9.53 1.79 56.94 7.62 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 ULMN 2 1ima_c00 INOSITOL MONOPHOSPHATASE (E.C.3.1.3.user 4 2 # 4 A 70 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 95 THR B 82 THR.? 29.24 O1 EDO A 124 coo 9.44 55.07 5.90 7.73 55.00 7.18 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 0.81 57.04 9.53 1.79 56.94 7.62 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 1ima_c00 source 1ima INOSITOL MONOPHOSPHATASE (E.C.3.1.3.25) COMPLE: 4 hits 1ima_c00 naa= 2 ULMN 2 1ima_c01 INOSITOL MONOPHOSPHATASE (E.C.3.1.3.user 1 2 # 1 B 70 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 95 THR A 47 THR^? 4.31 C1 EDO A 124 coo -14.76 52.04 41.84 -13.24 52.19 40.40 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -6.40 55.00 38.40 -7.32 54.60 40.33 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 ULMN 2 1ima_c01 INOSITOL MONOPHOSPHATASE (E.C.3.1.3.user 2 2 # 2 B 70 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 95 THR A 82 THR.? 18.68 O1 EDO A 125 coo -14.76 52.04 41.84 -13.24 52.19 40.40 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -6.40 55.00 38.40 -7.32 54.60 40.33 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 ULMN 2 1ima_c01 INOSITOL MONOPHOSPHATASE (E.C.3.1.3.user 3 2 # 3 B 70 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 95 THR B 47 THR^? 9.39 O1 EDO A 124 coo -14.76 52.04 41.84 -13.24 52.19 40.40 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -6.40 55.00 38.40 -7.32 54.60 40.33 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 ULMN 2 1ima_c01 INOSITOL MONOPHOSPHATASE (E.C.3.1.3.user 4 2 # 4 B 70 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 95 THR B 82 THR.? 29.24 O1 EDO A 124 coo -14.76 52.04 41.84 -13.24 52.19 40.40 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -6.40 55.00 38.40 -7.32 54.60 40.33 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 1ima_c01 source 1ima INOSITOL MONOPHOSPHATASE (E.C.3.1.3.25) COMPLE: 4 hits 1ima_c01 naa= 2 ULMN 2 1inp_c00 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 2 # 1 133 ASP A 41 ASP^? -2.91 O2 EDO A 124s 158 THR B 82 THR.? 29.24 O1 EDO A 124 coo -28.29 -4.39 34.54 -29.89 -5.44 33.65 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 ULMN 2 1inp_c00 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 2 # 2 133 ASP B 41 ASP^? 12.31 O1 EDO A 124 158 THR A 82 THR.? 18.68 O1 EDO A 125 coo -28.29 -4.39 34.54 -29.89 -5.44 33.65 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 1inp_c00 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 2 hits 1inp_c00 naa= 2 ULMN 2 1inp_c01 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 2 # 1 37 LYS A 28 LYS^? 7.39 O2 EDO A 124 158 THR A 47 THR^? 4.31 C1 EDO A 124 coo 2.85 17.07 38.64 -1.64 15.65 41.27 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 ULMN 2 1inp_c01 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 2 # 2 37 LYS B 28 LYS^? -17.65 O1 EDO A 124s 158 THR B 47 THR^? 9.39 O1 EDO A 124 coo 2.85 17.07 38.64 -1.64 15.65 41.27 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 1inp_c01 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 2 hits 1inp_c01 naa= 2 ULMN 2 1inp_c03 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 2 # 1 79 GLU A 43 GLU.? 14.35 O2 EDO A 124 158 THR A 47 THR^? 4.31 C1 EDO A 124 coo -6.22 13.24 31.73 -5.30 13.57 33.58 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 ULMN 2 1inp_c03 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 2 # 2 79 GLU A 59 GLU.? 11.26 O1 EDO A 125 158 THR A 99 THR~? 7.67 C2 EDO A 125 coo -6.22 13.24 31.73 -5.30 13.57 33.58 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -24.60 -55.51 -20.10 -23.07 -56.46 -21.32 ULMN 2 1inp_c03 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 2 # 3 79 GLU A 70 GLU^? 16.40 O1 EDO A 125 158 THR A 82 THR.? 18.68 O1 EDO A 125 coo -6.22 13.24 31.73 -5.30 13.57 33.58 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 ULMN 2 1inp_c03 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 4 2 # 4 79 GLU B 43 GLU.? 19.28 O2 EDO A 125 158 THR B 47 THR^? 9.39 O1 EDO A 124 coo -6.22 13.24 31.73 -5.30 13.57 33.58 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 ULMN 2 1inp_c03 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 5 2 # 5 79 GLU B 59 GLU.? 24.69 C1 EDO A 124 158 THR B 99 THR.? 28.08 C1 EDO A 124 coo -6.22 13.24 31.73 -5.30 13.57 33.58 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -53.39 -38.76 -24.48 -55.06 -37.90 -23.47 ULMN 2 1inp_c03 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 6 2 # 6 79 GLU B 70 GLU^? 26.28 O1 EDO A 124 158 THR B 82 THR.? 29.24 O1 EDO A 124 coo -6.22 13.24 31.73 -5.30 13.57 33.58 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 1inp_c03 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 6 hits 1inp_c03 naa= 2 ULMN 2 1ir3_c00 INSULIN RECEPTOR user 1 2 # 1 A1132 ASP A 32 ASP^? 7.79 O1 EDO A 124 A1136 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo -27.05 34.58 17.12 -25.81 32.84 17.16 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -21.15 30.60 15.10 -21.49 31.93 17.86 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1ir3_c00 INSULIN RECEPTOR user 2 2 # 2 A1132 ASP A 32 ASP^? 7.79 O1 EDO A 124 A1136 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -21.15 30.60 15.10 -21.49 31.93 17.86 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1ir3_c00 INSULIN RECEPTOR user 3 2 # 3 A1132 ASP A 32 ASP^? 7.79 O1 EDO A 124 A1136 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -21.15 30.60 15.10 -21.49 31.93 17.86 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1ir3_c00 INSULIN RECEPTOR user 4 2 # 4 A1132 ASP A 41 ASP^? -2.91 O2 EDO A 124s A1136 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo -27.05 34.58 17.12 -25.81 32.84 17.16 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo -21.15 30.60 15.10 -21.49 31.93 17.86 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1ir3_c00 INSULIN RECEPTOR user 5 2 # 5 A1132 ASP A 63 ASP~? 17.25 O1 EDO A 124 A1136 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo -21.15 30.60 15.10 -21.49 31.93 17.86 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1ir3_c00 INSULIN RECEPTOR user 6 2 # 6 A1132 ASP A 64 ASP~? 20.53 O2 EDO A 124 A1136 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo -21.15 30.60 15.10 -21.49 31.93 17.86 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1ir3_c00 INSULIN RECEPTOR user 7 2 # 7 A1132 ASP B 32 ASP^? 9.42 O1 EDO A 124 A1136 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -21.15 30.60 15.10 -21.49 31.93 17.86 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1ir3_c00 INSULIN RECEPTOR user 8 2 # 8 A1132 ASP B 32 ASP^? 9.42 O1 EDO A 124 A1136 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -21.15 30.60 15.10 -21.49 31.93 17.86 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1ir3_c00 INSULIN RECEPTOR user 9 2 # 9 A1132 ASP B 32 ASP^? 9.42 O1 EDO A 124 A1136 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -21.15 30.60 15.10 -21.49 31.93 17.86 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1ir3_c00 INSULIN RECEPTOR user 10 2 # 10 A1132 ASP B 41 ASP^? 12.31 O1 EDO A 124 A1136 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo -21.15 30.60 15.10 -21.49 31.93 17.86 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1ir3_c00 INSULIN RECEPTOR user 11 2 # 11 A1132 ASP B 64 ASP~? 23.62 O1 EDO A 124 A1136 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo -21.15 30.60 15.10 -21.49 31.93 17.86 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 1ir3_c00 source 1ir3 INSULIN RECEPTOR : 11 hits 1ir3_c00 naa= 2 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 1 2 # 1 A1132 ASP A 32 ASP^? 7.79 O1 EDO A 124 A1134 ALA A 36 ALA.? 14.13 O1 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -18.11 -33.66 -20.67 -17.40 -34.10 -19.41 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 2 2 # 2 A1132 ASP A 32 ASP^? 7.79 O1 EDO A 124 A1134 ALA A 49 ALA^? 7.86 C1 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -27.58 -35.61 -22.27 -27.19 -34.24 -21.71 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 3 2 # 3 A1132 ASP A 41 ASP^? -2.91 O2 EDO A 124s A1134 ALA A 26 ALA^? 11.43 O2 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -31.83 -39.03 -32.30 -30.50 -39.69 -32.00 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 4 2 # 4 A1132 ASP A 41 ASP^? -2.91 O2 EDO A 124s A1134 ALA A 27 ALA^? 9.68 O2 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -31.77 -36.20 -34.87 -32.75 -35.04 -34.84 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 5 2 # 5 A1132 ASP A 41 ASP^? -2.91 O2 EDO A 124s A1134 ALA A 29 ALA^? 9.43 O2 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -25.58 -35.99 -31.45 -25.46 -37.49 -31.45 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 6 2 # 6 A1132 ASP A 63 ASP~? 17.25 O1 EDO A 124 A1134 ALA A 36 ALA.? 14.13 O1 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -18.11 -33.66 -20.67 -17.40 -34.10 -19.41 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 7 2 # 7 A1132 ASP A 63 ASP~? 17.25 O1 EDO A 124 A1134 ALA A 61 ALA.? 14.64 O1 EDO A 125 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -11.93 -42.70 -24.53 -13.20 -42.73 -25.33 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 8 2 # 8 A1132 ASP A 64 ASP~? 20.53 O2 EDO A 124 A1134 ALA A 61 ALA.? 14.64 O1 EDO A 125 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -11.93 -42.70 -24.53 -13.20 -42.73 -25.33 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 9 2 # 9 A1132 ASP A 64 ASP~? 20.53 O2 EDO A 124 A1134 ALA A 68 ALA.? 16.39 O1 EDO A 125 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -16.63 -39.03 -33.40 -15.61 -40.17 -33.58 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 10 2 # 10 A1132 ASP B 32 ASP^? 9.42 O1 EDO A 124 A1134 ALA B 36 ALA.? 11.83 C1 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -37.66 -22.00 -23.01 -38.34 -21.47 -24.23 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 11 2 # 11 A1132 ASP B 32 ASP^? 9.42 O1 EDO A 124 A1134 ALA B 49 ALA^? 7.26 C1 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -35.14 -31.27 -21.36 -34.12 -30.27 -21.87 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 12 2 # 12 A1132 ASP B 41 ASP^? 12.31 O1 EDO A 124 A1134 ALA B 26 ALA^? 18.43 C1 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -35.37 -36.70 -11.28 -36.61 -35.88 -11.60 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 13 2 # 13 A1132 ASP B 41 ASP^? 12.31 O1 EDO A 124 A1134 ALA B 27 ALA^? 18.83 O1 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -32.94 -35.10 -8.82 -31.45 -35.26 -8.89 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 14 2 # 14 A1132 ASP B 41 ASP^? 12.31 O1 EDO A 124 A1134 ALA B 29 ALA^? 16.76 O1 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -36.15 -29.79 -12.19 -37.52 -30.44 -12.12 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 15 2 # 15 A1132 ASP B 63 ASP~? 17.37 O1 EDO A 124 A1134 ALA B 36 ALA.? 11.83 C1 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -37.66 -22.00 -23.01 -38.34 -21.47 -24.23 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 16 2 # 16 A1132 ASP B 63 ASP~? 17.37 O1 EDO A 124 A1134 ALA B 61 ALA.? 21.66 C1 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -48.78 -21.46 -18.93 -48.15 -22.68 -18.28 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 17 2 # 17 A1132 ASP B 64 ASP~? 23.62 O1 EDO A 124 A1134 ALA B 61 ALA.? 21.66 C1 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -48.78 -21.46 -18.93 -48.15 -22.68 -18.28 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 18 2 # 18 A1132 ASP B 64 ASP~? 23.62 O1 EDO A 124 A1134 ALA B 68 ALA.? 23.26 O1 EDO A 124 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -43.26 -23.68 -10.03 -44.76 -23.42 -9.87 1ir3_c01 source 1ir3 INSULIN RECEPTOR : 18 hits 1ir3_c01 naa= 2 ULMN 2 1it4_c00 PHOSPHOLIPASE A2 user 1 2 # 1 A 64 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 85 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 6.39 13.83 33.30 4.37 13.42 33.17 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 2.06 10.49 36.48 1.25 11.00 34.58 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1it4_c00 PHOSPHOLIPASE A2 user 2 2 # 2 A 64 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 85 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 6.39 13.83 33.30 4.37 13.42 33.17 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 2.06 10.49 36.48 1.25 11.00 34.58 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1it4_c00 PHOSPHOLIPASE A2 user 3 2 # 3 A 64 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 85 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 6.39 13.83 33.30 4.37 13.42 33.17 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 2.06 10.49 36.48 1.25 11.00 34.58 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1it4_c00 PHOSPHOLIPASE A2 user 4 2 # 4 A 64 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 85 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 6.39 13.83 33.30 4.37 13.42 33.17 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 2.06 10.49 36.48 1.25 11.00 34.58 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1it4_c00 source 1it4 PHOSPHOLIPASE A2 : 4 hits 1it4_c00 naa= 2 ULMN 2 1itx_c02 GLYCOSYL HYDROLASE user 1 2 # 1 A 200 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 204 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 1.52 9.98 32.08 2.12 9.01 30.34 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 7.79 1.83 27.81 9.08 3.25 26.92 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1itx_c02 GLYCOSYL HYDROLASE user 2 2 # 2 A 200 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 204 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 1.52 9.98 32.08 2.12 9.01 30.34 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 7.79 1.83 27.81 9.08 3.25 26.92 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1itx_c02 GLYCOSYL HYDROLASE user 3 2 # 3 A 200 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 204 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 1.52 9.98 32.08 2.12 9.01 30.34 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 7.79 1.83 27.81 9.08 3.25 26.92 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1itx_c02 GLYCOSYL HYDROLASE user 4 2 # 4 A 200 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 204 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 1.52 9.98 32.08 2.12 9.01 30.34 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 7.79 1.83 27.81 9.08 3.25 26.92 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1itx_c02 GLYCOSYL HYDROLASE user 5 2 # 5 A 200 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 204 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 1.52 9.98 32.08 2.12 9.01 30.34 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 7.79 1.83 27.81 9.08 3.25 26.92 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1itx_c02 GLYCOSYL HYDROLASE user 6 2 # 6 A 200 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 204 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 1.52 9.98 32.08 2.12 9.01 30.34 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 7.79 1.83 27.81 9.08 3.25 26.92 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1itx_c02 source 1itx GLYCOSYL HYDROLASE : 6 hits 1itx_c02 naa= 2 ULMN 2 1j49_c02 D-LACTATE DEHYDROGENASE user 1 2 # 1 A 265 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 297 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 47.07 34.33 103.36 48.88 33.52 104.12 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 51.04 30.36 104.92 51.06 31.23 106.83 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1j49_c02 D-LACTATE DEHYDROGENASE user 2 2 # 2 A 265 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 297 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 47.07 34.33 103.36 48.88 33.52 104.12 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 51.04 30.36 104.92 51.06 31.23 106.83 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1j49_c02 D-LACTATE DEHYDROGENASE user 3 2 # 3 A 265 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 297 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 47.07 34.33 103.36 48.88 33.52 104.12 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 51.04 30.36 104.92 51.06 31.23 106.83 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 ULMN 2 1j49_c02 D-LACTATE DEHYDROGENASE user 4 2 # 4 A 265 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 297 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 47.07 34.33 103.36 48.88 33.52 104.12 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 51.04 30.36 104.92 51.06 31.23 106.83 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1j49_c02 source 1j49 D-LACTATE DEHYDROGENASE : 4 hits 1j49_c02 naa= 2 ULMN 2 1j49_c03 D-LACTATE DEHYDROGENASE user 1 2 # 1 B 265 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 297 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 80.24 24.01 79.32 80.63 24.74 81.26 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 80.60 28.06 83.54 82.56 27.56 84.07 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1j49_c03 D-LACTATE DEHYDROGENASE user 2 2 # 2 B 265 GLU A 81 GLU.? 16.59 O1 EDO A 125 B 297 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 80.24 24.01 79.32 80.63 24.74 81.26 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 80.60 28.06 83.54 82.56 27.56 84.07 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1j49_c03 D-LACTATE DEHYDROGENASE user 3 2 # 3 B 265 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 297 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 80.24 24.01 79.32 80.63 24.74 81.26 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 80.60 28.06 83.54 82.56 27.56 84.07 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 ULMN 2 1j49_c03 D-LACTATE DEHYDROGENASE user 4 2 # 4 B 265 GLU B 81 GLU.? 30.69 O1 EDO A 124 B 297 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 80.24 24.01 79.32 80.63 24.74 81.26 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 80.60 28.06 83.54 82.56 27.56 84.07 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1j49_c03 source 1j49 D-LACTATE DEHYDROGENASE : 4 hits 1j49_c03 naa= 2 ULMN 2 1j53_c01 DNA POLYMERASE III, EPSILON CHAIN user 1 2 # 1 A 14 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 162 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1j53_c01 DNA POLYMERASE III, EPSILON CHAIN user 2 2 # 2 A 14 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 162 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1j53_c01 DNA POLYMERASE III, EPSILON CHAIN user 3 2 # 3 A 14 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 162 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 ULMN 2 1j53_c01 DNA POLYMERASE III, EPSILON CHAIN user 4 2 # 4 A 14 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 162 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1j53_c01 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 4 hits 1j53_c01 naa= 2 ULMN 2 1jag_c00 DEOXYGUANOSINE KINASE user 1 2 # 1 A 70 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 142 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 41.69 114.28 15.66 40.58 112.97 16.94 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 35.72 115.53 15.77 35.79 117.41 13.37 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1jag_c00 DEOXYGUANOSINE KINASE user 2 2 # 2 A 70 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 142 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 41.69 114.28 15.66 40.58 112.97 16.94 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 35.72 115.53 15.77 35.79 117.41 13.37 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1jag_c00 DEOXYGUANOSINE KINASE user 3 2 # 3 A 70 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 142 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 41.69 114.28 15.66 40.58 112.97 16.94 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 35.72 115.53 15.77 35.79 117.41 13.37 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1jag_c00 DEOXYGUANOSINE KINASE user 4 2 # 4 A 70 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 142 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo 41.69 114.28 15.66 40.58 112.97 16.94 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 35.72 115.53 15.77 35.79 117.41 13.37 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1jag_c00 DEOXYGUANOSINE KINASE user 5 2 # 5 A 70 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 142 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 41.69 114.28 15.66 40.58 112.97 16.94 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 35.72 115.53 15.77 35.79 117.41 13.37 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1jag_c00 DEOXYGUANOSINE KINASE user 6 2 # 6 A 70 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 142 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 41.69 114.28 15.66 40.58 112.97 16.94 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 35.72 115.53 15.77 35.79 117.41 13.37 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1jag_c00 DEOXYGUANOSINE KINASE user 7 2 # 7 A 70 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 142 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 41.69 114.28 15.66 40.58 112.97 16.94 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 35.72 115.53 15.77 35.79 117.41 13.37 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1jag_c00 source 1jag DEOXYGUANOSINE KINASE : 7 hits 1jag_c00 naa= 2 ULMN 2 1jag_c01 DEOXYGUANOSINE KINASE user 1 2 # 1 B 70 GLU A 23 GLU.? 13.04 O2 EDO A 125 B 142 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 31.07 79.69 19.07 32.57 81.08 19.72 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 36.62 78.39 16.92 35.66 76.33 14.89 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1jag_c01 DEOXYGUANOSINE KINASE user 2 2 # 2 B 70 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 142 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 31.07 79.69 19.07 32.57 81.08 19.72 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 36.62 78.39 16.92 35.66 76.33 14.89 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1jag_c01 DEOXYGUANOSINE KINASE user 3 2 # 3 B 70 GLU A 59 GLU.? 11.26 O1 EDO A 125 B 142 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 31.07 79.69 19.07 32.57 81.08 19.72 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 36.62 78.39 16.92 35.66 76.33 14.89 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1jag_c01 DEOXYGUANOSINE KINASE user 4 2 # 4 B 70 GLU A 59 GLU.? 11.26 O1 EDO A 125 B 142 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo 31.07 79.69 19.07 32.57 81.08 19.72 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 36.62 78.39 16.92 35.66 76.33 14.89 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1jag_c01 DEOXYGUANOSINE KINASE user 5 2 # 5 B 70 GLU B 23 GLU.? 12.57 O2 EDO A 125 B 142 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 31.07 79.69 19.07 32.57 81.08 19.72 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 36.62 78.39 16.92 35.66 76.33 14.89 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1jag_c01 DEOXYGUANOSINE KINASE user 6 2 # 6 B 70 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 142 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 31.07 79.69 19.07 32.57 81.08 19.72 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 36.62 78.39 16.92 35.66 76.33 14.89 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1jag_c01 DEOXYGUANOSINE KINASE user 7 2 # 7 B 70 GLU B 59 GLU.? 24.69 C1 EDO A 124 B 142 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 31.07 79.69 19.07 32.57 81.08 19.72 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 36.62 78.39 16.92 35.66 76.33 14.89 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1jag_c01 source 1jag DEOXYGUANOSINE KINASE : 7 hits 1jag_c01 naa= 2 ULMN 2 1jag_c02 DEOXYGUANOSINE KINASE user 1 2 # 1 C 70 GLU A 23 GLU.? 13.04 O2 EDO A 125 C 142 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 55.48 107.82 136.32 56.60 106.34 135.24 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 61.38 109.25 135.73 61.32 111.53 137.75 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1jag_c02 DEOXYGUANOSINE KINASE user 2 2 # 2 C 70 GLU A 43 GLU.? 14.35 O2 EDO A 124 C 142 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 55.48 107.82 136.32 56.60 106.34 135.24 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 61.38 109.25 135.73 61.32 111.53 137.75 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1jag_c02 DEOXYGUANOSINE KINASE user 3 2 # 3 C 70 GLU A 59 GLU.? 11.26 O1 EDO A 125 C 142 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 55.48 107.82 136.32 56.60 106.34 135.24 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 61.38 109.25 135.73 61.32 111.53 137.75 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1jag_c02 DEOXYGUANOSINE KINASE user 4 2 # 4 C 70 GLU A 59 GLU.? 11.26 O1 EDO A 125 C 142 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo 55.48 107.82 136.32 56.60 106.34 135.24 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 61.38 109.25 135.73 61.32 111.53 137.75 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1jag_c02 DEOXYGUANOSINE KINASE user 5 2 # 5 C 70 GLU B 23 GLU.? 12.57 O2 EDO A 125 C 142 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 55.48 107.82 136.32 56.60 106.34 135.24 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 61.38 109.25 135.73 61.32 111.53 137.75 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1jag_c02 DEOXYGUANOSINE KINASE user 6 2 # 6 C 70 GLU B 43 GLU.? 19.28 O2 EDO A 125 C 142 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 55.48 107.82 136.32 56.60 106.34 135.24 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 61.38 109.25 135.73 61.32 111.53 137.75 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1jag_c02 DEOXYGUANOSINE KINASE user 7 2 # 7 C 70 GLU B 59 GLU.? 24.69 C1 EDO A 124 C 142 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 55.48 107.82 136.32 56.60 106.34 135.24 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 61.38 109.25 135.73 61.32 111.53 137.75 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1jag_c02 source 1jag DEOXYGUANOSINE KINASE : 7 hits 1jag_c02 naa= 2 ULMN 2 1jag_c03 DEOXYGUANOSINE KINASE user 1 2 # 1 D 70 GLU A 23 GLU.? 13.04 O2 EDO A 125 D 142 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 67.23 73.46 138.83 65.67 74.68 137.98 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 61.78 72.49 141.39 62.87 70.87 143.74 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1jag_c03 DEOXYGUANOSINE KINASE user 2 2 # 2 D 70 GLU A 43 GLU.? 14.35 O2 EDO A 124 D 142 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 67.23 73.46 138.83 65.67 74.68 137.98 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 61.78 72.49 141.39 62.87 70.87 143.74 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1jag_c03 DEOXYGUANOSINE KINASE user 3 2 # 3 D 70 GLU A 59 GLU.? 11.26 O1 EDO A 125 D 142 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 67.23 73.46 138.83 65.67 74.68 137.98 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 61.78 72.49 141.39 62.87 70.87 143.74 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1jag_c03 DEOXYGUANOSINE KINASE user 4 2 # 4 D 70 GLU A 59 GLU.? 11.26 O1 EDO A 125 D 142 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo 67.23 73.46 138.83 65.67 74.68 137.98 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 61.78 72.49 141.39 62.87 70.87 143.74 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1jag_c03 DEOXYGUANOSINE KINASE user 5 2 # 5 D 70 GLU B 23 GLU.? 12.57 O2 EDO A 125 D 142 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 67.23 73.46 138.83 65.67 74.68 137.98 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 61.78 72.49 141.39 62.87 70.87 143.74 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1jag_c03 DEOXYGUANOSINE KINASE user 6 2 # 6 D 70 GLU B 43 GLU.? 19.28 O2 EDO A 125 D 142 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 67.23 73.46 138.83 65.67 74.68 137.98 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 61.78 72.49 141.39 62.87 70.87 143.74 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1jag_c03 DEOXYGUANOSINE KINASE user 7 2 # 7 D 70 GLU B 59 GLU.? 24.69 C1 EDO A 124 D 142 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 67.23 73.46 138.83 65.67 74.68 137.98 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 61.78 72.49 141.39 62.87 70.87 143.74 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1jag_c03 source 1jag DEOXYGUANOSINE KINASE : 7 hits 1jag_c03 naa= 2 ULMN 2 1jag_c04 DEOXYGUANOSINE KINASE user 1 2 # 1 E 70 GLU A 23 GLU.? 13.04 O2 EDO A 125 E 142 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 59.48 65.31 58.13 60.88 63.94 57.24 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 65.31 66.97 58.90 64.71 69.12 60.98 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1jag_c04 DEOXYGUANOSINE KINASE user 2 2 # 2 E 70 GLU A 43 GLU.? 14.35 O2 EDO A 124 E 142 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 59.48 65.31 58.13 60.88 63.94 57.24 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 65.31 66.97 58.90 64.71 69.12 60.98 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1jag_c04 DEOXYGUANOSINE KINASE user 3 2 # 3 E 70 GLU A 59 GLU.? 11.26 O1 EDO A 125 E 142 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 59.48 65.31 58.13 60.88 63.94 57.24 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 65.31 66.97 58.90 64.71 69.12 60.98 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1jag_c04 DEOXYGUANOSINE KINASE user 4 2 # 4 E 70 GLU A 59 GLU.? 11.26 O1 EDO A 125 E 142 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo 59.48 65.31 58.13 60.88 63.94 57.24 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 65.31 66.97 58.90 64.71 69.12 60.98 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1jag_c04 DEOXYGUANOSINE KINASE user 5 2 # 5 E 70 GLU B 23 GLU.? 12.57 O2 EDO A 125 E 142 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 59.48 65.31 58.13 60.88 63.94 57.24 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 65.31 66.97 58.90 64.71 69.12 60.98 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1jag_c04 DEOXYGUANOSINE KINASE user 6 2 # 6 E 70 GLU B 43 GLU.? 19.28 O2 EDO A 125 E 142 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 59.48 65.31 58.13 60.88 63.94 57.24 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 65.31 66.97 58.90 64.71 69.12 60.98 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1jag_c04 DEOXYGUANOSINE KINASE user 7 2 # 7 E 70 GLU B 59 GLU.? 24.69 C1 EDO A 124 E 142 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 59.48 65.31 58.13 60.88 63.94 57.24 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 65.31 66.97 58.90 64.71 69.12 60.98 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1jag_c04 source 1jag DEOXYGUANOSINE KINASE : 7 hits 1jag_c04 naa= 2 ULMN 2 1jag_c05 DEOXYGUANOSINE KINASE user 1 2 # 1 F 70 GLU A 23 GLU.? 13.04 O2 EDO A 125 F 142 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 72.50 31.52 60.99 71.07 32.72 59.92 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 66.72 30.06 62.29 67.42 28.32 64.70 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1jag_c05 DEOXYGUANOSINE KINASE user 2 2 # 2 F 70 GLU A 43 GLU.? 14.35 O2 EDO A 124 F 142 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 72.50 31.52 60.99 71.07 32.72 59.92 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 66.72 30.06 62.29 67.42 28.32 64.70 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1jag_c05 DEOXYGUANOSINE KINASE user 3 2 # 3 F 70 GLU A 59 GLU.? 11.26 O1 EDO A 125 F 142 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 72.50 31.52 60.99 71.07 32.72 59.92 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 66.72 30.06 62.29 67.42 28.32 64.70 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1jag_c05 DEOXYGUANOSINE KINASE user 4 2 # 4 F 70 GLU A 59 GLU.? 11.26 O1 EDO A 125 F 142 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo 72.50 31.52 60.99 71.07 32.72 59.92 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 66.72 30.06 62.29 67.42 28.32 64.70 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1jag_c05 DEOXYGUANOSINE KINASE user 5 2 # 5 F 70 GLU B 23 GLU.? 12.57 O2 EDO A 125 F 142 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 72.50 31.52 60.99 71.07 32.72 59.92 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 66.72 30.06 62.29 67.42 28.32 64.70 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1jag_c05 DEOXYGUANOSINE KINASE user 6 2 # 6 F 70 GLU B 43 GLU.? 19.28 O2 EDO A 125 F 142 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 72.50 31.52 60.99 71.07 32.72 59.92 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 66.72 30.06 62.29 67.42 28.32 64.70 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1jag_c05 DEOXYGUANOSINE KINASE user 7 2 # 7 F 70 GLU B 59 GLU.? 24.69 C1 EDO A 124 F 142 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 72.50 31.52 60.99 71.07 32.72 59.92 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 66.72 30.06 62.29 67.42 28.32 64.70 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1jag_c05 source 1jag DEOXYGUANOSINE KINASE : 7 hits 1jag_c05 naa= 2 ULMN 2 1jag_c06 DEOXYGUANOSINE KINASE user 1 2 # 1 G 70 GLU A 23 GLU.? 13.04 O2 EDO A 125 G 142 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 23.29 16.67 58.82 24.61 15.29 57.84 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 29.15 18.37 59.04 28.72 20.55 61.13 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1jag_c06 DEOXYGUANOSINE KINASE user 2 2 # 2 G 70 GLU A 43 GLU.? 14.35 O2 EDO A 124 G 142 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 23.29 16.67 58.82 24.61 15.29 57.84 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 29.15 18.37 59.04 28.72 20.55 61.13 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1jag_c06 DEOXYGUANOSINE KINASE user 3 2 # 3 G 70 GLU A 59 GLU.? 11.26 O1 EDO A 125 G 142 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 23.29 16.67 58.82 24.61 15.29 57.84 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 29.15 18.37 59.04 28.72 20.55 61.13 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1jag_c06 DEOXYGUANOSINE KINASE user 4 2 # 4 G 70 GLU A 59 GLU.? 11.26 O1 EDO A 125 G 142 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo 23.29 16.67 58.82 24.61 15.29 57.84 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 29.15 18.37 59.04 28.72 20.55 61.13 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1jag_c06 DEOXYGUANOSINE KINASE user 5 2 # 5 G 70 GLU B 23 GLU.? 12.57 O2 EDO A 125 G 142 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 23.29 16.67 58.82 24.61 15.29 57.84 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 29.15 18.37 59.04 28.72 20.55 61.13 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1jag_c06 DEOXYGUANOSINE KINASE user 6 2 # 6 G 70 GLU B 43 GLU.? 19.28 O2 EDO A 125 G 142 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 23.29 16.67 58.82 24.61 15.29 57.84 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 29.15 18.37 59.04 28.72 20.55 61.13 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1jag_c06 DEOXYGUANOSINE KINASE user 7 2 # 7 G 70 GLU B 59 GLU.? 24.69 C1 EDO A 124 G 142 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 23.29 16.67 58.82 24.61 15.29 57.84 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 29.15 18.37 59.04 28.72 20.55 61.13 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1jag_c06 source 1jag DEOXYGUANOSINE KINASE : 7 hits 1jag_c06 naa= 2 ULMN 2 1jag_c07 DEOXYGUANOSINE KINASE user 1 2 # 1 H 70 GLU A 23 GLU.? 13.04 O2 EDO A 125 H 142 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 36.70 -17.02 61.11 35.17 -15.85 60.14 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 31.05 -18.48 62.92 31.95 -20.16 65.30 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1jag_c07 DEOXYGUANOSINE KINASE user 2 2 # 2 H 70 GLU A 43 GLU.? 14.35 O2 EDO A 124 H 142 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 36.70 -17.02 61.11 35.17 -15.85 60.14 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 31.05 -18.48 62.92 31.95 -20.16 65.30 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1jag_c07 DEOXYGUANOSINE KINASE user 3 2 # 3 H 70 GLU A 59 GLU.? 11.26 O1 EDO A 125 H 142 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 36.70 -17.02 61.11 35.17 -15.85 60.14 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 31.05 -18.48 62.92 31.95 -20.16 65.30 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1jag_c07 DEOXYGUANOSINE KINASE user 4 2 # 4 H 70 GLU A 59 GLU.? 11.26 O1 EDO A 125 H 142 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo 36.70 -17.02 61.11 35.17 -15.85 60.14 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 31.05 -18.48 62.92 31.95 -20.16 65.30 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 1jag_c07 DEOXYGUANOSINE KINASE user 5 2 # 5 H 70 GLU B 23 GLU.? 12.57 O2 EDO A 125 H 142 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 36.70 -17.02 61.11 35.17 -15.85 60.14 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 31.05 -18.48 62.92 31.95 -20.16 65.30 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1jag_c07 DEOXYGUANOSINE KINASE user 6 2 # 6 H 70 GLU B 43 GLU.? 19.28 O2 EDO A 125 H 142 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 36.70 -17.02 61.11 35.17 -15.85 60.14 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 31.05 -18.48 62.92 31.95 -20.16 65.30 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 1jag_c07 DEOXYGUANOSINE KINASE user 7 2 # 7 H 70 GLU B 59 GLU.? 24.69 C1 EDO A 124 H 142 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 36.70 -17.02 61.11 35.17 -15.85 60.14 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 31.05 -18.48 62.92 31.95 -20.16 65.30 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1jag_c07 source 1jag DEOXYGUANOSINE KINASE : 7 hits 1jag_c07 naa= 2 ULMN 2 1jm6_c00 PYRUVATE DEHYDROGENASE KINASE, ISOZYuser 1 2 # 1 A1239 HIS A 79 HIS^? 12.23 O1 EDO A 125 A1243 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 7.90 -1.75 34.47 6.34 -3.06 33.92 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 9.27 -6.20 35.02 7.86 -7.40 36.06 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1jm6_c00 PYRUVATE DEHYDROGENASE KINASE, ISOZYuser 2 2 # 2 A1239 HIS A 79 HIS^? 12.23 O1 EDO A 125 A1243 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 7.90 -1.75 34.47 6.34 -3.06 33.92 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 9.27 -6.20 35.02 7.86 -7.40 36.06 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1jm6_c00 PYRUVATE DEHYDROGENASE KINASE, ISOZYuser 3 2 # 3 A1239 HIS B 79 HIS^? 26.86 C1 EDO A 124 A1243 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 7.90 -1.75 34.47 6.34 -3.06 33.92 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 9.27 -6.20 35.02 7.86 -7.40 36.06 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1jm6_c00 PYRUVATE DEHYDROGENASE KINASE, ISOZYuser 4 2 # 4 A1239 HIS B 79 HIS^? 26.86 C1 EDO A 124 A1243 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 7.90 -1.75 34.47 6.34 -3.06 33.92 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 9.27 -6.20 35.02 7.86 -7.40 36.06 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1jm6_c00 source 1jm6 PYRUVATE DEHYDROGENASE KINASE, ISOZYME 2 : 4 hits 1jm6_c00 naa= 2 ULMN 2 1jm6_c01 PYRUVATE DEHYDROGENASE KINASE, ISOZYuser 1 2 # 1 B1239 HIS A 79 HIS^? 12.23 O1 EDO A 125 B1243 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 39.87 -17.78 10.40 40.06 -16.28 8.94 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 39.25 -13.41 11.81 40.77 -12.18 11.06 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1jm6_c01 PYRUVATE DEHYDROGENASE KINASE, ISOZYuser 2 2 # 2 B1239 HIS A 79 HIS^? 12.23 O1 EDO A 125 B1243 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 39.87 -17.78 10.40 40.06 -16.28 8.94 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 39.25 -13.41 11.81 40.77 -12.18 11.06 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1jm6_c01 PYRUVATE DEHYDROGENASE KINASE, ISOZYuser 3 2 # 3 B1239 HIS B 79 HIS^? 26.86 C1 EDO A 124 B1243 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 39.87 -17.78 10.40 40.06 -16.28 8.94 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 39.25 -13.41 11.81 40.77 -12.18 11.06 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1jm6_c01 PYRUVATE DEHYDROGENASE KINASE, ISOZYuser 4 2 # 4 B1239 HIS B 79 HIS^? 26.86 C1 EDO A 124 B1243 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 39.87 -17.78 10.40 40.06 -16.28 8.94 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 39.25 -13.41 11.81 40.77 -12.18 11.06 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1jm6_c01 source 1jm6 PYRUVATE DEHYDROGENASE KINASE, ISOZYME 2 : 4 hits 1jm6_c01 naa= 2 ULMN 2 1jrp_c04 XANTHINE DEHYDROGENASE user 1 2 # 1 B 310 ARG A 25 ARG.? 17.39 O2 EDO A 124 B 730 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 21.65 14.36 26.83 22.79 11.61 26.21 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 22.19 14.33 19.31 20.96 13.74 20.93 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1jrp_c04 XANTHINE DEHYDROGENASE user 2 2 # 2 B 310 ARG A 25 ARG.? 17.39 O2 EDO A 124 B 730 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 21.65 14.36 26.83 22.79 11.61 26.21 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 22.19 14.33 19.31 20.96 13.74 20.93 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1jrp_c04 XANTHINE DEHYDROGENASE user 3 2 # 3 B 310 ARG A 53 ARG~? 17.45 O1 EDO A 125 B 730 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 21.65 14.36 26.83 22.79 11.61 26.21 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 22.19 14.33 19.31 20.96 13.74 20.93 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1jrp_c04 XANTHINE DEHYDROGENASE user 4 2 # 4 B 310 ARG A 106 ARG.? 12.91 O2 EDO A 125 B 730 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 21.65 14.36 26.83 22.79 11.61 26.21 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo 22.19 14.33 19.31 20.96 13.74 20.93 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1jrp_c04 XANTHINE DEHYDROGENASE user 5 2 # 5 B 310 ARG B 25 ARG.? 18.77 O2 EDO A 125 B 730 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 21.65 14.36 26.83 22.79 11.61 26.21 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 22.19 14.33 19.31 20.96 13.74 20.93 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1jrp_c04 XANTHINE DEHYDROGENASE user 6 2 # 6 B 310 ARG B 25 ARG.? 18.77 O2 EDO A 125 B 730 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 21.65 14.36 26.83 22.79 11.61 26.21 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 22.19 14.33 19.31 20.96 13.74 20.93 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1jrp_c04 XANTHINE DEHYDROGENASE user 7 2 # 7 B 310 ARG B 53 ARG~? 17.71 C1 EDO A 124 B 730 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 21.65 14.36 26.83 22.79 11.61 26.21 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 22.19 14.33 19.31 20.96 13.74 20.93 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 1jrp_c04 source 1jrp XANTHINE DEHYDROGENASE : 7 hits 1jrp_c04 naa= 2 ULMN 2 1jrp_c05 XANTHINE DEHYDROGENASE user 1 2 # 1 D 310 ARG A 25 ARG.? 17.39 O2 EDO A 124 D 730 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 4.69 -35.05 -10.07 6.51 -34.84 -7.57 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo -0.28 -31.99 -5.65 1.65 -31.50 -6.36 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1jrp_c05 XANTHINE DEHYDROGENASE user 2 2 # 2 D 310 ARG A 25 ARG.? 17.39 O2 EDO A 124 D 730 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 4.69 -35.05 -10.07 6.51 -34.84 -7.57 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo -0.28 -31.99 -5.65 1.65 -31.50 -6.36 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1jrp_c05 XANTHINE DEHYDROGENASE user 3 2 # 3 D 310 ARG A 53 ARG~? 17.45 O1 EDO A 125 D 730 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 4.69 -35.05 -10.07 6.51 -34.84 -7.57 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo -0.28 -31.99 -5.65 1.65 -31.50 -6.36 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1jrp_c05 XANTHINE DEHYDROGENASE user 4 2 # 4 D 310 ARG A 106 ARG.? 12.91 O2 EDO A 125 D 730 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 4.69 -35.05 -10.07 6.51 -34.84 -7.57 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo -0.28 -31.99 -5.65 1.65 -31.50 -6.36 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1jrp_c05 XANTHINE DEHYDROGENASE user 5 2 # 5 D 310 ARG B 25 ARG.? 18.77 O2 EDO A 125 D 730 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 4.69 -35.05 -10.07 6.51 -34.84 -7.57 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo -0.28 -31.99 -5.65 1.65 -31.50 -6.36 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1jrp_c05 XANTHINE DEHYDROGENASE user 6 2 # 6 D 310 ARG B 25 ARG.? 18.77 O2 EDO A 125 D 730 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 4.69 -35.05 -10.07 6.51 -34.84 -7.57 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo -0.28 -31.99 -5.65 1.65 -31.50 -6.36 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1jrp_c05 XANTHINE DEHYDROGENASE user 7 2 # 7 D 310 ARG B 53 ARG~? 17.71 C1 EDO A 124 D 730 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 4.69 -35.05 -10.07 6.51 -34.84 -7.57 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo -0.28 -31.99 -5.65 1.65 -31.50 -6.36 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 1jrp_c05 source 1jrp XANTHINE DEHYDROGENASE : 7 hits 1jrp_c05 naa= 2 ULMN 2 1jrp_c06 XANTHINE DEHYDROGENASE user 1 2 # 1 F 310 ARG A 25 ARG.? 17.39 O2 EDO A 124 F 730 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 5.26 36.61 70.62 3.67 36.04 68.06 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 8.70 41.35 66.26 6.78 41.28 67.16 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1jrp_c06 XANTHINE DEHYDROGENASE user 2 2 # 2 F 310 ARG A 25 ARG.? 17.39 O2 EDO A 124 F 730 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 5.26 36.61 70.62 3.67 36.04 68.06 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 8.70 41.35 66.26 6.78 41.28 67.16 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1jrp_c06 XANTHINE DEHYDROGENASE user 3 2 # 3 F 310 ARG A 53 ARG~? 17.45 O1 EDO A 125 F 730 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 5.26 36.61 70.62 3.67 36.04 68.06 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 8.70 41.35 66.26 6.78 41.28 67.16 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1jrp_c06 XANTHINE DEHYDROGENASE user 4 2 # 4 F 310 ARG A 106 ARG.? 12.91 O2 EDO A 125 F 730 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 5.26 36.61 70.62 3.67 36.04 68.06 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo 8.70 41.35 66.26 6.78 41.28 67.16 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1jrp_c06 XANTHINE DEHYDROGENASE user 5 2 # 5 F 310 ARG B 25 ARG.? 18.77 O2 EDO A 125 F 730 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 5.26 36.61 70.62 3.67 36.04 68.06 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 8.70 41.35 66.26 6.78 41.28 67.16 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1jrp_c06 XANTHINE DEHYDROGENASE user 6 2 # 6 F 310 ARG B 25 ARG.? 18.77 O2 EDO A 125 F 730 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 5.26 36.61 70.62 3.67 36.04 68.06 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 8.70 41.35 66.26 6.78 41.28 67.16 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1jrp_c06 XANTHINE DEHYDROGENASE user 7 2 # 7 F 310 ARG B 53 ARG~? 17.71 C1 EDO A 124 F 730 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 5.26 36.61 70.62 3.67 36.04 68.06 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 8.70 41.35 66.26 6.78 41.28 67.16 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 1jrp_c06 source 1jrp XANTHINE DEHYDROGENASE : 7 hits 1jrp_c06 naa= 2 ULMN 2 1jrp_c07 XANTHINE DEHYDROGENASE user 1 2 # 1 H 310 ARG A 25 ARG.? 17.39 O2 EDO A 124 H 730 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -28.90 76.02 33.83 -29.02 73.00 34.22 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo -29.55 75.84 41.31 -28.10 75.67 39.75 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1jrp_c07 XANTHINE DEHYDROGENASE user 2 2 # 2 H 310 ARG A 25 ARG.? 17.39 O2 EDO A 124 H 730 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -28.90 76.02 33.83 -29.02 73.00 34.22 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo -29.55 75.84 41.31 -28.10 75.67 39.75 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1jrp_c07 XANTHINE DEHYDROGENASE user 3 2 # 3 H 310 ARG A 53 ARG~? 17.45 O1 EDO A 125 H 730 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -28.90 76.02 33.83 -29.02 73.00 34.22 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo -29.55 75.84 41.31 -28.10 75.67 39.75 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1jrp_c07 XANTHINE DEHYDROGENASE user 4 2 # 4 H 310 ARG A 106 ARG.? 12.91 O2 EDO A 125 H 730 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -28.90 76.02 33.83 -29.02 73.00 34.22 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo -29.55 75.84 41.31 -28.10 75.67 39.75 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1jrp_c07 XANTHINE DEHYDROGENASE user 5 2 # 5 H 310 ARG B 25 ARG.? 18.77 O2 EDO A 125 H 730 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -28.90 76.02 33.83 -29.02 73.00 34.22 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo -29.55 75.84 41.31 -28.10 75.67 39.75 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1jrp_c07 XANTHINE DEHYDROGENASE user 6 2 # 6 H 310 ARG B 25 ARG.? 18.77 O2 EDO A 125 H 730 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -28.90 76.02 33.83 -29.02 73.00 34.22 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo -29.55 75.84 41.31 -28.10 75.67 39.75 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1jrp_c07 XANTHINE DEHYDROGENASE user 7 2 # 7 H 310 ARG B 53 ARG~? 17.71 C1 EDO A 124 H 730 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo -28.90 76.02 33.83 -29.02 73.00 34.22 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo -29.55 75.84 41.31 -28.10 75.67 39.75 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 1jrp_c07 source 1jrp XANTHINE DEHYDROGENASE : 7 hits 1jrp_c07 naa= 2 ULMN 2 1jrp_c08 XANTHINE DEHYDROGENASE user 1 2 # 1 B 197 GLN A 56 GLN.? 7.55 C1 EDO A 125 B 342 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 12.40 11.20 14.87 13.43 12.44 16.24 -19.66 -52.09 -22.06 -20.64 -53.94 -21.94 coo 20.56 18.81 16.07 21.88 18.50 13.41 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1jrp_c08 XANTHINE DEHYDROGENASE user 2 2 # 2 B 197 GLN A 65 GLN~? 18.24 O1 EDO A 125 B 342 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 12.40 11.20 14.87 13.43 12.44 16.24 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 coo 20.56 18.81 16.07 21.88 18.50 13.41 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1jrp_c08 XANTHINE DEHYDROGENASE user 3 2 # 3 B 197 GLN A 65 GLN~? 18.24 O1 EDO A 125 B 342 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 12.40 11.20 14.87 13.43 12.44 16.24 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 coo 20.56 18.81 16.07 21.88 18.50 13.41 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1jrp_c08 XANTHINE DEHYDROGENASE user 4 2 # 4 B 197 GLN B 56 GLN.? 26.20 C1 EDO A 124 B 342 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 12.40 11.20 14.87 13.43 12.44 16.24 -52.89 -32.90 -22.16 -54.01 -34.64 -22.72 coo 20.56 18.81 16.07 21.88 18.50 13.41 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1jrp_c08 XANTHINE DEHYDROGENASE user 5 2 # 5 B 197 GLN B 65 GLN~? 25.71 C1 EDO A 124 B 342 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 12.40 11.20 14.87 13.43 12.44 16.24 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 coo 20.56 18.81 16.07 21.88 18.50 13.41 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1jrp_c08 XANTHINE DEHYDROGENASE user 6 2 # 6 B 197 GLN B 65 GLN~? 25.71 C1 EDO A 124 B 342 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 12.40 11.20 14.87 13.43 12.44 16.24 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 coo 20.56 18.81 16.07 21.88 18.50 13.41 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1jrp_c08 source 1jrp XANTHINE DEHYDROGENASE : 6 hits 1jrp_c08 naa= 2 ULMN 2 1jrp_c09 XANTHINE DEHYDROGENASE user 1 2 # 1 D 197 GLN A 56 GLN.? 7.55 C1 EDO A 125 D 342 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 0.11 -20.91 -6.95 -0.04 -22.94 -7.51 -19.66 -52.09 -22.06 -20.64 -53.94 -21.94 coo -5.46 -30.74 -6.45 -6.82 -30.17 -3.84 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1jrp_c09 XANTHINE DEHYDROGENASE user 2 2 # 2 D 197 GLN A 65 GLN~? 18.24 O1 EDO A 125 D 342 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 0.11 -20.91 -6.95 -0.04 -22.94 -7.51 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 coo -5.46 -30.74 -6.45 -6.82 -30.17 -3.84 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1jrp_c09 XANTHINE DEHYDROGENASE user 3 2 # 3 D 197 GLN A 65 GLN~? 18.24 O1 EDO A 125 D 342 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 0.11 -20.91 -6.95 -0.04 -22.94 -7.51 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 coo -5.46 -30.74 -6.45 -6.82 -30.17 -3.84 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1jrp_c09 XANTHINE DEHYDROGENASE user 4 2 # 4 D 197 GLN B 56 GLN.? 26.20 C1 EDO A 124 D 342 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 0.11 -20.91 -6.95 -0.04 -22.94 -7.51 -52.89 -32.90 -22.16 -54.01 -34.64 -22.72 coo -5.46 -30.74 -6.45 -6.82 -30.17 -3.84 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1jrp_c09 XANTHINE DEHYDROGENASE user 5 2 # 5 D 197 GLN B 65 GLN~? 25.71 C1 EDO A 124 D 342 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 0.11 -20.91 -6.95 -0.04 -22.94 -7.51 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 coo -5.46 -30.74 -6.45 -6.82 -30.17 -3.84 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1jrp_c09 XANTHINE DEHYDROGENASE user 6 2 # 6 D 197 GLN B 65 GLN~? 25.71 C1 EDO A 124 D 342 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 0.11 -20.91 -6.95 -0.04 -22.94 -7.51 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 coo -5.46 -30.74 -6.45 -6.82 -30.17 -3.84 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1jrp_c09 source 1jrp XANTHINE DEHYDROGENASE : 6 hits 1jrp_c09 naa= 2 ULMN 2 1jrp_c10 XANTHINE DEHYDROGENASE user 1 2 # 1 F 197 GLN A 56 GLN.? 7.55 C1 EDO A 125 F 342 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 4.07 51.31 67.51 4.98 49.46 68.21 -19.66 -52.09 -22.06 -20.64 -53.94 -21.94 coo 13.05 44.40 67.13 14.11 45.54 64.65 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1jrp_c10 XANTHINE DEHYDROGENASE user 2 2 # 2 F 197 GLN A 65 GLN~? 18.24 O1 EDO A 125 F 342 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 4.07 51.31 67.51 4.98 49.46 68.21 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 coo 13.05 44.40 67.13 14.11 45.54 64.65 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1jrp_c10 XANTHINE DEHYDROGENASE user 3 2 # 3 F 197 GLN A 65 GLN~? 18.24 O1 EDO A 125 F 342 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 4.07 51.31 67.51 4.98 49.46 68.21 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 coo 13.05 44.40 67.13 14.11 45.54 64.65 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1jrp_c10 XANTHINE DEHYDROGENASE user 4 2 # 4 F 197 GLN B 56 GLN.? 26.20 C1 EDO A 124 F 342 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 4.07 51.31 67.51 4.98 49.46 68.21 -52.89 -32.90 -22.16 -54.01 -34.64 -22.72 coo 13.05 44.40 67.13 14.11 45.54 64.65 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1jrp_c10 XANTHINE DEHYDROGENASE user 5 2 # 5 F 197 GLN B 65 GLN~? 25.71 C1 EDO A 124 F 342 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 4.07 51.31 67.51 4.98 49.46 68.21 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 coo 13.05 44.40 67.13 14.11 45.54 64.65 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1jrp_c10 XANTHINE DEHYDROGENASE user 6 2 # 6 F 197 GLN B 65 GLN~? 25.71 C1 EDO A 124 F 342 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 4.07 51.31 67.51 4.98 49.46 68.21 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 coo 13.05 44.40 67.13 14.11 45.54 64.65 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1jrp_c10 source 1jrp XANTHINE DEHYDROGENASE : 6 hits 1jrp_c10 naa= 2 ULMN 2 1jrp_c11 XANTHINE DEHYDROGENASE user 1 2 # 1 H 197 GLN A 56 GLN.? 7.55 C1 EDO A 125 H 342 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -19.15 76.76 45.68 -20.69 77.29 44.27 -19.66 -52.09 -22.06 -20.64 -53.94 -21.94 coo -29.73 80.59 44.58 -30.82 79.63 47.24 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1jrp_c11 XANTHINE DEHYDROGENASE user 2 2 # 2 H 197 GLN A 65 GLN~? 18.24 O1 EDO A 125 H 342 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo -19.15 76.76 45.68 -20.69 77.29 44.27 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 coo -29.73 80.59 44.58 -30.82 79.63 47.24 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1jrp_c11 XANTHINE DEHYDROGENASE user 3 2 # 3 H 197 GLN A 65 GLN~? 18.24 O1 EDO A 125 H 342 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -19.15 76.76 45.68 -20.69 77.29 44.27 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 coo -29.73 80.59 44.58 -30.82 79.63 47.24 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1jrp_c11 XANTHINE DEHYDROGENASE user 4 2 # 4 H 197 GLN B 56 GLN.? 26.20 C1 EDO A 124 H 342 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo -19.15 76.76 45.68 -20.69 77.29 44.27 -52.89 -32.90 -22.16 -54.01 -34.64 -22.72 coo -29.73 80.59 44.58 -30.82 79.63 47.24 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1jrp_c11 XANTHINE DEHYDROGENASE user 5 2 # 5 H 197 GLN B 65 GLN~? 25.71 C1 EDO A 124 H 342 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo -19.15 76.76 45.68 -20.69 77.29 44.27 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 coo -29.73 80.59 44.58 -30.82 79.63 47.24 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1jrp_c11 XANTHINE DEHYDROGENASE user 6 2 # 6 H 197 GLN B 65 GLN~? 25.71 C1 EDO A 124 H 342 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo -19.15 76.76 45.68 -20.69 77.29 44.27 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 coo -29.73 80.59 44.58 -30.82 79.63 47.24 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1jrp_c11 source 1jrp XANTHINE DEHYDROGENASE : 6 hits 1jrp_c11 naa= 2 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 1 2 # 1 A 176 LYS A 28 LYS^? 7.39 O2 EDO A 124 A 210 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 34.14 63.09 78.07 32.63 58.11 75.17 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 33.03 52.38 67.66 33.41 53.06 67.61 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 2 2 # 2 A 176 LYS A 100 LYS~? 11.56 C2 EDO A 125 A 210 GLY A 57 GLY.? 9.42 O1 EDO A 125 coo 34.14 63.09 78.07 32.63 58.11 75.17 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo 33.03 52.38 67.66 33.41 53.06 67.61 -16.91 -49.31 -24.24 -17.01 -48.68 -23.74 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 3 2 # 3 A 176 LYS B 28 LYS^? -17.65 O1 EDO A 124s A 210 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 34.14 63.09 78.07 32.63 58.11 75.17 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 33.03 52.38 67.66 33.41 53.06 67.61 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 1jxh_c00 source 1jxh PHOSPHOMETHYLPYRIMIDINE KINASE : 3 hits 1jxh_c00 naa= 2 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 1 2 # 1 B 176 LYS A 28 LYS^? 7.39 O2 EDO A 124 B 210 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 37.67 14.56 60.47 35.43 19.31 63.31 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 34.81 25.02 70.85 35.27 24.39 70.91 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 2 2 # 2 B 176 LYS A 100 LYS~? 11.56 C2 EDO A 125 B 210 GLY A 57 GLY.? 9.42 O1 EDO A 125 coo 37.67 14.56 60.47 35.43 19.31 63.31 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo 34.81 25.02 70.85 35.27 24.39 70.91 -16.91 -49.31 -24.24 -17.01 -48.68 -23.74 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 3 2 # 3 B 176 LYS B 28 LYS^? -17.65 O1 EDO A 124s B 210 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 37.67 14.56 60.47 35.43 19.31 63.31 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 34.81 25.02 70.85 35.27 24.39 70.91 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 1jxh_c01 source 1jxh PHOSPHOMETHYLPYRIMIDINE KINASE : 3 hits 1jxh_c01 naa= 2 ULMN 2 1k30_c00 GLYCEROL-3-PHOSPHATE ACYLTRANSFERASEuser 1 2 # 1 A 139 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 144 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 35.15 31.04 36.07 34.55 31.88 37.89 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 38.69 29.16 39.70 37.18 28.00 38.75 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1k30_c00 GLYCEROL-3-PHOSPHATE ACYLTRANSFERASEuser 2 2 # 2 A 139 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 144 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 35.15 31.04 36.07 34.55 31.88 37.89 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 38.69 29.16 39.70 37.18 28.00 38.75 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1k30_c00 source 1k30 GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE : 2 hits 1k30_c00 naa= 2 ULMN 2 1kae_c00 HISTIDINOL DEHYDROGENASE user 1 2 # 1 A 326 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 327 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 13.89 116.20 59.19 15.25 115.41 60.61 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 10.98 116.96 62.31 12.07 115.17 62.46 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1kae_c00 HISTIDINOL DEHYDROGENASE user 2 2 # 2 A 326 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 327 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 13.89 116.20 59.19 15.25 115.41 60.61 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 10.98 116.96 62.31 12.07 115.17 62.46 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1kae_c00 HISTIDINOL DEHYDROGENASE user 3 2 # 3 A 326 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 327 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 13.89 116.20 59.19 15.25 115.41 60.61 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 10.98 116.96 62.31 12.07 115.17 62.46 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1kae_c00 source 1kae HISTIDINOL DEHYDROGENASE : 3 hits 1kae_c00 naa= 2 ULMN 2 1kae_c01 HISTIDINOL DEHYDROGENASE user 1 2 # 1 B 326 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 327 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 16.56 100.37 30.04 17.64 101.54 28.62 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 14.04 98.68 26.87 14.57 100.69 26.53 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1kae_c01 HISTIDINOL DEHYDROGENASE user 2 2 # 2 B 326 GLU A 81 GLU.? 16.59 O1 EDO A 125 B 327 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 16.56 100.37 30.04 17.64 101.54 28.62 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 14.04 98.68 26.87 14.57 100.69 26.53 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1kae_c01 HISTIDINOL DEHYDROGENASE user 3 2 # 3 B 326 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 327 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 16.56 100.37 30.04 17.64 101.54 28.62 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 14.04 98.68 26.87 14.57 100.69 26.53 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 ULMN 2 1kae_c01 HISTIDINOL DEHYDROGENASE user 4 2 # 4 B 326 GLU B 81 GLU.? 30.69 O1 EDO A 124 B 327 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 16.56 100.37 30.04 17.64 101.54 28.62 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 14.04 98.68 26.87 14.57 100.69 26.53 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1kae_c01 source 1kae HISTIDINOL DEHYDROGENASE : 4 hits 1kae_c01 naa= 2 ULMN 2 1kc7_c00 PYRUVATE PHOSPHATE DIKINASE user 1 2 # 1 A 455 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 831 CYH B 67 CYH~? 18.88 O1 EDO A 124 coo 30.52 6.61 -28.80 28.60 6.82 -27.98 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 17.28 11.86 5.14 15.61 10.84 7.17 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 ULMN 2 1kc7_c00 PYRUVATE PHOSPHATE DIKINASE user 2 2 # 2 A 455 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 831 CYH A 67 CYH~? 14.35 O2 EDO A 124 coo 30.52 6.61 -28.80 28.60 6.82 -27.98 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 17.28 11.86 5.14 15.61 10.84 7.17 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 1kc7_c00 source 1kc7 PYRUVATE PHOSPHATE DIKINASE : 2 hits 1kc7_c00 naa= 2 ULMN 2 1kcz_c00 BETA-METHYLASPARTASE user 1 2 # 1 A 194 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 331 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 39.14 -7.49 11.72 40.95 -7.65 12.80 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 45.74 3.70 15.16 49.86 -1.10 14.66 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1kcz_c00 BETA-METHYLASPARTASE user 2 2 # 2 A 194 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 331 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 39.14 -7.49 11.72 40.95 -7.65 12.80 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 45.74 3.70 15.16 49.86 -1.10 14.66 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1kcz_c00 source 1kcz BETA-METHYLASPARTASE : 2 hits 1kcz_c00 naa= 2 ULMN 2 1kcz_c01 BETA-METHYLASPARTASE user 1 2 # 1 B 194 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 331 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 13.97 -7.54 29.73 12.23 -7.62 28.56 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 7.43 3.70 26.25 3.47 -1.18 26.49 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1kcz_c01 BETA-METHYLASPARTASE user 2 2 # 2 B 194 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 331 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 13.97 -7.54 29.73 12.23 -7.62 28.56 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 7.43 3.70 26.25 3.47 -1.18 26.49 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1kcz_c01 source 1kcz BETA-METHYLASPARTASE : 2 hits 1kcz_c01 naa= 2 ULMN 2 1kny_c00 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 1 2 # 1 A 145 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 149 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 38.29 43.93 28.58 37.89 45.59 29.77 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 40.71 37.48 29.08 37.62 41.79 32.12 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1kny_c00 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 2 2 # 2 A 145 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 149 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 38.29 43.93 28.58 37.89 45.59 29.77 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 40.71 37.48 29.08 37.62 41.79 32.12 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1kny_c00 source 1kny KANAMYCIN NUCLEOTIDYLTRANSFERASE : 2 hits 1kny_c00 naa= 2 ULMN 2 1kny_c01 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 1 2 # 1 B 145 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 149 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 16.16 40.65 44.70 16.29 42.36 43.62 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 15.03 33.77 42.69 17.13 39.10 39.90 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1kny_c01 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 2 2 # 2 B 145 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 149 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 16.16 40.65 44.70 16.29 42.36 43.62 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 15.03 33.77 42.69 17.13 39.10 39.90 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1kny_c01 source 1kny KANAMYCIN NUCLEOTIDYLTRANSFERASE : 2 hits 1kny_c01 naa= 2 ULMN 2 1kp2_c00 ARGININOSUCCINATE SYNTHETASE user 1 2 # 1 A 106 ARG A 30 ARG^? -2.97 O2 EDO A 124s A 135 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 27.12 14.95 42.29 27.92 17.73 41.22 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 31.19 14.02 39.72 30.95 15.42 41.26 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1kp2_c00 ARGININOSUCCINATE SYNTHETASE user 2 2 # 2 A 106 ARG A 33 ARG.? 17.39 O2 EDO A 124 A 135 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 27.12 14.95 42.29 27.92 17.73 41.22 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 31.19 14.02 39.72 30.95 15.42 41.26 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1kp2_c00 ARGININOSUCCINATE SYNTHETASE user 3 2 # 3 A 106 ARG B 30 ARG^? 10.56 O1 EDO A 124 A 135 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 27.12 14.95 42.29 27.92 17.73 41.22 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 31.19 14.02 39.72 30.95 15.42 41.26 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1kp2_c00 ARGININOSUCCINATE SYNTHETASE user 4 2 # 4 A 106 ARG B 33 ARG.? 19.94 O1 EDO A 124 A 135 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 27.12 14.95 42.29 27.92 17.73 41.22 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 31.19 14.02 39.72 30.95 15.42 41.26 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1kp2_c00 source 1kp2 ARGININOSUCCINATE SYNTHETASE : 4 hits 1kp2_c00 naa= 2 ULMN 2 1l0o_c00 ANTI-SIGMA F FACTOR user 1 2 # 1 A 46 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 105 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 4.64 17.62 61.98 3.43 16.11 62.87 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -1.86 8.63 61.10 0.28 9.55 63.06 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1l0o_c00 ANTI-SIGMA F FACTOR user 2 2 # 2 A 46 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 105 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 4.64 17.62 61.98 3.43 16.11 62.87 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -1.86 8.63 61.10 0.28 9.55 63.06 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 1l0o_c00 source 1l0o ANTI-SIGMA F FACTOR : 2 hits 1l0o_c00 naa= 2 ULMN 2 1l1r_c00 ADENINE PHOSPHORIBOSYLTRANSFERASE user 1 2 # 1 A 63 ARG A 30 ARG^? -2.97 O2 EDO A 124s A 100 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 9.84 40.26 39.90 8.84 37.40 40.32 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 2.80 29.73 38.19 4.17 29.64 39.81 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1l1r_c00 ADENINE PHOSPHORIBOSYLTRANSFERASE user 2 2 # 2 A 63 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 100 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 9.84 40.26 39.90 8.84 37.40 40.32 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 2.80 29.73 38.19 4.17 29.64 39.81 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1l1r_c00 ADENINE PHOSPHORIBOSYLTRANSFERASE user 3 2 # 3 A 63 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 100 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 9.84 40.26 39.90 8.84 37.40 40.32 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 2.80 29.73 38.19 4.17 29.64 39.81 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1l1r_c00 ADENINE PHOSPHORIBOSYLTRANSFERASE user 4 2 # 4 A 63 ARG B 30 ARG^? 10.56 O1 EDO A 124 A 100 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 9.84 40.26 39.90 8.84 37.40 40.32 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 2.80 29.73 38.19 4.17 29.64 39.81 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1l1r_c00 ADENINE PHOSPHORIBOSYLTRANSFERASE user 5 2 # 5 A 63 ARG B 37 ARG^? 8.36 C1 EDO A 124 A 100 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 9.84 40.26 39.90 8.84 37.40 40.32 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 2.80 29.73 38.19 4.17 29.64 39.81 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 1l1r_c00 source 1l1r ADENINE PHOSPHORIBOSYLTRANSFERASE : 5 hits 1l1r_c00 naa= 2 ULMN 2 1l7n_c00 PHOSPHOSERINE PHOSPHATASE user 1 2 # 1 A 11 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 13 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 53.27 18.00 2.23 52.37 17.52 4.06 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 48.69 14.85 6.40 49.14 12.85 6.94 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1l7n_c00 PHOSPHOSERINE PHOSPHATASE user 2 2 # 2 A 11 ASP A 64 ASP~? 20.53 O2 EDO A 124 A 13 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 53.27 18.00 2.23 52.37 17.52 4.06 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 48.69 14.85 6.40 49.14 12.85 6.94 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1l7n_c00 PHOSPHOSERINE PHOSPHATASE user 3 2 # 3 A 11 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 13 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 53.27 18.00 2.23 52.37 17.52 4.06 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 48.69 14.85 6.40 49.14 12.85 6.94 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1l7n_c00 PHOSPHOSERINE PHOSPHATASE user 4 2 # 4 A 11 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 13 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 53.27 18.00 2.23 52.37 17.52 4.06 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 48.69 14.85 6.40 49.14 12.85 6.94 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1l7n_c00 PHOSPHOSERINE PHOSPHATASE user 5 2 # 5 A 11 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 13 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 53.27 18.00 2.23 52.37 17.52 4.06 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 48.69 14.85 6.40 49.14 12.85 6.94 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1l7n_c00 PHOSPHOSERINE PHOSPHATASE user 6 2 # 6 A 11 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 13 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 53.27 18.00 2.23 52.37 17.52 4.06 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 48.69 14.85 6.40 49.14 12.85 6.94 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1l7n_c00 PHOSPHOSERINE PHOSPHATASE user 7 2 # 7 A 11 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 13 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 53.27 18.00 2.23 52.37 17.52 4.06 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 48.69 14.85 6.40 49.14 12.85 6.94 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1l7n_c00 PHOSPHOSERINE PHOSPHATASE user 8 2 # 8 A 11 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 13 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 53.27 18.00 2.23 52.37 17.52 4.06 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 48.69 14.85 6.40 49.14 12.85 6.94 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1l7n_c00 source 1l7n PHOSPHOSERINE PHOSPHATASE : 8 hits 1l7n_c00 naa= 2 ULMN 2 1l7n_c01 PHOSPHOSERINE PHOSPHATASE user 1 2 # 1 B 511 ASP A 63 ASP~? 17.25 O1 EDO A 124 B 513 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 62.03 15.32 45.23 61.67 14.72 47.22 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 59.25 15.58 51.55 57.26 14.91 51.77 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1l7n_c01 PHOSPHOSERINE PHOSPHATASE user 2 2 # 2 B 511 ASP A 64 ASP~? 20.53 O2 EDO A 124 B 513 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 62.03 15.32 45.23 61.67 14.72 47.22 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 59.25 15.58 51.55 57.26 14.91 51.77 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1l7n_c01 PHOSPHOSERINE PHOSPHATASE user 3 2 # 3 B 511 ASP A 84 ASP.? 13.20 O1 EDO A 125 B 513 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 62.03 15.32 45.23 61.67 14.72 47.22 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 59.25 15.58 51.55 57.26 14.91 51.77 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1l7n_c01 PHOSPHOSERINE PHOSPHATASE user 4 2 # 4 B 511 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 513 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 62.03 15.32 45.23 61.67 14.72 47.22 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 59.25 15.58 51.55 57.26 14.91 51.77 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1l7n_c01 PHOSPHOSERINE PHOSPHATASE user 5 2 # 5 B 511 ASP B 63 ASP~? 17.37 O1 EDO A 124 B 513 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 62.03 15.32 45.23 61.67 14.72 47.22 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 59.25 15.58 51.55 57.26 14.91 51.77 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1l7n_c01 PHOSPHOSERINE PHOSPHATASE user 6 2 # 6 B 511 ASP B 64 ASP~? 23.62 O1 EDO A 124 B 513 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 62.03 15.32 45.23 61.67 14.72 47.22 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 59.25 15.58 51.55 57.26 14.91 51.77 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1l7n_c01 PHOSPHOSERINE PHOSPHATASE user 7 2 # 7 B 511 ASP B 84 ASP.? 30.86 C1 EDO A 124 B 513 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 62.03 15.32 45.23 61.67 14.72 47.22 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 59.25 15.58 51.55 57.26 14.91 51.77 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1l7n_c01 PHOSPHOSERINE PHOSPHATASE user 8 2 # 8 B 511 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 513 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 62.03 15.32 45.23 61.67 14.72 47.22 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 59.25 15.58 51.55 57.26 14.91 51.77 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1l7n_c01 source 1l7n PHOSPHOSERINE PHOSPHATASE : 8 hits 1l7n_c01 naa= 2 ULMN 2 1l8t_c00 AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASEuser 1 2 # 1 A 44 LYS A 28 LYS^? 7.39 O2 EDO A 124 A 190 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 64.41 0.88-268.84 63.58 4.71-273.83 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 62.52 10.21-280.32 62.21 11.74-278.89 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1l8t_c00 AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASEuser 2 2 # 2 A 44 LYS A 100 LYS~? 11.56 C2 EDO A 125 A 190 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 64.41 0.88-268.84 63.58 4.71-273.83 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo 62.52 10.21-280.32 62.21 11.74-278.89 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1l8t_c00 AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASEuser 3 2 # 3 A 44 LYS B 28 LYS^? -17.65 O1 EDO A 124s A 190 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 64.41 0.88-268.84 63.58 4.71-273.83 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 62.52 10.21-280.32 62.21 11.74-278.89 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1l8t_c00 source 1l8t AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE : 3 hits 1l8t_c00 naa= 2 ULMN 2 1ldm_c00 M4 LACTATE DEHYDROGENASE user 1 2 # 1 166 ASP A 86 ASP^? 9.05 O1 EDO A 125 193 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 20.88 15.91 3.60 20.25 17.72 4.50 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 18.81 19.85 7.63 17.55 19.89 5.97 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1ldm_c00 M4 LACTATE DEHYDROGENASE user 2 2 # 2 166 ASP B 86 ASP^? 26.97 C1 EDO A 124 193 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 20.88 15.91 3.60 20.25 17.72 4.50 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 18.81 19.85 7.63 17.55 19.89 5.97 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1ldm_c00 source 1ldm M4 LACTATE DEHYDROGENASE : 2 hits 1ldm_c00 naa= 2 ULMN 2 1lij_c00 ADENOSINE KINASE user 1 2 # 1 A 136 ARG A 30 ARG^? -2.97 O2 EDO A 124s A 318 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 140.87 17.93 -10.99 141.89 20.68 -12.00 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1lij_c00 ADENOSINE KINASE user 2 2 # 2 A 136 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 318 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 140.87 17.93 -10.99 141.89 20.68 -12.00 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1lij_c00 ADENOSINE KINASE user 3 2 # 3 A 136 ARG A 53 ARG~? 17.45 O1 EDO A 125 A 318 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 140.87 17.93 -10.99 141.89 20.68 -12.00 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1lij_c00 ADENOSINE KINASE user 4 2 # 4 A 136 ARG A 53 ARG~? 17.45 O1 EDO A 125 A 318 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 140.87 17.93 -10.99 141.89 20.68 -12.00 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1lij_c00 ADENOSINE KINASE user 5 2 # 5 A 136 ARG B 30 ARG^? 10.56 O1 EDO A 124 A 318 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 140.87 17.93 -10.99 141.89 20.68 -12.00 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1lij_c00 ADENOSINE KINASE user 6 2 # 6 A 136 ARG B 37 ARG^? 8.36 C1 EDO A 124 A 318 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 140.87 17.93 -10.99 141.89 20.68 -12.00 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1lij_c00 ADENOSINE KINASE user 7 2 # 7 A 136 ARG B 53 ARG~? 17.71 C1 EDO A 124 A 318 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 140.87 17.93 -10.99 141.89 20.68 -12.00 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1lij_c00 source 1lij ADENOSINE KINASE : 7 hits 1lij_c00 naa= 2 ULMN 2 1lio_c00 ADENOSINE KINASE user 1 2 # 1 A 136 ARG A 25 ARG.? 17.39 O2 EDO A 124 A 318 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 29.35 33.68 50.39 31.26 31.83 51.65 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 32.11 22.71 40.58 33.42 24.22 39.78 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1lio_c00 ADENOSINE KINASE user 2 2 # 2 A 136 ARG A 30 ARG^? -2.97 O2 EDO A 124s A 318 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 29.35 33.68 50.39 31.26 31.83 51.65 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 32.11 22.71 40.58 33.42 24.22 39.78 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1lio_c00 ADENOSINE KINASE user 3 2 # 3 A 136 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 318 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 29.35 33.68 50.39 31.26 31.83 51.65 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 32.11 22.71 40.58 33.42 24.22 39.78 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1lio_c00 ADENOSINE KINASE user 4 2 # 4 A 136 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 318 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 29.35 33.68 50.39 31.26 31.83 51.65 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 32.11 22.71 40.58 33.42 24.22 39.78 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1lio_c00 ADENOSINE KINASE user 5 2 # 5 A 136 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 318 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 29.35 33.68 50.39 31.26 31.83 51.65 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 32.11 22.71 40.58 33.42 24.22 39.78 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1lio_c00 ADENOSINE KINASE user 6 2 # 6 A 136 ARG B 25 ARG.? 18.77 O2 EDO A 125 A 318 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 29.35 33.68 50.39 31.26 31.83 51.65 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 32.11 22.71 40.58 33.42 24.22 39.78 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1lio_c00 ADENOSINE KINASE user 7 2 # 7 A 136 ARG B 30 ARG^? 10.56 O1 EDO A 124 A 318 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 29.35 33.68 50.39 31.26 31.83 51.65 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 32.11 22.71 40.58 33.42 24.22 39.78 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1lio_c00 ADENOSINE KINASE user 8 2 # 8 A 136 ARG B 37 ARG^? 8.36 C1 EDO A 124 A 318 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 29.35 33.68 50.39 31.26 31.83 51.65 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 32.11 22.71 40.58 33.42 24.22 39.78 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1lio_c00 ADENOSINE KINASE user 9 2 # 9 A 136 ARG B 37 ARG^? 8.36 C1 EDO A 124 A 318 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 29.35 33.68 50.39 31.26 31.83 51.65 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 32.11 22.71 40.58 33.42 24.22 39.78 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1lio_c00 ADENOSINE KINASE user 10 2 # 10 A 136 ARG B 53 ARG~? 17.71 C1 EDO A 124 A 318 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 29.35 33.68 50.39 31.26 31.83 51.65 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 32.11 22.71 40.58 33.42 24.22 39.78 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1lio_c00 ADENOSINE KINASE user 11 2 # 11 A 136 ARG B 53 ARG~? 17.71 C1 EDO A 124 A 318 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 29.35 33.68 50.39 31.26 31.83 51.65 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 32.11 22.71 40.58 33.42 24.22 39.78 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1lio_c00 source 1lio ADENOSINE KINASE : 11 hits 1lio_c00 naa= 2 ULMN 2 1lya_c00 CATHEPSIN D (E.C.3.4.23.5) user 1 2 # 1 A 33 ASP A 84 ASP.? 13.20 O1 EDO A 125 B 231 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 15.90 92.23 15.07 17.09 93.64 14.08 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 23.08 94.21 15.45 21.39 94.32 14.19 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1lya_c00 CATHEPSIN D (E.C.3.4.23.5) user 2 2 # 2 A 33 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 231 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 15.90 92.23 15.07 17.09 93.64 14.08 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 23.08 94.21 15.45 21.39 94.32 14.19 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1lya_c00 CATHEPSIN D (E.C.3.4.23.5) user 3 2 # 3 A 33 ASP B 84 ASP.? 30.86 C1 EDO A 124 B 231 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 15.90 92.23 15.07 17.09 93.64 14.08 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 23.08 94.21 15.45 21.39 94.32 14.19 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1lya_c00 CATHEPSIN D (E.C.3.4.23.5) user 4 2 # 4 A 33 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 231 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 15.90 92.23 15.07 17.09 93.64 14.08 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 23.08 94.21 15.45 21.39 94.32 14.19 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1lya_c00 source 1lya CATHEPSIN D (E.C.3.4.23.5) : 4 hits 1lya_c00 naa= 2 ULMN 2 1lya_c01 CATHEPSIN D (E.C.3.4.23.5) user 1 2 # 1 C 33 ASP A 84 ASP.? 13.20 O1 EDO A 125 D 231 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo -5.36 44.72 8.41 -3.34 44.21 8.70 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 0.87 48.30 6.85 0.22 46.73 8.13 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1lya_c01 CATHEPSIN D (E.C.3.4.23.5) user 2 2 # 2 C 33 ASP A 86 ASP^? 9.05 O1 EDO A 125 D 231 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo -5.36 44.72 8.41 -3.34 44.21 8.70 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 0.87 48.30 6.85 0.22 46.73 8.13 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1lya_c01 CATHEPSIN D (E.C.3.4.23.5) user 3 2 # 3 C 33 ASP B 63 ASP~? 17.37 O1 EDO A 124 D 231 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo -5.36 44.72 8.41 -3.34 44.21 8.70 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 0.87 48.30 6.85 0.22 46.73 8.13 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1lya_c01 CATHEPSIN D (E.C.3.4.23.5) user 4 2 # 4 C 33 ASP B 64 ASP~? 23.62 O1 EDO A 124 D 231 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -5.36 44.72 8.41 -3.34 44.21 8.70 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 0.87 48.30 6.85 0.22 46.73 8.13 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1lya_c01 CATHEPSIN D (E.C.3.4.23.5) user 5 2 # 5 C 33 ASP B 84 ASP.? 30.86 C1 EDO A 124 D 231 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo -5.36 44.72 8.41 -3.34 44.21 8.70 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 0.87 48.30 6.85 0.22 46.73 8.13 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1lya_c01 CATHEPSIN D (E.C.3.4.23.5) user 6 2 # 6 C 33 ASP B 86 ASP^? 26.97 C1 EDO A 124 D 231 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo -5.36 44.72 8.41 -3.34 44.21 8.70 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 0.87 48.30 6.85 0.22 46.73 8.13 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1lya_c01 source 1lya CATHEPSIN D (E.C.3.4.23.5) : 6 hits 1lya_c01 naa= 2 ULMN 2 1lz1_c00 LYSOZYME (E.C.3.2.1.17) user 1 2 # 1 35 GLU A 43 GLU.? 14.35 O2 EDO A 124 53 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 13.77 10.94 24.74 13.94 8.84 25.14 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 8.07 6.88 28.19 9.18 5.27 28.79 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1lz1_c00 LYSOZYME (E.C.3.2.1.17) user 2 2 # 2 35 GLU A 81 GLU.? 16.59 O1 EDO A 125 53 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 13.77 10.94 24.74 13.94 8.84 25.14 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 8.07 6.88 28.19 9.18 5.27 28.79 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1lz1_c00 LYSOZYME (E.C.3.2.1.17) user 3 2 # 3 35 GLU B 43 GLU.? 19.28 O2 EDO A 125 53 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 13.77 10.94 24.74 13.94 8.84 25.14 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 8.07 6.88 28.19 9.18 5.27 28.79 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1lz1_c00 LYSOZYME (E.C.3.2.1.17) user 4 2 # 4 35 GLU B 81 GLU.? 30.69 O1 EDO A 124 53 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 13.77 10.94 24.74 13.94 8.84 25.14 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 8.07 6.88 28.19 9.18 5.27 28.79 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1lz1_c00 source 1lz1 LYSOZYME (E.C.3.2.1.17) : 4 hits 1lz1_c00 naa= 2 ULMN 2 1m53_c01 ISOMALTULOSE SYNTHASE user 1 2 # 1 A 241 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 295 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 11.74 38.14 80.19 10.63 36.40 80.65 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 16.11 33.72 80.99 14.10 33.54 81.63 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1m53_c01 ISOMALTULOSE SYNTHASE user 2 2 # 2 A 241 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 295 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 16.11 33.72 80.99 14.10 33.54 81.63 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1m53_c01 ISOMALTULOSE SYNTHASE user 3 2 # 3 A 241 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 295 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 11.74 38.14 80.19 10.63 36.40 80.65 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 16.11 33.72 80.99 14.10 33.54 81.63 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1m53_c01 source 1m53 ISOMALTULOSE SYNTHASE : 3 hits 1m53_c01 naa= 2 ULMN 2 1m54_c00 CYSTATHIONINE BETA-SYNTHASE user 1 2 # 1 A 119 LYS A 28 LYS^? 7.39 O2 EDO A 124 A 349 SER A 88 SER^? -5.03 C1 EDO A 125s coo 3.13 2.91 12.86 6.03 -0.38 15.33 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 5.51 -9.50 11.91 4.63 -7.71 13.23 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1m54_c00 CYSTATHIONINE BETA-SYNTHASE user 2 2 # 2 A 119 LYS A 100 LYS~? 11.56 C2 EDO A 125 A 349 SER A 88 SER^? -5.03 C1 EDO A 125s coo 3.13 2.91 12.86 6.03 -0.38 15.33 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo 5.51 -9.50 11.91 4.63 -7.71 13.23 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1m54_c00 CYSTATHIONINE BETA-SYNTHASE user 3 2 # 3 A 119 LYS B 28 LYS^? -17.65 O1 EDO A 124s A 349 SER B 88 SER^? 19.82 O2 EDO A 125 coo 3.13 2.91 12.86 6.03 -0.38 15.33 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 5.51 -9.50 11.91 4.63 -7.71 13.23 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 1m54_c00 source 1m54 CYSTATHIONINE BETA-SYNTHASE : 3 hits 1m54_c00 naa= 2 ULMN 2 1m54_c02 CYSTATHIONINE BETA-SYNTHASE user 1 2 # 1 C 119 LYS A 28 LYS^? 7.39 O2 EDO A 124 C 349 SER A 88 SER^? -5.03 C1 EDO A 125s coo -20.84 30.72 17.88 -25.98 31.63 17.66 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo -29.13 36.71 25.20 -26.79 36.20 25.00 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1m54_c02 CYSTATHIONINE BETA-SYNTHASE user 2 2 # 2 C 119 LYS A 100 LYS~? 11.56 C2 EDO A 125 C 349 SER A 88 SER^? -5.03 C1 EDO A 125s coo -20.84 30.72 17.88 -25.98 31.63 17.66 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo -29.13 36.71 25.20 -26.79 36.20 25.00 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1m54_c02 CYSTATHIONINE BETA-SYNTHASE user 3 2 # 3 C 119 LYS B 28 LYS^? -17.65 O1 EDO A 124s C 349 SER B 88 SER^? 19.82 O2 EDO A 125 coo -20.84 30.72 17.88 -25.98 31.63 17.66 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo -29.13 36.71 25.20 -26.79 36.20 25.00 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 1m54_c02 source 1m54 CYSTATHIONINE BETA-SYNTHASE : 3 hits 1m54_c02 naa= 2 ULMN 2 1m54_c03 CYSTATHIONINE BETA-SYNTHASE user 1 2 # 1 D 119 LYS A 28 LYS^? 7.39 O2 EDO A 124 D 349 SER A 88 SER^? -5.03 C1 EDO A 125s coo -5.37 44.26 36.87 -2.80 48.80 34.89 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo -0.72 48.15 25.83 -2.20 46.60 26.98 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1m54_c03 CYSTATHIONINE BETA-SYNTHASE user 2 2 # 2 D 119 LYS A 100 LYS~? 11.56 C2 EDO A 125 D 349 SER A 88 SER^? -5.03 C1 EDO A 125s coo -5.37 44.26 36.87 -2.80 48.80 34.89 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo -0.72 48.15 25.83 -2.20 46.60 26.98 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1m54_c03 CYSTATHIONINE BETA-SYNTHASE user 3 2 # 3 D 119 LYS B 28 LYS^? -17.65 O1 EDO A 124s D 349 SER B 88 SER^? 19.82 O2 EDO A 125 coo -5.37 44.26 36.87 -2.80 48.80 34.89 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo -0.72 48.15 25.83 -2.20 46.60 26.98 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 1m54_c03 source 1m54 CYSTATHIONINE BETA-SYNTHASE : 3 hits 1m54_c03 naa= 2 ULMN 2 1m54_c05 CYSTATHIONINE BETA-SYNTHASE user 1 2 # 1 F 119 LYS A 28 LYS^? 7.39 O2 EDO A 124 F 349 SER A 88 SER^? -5.03 C1 EDO A 125s coo -7.84 18.42 63.15 -7.36 13.76 64.43 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo -1.89 11.37 72.02 -3.31 13.25 71.54 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1m54_c05 CYSTATHIONINE BETA-SYNTHASE user 2 2 # 2 F 119 LYS A 100 LYS~? 11.56 C2 EDO A 125 F 349 SER A 88 SER^? -5.03 C1 EDO A 125s coo -7.84 18.42 63.15 -7.36 13.76 64.43 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo -1.89 11.37 72.02 -3.31 13.25 71.54 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1m54_c05 CYSTATHIONINE BETA-SYNTHASE user 3 2 # 3 F 119 LYS B 28 LYS^? -17.65 O1 EDO A 124s F 349 SER B 88 SER^? 19.82 O2 EDO A 125 coo -7.84 18.42 63.15 -7.36 13.76 64.43 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo -1.89 11.37 72.02 -3.31 13.25 71.54 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 1m54_c05 source 1m54 CYSTATHIONINE BETA-SYNTHASE : 3 hits 1m54_c05 naa= 2 ULMN 2 1mfp_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 A 159 MET A 103 MET?? 8.30 O2 EDO A 125 A 163 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo -3.35 25.69 137.79 -1.64 22.92 138.74 -21.98 -53.69 -14.57 -25.85 -52.15 -15.50 coo 0.83 29.26 140.07 3.97 24.87 138.74 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 1mfp_c02 source 1mfp ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH] : 1 hits 1mfp_c02 naa= 2 ULMN 2 1mfp_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 B1159 MET A 103 MET?? 8.30 O2 EDO A 125 B1163 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo -3.50 36.78 152.46 -6.57 36.72 153.25 -21.98 -53.69 -14.57 -25.85 -52.15 -15.50 coo -5.16 37.67 146.77 -9.21 40.09 149.15 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 1mfp_c03 source 1mfp ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH] : 1 hits 1mfp_c03 naa= 2 ULMN 2 1mht_c00 HHAI METHYLTRANSFERASE user 1 2 # 1 A 81 CYH A 46 CYH.? 11.48 C1 EDO A 124 A 119 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo -14.24 38.25 87.68 -17.04 38.68 87.49 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo -16.93 37.35 78.96 -17.46 37.15 81.01 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1mht_c00 HHAI METHYLTRANSFERASE user 2 2 # 2 A 81 CYH A 67 CYH~? 14.35 O2 EDO A 124 A 119 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -14.24 38.25 87.68 -17.04 38.68 87.49 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo -16.93 37.35 78.96 -17.46 37.15 81.01 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1mht_c00 HHAI METHYLTRANSFERASE user 3 2 # 3 A 81 CYH B 46 CYH.? 10.55 O2 EDO A 125 A 119 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -14.24 38.25 87.68 -17.04 38.68 87.49 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo -16.93 37.35 78.96 -17.46 37.15 81.01 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1mht_c00 HHAI METHYLTRANSFERASE user 4 2 # 4 A 81 CYH B 67 CYH~? 18.88 O1 EDO A 124 A 119 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo -14.24 38.25 87.68 -17.04 38.68 87.49 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo -16.93 37.35 78.96 -17.46 37.15 81.01 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1mht_c00 source 1mht HHAI METHYLTRANSFERASE : 4 hits 1mht_c00 naa= 2 ULMN 2 1mhy_c00 METHANE MONOOXYGENASE HYDROXYLASE user 1 2 # 1 D 151 CYH A 67 CYH~? 14.35 O2 EDO A 124 D 213 THR A 82 THR.? 18.68 O1 EDO A 125 coo -42.45 81.56 14.53 -42.56 80.44 17.02 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo -44.48 73.73 25.06 -42.89 75.12 24.56 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 1mhy_c00 source 1mhy METHANE MONOOXYGENASE HYDROXYLASE : 1 hits 1mhy_c00 naa= 2 ULMN 2 1mud_c00 ADENINE GLYCOSYLASE user 1 2 # 1 A 37 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 138 ASN A 44 ASN.? 12.85 O2 EDO A 124 coo -28.98 -13.86 16.88 -27.45 -12.37 16.83 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -28.13 -6.05 12.73 -26.20 -6.06 13.74 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 ULMN 2 1mud_c00 ADENINE GLYCOSYLASE user 2 2 # 2 A 37 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 138 ASN B 44 ASN.? 11.30 O2 EDO A 125 coo -28.98 -13.86 16.88 -27.45 -12.37 16.83 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -28.13 -6.05 12.73 -26.20 -6.06 13.74 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 1mud_c00 source 1mud ADENINE GLYCOSYLASE : 2 hits 1mud_c00 naa= 2 ULMN 2 1mvn_c00 PPC DECARBOXYLASE ATHAL3A user 1 2 # 1 A 90 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 175 SER B 34 SER.? 9.94 O1 EDO A 124 coo 40.70 24.20 -17.92 39.73 26.03 -17.59 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 73.56 14.52 -17.97 72.80 14.99 -15.70 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 ULMN 2 1mvn_c00 PPC DECARBOXYLASE ATHAL3A user 2 2 # 2 A 90 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 175 SER A 34 SER.? 10.92 O1 EDO A 124 coo 40.70 24.20 -17.92 39.73 26.03 -17.59 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 73.56 14.52 -17.97 72.80 14.99 -15.70 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 1mvn_c00 source 1mvn PPC DECARBOXYLASE ATHAL3A : 2 hits 1mvn_c00 naa= 2 ULMN 2 1myr_c01 MYROSINASE user 1 2 # 1 187 GLN A 56 GLN.? 7.55 C1 EDO A 125 409 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 45.09 114.33 52.30 45.59 116.18 51.29 -19.66 -52.09 -22.06 -20.64 -53.94 -21.94 coo 42.69 118.64 56.27 44.58 118.34 55.45 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1myr_c01 MYROSINASE user 2 2 # 2 187 GLN B 56 GLN.? 26.20 C1 EDO A 124 409 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 45.09 114.33 52.30 45.59 116.18 51.29 -52.89 -32.90 -22.16 -54.01 -34.64 -22.72 coo 42.69 118.64 56.27 44.58 118.34 55.45 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 1myr_c01 source 1myr MYROSINASE : 2 hits 1myr_c01 naa= 2 ULMN 2 1n20_c00 (+)-BORNYL DIPHOSPHATE SYNTHASE user 1 2 # 1 A 323 TRP A 102 TRP~? 9.51 C2 EDO A 125 A 578 PHE A 97 PHE.? 7.14 O2 EDO A 125 coo 42.22 39.02 48.32 44.24 41.75 50.32 -18.50 -53.08 -18.95 -20.92 -50.18 -17.77 coo 48.42 44.12 48.01 47.31 44.28 45.42 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 ULMN 2 1n20_c00 (+)-BORNYL DIPHOSPHATE SYNTHASE user 2 2 # 2 A 323 TRP B 102 TRP.? 23.62 C1 EDO A 124 A 578 PHE B 97 PHE.? 16.35 C1 EDO A 124 coo 42.22 39.02 48.32 44.24 41.75 50.32 -54.10 -32.30 -25.44 -50.24 -31.83 -25.86 coo 48.42 44.12 48.01 47.31 44.28 45.42 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 1n20_c00 source 1n20 (+)-BORNYL DIPHOSPHATE SYNTHASE : 2 hits 1n20_c00 naa= 2 ULMN 2 1n20_c01 (+)-BORNYL DIPHOSPHATE SYNTHASE user 1 2 # 1 B 323 TRP A 102 TRP~? 9.51 C2 EDO A 125 B 578 PHE A 97 PHE.? 7.14 O2 EDO A 125 coo 43.23 41.00 1.45 40.43 39.01 -0.47 -18.50 -53.08 -18.95 -20.92 -50.18 -17.77 coo 37.75 35.24 1.51 37.38 36.07 4.16 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 ULMN 2 1n20_c01 (+)-BORNYL DIPHOSPHATE SYNTHASE user 2 2 # 2 B 323 TRP B 102 TRP.? 23.62 C1 EDO A 124 B 578 PHE B 97 PHE.? 16.35 C1 EDO A 124 coo 43.23 41.00 1.45 40.43 39.01 -0.47 -54.10 -32.30 -25.44 -50.24 -31.83 -25.86 coo 37.75 35.24 1.51 37.38 36.07 4.16 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 1n20_c01 source 1n20 (+)-BORNYL DIPHOSPHATE SYNTHASE : 2 hits 1n20_c01 naa= 2 ULMN 2 1n29_c00 PHOSPHOLIPASE A2, MEMBRANE ASSOCIATEuser 1 2 # 1 A 47 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 91 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo -41.21 130.11 53.96 -42.35 128.64 54.89 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -43.18 124.10 53.29 -44.35 125.07 54.78 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1n29_c00 PHOSPHOLIPASE A2, MEMBRANE ASSOCIATEuser 2 2 # 2 A 47 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 91 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo -41.21 130.11 53.96 -42.35 128.64 54.89 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -43.18 124.10 53.29 -44.35 125.07 54.78 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1n29_c00 PHOSPHOLIPASE A2, MEMBRANE ASSOCIATEuser 3 2 # 3 A 47 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 91 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo -41.21 130.11 53.96 -42.35 128.64 54.89 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -43.18 124.10 53.29 -44.35 125.07 54.78 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1n29_c00 PHOSPHOLIPASE A2, MEMBRANE ASSOCIATEuser 4 2 # 4 A 47 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 91 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo -41.21 130.11 53.96 -42.35 128.64 54.89 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -43.18 124.10 53.29 -44.35 125.07 54.78 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1n29_c00 source 1n29 PHOSPHOLIPASE A2, MEMBRANE ASSOCIATED : 4 hits 1n29_c00 naa= 2 ULMN 2 1n2c_c00 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 E 12 GLY A 75 GLY.? 13.18 O1 EDO A 125 E 15 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo -2.44 154.43 53.79 -2.04 154.61 53.14 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 coo -6.07 154.37 47.56 -2.16 152.62 49.36 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1n2c_c00 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 E 12 GLY A 98 GLY.? 4.74 C2 EDO A 125 E 15 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo -2.44 154.43 53.79 -2.04 154.61 53.14 -24.21 -51.77 -20.47 -24.90 -51.86 -20.04 coo -6.07 154.37 47.56 -2.16 152.62 49.36 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 ULMN 2 1n2c_c00 NITROGENASE MOLYBDENUM-IRON PROTEIN user 3 2 # 3 E 12 GLY B 75 GLY.? 21.06 O2 EDO A 125 E 15 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo -2.44 154.43 53.79 -2.04 154.61 53.14 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 coo -6.07 154.37 47.56 -2.16 152.62 49.36 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1n2c_c00 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 3 hits 1n2c_c00 naa= 2 ULMN 2 1n2c_c01 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 F 12 GLY A 75 GLY.? 13.18 O1 EDO A 125 F 15 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 1.70 155.20 55.76 1.33 154.96 56.40 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 coo 5.42 154.93 61.93 2.65 152.21 59.38 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1n2c_c01 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 F 12 GLY A 98 GLY.? 4.74 C2 EDO A 125 F 15 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 1.70 155.20 55.76 1.33 154.96 56.40 -24.21 -51.77 -20.47 -24.90 -51.86 -20.04 coo 5.42 154.93 61.93 2.65 152.21 59.38 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 ULMN 2 1n2c_c01 NITROGENASE MOLYBDENUM-IRON PROTEIN user 3 2 # 3 F 12 GLY B 75 GLY.? 21.06 O2 EDO A 125 F 15 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 1.70 155.20 55.76 1.33 154.96 56.40 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 coo 5.42 154.93 61.93 2.65 152.21 59.38 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1n2c_c01 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 3 hits 1n2c_c01 naa= 2 ULMN 2 1n2c_c02 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 G 12 GLY A 75 GLY.? 13.18 O1 EDO A 125 G 15 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 8.39 23.19 11.96 7.87 23.40 11.41 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 coo 10.78 26.96 6.29 7.40 27.17 9.46 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1n2c_c02 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 G 12 GLY A 98 GLY.? 4.74 C2 EDO A 125 G 15 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 8.39 23.19 11.96 7.87 23.40 11.41 -24.21 -51.77 -20.47 -24.90 -51.86 -20.04 coo 10.78 26.96 6.29 7.40 27.17 9.46 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 ULMN 2 1n2c_c02 NITROGENASE MOLYBDENUM-IRON PROTEIN user 3 2 # 3 G 12 GLY B 75 GLY.? 21.06 O2 EDO A 125 G 15 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 8.39 23.19 11.96 7.87 23.40 11.41 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 coo 10.78 26.96 6.29 7.40 27.17 9.46 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1n2c_c02 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 3 hits 1n2c_c02 naa= 2 ULMN 2 1n2c_c03 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 H 12 GLY A 75 GLY.? 13.18 O1 EDO A 125 H 15 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 4.68 21.14 13.82 5.18 21.00 14.40 -32.08 -43.13 -35.24 -32.38 -43.83 -34.91 coo 2.21 17.68 19.65 4.60 21.51 18.60 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1n2c_c03 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 H 12 GLY A 98 GLY.? 4.74 C2 EDO A 125 H 15 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 4.68 21.14 13.82 5.18 21.00 14.40 -24.21 -51.77 -20.47 -24.90 -51.86 -20.04 coo 2.21 17.68 19.65 4.60 21.51 18.60 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 ULMN 2 1n2c_c03 NITROGENASE MOLYBDENUM-IRON PROTEIN user 3 2 # 3 H 12 GLY B 75 GLY.? 21.06 O2 EDO A 125 H 15 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 4.68 21.14 13.82 5.18 21.00 14.40 -38.61 -38.85 -8.37 -39.07 -39.52 -8.69 coo 2.21 17.68 19.65 4.60 21.51 18.60 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1n2c_c03 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 3 hits 1n2c_c03 naa= 2 ULMN 2 1n2c_c07 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 D 153 CYH A 67 CYH~? 14.35 O2 EDO A 124 D 157 VAL A 69 VAL.? 13.01 O1 EDO A 125 coo 1.13 50.61 23.79 0.62 51.39 26.43 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo 2.55 45.49 21.08 2.56 44.84 23.18 -20.19 -39.87 -32.28 -21.73 -38.92 -31.10 ULMN 2 1n2c_c07 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 D 153 CYH B 67 CYH~? 18.88 O1 EDO A 124 D 157 VAL B 69 VAL.? 19.16 O1 EDO A 124 coo 1.13 50.61 23.79 0.62 51.39 26.43 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo 2.55 45.49 21.08 2.56 44.84 23.18 -42.17 -27.20 -11.15 -40.62 -28.02 -12.49 1n2c_c07 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 2 hits 1n2c_c07 naa= 2 ULMN 2 1n2c_c08 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 A 154 CYH A 46 CYH.? 11.48 C1 EDO A 124 A 158 LEU A 42 LEU^? 10.34 O2 EDO A 124 coo 9.89 125.56 52.05 11.13 124.71 49.65 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 7.79 131.42 52.52 9.06 131.14 50.79 -35.18 -36.23 -29.00 -34.50 -37.80 -27.68 ULMN 2 1n2c_c08 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 A 154 CYH A 46 CYH.? 11.48 C1 EDO A 124 A 158 LEU B 54 LEU~? 14.98 C1 EDO A 124 coo 9.89 125.56 52.05 11.13 124.71 49.65 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 7.79 131.42 52.52 9.06 131.14 50.79 -44.12 -30.81 -26.43 -43.06 -31.04 -28.33 ULMN 2 1n2c_c08 NITROGENASE MOLYBDENUM-IRON PROTEIN user 3 2 # 3 A 154 CYH A 67 CYH~? 14.35 O2 EDO A 124 A 158 LEU A 66 LEU~? 14.48 O1 EDO A 125 coo 9.89 125.56 52.05 11.13 124.71 49.65 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo 7.79 131.42 52.52 9.06 131.14 50.79 -15.97 -38.44 -26.63 -16.10 -39.71 -24.86 ULMN 2 1n2c_c08 NITROGENASE MOLYBDENUM-IRON PROTEIN user 4 2 # 4 A 154 CYH B 46 CYH.? 10.55 O2 EDO A 125 A 158 LEU B 42 LEU^? 14.47 O2 EDO A 125 coo 9.89 125.56 52.05 11.13 124.71 49.65 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo 7.79 131.42 52.52 9.06 131.14 50.79 -31.56 -38.10 -14.56 -33.31 -38.25 -15.79 ULMN 2 1n2c_c08 NITROGENASE MOLYBDENUM-IRON PROTEIN user 5 2 # 5 A 154 CYH B 67 CYH~? 18.88 O1 EDO A 124 A 158 LEU B 66 LEU~? 17.96 C1 EDO A 124 coo 9.89 125.56 52.05 11.13 124.71 49.65 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo 7.79 131.42 52.52 9.06 131.14 50.79 -43.15 -22.70 -16.79 -44.19 -23.46 -18.56 1n2c_c08 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 5 hits 1n2c_c08 naa= 2 ULMN 2 1n2c_c09 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 C 154 CYH A 46 CYH.? 11.48 C1 EDO A 124 C 158 LEU A 42 LEU^? 10.34 O2 EDO A 124 coo -2.34 47.38 28.79 -3.93 49.36 27.56 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo -0.52 42.39 25.49 -2.04 43.54 24.47 -35.18 -36.23 -29.00 -34.50 -37.80 -27.68 ULMN 2 1n2c_c09 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 C 154 CYH A 46 CYH.? 11.48 C1 EDO A 124 C 158 LEU B 54 LEU~? 14.98 C1 EDO A 124 coo -2.34 47.38 28.79 -3.93 49.36 27.56 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo -0.52 42.39 25.49 -2.04 43.54 24.47 -44.12 -30.81 -26.43 -43.06 -31.04 -28.33 ULMN 2 1n2c_c09 NITROGENASE MOLYBDENUM-IRON PROTEIN user 3 2 # 3 C 154 CYH A 67 CYH~? 14.35 O2 EDO A 124 C 158 LEU A 66 LEU~? 14.48 O1 EDO A 125 coo -2.34 47.38 28.79 -3.93 49.36 27.56 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo -0.52 42.39 25.49 -2.04 43.54 24.47 -15.97 -38.44 -26.63 -16.10 -39.71 -24.86 ULMN 2 1n2c_c09 NITROGENASE MOLYBDENUM-IRON PROTEIN user 4 2 # 4 C 154 CYH B 46 CYH.? 10.55 O2 EDO A 125 C 158 LEU B 42 LEU^? 14.47 O2 EDO A 125 coo -2.34 47.38 28.79 -3.93 49.36 27.56 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo -0.52 42.39 25.49 -2.04 43.54 24.47 -31.56 -38.10 -14.56 -33.31 -38.25 -15.79 ULMN 2 1n2c_c09 NITROGENASE MOLYBDENUM-IRON PROTEIN user 5 2 # 5 C 154 CYH B 67 CYH~? 18.88 O1 EDO A 124 C 158 LEU B 66 LEU~? 17.96 C1 EDO A 124 coo -2.34 47.38 28.79 -3.93 49.36 27.56 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo -0.52 42.39 25.49 -2.04 43.54 24.47 -43.15 -22.70 -16.79 -44.19 -23.46 -18.56 1n2c_c09 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 5 hits 1n2c_c09 naa= 2 ULMN 2 1ndi_c02 CARNITINE ACETYLTRANSFERASE user 1 2 # 1 A 343 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 554 SER A 88 SER^? -5.03 C1 EDO A 125s coo 31.51 35.76 91.64 29.77 35.09 90.70 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 24.54 30.87 84.61 26.81 31.67 85.10 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1ndi_c02 CARNITINE ACETYLTRANSFERASE user 2 2 # 2 A 343 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 554 SER B 88 SER^? 19.82 O2 EDO A 125 coo 31.51 35.76 91.64 29.77 35.09 90.70 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 24.54 30.87 84.61 26.81 31.67 85.10 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 1ndi_c02 source 1ndi CARNITINE ACETYLTRANSFERASE : 2 hits 1ndi_c02 naa= 2 ULMN 2 1ndi_c03 CARNITINE ACETYLTRANSFERASE user 1 2 # 1 B 343 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 554 SER A 88 SER^? -5.03 C1 EDO A 125s coo 15.05 2.97 49.11 16.83 2.62 48.07 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 21.79 0.25 40.42 20.02 -0.06 42.06 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1ndi_c03 CARNITINE ACETYLTRANSFERASE user 2 2 # 2 B 343 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 554 SER B 88 SER^? 19.82 O2 EDO A 125 coo 15.05 2.97 49.11 16.83 2.62 48.07 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 21.79 0.25 40.42 20.02 -0.06 42.06 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 1ndi_c03 source 1ndi CARNITINE ACETYLTRANSFERASE : 2 hits 1ndi_c03 naa= 2 ULMN 2 1nhx_c01 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 2 # 1 A 264 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 405 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 41.33 25.99 28.05 41.95 26.95 29.80 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 42.28 27.98 41.30 43.16 28.14 38.35 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1nhx_c01 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 2 2 # 2 A 264 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 405 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 41.33 25.99 28.05 41.95 26.95 29.80 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 42.28 27.98 41.30 43.16 28.14 38.35 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 1nhx_c01 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 2 hits 1nhx_c01 naa= 2 ULMN 2 1nid_c00 NITRITE REDUCTASE user 1 2 # 1 A 64 PHE A 48 PHE^? 10.34 O2 EDO A 125 A 66 GLY A 91 GLY~? 3.77 O2 EDO A 125 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -31.34 -48.06 -23.33 -31.38 -47.22 -23.45 ULMN 2 1nid_c00 NITRITE REDUCTASE user 2 2 # 2 A 64 PHE A 48 PHE^? 10.34 O2 EDO A 125 A 66 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1nid_c00 NITRITE REDUCTASE user 3 2 # 3 A 64 PHE A 50 PHE^? 8.88 O1 EDO A 125 A 66 GLY A 91 GLY~? 3.77 O2 EDO A 125 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -31.34 -48.06 -23.33 -31.38 -47.22 -23.45 ULMN 2 1nid_c00 NITRITE REDUCTASE user 4 2 # 4 A 64 PHE A 50 PHE^? 8.88 O1 EDO A 125 A 66 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1nid_c00 NITRITE REDUCTASE user 5 2 # 5 A 64 PHE A 50 PHE^? 8.88 O1 EDO A 125 A 66 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1nid_c00 NITRITE REDUCTASE user 6 2 # 6 A 64 PHE A 97 PHE.? 7.14 O2 EDO A 125 A 66 GLY A 91 GLY~? 3.77 O2 EDO A 125 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -31.34 -48.06 -23.33 -31.38 -47.22 -23.45 ULMN 2 1nid_c00 NITRITE REDUCTASE user 7 2 # 7 A 64 PHE A 97 PHE.? 7.14 O2 EDO A 125 A 66 GLY A 98 GLY.? 4.74 C2 EDO A 125 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -24.21 -51.77 -20.47 -24.90 -51.86 -20.04 ULMN 2 1nid_c00 NITRITE REDUCTASE user 8 2 # 8 A 64 PHE A 97 PHE.? 7.14 O2 EDO A 125 A 66 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1nid_c00 NITRITE REDUCTASE user 9 2 # 9 A 64 PHE B 48 PHE^? 12.04 C1 EDO A 124 A 66 GLY B 91 GLY~? 18.21 O2 EDO A 125 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -43.74 -41.04 -20.11 -43.00 -40.62 -20.02 ULMN 2 1nid_c00 NITRITE REDUCTASE user 10 2 # 10 A 64 PHE B 48 PHE^? 12.04 C1 EDO A 124 A 66 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1nid_c00 NITRITE REDUCTASE user 11 2 # 11 A 64 PHE B 50 PHE^? 13.90 C1 EDO A 124 A 66 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1nid_c00 NITRITE REDUCTASE user 12 2 # 12 A 64 PHE B 50 PHE^? 13.90 C1 EDO A 124 A 66 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1nid_c00 NITRITE REDUCTASE user 13 2 # 13 A 64 PHE B 97 PHE.? 16.35 C1 EDO A 124 A 66 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1nid_c00 NITRITE REDUCTASE user 14 2 # 14 A 64 PHE B 97 PHE.? 16.35 C1 EDO A 124 A 66 GLY B 91 GLY~? 18.21 O2 EDO A 125 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -43.74 -41.04 -20.11 -43.00 -40.62 -20.02 1nid_c00 source 1nid NITRITE REDUCTASE : 14 hits 1nid_c00 naa= 2 ULMN 2 1nid_c01 NITRITE REDUCTASE user 1 2 # 1 A 98 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 255 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 20.32 -11.73 7.16 18.14 -11.39 7.16 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 8.27 11.62 -8.39 7.16 12.84 -9.70 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 ULMN 2 1nid_c01 NITRITE REDUCTASE user 2 2 # 2 A 98 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 255 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 20.32 -11.73 7.16 18.14 -11.39 7.16 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 8.27 11.62 -8.39 7.16 12.84 -9.70 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 1nid_c01 source 1nid NITRITE REDUCTASE : 2 hits 1nid_c01 naa= 2 ULMN 2 1nml_c00 DI-HAEM CYTOCHROME C PEROXIDASE user 1 2 # 1 A 94 TRP A 80 TRP^? 10.72 O1 EDO A 125 A 114 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 39.74 24.82 20.22 40.15 25.23 24.11 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 44.34 21.01 32.31 43.64 21.69 30.42 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1nml_c00 DI-HAEM CYTOCHROME C PEROXIDASE user 2 2 # 2 A 94 TRP B 80 TRP^? 20.31 C1 EDO A 124 A 114 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 39.74 24.82 20.22 40.15 25.23 24.11 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 44.34 21.01 32.31 43.64 21.69 30.42 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 1nml_c00 source 1nml DI-HAEM CYTOCHROME C PEROXIDASE : 2 hits 1nml_c00 naa= 2 ULMN 2 1nsj_c00 PHOSPHORIBOSYL ANTHRANILATE ISOMERASuser 1 2 # 1 7 CYH A 46 CYH.? 11.48 C1 EDO A 124 126 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 10.76 29.56 55.88 9.84 31.65 57.57 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 5.60 29.99 66.94 7.71 29.76 66.83 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1nsj_c00 PHOSPHORIBOSYL ANTHRANILATE ISOMERASuser 2 2 # 2 7 CYH B 46 CYH.? 10.55 O2 EDO A 125 126 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 10.76 29.56 55.88 9.84 31.65 57.57 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo 5.60 29.99 66.94 7.71 29.76 66.83 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 1nsj_c00 source 1nsj PHOSPHORIBOSYL ANTHRANILATE ISOMERASE : 2 hits 1nsj_c00 naa= 2 ULMN 2 1nsp_c00 NUCLEOSIDE DIPHOSPHATE KINASE (E.C.2user 1 2 # 1 A 16 LYS A 100 LYS~? 11.56 C2 EDO A 125 A 119 ASN B 22 ASN.? 13.33 O2 EDO A 125 coo -11.95 25.45 17.71 -10.57 25.01 12.04 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo -6.02 27.15 11.24 -7.88 26.67 10.45 -33.78 -50.89 -12.81 -33.60 -52.50 -11.46 1nsp_c00 source 1nsp NUCLEOSIDE DIPHOSPHATE KINASE (E.C.2.7.4.6) : 1 hits 1nsp_c00 naa= 2 ULMN 2 1nsp_c01 NUCLEOSIDE DIPHOSPHATE KINASE (E.C.2user 1 2 # 1 A 16 LYS A 28 LYS^? 7.39 O2 EDO A 124 A 56 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo -11.95 25.45 17.71 -10.57 25.01 12.04 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo -17.06 21.36 8.56 -15.07 22.55 10.13 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1nsp_c01 NUCLEOSIDE DIPHOSPHATE KINASE (E.C.2user 2 2 # 2 A 16 LYS A 28 LYS^? 7.39 O2 EDO A 124 A 56 TYR A 76 TYR.? 12.73 O1 EDO A 125 coo -11.95 25.45 17.71 -10.57 25.01 12.04 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo -17.06 21.36 8.56 -15.07 22.55 10.13 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 ULMN 2 1nsp_c01 NUCLEOSIDE DIPHOSPHATE KINASE (E.C.2user 3 2 # 3 A 16 LYS B 28 LYS^? -17.65 O1 EDO A 124s A 56 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo -11.95 25.45 17.71 -10.57 25.01 12.04 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo -17.06 21.36 8.56 -15.07 22.55 10.13 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 ULMN 2 1nsp_c01 NUCLEOSIDE DIPHOSPHATE KINASE (E.C.2user 4 2 # 4 A 16 LYS B 28 LYS^? -17.65 O1 EDO A 124s A 56 TYR B 76 TYR.? 17.92 O2 EDO A 125 coo -11.95 25.45 17.71 -10.57 25.01 12.04 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo -17.06 21.36 8.56 -15.07 22.55 10.13 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 1nsp_c01 source 1nsp NUCLEOSIDE DIPHOSPHATE KINASE (E.C.2.7.4.6) : 4 hits 1nsp_c01 naa= 2 ULMN 2 1o8a_c00 ANGIOTENSIN CONVERTING ENZYME user 1 2 # 1 A 411 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 523 TYR A 76 TYR.? 12.73 O1 EDO A 125 coo 42.59 41.82 44.54 42.65 40.34 46.03 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 39.81 39.01 41.64 39.68 38.13 44.30 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 ULMN 2 1o8a_c00 ANGIOTENSIN CONVERTING ENZYME user 2 2 # 2 A 411 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 523 TYR B 76 TYR.? 17.92 O2 EDO A 125 coo 42.59 41.82 44.54 42.65 40.34 46.03 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 39.81 39.01 41.64 39.68 38.13 44.30 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 1o8a_c00 source 1o8a ANGIOTENSIN CONVERTING ENZYME : 2 hits 1o8a_c00 naa= 2 ULMN 2 1oas_c00 O-ACETYLSERINE SULFHYDRYLASE user 1 2 # 1 A 41 LYS A 28 LYS^? 7.39 O2 EDO A 124 A 272 SER A 88 SER^? -5.03 C1 EDO A 125s coo 17.84 11.94 36.57 13.01 10.24 35.93 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 9.36 2.57 41.22 10.95 4.31 40.56 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1oas_c00 O-ACETYLSERINE SULFHYDRYLASE user 2 2 # 2 A 41 LYS A 100 LYS~? 11.56 C2 EDO A 125 A 272 SER A 88 SER^? -5.03 C1 EDO A 125s coo 17.84 11.94 36.57 13.01 10.24 35.93 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo 9.36 2.57 41.22 10.95 4.31 40.56 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1oas_c00 O-ACETYLSERINE SULFHYDRYLASE user 3 2 # 3 A 41 LYS B 28 LYS^? -17.65 O1 EDO A 124s A 272 SER B 88 SER^? 19.82 O2 EDO A 125 coo 17.84 11.94 36.57 13.01 10.24 35.93 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 9.36 2.57 41.22 10.95 4.31 40.56 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 1oas_c00 source 1oas O-ACETYLSERINE SULFHYDRYLASE : 3 hits 1oas_c00 naa= 2 ULMN 2 1oas_c01 O-ACETYLSERINE SULFHYDRYLASE user 1 2 # 1 B 41 LYS A 28 LYS^? 7.39 O2 EDO A 124 B 272 SER A 88 SER^? -5.03 C1 EDO A 125s coo 27.89 7.89 59.43 27.49 11.76 62.82 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 26.69 21.30 59.90 26.75 18.87 59.68 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1oas_c01 O-ACETYLSERINE SULFHYDRYLASE user 2 2 # 2 B 41 LYS A 100 LYS~? 11.56 C2 EDO A 125 B 272 SER A 88 SER^? -5.03 C1 EDO A 125s coo 27.89 7.89 59.43 27.49 11.76 62.82 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo 26.69 21.30 59.90 26.75 18.87 59.68 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1oas_c01 O-ACETYLSERINE SULFHYDRYLASE user 3 2 # 3 B 41 LYS B 28 LYS^? -17.65 O1 EDO A 124s B 272 SER B 88 SER^? 19.82 O2 EDO A 125 coo 27.89 7.89 59.43 27.49 11.76 62.82 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 26.69 21.30 59.90 26.75 18.87 59.68 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 1oas_c01 source 1oas O-ACETYLSERINE SULFHYDRYLASE : 3 hits 1oas_c01 naa= 2 ULMN 2 1odt_c02 CEPHALOSPORIN C DEACETYLASE user 1 2 # 1 C 166 SER A 34 SER.? 10.92 O1 EDO A 124 C 298 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 43.52 66.08 46.50 43.81 67.66 48.38 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo 13.42 79.87 46.31 15.44 80.29 45.93 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 ULMN 2 1odt_c02 CEPHALOSPORIN C DEACETYLASE user 2 2 # 2 C 166 SER A 88 SER^? -5.03 C1 EDO A 125s C 298 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 43.52 66.08 46.50 43.81 67.66 48.38 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 coo 13.42 79.87 46.31 15.44 80.29 45.93 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 ULMN 2 1odt_c02 CEPHALOSPORIN C DEACETYLASE user 3 2 # 3 C 166 SER B 34 SER.? 9.94 O1 EDO A 124 C 298 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 43.52 66.08 46.50 43.81 67.66 48.38 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 coo 13.42 79.87 46.31 15.44 80.29 45.93 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1odt_c02 CEPHALOSPORIN C DEACETYLASE user 4 2 # 4 C 166 SER B 88 SER^? 19.82 O2 EDO A 125 C 298 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 43.52 66.08 46.50 43.81 67.66 48.38 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 coo 13.42 79.87 46.31 15.44 80.29 45.93 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 1odt_c02 source 1odt CEPHALOSPORIN C DEACETYLASE : 4 hits 1odt_c02 naa= 2 ULMN 2 1odt_c03 CEPHALOSPORIN C DEACETYLASE user 1 2 # 1 H 166 SER A 34 SER.? 10.92 O1 EDO A 124 H 298 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 39.89 121.01 63.83 40.38 119.49 62.00 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo 11.89 103.25 63.94 13.96 103.24 64.24 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 ULMN 2 1odt_c03 CEPHALOSPORIN C DEACETYLASE user 2 2 # 2 H 166 SER B 34 SER.? 9.94 O1 EDO A 124 H 298 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 39.89 121.01 63.83 40.38 119.49 62.00 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 coo 11.89 103.25 63.94 13.96 103.24 64.24 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1odt_c03 CEPHALOSPORIN C DEACETYLASE user 3 2 # 3 H 166 SER B 88 SER^? 19.82 O2 EDO A 125 H 298 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 39.89 121.01 63.83 40.38 119.49 62.00 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 coo 11.89 103.25 63.94 13.96 103.24 64.24 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 1odt_c03 source 1odt CEPHALOSPORIN C DEACETYLASE : 3 hits 1odt_c03 naa= 2 ULMN 2 1ogo_c00 DEXTRANASE user 1 2 # 1 X 376 ASP A 63 ASP~? 17.25 O1 EDO A 124 X 395 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 18.58 14.19 10.77 18.44 12.41 11.84 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 16.42 13.96 7.23 14.37 13.48 7.58 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1ogo_c00 DEXTRANASE user 2 2 # 2 X 376 ASP A 64 ASP~? 20.53 O2 EDO A 124 X 395 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 18.58 14.19 10.77 18.44 12.41 11.84 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 16.42 13.96 7.23 14.37 13.48 7.58 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1ogo_c00 DEXTRANASE user 3 2 # 3 X 376 ASP B 63 ASP~? 17.37 O1 EDO A 124 X 395 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 18.58 14.19 10.77 18.44 12.41 11.84 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 16.42 13.96 7.23 14.37 13.48 7.58 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1ogo_c00 DEXTRANASE user 4 2 # 4 X 376 ASP B 64 ASP~? 23.62 O1 EDO A 124 X 395 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 18.58 14.19 10.77 18.44 12.41 11.84 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 16.42 13.96 7.23 14.37 13.48 7.58 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 1ogo_c00 source 1ogo DEXTRANASE : 4 hits 1ogo_c00 naa= 2 ULMN 2 1or8_c00 SUBSTRATE PEPTIDE user 1 2 # 1 A 144 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 153 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 5.94 27.66 26.60 4.79 28.74 25.22 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 11.22 39.04 26.68 10.07 39.51 28.37 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1or8_c00 SUBSTRATE PEPTIDE user 2 2 # 2 A 144 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 153 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 5.94 27.66 26.60 4.79 28.74 25.22 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 11.22 39.04 26.68 10.07 39.51 28.37 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1or8_c00 SUBSTRATE PEPTIDE user 3 2 # 3 A 144 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 153 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 5.94 27.66 26.60 4.79 28.74 25.22 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 11.22 39.04 26.68 10.07 39.51 28.37 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1or8_c00 SUBSTRATE PEPTIDE user 4 2 # 4 A 144 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 153 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 5.94 27.66 26.60 4.79 28.74 25.22 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 11.22 39.04 26.68 10.07 39.51 28.37 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1or8_c00 source 1or8 SUBSTRATE PEPTIDE : 4 hits 1or8_c00 naa= 2 ULMN 2 1ord_c00 ORNITHINE DECARBOXYLASE user 1 2 # 1 A 223 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 316 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 68.60 29.21 36.20 67.18 29.39 37.73 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 71.59 23.36 32.53 70.12 24.30 33.70 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1ord_c00 ORNITHINE DECARBOXYLASE user 2 2 # 2 A 223 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 316 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 68.60 29.21 36.20 67.18 29.39 37.73 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 71.59 23.36 32.53 70.12 24.30 33.70 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1ord_c00 ORNITHINE DECARBOXYLASE user 3 2 # 3 A 223 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 316 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 68.60 29.21 36.20 67.18 29.39 37.73 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 71.59 23.36 32.53 70.12 24.30 33.70 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1ord_c00 ORNITHINE DECARBOXYLASE user 4 2 # 4 A 223 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 316 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 68.60 29.21 36.20 67.18 29.39 37.73 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 71.59 23.36 32.53 70.12 24.30 33.70 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1ord_c00 source 1ord ORNITHINE DECARBOXYLASE : 4 hits 1ord_c00 naa= 2 ULMN 2 1ord_c01 ORNITHINE DECARBOXYLASE user 1 2 # 1 B 223 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 316 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 72.29 18.19 61.38 71.26 17.18 59.86 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 71.16 24.62 65.07 70.49 22.99 63.86 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1ord_c01 ORNITHINE DECARBOXYLASE user 2 2 # 2 B 223 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 316 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 72.29 18.19 61.38 71.26 17.18 59.86 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 71.16 24.62 65.07 70.49 22.99 63.86 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1ord_c01 ORNITHINE DECARBOXYLASE user 3 2 # 3 B 223 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 316 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 72.29 18.19 61.38 71.26 17.18 59.86 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 71.16 24.62 65.07 70.49 22.99 63.86 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 1ord_c01 ORNITHINE DECARBOXYLASE user 4 2 # 4 B 223 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 316 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 72.29 18.19 61.38 71.26 17.18 59.86 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 71.16 24.62 65.07 70.49 22.99 63.86 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1ord_c01 source 1ord ORNITHINE DECARBOXYLASE : 4 hits 1ord_c01 naa= 2 ULMN 2 1oro_c01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 1 2 # 1 A 73 LYS A 28 LYS^? 7.39 O2 EDO A 124 A 104 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1oro_c01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 2 2 # 2 A 73 LYS B 28 LYS^? -17.65 O1 EDO A 124s A 104 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 31.47 -3.50 41.26 35.45 -5.61 44.66 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 1oro_c01 source 1oro OROTATE PHOSPHORIBOSYLTRANSFERASE : 2 hits 1oro_c01 naa= 2 ULMN 2 1otg_c00 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 1 2 # 1 A 35 PHE A 48 PHE^? 10.34 O2 EDO A 125 A 41 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 20.83 81.45 8.08 22.53 83.03 6.59 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 18.84 70.08 4.69 16.77 72.07 3.55 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1otg_c00 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 2 2 # 2 A 35 PHE A 48 PHE^? 10.34 O2 EDO A 125 A 41 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 20.83 81.45 8.08 22.53 83.03 6.59 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 18.84 70.08 4.69 16.77 72.07 3.55 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1otg_c00 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 3 2 # 3 A 35 PHE A 48 PHE^? 10.34 O2 EDO A 125 A 41 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 20.83 81.45 8.08 22.53 83.03 6.59 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 18.84 70.08 4.69 16.77 72.07 3.55 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1otg_c00 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 4 2 # 4 A 35 PHE A 50 PHE^? 8.88 O1 EDO A 125 A 41 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 20.83 81.45 8.08 22.53 83.03 6.59 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 18.84 70.08 4.69 16.77 72.07 3.55 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1otg_c00 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 5 2 # 5 A 35 PHE A 50 PHE^? 8.88 O1 EDO A 125 A 41 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 20.83 81.45 8.08 22.53 83.03 6.59 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 18.84 70.08 4.69 16.77 72.07 3.55 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1otg_c00 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 6 2 # 6 A 35 PHE A 97 PHE.? 7.14 O2 EDO A 125 A 41 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 20.83 81.45 8.08 22.53 83.03 6.59 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 18.84 70.08 4.69 16.77 72.07 3.55 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1otg_c00 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 7 2 # 7 A 35 PHE A 97 PHE.? 7.14 O2 EDO A 125 A 41 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 20.83 81.45 8.08 22.53 83.03 6.59 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 18.84 70.08 4.69 16.77 72.07 3.55 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1otg_c00 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 8 2 # 8 A 35 PHE B 48 PHE^? 12.04 C1 EDO A 124 A 41 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 20.83 81.45 8.08 22.53 83.03 6.59 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 18.84 70.08 4.69 16.77 72.07 3.55 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1otg_c00 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 9 2 # 9 A 35 PHE B 48 PHE^? 12.04 C1 EDO A 124 A 41 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 20.83 81.45 8.08 22.53 83.03 6.59 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 18.84 70.08 4.69 16.77 72.07 3.55 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1otg_c00 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 10 2 # 10 A 35 PHE B 50 PHE^? 13.90 C1 EDO A 124 A 41 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 20.83 81.45 8.08 22.53 83.03 6.59 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 18.84 70.08 4.69 16.77 72.07 3.55 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1otg_c00 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 11 2 # 11 A 35 PHE B 50 PHE^? 13.90 C1 EDO A 124 A 41 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 20.83 81.45 8.08 22.53 83.03 6.59 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 18.84 70.08 4.69 16.77 72.07 3.55 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1otg_c00 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 12 2 # 12 A 35 PHE B 97 PHE.? 16.35 C1 EDO A 124 A 41 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 20.83 81.45 8.08 22.53 83.03 6.59 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 18.84 70.08 4.69 16.77 72.07 3.55 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1otg_c00 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 13 2 # 13 A 35 PHE B 97 PHE.? 16.35 C1 EDO A 124 A 41 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 20.83 81.45 8.08 22.53 83.03 6.59 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 18.84 70.08 4.69 16.77 72.07 3.55 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1otg_c00 source 1otg 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISOMERASE : 13 hits 1otg_c00 naa= 2 ULMN 2 1otg_c01 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 1 2 # 1 B 35 PHE A 48 PHE^? 10.34 O2 EDO A 125 B 41 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 17.99 68.15 -20.87 17.37 70.55 -19.52 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 28.06 62.63 -17.73 28.42 64.87 -19.93 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 1otg_c01 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 2 2 # 2 B 35 PHE A 48 PHE^? 10.34 O2 EDO A 125 B 41 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 17.99 68.15 -20.87 17.37 70.55 -19.52 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 28.06 62.63 -17.73 28.42 64.87 -19.93 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1otg_c01 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 3 2 # 3 B 35 PHE A 48 PHE^? 10.34 O2 EDO A 125 B 41 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 17.99 68.15 -20.87 17.37 70.55 -19.52 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 28.06 62.63 -17.73 28.42 64.87 -19.93 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1otg_c01 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 4 2 # 4 B 35 PHE A 50 PHE^? 8.88 O1 EDO A 125 B 41 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 17.99 68.15 -20.87 17.37 70.55 -19.52 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 28.06 62.63 -17.73 28.42 64.87 -19.93 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1otg_c01 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 5 2 # 5 B 35 PHE A 50 PHE^? 8.88 O1 EDO A 125 B 41 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 17.99 68.15 -20.87 17.37 70.55 -19.52 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 28.06 62.63 -17.73 28.42 64.87 -19.93 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1otg_c01 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 6 2 # 6 B 35 PHE A 97 PHE.? 7.14 O2 EDO A 125 B 41 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 17.99 68.15 -20.87 17.37 70.55 -19.52 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 28.06 62.63 -17.73 28.42 64.87 -19.93 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1otg_c01 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 7 2 # 7 B 35 PHE A 97 PHE.? 7.14 O2 EDO A 125 B 41 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 17.99 68.15 -20.87 17.37 70.55 -19.52 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 28.06 62.63 -17.73 28.42 64.87 -19.93 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1otg_c01 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 8 2 # 8 B 35 PHE B 48 PHE^? 12.04 C1 EDO A 124 B 41 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 17.99 68.15 -20.87 17.37 70.55 -19.52 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 28.06 62.63 -17.73 28.42 64.87 -19.93 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1otg_c01 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 9 2 # 9 B 35 PHE B 48 PHE^? 12.04 C1 EDO A 124 B 41 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 17.99 68.15 -20.87 17.37 70.55 -19.52 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 28.06 62.63 -17.73 28.42 64.87 -19.93 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1otg_c01 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 10 2 # 10 B 35 PHE B 50 PHE^? 13.90 C1 EDO A 124 B 41 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 17.99 68.15 -20.87 17.37 70.55 -19.52 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 28.06 62.63 -17.73 28.42 64.87 -19.93 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1otg_c01 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 11 2 # 11 B 35 PHE B 50 PHE^? 13.90 C1 EDO A 124 B 41 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 17.99 68.15 -20.87 17.37 70.55 -19.52 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 28.06 62.63 -17.73 28.42 64.87 -19.93 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1otg_c01 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 12 2 # 12 B 35 PHE B 97 PHE.? 16.35 C1 EDO A 124 B 41 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 17.99 68.15 -20.87 17.37 70.55 -19.52 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 28.06 62.63 -17.73 28.42 64.87 -19.93 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1otg_c01 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 13 2 # 13 B 35 PHE B 97 PHE.? 16.35 C1 EDO A 124 B 41 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 17.99 68.15 -20.87 17.37 70.55 -19.52 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 28.06 62.63 -17.73 28.42 64.87 -19.93 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1otg_c01 source 1otg 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISOMERASE : 13 hits 1otg_c01 naa= 2 ULMN 2 1otg_c02 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 1 2 # 1 C 35 PHE A 48 PHE^? 10.34 O2 EDO A 125 C 41 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 46.40 79.01 -10.71 44.33 79.70 -12.40 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 43.33 73.68 -0.92 43.32 76.78 -0.74 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1otg_c02 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 2 2 # 2 C 35 PHE A 48 PHE^? 10.34 O2 EDO A 125 C 41 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 46.40 79.01 -10.71 44.33 79.70 -12.40 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 43.33 73.68 -0.92 43.32 76.78 -0.74 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1otg_c02 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 3 2 # 3 C 35 PHE A 48 PHE^? 10.34 O2 EDO A 125 C 41 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 46.40 79.01 -10.71 44.33 79.70 -12.40 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 43.33 73.68 -0.92 43.32 76.78 -0.74 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1otg_c02 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 4 2 # 4 C 35 PHE A 50 PHE^? 8.88 O1 EDO A 125 C 41 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 46.40 79.01 -10.71 44.33 79.70 -12.40 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 43.33 73.68 -0.92 43.32 76.78 -0.74 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 1otg_c02 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 5 2 # 5 C 35 PHE A 50 PHE^? 8.88 O1 EDO A 125 C 41 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 46.40 79.01 -10.71 44.33 79.70 -12.40 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 43.33 73.68 -0.92 43.32 76.78 -0.74 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1otg_c02 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 6 2 # 6 C 35 PHE A 97 PHE.? 7.14 O2 EDO A 125 C 41 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 46.40 79.01 -10.71 44.33 79.70 -12.40 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 43.33 73.68 -0.92 43.32 76.78 -0.74 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1otg_c02 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 7 2 # 7 C 35 PHE A 97 PHE.? 7.14 O2 EDO A 125 C 41 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 46.40 79.01 -10.71 44.33 79.70 -12.40 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 43.33 73.68 -0.92 43.32 76.78 -0.74 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1otg_c02 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 8 2 # 8 C 35 PHE B 48 PHE^? 12.04 C1 EDO A 124 C 41 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 46.40 79.01 -10.71 44.33 79.70 -12.40 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 43.33 73.68 -0.92 43.32 76.78 -0.74 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1otg_c02 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 9 2 # 9 C 35 PHE B 48 PHE^? 12.04 C1 EDO A 124 C 41 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 46.40 79.01 -10.71 44.33 79.70 -12.40 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 43.33 73.68 -0.92 43.32 76.78 -0.74 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1otg_c02 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 10 2 # 10 C 35 PHE B 50 PHE^? 13.90 C1 EDO A 124 C 41 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 46.40 79.01 -10.71 44.33 79.70 -12.40 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 43.33 73.68 -0.92 43.32 76.78 -0.74 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 1otg_c02 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 11 2 # 11 C 35 PHE B 50 PHE^? 13.90 C1 EDO A 124 C 41 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 46.40 79.01 -10.71 44.33 79.70 -12.40 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 43.33 73.68 -0.92 43.32 76.78 -0.74 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1otg_c02 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 12 2 # 12 C 35 PHE B 97 PHE.? 16.35 C1 EDO A 124 C 41 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 46.40 79.01 -10.71 44.33 79.70 -12.40 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 43.33 73.68 -0.92 43.32 76.78 -0.74 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1otg_c02 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 13 2 # 13 C 35 PHE B 97 PHE.? 16.35 C1 EDO A 124 C 41 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 46.40 79.01 -10.71 44.33 79.70 -12.40 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 43.33 73.68 -0.92 43.32 76.78 -0.74 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1otg_c02 source 1otg 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISOMERASE : 13 hits 1otg_c02 naa= 2 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 1 2 # 1 X 16 LYS A 100 LYS~? 11.56 C2 EDO A 125 X 119 ASN B 22 ASN.? 13.33 O2 EDO A 125 coo 9.69 63.83 35.55 11.00 62.83 41.36 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo 11.13 57.62 41.98 10.56 59.50 42.87 -33.78 -50.89 -12.81 -33.60 -52.50 -11.46 1pae_c00 source 1pae NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSOLIC : 1 hits 1pae_c00 naa= 2 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 1 2 # 1 X 16 LYS A 28 LYS^? 7.39 O2 EDO A 124 X 56 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 9.69 63.83 35.55 11.00 62.83 41.36 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 10.51 70.44 44.57 10.41 68.10 43.00 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 2 2 # 2 X 16 LYS A 28 LYS^? 7.39 O2 EDO A 124 X 56 TYR A 76 TYR.? 12.73 O1 EDO A 125 coo 9.69 63.83 35.55 11.00 62.83 41.36 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 10.51 70.44 44.57 10.41 68.10 43.00 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 3 2 # 3 X 16 LYS B 28 LYS^? -17.65 O1 EDO A 124s X 56 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo 9.69 63.83 35.55 11.00 62.83 41.36 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 10.51 70.44 44.57 10.41 68.10 43.00 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 4 2 # 4 X 16 LYS B 28 LYS^? -17.65 O1 EDO A 124s X 56 TYR B 76 TYR.? 17.92 O2 EDO A 125 coo 9.69 63.83 35.55 11.00 62.83 41.36 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 10.51 70.44 44.57 10.41 68.10 43.00 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 1pae_c01 source 1pae NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSOLIC : 4 hits 1pae_c01 naa= 2 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 A 160 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 375 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 63.94 10.02 33.47 64.31 8.24 32.38 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 61.89 10.05 27.30 63.60 9.39 28.40 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 A 160 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 375 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 63.94 10.02 33.47 64.31 8.24 32.38 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 61.89 10.05 27.30 63.60 9.39 28.40 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 A 160 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 375 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 63.94 10.02 33.47 64.31 8.24 32.38 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 61.89 10.05 27.30 63.60 9.39 28.40 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 A 160 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 375 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 63.94 10.02 33.47 64.31 8.24 32.38 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 61.89 10.05 27.30 63.60 9.39 28.40 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1pbg_c02 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 4 hits 1pbg_c02 naa= 2 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 B 160 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 375 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 23.66 16.69 85.20 24.17 18.76 84.94 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 21.67 20.74 89.92 23.35 20.55 88.67 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 B 160 GLU A 81 GLU.? 16.59 O1 EDO A 125 B 375 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 23.66 16.69 85.20 24.17 18.76 84.94 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 21.67 20.74 89.92 23.35 20.55 88.67 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 B 160 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 375 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 23.66 16.69 85.20 24.17 18.76 84.94 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 21.67 20.74 89.92 23.35 20.55 88.67 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 B 160 GLU B 81 GLU.? 30.69 O1 EDO A 124 B 375 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 23.66 16.69 85.20 24.17 18.76 84.94 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 21.67 20.74 89.92 23.35 20.55 88.67 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1pbg_c03 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 4 hits 1pbg_c03 naa= 2 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 A 160 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 269 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 63.94 10.02 33.47 64.31 8.24 32.38 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 A 160 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 269 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 63.94 10.02 33.47 64.31 8.24 32.38 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 A 160 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 269 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 63.94 10.02 33.47 64.31 8.24 32.38 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 A 160 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 269 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 63.94 10.02 33.47 64.31 8.24 32.38 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 5 2 # 5 A 160 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 269 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 63.94 10.02 33.47 64.31 8.24 32.38 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 6 2 # 6 A 160 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 269 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 63.94 10.02 33.47 64.31 8.24 32.38 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 7 2 # 7 A 160 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 269 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 63.94 10.02 33.47 64.31 8.24 32.38 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 8 2 # 8 A 160 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 269 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 63.94 10.02 33.47 64.31 8.24 32.38 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1pbg_c04 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 8 hits 1pbg_c04 naa= 2 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 B 160 GLU A 23 GLU.? 13.04 O2 EDO A 125 B 269 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 23.66 16.69 85.20 24.17 18.76 84.94 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 21.20 8.49 59.63 20.88 8.62 57.55 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 B 160 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 269 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 23.66 16.69 85.20 24.17 18.76 84.94 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 21.20 8.49 59.63 20.88 8.62 57.55 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 B 160 GLU A 59 GLU.? 11.26 O1 EDO A 125 B 269 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 23.66 16.69 85.20 24.17 18.76 84.94 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 21.20 8.49 59.63 20.88 8.62 57.55 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 B 160 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 269 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 23.66 16.69 85.20 24.17 18.76 84.94 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 21.20 8.49 59.63 20.88 8.62 57.55 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 5 2 # 5 B 160 GLU B 23 GLU.? 12.57 O2 EDO A 125 B 269 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 23.66 16.69 85.20 24.17 18.76 84.94 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 21.20 8.49 59.63 20.88 8.62 57.55 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 6 2 # 6 B 160 GLU B 23 GLU.? 12.57 O2 EDO A 125 B 269 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 23.66 16.69 85.20 24.17 18.76 84.94 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 21.20 8.49 59.63 20.88 8.62 57.55 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 7 2 # 7 B 160 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 269 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 23.66 16.69 85.20 24.17 18.76 84.94 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 21.20 8.49 59.63 20.88 8.62 57.55 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 8 2 # 8 B 160 GLU B 59 GLU.? 24.69 C1 EDO A 124 B 269 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 23.66 16.69 85.20 24.17 18.76 84.94 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 21.20 8.49 59.63 20.88 8.62 57.55 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1pbg_c05 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 8 hits 1pbg_c05 naa= 2 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 1 2 # 1 60 ASP A 41 ASP^? -2.91 O2 EDO A 124s 206 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 2 2 # 2 60 ASP A 84 ASP.? 13.20 O1 EDO A 125 206 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 3 2 # 3 60 ASP A 86 ASP^? 9.05 O1 EDO A 125 206 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 4 2 # 4 60 ASP B 41 ASP^? 12.31 O1 EDO A 124 206 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 5 2 # 5 60 ASP B 84 ASP.? 30.86 C1 EDO A 124 206 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 6 2 # 6 60 ASP B 86 ASP^? 26.97 C1 EDO A 124 206 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1pgs_c00 source 1pgs PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSAMINYL) AS: 6 hits 1pgs_c00 naa= 2 ULMN 2 1pii_c01 N-(5'PHOSPHORIBOSYL)ANTHRANILATE ISOuser 1 2 # 1 260 CYH A 46 CYH.? 11.48 C1 EDO A 124 379 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 42.75 2.82 -9.23 44.92 1.06 -8.97 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 coo 41.40 -8.29 -7.85 42.85 -8.47 -9.32 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1pii_c01 N-(5'PHOSPHORIBOSYL)ANTHRANILATE ISOuser 2 2 # 2 260 CYH A 67 CYH~? 14.35 O2 EDO A 124 379 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 42.75 2.82 -9.23 44.92 1.06 -8.97 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo 41.40 -8.29 -7.85 42.85 -8.47 -9.32 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1pii_c01 N-(5'PHOSPHORIBOSYL)ANTHRANILATE ISOuser 3 2 # 3 260 CYH B 46 CYH.? 10.55 O2 EDO A 125 379 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 42.75 2.82 -9.23 44.92 1.06 -8.97 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 coo 41.40 -8.29 -7.85 42.85 -8.47 -9.32 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1pii_c01 N-(5'PHOSPHORIBOSYL)ANTHRANILATE ISOuser 4 2 # 4 260 CYH B 67 CYH~? 18.88 O1 EDO A 124 379 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 42.75 2.82 -9.23 44.92 1.06 -8.97 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo 41.40 -8.29 -7.85 42.85 -8.47 -9.32 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 1pii_c01 source 1pii N-(5'PHOSPHORIBOSYL)ANTHRANILATE ISOMERASE (E.: 4 hits 1pii_c01 naa= 2 ULMN 2 1psd_c00 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 1 2 # 1 A 269 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 292 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 38.27 25.19 38.30 39.02 23.31 37.65 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 41.07 20.90 35.69 40.38 19.20 36.71 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1psd_c00 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 2 2 # 2 A 269 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 292 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 38.27 25.19 38.30 39.02 23.31 37.65 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 41.07 20.90 35.69 40.38 19.20 36.71 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1psd_c00 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 3 2 # 3 A 269 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 292 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 38.27 25.19 38.30 39.02 23.31 37.65 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 41.07 20.90 35.69 40.38 19.20 36.71 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 ULMN 2 1psd_c00 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 4 2 # 4 A 269 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 292 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 38.27 25.19 38.30 39.02 23.31 37.65 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 41.07 20.90 35.69 40.38 19.20 36.71 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1psd_c00 source 1psd D-3-PHOSPHOGLYCERATE DEHYDROGENASE (PHOSPHOGLY: 4 hits 1psd_c00 naa= 2 ULMN 2 1psd_c01 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 1 2 # 1 B 269 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 292 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 73.23 38.34 28.02 73.78 36.50 28.89 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 73.82 33.94 31.43 75.53 32.98 30.68 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1psd_c01 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 2 2 # 2 B 269 GLU A 81 GLU.? 16.59 O1 EDO A 125 B 292 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 73.23 38.34 28.02 73.78 36.50 28.89 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 73.82 33.94 31.43 75.53 32.98 30.68 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1psd_c01 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 3 2 # 3 B 269 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 292 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 73.23 38.34 28.02 73.78 36.50 28.89 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 73.82 33.94 31.43 75.53 32.98 30.68 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 ULMN 2 1psd_c01 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 4 2 # 4 B 269 GLU B 81 GLU.? 30.69 O1 EDO A 124 B 292 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 73.23 38.34 28.02 73.78 36.50 28.89 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 73.82 33.94 31.43 75.53 32.98 30.68 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1psd_c01 source 1psd D-3-PHOSPHOGLYCERATE DEHYDROGENASE (PHOSPHOGLY: 4 hits 1psd_c01 naa= 2 ULMN 2 1pwv_c00 LETHAL FACTOR user 1 2 # 1 A 687 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 728 TYR A 76 TYR.? 12.73 O1 EDO A 125 coo 77.63 40.02 139.16 79.74 39.94 138.95 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 84.86 31.94 140.08 85.28 34.63 139.44 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 ULMN 2 1pwv_c00 LETHAL FACTOR user 2 2 # 2 A 687 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 728 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 77.63 40.02 139.16 79.74 39.94 138.95 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 84.86 31.94 140.08 85.28 34.63 139.44 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1pwv_c00 LETHAL FACTOR user 3 2 # 3 A 687 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 728 TYR B 76 TYR.? 17.92 O2 EDO A 125 coo 77.63 40.02 139.16 79.74 39.94 138.95 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 84.86 31.94 140.08 85.28 34.63 139.44 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 1pwv_c00 source 1pwv LETHAL FACTOR : 3 hits 1pwv_c00 naa= 2 ULMN 2 1pwv_c01 LETHAL FACTOR user 1 2 # 1 B 687 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 728 TYR A 76 TYR.? 12.73 O1 EDO A 125 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 105.30 6.94 120.65 104.99 4.15 120.81 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 ULMN 2 1pwv_c01 LETHAL FACTOR user 2 2 # 2 B 687 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 728 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 105.30 6.94 120.65 104.99 4.15 120.81 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1pwv_c01 LETHAL FACTOR user 3 2 # 3 B 687 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 728 TYR B 76 TYR.? 17.92 O2 EDO A 125 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 105.30 6.94 120.65 104.99 4.15 120.81 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 1pwv_c01 source 1pwv LETHAL FACTOR : 3 hits 1pwv_c01 naa= 2 ULMN 2 1q6l_c00 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 2 # 1 A 62 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 64 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 61.71 14.20 19.64 60.68 14.94 21.37 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 55.72 12.42 20.66 58.31 17.81 21.97 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1q6l_c00 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 2 # 2 A 62 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 64 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 61.71 14.20 19.64 60.68 14.94 21.37 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 55.72 12.42 20.66 58.31 17.81 21.97 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1q6l_c00 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 2 hits 1q6l_c00 naa= 2 ULMN 2 1q6l_c01 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 2 # 1 B 62 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 64 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 45.81 14.64 11.83 45.04 13.82 13.65 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 48.63 16.35 17.25 45.95 10.72 16.28 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1q6l_c01 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 2 # 2 B 62 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 64 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 45.81 14.64 11.83 45.04 13.82 13.65 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 48.63 16.35 17.25 45.95 10.72 16.28 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1q6l_c01 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 2 hits 1q6l_c01 naa= 2 ULMN 2 1q6x_c02 CHOLINE O-ACETYLTRANSFERASE user 1 2 # 1 A 334 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 550 SER A 88 SER^? -5.03 C1 EDO A 125s coo 38.40 88.96 58.48 39.26 87.53 59.75 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 46.35 85.43 65.37 45.80 86.30 63.18 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1q6x_c02 CHOLINE O-ACETYLTRANSFERASE user 2 2 # 2 A 334 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 550 SER B 88 SER^? 19.82 O2 EDO A 125 coo 38.40 88.96 58.48 39.26 87.53 59.75 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 46.35 85.43 65.37 45.80 86.30 63.18 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 1q6x_c02 source 1q6x CHOLINE O-ACETYLTRANSFERASE : 2 hits 1q6x_c02 naa= 2 ULMN 2 1q6x_c03 CHOLINE O-ACETYLTRANSFERASE user 1 2 # 1 B 334 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 550 SER A 88 SER^? -5.03 C1 EDO A 125s coo 11.97 -36.55 1.94 11.54 -35.11 0.47 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 11.79 -32.98 -8.58 13.12 -33.83 -6.73 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1q6x_c03 CHOLINE O-ACETYLTRANSFERASE user 2 2 # 2 B 334 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 550 SER B 88 SER^? 19.82 O2 EDO A 125 coo 11.97 -36.55 1.94 11.54 -35.11 0.47 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 11.79 -32.98 -8.58 13.12 -33.83 -6.73 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 1q6x_c03 source 1q6x CHOLINE O-ACETYLTRANSFERASE : 2 hits 1q6x_c03 naa= 2 ULMN 2 1q91_c00 5(3)-DEOXYRIBONUCLEOTIDASE user 1 2 # 1 A 41 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 43 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 19.89 38.63 33.96 18.35 38.95 32.59 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 13.89 41.64 32.32 13.68 43.65 31.73 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1q91_c00 5(3)-DEOXYRIBONUCLEOTIDASE user 2 2 # 2 A 41 ASP A 64 ASP~? 20.53 O2 EDO A 124 A 43 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 19.89 38.63 33.96 18.35 38.95 32.59 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 13.89 41.64 32.32 13.68 43.65 31.73 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1q91_c00 5(3)-DEOXYRIBONUCLEOTIDASE user 3 2 # 3 A 41 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 43 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 19.89 38.63 33.96 18.35 38.95 32.59 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 13.89 41.64 32.32 13.68 43.65 31.73 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1q91_c00 5(3)-DEOXYRIBONUCLEOTIDASE user 4 2 # 4 A 41 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 43 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 19.89 38.63 33.96 18.35 38.95 32.59 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 13.89 41.64 32.32 13.68 43.65 31.73 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1q91_c00 5(3)-DEOXYRIBONUCLEOTIDASE user 5 2 # 5 A 41 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 43 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 19.89 38.63 33.96 18.35 38.95 32.59 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 13.89 41.64 32.32 13.68 43.65 31.73 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1q91_c00 5(3)-DEOXYRIBONUCLEOTIDASE user 6 2 # 6 A 41 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 43 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 19.89 38.63 33.96 18.35 38.95 32.59 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 13.89 41.64 32.32 13.68 43.65 31.73 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1q91_c00 5(3)-DEOXYRIBONUCLEOTIDASE user 7 2 # 7 A 41 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 43 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 19.89 38.63 33.96 18.35 38.95 32.59 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 13.89 41.64 32.32 13.68 43.65 31.73 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1q91_c00 5(3)-DEOXYRIBONUCLEOTIDASE user 8 2 # 8 A 41 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 43 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 19.89 38.63 33.96 18.35 38.95 32.59 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 13.89 41.64 32.32 13.68 43.65 31.73 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1q91_c00 source 1q91 5(3)-DEOXYRIBONUCLEOTIDASE : 8 hits 1q91_c00 naa= 2 ULMN 2 1qam_c00 ERMC' METHYLTRANSFERASE user 1 2 # 1 A 59 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 101 ASN B 44 ASN.? 11.30 O2 EDO A 125 coo 17.21 39.80 29.23 17.83 38.53 27.67 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 11.70 33.75 21.15 12.72 34.11 19.33 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 ULMN 2 1qam_c00 ERMC' METHYLTRANSFERASE user 2 2 # 2 A 59 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 101 ASN B 22 ASN.? 13.33 O2 EDO A 125 coo 17.21 39.80 29.23 17.83 38.53 27.67 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 11.70 33.75 21.15 12.72 34.11 19.33 -33.78 -50.89 -12.81 -33.60 -52.50 -11.46 1qam_c00 source 1qam ERMC' METHYLTRANSFERASE : 2 hits 1qam_c00 naa= 2 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 1 2 # 1 C 142 HIS A 79 HIS^? 12.23 O1 EDO A 125 D 146 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 15.87 13.94 20.94 16.37 13.66 20.42 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 2 2 # 2 C 142 HIS A 79 HIS^? 12.23 O1 EDO A 125 D 146 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 15.87 13.94 20.94 16.37 13.66 20.42 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 3 2 # 3 C 142 HIS A 79 HIS^? 12.23 O1 EDO A 125 D 146 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 15.87 13.94 20.94 16.37 13.66 20.42 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 4 2 # 4 C 142 HIS A 79 HIS^? 12.23 O1 EDO A 125 D 146 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 15.87 13.94 20.94 16.37 13.66 20.42 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 5 2 # 5 C 142 HIS B 79 HIS^? 26.86 C1 EDO A 124 D 146 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 15.87 13.94 20.94 16.37 13.66 20.42 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 6 2 # 6 C 142 HIS B 79 HIS^? 26.86 C1 EDO A 124 D 146 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 15.87 13.94 20.94 16.37 13.66 20.42 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 7 2 # 7 C 142 HIS B 79 HIS^? 26.86 C1 EDO A 124 D 146 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 15.87 13.94 20.94 16.37 13.66 20.42 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 8 2 # 8 C 142 HIS B 79 HIS^? 26.86 C1 EDO A 124 D 146 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 15.87 13.94 20.94 16.37 13.66 20.42 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 1qd6_c00 source 1qd6 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA) : 8 hits 1qd6_c00 naa= 2 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 1 2 # 1 A 72 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 147 THR A 47 THR^? 4.31 C1 EDO A 124 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 2 2 # 2 A 72 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 147 THR A 82 THR.? 18.68 O1 EDO A 125 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 3 2 # 3 A 72 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 147 THR B 47 THR^? 9.39 O1 EDO A 124 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 4 2 # 4 A 72 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 147 THR B 82 THR.? 29.24 O1 EDO A 124 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 1qgx_c00 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 4 hits 1qgx_c00 naa= 2 ULMN 2 1qho_c00 ALPHA-AMYLASE user 1 2 # 1 A 228 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 253 LEU A 78 LEU^? 8.41 O1 EDO A 125 coo 28.46 69.88 26.74 30.40 70.70 26.53 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 18.60 67.37 33.24 17.63 66.99 31.31 -25.02 -43.13 -29.94 -26.24 -41.39 -29.47 ULMN 2 1qho_c00 ALPHA-AMYLASE user 2 2 # 2 A 228 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 253 LEU A 89 LEU~? 8.99 O1 EDO A 125 coo 28.46 69.88 26.74 30.40 70.70 26.53 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 18.60 67.37 33.24 17.63 66.99 31.31 -31.04 -43.51 -28.26 -31.53 -41.41 -28.05 ULMN 2 1qho_c00 ALPHA-AMYLASE user 3 2 # 3 A 228 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 253 LEU B 54 LEU~? 14.98 C1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 18.60 67.37 33.24 17.63 66.99 31.31 -44.12 -30.81 -26.43 -43.06 -31.04 -28.33 ULMN 2 1qho_c00 ALPHA-AMYLASE user 4 2 # 4 A 228 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 253 LEU A 58 LEU.? 9.87 O1 EDO A 125 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 18.60 67.37 33.24 17.63 66.99 31.31 -17.29 -44.63 -24.09 -18.05 -44.29 -26.14 ULMN 2 1qho_c00 ALPHA-AMYLASE user 5 2 # 5 A 228 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 253 LEU A 83 LEU.? 13.93 O1 EDO A 125 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 18.60 67.37 33.24 17.63 66.99 31.31 -14.15 -46.42 -30.21 -12.97 -45.12 -28.95 ULMN 2 1qho_c00 ALPHA-AMYLASE user 6 2 # 6 A 228 ASP A 64 ASP~? 20.53 O2 EDO A 124 A 253 LEU A 58 LEU.? 9.87 O1 EDO A 125 coo 28.46 69.88 26.74 30.40 70.70 26.53 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 18.60 67.37 33.24 17.63 66.99 31.31 -17.29 -44.63 -24.09 -18.05 -44.29 -26.14 ULMN 2 1qho_c00 ALPHA-AMYLASE user 7 2 # 7 A 228 ASP A 64 ASP~? 20.53 O2 EDO A 124 A 253 LEU A 83 LEU.? 13.93 O1 EDO A 125 coo 28.46 69.88 26.74 30.40 70.70 26.53 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 18.60 67.37 33.24 17.63 66.99 31.31 -14.15 -46.42 -30.21 -12.97 -45.12 -28.95 ULMN 2 1qho_c00 ALPHA-AMYLASE user 8 2 # 8 A 228 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 253 LEU A 58 LEU.? 9.87 O1 EDO A 125 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 18.60 67.37 33.24 17.63 66.99 31.31 -17.29 -44.63 -24.09 -18.05 -44.29 -26.14 ULMN 2 1qho_c00 ALPHA-AMYLASE user 9 2 # 9 A 228 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 253 LEU A 72 LEU^? 13.09 O1 EDO A 125 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 18.60 67.37 33.24 17.63 66.99 31.31 -25.96 -45.98 -36.98 -24.33 -45.96 -38.50 ULMN 2 1qho_c00 ALPHA-AMYLASE user 10 2 # 10 A 228 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 253 LEU A 78 LEU^? 8.41 O1 EDO A 125 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 18.60 67.37 33.24 17.63 66.99 31.31 -25.02 -43.13 -29.94 -26.24 -41.39 -29.47 ULMN 2 1qho_c00 ALPHA-AMYLASE user 11 2 # 11 A 228 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 253 LEU A 87 LEU^? -4.03 O1 EDO A 125s coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 18.60 67.37 33.24 17.63 66.99 31.31 -24.54 -46.53 -26.85 -22.75 -46.35 -25.59 ULMN 2 1qho_c00 ALPHA-AMYLASE user 12 2 # 12 A 228 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 253 LEU A 58 LEU.? 9.87 O1 EDO A 125 coo 28.46 69.88 26.74 30.40 70.70 26.53 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 18.60 67.37 33.24 17.63 66.99 31.31 -17.29 -44.63 -24.09 -18.05 -44.29 -26.14 ULMN 2 1qho_c00 ALPHA-AMYLASE user 13 2 # 13 A 228 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 253 LEU A 89 LEU~? 8.99 O1 EDO A 125 coo 28.46 69.88 26.74 30.40 70.70 26.53 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 18.60 67.37 33.24 17.63 66.99 31.31 -31.04 -43.51 -28.26 -31.53 -41.41 -28.05 ULMN 2 1qho_c00 ALPHA-AMYLASE user 14 2 # 14 A 228 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 253 LEU A 92 LEU~? 5.17 O2 EDO A 125 coo 28.46 69.88 26.74 30.40 70.70 26.53 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 18.60 67.37 33.24 17.63 66.99 31.31 -28.52 -44.11 -23.20 -26.40 -44.39 -23.68 ULMN 2 1qho_c00 ALPHA-AMYLASE user 15 2 # 15 A 228 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 253 LEU B 58 LEU.? 19.52 C1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 18.60 67.37 33.24 17.63 66.99 31.31 -47.35 -27.17 -19.69 -46.30 -27.92 -17.93 ULMN 2 1qho_c00 ALPHA-AMYLASE user 16 2 # 16 A 228 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 253 LEU B 78 LEU^? 18.42 C1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 18.60 67.37 33.24 17.63 66.99 31.31 -42.62 -33.09 -13.72 -40.58 -33.23 -14.47 ULMN 2 1qho_c00 ALPHA-AMYLASE user 17 2 # 17 A 228 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 253 LEU B 89 LEU~? 17.71 C1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 18.60 67.37 33.24 17.63 66.99 31.31 -39.89 -38.23 -15.28 -37.88 -37.43 -15.63 ULMN 2 1qho_c00 ALPHA-AMYLASE user 18 2 # 18 A 228 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 253 LEU B 92 LEU~? 16.78 C1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 18.60 67.37 33.24 17.63 66.99 31.31 -41.76 -36.62 -20.33 -43.11 -34.97 -19.88 ULMN 2 1qho_c00 ALPHA-AMYLASE user 19 2 # 19 A 228 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 253 LEU B 58 LEU.? 19.52 C1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 18.60 67.37 33.24 17.63 66.99 31.31 -47.35 -27.17 -19.69 -46.30 -27.92 -17.93 ULMN 2 1qho_c00 ALPHA-AMYLASE user 20 2 # 20 A 228 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 253 LEU B 83 LEU.? 25.07 C1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 18.60 67.37 33.24 17.63 66.99 31.31 -50.68 -25.61 -13.23 -49.92 -24.11 -14.54 ULMN 2 1qho_c00 ALPHA-AMYLASE user 21 2 # 21 A 228 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 253 LEU B 58 LEU.? 19.52 C1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 18.60 67.37 33.24 17.63 66.99 31.31 -47.35 -27.17 -19.69 -46.30 -27.92 -17.93 ULMN 2 1qho_c00 ALPHA-AMYLASE user 22 2 # 22 A 228 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 253 LEU B 83 LEU.? 25.07 C1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 18.60 67.37 33.24 17.63 66.99 31.31 -50.68 -25.61 -13.23 -49.92 -24.11 -14.54 ULMN 2 1qho_c00 ALPHA-AMYLASE user 23 2 # 23 A 228 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 253 LEU B 58 LEU.? 19.52 C1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 18.60 67.37 33.24 17.63 66.99 31.31 -47.35 -27.17 -19.69 -46.30 -27.92 -17.93 ULMN 2 1qho_c00 ALPHA-AMYLASE user 24 2 # 24 A 228 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 253 LEU B 72 LEU^? 26.85 C1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 18.60 67.37 33.24 17.63 66.99 31.31 -44.25 -35.46 -6.58 -45.01 -34.22 -4.94 ULMN 2 1qho_c00 ALPHA-AMYLASE user 25 2 # 25 A 228 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 253 LEU B 78 LEU^? 18.42 C1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 18.60 67.37 33.24 17.63 66.99 31.31 -42.62 -33.09 -13.72 -40.58 -33.23 -14.47 ULMN 2 1qho_c00 ALPHA-AMYLASE user 26 2 # 26 A 228 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 253 LEU B 87 LEU^? 20.22 C1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 18.60 67.37 33.24 17.63 66.99 31.31 -45.62 -34.34 -16.64 -46.54 -32.89 -17.98 ULMN 2 1qho_c00 ALPHA-AMYLASE user 27 2 # 27 A 228 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 253 LEU B 58 LEU.? 19.52 C1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 18.60 67.37 33.24 17.63 66.99 31.31 -47.35 -27.17 -19.69 -46.30 -27.92 -17.93 ULMN 2 1qho_c00 ALPHA-AMYLASE user 28 2 # 28 A 228 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 253 LEU B 89 LEU~? 17.71 C1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 18.60 67.37 33.24 17.63 66.99 31.31 -39.89 -38.23 -15.28 -37.88 -37.43 -15.63 ULMN 2 1qho_c00 ALPHA-AMYLASE user 29 2 # 29 A 228 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 253 LEU B 92 LEU~? 16.78 C1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 18.60 67.37 33.24 17.63 66.99 31.31 -41.76 -36.62 -20.33 -43.11 -34.97 -19.88 1qho_c00 source 1qho ALPHA-AMYLASE : 29 hits 1qho_c00 naa= 2 ULMN 2 1qho_c02 ALPHA-AMYLASE user 1 2 # 1 A 228 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 256 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 30.54 71.65 32.58 31.73 72.26 30.92 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1qho_c02 ALPHA-AMYLASE user 2 2 # 2 A 228 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 256 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 30.54 71.65 32.58 31.73 72.26 30.92 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1qho_c02 ALPHA-AMYLASE user 3 2 # 3 A 228 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 256 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 28.46 69.88 26.74 30.40 70.70 26.53 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 30.54 71.65 32.58 31.73 72.26 30.92 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1qho_c02 source 1qho ALPHA-AMYLASE : 3 hits 1qho_c02 naa= 2 ULMN 2 1qi9_c00 VANADIUM BROMOPEROXIDASE user 1 2 # 1 A 341 LYS A 28 LYS^? 7.39 O2 EDO A 124 A 418 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 104.35 34.37 32.90 100.82 36.32 29.09 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 96.54 35.93 21.66 94.52 36.26 22.15 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1qi9_c00 VANADIUM BROMOPEROXIDASE user 2 2 # 2 A 341 LYS B 28 LYS^? -17.65 O1 EDO A 124s A 418 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 104.35 34.37 32.90 100.82 36.32 29.09 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 96.54 35.93 21.66 94.52 36.26 22.15 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1qi9_c00 source 1qi9 VANADIUM BROMOPEROXIDASE : 2 hits 1qi9_c00 naa= 2 ULMN 2 1qi9_c01 VANADIUM BROMOPEROXIDASE user 1 2 # 1 B 341 LYS A 28 LYS^? 7.39 O2 EDO A 124 B 418 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 86.35 -0.78 12.68 84.14 3.90 10.48 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 81.39 11.93 10.46 82.24 12.93 8.84 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1qi9_c01 VANADIUM BROMOPEROXIDASE user 2 2 # 2 B 341 LYS B 28 LYS^? -17.65 O1 EDO A 124s B 418 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 86.35 -0.78 12.68 84.14 3.90 10.48 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 81.39 11.93 10.46 82.24 12.93 8.84 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1qi9_c01 source 1qi9 VANADIUM BROMOPEROXIDASE : 2 hits 1qi9_c01 naa= 2 ULMN 2 1qib_c00 GELATINASE A user 1 2 # 1 A 202 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 219 MET A 93 MET?? 10.81 O2 EDO A 125 coo 69.37 28.50 22.00 67.35 27.95 22.47 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 67.80 19.62 26.30 69.14 20.29 23.54 -32.62 -43.10 -21.62 -33.95 -40.68 -24.94 ULMN 2 1qib_c00 GELATINASE A user 2 2 # 2 A 202 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 219 MET B 93 MET?? 13.65 O2 EDO A 125 coo 69.37 28.50 22.00 67.35 27.95 22.47 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 67.80 19.62 26.30 69.14 20.29 23.54 -38.81 -39.61 -21.96 -36.01 -39.35 -18.74 ULMN 2 1qib_c00 GELATINASE A user 3 2 # 3 A 202 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 219 MET A 103 MET?? 8.30 O2 EDO A 125 coo 69.37 28.50 22.00 67.35 27.95 22.47 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 67.80 19.62 26.30 69.14 20.29 23.54 -21.98 -53.69 -14.57 -25.85 -52.15 -15.50 ULMN 2 1qib_c00 GELATINASE A user 4 2 # 4 A 202 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 219 MET A 93 MET?? 10.81 O2 EDO A 125 coo 69.37 28.50 22.00 67.35 27.95 22.47 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 67.80 19.62 26.30 69.14 20.29 23.54 -32.62 -43.10 -21.62 -33.95 -40.68 -24.94 ULMN 2 1qib_c00 GELATINASE A user 5 2 # 5 A 202 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 219 MET B 93 MET?? 13.65 O2 EDO A 125 coo 69.37 28.50 22.00 67.35 27.95 22.47 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 67.80 19.62 26.30 69.14 20.29 23.54 -38.81 -39.61 -21.96 -36.01 -39.35 -18.74 ULMN 2 1qib_c00 GELATINASE A user 6 2 # 6 A 202 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 219 MET B 103 MET?? 21.79 C1 EDO A 124 coo 69.37 28.50 22.00 67.35 27.95 22.47 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 67.80 19.62 26.30 69.14 20.29 23.54 -51.26 -35.87 -29.54 -48.31 -38.03 -27.58 1qib_c00 source 1qib GELATINASE A : 6 hits 1qib_c00 naa= 2 ULMN 2 1qj2_c02 CARBON MONOXIDE DEHYDROGENASE user 1 2 # 1 B 240 GLN A 56 GLN.? 7.55 C1 EDO A 125 B 387 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 41.56 93.59 65.64 41.16 91.60 64.94 -19.66 -52.09 -22.06 -20.64 -53.94 -21.94 coo 33.50 85.40 62.90 31.25 87.48 62.36 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1qj2_c02 CARBON MONOXIDE DEHYDROGENASE user 2 2 # 2 B 240 GLN A 65 GLN~? 18.24 O1 EDO A 125 B 387 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 41.56 93.59 65.64 41.16 91.60 64.94 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 coo 33.50 85.40 62.90 31.25 87.48 62.36 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1qj2_c02 CARBON MONOXIDE DEHYDROGENASE user 3 2 # 3 B 240 GLN A 65 GLN~? 18.24 O1 EDO A 125 B 387 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 41.56 93.59 65.64 41.16 91.60 64.94 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 coo 33.50 85.40 62.90 31.25 87.48 62.36 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1qj2_c02 CARBON MONOXIDE DEHYDROGENASE user 4 2 # 4 B 240 GLN B 56 GLN.? 26.20 C1 EDO A 124 B 387 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 41.56 93.59 65.64 41.16 91.60 64.94 -52.89 -32.90 -22.16 -54.01 -34.64 -22.72 coo 33.50 85.40 62.90 31.25 87.48 62.36 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1qj2_c02 CARBON MONOXIDE DEHYDROGENASE user 5 2 # 5 B 240 GLN B 65 GLN~? 25.71 C1 EDO A 124 B 387 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 41.56 93.59 65.64 41.16 91.60 64.94 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 coo 33.50 85.40 62.90 31.25 87.48 62.36 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1qj2_c02 CARBON MONOXIDE DEHYDROGENASE user 6 2 # 6 B 240 GLN B 65 GLN~? 25.71 C1 EDO A 124 B 387 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 41.56 93.59 65.64 41.16 91.60 64.94 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 coo 33.50 85.40 62.90 31.25 87.48 62.36 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1qj2_c02 source 1qj2 CARBON MONOXIDE DEHYDROGENASE : 6 hits 1qj2_c02 naa= 2 ULMN 2 1qj2_c03 CARBON MONOXIDE DEHYDROGENASE user 1 2 # 1 H 240 GLN A 56 GLN.? 7.55 C1 EDO A 125 H 387 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 41.71 128.87 87.62 42.13 130.32 89.13 -19.66 -52.09 -22.06 -20.64 -53.94 -21.94 coo 49.59 134.55 94.31 52.01 134.13 92.45 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1qj2_c03 CARBON MONOXIDE DEHYDROGENASE user 2 2 # 2 H 240 GLN A 65 GLN~? 18.24 O1 EDO A 125 H 387 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 41.71 128.87 87.62 42.13 130.32 89.13 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 coo 49.59 134.55 94.31 52.01 134.13 92.45 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1qj2_c03 CARBON MONOXIDE DEHYDROGENASE user 3 2 # 3 H 240 GLN A 65 GLN~? 18.24 O1 EDO A 125 H 387 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 41.71 128.87 87.62 42.13 130.32 89.13 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 coo 49.59 134.55 94.31 52.01 134.13 92.45 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1qj2_c03 CARBON MONOXIDE DEHYDROGENASE user 4 2 # 4 H 240 GLN B 56 GLN.? 26.20 C1 EDO A 124 H 387 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 41.71 128.87 87.62 42.13 130.32 89.13 -52.89 -32.90 -22.16 -54.01 -34.64 -22.72 coo 49.59 134.55 94.31 52.01 134.13 92.45 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1qj2_c03 CARBON MONOXIDE DEHYDROGENASE user 5 2 # 5 H 240 GLN B 65 GLN~? 25.71 C1 EDO A 124 H 387 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 41.71 128.87 87.62 42.13 130.32 89.13 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 coo 49.59 134.55 94.31 52.01 134.13 92.45 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1qj2_c03 CARBON MONOXIDE DEHYDROGENASE user 6 2 # 6 H 240 GLN B 65 GLN~? 25.71 C1 EDO A 124 H 387 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 41.71 128.87 87.62 42.13 130.32 89.13 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 coo 49.59 134.55 94.31 52.01 134.13 92.45 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 1qj2_c03 source 1qj2 CARBON MONOXIDE DEHYDROGENASE : 6 hits 1qj2_c03 naa= 2 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 1 2 # 1 A 221 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 401 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 25.04 36.98 34.15 26.35 36.27 32.62 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 33.28 34.18 40.93 33.02 35.91 42.11 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 2 2 # 2 A 221 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 401 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 25.04 36.98 34.15 26.35 36.27 32.62 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 33.28 34.18 40.93 33.02 35.91 42.11 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 3 2 # 3 A 221 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 401 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 25.04 36.98 34.15 26.35 36.27 32.62 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 33.28 34.18 40.93 33.02 35.91 42.11 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 4 2 # 4 A 221 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 401 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 25.04 36.98 34.15 26.35 36.27 32.62 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 33.28 34.18 40.93 33.02 35.91 42.11 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 5 2 # 5 A 221 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 401 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 25.04 36.98 34.15 26.35 36.27 32.62 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 33.28 34.18 40.93 33.02 35.91 42.11 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 6 2 # 6 A 221 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 401 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 25.04 36.98 34.15 26.35 36.27 32.62 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 33.28 34.18 40.93 33.02 35.91 42.11 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 7 2 # 7 A 221 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 401 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 25.04 36.98 34.15 26.35 36.27 32.62 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 33.28 34.18 40.93 33.02 35.91 42.11 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 8 2 # 8 A 221 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 401 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 25.04 36.98 34.15 26.35 36.27 32.62 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 33.28 34.18 40.93 33.02 35.91 42.11 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 1qk2_c02 source 1qk2 CELLOBIOHYDROLASE CEL6A (FORMERLY CALLED CBH I: 8 hits 1qk2_c02 naa= 2 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 1 2 # 1 B 221 ASP A 32 ASP^? 7.79 O1 EDO A 124 B 401 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 39.21 84.85 78.75 40.59 84.11 77.32 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 47.27 82.90 85.84 46.75 84.63 86.91 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 2 2 # 2 B 221 ASP A 32 ASP^? 7.79 O1 EDO A 124 B 401 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 39.21 84.85 78.75 40.59 84.11 77.32 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 47.27 82.90 85.84 46.75 84.63 86.91 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 3 2 # 3 B 221 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 401 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 39.21 84.85 78.75 40.59 84.11 77.32 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 47.27 82.90 85.84 46.75 84.63 86.91 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 4 2 # 4 B 221 ASP A 63 ASP~? 17.25 O1 EDO A 124 B 401 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 39.21 84.85 78.75 40.59 84.11 77.32 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 47.27 82.90 85.84 46.75 84.63 86.91 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 5 2 # 5 B 221 ASP B 32 ASP^? 9.42 O1 EDO A 124 B 401 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 39.21 84.85 78.75 40.59 84.11 77.32 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 47.27 82.90 85.84 46.75 84.63 86.91 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 6 2 # 6 B 221 ASP B 32 ASP^? 9.42 O1 EDO A 124 B 401 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 39.21 84.85 78.75 40.59 84.11 77.32 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 47.27 82.90 85.84 46.75 84.63 86.91 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 7 2 # 7 B 221 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 401 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 39.21 84.85 78.75 40.59 84.11 77.32 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 47.27 82.90 85.84 46.75 84.63 86.91 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 8 2 # 8 B 221 ASP B 63 ASP~? 17.37 O1 EDO A 124 B 401 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 39.21 84.85 78.75 40.59 84.11 77.32 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 47.27 82.90 85.84 46.75 84.63 86.91 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 1qk2_c03 source 1qk2 CELLOBIOHYDROLASE CEL6A (FORMERLY CALLED CBH I: 8 hits 1qk2_c03 naa= 2 ULMN 2 1qsg_c08 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 A 159 MET A 103 MET?? 8.30 O2 EDO A 125 A 163 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 15.30 11.46 5.20 16.71 11.94 8.23 -21.98 -53.69 -14.57 -25.85 -52.15 -15.50 coo 12.44 6.23 6.82 12.36 8.68 11.73 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 1qsg_c08 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 1 hits 1qsg_c08 naa= 2 ULMN 2 1qsg_c09 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 B 159 MET A 103 MET?? 8.30 O2 EDO A 125 B 163 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 18.85 -6.40 0.99 21.20 -6.37 -1.37 -21.98 -53.69 -14.57 -25.85 -52.15 -15.50 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 1qsg_c09 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 1 hits 1qsg_c09 naa= 2 ULMN 2 1qsg_c10 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 C 159 MET A 103 MET?? 8.30 O2 EDO A 125 C 163 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo -16.80 -11.04 0.24 -19.13 -11.19 2.62 -21.98 -53.69 -14.57 -25.85 -52.15 -15.50 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 1qsg_c10 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 1 hits 1qsg_c10 naa= 2 ULMN 2 1qsg_c11 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 D 159 MET A 103 MET?? 8.30 O2 EDO A 125 D 163 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo -17.84 6.15 -6.96 -19.17 5.84 -10.03 -21.98 -53.69 -14.57 -25.85 -52.15 -15.50 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 1qsg_c11 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 1 hits 1qsg_c11 naa= 2 ULMN 2 1qsg_c12 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 E 159 MET A 103 MET?? 8.30 O2 EDO A 125 E 163 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 62.44 51.05 39.00 65.02 51.33 41.23 -21.98 -53.69 -14.57 -25.85 -52.15 -15.50 coo 60.51 45.70 41.25 62.67 47.81 45.91 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 1qsg_c12 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 1 hits 1qsg_c12 naa= 2 ULMN 2 1qsg_c13 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 F 159 MET A 103 MET?? 8.30 O2 EDO A 125 F 163 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 63.19 33.83 31.94 64.21 34.12 28.72 -21.98 -53.69 -14.57 -25.85 -52.15 -15.50 coo 58.88 38.21 31.46 58.96 36.46 26.25 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 1qsg_c13 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 1 hits 1qsg_c13 naa= 2 ULMN 2 1qsg_c14 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 G 159 MET A 103 MET?? 8.30 O2 EDO A 125 G 163 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 31.37 28.05 46.83 30.31 27.54 50.00 -21.98 -53.69 -14.57 -25.85 -52.15 -15.50 coo 34.29 33.26 48.25 34.81 30.77 53.10 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 1qsg_c14 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 1 hits 1qsg_c14 naa= 2 ULMN 2 1qsg_c15 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 H 159 MET A 103 MET?? 8.30 O2 EDO A 125 H 163 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 27.28 45.88 42.95 24.68 45.76 40.77 -21.98 -53.69 -14.57 -25.85 -52.15 -15.50 coo 30.50 41.69 39.85 27.67 43.89 35.58 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 1qsg_c15 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 1 hits 1qsg_c15 naa= 2 ULMN 2 1qwn_c00 ALPHA-MANNOSIDASE II user 1 2 # 1 A 204 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 341 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 33.05 61.37 6.97 31.64 62.95 7.54 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 33.24 65.52 14.74 32.32 65.05 12.93 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1qwn_c00 ALPHA-MANNOSIDASE II user 2 2 # 2 A 204 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 341 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 33.05 61.37 6.97 31.64 62.95 7.54 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 33.24 65.52 14.74 32.32 65.05 12.93 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1qwn_c00 ALPHA-MANNOSIDASE II user 3 2 # 3 A 204 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 341 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 33.05 61.37 6.97 31.64 62.95 7.54 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 33.24 65.52 14.74 32.32 65.05 12.93 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1qwn_c00 ALPHA-MANNOSIDASE II user 4 2 # 4 A 204 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 341 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 33.05 61.37 6.97 31.64 62.95 7.54 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 33.24 65.52 14.74 32.32 65.05 12.93 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1qwn_c00 ALPHA-MANNOSIDASE II user 5 2 # 5 A 204 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 341 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 33.05 61.37 6.97 31.64 62.95 7.54 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 33.24 65.52 14.74 32.32 65.05 12.93 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1qwn_c00 ALPHA-MANNOSIDASE II user 6 2 # 6 A 204 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 341 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 33.05 61.37 6.97 31.64 62.95 7.54 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 33.24 65.52 14.74 32.32 65.05 12.93 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1qwn_c00 ALPHA-MANNOSIDASE II user 7 2 # 7 A 204 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 341 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 33.05 61.37 6.97 31.64 62.95 7.54 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 33.24 65.52 14.74 32.32 65.05 12.93 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1qwn_c00 ALPHA-MANNOSIDASE II user 8 2 # 8 A 204 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 341 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 33.05 61.37 6.97 31.64 62.95 7.54 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 33.24 65.52 14.74 32.32 65.05 12.93 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1qwn_c00 source 1qwn ALPHA-MANNOSIDASE II : 8 hits 1qwn_c00 naa= 2 ULMN 2 1qz9_c00 KYNURENINASE user 1 2 # 1 A 129 PHE A 48 PHE^? 10.34 O2 EDO A 125 A 201 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 23.39 49.81 32.16 21.33 51.68 32.26 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 25.52 45.12 37.98 23.98 46.65 37.85 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1qz9_c00 KYNURENINASE user 2 2 # 2 A 129 PHE B 48 PHE^? 12.04 C1 EDO A 124 A 201 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 23.39 49.81 32.16 21.33 51.68 32.26 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 25.52 45.12 37.98 23.98 46.65 37.85 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 1qz9_c00 source 1qz9 KYNURENINASE : 2 hits 1qz9_c00 naa= 2 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 1 2 # 1 A 98 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 179 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 34.76 2.28 18.45 36.75 1.46 18.65 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 2 2 # 2 A 98 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 179 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 34.76 2.28 18.45 36.75 1.46 18.65 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 3 2 # 3 A 98 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 179 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 34.76 2.28 18.45 36.75 1.46 18.65 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 4 2 # 4 A 98 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 179 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 34.76 2.28 18.45 36.75 1.46 18.65 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1r16_c00 source 1r16 ADP-RIBOSYL CYCLASE : 4 hits 1r16_c00 naa= 2 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 1 2 # 1 B 98 GLU A 23 GLU.? 13.04 O2 EDO A 125 B 179 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 2 2 # 2 B 98 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 179 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 3 2 # 3 B 98 GLU B 23 GLU.? 12.57 O2 EDO A 125 B 179 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 4 2 # 4 B 98 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 179 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1r16_c01 source 1r16 ADP-RIBOSYL CYCLASE : 4 hits 1r16_c01 naa= 2 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 A 71 ARG A 30 ARG^? -2.97 O2 EDO A 124s A 181 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 29.52 23.28 0.51 26.83 22.05 1.22 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 18.49 20.71 4.77 20.29 21.80 4.49 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 A 71 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 181 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 29.52 23.28 0.51 26.83 22.05 1.22 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 18.49 20.71 4.77 20.29 21.80 4.49 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 A 71 ARG B 30 ARG^? 10.56 O1 EDO A 124 A 181 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 29.52 23.28 0.51 26.83 22.05 1.22 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 18.49 20.71 4.77 20.29 21.80 4.49 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1r44_c00 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 3 hits 1r44_c00 naa= 2 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 B 71 ARG A 30 ARG^? -2.97 O2 EDO A 124s B 181 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 25.64 17.80 33.30 23.89 16.05 31.49 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 20.92 9.87 25.44 22.46 10.92 26.39 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 B 71 ARG A 37 ARG^? 13.77 O1 EDO A 124 B 181 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 25.64 17.80 33.30 23.89 16.05 31.49 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 20.92 9.87 25.44 22.46 10.92 26.39 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 B 71 ARG B 30 ARG^? 10.56 O1 EDO A 124 B 181 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 25.64 17.80 33.30 23.89 16.05 31.49 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 20.92 9.87 25.44 22.46 10.92 26.39 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1r44_c01 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 3 hits 1r44_c01 naa= 2 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 C 71 ARG A 30 ARG^? -2.97 O2 EDO A 124s C 181 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 C 71 ARG A 37 ARG^? 13.77 O1 EDO A 124 C 181 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 C 71 ARG B 30 ARG^? 10.56 O1 EDO A 124 C 181 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1r44_c02 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 3 hits 1r44_c02 naa= 2 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 D 71 ARG A 30 ARG^? -2.97 O2 EDO A 124s D 181 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 2.99 23.21 78.86 1.22 24.31 78.95 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 D 71 ARG A 37 ARG^? 13.77 O1 EDO A 124 D 181 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 2.99 23.21 78.86 1.22 24.31 78.95 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 D 71 ARG B 30 ARG^? 10.56 O1 EDO A 124 D 181 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 2.99 23.21 78.86 1.22 24.31 78.95 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1r44_c03 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 3 hits 1r44_c03 naa= 2 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 E 71 ARG A 30 ARG^? -2.97 O2 EDO A 124s E 181 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 E 71 ARG A 37 ARG^? 13.77 O1 EDO A 124 E 181 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 E 71 ARG B 30 ARG^? 10.56 O1 EDO A 124 E 181 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1r44_c04 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 3 hits 1r44_c04 naa= 2 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 F 71 ARG A 30 ARG^? -2.97 O2 EDO A 124s F 181 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 F 71 ARG A 37 ARG^? 13.77 O1 EDO A 124 F 181 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 F 71 ARG B 30 ARG^? 10.56 O1 EDO A 124 F 181 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 1r44_c05 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 3 hits 1r44_c05 naa= 2 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 1 2 # 1 A 133 ARG A 33 ARG.? 17.39 O2 EDO A 124 A 235 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 31.15 12.07 13.86 31.85 13.16 16.74 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 27.79 29.07 13.69 29.71 23.15 14.63 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 2 2 # 2 A 133 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 235 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 31.15 12.07 13.86 31.85 13.16 16.74 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 27.79 29.07 13.69 29.71 23.15 14.63 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 3 2 # 3 A 133 ARG B 33 ARG.? 19.94 O1 EDO A 124 A 235 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 31.15 12.07 13.86 31.85 13.16 16.74 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 27.79 29.07 13.69 29.71 23.15 14.63 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 4 2 # 4 A 133 ARG B 37 ARG^? 8.36 C1 EDO A 124 A 235 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 31.15 12.07 13.86 31.85 13.16 16.74 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 27.79 29.07 13.69 29.71 23.15 14.63 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1r6w_c00 source 1r6w O-SUCCINYLBENZOATE SYNTHASE : 4 hits 1r6w_c00 naa= 2 ULMN 2 1r76_c00 PECTATE LYASE user 1 2 # 1 A 172 ASN A 44 ASN.? 12.85 O2 EDO A 124 A 307 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 22.99 58.57 18.19 23.89 56.65 18.30 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 coo 20.34 46.40 20.83 22.83 48.18 20.99 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1r76_c00 PECTATE LYASE user 2 2 # 2 A 172 ASN B 44 ASN.? 11.30 O2 EDO A 125 A 307 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo 22.99 58.57 18.19 23.89 56.65 18.30 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 coo 20.34 46.40 20.83 22.83 48.18 20.99 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 1r76_c00 source 1r76 PECTATE LYASE : 2 hits 1r76_c00 naa= 2 ULMN 2 1ra0_c00 CYTOSINE DEAMINASE user 1 2 # 1 A 156 GLN A 65 GLN~? 18.24 O1 EDO A 125 A 217 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 0.57 24.33 98.25 1.75 23.60 99.87 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 coo 5.48 17.66 105.85 5.34 19.71 105.34 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1ra0_c00 CYTOSINE DEAMINASE user 2 2 # 2 A 156 GLN A 65 GLN~? 18.24 O1 EDO A 125 A 217 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 0.57 24.33 98.25 1.75 23.60 99.87 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 coo 5.48 17.66 105.85 5.34 19.71 105.34 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1ra0_c00 CYTOSINE DEAMINASE user 3 2 # 3 A 156 GLN B 65 GLN~? 25.71 C1 EDO A 124 A 217 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 0.57 24.33 98.25 1.75 23.60 99.87 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 coo 5.48 17.66 105.85 5.34 19.71 105.34 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 ULMN 2 1ra0_c00 CYTOSINE DEAMINASE user 4 2 # 4 A 156 GLN B 65 GLN~? 25.71 C1 EDO A 124 A 217 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 0.57 24.33 98.25 1.75 23.60 99.87 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 coo 5.48 17.66 105.85 5.34 19.71 105.34 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 ULMN 2 1ra0_c00 CYTOSINE DEAMINASE user 5 2 # 5 A 156 GLN B 74 GLN.? 24.11 O2 EDO A 125 A 217 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 0.57 24.33 98.25 1.75 23.60 99.87 -39.96 -43.67 -5.29 -40.15 -43.70 -3.16 coo 5.48 17.66 105.85 5.34 19.71 105.34 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1ra0_c00 CYTOSINE DEAMINASE user 6 2 # 6 A 156 GLN B 74 GLN.? 24.11 O2 EDO A 125 A 217 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 0.57 24.33 98.25 1.75 23.60 99.87 -39.96 -43.67 -5.29 -40.15 -43.70 -3.16 coo 5.48 17.66 105.85 5.34 19.71 105.34 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 1ra0_c00 source 1ra0 CYTOSINE DEAMINASE : 6 hits 1ra0_c00 naa= 2 ULMN 2 1req_c08 METHYLMALONYL-COA MUTASE user 1 2 # 1 A 608 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 610 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 75.99 81.56 1.86 73.91 81.34 2.28 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 71.04 78.84 0.46 71.54 76.90 1.02 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1req_c08 METHYLMALONYL-COA MUTASE user 2 2 # 2 A 608 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 610 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 75.99 81.56 1.86 73.91 81.34 2.28 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 71.04 78.84 0.46 71.54 76.90 1.02 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1req_c08 source 1req METHYLMALONYL-COA MUTASE : 2 hits 1req_c08 naa= 2 ULMN 2 1req_c09 METHYLMALONYL-COA MUTASE user 1 2 # 1 C 608 ASP A 86 ASP^? 9.05 O1 EDO A 125 C 610 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1req_c09 METHYLMALONYL-COA MUTASE user 2 2 # 2 C 608 ASP B 86 ASP^? 26.97 C1 EDO A 124 C 610 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1req_c09 source 1req METHYLMALONYL-COA MUTASE : 2 hits 1req_c09 naa= 2 ULMN 2 1rql_c00 PHOSPHONOACETALDEHYDE HYDROLASE user 1 2 # 1 A 126 THR A 47 THR^? 4.31 C1 EDO A 124 A 160 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 51.19 2.52 10.94 50.16 2.43 9.01 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 51.97 0.60 16.16 51.18 3.08 14.54 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1rql_c00 PHOSPHONOACETALDEHYDE HYDROLASE user 2 2 # 2 A 126 THR B 47 THR^? 9.39 O1 EDO A 124 A 160 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 51.19 2.52 10.94 50.16 2.43 9.01 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 51.97 0.60 16.16 51.18 3.08 14.54 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 1rql_c00 source 1rql PHOSPHONOACETALDEHYDE HYDROLASE : 2 hits 1rql_c00 naa= 2 ULMN 2 1rql_c01 PHOSPHONOACETALDEHYDE HYDROLASE user 1 2 # 1 B 126 THR A 47 THR^? 4.31 C1 EDO A 124 B 160 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 81.10 -6.09 8.07 81.50 -7.56 6.55 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 81.89 -1.02 10.42 82.47 -4.03 10.41 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 1rql_c01 PHOSPHONOACETALDEHYDE HYDROLASE user 2 2 # 2 B 126 THR B 47 THR^? 9.39 O1 EDO A 124 B 160 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 81.10 -6.09 8.07 81.50 -7.56 6.55 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 81.89 -1.02 10.42 82.47 -4.03 10.41 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 1rql_c01 source 1rql PHOSPHONOACETALDEHYDE HYDROLASE : 2 hits 1rql_c01 naa= 2 ULMN 2 1rtf_c00 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 2 # 1 B 57 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 102 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1rtf_c00 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 2 # 2 B 57 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 102 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1rtf_c00 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 2 hits 1rtf_c00 naa= 2 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 2 # 1 B 195 SER A 88 SER^? -5.03 C1 EDO A 125s B 196 GLY A 77 GLY^? 7.89 O1 EDO A 125 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 coo 0.64 25.09 37.94 0.51 25.31 37.16 -28.29 -45.93 -31.97 -28.42 -45.22 -32.28 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 2 # 2 B 195 SER A 88 SER^? -5.03 C1 EDO A 125s B 196 GLY A 91 GLY~? 3.77 O2 EDO A 125 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 coo 0.64 25.09 37.94 0.51 25.31 37.16 -31.34 -48.06 -23.33 -31.38 -47.22 -23.45 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 2 # 3 B 195 SER B 88 SER^? 19.82 O2 EDO A 125 B 196 GLY B 77 GLY^? 22.66 C1 EDO A 124 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 coo 0.64 25.09 37.94 0.51 25.31 37.16 -43.26 -37.30 -11.50 -42.54 -37.05 -11.23 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 2 # 4 B 195 SER B 88 SER^? 19.82 O2 EDO A 125 B 196 GLY B 91 GLY~? 18.21 O2 EDO A 125 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 coo 0.64 25.09 37.94 0.51 25.31 37.16 -43.74 -41.04 -20.11 -43.00 -40.62 -20.02 1rtf_c01 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 4 hits 1rtf_c01 naa= 2 ULMN 2 1s2k_c00 ALA-ILE-HIS TRIPEPTIDE user 1 2 # 1 A 53 GLN B 74 GLN.? 24.11 O2 EDO A 125 A 136 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 80.69 40.00 16.06 79.05 40.72 17.21 -39.96 -43.67 -5.29 -40.15 -43.70 -3.16 coo 71.34 40.73 18.57 73.36 41.35 18.80 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1s2k_c00 ALA-ILE-HIS TRIPEPTIDE user 2 2 # 2 A 53 GLN B 74 GLN.? 24.11 O2 EDO A 125 A 136 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 80.69 40.00 16.06 79.05 40.72 17.21 -39.96 -43.67 -5.29 -40.15 -43.70 -3.16 coo 71.34 40.73 18.57 73.36 41.35 18.80 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 1s2k_c00 source 1s2k ALA-ILE-HIS TRIPEPTIDE : 2 hits 1s2k_c00 naa= 2 ULMN 2 1s3i_c01 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 1 2 # 1 A 106 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 142 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1s3i_c01 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 2 2 # 2 A 106 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 142 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1s3i_c01 source 1s3i 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE : 2 hits 1s3i_c01 naa= 2 ULMN 2 1s95_c00 SERINE/THREONINE PROTEIN PHOSPHATASEuser 1 2 # 1 A 274 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 304 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 18.41 23.75 25.69 20.54 23.70 26.14 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 18.06 23.17 29.78 17.74 21.15 29.38 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1s95_c00 SERINE/THREONINE PROTEIN PHOSPHATASEuser 2 2 # 2 A 274 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 304 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 18.41 23.75 25.69 20.54 23.70 26.14 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 18.06 23.17 29.78 17.74 21.15 29.38 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1s95_c00 source 1s95 SERINE/THREONINE PROTEIN PHOSPHATASE 5 : 2 hits 1s95_c00 naa= 2 ULMN 2 1s95_c01 SERINE/THREONINE PROTEIN PHOSPHATASEuser 1 2 # 1 B 274 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 304 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 11.08 2.22 21.17 12.89 1.17 20.72 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 10.74 3.09 17.16 11.36 5.03 17.57 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1s95_c01 SERINE/THREONINE PROTEIN PHOSPHATASEuser 2 2 # 2 B 274 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 304 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 11.08 2.22 21.17 12.89 1.17 20.72 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 10.74 3.09 17.16 11.36 5.03 17.57 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1s95_c01 source 1s95 SERINE/THREONINE PROTEIN PHOSPHATASE 5 : 2 hits 1s95_c01 naa= 2 ULMN 2 1slm_c00 STROMELYSIN-1 user 1 2 # 1 202 GLU A 23 GLU.? 13.04 O2 EDO A 125 219 MET A 93 MET?? 10.81 O2 EDO A 125 coo 17.90 89.78 76.20 17.93 89.03 78.20 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 23.61 94.73 82.41 24.46 93.13 79.93 -32.62 -43.10 -21.62 -33.95 -40.68 -24.94 ULMN 2 1slm_c00 STROMELYSIN-1 user 2 2 # 2 202 GLU A 23 GLU.? 13.04 O2 EDO A 125 219 MET B 93 MET?? 13.65 O2 EDO A 125 coo 17.90 89.78 76.20 17.93 89.03 78.20 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo 23.61 94.73 82.41 24.46 93.13 79.93 -38.81 -39.61 -21.96 -36.01 -39.35 -18.74 ULMN 2 1slm_c00 STROMELYSIN-1 user 3 2 # 3 202 GLU A 59 GLU.? 11.26 O1 EDO A 125 219 MET A 103 MET?? 8.30 O2 EDO A 125 coo 17.90 89.78 76.20 17.93 89.03 78.20 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo 23.61 94.73 82.41 24.46 93.13 79.93 -21.98 -53.69 -14.57 -25.85 -52.15 -15.50 ULMN 2 1slm_c00 STROMELYSIN-1 user 4 2 # 4 202 GLU B 23 GLU.? 12.57 O2 EDO A 125 219 MET A 93 MET?? 10.81 O2 EDO A 125 coo 17.90 89.78 76.20 17.93 89.03 78.20 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 23.61 94.73 82.41 24.46 93.13 79.93 -32.62 -43.10 -21.62 -33.95 -40.68 -24.94 ULMN 2 1slm_c00 STROMELYSIN-1 user 5 2 # 5 202 GLU B 23 GLU.? 12.57 O2 EDO A 125 219 MET B 93 MET?? 13.65 O2 EDO A 125 coo 17.90 89.78 76.20 17.93 89.03 78.20 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo 23.61 94.73 82.41 24.46 93.13 79.93 -38.81 -39.61 -21.96 -36.01 -39.35 -18.74 ULMN 2 1slm_c00 STROMELYSIN-1 user 6 2 # 6 202 GLU B 59 GLU.? 24.69 C1 EDO A 124 219 MET B 103 MET?? 21.79 C1 EDO A 124 coo 17.90 89.78 76.20 17.93 89.03 78.20 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo 23.61 94.73 82.41 24.46 93.13 79.93 -51.26 -35.87 -29.54 -48.31 -38.03 -27.58 1slm_c00 source 1slm STROMELYSIN-1 : 6 hits 1slm_c00 naa= 2 ULMN 2 1sme_c10 PLASMEPSIN II user 1 2 # 1 A 34 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 214 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 51.75 60.57 19.10 52.05 60.90 21.19 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 48.59 58.89 25.78 50.13 59.74 24.61 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1sme_c10 PLASMEPSIN II user 2 2 # 2 A 34 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 214 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 51.75 60.57 19.10 52.05 60.90 21.19 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 48.59 58.89 25.78 50.13 59.74 24.61 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1sme_c10 PLASMEPSIN II user 3 2 # 3 A 34 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 214 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 51.75 60.57 19.10 52.05 60.90 21.19 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 48.59 58.89 25.78 50.13 59.74 24.61 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1sme_c10 PLASMEPSIN II user 4 2 # 4 A 34 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 214 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 51.75 60.57 19.10 52.05 60.90 21.19 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 48.59 58.89 25.78 50.13 59.74 24.61 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1sme_c10 source 1sme PLASMEPSIN II : 4 hits 1sme_c10 naa= 2 ULMN 2 1sme_c11 PLASMEPSIN II user 1 2 # 1 B 34 ASP A 32 ASP^? 7.79 O1 EDO A 124 B 214 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 17.69 97.58 52.73 17.33 97.19 54.77 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 12.41 98.71 58.47 14.37 98.17 58.05 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1sme_c11 PLASMEPSIN II user 2 2 # 2 B 34 ASP A 63 ASP~? 17.25 O1 EDO A 124 B 214 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 17.69 97.58 52.73 17.33 97.19 54.77 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 12.41 98.71 58.47 14.37 98.17 58.05 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1sme_c11 PLASMEPSIN II user 3 2 # 3 B 34 ASP A 84 ASP.? 13.20 O1 EDO A 125 B 214 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 17.69 97.58 52.73 17.33 97.19 54.77 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 12.41 98.71 58.47 14.37 98.17 58.05 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1sme_c11 PLASMEPSIN II user 4 2 # 4 B 34 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 214 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 17.69 97.58 52.73 17.33 97.19 54.77 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 12.41 98.71 58.47 14.37 98.17 58.05 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1sme_c11 PLASMEPSIN II user 5 2 # 5 B 34 ASP B 84 ASP.? 30.86 C1 EDO A 124 B 214 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 17.69 97.58 52.73 17.33 97.19 54.77 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 12.41 98.71 58.47 14.37 98.17 58.05 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 1sme_c11 PLASMEPSIN II user 6 2 # 6 B 34 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 214 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 17.69 97.58 52.73 17.33 97.19 54.77 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 12.41 98.71 58.47 14.37 98.17 58.05 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1sme_c11 source 1sme PLASMEPSIN II : 6 hits 1sme_c11 naa= 2 ULMN 2 1snz_c00 ALDOSE 1-EPIMERASE user 1 2 # 1 A 176 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 307 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -11.45 7.93 45.89 -12.23 7.21 44.11 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -12.20 3.67 48.18 -13.56 4.31 46.73 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1snz_c00 ALDOSE 1-EPIMERASE user 2 2 # 2 A 176 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 307 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo -11.45 7.93 45.89 -12.23 7.21 44.11 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -12.20 3.67 48.18 -13.56 4.31 46.73 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1snz_c00 ALDOSE 1-EPIMERASE user 3 2 # 3 A 176 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 307 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo -11.45 7.93 45.89 -12.23 7.21 44.11 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -12.20 3.67 48.18 -13.56 4.31 46.73 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1snz_c00 ALDOSE 1-EPIMERASE user 4 2 # 4 A 176 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 307 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo -11.45 7.93 45.89 -12.23 7.21 44.11 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -12.20 3.67 48.18 -13.56 4.31 46.73 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1snz_c00 source 1snz ALDOSE 1-EPIMERASE : 4 hits 1snz_c00 naa= 2 ULMN 2 1snz_c01 ALDOSE 1-EPIMERASE user 1 2 # 1 B 176 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 307 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 24.63 93.76 22.10 25.63 93.50 23.91 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 26.56 90.05 20.00 27.80 91.02 21.36 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1snz_c01 ALDOSE 1-EPIMERASE user 2 2 # 2 B 176 HIS A 79 HIS^? 12.23 O1 EDO A 125 B 307 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 24.63 93.76 22.10 25.63 93.50 23.91 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 26.56 90.05 20.00 27.80 91.02 21.36 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1snz_c01 ALDOSE 1-EPIMERASE user 3 2 # 3 B 176 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 307 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 24.63 93.76 22.10 25.63 93.50 23.91 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 26.56 90.05 20.00 27.80 91.02 21.36 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1snz_c01 ALDOSE 1-EPIMERASE user 4 2 # 4 B 176 HIS B 79 HIS^? 26.86 C1 EDO A 124 B 307 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 24.63 93.76 22.10 25.63 93.50 23.91 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 26.56 90.05 20.00 27.80 91.02 21.36 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1snz_c01 source 1snz ALDOSE 1-EPIMERASE : 4 hits 1snz_c01 naa= 2 ULMN 2 1sox_c00 SULFITE OXIDASE user 1 2 # 1 A 138 ARG A 30 ARG^? -2.97 O2 EDO A 124s A 322 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 29.11 98.43 27.28 31.52 97.24 28.79 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 28.34 90.08 25.08 29.22 92.59 25.94 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1sox_c00 SULFITE OXIDASE user 2 2 # 2 A 138 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 322 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 29.11 98.43 27.28 31.52 97.24 28.79 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 28.34 90.08 25.08 29.22 92.59 25.94 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1sox_c00 SULFITE OXIDASE user 3 2 # 3 A 138 ARG A 53 ARG~? 17.45 O1 EDO A 125 A 322 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 29.11 98.43 27.28 31.52 97.24 28.79 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 28.34 90.08 25.08 29.22 92.59 25.94 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1sox_c00 SULFITE OXIDASE user 4 2 # 4 A 138 ARG B 30 ARG^? 10.56 O1 EDO A 124 A 322 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo 29.11 98.43 27.28 31.52 97.24 28.79 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 28.34 90.08 25.08 29.22 92.59 25.94 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 ULMN 2 1sox_c00 SULFITE OXIDASE user 5 2 # 5 A 138 ARG B 37 ARG^? 8.36 C1 EDO A 124 A 322 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo 29.11 98.43 27.28 31.52 97.24 28.79 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 28.34 90.08 25.08 29.22 92.59 25.94 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 ULMN 2 1sox_c00 SULFITE OXIDASE user 6 2 # 6 A 138 ARG B 53 ARG~? 17.71 C1 EDO A 124 A 322 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo 29.11 98.43 27.28 31.52 97.24 28.79 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 28.34 90.08 25.08 29.22 92.59 25.94 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 1sox_c00 source 1sox SULFITE OXIDASE : 6 hits 1sox_c00 naa= 2 ULMN 2 1sox_c01 SULFITE OXIDASE user 1 2 # 1 B 138 ARG A 30 ARG^? -2.97 O2 EDO A 124s B 322 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1sox_c01 SULFITE OXIDASE user 2 2 # 2 B 138 ARG A 37 ARG^? 13.77 O1 EDO A 124 B 322 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1sox_c01 SULFITE OXIDASE user 3 2 # 3 B 138 ARG A 53 ARG~? 17.45 O1 EDO A 125 B 322 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1sox_c01 SULFITE OXIDASE user 4 2 # 4 B 138 ARG B 30 ARG^? 10.56 O1 EDO A 124 B 322 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 ULMN 2 1sox_c01 SULFITE OXIDASE user 5 2 # 5 B 138 ARG B 37 ARG^? 8.36 C1 EDO A 124 B 322 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 ULMN 2 1sox_c01 SULFITE OXIDASE user 6 2 # 6 B 138 ARG B 53 ARG~? 17.71 C1 EDO A 124 B 322 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 1sox_c01 source 1sox SULFITE OXIDASE : 6 hits 1sox_c01 naa= 2 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 1 2 # 1 E 166 ASP A 84 ASP.? 13.20 O1 EDO A 125 E 170 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 5.36 16.20 22.10 3.88 17.00 23.31 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 2.36 26.80 21.76 1.58 25.84 20.04 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 2 2 # 2 E 166 ASP A 86 ASP^? 9.05 O1 EDO A 125 E 170 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 5.36 16.20 22.10 3.88 17.00 23.31 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 2.36 26.80 21.76 1.58 25.84 20.04 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 3 2 # 3 E 166 ASP A 86 ASP^? 9.05 O1 EDO A 125 E 170 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 5.36 16.20 22.10 3.88 17.00 23.31 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 2.36 26.80 21.76 1.58 25.84 20.04 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 4 2 # 4 E 166 ASP B 84 ASP.? 30.86 C1 EDO A 124 E 170 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 5.36 16.20 22.10 3.88 17.00 23.31 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 2.36 26.80 21.76 1.58 25.84 20.04 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 5 2 # 5 E 166 ASP B 86 ASP^? 26.97 C1 EDO A 124 E 170 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 5.36 16.20 22.10 3.88 17.00 23.31 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 2.36 26.80 21.76 1.58 25.84 20.04 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 6 2 # 6 E 166 ASP B 86 ASP^? 26.97 C1 EDO A 124 E 170 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 5.36 16.20 22.10 3.88 17.00 23.31 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 2.36 26.80 21.76 1.58 25.84 20.04 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1stc_c00 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 6 hits 1stc_c00 naa= 2 ULMN 2 1t0u_c00 URIDINE PHOSPHORYLASE user 1 2 # 1 A 8 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 80 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -26.49 11.99 -26.21 -24.54 12.74 -26.25 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -26.78 7.08 -23.74 -27.10 9.15 -24.19 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 1t0u_c00 URIDINE PHOSPHORYLASE user 2 2 # 2 A 8 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 80 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo -26.49 11.99 -26.21 -24.54 12.74 -26.25 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -26.78 7.08 -23.74 -27.10 9.15 -24.19 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1t0u_c00 URIDINE PHOSPHORYLASE user 3 2 # 3 A 8 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 80 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo -26.49 11.99 -26.21 -24.54 12.74 -26.25 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -26.78 7.08 -23.74 -27.10 9.15 -24.19 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 1t0u_c00 URIDINE PHOSPHORYLASE user 4 2 # 4 A 8 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 80 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo -26.49 11.99 -26.21 -24.54 12.74 -26.25 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -26.78 7.08 -23.74 -27.10 9.15 -24.19 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1t0u_c00 source 1t0u URIDINE PHOSPHORYLASE : 4 hits 1t0u_c00 naa= 2 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 1 2 # 1 62 LYS A 28 LYS^? 7.39 O2 EDO A 124 288 SER A 88 SER^? -5.03 C1 EDO A 125s coo -13.90 11.27 16.35 -15.53 10.62 20.90 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 2 2 # 2 62 LYS A 100 LYS~? 11.56 C2 EDO A 125 288 SER A 88 SER^? -5.03 C1 EDO A 125s coo -13.90 11.27 16.35 -15.53 10.62 20.90 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 3 2 # 3 62 LYS B 28 LYS^? -17.65 O1 EDO A 124s 288 SER B 88 SER^? 19.82 O2 EDO A 125 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 1tdj_c00 source 1tdj BIOSYNTHETIC THREONINE DEAMINASE : 3 hits 1tdj_c00 naa= 2 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 1 2 # 1 117 ASP A 32 ASP^? 7.79 O1 EDO A 124 265 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 2 2 # 2 117 ASP A 32 ASP^? 7.79 O1 EDO A 124 265 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 3 2 # 3 117 ASP A 41 ASP^? -2.91 O2 EDO A 124s 265 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 4 2 # 4 117 ASP A 64 ASP~? 20.53 O2 EDO A 124 265 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 5 2 # 5 117 ASP B 32 ASP^? 9.42 O1 EDO A 124 265 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 6 2 # 6 117 ASP B 32 ASP^? 9.42 O1 EDO A 124 265 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 7 2 # 7 117 ASP B 41 ASP^? 12.31 O1 EDO A 124 265 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 8 2 # 8 117 ASP B 64 ASP~? 23.62 O1 EDO A 124 265 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 1tml_c01 source 1tml ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1.4) : 8 hits 1tml_c01 naa= 2 ULMN 2 1tmo_c02 TRIMETHYLAMINE N-OXIDE REDUCTASE user 1 2 # 1 116 THR A 82 THR.? 18.68 O1 EDO A 125 118 TRP A 80 TRP^? 10.72 O1 EDO A 125 coo 57.54 43.08 12.99 56.93 42.25 11.08 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 coo 50.24 43.58 16.89 46.55 44.75 16.20 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 ULMN 2 1tmo_c02 TRIMETHYLAMINE N-OXIDE REDUCTASE user 2 2 # 2 116 THR A 99 THR~? 7.67 C2 EDO A 125 118 TRP A 102 TRP~? 9.51 C2 EDO A 125 coo 57.54 43.08 12.99 56.93 42.25 11.08 -24.60 -55.51 -20.10 -23.07 -56.46 -21.32 coo 50.24 43.58 16.89 46.55 44.75 16.20 -18.50 -53.08 -18.95 -20.92 -50.18 -17.77 ULMN 2 1tmo_c02 TRIMETHYLAMINE N-OXIDE REDUCTASE user 3 2 # 3 116 THR B 82 THR.? 29.24 O1 EDO A 124 118 TRP B 80 TRP^? 20.31 C1 EDO A 124 coo 57.54 43.08 12.99 56.93 42.25 11.08 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 coo 50.24 43.58 16.89 46.55 44.75 16.20 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 ULMN 2 1tmo_c02 TRIMETHYLAMINE N-OXIDE REDUCTASE user 4 2 # 4 116 THR B 99 THR.? 28.08 C1 EDO A 124 118 TRP B 102 TRP.? 23.62 C1 EDO A 124 coo 57.54 43.08 12.99 56.93 42.25 11.08 -53.39 -38.76 -24.48 -55.06 -37.90 -23.47 coo 50.24 43.58 16.89 46.55 44.75 16.20 -54.10 -32.30 -25.44 -50.24 -31.83 -25.86 1tmo_c02 source 1tmo TRIMETHYLAMINE N-OXIDE REDUCTASE : 4 hits 1tmo_c02 naa= 2 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 1 2 # 1 A 130 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 185 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 8.81 3.41 29.07 10.49 4.61 29.53 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 17.44 9.63 28.94 15.61 8.68 29.31 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 2 2 # 2 A 130 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 185 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 8.81 3.41 29.07 10.49 4.61 29.53 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 17.44 9.63 28.94 15.61 8.68 29.31 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 3 2 # 3 A 130 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 185 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 8.81 3.41 29.07 10.49 4.61 29.53 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 17.44 9.63 28.94 15.61 8.68 29.31 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 4 2 # 4 A 130 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 185 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 8.81 3.41 29.07 10.49 4.61 29.53 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 17.44 9.63 28.94 15.61 8.68 29.31 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 5 2 # 5 A 130 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 185 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 8.81 3.41 29.07 10.49 4.61 29.53 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 17.44 9.63 28.94 15.61 8.68 29.31 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 6 2 # 6 A 130 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 185 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 8.81 3.41 29.07 10.49 4.61 29.53 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 17.44 9.63 28.94 15.61 8.68 29.31 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 7 2 # 7 A 130 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 185 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 8.81 3.41 29.07 10.49 4.61 29.53 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 17.44 9.63 28.94 15.61 8.68 29.31 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 8 2 # 8 A 130 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 185 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 8.81 3.41 29.07 10.49 4.61 29.53 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 17.44 9.63 28.94 15.61 8.68 29.31 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 1uas_c00 source 1uas ALPHA-GALACTOSIDASE : 8 hits 1uas_c00 naa= 2 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 1 2 # 1 199 ASP A 41 ASP^? -2.91 O2 EDO A 124s 255 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 49.16 35.16 15.19 51.08 34.43 15.65 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 52.57 37.12 10.17 53.37 35.95 11.75 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 2 2 # 2 199 ASP A 84 ASP.? 13.20 O1 EDO A 125 255 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 52.57 37.12 10.17 53.37 35.95 11.75 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 3 2 # 3 199 ASP B 84 ASP.? 30.86 C1 EDO A 124 255 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 49.16 35.16 15.19 51.08 34.43 15.65 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 52.57 37.12 10.17 53.37 35.95 11.75 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1uok_c01 source 1uok OLIGO-1,6-GLUCOSIDASE : 3 hits 1uok_c01 naa= 2 ULMN 2 1uox_c00 URATE OXIDASE user 1 2 # 1 28 THR A 47 THR^? 4.31 C1 EDO A 124 76 PRO A 51 PRO~? 12.56 O2 EDO A 125 coo 16.78 65.34 48.92 15.62 64.41 47.34 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 23.62 58.48 37.29 23.51 60.61 36.65 -22.81 -39.07 -17.47 -22.64 -38.62 -19.64 ULMN 2 1uox_c00 URATE OXIDASE user 2 2 # 2 28 THR A 47 THR^? 4.31 C1 EDO A 124 76 PRO A 52 PRO~? 11.69 O1 EDO A 125 coo 16.78 65.34 48.92 15.62 64.41 47.34 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 23.62 58.48 37.29 23.51 60.61 36.65 -19.24 -39.24 -23.00 -20.61 -40.50 -21.76 ULMN 2 1uox_c00 URATE OXIDASE user 3 2 # 3 28 THR A 47 THR^? 4.31 C1 EDO A 124 76 PRO A 90 PRO~? 7.68 O2 EDO A 125 coo 16.78 65.34 48.92 15.62 64.41 47.34 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 23.62 58.48 37.29 23.51 60.61 36.65 -34.27 -46.71 -27.76 -33.11 -45.80 -26.06 ULMN 2 1uox_c00 URATE OXIDASE user 4 2 # 4 28 THR A 47 THR^? 4.31 C1 EDO A 124 76 PRO B 24 PRO.? 11.94 O2 EDO A 125 coo 16.78 65.34 48.92 15.62 64.41 47.34 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 23.62 58.48 37.29 23.51 60.61 36.65 -34.76 -42.94 -16.24 -33.94 -43.43 -14.22 ULMN 2 1uox_c00 URATE OXIDASE user 5 2 # 5 28 THR A 47 THR^? 4.31 C1 EDO A 124 76 PRO B 90 PRO~? 16.38 O2 EDO A 125 coo 16.78 65.34 48.92 15.62 64.41 47.34 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 23.62 58.48 37.29 23.51 60.61 36.65 -40.98 -42.73 -15.66 -40.85 -41.32 -17.39 ULMN 2 1uox_c00 URATE OXIDASE user 6 2 # 6 28 THR A 82 THR.? 18.68 O1 EDO A 125 76 PRO A 52 PRO~? 11.69 O1 EDO A 125 coo 16.78 65.34 48.92 15.62 64.41 47.34 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 coo 23.62 58.48 37.29 23.51 60.61 36.65 -19.24 -39.24 -23.00 -20.61 -40.50 -21.76 ULMN 2 1uox_c00 URATE OXIDASE user 7 2 # 7 28 THR A 99 THR~? 7.67 C2 EDO A 125 76 PRO A 51 PRO~? 12.56 O2 EDO A 125 coo 16.78 65.34 48.92 15.62 64.41 47.34 -24.60 -55.51 -20.10 -23.07 -56.46 -21.32 coo 23.62 58.48 37.29 23.51 60.61 36.65 -22.81 -39.07 -17.47 -22.64 -38.62 -19.64 ULMN 2 1uox_c00 URATE OXIDASE user 8 2 # 8 28 THR A 99 THR~? 7.67 C2 EDO A 125 76 PRO A 90 PRO~? 7.68 O2 EDO A 125 coo 16.78 65.34 48.92 15.62 64.41 47.34 -24.60 -55.51 -20.10 -23.07 -56.46 -21.32 coo 23.62 58.48 37.29 23.51 60.61 36.65 -34.27 -46.71 -27.76 -33.11 -45.80 -26.06 ULMN 2 1uox_c00 URATE OXIDASE user 9 2 # 9 28 THR A 99 THR~? 7.67 C2 EDO A 125 76 PRO B 24 PRO.? 11.94 O2 EDO A 125 coo 16.78 65.34 48.92 15.62 64.41 47.34 -24.60 -55.51 -20.10 -23.07 -56.46 -21.32 coo 23.62 58.48 37.29 23.51 60.61 36.65 -34.76 -42.94 -16.24 -33.94 -43.43 -14.22 ULMN 2 1uox_c00 URATE OXIDASE user 10 2 # 10 28 THR B 47 THR^? 9.39 O1 EDO A 124 76 PRO A 24 PRO.? 13.79 O2 EDO A 125 coo 16.78 65.34 48.92 15.62 64.41 47.34 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 23.62 58.48 37.29 23.51 60.61 36.65 -37.37 -41.75 -27.30 -38.43 -41.33 -29.23 ULMN 2 1uox_c00 URATE OXIDASE user 11 2 # 11 28 THR B 47 THR^? 9.39 O1 EDO A 124 76 PRO A 90 PRO~? 7.68 O2 EDO A 125 coo 16.78 65.34 48.92 15.62 64.41 47.34 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 23.62 58.48 37.29 23.51 60.61 36.65 -34.27 -46.71 -27.76 -33.11 -45.80 -26.06 ULMN 2 1uox_c00 URATE OXIDASE user 12 2 # 12 28 THR B 47 THR^? 9.39 O1 EDO A 124 76 PRO B 51 PRO~? 11.19 C1 EDO A 124 coo 16.78 65.34 48.92 15.62 64.41 47.34 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 23.62 58.48 37.29 23.51 60.61 36.65 -40.15 -28.68 -26.59 -39.89 -28.23 -24.42 ULMN 2 1uox_c00 URATE OXIDASE user 13 2 # 13 28 THR B 47 THR^? 9.39 O1 EDO A 124 76 PRO B 52 PRO~? 14.52 C1 EDO A 124 coo 16.78 65.34 48.92 15.62 64.41 47.34 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 23.62 58.48 37.29 23.51 60.61 36.65 -42.56 -25.03 -21.82 -42.59 -27.16 -22.47 ULMN 2 1uox_c00 URATE OXIDASE user 14 2 # 14 28 THR B 47 THR^? 9.39 O1 EDO A 124 76 PRO B 90 PRO~? 16.38 O2 EDO A 125 coo 16.78 65.34 48.92 15.62 64.41 47.34 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 23.62 58.48 37.29 23.51 60.61 36.65 -40.98 -42.73 -15.66 -40.85 -41.32 -17.39 ULMN 2 1uox_c00 URATE OXIDASE user 15 2 # 15 28 THR B 82 THR.? 29.24 O1 EDO A 124 76 PRO B 52 PRO~? 14.52 C1 EDO A 124 coo 16.78 65.34 48.92 15.62 64.41 47.34 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 coo 23.62 58.48 37.29 23.51 60.61 36.65 -42.56 -25.03 -21.82 -42.59 -27.16 -22.47 ULMN 2 1uox_c00 URATE OXIDASE user 16 2 # 16 28 THR B 99 THR.? 28.08 C1 EDO A 124 76 PRO A 24 PRO.? 13.79 O2 EDO A 125 coo 16.78 65.34 48.92 15.62 64.41 47.34 -53.39 -38.76 -24.48 -55.06 -37.90 -23.47 coo 23.62 58.48 37.29 23.51 60.61 36.65 -37.37 -41.75 -27.30 -38.43 -41.33 -29.23 ULMN 2 1uox_c00 URATE OXIDASE user 17 2 # 17 28 THR B 99 THR.? 28.08 C1 EDO A 124 76 PRO B 51 PRO~? 11.19 C1 EDO A 124 coo 16.78 65.34 48.92 15.62 64.41 47.34 -53.39 -38.76 -24.48 -55.06 -37.90 -23.47 coo 23.62 58.48 37.29 23.51 60.61 36.65 -40.15 -28.68 -26.59 -39.89 -28.23 -24.42 ULMN 2 1uox_c00 URATE OXIDASE user 18 2 # 18 28 THR B 99 THR.? 28.08 C1 EDO A 124 76 PRO B 90 PRO~? 16.38 O2 EDO A 125 coo 16.78 65.34 48.92 15.62 64.41 47.34 -53.39 -38.76 -24.48 -55.06 -37.90 -23.47 coo 23.62 58.48 37.29 23.51 60.61 36.65 -40.98 -42.73 -15.66 -40.85 -41.32 -17.39 1uox_c00 source 1uox URATE OXIDASE : 18 hits 1uox_c00 naa= 2 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 1 2 # 1 A 86 ASP A 64 ASP~? 20.53 O2 EDO A 124 A 164 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 9.32 71.14 66.67 9.35 73.22 66.22 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 10.68 80.16 70.30 11.55 80.13 67.63 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 2 2 # 2 A 86 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 164 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo 9.32 71.14 66.67 9.35 73.22 66.22 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 10.68 80.16 70.30 11.55 80.13 67.63 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 1uro_c00 source 1uro UROPORPHYRINOGEN DECARBOXYLASE : 2 hits 1uro_c00 naa= 2 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 1 2 # 1 A 92 ARG A 25 ARG.? 17.39 O2 EDO A 124 A 162 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 22.28 19.87 14.60 19.43 20.27 13.40 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 20.49 15.91 11.17 19.72 15.53 13.15 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 2 2 # 2 A 92 ARG A 25 ARG.? 17.39 O2 EDO A 124 A 162 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 22.28 19.87 14.60 19.43 20.27 13.40 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo 20.49 15.91 11.17 19.72 15.53 13.15 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 3 2 # 3 A 92 ARG A 53 ARG~? 17.45 O1 EDO A 125 A 162 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 22.28 19.87 14.60 19.43 20.27 13.40 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 20.49 15.91 11.17 19.72 15.53 13.15 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 4 2 # 4 A 92 ARG A 106 ARG.? 12.91 O2 EDO A 125 A 162 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 22.28 19.87 14.60 19.43 20.27 13.40 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo 20.49 15.91 11.17 19.72 15.53 13.15 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 5 2 # 5 A 92 ARG B 25 ARG.? 18.77 O2 EDO A 125 A 162 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 22.28 19.87 14.60 19.43 20.27 13.40 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 20.49 15.91 11.17 19.72 15.53 13.15 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 6 2 # 6 A 92 ARG B 25 ARG.? 18.77 O2 EDO A 125 A 162 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 22.28 19.87 14.60 19.43 20.27 13.40 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 20.49 15.91 11.17 19.72 15.53 13.15 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 7 2 # 7 A 92 ARG B 53 ARG~? 17.71 C1 EDO A 124 A 162 GLU B 59 GLU.? 24.69 C1 EDO A 124 coo 22.28 19.87 14.60 19.43 20.27 13.40 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 20.49 15.91 11.17 19.72 15.53 13.15 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 1uw8_c02 source 1uw8 OXALATE DECARBOXYLASE OXDC : 7 hits 1uw8_c02 naa= 2 ULMN 2 1v25_c00 LONG-CHAIN-FATTY-ACID-COA SYNTHETASEuser 1 2 # 1 A 439 LYS A 100 LYS~? 11.56 C2 EDO A 125 A 444 TRP A 102 TRP~? 9.51 C2 EDO A 125 coo -0.26 64.22 156.87 2.65 58.72 157.59 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo 3.93 62.21 161.01 0.25 60.87 160.66 -18.50 -53.08 -18.95 -20.92 -50.18 -17.77 1v25_c00 source 1v25 LONG-CHAIN-FATTY-ACID-COA SYNTHETASE : 1 hits 1v25_c00 naa= 2 ULMN 2 1v25_c01 LONG-CHAIN-FATTY-ACID-COA SYNTHETASEuser 1 2 # 1 B 439 LYS A 100 LYS~? 11.56 C2 EDO A 125 B 444 TRP A 102 TRP~? 9.51 C2 EDO A 125 coo 23.39 6.36 151.97 20.82 11.81 153.70 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo 21.20 8.21 157.57 24.35 9.59 155.65 -18.50 -53.08 -18.95 -20.92 -50.18 -17.77 1v25_c01 source 1v25 LONG-CHAIN-FATTY-ACID-COA SYNTHETASE : 1 hits 1v25_c01 naa= 2 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 1 2 # 1 144 LYS A 28 LYS^? 7.39 O2 EDO A 124 199 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 2 2 # 2 144 LYS A 100 LYS~? 11.56 C2 EDO A 125 199 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 3 2 # 3 144 LYS A 100 LYS~? 11.56 C2 EDO A 125 199 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 4 2 # 4 144 LYS B 28 LYS^? -17.65 O1 EDO A 124s 199 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1vid_c00 source 1vid CATECHOL O-METHYLTRANSFERASE : 4 hits 1vid_c00 naa= 2 ULMN 2 1vnc_c00 VANADIUM-CONTAINING CHLOROPEROXIDASEuser 1 2 # 1 353 LYS A 28 LYS^? 7.39 O2 EDO A 124 404 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo -19.07 26.71 -0.11 -18.94 21.35 0.28 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo -22.51 13.48 0.87 -21.91 12.34 -0.78 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1vnc_c00 VANADIUM-CONTAINING CHLOROPEROXIDASEuser 2 2 # 2 353 LYS B 28 LYS^? -17.65 O1 EDO A 124s 404 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo -19.07 26.71 -0.11 -18.94 21.35 0.28 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo -22.51 13.48 0.87 -21.91 12.34 -0.78 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1vnc_c00 source 1vnc VANADIUM-CONTAINING CHLOROPEROXIDASE : 2 hits 1vnc_c00 naa= 2 ULMN 2 1vq1_c02 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 2 # 1 A 151 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 197 ASN A 44 ASN.? 12.85 O2 EDO A 124 coo 11.44 -10.39 31.15 9.67 -9.38 30.57 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 ULMN 2 1vq1_c02 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 2 # 2 A 151 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 197 ASN B 44 ASN.? 11.30 O2 EDO A 125 coo 11.44 -10.39 31.15 9.67 -9.38 30.57 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 1vq1_c02 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 2 hits 1vq1_c02 naa= 2 ULMN 2 1vq1_c03 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 2 # 1 B 151 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 197 ASN A 44 ASN.? 12.85 O2 EDO A 124 coo 22.17 -6.30 1.54 20.43 -7.30 0.84 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 ULMN 2 1vq1_c03 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 2 # 2 B 151 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 197 ASN B 44 ASN.? 11.30 O2 EDO A 125 coo 22.17 -6.30 1.54 20.43 -7.30 0.84 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 1vq1_c03 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 2 hits 1vq1_c03 naa= 2 ULMN 2 1w0h_c00 3-5 EXONUCLEASE ERI1 user 1 2 # 1 A 136 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 293 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 9.79 77.23 39.90 9.95 75.15 39.48 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 8.49 71.12 42.20 8.38 69.13 41.54 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1w0h_c00 3-5 EXONUCLEASE ERI1 user 2 2 # 2 A 136 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 293 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 9.79 77.23 39.90 9.95 75.15 39.48 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 8.49 71.12 42.20 8.38 69.13 41.54 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1w0h_c00 3-5 EXONUCLEASE ERI1 user 3 2 # 3 A 136 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 293 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 9.79 77.23 39.90 9.95 75.15 39.48 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 8.49 71.12 42.20 8.38 69.13 41.54 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 ULMN 2 1w0h_c00 3-5 EXONUCLEASE ERI1 user 4 2 # 4 A 136 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 293 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 9.79 77.23 39.90 9.95 75.15 39.48 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 8.49 71.12 42.20 8.38 69.13 41.54 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1w0h_c00 source 1w0h 3-5 EXONUCLEASE ERI1 : 4 hits 1w0h_c00 naa= 2 ULMN 2 1wnw_c00 HEME OXYGENASE user 1 2 # 1 A 136 ASN A 44 ASN.? 12.85 O2 EDO A 124 A 140 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1wnw_c00 HEME OXYGENASE user 2 2 # 2 A 136 ASN A 44 ASN.? 12.85 O2 EDO A 124 A 140 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1wnw_c00 HEME OXYGENASE user 3 2 # 3 A 136 ASN B 44 ASN.? 11.30 O2 EDO A 125 A 140 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1wnw_c00 HEME OXYGENASE user 4 2 # 4 A 136 ASN B 44 ASN.? 11.30 O2 EDO A 125 A 140 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 1wnw_c00 source 1wnw HEME OXYGENASE : 4 hits 1wnw_c00 naa= 2 ULMN 2 1wnw_c01 HEME OXYGENASE user 1 2 # 1 B 136 ASN A 44 ASN.? 12.85 O2 EDO A 124 B 140 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 10.41 13.55 22.30 12.49 13.88 22.44 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 coo 12.77 16.12 18.53 12.82 15.99 17.73 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1wnw_c01 HEME OXYGENASE user 2 2 # 2 B 136 ASN A 44 ASN.? 12.85 O2 EDO A 124 B 140 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 10.41 13.55 22.30 12.49 13.88 22.44 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 coo 12.77 16.12 18.53 12.82 15.99 17.73 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1wnw_c01 HEME OXYGENASE user 3 2 # 3 B 136 ASN B 44 ASN.? 11.30 O2 EDO A 125 B 140 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 10.41 13.55 22.30 12.49 13.88 22.44 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 coo 12.77 16.12 18.53 12.82 15.99 17.73 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1wnw_c01 HEME OXYGENASE user 4 2 # 4 B 136 ASN B 44 ASN.? 11.30 O2 EDO A 125 B 140 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 10.41 13.55 22.30 12.49 13.88 22.44 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 coo 12.77 16.12 18.53 12.82 15.99 17.73 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 1wnw_c01 source 1wnw HEME OXYGENASE : 4 hits 1wnw_c01 naa= 2 ULMN 2 1wnw_c02 HEME OXYGENASE user 1 2 # 1 C 136 ASN A 44 ASN.? 12.85 O2 EDO A 124 C 140 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 26.63 1.54 53.35 24.49 1.91 53.34 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 coo 23.86 0.66 57.49 23.81 0.02 58.00 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1wnw_c02 HEME OXYGENASE user 2 2 # 2 C 136 ASN A 44 ASN.? 12.85 O2 EDO A 124 C 140 GLY B 95 GLY~? 17.55 C1 EDO A 124 coo 26.63 1.54 53.35 24.49 1.91 53.34 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 coo 23.86 0.66 57.49 23.81 0.02 58.00 -42.20 -39.63 -26.00 -42.65 -39.90 -25.37 ULMN 2 1wnw_c02 HEME OXYGENASE user 3 2 # 3 C 136 ASN B 44 ASN.? 11.30 O2 EDO A 125 C 140 GLY A 95 GLY.? 7.33 O2 EDO A 125 coo 26.63 1.54 53.35 24.49 1.91 53.34 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 coo 23.86 0.66 57.49 23.81 0.02 58.00 -30.71 -45.77 -17.39 -30.76 -46.33 -18.00 ULMN 2 1wnw_c02 HEME OXYGENASE user 4 2 # 4 C 136 ASN B 44 ASN.? 11.30 O2 EDO A 125 C 140 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 26.63 1.54 53.35 24.49 1.91 53.34 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 coo 23.86 0.66 57.49 23.81 0.02 58.00 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 1wnw_c02 source 1wnw HEME OXYGENASE : 4 hits 1wnw_c02 naa= 2 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 1 2 # 1 A 56 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 228 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 27.49 35.40 20.60 28.62 36.02 22.28 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 33.88 38.22 25.20 34.46 38.14 23.17 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 2 2 # 2 A 56 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 228 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 27.49 35.40 20.60 28.62 36.02 22.28 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 33.88 38.22 25.20 34.46 38.14 23.17 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 3 2 # 3 A 56 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 228 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 27.49 35.40 20.60 28.62 36.02 22.28 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 33.88 38.22 25.20 34.46 38.14 23.17 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 4 2 # 4 A 56 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 228 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 27.49 35.40 20.60 28.62 36.02 22.28 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 33.88 38.22 25.20 34.46 38.14 23.17 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1x7d_c00 source 1x7d ORNITHINE CYCLODEAMINASE : 4 hits 1x7d_c00 naa= 2 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 1 2 # 1 B 56 GLU A 43 GLU.? 14.35 O2 EDO A 124 B 228 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 8.97 35.22 21.27 7.95 33.38 21.10 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 2.71 29.91 19.58 2.03 31.89 19.36 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 2 2 # 2 B 56 GLU A 81 GLU.? 16.59 O1 EDO A 125 B 228 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 8.97 35.22 21.27 7.95 33.38 21.10 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 2.71 29.91 19.58 2.03 31.89 19.36 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 3 2 # 3 B 56 GLU B 43 GLU.? 19.28 O2 EDO A 125 B 228 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 8.97 35.22 21.27 7.95 33.38 21.10 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 2.71 29.91 19.58 2.03 31.89 19.36 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 4 2 # 4 B 56 GLU B 81 GLU.? 30.69 O1 EDO A 124 B 228 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 8.97 35.22 21.27 7.95 33.38 21.10 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 2.71 29.91 19.58 2.03 31.89 19.36 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 1x7d_c01 source 1x7d ORNITHINE CYCLODEAMINASE : 4 hits 1x7d_c01 naa= 2 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 1 2 # 1 A 165 SER A 88 SER^? -5.03 C1 EDO A 125s A 187 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 8.34 44.73 23.71 9.07 45.54 21.52 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 coo 6.50 51.89 29.29 8.22 51.77 30.59 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 2 2 # 2 A 165 SER B 88 SER^? 19.82 O2 EDO A 125 A 187 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 8.34 44.73 23.71 9.07 45.54 21.52 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 coo 6.50 51.89 29.29 8.22 51.77 30.59 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1xgm_c00 source 1xgm METHIONINE AMINOPEPTIDASE : 2 hits 1xgm_c00 naa= 2 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 1 2 # 1 B 165 SER A 88 SER^? -5.03 C1 EDO A 125s B 187 GLU A 23 GLU.? 13.04 O2 EDO A 125 coo 12.53 42.28 15.16 11.35 44.10 16.30 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 coo 12.85 44.05 6.07 11.44 42.52 5.44 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 2 2 # 2 B 165 SER B 88 SER^? 19.82 O2 EDO A 125 B 187 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 12.53 42.28 15.16 11.35 44.10 16.30 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 coo 12.85 44.05 6.07 11.44 42.52 5.44 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 1xgm_c01 source 1xgm METHIONINE AMINOPEPTIDASE : 2 hits 1xgm_c01 naa= 2 ULMN 2 1xqd_c00 CYTOCHROME P450 55A1 user 1 2 # 1 A 242 ALA A 49 ALA^? 7.86 C1 EDO A 124 A 243 THR B 47 THR^? 9.39 O1 EDO A 124 coo 7.23 22.00 24.48 6.68 23.42 24.57 -27.58 -35.61 -22.27 -27.19 -34.24 -21.71 coo 9.58 21.79 21.50 11.25 23.03 20.90 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 ULMN 2 1xqd_c00 CYTOCHROME P450 55A1 user 2 2 # 2 A 242 ALA A 101 ALA~? 12.03 C2 EDO A 125 A 243 THR A 99 THR~? 7.67 C2 EDO A 125 coo 7.23 22.00 24.48 6.68 23.42 24.57 -22.27 -58.84 -16.86 -21.90 -59.72 -18.04 coo 9.58 21.79 21.50 11.25 23.03 20.90 -24.60 -55.51 -20.10 -23.07 -56.46 -21.32 ULMN 2 1xqd_c00 CYTOCHROME P450 55A1 user 3 2 # 3 A 242 ALA B 49 ALA^? 7.26 C1 EDO A 124 A 243 THR A 47 THR^? 4.31 C1 EDO A 124 coo 7.23 22.00 24.48 6.68 23.42 24.57 -35.14 -31.27 -21.36 -34.12 -30.27 -21.87 coo 9.58 21.79 21.50 11.25 23.03 20.90 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 ULMN 2 1xqd_c00 CYTOCHROME P450 55A1 user 4 2 # 4 A 242 ALA B 101 ALA.? 30.45 C1 EDO A 124 A 243 THR B 99 THR.? 28.08 C1 EDO A 124 coo 7.23 22.00 24.48 6.68 23.42 24.57 -56.51 -37.88 -28.60 -57.76 -37.79 -27.70 coo 9.58 21.79 21.50 11.25 23.03 20.90 -53.39 -38.76 -24.48 -55.06 -37.90 -23.47 1xqd_c00 source 1xqd CYTOCHROME P450 55A1 : 4 hits 1xqd_c00 naa= 2 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 1 2 # 1 A 286 SER A 34 SER.? 10.92 O1 EDO A 124 A 393 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 13.16 26.08 17.48 14.86 26.70 19.08 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo 8.26 27.79 16.87 9.99 28.97 17.08 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 2 2 # 2 A 286 SER A 35 SER.? 8.67 O1 EDO A 124 A 393 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 13.16 26.08 17.48 14.86 26.70 19.08 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo 8.26 27.79 16.87 9.99 28.97 17.08 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 3 2 # 3 A 286 SER A 62 SER~? 19.90 O1 EDO A 125 A 393 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 13.16 26.08 17.48 14.86 26.70 19.08 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo 8.26 27.79 16.87 9.99 28.97 17.08 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 4 2 # 4 A 286 SER A 62 SER~? 19.90 O1 EDO A 125 A 393 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 13.16 26.08 17.48 14.86 26.70 19.08 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo 8.26 27.79 16.87 9.99 28.97 17.08 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 5 2 # 5 A 286 SER A 88 SER^? -5.03 C1 EDO A 125s A 393 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 13.16 26.08 17.48 14.86 26.70 19.08 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 coo 8.26 27.79 16.87 9.99 28.97 17.08 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 6 2 # 6 A 286 SER B 34 SER.? 9.94 O1 EDO A 124 A 393 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 13.16 26.08 17.48 14.86 26.70 19.08 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 coo 8.26 27.79 16.87 9.99 28.97 17.08 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 7 2 # 7 A 286 SER B 35 SER.? 7.36 O1 EDO A 124 A 393 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 13.16 26.08 17.48 14.86 26.70 19.08 -33.90 -21.70 -23.70 -33.48 -23.60 -22.25 coo 8.26 27.79 16.87 9.99 28.97 17.08 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 8 2 # 8 A 286 SER B 62 SER~? 23.65 O1 EDO A 124 A 393 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 13.16 26.08 17.48 14.86 26.70 19.08 -46.80 -18.27 -18.25 -47.35 -17.46 -16.02 coo 8.26 27.79 16.87 9.99 28.97 17.08 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 9 2 # 9 A 286 SER B 62 SER~? 23.65 O1 EDO A 124 A 393 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 13.16 26.08 17.48 14.86 26.70 19.08 -46.80 -18.27 -18.25 -47.35 -17.46 -16.02 coo 8.26 27.79 16.87 9.99 28.97 17.08 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 10 2 # 10 A 286 SER B 88 SER^? 19.82 O2 EDO A 125 A 393 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 13.16 26.08 17.48 14.86 26.70 19.08 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 coo 8.26 27.79 16.87 9.99 28.97 17.08 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 1xqd_c01 source 1xqd CYTOCHROME P450 55A1 : 10 hits 1xqd_c01 naa= 2 ULMN 2 1xrs_c01 D-LYSINE 5,6-AMINOMUTASE BETA SUBUNIuser 1 2 # 1 B 131 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 133 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 81.14 48.06 68.84 80.66 49.22 70.52 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 78.80 48.83 73.93 80.34 49.02 75.34 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1xrs_c01 D-LYSINE 5,6-AMINOMUTASE BETA SUBUNIuser 2 2 # 2 B 131 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 133 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 81.14 48.06 68.84 80.66 49.22 70.52 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 78.80 48.83 73.93 80.34 49.02 75.34 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1xrs_c01 source 1xrs D-LYSINE 5,6-AMINOMUTASE BETA SUBUNIT : 2 hits 1xrs_c01 naa= 2 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 A 128 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 130 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 A 128 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 130 GLY A 77 GLY^? 7.89 O1 EDO A 125 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -28.29 -45.93 -31.97 -28.42 -45.22 -32.28 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 A 128 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 130 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 A 128 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 130 GLY B 77 GLY^? 22.66 C1 EDO A 124 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -43.26 -37.30 -11.50 -42.54 -37.05 -11.23 1xs1_c00 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c00 naa= 2 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 B 128 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 130 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 8.08 5.58 9.89 6.73 6.58 11.12 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 12.76 4.19 5.97 12.32 3.80 6.57 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 B 128 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 130 GLY A 77 GLY^? 7.89 O1 EDO A 125 coo 8.08 5.58 9.89 6.73 6.58 11.12 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 12.76 4.19 5.97 12.32 3.80 6.57 -28.29 -45.93 -31.97 -28.42 -45.22 -32.28 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 B 128 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 130 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 8.08 5.58 9.89 6.73 6.58 11.12 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 12.76 4.19 5.97 12.32 3.80 6.57 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 B 128 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 130 GLY B 77 GLY^? 22.66 C1 EDO A 124 coo 8.08 5.58 9.89 6.73 6.58 11.12 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 12.76 4.19 5.97 12.32 3.80 6.57 -43.26 -37.30 -11.50 -42.54 -37.05 -11.23 1xs1_c01 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c01 naa= 2 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 C 128 ASP A 41 ASP^? -2.91 O2 EDO A 124s C 130 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 C 128 ASP A 86 ASP^? 9.05 O1 EDO A 125 C 130 GLY A 77 GLY^? 7.89 O1 EDO A 125 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -28.29 -45.93 -31.97 -28.42 -45.22 -32.28 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 C 128 ASP B 41 ASP^? 12.31 O1 EDO A 124 C 130 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 C 128 ASP B 86 ASP^? 26.97 C1 EDO A 124 C 130 GLY B 77 GLY^? 22.66 C1 EDO A 124 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -43.26 -37.30 -11.50 -42.54 -37.05 -11.23 1xs1_c02 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c02 naa= 2 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 D 128 ASP A 41 ASP^? -2.91 O2 EDO A 124s D 130 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 D 128 ASP A 86 ASP^? 9.05 O1 EDO A 125 D 130 GLY A 77 GLY^? 7.89 O1 EDO A 125 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -28.29 -45.93 -31.97 -28.42 -45.22 -32.28 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 D 128 ASP B 41 ASP^? 12.31 O1 EDO A 124 D 130 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 D 128 ASP B 86 ASP^? 26.97 C1 EDO A 124 D 130 GLY B 77 GLY^? 22.66 C1 EDO A 124 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -43.26 -37.30 -11.50 -42.54 -37.05 -11.23 1xs1_c03 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c03 naa= 2 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 E 128 ASP A 41 ASP^? -2.91 O2 EDO A 124s E 130 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 E 128 ASP A 86 ASP^? 9.05 O1 EDO A 125 E 130 GLY A 77 GLY^? 7.89 O1 EDO A 125 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -28.29 -45.93 -31.97 -28.42 -45.22 -32.28 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 E 128 ASP B 41 ASP^? 12.31 O1 EDO A 124 E 130 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 E 128 ASP B 86 ASP^? 26.97 C1 EDO A 124 E 130 GLY B 77 GLY^? 22.66 C1 EDO A 124 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -43.26 -37.30 -11.50 -42.54 -37.05 -11.23 1xs1_c04 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c04 naa= 2 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 F 128 ASP A 41 ASP^? -2.91 O2 EDO A 124s F 130 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 F 128 ASP A 86 ASP^? 9.05 O1 EDO A 125 F 130 GLY A 77 GLY^? 7.89 O1 EDO A 125 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -28.29 -45.93 -31.97 -28.42 -45.22 -32.28 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 F 128 ASP B 41 ASP^? 12.31 O1 EDO A 124 F 130 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 F 128 ASP B 86 ASP^? 26.97 C1 EDO A 124 F 130 GLY B 77 GLY^? 22.66 C1 EDO A 124 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -43.26 -37.30 -11.50 -42.54 -37.05 -11.23 1xs1_c05 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c05 naa= 2 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 A 111 SER A 34 SER.? 10.92 O1 EDO A 124 A 115 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 6.26 6.70 20.48 8.06 5.10 20.15 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo 10.04 5.32 23.68 11.46 4.45 21.05 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 A 111 SER A 35 SER.? 8.67 O1 EDO A 124 A 115 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 6.26 6.70 20.48 8.06 5.10 20.15 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo 10.04 5.32 23.68 11.46 4.45 21.05 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 A 111 SER A 62 SER~? 19.90 O1 EDO A 125 A 115 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 6.26 6.70 20.48 8.06 5.10 20.15 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo 10.04 5.32 23.68 11.46 4.45 21.05 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 A 111 SER B 34 SER.? 9.94 O1 EDO A 124 A 115 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 6.26 6.70 20.48 8.06 5.10 20.15 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 coo 10.04 5.32 23.68 11.46 4.45 21.05 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 A 111 SER B 35 SER.? 7.36 O1 EDO A 124 A 115 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 6.26 6.70 20.48 8.06 5.10 20.15 -33.90 -21.70 -23.70 -33.48 -23.60 -22.25 coo 10.04 5.32 23.68 11.46 4.45 21.05 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 1xs1_c13 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 5 hits 1xs1_c13 naa= 2 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 B 111 SER A 34 SER.? 10.92 O1 EDO A 124 B 115 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 B 111 SER A 35 SER.? 8.67 O1 EDO A 124 B 115 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 B 111 SER A 62 SER~? 19.90 O1 EDO A 125 B 115 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 B 111 SER B 34 SER.? 9.94 O1 EDO A 124 B 115 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 B 111 SER B 35 SER.? 7.36 O1 EDO A 124 B 115 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 -33.90 -21.70 -23.70 -33.48 -23.60 -22.25 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 1xs1_c14 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 5 hits 1xs1_c14 naa= 2 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 D 111 SER A 34 SER.? 10.92 O1 EDO A 124 D 115 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo -4.43 14.92 60.69 -6.72 15.54 61.22 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo -7.63 17.31 57.53 -9.07 18.28 60.09 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 D 111 SER A 35 SER.? 8.67 O1 EDO A 124 D 115 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo -4.43 14.92 60.69 -6.72 15.54 61.22 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo -7.63 17.31 57.53 -9.07 18.28 60.09 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 D 111 SER A 62 SER~? 19.90 O1 EDO A 125 D 115 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -4.43 14.92 60.69 -6.72 15.54 61.22 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo -7.63 17.31 57.53 -9.07 18.28 60.09 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 D 111 SER B 34 SER.? 9.94 O1 EDO A 124 D 115 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo -4.43 14.92 60.69 -6.72 15.54 61.22 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 coo -7.63 17.31 57.53 -9.07 18.28 60.09 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 D 111 SER B 35 SER.? 7.36 O1 EDO A 124 D 115 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo -4.43 14.92 60.69 -6.72 15.54 61.22 -33.90 -21.70 -23.70 -33.48 -23.60 -22.25 coo -7.63 17.31 57.53 -9.07 18.28 60.09 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 1xs1_c15 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 5 hits 1xs1_c15 naa= 2 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 E 111 SER A 34 SER.? 10.92 O1 EDO A 124 E 115 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 E 111 SER A 35 SER.? 8.67 O1 EDO A 124 E 115 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 E 111 SER A 62 SER~? 19.90 O1 EDO A 125 E 115 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 E 111 SER B 34 SER.? 9.94 O1 EDO A 124 E 115 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 E 111 SER B 35 SER.? 7.36 O1 EDO A 124 E 115 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 -33.90 -21.70 -23.70 -33.48 -23.60 -22.25 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 1xs1_c16 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 5 hits 1xs1_c16 naa= 2 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 F 111 SER A 34 SER.? 10.92 O1 EDO A 124 F 115 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 F 111 SER A 35 SER.? 8.67 O1 EDO A 124 F 115 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 F 111 SER A 62 SER~? 19.90 O1 EDO A 125 F 115 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 F 111 SER B 34 SER.? 9.94 O1 EDO A 124 F 115 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 F 111 SER B 35 SER.? 7.36 O1 EDO A 124 F 115 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 -33.90 -21.70 -23.70 -33.48 -23.60 -22.25 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 1xs1_c17 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 5 hits 1xs1_c17 naa= 2 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 1 2 # 1 A 175 ARG A 30 ARG^? -2.97 O2 EDO A 124s A 242 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 56.19 79.96 8.87 56.06 80.16 11.92 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 63.28 81.69 5.71 63.99 80.11 7.80 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 2 2 # 2 A 175 ARG A 33 ARG.? 17.39 O2 EDO A 124 A 242 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 56.19 79.96 8.87 56.06 80.16 11.92 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 63.28 81.69 5.71 63.99 80.11 7.80 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 3 2 # 3 A 175 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 242 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 56.19 79.96 8.87 56.06 80.16 11.92 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 63.28 81.69 5.71 63.99 80.11 7.80 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 4 2 # 4 A 175 ARG A 53 ARG~? 17.45 O1 EDO A 125 A 242 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 56.19 79.96 8.87 56.06 80.16 11.92 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 63.28 81.69 5.71 63.99 80.11 7.80 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 5 2 # 5 A 175 ARG B 30 ARG^? 10.56 O1 EDO A 124 A 242 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo 56.19 79.96 8.87 56.06 80.16 11.92 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 63.28 81.69 5.71 63.99 80.11 7.80 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 6 2 # 6 A 175 ARG B 33 ARG.? 19.94 O1 EDO A 124 A 242 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo 56.19 79.96 8.87 56.06 80.16 11.92 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 63.28 81.69 5.71 63.99 80.11 7.80 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 7 2 # 7 A 175 ARG B 37 ARG^? 8.36 C1 EDO A 124 A 242 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo 56.19 79.96 8.87 56.06 80.16 11.92 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 63.28 81.69 5.71 63.99 80.11 7.80 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 1xva_c02 source 1xva GLYCINE N-METHYLTRANSFERASE : 7 hits 1xva_c02 naa= 2 ULMN 2 1y9m_c00 EXO-INULINASE user 1 2 # 1 A 41 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 241 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 24.90 6.62 22.11 24.45 8.58 22.70 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 19.12 12.64 24.04 21.16 13.15 23.94 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 1y9m_c00 EXO-INULINASE user 2 2 # 2 A 41 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 241 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 24.90 6.62 22.11 24.45 8.58 22.70 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 19.12 12.64 24.04 21.16 13.15 23.94 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 1y9m_c00 EXO-INULINASE user 3 2 # 3 A 41 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 241 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 24.90 6.62 22.11 24.45 8.58 22.70 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 19.12 12.64 24.04 21.16 13.15 23.94 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 1y9m_c00 EXO-INULINASE user 4 2 # 4 A 41 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 241 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 24.90 6.62 22.11 24.45 8.58 22.70 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 19.12 12.64 24.04 21.16 13.15 23.94 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 1y9m_c00 source 1y9m EXO-INULINASE : 4 hits 1y9m_c00 naa= 2 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 1 2 # 1 A 39 ASP A 64 ASP~? 20.53 O2 EDO A 124 A 67 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 2 2 # 2 A 39 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 67 TYR A 76 TYR.? 12.73 O1 EDO A 125 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 3 2 # 3 A 39 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 67 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 4 2 # 4 A 39 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 67 TYR B 76 TYR.? 17.92 O2 EDO A 125 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 1ze1_c00 source 1ze1 TRNA PSEUDOURIDINE SYNTHASE B : 4 hits 1ze1_c00 naa= 2 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 1 2 # 1 B 39 ASP A 64 ASP~? 20.53 O2 EDO A 124 B 67 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo -2.18 16.79 38.50 -4.08 16.27 37.73 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo -3.28 26.12 34.97 -5.09 24.87 36.72 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 2 2 # 2 B 39 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 67 TYR A 76 TYR.? 12.73 O1 EDO A 125 coo -2.18 16.79 38.50 -4.08 16.27 37.73 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -3.28 26.12 34.97 -5.09 24.87 36.72 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 3 2 # 3 B 39 ASP B 64 ASP~? 23.62 O1 EDO A 124 B 67 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo -2.18 16.79 38.50 -4.08 16.27 37.73 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo -3.28 26.12 34.97 -5.09 24.87 36.72 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 4 2 # 4 B 39 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 67 TYR B 76 TYR.? 17.92 O2 EDO A 125 coo -2.18 16.79 38.50 -4.08 16.27 37.73 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo -3.28 26.12 34.97 -5.09 24.87 36.72 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 1ze1_c01 source 1ze1 TRNA PSEUDOURIDINE SYNTHASE B : 4 hits 1ze1_c01 naa= 2 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 1 2 # 1 C 39 ASP A 64 ASP~? 20.53 O2 EDO A 124 C 67 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 2 2 # 2 C 39 ASP A 86 ASP^? 9.05 O1 EDO A 125 C 67 TYR A 76 TYR.? 12.73 O1 EDO A 125 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 3 2 # 3 C 39 ASP B 64 ASP~? 23.62 O1 EDO A 124 C 67 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 4 2 # 4 C 39 ASP B 86 ASP^? 26.97 C1 EDO A 124 C 67 TYR B 76 TYR.? 17.92 O2 EDO A 125 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 1ze1_c02 source 1ze1 TRNA PSEUDOURIDINE SYNTHASE B : 4 hits 1ze1_c02 naa= 2 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 1 2 # 1 D 39 ASP A 64 ASP~? 20.53 O2 EDO A 124 D 67 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 2 2 # 2 D 39 ASP A 86 ASP^? 9.05 O1 EDO A 125 D 67 TYR A 76 TYR.? 12.73 O1 EDO A 125 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 3 2 # 3 D 39 ASP B 64 ASP~? 23.62 O1 EDO A 124 D 67 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 4 2 # 4 D 39 ASP B 86 ASP^? 26.97 C1 EDO A 124 D 67 TYR B 76 TYR.? 17.92 O2 EDO A 125 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 1ze1_c03 source 1ze1 TRNA PSEUDOURIDINE SYNTHASE B : 4 hits 1ze1_c03 naa= 2 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 1 2 # 1 A 369 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 373 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo -5.17 31.09 15.73 -7.07 31.12 16.73 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 2 2 # 2 A 369 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 373 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 3 2 # 3 A 369 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 373 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 4 2 # 4 A 369 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 373 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 5 2 # 5 A 369 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 373 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 6 2 # 6 A 369 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 373 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 7 2 # 7 A 369 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 373 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 8 2 # 8 A 369 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 373 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 1zrz_c00 source 1zrz PROTEIN KINASE C, IOTA : 8 hits 1zrz_c00 naa= 2 ULMN 2 1zym_c00 ENZYME I user 1 2 # 1 A 168 THR A 82 THR.? 18.68 O1 EDO A 125 A 189 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 8.31 -2.39 92.48 6.24 -2.43 93.12 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 coo 1.62 -2.18 93.54 3.32 -3.39 93.35 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1zym_c00 ENZYME I user 2 2 # 2 A 168 THR B 82 THR.? 29.24 O1 EDO A 124 A 189 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 8.31 -2.39 92.48 6.24 -2.43 93.12 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 coo 1.62 -2.18 93.54 3.32 -3.39 93.35 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1zym_c00 source 1zym ENZYME I : 2 hits 1zym_c00 naa= 2 ULMN 2 1zym_c01 ENZYME I user 1 2 # 1 B 168 THR A 82 THR.? 18.68 O1 EDO A 125 B 189 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo -8.63 -3.73 134.97 -6.62 -3.52 134.27 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 coo -1.97 -3.14 134.00 -3.52 -4.53 134.20 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 1zym_c01 ENZYME I user 2 2 # 2 B 168 THR B 82 THR.? 29.24 O1 EDO A 124 B 189 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo -8.63 -3.73 134.97 -6.62 -3.52 134.27 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 coo -1.97 -3.14 134.00 -3.52 -4.53 134.20 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 1zym_c01 source 1zym ENZYME I : 2 hits 1zym_c01 naa= 2 ULMN 2 206l_c00 LYSOZYME user 1 2 # 1 A 11 GLU A 43 GLU.? 14.35 O2 EDO A 124 A 20 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 40.46 12.70 11.55 39.54 14.42 10.81 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 39.78 21.54 11.61 37.90 22.43 11.16 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 206l_c00 LYSOZYME user 2 2 # 2 A 11 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 20 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 40.46 12.70 11.55 39.54 14.42 10.81 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 39.78 21.54 11.61 37.90 22.43 11.16 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 206l_c00 LYSOZYME user 3 2 # 3 A 11 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 20 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 40.46 12.70 11.55 39.54 14.42 10.81 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 39.78 21.54 11.61 37.90 22.43 11.16 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 206l_c00 LYSOZYME user 4 2 # 4 A 11 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 20 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 40.46 12.70 11.55 39.54 14.42 10.81 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 39.78 21.54 11.61 37.90 22.43 11.16 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 206l_c00 LYSOZYME user 5 2 # 5 A 11 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 20 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 40.46 12.70 11.55 39.54 14.42 10.81 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 39.78 21.54 11.61 37.90 22.43 11.16 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 206l_c00 LYSOZYME user 6 2 # 6 A 11 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 20 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 40.46 12.70 11.55 39.54 14.42 10.81 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 39.78 21.54 11.61 37.90 22.43 11.16 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 206l_c00 source 206l LYSOZYME : 6 hits 206l_c00 naa= 2 ULMN 2 2a0n_c00 4.01.03.0000 user 1 2 # 1 A 11 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 130 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 25.89 89.29 37.40 24.53 87.99 36.37 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 22.18 80.79 26.12 23.22 81.35 27.91 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 2a0n_c00 4.01.03.0000 user 2 2 # 2 A 11 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 130 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 25.89 89.29 37.40 24.53 87.99 36.37 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 22.18 80.79 26.12 23.22 81.35 27.91 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 2a0n_c00 4.01.03.0000 user 3 2 # 3 A 11 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 130 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 25.89 89.29 37.40 24.53 87.99 36.37 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 22.18 80.79 26.12 23.22 81.35 27.91 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 2a0n_c00 4.01.03.0000 user 4 2 # 4 A 11 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 130 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 25.89 89.29 37.40 24.53 87.99 36.37 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 22.18 80.79 26.12 23.22 81.35 27.91 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 2a0n_c00 4.01.03.0000 user 5 2 # 5 A 11 ASP A 64 ASP~? 20.53 O2 EDO A 124 A 130 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 25.89 89.29 37.40 24.53 87.99 36.37 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 22.18 80.79 26.12 23.22 81.35 27.91 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 2a0n_c00 4.01.03.0000 user 6 2 # 6 A 11 ASP A 64 ASP~? 20.53 O2 EDO A 124 A 130 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 25.89 89.29 37.40 24.53 87.99 36.37 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 22.18 80.79 26.12 23.22 81.35 27.91 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 2a0n_c00 4.01.03.0000 user 7 2 # 7 A 11 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 130 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 25.89 89.29 37.40 24.53 87.99 36.37 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 22.18 80.79 26.12 23.22 81.35 27.91 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 2a0n_c00 4.01.03.0000 user 8 2 # 8 A 11 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 130 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 25.89 89.29 37.40 24.53 87.99 36.37 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 22.18 80.79 26.12 23.22 81.35 27.91 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 2a0n_c00 4.01.03.0000 user 9 2 # 9 A 11 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 130 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 25.89 89.29 37.40 24.53 87.99 36.37 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 22.18 80.79 26.12 23.22 81.35 27.91 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 2a0n_c00 4.01.03.0000 user 10 2 # 10 A 11 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 130 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 25.89 89.29 37.40 24.53 87.99 36.37 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 22.18 80.79 26.12 23.22 81.35 27.91 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 2a0n_c00 4.01.03.0000 user 11 2 # 11 A 11 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 130 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 25.89 89.29 37.40 24.53 87.99 36.37 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 22.18 80.79 26.12 23.22 81.35 27.91 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 2a0n_c00 4.01.03.0000 user 12 2 # 12 A 11 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 130 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 25.89 89.29 37.40 24.53 87.99 36.37 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 22.18 80.79 26.12 23.22 81.35 27.91 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 2a0n_c00 4.01.03.0000 user 13 2 # 13 A 11 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 130 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 25.89 89.29 37.40 24.53 87.99 36.37 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 22.18 80.79 26.12 23.22 81.35 27.91 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 2a0n_c00 4.01.03.0000 user 14 2 # 14 A 11 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 130 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 25.89 89.29 37.40 24.53 87.99 36.37 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 22.18 80.79 26.12 23.22 81.35 27.91 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 2a0n_c00 source 2a0n 4.01.03.0000 : 14 hits 2a0n_c00 naa= 2 ULMN 2 2aat_c00 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 1 2 # 1 142 TRP A 80 TRP^? 10.72 O1 EDO A 125 223 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 128.40 33.01 26.67 128.12 36.28 28.81 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 127.91 41.73 23.55 129.18 40.35 24.44 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 2aat_c00 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 2 2 # 2 142 TRP A 80 TRP^? 10.72 O1 EDO A 125 223 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 128.40 33.01 26.67 128.12 36.28 28.81 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 127.91 41.73 23.55 129.18 40.35 24.44 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 2aat_c00 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 3 2 # 3 142 TRP A 80 TRP^? 10.72 O1 EDO A 125 223 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 128.40 33.01 26.67 128.12 36.28 28.81 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 127.91 41.73 23.55 129.18 40.35 24.44 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 2aat_c00 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 4 2 # 4 142 TRP A 80 TRP^? 10.72 O1 EDO A 125 223 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 128.40 33.01 26.67 128.12 36.28 28.81 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 127.91 41.73 23.55 129.18 40.35 24.44 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 2aat_c00 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 5 2 # 5 142 TRP B 80 TRP^? 20.31 C1 EDO A 124 223 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 128.40 33.01 26.67 128.12 36.28 28.81 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 127.91 41.73 23.55 129.18 40.35 24.44 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 2aat_c00 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 6 2 # 6 142 TRP B 80 TRP^? 20.31 C1 EDO A 124 223 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 128.40 33.01 26.67 128.12 36.28 28.81 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 127.91 41.73 23.55 129.18 40.35 24.44 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 2aat_c00 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 7 2 # 7 142 TRP B 80 TRP^? 20.31 C1 EDO A 124 223 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 128.40 33.01 26.67 128.12 36.28 28.81 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 127.91 41.73 23.55 129.18 40.35 24.44 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 2aat_c00 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 8 2 # 8 142 TRP B 80 TRP^? 20.31 C1 EDO A 124 223 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 128.40 33.01 26.67 128.12 36.28 28.81 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 127.91 41.73 23.55 129.18 40.35 24.44 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 2aat_c00 source 2aat ASPARTATE AMINOTRANSFERASE (E.C.2.6.1.1) MUTAN: 8 hits 2aat_c00 naa= 2 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 2 # 1 193 ASP A 41 ASP^? -2.91 O2 EDO A 124s 218 GLY A 45 GLY.? 10.05 O2 EDO A 124 coo 27.89 102.52 14.98 29.35 101.92 13.57 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 21.10 106.02 13.04 21.16 106.76 12.59 -38.01 -31.54 -29.98 -37.78 -32.20 -29.62 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 2 # 2 193 ASP A 84 ASP.? 13.20 O1 EDO A 125 218 GLY A 57 GLY.? 9.42 O1 EDO A 125 coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 21.10 106.02 13.04 21.16 106.76 12.59 -16.91 -49.31 -24.24 -17.01 -48.68 -23.74 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 2 # 3 193 ASP A 86 ASP^? 9.05 O1 EDO A 125 218 GLY A 57 GLY.? 9.42 O1 EDO A 125 coo 27.89 102.52 14.98 29.35 101.92 13.57 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 21.10 106.02 13.04 21.16 106.76 12.59 -16.91 -49.31 -24.24 -17.01 -48.68 -23.74 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 2 # 4 193 ASP A 86 ASP^? 9.05 O1 EDO A 125 218 GLY A 73 GLY.? 12.76 O1 EDO A 125 coo 27.89 102.52 14.98 29.35 101.92 13.57 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 21.10 106.02 13.04 21.16 106.76 12.59 -30.36 -47.03 -37.01 -30.17 -46.21 -37.42 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 2 # 5 193 ASP A 86 ASP^? 9.05 O1 EDO A 125 218 GLY A 77 GLY^? 7.89 O1 EDO A 125 coo 27.89 102.52 14.98 29.35 101.92 13.57 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 21.10 106.02 13.04 21.16 106.76 12.59 -28.29 -45.93 -31.97 -28.42 -45.22 -32.28 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 2 # 6 193 ASP B 41 ASP^? 12.31 O1 EDO A 124 218 GLY B 45 GLY.? 14.70 O2 EDO A 125 coo 27.89 102.52 14.98 29.35 101.92 13.57 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 21.10 106.02 13.04 21.16 106.76 12.59 -25.91 -37.87 -14.15 -26.60 -38.11 -14.45 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 2 # 7 193 ASP B 84 ASP.? 30.86 C1 EDO A 124 218 GLY B 57 GLY.? 23.79 C1 EDO A 124 coo 27.89 102.52 14.98 29.35 101.92 13.57 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 21.10 106.02 13.04 21.16 106.76 12.59 -51.53 -29.44 -19.30 -51.09 -29.07 -19.90 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 2 # 8 193 ASP B 86 ASP^? 26.97 C1 EDO A 124 218 GLY B 57 GLY.? 23.79 C1 EDO A 124 coo 27.89 102.52 14.98 29.35 101.92 13.57 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 21.10 106.02 13.04 21.16 106.76 12.59 -51.53 -29.44 -19.30 -51.09 -29.07 -19.90 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 2 # 9 193 ASP B 86 ASP^? 26.97 C1 EDO A 124 218 GLY B 73 GLY.? 24.47 O2 EDO A 125 coo 27.89 102.52 14.98 29.35 101.92 13.57 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 21.10 106.02 13.04 21.16 106.76 12.59 -43.26 -39.74 -6.71 -42.70 -39.15 -6.19 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 2 # 10 193 ASP B 86 ASP^? 26.97 C1 EDO A 124 218 GLY B 77 GLY^? 22.66 C1 EDO A 124 coo 27.89 102.52 14.98 29.35 101.92 13.57 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 21.10 106.02 13.04 21.16 106.76 12.59 -43.26 -37.30 -11.50 -42.54 -37.05 -11.23 2amg_c00 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 10 hits 2amg_c00 naa= 2 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 2 # 1 193 ASP A 41 ASP^? -2.91 O2 EDO A 124s 219 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 27.89 102.52 14.98 29.35 101.92 13.57 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 25.84 105.87 9.06 27.86 105.55 8.74 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 2 # 2 193 ASP A 84 ASP.? 13.20 O1 EDO A 125 219 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 25.84 105.87 9.06 27.86 105.55 8.74 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 2 # 3 193 ASP B 41 ASP^? 12.31 O1 EDO A 124 219 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 27.89 102.52 14.98 29.35 101.92 13.57 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 25.84 105.87 9.06 27.86 105.55 8.74 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 2 # 4 193 ASP B 84 ASP.? 30.86 C1 EDO A 124 219 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 27.89 102.52 14.98 29.35 101.92 13.57 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 25.84 105.87 9.06 27.86 105.55 8.74 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 2amg_c03 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 4 hits 2amg_c03 naa= 2 ULMN 2 2bmi_c00 CLASS B BETA-LACTAMASE user 1 2 # 1 A 86 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 176 ASN A 44 ASN.? 12.85 O2 EDO A 124 coo 3.77 27.43 22.56 5.17 28.98 22.54 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 10.49 32.46 17.76 9.08 34.05 17.38 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 ULMN 2 2bmi_c00 CLASS B BETA-LACTAMASE user 2 2 # 2 A 86 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 176 ASN B 44 ASN.? 11.30 O2 EDO A 125 coo 3.77 27.43 22.56 5.17 28.98 22.54 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 10.49 32.46 17.76 9.08 34.05 17.38 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 2bmi_c00 source 2bmi CLASS B BETA-LACTAMASE : 2 hits 2bmi_c00 naa= 2 ULMN 2 2bmi_c01 CLASS B BETA-LACTAMASE user 1 2 # 1 B 86 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 176 ASN A 44 ASN.? 12.85 O2 EDO A 124 coo -11.22 46.67 61.63 -9.21 47.42 61.86 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo -3.84 50.99 67.30 -2.89 49.10 67.47 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 ULMN 2 2bmi_c01 CLASS B BETA-LACTAMASE user 2 2 # 2 B 86 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 176 ASN B 44 ASN.? 11.30 O2 EDO A 125 coo -11.22 46.67 61.63 -9.21 47.42 61.86 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo -3.84 50.99 67.30 -2.89 49.10 67.47 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 2bmi_c01 source 2bmi CLASS B BETA-LACTAMASE : 2 hits 2bmi_c01 naa= 2 ULMN 2 2c7v_c00 PTERIDINE REDUCTASE user 1 2 # 1 A 171 PHE A 48 PHE^? 10.34 O2 EDO A 125 A 178 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 7.07 -11.45 22.83 8.29 -13.66 21.61 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 2c7v_c00 PTERIDINE REDUCTASE user 2 2 # 2 A 171 PHE A 50 PHE^? 8.88 O1 EDO A 125 A 178 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 7.07 -11.45 22.83 8.29 -13.66 21.61 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 2c7v_c00 PTERIDINE REDUCTASE user 3 2 # 3 A 171 PHE A 97 PHE.? 7.14 O2 EDO A 125 A 178 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 7.07 -11.45 22.83 8.29 -13.66 21.61 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 ULMN 2 2c7v_c00 PTERIDINE REDUCTASE user 4 2 # 4 A 171 PHE B 48 PHE^? 12.04 C1 EDO A 124 A 178 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 7.07 -11.45 22.83 8.29 -13.66 21.61 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 2c7v_c00 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c00 naa= 2 ULMN 2 2c7v_c01 PTERIDINE REDUCTASE user 1 2 # 1 B 171 PHE A 48 PHE^? 10.34 O2 EDO A 125 B 178 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo -21.65 17.34 10.98 -21.84 19.41 9.11 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 2c7v_c01 PTERIDINE REDUCTASE user 2 2 # 2 B 171 PHE A 50 PHE^? 8.88 O1 EDO A 125 B 178 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo -21.65 17.34 10.98 -21.84 19.41 9.11 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 2c7v_c01 PTERIDINE REDUCTASE user 3 2 # 3 B 171 PHE A 97 PHE.? 7.14 O2 EDO A 125 B 178 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo -21.65 17.34 10.98 -21.84 19.41 9.11 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 ULMN 2 2c7v_c01 PTERIDINE REDUCTASE user 4 2 # 4 B 171 PHE B 48 PHE^? 12.04 C1 EDO A 124 B 178 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo -21.65 17.34 10.98 -21.84 19.41 9.11 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 2c7v_c01 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c01 naa= 2 ULMN 2 2c7v_c02 PTERIDINE REDUCTASE user 1 2 # 1 C 171 PHE A 48 PHE^? 10.34 O2 EDO A 125 C 178 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 6.32 17.53 24.32 6.46 19.72 26.09 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 3.63 7.30 27.09 2.92 9.52 32.06 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 2c7v_c02 PTERIDINE REDUCTASE user 2 2 # 2 C 171 PHE A 50 PHE^? 8.88 O1 EDO A 125 C 178 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 6.32 17.53 24.32 6.46 19.72 26.09 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 3.63 7.30 27.09 2.92 9.52 32.06 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 2c7v_c02 PTERIDINE REDUCTASE user 3 2 # 3 C 171 PHE A 97 PHE.? 7.14 O2 EDO A 125 C 178 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 6.32 17.53 24.32 6.46 19.72 26.09 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo 3.63 7.30 27.09 2.92 9.52 32.06 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 ULMN 2 2c7v_c02 PTERIDINE REDUCTASE user 4 2 # 4 C 171 PHE B 48 PHE^? 12.04 C1 EDO A 124 C 178 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 6.32 17.53 24.32 6.46 19.72 26.09 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 3.63 7.30 27.09 2.92 9.52 32.06 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 2c7v_c02 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c02 naa= 2 ULMN 2 2c7v_c03 PTERIDINE REDUCTASE user 1 2 # 1 D 171 PHE A 48 PHE^? 10.34 O2 EDO A 125 D 178 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo -23.14 -11.41 15.36 -24.46 -13.43 16.80 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 2c7v_c03 PTERIDINE REDUCTASE user 2 2 # 2 D 171 PHE A 50 PHE^? 8.88 O1 EDO A 125 D 178 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo -23.14 -11.41 15.36 -24.46 -13.43 16.80 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 2c7v_c03 PTERIDINE REDUCTASE user 3 2 # 3 D 171 PHE A 97 PHE.? 7.14 O2 EDO A 125 D 178 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo -23.14 -11.41 15.36 -24.46 -13.43 16.80 -25.06 -46.06 -18.40 -26.02 -43.50 -17.83 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 ULMN 2 2c7v_c03 PTERIDINE REDUCTASE user 4 2 # 4 D 171 PHE B 48 PHE^? 12.04 C1 EDO A 124 D 178 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo -23.14 -11.41 15.36 -24.46 -13.43 16.80 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 2c7v_c03 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c03 naa= 2 ULMN 2 2cpo_c00 CHLOROPEROXIDASE user 1 2 # 1 105 HIS A 79 HIS^? 12.23 O1 EDO A 125 183 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 12.48 24.12 -9.88 11.36 24.64 -8.18 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 7.40 22.78 -5.08 9.19 22.77 -6.20 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 2cpo_c00 CHLOROPEROXIDASE user 2 2 # 2 105 HIS A 79 HIS^? 12.23 O1 EDO A 125 183 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 12.48 24.12 -9.88 11.36 24.64 -8.18 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo 7.40 22.78 -5.08 9.19 22.77 -6.20 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 2cpo_c00 CHLOROPEROXIDASE user 3 2 # 3 105 HIS B 79 HIS^? 26.86 C1 EDO A 124 183 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 12.48 24.12 -9.88 11.36 24.64 -8.18 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 7.40 22.78 -5.08 9.19 22.77 -6.20 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 2cpo_c00 CHLOROPEROXIDASE user 4 2 # 4 105 HIS B 79 HIS^? 26.86 C1 EDO A 124 183 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 12.48 24.12 -9.88 11.36 24.64 -8.18 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo 7.40 22.78 -5.08 9.19 22.77 -6.20 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 2cpo_c00 source 2cpo CHLOROPEROXIDASE : 4 hits 2cpo_c00 naa= 2 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 1 2 # 1 A 197 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 236 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 12.51 17.07 49.46 12.44 16.89 47.35 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 2 2 # 2 A 197 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 236 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 12.51 17.07 49.46 12.44 16.89 47.35 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 3 2 # 3 A 197 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 236 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 12.51 17.07 49.46 12.44 16.89 47.35 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 4 2 # 4 A 197 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 236 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 12.51 17.07 49.46 12.44 16.89 47.35 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 5 2 # 5 A 197 ASP A 64 ASP~? 20.53 O2 EDO A 124 A 236 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 12.51 17.07 49.46 12.44 16.89 47.35 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 6 2 # 6 A 197 ASP A 64 ASP~? 20.53 O2 EDO A 124 A 236 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 12.51 17.07 49.46 12.44 16.89 47.35 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 7 2 # 7 A 197 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 236 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 12.51 17.07 49.46 12.44 16.89 47.35 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 8 2 # 8 A 197 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 236 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 12.51 17.07 49.46 12.44 16.89 47.35 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 9 2 # 9 A 197 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 236 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 12.51 17.07 49.46 12.44 16.89 47.35 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 10 2 # 10 A 197 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 236 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 12.51 17.07 49.46 12.44 16.89 47.35 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 11 2 # 11 A 197 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 236 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 12.51 17.07 49.46 12.44 16.89 47.35 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 12 2 # 12 A 197 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 236 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 12.51 17.07 49.46 12.44 16.89 47.35 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 13 2 # 13 A 197 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 236 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 12.51 17.07 49.46 12.44 16.89 47.35 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 14 2 # 14 A 197 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 236 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 12.51 17.07 49.46 12.44 16.89 47.35 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 2cpu_c00 source 2cpu ALPHA-AMYLASE : 14 hits 2cpu_c00 naa= 2 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 1 2 # 1 22 GLU A 43 GLU.? 14.35 O2 EDO A 124 100 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 48.89 50.87 68.09 48.88 49.14 69.31 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 41.76 43.63 69.91 46.12 48.11 71.43 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 2 2 # 2 22 GLU A 70 GLU^? 16.40 O1 EDO A 125 100 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 48.89 50.87 68.09 48.88 49.14 69.31 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 41.76 43.63 69.91 46.12 48.11 71.43 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 3 2 # 3 22 GLU B 43 GLU.? 19.28 O2 EDO A 125 100 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 48.89 50.87 68.09 48.88 49.14 69.31 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 41.76 43.63 69.91 46.12 48.11 71.43 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 4 2 # 4 22 GLU B 70 GLU^? 26.28 O1 EDO A 124 100 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 48.89 50.87 68.09 48.88 49.14 69.31 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 41.76 43.63 69.91 46.12 48.11 71.43 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 2dhn_c00 source 2dhn 7,8-DIHYDRONEOPTERIN ALDOLASE : 4 hits 2dhn_c00 naa= 2 ULMN 2 2dor_c00 DIHYDROOROTATE DEHYDROGENASE A user 1 2 # 1 A 43 LYS A 28 LYS^? 7.39 O2 EDO A 124 A 130 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo 3.62 55.50 16.52 4.39 51.53 12.77 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 9.77 45.38 15.71 9.55 46.94 13.47 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 ULMN 2 2dor_c00 DIHYDROOROTATE DEHYDROGENASE A user 2 2 # 2 A 43 LYS A 28 LYS^? 7.39 O2 EDO A 124 A 130 CYH A 67 CYH~? 14.35 O2 EDO A 124 coo 3.62 55.50 16.52 4.39 51.53 12.77 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 9.77 45.38 15.71 9.55 46.94 13.47 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 ULMN 2 2dor_c00 DIHYDROOROTATE DEHYDROGENASE A user 3 2 # 3 A 43 LYS B 28 LYS^? -17.65 O1 EDO A 124s A 130 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo 3.62 55.50 16.52 4.39 51.53 12.77 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 9.77 45.38 15.71 9.55 46.94 13.47 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 2 2dor_c00 DIHYDROOROTATE DEHYDROGENASE A user 4 2 # 4 A 43 LYS B 28 LYS^? -17.65 O1 EDO A 124s A 130 CYH B 67 CYH~? 18.88 O1 EDO A 124 coo 3.62 55.50 16.52 4.39 51.53 12.77 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 9.77 45.38 15.71 9.55 46.94 13.47 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 2dor_c00 source 2dor DIHYDROOROTATE DEHYDROGENASE A : 4 hits 2dor_c00 naa= 2 ULMN 2 2dor_c01 DIHYDROOROTATE DEHYDROGENASE A user 1 2 # 1 B 43 LYS A 28 LYS^? 7.39 O2 EDO A 124 B 130 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo 2.86 8.74 19.83 1.70 12.73 23.44 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 7.79 18.91 23.50 6.49 17.36 25.33 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 ULMN 2 2dor_c01 DIHYDROOROTATE DEHYDROGENASE A user 2 2 # 2 B 43 LYS A 28 LYS^? 7.39 O2 EDO A 124 B 130 CYH A 67 CYH~? 14.35 O2 EDO A 124 coo 2.86 8.74 19.83 1.70 12.73 23.44 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 7.79 18.91 23.50 6.49 17.36 25.33 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 ULMN 2 2dor_c01 DIHYDROOROTATE DEHYDROGENASE A user 3 2 # 3 B 43 LYS B 28 LYS^? -17.65 O1 EDO A 124s B 130 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo 2.86 8.74 19.83 1.70 12.73 23.44 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 7.79 18.91 23.50 6.49 17.36 25.33 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 ULMN 2 2dor_c01 DIHYDROOROTATE DEHYDROGENASE A user 4 2 # 4 B 43 LYS B 28 LYS^? -17.65 O1 EDO A 124s B 130 CYH B 67 CYH~? 18.88 O1 EDO A 124 coo 2.86 8.74 19.83 1.70 12.73 23.44 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 7.79 18.91 23.50 6.49 17.36 25.33 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 2dor_c01 source 2dor DIHYDROOROTATE DEHYDROGENASE A : 4 hits 2dor_c01 naa= 2 ULMN 2 2eng_c00 ENDOGLUCANASE V user 1 2 # 1 10 ASP A 32 ASP^? 7.79 O1 EDO A 124 121 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 2eng_c00 ENDOGLUCANASE V user 2 2 # 2 10 ASP A 63 ASP~? 17.25 O1 EDO A 124 121 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 2eng_c00 ENDOGLUCANASE V user 3 2 # 3 10 ASP A 84 ASP.? 13.20 O1 EDO A 125 121 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 2eng_c00 ENDOGLUCANASE V user 4 2 # 4 10 ASP A 86 ASP^? 9.05 O1 EDO A 125 121 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 2eng_c00 ENDOGLUCANASE V user 5 2 # 5 10 ASP B 32 ASP^? 9.42 O1 EDO A 124 121 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 2eng_c00 ENDOGLUCANASE V user 6 2 # 6 10 ASP B 32 ASP^? 9.42 O1 EDO A 124 121 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 2eng_c00 ENDOGLUCANASE V user 7 2 # 7 10 ASP B 41 ASP^? 12.31 O1 EDO A 124 121 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 2eng_c00 ENDOGLUCANASE V user 8 2 # 8 10 ASP B 63 ASP~? 17.37 O1 EDO A 124 121 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 2eng_c00 ENDOGLUCANASE V user 9 2 # 9 10 ASP B 84 ASP.? 30.86 C1 EDO A 124 121 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 2eng_c00 ENDOGLUCANASE V user 10 2 # 10 10 ASP B 86 ASP^? 26.97 C1 EDO A 124 121 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 2eng_c00 source 2eng ENDOGLUCANASE V : 10 hits 2eng_c00 naa= 2 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 1 2 # 1 35 GLU A 43 GLU.? 14.35 O2 EDO A 124 53 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 coo 24.12 3.58 26.55 22.78 2.48 27.73 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 2 2 # 2 35 GLU A 81 GLU.? 16.59 O1 EDO A 125 53 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo 24.12 3.58 26.55 22.78 2.48 27.73 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 3 2 # 3 35 GLU B 43 GLU.? 19.28 O2 EDO A 125 53 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo 24.12 3.58 26.55 22.78 2.48 27.73 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 4 2 # 4 35 GLU B 81 GLU.? 30.69 O1 EDO A 124 53 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo 24.12 3.58 26.55 22.78 2.48 27.73 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 2eql_c00 source 2eql LYSOZYME (APO FORM) : 4 hits 2eql_c00 naa= 2 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 1 2 # 1 A 28 GLU A 23 GLU.? 13.04 O2 EDO A 125 A 120 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 2 2 # 2 A 28 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 120 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 3 2 # 3 A 28 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 120 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 4 2 # 4 A 28 GLU A 59 GLU.? 11.26 O1 EDO A 125 A 120 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 5 2 # 5 A 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 120 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 6 2 # 6 A 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 120 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 7 2 # 7 A 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 120 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 8 2 # 8 A 28 GLU A 81 GLU.? 16.59 O1 EDO A 125 A 120 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 9 2 # 9 A 28 GLU B 23 GLU.? 12.57 O2 EDO A 125 A 120 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 10 2 # 10 A 28 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 120 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 11 2 # 11 A 28 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 120 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 12 2 # 12 A 28 GLU B 59 GLU.? 24.69 C1 EDO A 124 A 120 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 13 2 # 13 A 28 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 120 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 14 2 # 14 A 28 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 120 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 15 2 # 15 A 28 GLU B 70 GLU^? 26.28 O1 EDO A 124 A 120 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 16 2 # 16 A 28 GLU B 81 GLU.? 30.69 O1 EDO A 124 A 120 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 2fmn_c00 source 2fmn 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE : 16 hits 2fmn_c00 naa= 2 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 1 2 # 1 B 28 GLU A 23 GLU.? 13.04 O2 EDO A 125 B 120 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo -18.25 19.28 62.84 -16.77 17.78 62.83 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 2 2 # 2 B 28 GLU A 59 GLU.? 11.26 O1 EDO A 125 B 120 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 3 2 # 3 B 28 GLU A 59 GLU.? 11.26 O1 EDO A 125 B 120 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 4 2 # 4 B 28 GLU A 59 GLU.? 11.26 O1 EDO A 125 B 120 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 5 2 # 5 B 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 120 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo -18.25 19.28 62.84 -16.77 17.78 62.83 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 6 2 # 6 B 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 120 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 7 2 # 7 B 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 120 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 8 2 # 8 B 28 GLU A 81 GLU.? 16.59 O1 EDO A 125 B 120 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 9 2 # 9 B 28 GLU B 23 GLU.? 12.57 O2 EDO A 125 B 120 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 10 2 # 10 B 28 GLU B 59 GLU.? 24.69 C1 EDO A 124 B 120 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 11 2 # 11 B 28 GLU B 59 GLU.? 24.69 C1 EDO A 124 B 120 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 12 2 # 12 B 28 GLU B 59 GLU.? 24.69 C1 EDO A 124 B 120 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 13 2 # 13 B 28 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 120 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 14 2 # 14 B 28 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 120 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 15 2 # 15 B 28 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 120 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 16 2 # 16 B 28 GLU B 81 GLU.? 30.69 O1 EDO A 124 B 120 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 2fmn_c01 source 2fmn 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE : 16 hits 2fmn_c01 naa= 2 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 1 2 # 1 C 28 GLU A 23 GLU.? 13.04 O2 EDO A 125 C 120 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -39.20 -45.13 -30.01 -39.39 -46.36 -28.29 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 2 2 # 2 C 28 GLU A 59 GLU.? 11.26 O1 EDO A 125 C 120 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 3 2 # 3 C 28 GLU A 59 GLU.? 11.26 O1 EDO A 125 C 120 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 4 2 # 4 C 28 GLU A 59 GLU.? 11.26 O1 EDO A 125 C 120 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 5 2 # 5 C 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 C 120 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 6 2 # 6 C 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 C 120 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 7 2 # 7 C 28 GLU A 70 GLU^? 16.40 O1 EDO A 125 C 120 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 8 2 # 8 C 28 GLU A 81 GLU.? 16.59 O1 EDO A 125 C 120 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 9 2 # 9 C 28 GLU B 23 GLU.? 12.57 O2 EDO A 125 C 120 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 10 2 # 10 C 28 GLU B 59 GLU.? 24.69 C1 EDO A 124 C 120 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 11 2 # 11 C 28 GLU B 59 GLU.? 24.69 C1 EDO A 124 C 120 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 12 2 # 12 C 28 GLU B 59 GLU.? 24.69 C1 EDO A 124 C 120 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -51.65 -27.03 -23.81 -53.34 -28.06 -23.08 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 13 2 # 13 C 28 GLU B 70 GLU^? 26.28 O1 EDO A 124 C 120 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 14 2 # 14 C 28 GLU B 70 GLU^? 26.28 O1 EDO A 124 C 120 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 15 2 # 15 C 28 GLU B 70 GLU^? 26.28 O1 EDO A 124 C 120 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 16 2 # 16 C 28 GLU B 81 GLU.? 30.69 O1 EDO A 124 C 120 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 2fmn_c02 source 2fmn 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE : 16 hits 2fmn_c02 naa= 2 ULMN 2 2gsa_c00 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 A 150 TYR A 31 TYR^? 13.43 O2 EDO A 124 A 245 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 2gsa_c00 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 2 # 2 A 150 TYR B 31 TYR^? 14.49 O1 EDO A 124 A 245 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 2gsa_c00 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 2 hits 2gsa_c00 naa= 2 ULMN 2 2gsa_c01 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 B 150 TYR A 31 TYR^? 13.43 O2 EDO A 124 B 245 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 2gsa_c01 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 2 # 2 B 150 TYR B 31 TYR^? 14.49 O1 EDO A 124 B 245 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 2gsa_c01 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 2 hits 2gsa_c01 naa= 2 ULMN 2 2gsa_c03 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 B 150 TYR A 31 TYR^? 13.43 O2 EDO A 124 B 245 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 2gsa_c03 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 2 # 2 B 150 TYR B 31 TYR^? 14.49 O1 EDO A 124 B 245 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 2gsa_c03 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 2 hits 2gsa_c03 naa= 2 ULMN 2 2gsa_c05 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 B 157 PHE A 48 PHE^? 10.34 O2 EDO A 125 B 245 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 16.60 4.08 -19.14 19.31 4.55 -18.73 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 2gsa_c05 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 2 # 2 B 157 PHE A 50 PHE^? 8.88 O1 EDO A 125 B 245 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 16.60 4.08 -19.14 19.31 4.55 -18.73 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 2gsa_c05 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 2 # 3 B 157 PHE B 48 PHE^? 12.04 C1 EDO A 124 B 245 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 16.60 4.08 -19.14 19.31 4.55 -18.73 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 2gsa_c05 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 2 # 4 B 157 PHE B 50 PHE^? 13.90 C1 EDO A 124 B 245 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 16.60 4.08 -19.14 19.31 4.55 -18.73 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 2gsa_c05 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 4 hits 2gsa_c05 naa= 2 ULMN 2 2npx_c00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 1 2 # 1 37 ILE A 71 ILE^? 12.95 O2 EDO A 124 42 CYH A 46 CYH.? 11.48 C1 EDO A 124 coo 23.96 38.25 125.15 23.87 37.68 123.87 -27.38 -40.51 -35.55 -28.44 -39.68 -35.04 coo 36.88 46.86 127.06 36.03 46.98 124.43 -36.60 -32.80 -26.64 -38.89 -33.76 -25.53 ULMN 2 2npx_c00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 2 2 # 2 37 ILE B 71 ILE^? 21.20 O1 EDO A 124 42 CYH B 46 CYH.? 10.55 O2 EDO A 125 coo 23.96 38.25 125.15 23.87 37.68 123.87 -38.92 -33.72 -8.00 -37.68 -34.27 -8.56 coo 36.88 46.86 127.06 36.03 46.98 124.43 -28.14 -37.57 -17.20 -27.75 -39.99 -18.29 2npx_c00 source 2npx NADH PEROXIDASE (E.C.1.11.1.1) WITH CYS 42 OXI: 2 hits 2npx_c00 naa= 2 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 1 2 # 1 131 ASP A 32 ASP^? 7.79 O1 EDO A 124 218 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 2 2 # 2 131 ASP A 41 ASP^? -2.91 O2 EDO A 124s 218 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 3 2 # 3 131 ASP A 41 ASP^? -2.91 O2 EDO A 124s 218 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 4 2 # 4 131 ASP A 63 ASP~? 17.25 O1 EDO A 124 218 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 5 2 # 5 131 ASP A 63 ASP~? 17.25 O1 EDO A 124 218 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 6 2 # 6 131 ASP A 64 ASP~? 20.53 O2 EDO A 124 218 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 7 2 # 7 131 ASP B 41 ASP^? 12.31 O1 EDO A 124 218 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 8 2 # 8 131 ASP B 41 ASP^? 12.31 O1 EDO A 124 218 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 9 2 # 9 131 ASP B 63 ASP~? 17.37 O1 EDO A 124 218 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 10 2 # 10 131 ASP B 63 ASP~? 17.37 O1 EDO A 124 218 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 11 2 # 11 131 ASP B 63 ASP~? 17.37 O1 EDO A 124 218 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 12 2 # 12 131 ASP B 64 ASP~? 23.62 O1 EDO A 124 218 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 2pec_c00 source 2pec PECTATE LYASE C (PLC) (E.C.4.2.2.2) : 12 hits 2pec_c00 naa= 2 ULMN 2 2phk_c00 MC-PEPTIDE user 1 2 # 1 A 149 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 153 GLU A 43 GLU.? 14.35 O2 EDO A 124 coo 41.42 17.90 44.98 43.39 18.36 45.61 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 51.07 15.29 42.97 50.55 17.18 42.21 -36.51 -36.35 -35.74 -35.90 -38.00 -36.92 ULMN 2 2phk_c00 MC-PEPTIDE user 2 2 # 2 A 149 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 153 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 41.42 17.90 44.98 43.39 18.36 45.61 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 51.07 15.29 42.97 50.55 17.18 42.21 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 2phk_c00 MC-PEPTIDE user 3 2 # 3 A 149 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 153 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 41.42 17.90 44.98 43.39 18.36 45.61 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 51.07 15.29 42.97 50.55 17.18 42.21 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 2phk_c00 MC-PEPTIDE user 4 2 # 4 A 149 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 153 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 41.42 17.90 44.98 43.39 18.36 45.61 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 51.07 15.29 42.97 50.55 17.18 42.21 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 2phk_c00 MC-PEPTIDE user 5 2 # 5 A 149 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 153 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 41.42 17.90 44.98 43.39 18.36 45.61 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 51.07 15.29 42.97 50.55 17.18 42.21 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 2phk_c00 MC-PEPTIDE user 6 2 # 6 A 149 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 153 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 41.42 17.90 44.98 43.39 18.36 45.61 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 51.07 15.29 42.97 50.55 17.18 42.21 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 2phk_c00 source 2phk MC-PEPTIDE : 6 hits 2phk_c00 naa= 2 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 1 2 # 1 A 549 ASP A 32 ASP^? 7.79 O1 EDO A 124 A 655 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 2 2 # 2 A 549 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 655 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 3 2 # 3 A 549 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 655 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 4 2 # 4 A 549 ASP A 63 ASP~? 17.25 O1 EDO A 124 A 655 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 5 2 # 5 A 549 ASP A 64 ASP~? 20.53 O2 EDO A 124 A 655 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 6 2 # 6 A 549 ASP A 64 ASP~? 20.53 O2 EDO A 124 A 655 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 7 2 # 7 A 549 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 655 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 8 2 # 8 A 549 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 655 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 9 2 # 9 A 549 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 655 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 10 2 # 10 A 549 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 655 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 11 2 # 11 A 549 ASP B 32 ASP^? 9.42 O1 EDO A 124 A 655 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 12 2 # 12 A 549 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 655 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 13 2 # 13 A 549 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 655 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 14 2 # 14 A 549 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 655 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 15 2 # 15 A 549 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 655 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 16 2 # 16 A 549 ASP B 63 ASP~? 17.37 O1 EDO A 124 A 655 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 17 2 # 17 A 549 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 655 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 18 2 # 18 A 549 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 655 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 19 2 # 19 A 549 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 655 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 20 2 # 20 A 549 ASP B 84 ASP.? 30.86 C1 EDO A 124 A 655 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 21 2 # 21 A 549 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 655 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 22 2 # 22 A 549 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 655 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 2qf7_c00 source 2qf7 PYRUVATE CARBOXYLASE PROTEIN : 22 hits 2qf7_c00 naa= 2 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 1 2 # 1 B 549 ASP A 32 ASP^? 7.79 O1 EDO A 124 B 655 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 76.34 71.89 30.92 75.58 70.99 29.16 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 coo 66.54 57.43 28.71 66.94 55.81 27.41 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 2 2 # 2 B 549 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 655 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 76.34 71.89 30.92 75.58 70.99 29.16 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 66.54 57.43 28.71 66.94 55.81 27.41 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 3 2 # 3 B 549 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 655 ASP B 32 ASP^? 9.42 O1 EDO A 124 coo 76.34 71.89 30.92 75.58 70.99 29.16 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 66.54 57.43 28.71 66.94 55.81 27.41 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 4 2 # 4 B 549 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 655 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 76.34 71.89 30.92 75.58 70.99 29.16 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 66.54 57.43 28.71 66.94 55.81 27.41 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 5 2 # 5 B 549 ASP A 63 ASP~? 17.25 O1 EDO A 124 B 655 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 76.34 71.89 30.92 75.58 70.99 29.16 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 coo 66.54 57.43 28.71 66.94 55.81 27.41 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 6 2 # 6 B 549 ASP A 64 ASP~? 20.53 O2 EDO A 124 B 655 ASP A 84 ASP.? 13.20 O1 EDO A 125 coo 76.34 71.89 30.92 75.58 70.99 29.16 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 66.54 57.43 28.71 66.94 55.81 27.41 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 7 2 # 7 B 549 ASP A 64 ASP~? 20.53 O2 EDO A 124 B 655 ASP A 86 ASP^? 9.05 O1 EDO A 125 coo 76.34 71.89 30.92 75.58 70.99 29.16 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 66.54 57.43 28.71 66.94 55.81 27.41 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 8 2 # 8 B 549 ASP A 84 ASP.? 13.20 O1 EDO A 125 B 655 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo 76.34 71.89 30.92 75.58 70.99 29.16 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 66.54 57.43 28.71 66.94 55.81 27.41 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 9 2 # 9 B 549 ASP A 84 ASP.? 13.20 O1 EDO A 125 B 655 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 76.34 71.89 30.92 75.58 70.99 29.16 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 66.54 57.43 28.71 66.94 55.81 27.41 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 10 2 # 10 B 549 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 655 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 76.34 71.89 30.92 75.58 70.99 29.16 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 66.54 57.43 28.71 66.94 55.81 27.41 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 11 2 # 11 B 549 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 655 ASP A 64 ASP~? 20.53 O2 EDO A 124 coo 76.34 71.89 30.92 75.58 70.99 29.16 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 66.54 57.43 28.71 66.94 55.81 27.41 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 12 2 # 12 B 549 ASP B 32 ASP^? 9.42 O1 EDO A 124 B 655 ASP A 32 ASP^? 7.79 O1 EDO A 124 coo 76.34 71.89 30.92 75.58 70.99 29.16 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 66.54 57.43 28.71 66.94 55.81 27.41 -20.91 -30.64 -24.77 -20.66 -28.75 -23.92 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 13 2 # 13 B 549 ASP B 32 ASP^? 9.42 O1 EDO A 124 B 655 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 76.34 71.89 30.92 75.58 70.99 29.16 -33.94 -22.98 -18.86 -32.36 -21.71 -19.37 coo 66.54 57.43 28.71 66.94 55.81 27.41 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 14 2 # 14 B 549 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 655 ASP A 41 ASP^? -2.91 O2 EDO A 124s coo 76.34 71.89 30.92 75.58 70.99 29.16 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 66.54 57.43 28.71 66.94 55.81 27.41 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 15 2 # 15 B 549 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 655 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 76.34 71.89 30.92 75.58 70.99 29.16 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 66.54 57.43 28.71 66.94 55.81 27.41 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 16 2 # 16 B 549 ASP B 63 ASP~? 17.37 O1 EDO A 124 B 655 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 76.34 71.89 30.92 75.58 70.99 29.16 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 coo 66.54 57.43 28.71 66.94 55.81 27.41 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 17 2 # 17 B 549 ASP B 64 ASP~? 23.62 O1 EDO A 124 B 655 ASP B 84 ASP.? 30.86 C1 EDO A 124 coo 76.34 71.89 30.92 75.58 70.99 29.16 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 66.54 57.43 28.71 66.94 55.81 27.41 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 18 2 # 18 B 549 ASP B 64 ASP~? 23.62 O1 EDO A 124 B 655 ASP B 86 ASP^? 26.97 C1 EDO A 124 coo 76.34 71.89 30.92 75.58 70.99 29.16 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 66.54 57.43 28.71 66.94 55.81 27.41 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 19 2 # 19 B 549 ASP B 84 ASP.? 30.86 C1 EDO A 124 B 655 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo 76.34 71.89 30.92 75.58 70.99 29.16 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 66.54 57.43 28.71 66.94 55.81 27.41 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 20 2 # 20 B 549 ASP B 84 ASP.? 30.86 C1 EDO A 124 B 655 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 76.34 71.89 30.92 75.58 70.99 29.16 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 66.54 57.43 28.71 66.94 55.81 27.41 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 21 2 # 21 B 549 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 655 ASP B 41 ASP^? 12.31 O1 EDO A 124 coo 76.34 71.89 30.92 75.58 70.99 29.16 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 66.54 57.43 28.71 66.94 55.81 27.41 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 22 2 # 22 B 549 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 655 ASP B 64 ASP~? 23.62 O1 EDO A 124 coo 76.34 71.89 30.92 75.58 70.99 29.16 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 66.54 57.43 28.71 66.94 55.81 27.41 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 2qf7_c01 source 2qf7 PYRUVATE CARBOXYLASE PROTEIN : 22 hits 2qf7_c01 naa= 2 ULMN 2 2thi_c00 THIAMINASE I user 1 2 # 1 A 113 CYH A 67 CYH~? 14.35 O2 EDO A 124 A 241 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 34.48 86.17 8.89 35.98 87.52 6.88 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo 41.40 85.25 6.42 39.33 85.57 6.74 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 2thi_c00 THIAMINASE I user 2 2 # 2 A 113 CYH B 67 CYH~? 18.88 O1 EDO A 124 A 241 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 34.48 86.17 8.89 35.98 87.52 6.88 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo 41.40 85.25 6.42 39.33 85.57 6.74 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 2thi_c00 source 2thi THIAMINASE I : 2 hits 2thi_c00 naa= 2 ULMN 2 2thi_c01 THIAMINASE I user 1 2 # 1 B 113 CYH A 67 CYH~? 14.35 O2 EDO A 124 B 241 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 6.76 34.20 8.77 5.34 32.83 6.71 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo -0.20 35.10 6.38 1.89 34.79 6.65 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 2thi_c01 THIAMINASE I user 2 2 # 2 B 113 CYH B 67 CYH~? 18.88 O1 EDO A 124 B 241 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 6.76 34.20 8.77 5.34 32.83 6.71 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo -0.20 35.10 6.38 1.89 34.79 6.65 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 2thi_c01 source 2thi THIAMINASE I : 2 hits 2thi_c01 naa= 2 ULMN 2 3pca_c00 PROTOCATECHUATE 3,4-DIOXYGENASE user 1 2 # 1 M 447 TYR A 31 TYR^? 13.43 O2 EDO A 124 M 457 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 8.49 10.09 43.76 9.92 11.66 45.61 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 11.10 10.60 38.12 12.56 8.02 36.96 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 3pca_c00 PROTOCATECHUATE 3,4-DIOXYGENASE user 2 2 # 2 M 447 TYR A 31 TYR^? 13.43 O2 EDO A 124 M 457 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 8.49 10.09 43.76 9.92 11.66 45.61 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 11.10 10.60 38.12 12.56 8.02 36.96 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 3pca_c00 PROTOCATECHUATE 3,4-DIOXYGENASE user 3 2 # 3 M 447 TYR A 76 TYR.? 12.73 O1 EDO A 125 M 457 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 8.49 10.09 43.76 9.92 11.66 45.61 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 coo 11.10 10.60 38.12 12.56 8.02 36.96 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 3pca_c00 PROTOCATECHUATE 3,4-DIOXYGENASE user 4 2 # 4 M 447 TYR B 31 TYR^? 14.49 O1 EDO A 124 M 457 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 8.49 10.09 43.76 9.92 11.66 45.61 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 11.10 10.60 38.12 12.56 8.02 36.96 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 3pca_c00 PROTOCATECHUATE 3,4-DIOXYGENASE user 5 2 # 5 M 447 TYR B 31 TYR^? 14.49 O1 EDO A 124 M 457 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 8.49 10.09 43.76 9.92 11.66 45.61 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 11.10 10.60 38.12 12.56 8.02 36.96 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 3pca_c00 PROTOCATECHUATE 3,4-DIOXYGENASE user 6 2 # 6 M 447 TYR B 76 TYR.? 17.92 O2 EDO A 125 M 457 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 8.49 10.09 43.76 9.92 11.66 45.61 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 coo 11.10 10.60 38.12 12.56 8.02 36.96 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 3pca_c00 source 3pca PROTOCATECHUATE 3,4-DIOXYGENASE : 6 hits 3pca_c00 naa= 2 ULMN 2 3pca_c01 PROTOCATECHUATE 3,4-DIOXYGENASE user 1 2 # 1 N 447 TYR A 31 TYR^? 13.43 O2 EDO A 124 N 457 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 10.05 43.90 8.55 11.74 45.69 9.93 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 10.54 37.95 11.06 8.06 36.82 12.51 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 3pca_c01 PROTOCATECHUATE 3,4-DIOXYGENASE user 2 2 # 2 N 447 TYR A 31 TYR^? 13.43 O2 EDO A 124 N 457 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 10.05 43.90 8.55 11.74 45.69 9.93 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 10.54 37.95 11.06 8.06 36.82 12.51 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 3pca_c01 PROTOCATECHUATE 3,4-DIOXYGENASE user 3 2 # 3 N 447 TYR A 76 TYR.? 12.73 O1 EDO A 125 N 457 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 10.05 43.90 8.55 11.74 45.69 9.93 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 coo 10.54 37.95 11.06 8.06 36.82 12.51 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 3pca_c01 PROTOCATECHUATE 3,4-DIOXYGENASE user 4 2 # 4 N 447 TYR B 31 TYR^? 14.49 O1 EDO A 124 N 457 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 10.05 43.90 8.55 11.74 45.69 9.93 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 10.54 37.95 11.06 8.06 36.82 12.51 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 3pca_c01 PROTOCATECHUATE 3,4-DIOXYGENASE user 5 2 # 5 N 447 TYR B 31 TYR^? 14.49 O1 EDO A 124 N 457 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 10.05 43.90 8.55 11.74 45.69 9.93 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 10.54 37.95 11.06 8.06 36.82 12.51 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 3pca_c01 source 3pca PROTOCATECHUATE 3,4-DIOXYGENASE : 5 hits 3pca_c01 naa= 2 ULMN 2 3pca_c02 PROTOCATECHUATE 3,4-DIOXYGENASE user 1 2 # 1 O 447 TYR A 31 TYR^? 13.43 O2 EDO A 124 O 457 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 43.82 8.53 10.01 45.63 9.88 11.69 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 38.02 11.23 10.58 36.95 12.66 8.07 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 3pca_c02 PROTOCATECHUATE 3,4-DIOXYGENASE user 2 2 # 2 O 447 TYR A 31 TYR^? 13.43 O2 EDO A 124 O 457 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 43.82 8.53 10.01 45.63 9.88 11.69 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 38.02 11.23 10.58 36.95 12.66 8.07 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 3pca_c02 PROTOCATECHUATE 3,4-DIOXYGENASE user 3 2 # 3 O 447 TYR A 76 TYR.? 12.73 O1 EDO A 125 O 457 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 43.82 8.53 10.01 45.63 9.88 11.69 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 coo 38.02 11.23 10.58 36.95 12.66 8.07 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 3pca_c02 PROTOCATECHUATE 3,4-DIOXYGENASE user 4 2 # 4 O 447 TYR B 31 TYR^? 14.49 O1 EDO A 124 O 457 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 43.82 8.53 10.01 45.63 9.88 11.69 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 38.02 11.23 10.58 36.95 12.66 8.07 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 3pca_c02 PROTOCATECHUATE 3,4-DIOXYGENASE user 5 2 # 5 O 447 TYR B 31 TYR^? 14.49 O1 EDO A 124 O 457 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 43.82 8.53 10.01 45.63 9.88 11.69 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 38.02 11.23 10.58 36.95 12.66 8.07 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 3pca_c02 PROTOCATECHUATE 3,4-DIOXYGENASE user 6 2 # 6 O 447 TYR B 76 TYR.? 17.92 O2 EDO A 125 O 457 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 43.82 8.53 10.01 45.63 9.88 11.69 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 coo 38.02 11.23 10.58 36.95 12.66 8.07 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 3pca_c02 source 3pca PROTOCATECHUATE 3,4-DIOXYGENASE : 6 hits 3pca_c02 naa= 2 ULMN 2 3pca_c03 PROTOCATECHUATE 3,4-DIOXYGENASE user 1 2 # 1 P 447 TYR A 31 TYR^? 13.43 O2 EDO A 124 P 457 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo -8.57 -10.12 43.71 -9.76 -11.68 45.73 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo -11.16 -10.53 38.02 -12.60 -7.93 36.86 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 3pca_c03 PROTOCATECHUATE 3,4-DIOXYGENASE user 2 2 # 2 P 447 TYR A 31 TYR^? 13.43 O2 EDO A 124 P 457 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo -8.57 -10.12 43.71 -9.76 -11.68 45.73 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo -11.16 -10.53 38.02 -12.60 -7.93 36.86 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 3pca_c03 PROTOCATECHUATE 3,4-DIOXYGENASE user 3 2 # 3 P 447 TYR A 76 TYR.? 12.73 O1 EDO A 125 P 457 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -8.57 -10.12 43.71 -9.76 -11.68 45.73 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 coo -11.16 -10.53 38.02 -12.60 -7.93 36.86 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 3pca_c03 PROTOCATECHUATE 3,4-DIOXYGENASE user 4 2 # 4 P 447 TYR B 31 TYR^? 14.49 O1 EDO A 124 P 457 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo -8.57 -10.12 43.71 -9.76 -11.68 45.73 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo -11.16 -10.53 38.02 -12.60 -7.93 36.86 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 3pca_c03 PROTOCATECHUATE 3,4-DIOXYGENASE user 5 2 # 5 P 447 TYR B 31 TYR^? 14.49 O1 EDO A 124 P 457 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo -8.57 -10.12 43.71 -9.76 -11.68 45.73 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo -11.16 -10.53 38.02 -12.60 -7.93 36.86 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 3pca_c03 PROTOCATECHUATE 3,4-DIOXYGENASE user 6 2 # 6 P 447 TYR B 76 TYR.? 17.92 O2 EDO A 125 P 457 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -8.57 -10.12 43.71 -9.76 -11.68 45.73 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 coo -11.16 -10.53 38.02 -12.60 -7.93 36.86 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 3pca_c03 source 3pca PROTOCATECHUATE 3,4-DIOXYGENASE : 6 hits 3pca_c03 naa= 2 ULMN 2 3pca_c04 PROTOCATECHUATE 3,4-DIOXYGENASE user 1 2 # 1 Q 447 TYR A 31 TYR^? 13.43 O2 EDO A 124 Q 457 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo -10.11 -43.85 8.55 -11.75 -45.67 9.94 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo -10.52 -38.03 11.19 -7.90 -36.98 12.68 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 3pca_c04 PROTOCATECHUATE 3,4-DIOXYGENASE user 2 2 # 2 Q 447 TYR A 31 TYR^? 13.43 O2 EDO A 124 Q 457 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo -10.11 -43.85 8.55 -11.75 -45.67 9.94 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo -10.52 -38.03 11.19 -7.90 -36.98 12.68 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 3pca_c04 PROTOCATECHUATE 3,4-DIOXYGENASE user 3 2 # 3 Q 447 TYR A 76 TYR.? 12.73 O1 EDO A 125 Q 457 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -10.11 -43.85 8.55 -11.75 -45.67 9.94 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 coo -10.52 -38.03 11.19 -7.90 -36.98 12.68 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 3pca_c04 PROTOCATECHUATE 3,4-DIOXYGENASE user 4 2 # 4 Q 447 TYR B 31 TYR^? 14.49 O1 EDO A 124 Q 457 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo -10.11 -43.85 8.55 -11.75 -45.67 9.94 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo -10.52 -38.03 11.19 -7.90 -36.98 12.68 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 3pca_c04 PROTOCATECHUATE 3,4-DIOXYGENASE user 5 2 # 5 Q 447 TYR B 31 TYR^? 14.49 O1 EDO A 124 Q 457 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo -10.11 -43.85 8.55 -11.75 -45.67 9.94 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo -10.52 -38.03 11.19 -7.90 -36.98 12.68 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 3pca_c04 PROTOCATECHUATE 3,4-DIOXYGENASE user 6 2 # 6 Q 447 TYR B 76 TYR.? 17.92 O2 EDO A 125 Q 457 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -10.11 -43.85 8.55 -11.75 -45.67 9.94 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 coo -10.52 -38.03 11.19 -7.90 -36.98 12.68 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 3pca_c04 source 3pca PROTOCATECHUATE 3,4-DIOXYGENASE : 6 hits 3pca_c04 naa= 2 ULMN 2 3pca_c05 PROTOCATECHUATE 3,4-DIOXYGENASE user 1 2 # 1 R 447 TYR A 31 TYR^? 13.43 O2 EDO A 124 R 457 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo -43.75 -8.52 10.17 -45.67 -9.76 11.79 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo -37.85 -11.18 10.60 -36.87 -12.61 7.95 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 3pca_c05 PROTOCATECHUATE 3,4-DIOXYGENASE user 2 2 # 2 R 447 TYR A 31 TYR^? 13.43 O2 EDO A 124 R 457 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo -43.75 -8.52 10.17 -45.67 -9.76 11.79 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo -37.85 -11.18 10.60 -36.87 -12.61 7.95 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 3pca_c05 PROTOCATECHUATE 3,4-DIOXYGENASE user 3 2 # 3 R 447 TYR A 76 TYR.? 12.73 O1 EDO A 125 R 457 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -43.75 -8.52 10.17 -45.67 -9.76 11.79 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 coo -37.85 -11.18 10.60 -36.87 -12.61 7.95 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 3pca_c05 PROTOCATECHUATE 3,4-DIOXYGENASE user 4 2 # 4 R 447 TYR B 31 TYR^? 14.49 O1 EDO A 124 R 457 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo -43.75 -8.52 10.17 -45.67 -9.76 11.79 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo -37.85 -11.18 10.60 -36.87 -12.61 7.95 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 3pca_c05 PROTOCATECHUATE 3,4-DIOXYGENASE user 5 2 # 5 R 447 TYR B 31 TYR^? 14.49 O1 EDO A 124 R 457 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo -43.75 -8.52 10.17 -45.67 -9.76 11.79 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo -37.85 -11.18 10.60 -36.87 -12.61 7.95 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 3pca_c05 source 3pca PROTOCATECHUATE 3,4-DIOXYGENASE : 5 hits 3pca_c05 naa= 2 ULMN 2 4mdh_c00 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 2 # 1 A 158 ASP A 41 ASP^? -2.91 O2 EDO A 124s A 185 ASN A 44 ASN.? 12.85 O2 EDO A 124 coo 18.62 26.83 58.17 18.48 28.64 57.08 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 11.83 33.94 58.73 11.65 35.30 57.09 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 ULMN 2 4mdh_c00 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 2 # 2 A 158 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 185 ASN B 44 ASN.? 11.30 O2 EDO A 125 coo 18.62 26.83 58.17 18.48 28.64 57.08 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 11.83 33.94 58.73 11.65 35.30 57.09 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 4mdh_c00 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 2 hits 4mdh_c00 naa= 2 ULMN 2 4mdh_c01 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 2 # 1 B 158 ASP A 41 ASP^? -2.91 O2 EDO A 124s B 185 ASN A 44 ASN.? 12.85 O2 EDO A 124 coo 44.53 16.44 28.54 44.89 18.45 28.77 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 54.37 18.81 28.31 54.76 20.47 29.61 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 ULMN 2 4mdh_c01 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 2 # 2 B 158 ASP B 41 ASP^? 12.31 O1 EDO A 124 B 185 ASN B 44 ASN.? 11.30 O2 EDO A 125 coo 44.53 16.44 28.54 44.89 18.45 28.77 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 54.37 18.81 28.31 54.76 20.47 29.61 -28.13 -42.06 -13.38 -29.28 -41.52 -15.09 4mdh_c01 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 2 hits 4mdh_c01 naa= 2 ULMN 2 4mdh_c04 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 2 # 1 A 158 ASP A 86 ASP^? 9.05 O1 EDO A 125 A 186 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 18.62 26.83 58.17 18.48 28.64 57.08 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 16.67 31.22 54.64 18.74 31.15 54.14 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 4mdh_c04 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 2 # 2 A 158 ASP B 86 ASP^? 26.97 C1 EDO A 124 A 186 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 18.62 26.83 58.17 18.48 28.64 57.08 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 16.67 31.22 54.64 18.74 31.15 54.14 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 4mdh_c04 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 2 hits 4mdh_c04 naa= 2 ULMN 2 4mdh_c05 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 2 # 1 B 158 ASP A 86 ASP^? 9.05 O1 EDO A 125 B 186 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo 44.53 16.44 28.54 44.89 18.45 28.77 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 48.32 20.00 31.44 46.45 20.91 31.50 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 4mdh_c05 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 2 # 2 B 158 ASP B 86 ASP^? 26.97 C1 EDO A 124 B 186 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo 44.53 16.44 28.54 44.89 18.45 28.77 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 48.32 20.00 31.44 46.45 20.91 31.50 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 4mdh_c05 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 2 hits 4mdh_c05 naa= 2 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 2 # 1 127 ARG A 30 ARG^? -2.97 O2 EDO A 124s 270 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 2 # 2 127 ARG A 37 ARG^? 13.77 O1 EDO A 124 270 GLU A 59 GLU.? 11.26 O1 EDO A 125 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -15.74 -47.56 -18.76 -16.21 -49.13 -20.10 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 2 # 3 127 ARG A 37 ARG^? 13.77 O1 EDO A 124 270 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 2 # 4 127 ARG B 30 ARG^? 10.56 O1 EDO A 124 270 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 5cpa_c00 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 4 hits 5cpa_c00 naa= 2 ULMN 2 5eat_c00 5-EPI-ARISTOLOCHENE SYNTHASE user 1 2 # 1 273 TRP A 80 TRP^? 10.72 O1 EDO A 125 527 TYR A 31 TYR^? 13.43 O2 EDO A 124 coo 117.04 37.52 43.58 116.69 37.55 47.50 -17.54 -42.16 -30.37 -20.99 -42.75 -28.58 coo 115.56 42.29 49.60 115.28 44.39 47.77 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 ULMN 2 5eat_c00 5-EPI-ARISTOLOCHENE SYNTHASE user 2 2 # 2 273 TRP B 80 TRP^? 20.31 C1 EDO A 124 527 TYR B 31 TYR^? 14.49 O1 EDO A 124 coo 117.04 37.52 43.58 116.69 37.55 47.50 -45.45 -26.13 -12.93 -44.30 -29.29 -14.98 coo 115.56 42.29 49.60 115.28 44.39 47.77 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 5eat_c00 source 5eat 5-EPI-ARISTOLOCHENE SYNTHASE : 2 hits 5eat_c00 naa= 2 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 1 2 # 1 242 LYS A 28 LYS^? 7.39 O2 EDO A 124 345 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 99.51 55.26 43.28 102.26 58.28 46.19 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 103.66 43.57 23.68 98.86 47.65 23.32 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 2 2 # 2 242 LYS B 28 LYS^? -17.65 O1 EDO A 124s 345 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 99.51 55.26 43.28 102.26 58.28 46.19 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 103.66 43.57 23.68 98.86 47.65 23.32 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 5enl_c03 source 5enl ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- D-GLYCERATE: 2 hits 5enl_c03 naa= 2 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 1 2 # 1 151 ASP A 84 ASP.? 13.20 O1 EDO A 125 277 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 25.08 13.39 65.77 24.68 15.22 66.73 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 24.99 20.41 57.94 24.48 20.83 59.94 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 2 2 # 2 151 ASP A 86 ASP^? 9.05 O1 EDO A 125 277 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo 25.08 13.39 65.77 24.68 15.22 66.73 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 24.99 20.41 57.94 24.48 20.83 59.94 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 3 2 # 3 151 ASP A 86 ASP^? 9.05 O1 EDO A 125 277 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo 25.08 13.39 65.77 24.68 15.22 66.73 -23.11 -50.07 -31.35 -22.48 -49.66 -33.33 coo 24.99 20.41 57.94 24.48 20.83 59.94 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 4 2 # 4 151 ASP B 41 ASP^? 12.31 O1 EDO A 124 277 GLU B 43 GLU.? 19.28 O2 EDO A 125 coo 25.08 13.39 65.77 24.68 15.22 66.73 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 24.99 20.41 57.94 24.48 20.83 59.94 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 5 2 # 5 151 ASP B 84 ASP.? 30.86 C1 EDO A 124 277 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 25.08 13.39 65.77 24.68 15.22 66.73 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 24.99 20.41 57.94 24.48 20.83 59.94 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 6 2 # 6 151 ASP B 86 ASP^? 26.97 C1 EDO A 124 277 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo 25.08 13.39 65.77 24.68 15.22 66.73 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 24.99 20.41 57.94 24.48 20.83 59.94 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 7 2 # 7 151 ASP B 86 ASP^? 26.97 C1 EDO A 124 277 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo 25.08 13.39 65.77 24.68 15.22 66.73 -49.36 -34.92 -12.06 -49.49 -34.12 -10.11 coo 24.99 20.41 57.94 24.48 20.83 59.94 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 7nn9_c00 source 7nn9 NEURAMINIDASE N9 : 7 hits 7nn9_c00 naa= 2 ULMN 2 7odc_c01 ORNITHINE DECARBOXYLASE user 1 2 # 1 A 197 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 274 GLU A 70 GLU^? 16.40 O1 EDO A 125 coo -14.36 14.33 -4.23 -14.32 12.27 -4.70 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -17.27 16.20 -10.72 -15.74 17.25 -9.63 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 ULMN 2 7odc_c01 ORNITHINE DECARBOXYLASE user 2 2 # 2 A 197 HIS A 79 HIS^? 12.23 O1 EDO A 125 A 274 GLU A 81 GLU.? 16.59 O1 EDO A 125 coo -14.36 14.33 -4.23 -14.32 12.27 -4.70 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 coo -17.27 16.20 -10.72 -15.74 17.25 -9.63 -16.00 -46.15 -38.38 -17.64 -47.22 -39.14 ULMN 2 7odc_c01 ORNITHINE DECARBOXYLASE user 3 2 # 3 A 197 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 274 GLU B 70 GLU^? 26.28 O1 EDO A 124 coo -14.36 14.33 -4.23 -14.32 12.27 -4.70 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -17.27 16.20 -10.72 -15.74 17.25 -9.63 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 ULMN 2 7odc_c01 ORNITHINE DECARBOXYLASE user 4 2 # 4 A 197 HIS B 79 HIS^? 26.86 C1 EDO A 124 A 274 GLU B 81 GLU.? 30.69 O1 EDO A 124 coo -14.36 14.33 -4.23 -14.32 12.27 -4.70 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 coo -17.27 16.20 -10.72 -15.74 17.25 -9.63 -49.73 -27.02 -4.93 -50.17 -29.00 -4.35 7odc_c01 source 7odc ORNITHINE DECARBOXYLASE : 4 hits 7odc_c01 naa= 2 ULMN 2 1a0h_p00 MEIZOTHROMBIN user 1 2 # 1 A 235 ASP A 64 ASP~? 20.53 O2 EDO A 124 A 236 GLN A 65 GLN~? 18.24 O1 EDO A 125 coo 80.56 14.43 9.14 80.22 13.74 11.11 -9.63 -36.32 -29.61 -8.64 -34.46 -29.79 coo 77.64 16.20 13.10 76.02 15.17 12.31 -10.34 -41.26 -29.26 -9.49 -42.98 -28.40 ULMN 2 1a0h_p00 MEIZOTHROMBIN user 2 2 # 2 A 235 ASP B 64 ASP~? 23.62 O1 EDO A 124 A 236 GLN B 65 GLN~? 25.71 C1 EDO A 124 coo 80.56 14.43 9.14 80.22 13.74 11.11 -44.68 -16.31 -13.41 -43.59 -14.49 -13.24 coo 77.64 16.20 13.10 76.02 15.17 12.31 -48.70 -19.66 -14.16 -50.49 -19.81 -15.35 1a0h_p00 source 1a0h MEIZOTHROMBIN : 2 hits 1a0h_p00 naa= 2 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 188 TYR A 31 TYR^? 13.43 O2 EDO A 124 A 190 SER A 35 SER.? 8.67 O1 EDO A 124 coo 37.69 7.64 13.51 38.82 8.84 16.11 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 47.14 12.10 13.73 48.75 12.33 16.01 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 43.77 6.93 15.46 45.49 7.21 17.11 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 2p3i_p00 source 2p3i VP4 : 1 hits 2p3i_p00 naa= 3 ULMN 2 2p3j_p00 VP4 user 1 2 # 1 A 188 TYR A 31 TYR^? 13.43 O2 EDO A 124 A 190 SER A 35 SER.? 8.67 O1 EDO A 124 coo 47.26 12.29 13.69 48.76 12.40 16.04 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 43.90 7.13 15.43 45.58 7.50 17.10 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 ULMN 2 2p3j_p00 VP4 user 2 2 # 2 A 188 TYR A 76 TYR.? 12.73 O1 EDO A 125 A 190 SER A 88 SER^? -5.03 C1 EDO A 125s coo 47.26 12.29 13.69 48.76 12.40 16.04 -34.39 -46.20 -32.52 -36.95 -45.73 -33.57 coo 43.90 7.13 15.43 45.58 7.50 17.10 -28.78 -47.83 -27.62 -30.92 -48.77 -27.01 ULMN 2 2p3j_p00 VP4 user 3 2 # 3 A 188 TYR B 76 TYR.? 17.92 O2 EDO A 125 A 190 SER B 88 SER^? 19.82 O2 EDO A 125 coo 47.26 12.29 13.69 48.76 12.40 16.04 -40.23 -42.56 -10.93 -38.32 -44.50 -10.26 coo 43.90 7.13 15.43 45.58 7.50 17.10 -44.76 -38.78 -15.84 -44.55 -41.13 -16.39 2p3j_p00 source 2p3j VP4 : 3 hits 2p3j_p00 naa= 2 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 44 ASN.? 12.85 O2 EDO A 124 A 384 ASN B 22 ASN.? 13.33 O2 EDO A 125 A 385 GLU B 23 GLU.? 12.57 O2 EDO A 125 coo 22.28 63.17 110.61 22.47 65.06 111.53 -40.16 -35.85 -30.25 -38.99 -36.20 -28.51 coo 7.06 50.07 96.17 8.50 48.54 96.31 -33.78 -50.89 -12.81 -33.60 -52.50 -11.46 coo 11.59 49.83 99.41 10.92 47.97 100.16 -37.28 -45.83 -14.10 -37.69 -47.33 -15.55 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 1 hits 2v3r_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 37 ARG^? 13.77 O1 EDO A 124 B 6 THR B 47 THR^? 9.39 O1 EDO A 124 B 8 THR A 47 THR^? 4.31 C1 EDO A 124 coo 40.52 16.08 100.90 37.97 16.41 102.60 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 36.11 13.64 95.03 34.54 14.86 95.91 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 32.72 8.05 92.39 31.25 9.11 91.35 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 1b01_d00 source 1b01 GENE REGULATION/DNA : 1 hits 1b01_d00 naa= 3 ULMN 2 1c9b_d00 TRANSCRIPTION/DNA user 1 2 # 1 M 283 VAL A 38 VAL^? 10.40 O2 EDO A 124 M 286 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo -16.31 9.66 78.56 -17.13 11.49 79.44 -22.90 -36.20 -25.23 -22.48 -38.06 -26.28 coo -13.19 9.14 75.65 -14.58 11.70 74.73 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 1c9b_d00 TRANSCRIPTION/DNA user 2 2 # 2 M 283 VAL B 38 VAL^? 13.01 C1 EDO A 124 M 286 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo -16.31 9.66 78.56 -17.13 11.49 79.44 -37.94 -27.56 -18.58 -39.85 -28.20 -17.77 coo -13.19 9.14 75.65 -14.58 11.70 74.73 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 1c9b_d00 source 1c9b TRANSCRIPTION/DNA : 2 hits 1c9b_d00 naa= 2 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 31 TYR^? 13.43 O2 EDO A 124 I 306 VAL A 38 VAL^? 10.40 O2 EDO A 124 I 308 VAL A 40 VAL^? 7.77 O2 EDO A 124 coo 26.18 35.24 6.87 24.33 35.18 8.97 -17.80 -35.20 -26.15 -16.47 -35.25 -23.71 coo 23.55 29.53 9.81 23.15 27.39 10.24 -22.90 -36.20 -25.23 -22.48 -38.06 -26.28 coo 16.43 30.18 9.35 15.05 30.67 11.01 -28.60 -35.61 -28.16 -28.72 -37.78 -28.22 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR B 31 TYR^? 14.49 O1 EDO A 124 I 306 VAL B 38 VAL^? 13.01 C1 EDO A 124 I 308 VAL B 40 VAL^? 13.65 C1 EDO A 124 coo 26.18 35.24 6.87 24.33 35.18 8.97 -39.54 -22.77 -17.56 -40.07 -21.56 -20.02 coo 23.55 29.53 9.81 23.15 27.39 10.24 -37.94 -27.56 -18.58 -39.85 -28.20 -17.77 coo 16.43 30.18 9.35 15.05 30.67 11.01 -34.56 -32.20 -15.54 -36.28 -33.47 -15.29 1cqt_d00 source 1cqt GENE REGULATION/DNA : 2 hits 1cqt_d00 naa= 3 ULMN 2 1egw_d00 TRANSCRIPTION/DNA user 1 2 # 1 B 3 ARG A 33 ARG.? 17.39 O2 EDO A 124 B 23 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo -9.35 -6.75 13.18 -8.87 -6.96 16.20 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo -4.82 6.94 7.68 -7.31 2.71 11.39 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1egw_d00 TRANSCRIPTION/DNA user 2 2 # 2 B 3 ARG A 37 ARG^? 13.77 O1 EDO A 124 B 23 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo -9.35 -6.75 13.18 -8.87 -6.96 16.20 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo -4.82 6.94 7.68 -7.31 2.71 11.39 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1egw_d00 TRANSCRIPTION/DNA user 3 2 # 3 B 3 ARG A 37 ARG^? 13.77 O1 EDO A 124 B 23 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo -9.35 -6.75 13.18 -8.87 -6.96 16.20 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo -4.82 6.94 7.68 -7.31 2.71 11.39 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 ULMN 2 1egw_d00 TRANSCRIPTION/DNA user 4 2 # 4 B 3 ARG B 33 ARG.? 19.94 O1 EDO A 124 B 23 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo -9.35 -6.75 13.18 -8.87 -6.96 16.20 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo -4.82 6.94 7.68 -7.31 2.71 11.39 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 ULMN 2 1egw_d00 TRANSCRIPTION/DNA user 5 2 # 5 B 3 ARG B 37 ARG^? 8.36 C1 EDO A 124 B 23 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo -9.35 -6.75 13.18 -8.87 -6.96 16.20 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo -4.82 6.94 7.68 -7.31 2.71 11.39 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1egw_d00 TRANSCRIPTION/DNA user 6 2 # 6 B 3 ARG B 37 ARG^? 8.36 C1 EDO A 124 B 23 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo -9.35 -6.75 13.18 -8.87 -6.96 16.20 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo -4.82 6.94 7.68 -7.31 2.71 11.39 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1egw_d00 source 1egw TRANSCRIPTION/DNA : 6 hits 1egw_d00 naa= 2 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 51 PRO~? 12.56 O2 EDO A 125 A 272 LEU A 54 LEU~? 11.35 O2 EDO A 125 A 276 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -22.81 -39.07 -17.47 -22.64 -38.62 -19.64 coo 10.97 0.43 16.73 11.31 2.11 18.06 -21.53 -43.50 -17.11 -21.49 -42.48 -15.18 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO A 52 PRO~? 11.69 O1 EDO A 125 A 272 LEU A 66 LEU~? 14.48 O1 EDO A 125 A 276 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -19.24 -39.24 -23.00 -20.61 -40.50 -21.76 coo 10.97 0.43 16.73 11.31 2.11 18.06 -15.97 -38.44 -26.63 -16.10 -39.71 -24.86 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 3 1emh_d00 HYDROLASE/DNA user 3 3 # 3 A 271 PRO B 52 PRO~? 14.52 C1 EDO A 124 A 272 LEU B 66 LEU~? 17.96 C1 EDO A 124 A 276 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -42.56 -25.03 -21.82 -42.59 -27.16 -22.47 coo 10.97 0.43 16.73 11.31 2.11 18.06 -43.15 -22.70 -16.79 -44.19 -23.46 -18.56 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 1emh_d00 source 1emh HYDROLASE/DNA : 3 hits 1emh_d00 naa= 3 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG A 30 ARG^? -2.97 O2 EDO A 124s C 71 LYS A 28 LYS^? 7.39 O2 EDO A 124 C 72 VAL A 40 VAL^? 7.77 O2 EDO A 124 coo 23.89 33.54 29.21 26.59 34.86 28.68 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 25.82 26.89 29.68 23.33 22.98 25.84 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 28.86 29.08 30.37 28.04 31.02 29.93 -28.60 -35.61 -28.16 -28.72 -37.78 -28.22 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 2 3 # 2 C 70 ARG B 30 ARG^? 10.56 O1 EDO A 124 C 71 LYS B 28 LYS^? -17.65 O1 EDO A 124s C 72 VAL B 40 VAL^? 13.65 C1 EDO A 124 coo 23.89 33.54 29.21 26.59 34.86 28.68 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 25.82 26.89 29.68 23.33 22.98 25.84 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 28.86 29.08 30.37 28.04 31.02 29.93 -34.56 -32.20 -15.54 -36.28 -33.47 -15.29 1hwt_d00 source 1hwt GENE REGULATION/DNA : 2 hits 1hwt_d00 naa= 3 ULMN 2 1kx5_d00 STRUCTURAL PROTEIN/DNA user 1 2 # 1 B 17 ARG A 33 ARG.? 17.39 O2 EDO A 124 B 45 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 85.67 104.47 25.60 87.75 106.18 24.18 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 63.66 119.10 3.70 63.57 121.27 5.89 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 1kx5_d00 STRUCTURAL PROTEIN/DNA user 2 2 # 2 B 17 ARG A 53 ARG~? 17.45 O1 EDO A 125 B 45 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 85.67 104.47 25.60 87.75 106.18 24.18 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 63.66 119.10 3.70 63.57 121.27 5.89 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 1kx5_d00 STRUCTURAL PROTEIN/DNA user 3 2 # 3 B 17 ARG B 33 ARG.? 19.94 O1 EDO A 124 B 45 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 85.67 104.47 25.60 87.75 106.18 24.18 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 63.66 119.10 3.70 63.57 121.27 5.89 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 1kx5_d00 STRUCTURAL PROTEIN/DNA user 4 2 # 4 B 17 ARG B 53 ARG~? 17.71 C1 EDO A 124 B 45 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 85.67 104.47 25.60 87.75 106.18 24.18 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 63.66 119.10 3.70 63.57 121.27 5.89 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 1kx5_d00 source 1kx5 STRUCTURAL PROTEIN/DNA : 4 hits 1kx5_d00 naa= 2 ULMN 2 1oup_d00 HYDROLASE/DNA user 1 2 # 1 A 72 ARG A 33 ARG.? 17.39 O2 EDO A 124 A 100 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 19.97 27.85 31.70 17.85 26.95 29.64 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 15.66 34.43 15.50 18.97 32.01 19.25 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 1oup_d00 HYDROLASE/DNA user 2 2 # 2 A 72 ARG B 25 ARG.? 18.77 O2 EDO A 125 A 100 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 19.97 27.85 31.70 17.85 26.95 29.64 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 15.66 34.43 15.50 18.97 32.01 19.25 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 ULMN 2 1oup_d00 HYDROLASE/DNA user 3 2 # 3 A 72 ARG B 33 ARG.? 19.94 O1 EDO A 124 A 100 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 19.97 27.85 31.70 17.85 26.95 29.64 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 15.66 34.43 15.50 18.97 32.01 19.25 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 1oup_d00 source 1oup HYDROLASE/DNA : 3 hits 1oup_d00 naa= 2 ULMN 2 2bnw_d00 DNA-BINDING/REGULATORY PROTEIN user 1 2 # 1 C 29 THR A 47 THR^? 4.31 C1 EDO A 124 C 31 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 34.25 12.25 21.93 34.58 12.95 19.89 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 coo 26.40 15.79 19.69 26.97 16.79 16.86 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 2bnw_d00 DNA-BINDING/REGULATORY PROTEIN user 2 2 # 2 C 29 THR A 99 THR~? 7.67 C2 EDO A 125 C 31 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo 34.25 12.25 21.93 34.58 12.95 19.89 -24.60 -55.51 -20.10 -23.07 -56.46 -21.32 coo 26.40 15.79 19.69 26.97 16.79 16.86 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 2bnw_d00 DNA-BINDING/REGULATORY PROTEIN user 3 2 # 3 C 29 THR B 47 THR^? 9.39 O1 EDO A 124 C 31 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 34.25 12.25 21.93 34.58 12.95 19.89 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 coo 26.40 15.79 19.69 26.97 16.79 16.86 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 2bnw_d00 source 2bnw DNA-BINDING/REGULATORY PROTEIN : 3 hits 2bnw_d00 naa= 2 ULMN 2 2f8n_d00 STRUCTURAL PROTEIN/DNA user 1 2 # 1 G1014 LYS A 28 LYS^? 7.39 O2 EDO A 124 G1042 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo -84.33 -13.90 85.53 -85.53 -20.01 86.48 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo -63.29 -26.20 76.78 -63.72 -25.66 79.76 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 2f8n_d00 STRUCTURAL PROTEIN/DNA user 2 2 # 2 G1014 LYS A 28 LYS^? 7.39 O2 EDO A 124 G1042 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -84.33 -13.90 85.53 -85.53 -20.01 86.48 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo -63.29 -26.20 76.78 -63.72 -25.66 79.76 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 2f8n_d00 STRUCTURAL PROTEIN/DNA user 3 2 # 3 G1014 LYS A 28 LYS^? 7.39 O2 EDO A 124 G1042 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo -84.33 -13.90 85.53 -85.53 -20.01 86.48 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo -63.29 -26.20 76.78 -63.72 -25.66 79.76 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 2f8n_d00 STRUCTURAL PROTEIN/DNA user 4 2 # 4 G1014 LYS A 28 LYS^? 7.39 O2 EDO A 124 G1042 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo -84.33 -13.90 85.53 -85.53 -20.01 86.48 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo -63.29 -26.20 76.78 -63.72 -25.66 79.76 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 2f8n_d00 STRUCTURAL PROTEIN/DNA user 5 2 # 5 G1014 LYS A 100 LYS~? 11.56 C2 EDO A 125 G1042 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -84.33 -13.90 85.53 -85.53 -20.01 86.48 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 coo -63.29 -26.20 76.78 -63.72 -25.66 79.76 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 2f8n_d00 STRUCTURAL PROTEIN/DNA user 6 2 # 6 G1014 LYS B 28 LYS^? -17.65 O1 EDO A 124s G1042 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -84.33 -13.90 85.53 -85.53 -20.01 86.48 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo -63.29 -26.20 76.78 -63.72 -25.66 79.76 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 2f8n_d00 STRUCTURAL PROTEIN/DNA user 7 2 # 7 G1014 LYS B 28 LYS^? -17.65 O1 EDO A 124s G1042 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo -84.33 -13.90 85.53 -85.53 -20.01 86.48 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo -63.29 -26.20 76.78 -63.72 -25.66 79.76 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 2f8n_d00 STRUCTURAL PROTEIN/DNA user 8 2 # 8 G1014 LYS B 28 LYS^? -17.65 O1 EDO A 124s G1042 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo -84.33 -13.90 85.53 -85.53 -20.01 86.48 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo -63.29 -26.20 76.78 -63.72 -25.66 79.76 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 2f8n_d00 source 2f8n STRUCTURAL PROTEIN/DNA : 8 hits 2f8n_d00 naa= 2 ULMN 2 2fio_d00 TRANSCRIPTION/DNA user 1 2 # 1 A 5 GLN B 74 GLN.? 24.11 O2 EDO A 125 A 6 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo 36.22 9.81 10.57 38.06 10.80 10.10 -39.96 -43.67 -5.29 -40.15 -43.70 -3.16 coo 37.83 5.78 14.80 40.45 4.78 13.50 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 2fio_d00 source 2fio TRANSCRIPTION/DNA : 1 hits 2fio_d00 naa= 2 ULMN 2 2jxi_d00 DNA BINDING PROTEIN, DNA user 1 2 # 1 B 50 THR A 82 THR.? 18.68 O1 EDO A 125 B 75 HIS A 79 HIS^? 12.23 O1 EDO A 125 coo -0.41 4.77 5.26 -2.32 5.64 4.71 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 coo -8.73 -0.98 4.47 -7.89 0.86 5.05 -21.34 -46.36 -35.23 -19.90 -47.56 -36.18 ULMN 2 2jxi_d00 DNA BINDING PROTEIN, DNA user 2 2 # 2 B 50 THR B 82 THR.? 29.24 O1 EDO A 124 B 75 HIS B 79 HIS^? 26.86 C1 EDO A 124 coo -0.41 4.77 5.26 -2.32 5.64 4.71 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 coo -8.73 -0.98 4.47 -7.89 0.86 5.05 -46.94 -31.68 -8.21 -48.72 -31.20 -7.20 2jxi_d00 source 2jxi DNA BINDING PROTEIN, DNA : 2 hits 2jxi_d00 naa= 2 ULMN 2 3aaf_d00 DNA BINDING PROTEIN/DNA user 1 2 # 1 B1037 PHE A 48 PHE^? 10.34 O2 EDO A 125 B1038 MET A 93 MET?? 10.81 O2 EDO A 125 coo 75.62 4.14 31.78 75.39 4.66 34.53 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 coo 76.36 2.57 26.22 76.80 5.66 26.74 -32.62 -43.10 -21.62 -33.95 -40.68 -24.94 ULMN 2 3aaf_d00 DNA BINDING PROTEIN/DNA user 2 2 # 2 B1037 PHE B 48 PHE^? 12.04 C1 EDO A 124 B1038 MET B 93 MET?? 13.65 O2 EDO A 125 coo 75.62 4.14 31.78 75.39 4.66 34.53 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 coo 76.36 2.57 26.22 76.80 5.66 26.74 -38.81 -39.61 -21.96 -36.01 -39.35 -18.74 ULMN 2 3aaf_d00 DNA BINDING PROTEIN/DNA user 3 2 # 3 B1037 PHE B 97 PHE.? 16.35 C1 EDO A 124 B1038 MET B 103 MET?? 21.79 C1 EDO A 124 coo 75.62 4.14 31.78 75.39 4.66 34.53 -44.93 -35.08 -25.21 -42.32 -35.38 -26.11 coo 76.36 2.57 26.22 76.80 5.66 26.74 -51.26 -35.87 -29.54 -48.31 -38.03 -27.58 3aaf_d00 source 3aaf DNA BINDING PROTEIN/DNA : 3 hits 3aaf_d00 naa= 2 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 1 2 # 1 C 11 ARG A 25 ARG.? 17.39 O2 EDO A 124 C 42 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 2 2 # 2 C 11 ARG A 25 ARG.? 17.39 O2 EDO A 124 C 42 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 3 2 # 3 C 11 ARG A 25 ARG.? 17.39 O2 EDO A 124 C 42 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 4 2 # 4 C 11 ARG A 25 ARG.? 17.39 O2 EDO A 124 C 42 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 5 2 # 5 C 11 ARG A 25 ARG.? 17.39 O2 EDO A 124 C 42 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 6 2 # 6 C 11 ARG A 30 ARG^? -2.97 O2 EDO A 124s C 42 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 7 2 # 7 C 11 ARG A 30 ARG^? -2.97 O2 EDO A 124s C 42 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 8 2 # 8 C 11 ARG A 30 ARG^? -2.97 O2 EDO A 124s C 42 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 9 2 # 9 C 11 ARG A 33 ARG.? 17.39 O2 EDO A 124 C 42 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 10 2 # 10 C 11 ARG A 33 ARG.? 17.39 O2 EDO A 124 C 42 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 11 2 # 11 C 11 ARG A 37 ARG^? 13.77 O1 EDO A 124 C 42 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 12 2 # 12 C 11 ARG A 53 ARG~? 17.45 O1 EDO A 125 C 42 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 13 2 # 13 C 11 ARG A 53 ARG~? 17.45 O1 EDO A 125 C 42 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 14 2 # 14 C 11 ARG A 53 ARG~? 17.45 O1 EDO A 125 C 42 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 15 2 # 15 C 11 ARG A 53 ARG~? 17.45 O1 EDO A 125 C 42 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 16 2 # 16 C 11 ARG A 106 ARG.? 12.91 O2 EDO A 125 C 42 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 17 2 # 17 C 11 ARG A 106 ARG.? 12.91 O2 EDO A 125 C 42 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 18 2 # 18 C 11 ARG B 25 ARG.? 18.77 O2 EDO A 125 C 42 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 19 2 # 19 C 11 ARG B 25 ARG.? 18.77 O2 EDO A 125 C 42 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 20 2 # 20 C 11 ARG B 25 ARG.? 18.77 O2 EDO A 125 C 42 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 21 2 # 21 C 11 ARG B 25 ARG.? 18.77 O2 EDO A 125 C 42 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 22 2 # 22 C 11 ARG B 25 ARG.? 18.77 O2 EDO A 125 C 42 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 23 2 # 23 C 11 ARG B 30 ARG^? 10.56 O1 EDO A 124 C 42 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 24 2 # 24 C 11 ARG B 30 ARG^? 10.56 O1 EDO A 124 C 42 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 25 2 # 25 C 11 ARG B 33 ARG.? 19.94 O1 EDO A 124 C 42 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 26 2 # 26 C 11 ARG B 37 ARG^? 8.36 C1 EDO A 124 C 42 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 27 2 # 27 C 11 ARG B 53 ARG~? 17.71 C1 EDO A 124 C 42 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 28 2 # 28 C 11 ARG B 53 ARG~? 17.71 C1 EDO A 124 C 42 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 29 2 # 29 C 11 ARG B 53 ARG~? 17.71 C1 EDO A 124 C 42 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 3azg_d00 STRUCTURAL PROTEIN/DNA user 30 2 # 30 C 11 ARG B 53 ARG~? 17.71 C1 EDO A 124 C 42 ARG B 25 ARG.? 18.77 O2 EDO A 125 coo -0.78 2.85 5.40 -0.95 -0.11 6.16 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo -22.18 -9.91 14.81 -21.67 -7.33 13.26 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 3azg_d00 source 3azg STRUCTURAL PROTEIN/DNA : 30 hits 3azg_d00 naa= 2 ULMN 2 3gfi_d00 TRANSCRIPTION/DNA user 1 2 # 1 A 86 ARG A 30 ARG^? -2.97 O2 EDO A 124s A 92 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 75.64 41.38 9.40 75.07 44.20 10.47 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 68.74 46.63 6.45 66.12 46.59 4.85 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 3gfi_d00 TRANSCRIPTION/DNA user 2 2 # 2 A 86 ARG A 33 ARG.? 17.39 O2 EDO A 124 A 92 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 75.64 41.38 9.40 75.07 44.20 10.47 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 coo 68.74 46.63 6.45 66.12 46.59 4.85 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 3gfi_d00 TRANSCRIPTION/DNA user 3 2 # 3 A 86 ARG A 37 ARG^? 13.77 O1 EDO A 124 A 92 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 75.64 41.38 9.40 75.07 44.20 10.47 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 coo 68.74 46.63 6.45 66.12 46.59 4.85 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 3gfi_d00 TRANSCRIPTION/DNA user 4 2 # 4 A 86 ARG A 53 ARG~? 17.45 O1 EDO A 125 A 92 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 75.64 41.38 9.40 75.07 44.20 10.47 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 coo 68.74 46.63 6.45 66.12 46.59 4.85 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 3gfi_d00 TRANSCRIPTION/DNA user 5 2 # 5 A 86 ARG B 30 ARG^? 10.56 O1 EDO A 124 A 92 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 75.64 41.38 9.40 75.07 44.20 10.47 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 68.74 46.63 6.45 66.12 46.59 4.85 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 3gfi_d00 TRANSCRIPTION/DNA user 6 2 # 6 A 86 ARG B 33 ARG.? 19.94 O1 EDO A 124 A 92 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 75.64 41.38 9.40 75.07 44.20 10.47 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 coo 68.74 46.63 6.45 66.12 46.59 4.85 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 3gfi_d00 TRANSCRIPTION/DNA user 7 2 # 7 A 86 ARG B 37 ARG^? 8.36 C1 EDO A 124 A 92 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 75.64 41.38 9.40 75.07 44.20 10.47 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 coo 68.74 46.63 6.45 66.12 46.59 4.85 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 3gfi_d00 TRANSCRIPTION/DNA user 8 2 # 8 A 86 ARG B 53 ARG~? 17.71 C1 EDO A 124 A 92 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 75.64 41.38 9.40 75.07 44.20 10.47 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 coo 68.74 46.63 6.45 66.12 46.59 4.85 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 3gfi_d00 source 3gfi TRANSCRIPTION/DNA : 8 hits 3gfi_d00 naa= 2 ULMN 2 3gx4_d00 DNA BINDING PROTEIN/DNA user 1 2 # 1 X 39 ARG A 106 ARG.? 12.91 O2 EDO A 125 X 40 GLN A 56 GLN.? 7.55 C1 EDO A 125 coo 30.78 -34.55 9.04 29.07 -36.88 7.60 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 coo 32.04 -29.42 12.94 31.80 -31.45 12.44 -19.66 -52.09 -22.06 -20.64 -53.94 -21.94 ULMN 2 3gx4_d00 DNA BINDING PROTEIN/DNA user 2 2 # 2 X 39 ARG B 25 ARG.? 18.77 O2 EDO A 125 X 40 GLN B 74 GLN.? 24.11 O2 EDO A 125 coo 30.78 -34.55 9.04 29.07 -36.88 7.60 -36.52 -42.46 -8.39 -34.07 -42.97 -6.57 coo 32.04 -29.42 12.94 31.80 -31.45 12.44 -39.96 -43.67 -5.29 -40.15 -43.70 -3.16 3gx4_d00 source 3gx4 DNA BINDING PROTEIN/DNA : 2 hits 3gx4_d00 naa= 2 ULMN 2 3o1t_d00 OXIDOREDUCTASE user 1 2 # 1 A 129 CYH A 67 CYH~? 14.35 O2 EDO A 124 A 161 ARG A 30 ARG^? -2.97 O2 EDO A 124s coo 3.14 -10.56 19.72 2.81 -13.30 19.92 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo 6.57 -10.78 11.64 6.13 -13.62 12.66 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 ULMN 2 3o1t_d00 OXIDOREDUCTASE user 2 2 # 2 A 129 CYH A 67 CYH~? 14.35 O2 EDO A 124 A 161 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 3.14 -10.56 19.72 2.81 -13.30 19.92 -16.46 -36.33 -30.73 -15.07 -34.22 -29.77 coo 6.57 -10.78 11.64 6.13 -13.62 12.66 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 3o1t_d00 OXIDOREDUCTASE user 3 2 # 3 A 129 CYH B 67 CYH~? 18.88 O1 EDO A 124 A 161 ARG B 30 ARG^? 10.56 O1 EDO A 124 coo 3.14 -10.56 19.72 2.81 -13.30 19.92 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo 6.57 -10.78 11.64 6.13 -13.62 12.66 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 ULMN 2 3o1t_d00 OXIDOREDUCTASE user 4 2 # 4 A 129 CYH B 67 CYH~? 18.88 O1 EDO A 124 A 161 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 3.14 -10.56 19.72 2.81 -13.30 19.92 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 coo 6.57 -10.78 11.64 6.13 -13.62 12.66 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 3o1t_d00 source 3o1t OXIDOREDUCTASE : 4 hits 3o1t_d00 naa= 2 ULMN 2 4a0b_d00 DNA BINDING PROTEIN/DNA user 1 2 # 1 A 197 LEU A 54 LEU~? 11.35 O2 EDO A 125 A 198 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 2.94 -58.19 -6.68 1.22 -59.24 -5.75 -21.53 -43.50 -17.11 -21.49 -42.48 -15.18 coo 6.54 -59.29 -1.18 8.32 -57.82 0.86 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 4a0b_d00 DNA BINDING PROTEIN/DNA user 2 2 # 2 A 197 LEU A 54 LEU~? 11.35 O2 EDO A 125 A 198 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 2.94 -58.19 -6.68 1.22 -59.24 -5.75 -21.53 -43.50 -17.11 -21.49 -42.48 -15.18 coo 6.54 -59.29 -1.18 8.32 -57.82 0.86 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 4a0b_d00 DNA BINDING PROTEIN/DNA user 3 2 # 3 A 197 LEU A 54 LEU~? 11.35 O2 EDO A 125 A 198 ARG A 106 ARG.? 12.91 O2 EDO A 125 coo 2.94 -58.19 -6.68 1.22 -59.24 -5.75 -21.53 -43.50 -17.11 -21.49 -42.48 -15.18 coo 6.54 -59.29 -1.18 8.32 -57.82 0.86 -18.96 -50.95 -13.67 -17.68 -48.53 -15.14 ULMN 2 4a0b_d00 DNA BINDING PROTEIN/DNA user 4 2 # 4 A 197 LEU A 58 LEU.? 9.87 O1 EDO A 125 A 198 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 2.94 -58.19 -6.68 1.22 -59.24 -5.75 -17.29 -44.63 -24.09 -18.05 -44.29 -26.14 coo 6.54 -59.29 -1.18 8.32 -57.82 0.86 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 4a0b_d00 DNA BINDING PROTEIN/DNA user 5 2 # 5 A 197 LEU A 66 LEU~? 14.48 O1 EDO A 125 A 198 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 2.94 -58.19 -6.68 1.22 -59.24 -5.75 -15.97 -38.44 -26.63 -16.10 -39.71 -24.86 coo 6.54 -59.29 -1.18 8.32 -57.82 0.86 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 4a0b_d00 DNA BINDING PROTEIN/DNA user 6 2 # 6 A 197 LEU A 66 LEU~? 14.48 O1 EDO A 125 A 198 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 2.94 -58.19 -6.68 1.22 -59.24 -5.75 -15.97 -38.44 -26.63 -16.10 -39.71 -24.86 coo 6.54 -59.29 -1.18 8.32 -57.82 0.86 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 4a0b_d00 DNA BINDING PROTEIN/DNA user 7 2 # 7 A 197 LEU A 89 LEU~? 8.99 O1 EDO A 125 A 198 ARG A 25 ARG.? 17.39 O2 EDO A 124 coo 2.94 -58.19 -6.68 1.22 -59.24 -5.75 -31.04 -43.51 -28.26 -31.53 -41.41 -28.05 coo 6.54 -59.29 -1.18 8.32 -57.82 0.86 -36.33 -42.91 -35.14 -37.90 -40.94 -36.97 ULMN 2 4a0b_d00 DNA BINDING PROTEIN/DNA user 8 2 # 8 A 197 LEU B 54 LEU~? 14.98 C1 EDO A 124 A 198 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 2.94 -58.19 -6.68 1.22 -59.24 -5.75 -44.12 -30.81 -26.43 -43.06 -31.04 -28.33 coo 6.54 -59.29 -1.18 8.32 -57.82 0.86 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 4a0b_d00 DNA BINDING PROTEIN/DNA user 9 2 # 9 A 197 LEU B 58 LEU.? 19.52 C1 EDO A 124 A 198 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 2.94 -58.19 -6.68 1.22 -59.24 -5.75 -47.35 -27.17 -19.69 -46.30 -27.92 -17.93 coo 6.54 -59.29 -1.18 8.32 -57.82 0.86 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 ULMN 2 4a0b_d00 DNA BINDING PROTEIN/DNA user 10 2 # 10 A 197 LEU B 66 LEU~? 17.96 C1 EDO A 124 A 198 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 2.94 -58.19 -6.68 1.22 -59.24 -5.75 -43.15 -22.70 -16.79 -44.19 -23.46 -18.56 coo 6.54 -59.29 -1.18 8.32 -57.82 0.86 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 4a0b_d00 DNA BINDING PROTEIN/DNA user 11 2 # 11 A 197 LEU B 66 LEU~? 17.96 C1 EDO A 124 A 198 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 2.94 -58.19 -6.68 1.22 -59.24 -5.75 -43.15 -22.70 -16.79 -44.19 -23.46 -18.56 coo 6.54 -59.29 -1.18 8.32 -57.82 0.86 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 4a0b_d00 source 4a0b DNA BINDING PROTEIN/DNA : 11 hits 4a0b_d00 naa= 2 ULMN 2 4av1_d00 TRANSFERASE user 1 2 # 1 A 16 SER A 34 SER.? 10.92 O1 EDO A 124 A 18 ARG A 33 ARG.? 17.39 O2 EDO A 124 coo 11.59 -11.82 19.62 13.22 -10.05 19.96 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo 17.80 -8.92 20.54 20.05 -8.13 22.58 -13.24 -30.66 -26.46 -11.23 -31.73 -28.50 ULMN 2 4av1_d00 TRANSFERASE user 2 2 # 2 A 16 SER A 35 SER.? 8.67 O1 EDO A 124 A 18 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 11.59 -11.82 19.62 13.22 -10.05 19.96 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo 17.80 -8.92 20.54 20.05 -8.13 22.58 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 2 4av1_d00 TRANSFERASE user 3 2 # 3 A 16 SER A 62 SER~? 19.90 O1 EDO A 125 A 18 ARG A 53 ARG~? 17.45 O1 EDO A 125 coo 11.59 -11.82 19.62 13.22 -10.05 19.96 -10.44 -39.22 -24.93 -9.30 -39.10 -27.06 coo 17.80 -8.92 20.54 20.05 -8.13 22.58 -14.38 -40.26 -19.61 -13.64 -37.85 -21.39 ULMN 2 4av1_d00 TRANSFERASE user 4 2 # 4 A 16 SER B 34 SER.? 9.94 O1 EDO A 124 A 18 ARG B 33 ARG.? 19.94 O1 EDO A 124 coo 11.59 -11.82 19.62 13.22 -10.05 19.96 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 coo 17.80 -8.92 20.54 20.05 -8.13 22.58 -38.02 -16.52 -17.05 -40.13 -15.36 -15.15 ULMN 2 4av1_d00 TRANSFERASE user 5 2 # 5 A 16 SER B 35 SER.? 7.36 O1 EDO A 124 A 18 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 11.59 -11.82 19.62 13.22 -10.05 19.96 -33.90 -21.70 -23.70 -33.48 -23.60 -22.25 coo 17.80 -8.92 20.54 20.05 -8.13 22.58 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 ULMN 2 4av1_d00 TRANSFERASE user 6 2 # 6 A 16 SER B 62 SER~? 23.65 O1 EDO A 124 A 18 ARG B 53 ARG~? 17.71 C1 EDO A 124 coo 11.59 -11.82 19.62 13.22 -10.05 19.96 -46.80 -18.27 -18.25 -47.35 -17.46 -16.02 coo 17.80 -8.92 20.54 20.05 -8.13 22.58 -46.71 -22.81 -24.44 -44.72 -21.34 -22.56 4av1_d00 source 4av1 TRANSFERASE : 6 hits 4av1_d00 naa= 2 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 78 ARG A 30 ARG^? -2.97 O2 EDO A 124s A 82 LYS A 28 LYS^? 7.39 O2 EDO A 124 A 97 ARG A 37 ARG^? 13.77 O1 EDO A 124 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -23.15 -30.49 -30.18 -25.43 -29.17 -28.55 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -22.85 -35.16 -19.08 -21.11 -34.86 -16.48 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 78 ARG B 30 ARG^? 10.56 O1 EDO A 124 A 82 LYS B 28 LYS^? -17.65 O1 EDO A 124s A 97 ARG B 37 ARG^? 8.36 C1 EDO A 124 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -32.75 -24.83 -13.79 -30.54 -26.25 -15.42 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -36.51 -26.95 -24.45 -36.69 -25.29 -27.04 4er8_d00 source 4er8 DNA BINDING PROTEIN/DNA : 2 hits 4er8_d00 naa= 3 ULMN 2 4g92_d01 TRANSCRIPTION/DNA user 1 2 # 1 B 51 ALA A 49 ALA^? 7.86 C1 EDO A 124 B 66 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 39.86 -30.00 -40.76 38.60 -29.19 -40.47 -27.58 -35.61 -22.27 -27.19 -34.24 -21.71 coo 48.71 -26.46 -51.44 46.36 -23.54 -56.56 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 ULMN 2 4g92_d01 TRANSCRIPTION/DNA user 2 2 # 2 B 51 ALA A 68 ALA.? 16.39 O1 EDO A 125 B 66 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 39.86 -30.00 -40.76 38.60 -29.19 -40.47 -16.63 -39.03 -33.40 -15.61 -40.17 -33.58 coo 48.71 -26.46 -51.44 46.36 -23.54 -56.56 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 4g92_d01 TRANSCRIPTION/DNA user 3 2 # 3 B 51 ALA A 94 ALA~? 7.26 O2 EDO A 125 B 66 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 39.86 -30.00 -40.76 38.60 -29.19 -40.47 -33.85 -46.06 -19.52 -34.14 -47.43 -20.08 coo 48.71 -26.46 -51.44 46.36 -23.54 -56.56 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 ULMN 2 4g92_d01 TRANSCRIPTION/DNA user 4 2 # 4 B 51 ALA A 107 ALA.? 20.71 C2 EDO A 125 B 66 LYS A 100 LYS~? 11.56 C2 EDO A 125 coo 39.86 -30.00 -40.76 38.60 -29.19 -40.47 -16.42 -54.53 -7.60 -16.03 -56.00 -7.26 coo 48.71 -26.46 -51.44 46.36 -23.54 -56.56 -25.42 -56.72 -16.60 -31.34 -56.90 -14.61 ULMN 2 4g92_d01 TRANSCRIPTION/DNA user 5 2 # 5 B 51 ALA B 49 ALA^? 7.26 C1 EDO A 124 B 66 LYS A 28 LYS^? 7.39 O2 EDO A 124 coo 39.86 -30.00 -40.76 38.60 -29.19 -40.47 -35.14 -31.27 -21.36 -34.12 -30.27 -21.87 coo 48.71 -26.46 -51.44 46.36 -23.54 -56.56 -28.32 -34.86 -33.86 -29.06 -28.94 -36.08 ULMN 2 4g92_d01 TRANSCRIPTION/DNA user 6 2 # 6 B 51 ALA B 68 ALA.? 23.26 O1 EDO A 124 B 66 LYS B 28 LYS^? -17.65 O1 EDO A 124s coo 39.86 -30.00 -40.76 38.60 -29.19 -40.47 -43.26 -23.68 -10.03 -44.76 -23.42 -9.87 coo 48.71 -26.46 -51.44 46.36 -23.54 -56.56 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 4g92_d01 source 4g92 TRANSCRIPTION/DNA : 6 hits 4g92_d01 naa= 2 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER B 35 SER.? 7.36 O1 EDO A 124 A 166 PHE B 50 PHE^? 13.90 C1 EDO A 124 A 182 PHE B 48 PHE^? 12.04 C1 EDO A 124 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -33.90 -21.70 -23.70 -33.48 -23.60 -22.25 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 1 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER B 35 SER.? 7.36 O1 EDO A 124 B 166 PHE B 50 PHE^? 13.90 C1 EDO A 124 B 182 PHE B 48 PHE^? 12.04 C1 EDO A 124 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -33.90 -21.70 -23.70 -33.48 -23.60 -22.25 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 1 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER B 35 SER.? 7.36 O1 EDO A 124 C 166 PHE B 50 PHE^? 13.90 C1 EDO A 124 C 182 PHE B 48 PHE^? 12.04 C1 EDO A 124 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -33.90 -21.70 -23.70 -33.48 -23.60 -22.25 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 1 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 35 SER.? 8.67 O1 EDO A 124 D 166 PHE A 50 PHE^? 8.88 O1 EDO A 125 D 182 PHE A 48 PHE^? 10.34 O2 EDO A 125 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -25.34 -40.24 -22.63 -24.26 -40.99 -25.13 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -30.93 -38.41 -23.20 -29.91 -40.39 -21.53 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER B 35 SER.? 7.36 O1 EDO A 124 D 166 PHE B 50 PHE^? 13.90 C1 EDO A 124 D 182 PHE B 48 PHE^? 12.04 C1 EDO A 124 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -33.90 -21.70 -23.70 -33.48 -23.60 -22.25 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -40.20 -31.46 -21.33 -41.48 -31.09 -18.84 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -35.79 -35.63 -20.60 -37.94 -35.83 -22.37 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 2 hits 2r11_o03 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 70 GLU^? 16.40 O1 EDO A 125 A 44 ASP A 84 ASP.? 13.20 O1 EDO A 125 A 50 THR A 82 THR.? 18.68 O1 EDO A 125 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU B 43 GLU.? 19.28 O2 EDO A 125 A 44 ASP B 41 ASP^? 12.31 O1 EDO A 124 A 50 THR B 47 THR^? 9.39 O1 EDO A 124 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -30.51 -39.33 -8.01 -32.05 -40.04 -6.75 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 3hde_o00 source 3HDE LYSOZYME : 2 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 70 GLU^? 16.40 O1 EDO A 125 B 44 ASP A 84 ASP.? 13.20 O1 EDO A 125 B 50 THR A 82 THR.? 18.68 O1 EDO A 125 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU B 70 GLU^? 26.28 O1 EDO A 124 B 44 ASP B 84 ASP.? 30.86 C1 EDO A 124 B 50 THR B 82 THR.? 29.24 O1 EDO A 124 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 3hde_o01 source 3HDE LYSOZYME : 2 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 70 GLU^? 16.40 O1 EDO A 125 C 44 ASP A 84 ASP.? 13.20 O1 EDO A 125 C 50 THR A 82 THR.? 18.68 O1 EDO A 125 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -20.78 -40.93 -37.02 -20.07 -42.22 -38.56 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 25.48 4.87 1.60 23.90 4.95 0.15 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU B 70 GLU^? 26.28 O1 EDO A 124 C 44 ASP B 84 ASP.? 30.86 C1 EDO A 124 C 50 THR B 82 THR.? 29.24 O1 EDO A 124 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -42.61 -28.49 -6.30 -44.11 -28.60 -4.83 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 25.48 4.87 1.60 23.90 4.95 0.15 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 3hde_o02 source 3HDE LYSOZYME : 2 hits 3hde_o02 naa= 3 ULMN 2 3hde_o03 LYSOZYME user 1 2 # 1 D 44 ASP A 41 ASP^? -2.91 O2 EDO A 124s D 50 THR A 47 THR^? 4.31 C1 EDO A 124 coo 21.14 2.63 -8.02 19.80 2.68 -9.68 -30.95 -32.49 -30.99 -29.58 -31.06 -30.32 coo 25.02 -1.03 -10.60 24.75 1.10 -10.80 -32.95 -33.12 -25.53 -31.82 -31.29 -25.77 ULMN 2 3hde_o03 LYSOZYME user 2 2 # 2 D 44 ASP A 84 ASP.? 13.20 O1 EDO A 125 D 50 THR A 82 THR.? 18.68 O1 EDO A 125 coo 21.14 2.63 -8.02 19.80 2.68 -9.68 -15.37 -51.13 -32.78 -16.55 -52.78 -33.34 coo 25.02 -1.03 -10.60 24.75 1.10 -10.80 -12.90 -46.31 -34.92 -11.19 -45.02 -35.26 ULMN 2 3hde_o03 LYSOZYME user 3 2 # 3 D 44 ASP B 41 ASP^? 12.31 O1 EDO A 124 D 50 THR B 47 THR^? 9.39 O1 EDO A 124 coo 21.14 2.63 -8.02 19.80 2.68 -9.68 -30.48 -32.41 -13.05 -30.04 -30.54 -13.91 coo 25.02 -1.03 -10.60 24.75 1.10 -10.80 -30.27 -34.63 -18.25 -29.31 -32.68 -18.02 ULMN 2 3hde_o03 LYSOZYME user 4 2 # 4 D 44 ASP B 84 ASP.? 30.86 C1 EDO A 124 D 50 THR B 82 THR.? 29.24 O1 EDO A 124 coo 21.14 2.63 -8.02 19.80 2.68 -9.68 -54.21 -28.97 -10.66 -54.93 -30.88 -10.14 coo 25.02 -1.03 -10.60 24.75 1.10 -10.80 -51.26 -24.31 -8.54 -50.96 -22.21 -8.11 3hde_o03 source 3HDE LYSOZYME : 4 hits 3hde_o03 naa= 2 ULMN 2 3o4g_o01 ACYLAMINO-ACID-RELEASING ENZYME user 1 2 # 1 B 445 SER A 34 SER.? 10.92 O1 EDO A 124 B 524 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -12.54 -12.66 -2.73 -13.74 -14.77 -2.32 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo -2.46 -15.93 -4.29 -3.78 -17.32 -3.34 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 3o4g_o01 ACYLAMINO-ACID-RELEASING ENZYME user 2 2 # 2 B 445 SER A 35 SER.? 8.67 O1 EDO A 124 B 524 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -12.54 -12.66 -2.73 -13.74 -14.77 -2.32 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo -2.46 -15.93 -4.29 -3.78 -17.32 -3.34 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 3o4g_o01 ACYLAMINO-ACID-RELEASING ENZYME user 3 2 # 3 B 445 SER B 34 SER.? 9.94 O1 EDO A 124 B 524 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -12.54 -12.66 -2.73 -13.74 -14.77 -2.32 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 coo -2.46 -15.93 -4.29 -3.78 -17.32 -3.34 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 3o4g_o01 ACYLAMINO-ACID-RELEASING ENZYME user 4 2 # 4 B 445 SER B 35 SER.? 7.36 O1 EDO A 124 B 524 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -12.54 -12.66 -2.73 -13.74 -14.77 -2.32 -33.90 -21.70 -23.70 -33.48 -23.60 -22.25 coo -2.46 -15.93 -4.29 -3.78 -17.32 -3.34 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 3o4g_o01 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 4 hits 3o4g_o01 naa= 2 ULMN 2 3o4g_o03 ACYLAMINO-ACID-RELEASING ENZYME user 1 2 # 1 D 445 SER A 34 SER.? 10.92 O1 EDO A 124 D 524 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -21.22 29.97 46.24 -19.61 31.88 46.01 -17.26 -28.12 -21.59 -18.39 -26.11 -20.84 coo -18.89 26.14 55.97 -17.47 27.48 55.08 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 3o4g_o03 ACYLAMINO-ACID-RELEASING ENZYME user 2 2 # 2 D 445 SER A 35 SER.? 8.67 O1 EDO A 124 D 524 ASP A 63 ASP~? 17.25 O1 EDO A 124 coo -21.22 29.97 46.24 -19.61 31.88 46.01 -19.76 -30.33 -19.75 -21.66 -30.91 -21.11 coo -18.89 26.14 55.97 -17.47 27.48 55.08 -12.06 -34.63 -25.15 -12.54 -34.29 -23.12 ULMN 2 3o4g_o03 ACYLAMINO-ACID-RELEASING ENZYME user 3 2 # 3 D 445 SER B 34 SER.? 9.94 O1 EDO A 124 D 524 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -21.22 29.97 46.24 -19.61 31.88 46.01 -33.53 -18.42 -21.75 -31.18 -18.44 -22.38 coo -18.89 26.14 55.97 -17.47 27.48 55.08 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 ULMN 2 3o4g_o03 ACYLAMINO-ACID-RELEASING ENZYME user 4 2 # 4 D 445 SER B 35 SER.? 7.36 O1 EDO A 124 D 524 ASP B 63 ASP~? 17.37 O1 EDO A 124 coo -21.22 29.97 46.24 -19.61 31.88 46.01 -33.90 -21.70 -23.70 -33.48 -23.60 -22.25 coo -18.89 26.14 55.97 -17.47 27.48 55.08 -42.00 -17.28 -18.02 -41.30 -17.50 -20.04 3o4g_o03 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 4 hits 3o4g_o03 naa= 2 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 1 3 # 1 H 28 VAL B 38 VAL^? 13.01 C1 EDO A 124 H 117 LYS B 28 LYS^? -17.65 O1 EDO A 124s H 150 CYH B 67 CYH~? 18.88 O1 EDO A 124 coo 45.82 27.58 23.40 45.30 28.87 21.66 -37.94 -27.56 -18.58 -39.85 -28.20 -17.77 coo 38.01 32.08 28.20 39.46 29.85 23.57 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 41.19 29.62 18.76 39.21 28.51 20.32 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 2 3 # 2 H 28 VAL B 69 VAL.? 19.16 O1 EDO A 124 H 117 LYS B 28 LYS^? -17.65 O1 EDO A 124s H 150 CYH B 67 CYH~? 18.88 O1 EDO A 124 coo 45.82 27.58 23.40 45.30 28.87 21.66 -42.17 -27.20 -11.15 -40.62 -28.02 -12.49 coo 38.01 32.08 28.20 39.46 29.85 23.57 -33.73 -31.52 -9.87 -27.90 -29.61 -8.14 coo 41.19 29.62 18.76 39.21 28.51 20.32 -41.11 -22.14 -12.69 -40.26 -19.73 -13.32 3uao_o07 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o07 naa= 3